
<html lang="en"     class="pb-page"  data-request-id="cf3ac769-2894-4a59-a2e4-7c266090a0f1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b01499;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-15;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility" /></meta><meta name="dc.Creator" content="Nurulain T.  Zaveri" /></meta><meta name="dc.Description" content="In the two decades since the discovery of the nociceptin opioid receptor (NOP) and its ligand, nociceptin/orphaninFQ (N/OFQ), steady progress has been achieved in understanding the pharmacology of ..." /></meta><meta name="Description" content="In the two decades since the discovery of the nociceptin opioid receptor (NOP) and its ligand, nociceptin/orphaninFQ (N/OFQ), steady progress has been achieved in understanding the pharmacology of ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 14, 2016" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01499" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01499" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01499" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01499" /></link>
        
    
    

<title>Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01499" /></meta><meta property="og:title" content="Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0004.jpeg" /></meta><meta property="og:description" content="In the two decades since the discovery of the nociceptin opioid receptor (NOP) and its ligand, nociceptin/orphaninFQ (N/OFQ), steady progress has been achieved in understanding the pharmacology of this fourth opioid receptor/peptide system, aided by genetic and pharmacologic approaches. This research spawned an explosion of small-molecule NOP receptor ligands from discovery programs in major pharmaceutical companies. NOP agonists have been investigated for their efficacy in preclinical models of anxiety, cough, substance abuse, pain (spinal and peripheral), and urinary incontinence, whereas NOP antagonists have been investigated for treatment of pain, depression, and motor symptoms in Parkinson’s disease. Translation of preclinical findings into the clinic is guided by PET and receptor occupancy studies, particularly for NOP antagonists. Recent progress in preclinical NOP research suggests that NOP agonists may have clinical utility for pain treatment and substance abuse pharmacotherapy. This review discusses the progress toward validating the NOP–N/OFQ system as a therapeutic target." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01499"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01499">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01499&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01499&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01499&amp;href=/doi/10.1021/acs.jmedchem.5b01499" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 7011-7028</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01338" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b01813" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nurulain+T.++Zaveri">Nurulain T. Zaveri</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Astraea Therapeutics, 320 Logue Avenue, Suite 142, Mountain View, California 94043, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 650-254-0786. Fax: 650-254-0787. E-mail: <a href="/cdn-cgi/l/email-protection#4d23383f38212c24230d2c3e393f2c282c3925283f2c3d283839242e3e632e2220"><span class="__cf_email__" data-cfemail="88e6fdfafde4e9e1e6c8e9fbfcfae9ede9fce0edfae9f8edfdfce1ebfba6ebe7e5">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01499&amp;href=/doi/10.1021%2Facs.jmedchem.5b01499" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 7011–7028</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 15, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 September 2015</li><li><span class="item_label"><b>Published</b> online</span>14 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01499" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01499</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7011%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNurulain%2BT.%2BZaveri%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D15%26contentID%3Dacs.jmedchem.5b01499%26title%3DNociceptin%2BOpioid%2BReceptor%2B%2528NOP%2529%2Bas%2Ba%2BTherapeutic%2BTarget%253A%2BProgress%2Bin%2BTranslation%2Bfrom%2BPreclinical%2BResearch%2Bto%2BClinical%2BUtility%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7028%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01499"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1877</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01499" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nurulain&quot;,&quot;last_name&quot;:&quot;T. Zaveri&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7011-7028&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01499&quot;},&quot;abstract&quot;:&quot;In the two decades since the discovery of the nociceptin opioid receptor (NOP) and its ligand, nociceptin/orphaninFQ (N/OFQ), steady progress has been achieved in understanding the pharmacology of this fourth opioid receptor/peptide system, aided by genetic and pharmacologic approaches. This research spawned an explosion of small-molecule NOP receptor ligands from discovery programs in major pharmaceutical companies. NOP agonists have been investigated for their efficacy in preclinical models of anxiety, cough, substance abuse, pain (spinal and peripheral), and urinary incontinence, whereas NOP antagonists have been investigated for treatment of pain, depression, and motor symptoms in Parkinson’s disease. Translation of preclinical findings into the clinic is guided by PET and receptor occupancy studies, particularly for NOP antagonists. Recent progress in preclinical NOP research suggests that NOP agonists may have clinical utility for pain treatment and substance abuse pharmacotherapy. This review discusses&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01499&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01499" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01499&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01499" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01499&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01499" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01499&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01499&amp;href=/doi/10.1021/acs.jmedchem.5b01499" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01499" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01499" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01499%26sid%3Dliteratum%253Aachs%26pmid%3D26878436%26genre%3Darticle%26aulast%3DZaveri%26date%3D2016%26atitle%3DNociceptin%2BOpioid%2BReceptor%2B%2528NOP%2529%2Bas%2Ba%2BTherapeutic%2BTarget%253A%2BProgress%2Bin%2BTranslation%2Bfrom%2BPreclinical%2BResearch%2Bto%2BClinical%2BUtility%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D15%26spage%3D7011%26epage%3D7028%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/jmcmar.2016.59.issue-15/20160811-01/jmcmar.2016.59.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In the two decades since the discovery of the nociceptin opioid receptor (NOP) and its ligand, nociceptin/orphaninFQ (N/OFQ), steady progress has been achieved in understanding the pharmacology of this fourth opioid receptor/peptide system, aided by genetic and pharmacologic approaches. This research spawned an explosion of small-molecule NOP receptor ligands from discovery programs in major pharmaceutical companies. NOP agonists have been investigated for their efficacy in preclinical models of anxiety, cough, substance abuse, pain (spinal and peripheral), and urinary incontinence, whereas NOP antagonists have been investigated for treatment of pain, depression, and motor symptoms in Parkinson’s disease. Translation of preclinical findings into the clinic is guided by PET and receptor occupancy studies, particularly for NOP antagonists. Recent progress in preclinical NOP research suggests that NOP agonists may have clinical utility for pain treatment and substance abuse pharmacotherapy. This review discusses the progress toward validating the NOP–N/OFQ system as a therapeutic target.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The nociceptin opioid peptide receptor (NOP) was discovered in 1994 after cloning of the other three opioid receptors μ, δ, and κ (MOP, DOP, and KOP in IUPHAR nomenclature).<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> The characterization that rapidly followed clearly placed the NOP receptor (previously named the opioid receptor-like receptor 1, ORL-1) in the opioid receptor family of GPCRs, which couples to Gi/Go and inhibits adenylate cyclase activity. These properties informed the quest for an endogenous ligand for this ‘then orphan’ opioid receptor and a year later resulted in the successful identification, by two independent groups, of a heptadecapeptide from rat and porcine brains, which was named nociceptin and orphanin FQ, respectively.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> This neuropeptide, henceforth referred to as N/OFQ, has a high degree of similarity with the heptadecapeptide dynorphin, an endogenous neuropeptide that binds the κ opioid receptor. It is therefore remarkable that N/OFQ has a 1000-fold lower affinity for the κ opioid receptor than for NOP.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Further, N/OFQ has no measurable affinity for the μ or δ opioid receptors. While both the NOP receptor and its endogenous ligand N/OFQ have structural and functional similarity to the other three opioid receptors and their respective endogenous ligands, the NOP receptor does not bind classical opioid ligands, whereas the NOP ligand N/OFQ does not bind to other opioid receptors, making the NOP–N/OFQ receptor–ligand system a class in itself, distinct from the opioid family in several important ways.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">NOP–N/OFQ Receptor–Ligand System</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the two decades since its discovery, the study of NOP–N/OFQ pharmacology revealed similarities and differences of this system from the opioid receptor family and continues to be actively pursued in the hope that the NOP receptor can be a valuable therapeutic target for pharmacotherapy of various human conditions, provided that suitable NOP receptor-targeted compounds can be developed. The importance of the NOP–N/OFQ system in physiological processes is suggested by its widespread distribution in the brain, spinal cord, and peripheral organs. Under normal homeostatic conditions, the endogenous peptide N/OFQ functions primarily as an inhibitory neurotransmitter, acting via the NOP receptor, to suppress cellular neuronal activity and release of other neurotransmitters.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This functional activity may provide a balance with other excitatory systems to maintain a homeostatic state of a physiological process. At the molecular level, N/OFQ actions at the NOP receptor results in inhibition of adenylate cyclase, increase in K<sup>+</sup> conductance (which leads to hyperpolarization in neuronal cells), and inhibition of Ca<sup>2+</sup> conductance.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, dysregulation of the NOP–N/OFQ system has been shown for many pathophysiological states, justifying the interest in this system as a potential therapeutic target in these disease states. Examples of disease states where the NOP–N/OFQ system is upregulated are the development of chronic pain, Parkinson’s disease, and depression. For instance, NOP receptor mRNA is upregulated in various regions of the brain and spinal cord in rats after induction of chronic constriction injury, a model of neuropathic pain.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> Interestingly, both NOP receptor protein and N/OFQ immunoreactivity were increased in rats with inflammatory pain induced by Complete Freund’s adjuvant (CFA) and intrathecal administration of N/OFQ decreased inflammatory pain markers.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> The significance of the NOP receptor as a target for pain therapeutics is on the verge of clinical validation (as discussed below), but target validation thus far has been riddled with complexities arising from species differences and site-specific pharmacology. N/OFQ levels were found to be elevated in the cerebrospinal fluid of parkinsonian patients,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> providing the first clinical evidence implicating N/OFQ upregulation in the pathophysiology of Parkinson’s disease in humans. These findings suggest a rationale for developing NOP receptor antagonists as antiparkinsonian drugs.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a></div><div class="NLM_p">Alternatively, the NOP–N/OFQ system may be activated (using NOP agonists) to provide inhibitory control over physiological processes errantly upregulated during disease states. For example, most drugs of abuse (such as opioids, nicotine, cocaine, and even alcohol) cause an increase in dopamine levels in the nucleus accumbens, an area of the brain that is the nexus of the brain reward circuitry.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Exogenous administration of N/OFQ suppresses basal and drug-induced dopamine release in the nucleus accumbens,<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> a phenomenon known to decrease the rewarding effects of abused drugs.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30">(26-30)</a> NOP agonists, therefore, would be potentially useful as medications for drug abuse.</div><div class="NLM_p">The widespread distribution of the NOP receptor and N/OFQ throughout the central nervous system (CNS) and in many peripheral organs is now well documented from studies in rodents, non-human primates and humans. However, the involvement of the NOP system in disease states has been mainly obtained from rodent studies. Further, the majority of studies to understand the pharmacology of NOP receptor have been carried out in rodents. A caveat that is unfolding as the NOP receptor is being vetted as a human clinical target is that there are significant differences in the pharmacological effects of NOP ligands in rodents, compared to those in non-human primates and possibly humans, that need to be carefully considered and that impact the success of preclinical advancement of suitable drug candidates and selection of clinical end points. Studies on localization of the NOP system in the rodent,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> primate,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> and human brain<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> suggest that there are important differences in the distribution and localization of the NOP–N/OFQ system between species that may play a significant role in translating the validation of this system as a potential target for different pathophysiological states.</div><div class="NLM_p last">This review attempts to correlate and compare NOP pharmacology from rodent and primate studies to what is being revealed about NOP ligands in the clinic from PET and human occupancy studies, in order to highlight challenges and promises of this target for clinical translation. It is not the intent of this review to recapitulate the extensive literature on NOP pharmacology. For that, the reader is referred to several excellent in-depth reviews published recently.<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37-40)</a> Previous studies on NOP–N/OFQ localization in the rodent, primate, and human brain can be correlated to understand the relevance and face validity of rodent or primate models used in preclinical development, to inform efficacy in human clinical trials. This review highlights the issues and challenges revealed in the translation of preclinical rodent data to efficacy in human. Given that the NOP receptor is primarily a CNS target, the development of NOP-targeted drug candidates is also faced with the usual challenges of CNS drug development. The discussion of preclinical data presented here will hopefully provide a broad perspective on the issues encountered during development of NOP-targeted drug candidates and encourage new research to ease the challenges of translating preclinical findings into human therapeutic potential.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">NOP Receptor-Targeted Compounds in the Pipeline from Research to the Clinic</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fast forwarding to the present, the current state of progress in translation of NOP–N/OFQ research into clinical therapeutics development is, at the time of writing this review, limited to just one compound, a dual-targeted NOP agonist–MOP agonist cebranopadol<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (<b>1</b>, GRT 6005, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) from Grunenthal, for which Phase III clinical trials are currently ongoing, for treatment of various pain conditions.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> Thus far, this is the most advanced into clinical development that any NOP-targeted compound has reached (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). A NOP antagonist from Eli Lilly, <b>2</b> (LY2940094),<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> is also in Phase II clinical trials for major depressive disorder<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and for alcohol dependence,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> but no further information is available regarding the outcome of these trials or future progress of this compound (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). MK-5757 (<b>3</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), a NOP antagonist identified as a clinical candidate after extensive optimization by Banyu,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> was in Phase II clinical trials, for the treatment of cognitive impairment in men with schizophrenia. Although the trial has been completed, no results have been yet disclosed.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">One of the first investigations into the therapeutic applications of the NOP–N/OFQ system suggested that NOP agonists, including the natural peptide N/OFQ, had anxiolytic activity in several animal models.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> However, the only small-molecule NOP agonist that appears to have entered human clinical trials is <b>5</b> (JNJ-19385899),<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> for which no structural or biological information is available. A Phase I pharmacodynamics/pharmacokinetics (PKPD) and safety study suggested an inverted U-shaped dose–response curve for this NOP agonist;<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> however, no further information is available on the status of its development. Among peptidic NOP agonists, compound <b>6</b> (ZP-120, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), a dodecapeptide NOP partial agonist,<a onclick="showRef(event, 'ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55">(52-55)</a> now called SER100 (licensed from Zealand Pharmaceuticals by Serodus ASA, Norway), completed a Phase IIa clinical trial for systolic hypertension. However, there is no further information on the clinical progression of <b>6</b>. Zealand Pharma previously advanced <b>6</b> up to Phase II clinical trials for urinary incontinence, but its development was terminated because of a blood-pressure-lowering side effect. This sodium-sparing peripherally targeted peptide was resurrected by Serodus, which capitalized on the blood-pressure-lowering side effect as a potential approach in patients with treatment-resistant isolated systolic hypertension and advanced it to Phase IIa, with plans for further development with an oral formulation.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">There have been NOP-targeted compounds that were advanced into clinical development but later terminated due to various reasons. The NOP full agonist <b>4</b> (SCH486757, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) was advanced into Phase I clinical trials as a potential treatment for cough.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> However, its development was terminated due to lack of efficacy and therapeutic window separating the efficacy and the somnolence effect in patients. NOP antagonist <b>7</b> (JTC-801, from Japan Tobacco, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was also taken into Phase II clinical trials in Japan and the U.K. as an injectable and oral formulation for the treatment of neuropathic and postoperative pain<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> but was dropped from further development due to unknown reasons. The natural peptide N/OFQ itself has also been investigated in patients as an intravesical injection for the control of neurogenic detrusor overactivity in a placebo controlled, randomized exploratory trial in Italy and demonstrated clinical efficacy during 10 days of treatment.<a onclick="showRef(event, 'ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62">(60-62)</a> While these findings support the use of NOP agonists as a potential therapy for urinary incontinence, no investigations of this therapeutic approach have been reported with small-molecule NOP agonists.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Status of NOP-Targeted Compounds That Entered Clinical Development</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0003.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p">The discovery of the endogenous N/OFQ peptide and investigations into the pharmacology of the NOP–N/OFQ system spawned a large effort to discover small-molecule NOP ligands in almost every major pharmaceutical company.<a onclick="showRef(event, 'ref63 ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65 ref66 ref67">(63-67)</a> From this effort, several small-molecule NOP agonists and antagonists emerged as being suitable for in vivo pharmacological evaluation in animal models, using systemic routes of administration. These NOP ligands have been invaluable as tools to investigate the modulation of NOP pharmacology for therapeutic benefit and characterize other target-related pharmacology that may impact a useful therapeutic profile, and as lead compounds for drug development. Presented below is a collection of small-molecule NOP agonists and antagonists that have been well characterized in the literature. The pharmacological characterization of these “literature” NOP compounds in various preclinical disease models (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) reveals several issues and challenges that have plagued NOP-targeted drug development and slowed the clinical validation of the NOP receptor as a pharmacological target. Rather than being an exhaustive compilation of every study published with these known NOP ligands, the discussion below presents interesting observations from these studies that point to the therapeutic potential of NOP ligands and highlight the issues related to animal models, on-target/off-target effects, and other challenges that must be addressed on the path to translation of the NOP receptor as a viable clinical target.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. NOP-Selective Agonists and Antagonists: Preclinical Testing and Outcomes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">indication</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">preclinical species</th><th class="colsep0 rowsep0" align="center">preclinical model (dose, route)</th><th class="colsep0 rowsep0" align="center">outcomes (side effects)</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep1 rowsep0" colspan="6" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center"><b>NOP Agonists</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Anxiety<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Elevated plus-maze (1.0, 3.2 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Decreased open arm avoidance <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">50</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Fear-potentiated auditory startle (3.2, 10 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Attenuated startle responses <i>(no effect on locomotion at 3.2 mg/kg dose but impaired motor activity at 10 mg/kg dose)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">50</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Modified Geller–Seifter conflict procedure (0.3, 1, and 3.2 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Bell-shaped dose–response, highest response at 1 mg/kg <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">50</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Conditioned lick suppression (punished responding) (1, 3, 10 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">3 and 10 mg/kg doses increased punished licking <i>(impaired motor activity at 10 mg/kg and above)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">71</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Panic-like anxiety test (1, 3.2, 10 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">No effect at 1 and 3.2 mg/kg <i>(impaired motor activity at 10 mg/kg dose but not lower doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">50</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Separation-induced rat pup vocalization (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">1 and 3 mg/kg doses decreased vocalization <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">71</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Vogel conflict drinking (punished responding) (0.1, 0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">1 and 3 mg/kg doses increased punished drinking <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">76</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Social approach avoidance (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">All three doses increased time in social compartment</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">76</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (C57BL/6-129X1Sv mixed)</td><td class="colsep0 rowsep0" align="left">Mouse Geller–Seifter conflict procedure (1 and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Increase in punished responding at 3 mg/kg dose <i>(decreased time on rotarod and locomotor activity at 3 and 10 mg/kg)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">71</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (C57Bl/6)</td><td class="colsep0 rowsep0" align="left">Novelty-induced hypophagia (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">In novel cage, decrease in latency to drink at 1 mg/kg and increase in milk intake at 0.3 and 1 mg/kg <i>(in home cage, increase in latency to drink and decrease in intake at 1 and 3 mg/kg, due to sedative effects)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">76</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (C57BL/6)</td><td class="colsep0 rowsep0" align="left">Stress-induced hyperthermia (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">All three doses reversed stress-induced hyperthermia <i>(no effect on baseline temperature measures at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">76</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Elevated plus-maze (0.32, 1, and 3.2 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Increased time in open arms at 1 and 3.2 mg/kg doses <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">102</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Elevated plus-maze (1, 3, and 10 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Increased open arm time and entries at 3 and 10 mg/kg doses <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">108</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Vogel conflict drinking (punished responding) (1, 3, 10, and 30 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">3, 10, and 30 mg/kg doses increased punished drinking <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">108</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Conditioned lick suppression (punished responding) (1, 3, 10 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Only the 10 mg/kg dose increased punished licking <i>(no effect on locomotion at this dose)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">108</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Fear-potentiated auditory startle (3, 6, and 10 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Attenuated startle responses at 10 mg/kg <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">108</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Conditioned lick suppression (punished responding) (1, 3, 10 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">3 and 10 mg/kg doses increased punished licking response <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">73</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Fear-potentiated startle (1, 3, and 10 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Decreased startle response at 3 and 10 mg/kg <i>(no effect on locomotion at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">73</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (C57BL/6)</td><td class="colsep0 rowsep0" align="left">Mouse Geller–Seifter conflict procedure (3, 10, and 30 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Increase in punished responding at 30 mg/kg dose only <i>(decreased time on rotarod and locomotor activity at 30 mg/kg)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">73</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Marble burying activity (3, 10, and 30 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Decrease in number of marbles buried at 30 mg/kg dose only <i>(decreased time on rotarod and locomotor activity at 30 mg/kg)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">73</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">Mice (ddY strain)</td><td class="colsep0 rowsep0" align="left">Mouse Vogel conflict test (3, 10, and 30 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Only the 10 mg/kg dose increased the number of shocks accepted, bell-shaped dose–response <i>(no decrease in locomotion observed at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">75</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pain (Acute)</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Mice (Swiss)</td><td class="colsep0 rowsep0" align="left">Thermal tail immersion test (1 and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">No effect on latency <i>(ataxia observed at both doses in mice for first 30 min)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">84</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (C57BL/6N)</td><td class="colsep0 rowsep0" align="left">Tail-flick test (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Increases in pain sensitivity, decrease in tail-flick latency at 1 and 3 mg/kg doses <i>(decrease in locomotion observed at 3 mg/kg dose)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">85</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Hot-plate test (forepaw licking and jump latency) (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Decreases in pain sensitivity, increase in latency of forepaw licking at 3 mg/kg, and jump latency at all three doses <i>(decrease in locomotion observed at 3 mg/kg dose)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">85</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Shock threshold test (flinch and vocalization latency and jump threshold) (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">No effect on flinch latency, increase in vocalization latency at all doses, trend to increase in jump threshold <i>(decrease in locomotion observed at 3 mg/kg dose)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">85</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Non-human primate (rhesus)</td><td class="colsep0 rowsep0" align="left">Warm water (50 °C) tail withdrawal (0.001–0.06 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Increase in withdrawal latency at all doses <i>(no side effect on respiration, itch response or activity observed)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">78</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Capsaicin-induced allodynia (46 °C warm water withdrawal latency) (0.001–0.06 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Increase in withdrawal latency at all doses <i>(no side effect on respiration, itch response or activity observed)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">78</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Non-human primate (squirrel monkeys)</td><td class="colsep0 rowsep0" align="left">Operant antinociception assay (increase in thermal threshold and pull duration of thermode for a food reward) (0.003, 0.01, and 0.03 mg/kg, im)</td><td class="colsep0 rowsep0" align="left">Produced larger antinociceptive effects than morphine, increased thermal threshold and pull duration of a thermode linked to a food reward in the operant paradigm <i>(no disruptions in activity noted)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">112</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Mice (ICR)</td><td class="colsep0 rowsep0" align="left">Tail-flick assay (3, 10, and 30 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">No effect on tail-flick latency <i>(no effect on locomotor activity at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">74</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Mice (ICR)</td><td class="colsep0 rowsep0" align="left">Tail-flick assay (3, 10, and 30 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Increase in tail-flick latency at the 10 and 30 mg/kg doses <i>(30 mg/kg dose causes decrease in locomotor activity)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">74</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">UFP-112</td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Paw pressure/vocalization or withdrawal threshold (0.03, 0.1, and 0.3 nmol it.)</td><td class="colsep0 rowsep0" align="left">Antinociceptive response at the 0.1 and 0.3 nmol doses, lower doses than morphine <i>(no effect on activity)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">163</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Non-human primate (rhesus)</td><td class="colsep0 rowsep0" align="left">Warm water (50 °C) tail withdrawal (1, 3, and 10 nmol, it.)</td><td class="colsep0 rowsep0" align="left">Increase in withdrawal latency at 3 and 10 nmol doses <i>(no side effect on itch response observed)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">90</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Capsaicin-induced allodynia (46 °C warm water withdrawal latency) (10 nmol, it.)</td><td class="colsep0 rowsep0" align="left">Increase in withdrawal latency up to 4 h <i>(no side effect on itch response observed)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">90</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pain (Chronic, neuropathic, inflammatory)</td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Sciatic nerve injury (0.2, 2.3, 11.5, 23 nmol, it.)</td><td class="colsep0 rowsep0" align="left">Antiallodynic effects (Von Frey) and (thermal cold water allodynia) at doses above 2.3 nmol (no locomotor effects reported)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">91</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Sciatic nerve injury (23, 46, 69 nmol, intraplantar)</td><td class="colsep0 rowsep0" align="left">Antiallodynic effects (Von Frey) and (thermal cold water allodynia) at the 46 and 69 nmol doses</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">91</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Sciatic nerve injury (262 nmol/kg, sc)</td><td class="colsep0 rowsep0" align="left">No antiallodynic effects observed</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">91</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Non-human Primates</td><td class="colsep0 rowsep0" align="left">Carrageenan-induced thermal hyperalgesia (46 °C warm water withdrawal latency) (0.0003, 0.001, and 0.003 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Dose-dependent increase in % maxiumum possible antihyperalgesic effect <i>(no side effects on respiration, itch or activity)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">86</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Streptozotocin-induced diabetic polyneuropathy (mechanical paw withdrawal) (7.1, 23.8, and 71.4 nmol, intraplantar)</td><td class="colsep0 rowsep0" align="left">Dose-dependent increase in % maxiumum possible antihyperalgesic effect (no confounding effects via this route at these doses)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">104</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (ICR)</td><td class="colsep0 rowsep0" align="left">Formalin paw withdrawal (formalin-induced licking, flinching, paw-lifting) (0.03, 0.1, 0.3, and 1 micromol/kg, iv)</td><td class="colsep0 rowsep0" align="left">Dose-dependent inhibition of formalin-induced hyperalgesic effects <i>(highest dose caused loss of righting reflex)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">106</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Mice (BalbC)</td><td class="colsep0 rowsep0" align="left">Mustard oil-induced abdominal pain in mice with colitis (3 mg/kg po)</td><td class="colsep0 rowsep0" align="left">Significant antinociceptive activity in an acutely inflamed intestinal colitis model</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">114</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Mice (ICR)</td><td class="colsep0 rowsep0" align="left">Spinal nerve ligation model of neuropathic pain (10 and 30 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Significant mechanical antiallodynic effects (Von Frey) but not thermal antinociception in tail-flick <i>(no effect on locomotor activity)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">128</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Mice (ICR)</td><td class="colsep0 rowsep0" align="left">Spinal nerve ligation model of neuropathic pain (3 and 10 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Significant mechanical antiallodynic effects (Von Frey) and thermal antinociception in tail-flick assay <i>(no decrease in locomotor activity at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">128</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Chronic constriction injury model of neuropathic pain (1.0, 10, and 30 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Significant mechanical antiallodynic effects (Von Frey) <i>(no effect on locomotor activity at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">127</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Chronic constriction injury model of neuropathic pain (5.5, 55, and 170 nmol, it.)</td><td class="colsep0 rowsep0" align="left">Significant mechanical antiallodynic effects (Von Frey) at 55 and 170 nmol doses</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">127</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Chronic constriction injury model of neuropathic pain (5.5, 55, and 170 nmol, icv)</td><td class="colsep0 rowsep0" align="left">No antiallodynic effects (Von Frey) at any dose</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">127</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Substance Abuse Disorders<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Mice (C57BL/6)</td><td class="colsep0 rowsep0" align="left">Morphine conditioned place preference (0.3 and 1 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">1 mg/kg blocked acquisition of morphine CPP and morphine prime-induced reinstatement of CPP but not the expression of morphine CPP or the rate of extinction of morphine CPP <i>(no effect on locomotor)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">96</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (NMRI)</td><td class="colsep0 rowsep0" align="left">Alcohol conditioned place preference (0.1, 0.3, and 1 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">0.3 and 1 mg/kg blocked acquisition, expression as well as alcohol prime-induced reinstatement of alcohol CPP <i>(decrease in locomotor activity at this dose)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">97</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Rats (Wistar)</td><td class="colsep0 rowsep0" align="left">Alcohol self-administration and deprivation-induced relapse (0.1, 0.3, and 1 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Dose-dependent decrease in alcohol self-administration. Decreased deprivation-induced increase in alcohol intake</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">98</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Rats (alcohol-preferring msP rats)</td><td class="colsep0 rowsep0" align="left">Alcohol self-administration (0.3 and 1 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Increase in alcohol consumption at the 1 mg/kg dose, reversible by naloxone</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">99</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Remifentanil (opioid) self-administration (1, 3, 10, 30 mg/kg sc)</td><td class="colsep0 rowsep0" align="left">Only the 30 mg/kg dose decreased remifentanil self-administration <i>(at this dose, rats were unresponsive and showed loss of righting reflex)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">110</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Remifentanil (opioid) self-administration (0.3, 1, 3 μg intracisternally)</td><td class="colsep0 rowsep0" align="left">All three doses decrease remifentanil self-administration <i>(at 3 μg, sedation observed)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">110</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Rats (msP rats)</td><td class="colsep0 rowsep0" align="left">Alcohol self-administration and cue- and stress-induced reinstatement (0.3, 1, and 3 mg/kg po)</td><td class="colsep0 rowsep0" align="left">Decrease in alcohol self-administration and reinstatement <i>(no effect on locomotion observed)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">100</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Rats (Wistar)</td><td class="colsep0 rowsep0" align="left">Alcohol withdrawal in dependent rats (1, 3, and 10 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Decreased withdrawal signs at 3 and 10 mg/kg doses</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">100</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Alcohol self-administration and reinstatement in postdependent rats (0.3 and 1 mg/kg po)</td><td class="colsep0 rowsep0" align="left">Decrease in alcohol self-administration and reinstatement</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">123</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Mice (ICR)</td><td class="colsep0 rowsep0" align="left">Morphine CPP (3, 10, and 30 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">Decrease in morphine CPP <i>(no effect on locomotor activity at these doses)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">74</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Mice (ICR)</td><td class="colsep0 rowsep0" align="left">Cocaine CPP and prime- and stress-induced reinstatement (3, 10, and 30 mg/kg, sc)</td><td class="colsep0 rowsep0" align="left">No effect on acquisition of cocaine CPP. But 30 mg/kg blocked cocaine prime- and stress-induced reinstatement of CPP <i>(no effect on locomotor activity at this dose)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">134</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Inflammatory bowel disease</td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Mice (BalbC)</td><td class="colsep0 rowsep0" align="left">2,4,6-Trinitrobenzesulfonic acid (TNBS)-induced colitis (twice daily 0.1 and 1 mg/kg ip or 3 mg/kg po)</td><td class="colsep0 rowsep0" align="left">Attenuation of TNBS colitis via both routes but not intracolonic route</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">114</a></td></tr><tr valign="top" class="colsep0"><td class="colsep1 rowsep0" colspan="6" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center"><b>NOP Antagonists</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Depression</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Mice (CD-1)</td><td class="colsep0 rowsep0" align="left">Forced swim test (20 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Decreased immobility time <i>(no effect on general locomotor activity)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">144</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Mice (Swiss)</td><td class="colsep0 rowsep0" align="left">Forced swim test (1, 3, and 10 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">10 mg/kg dose decreased immobility time</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">141</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Forced swim test (10 and 30 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">30 mg/kg decreased immobility time</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">44</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Parkinson’s disease</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Mice</td><td class="colsep0 rowsep0" align="left">MPTP-induced Parkinson’s model (0.01 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Improved motor performance in several motor tests <i>(higher doses 10 mg/kg worsened hypokinesia)</i></td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Non-human primate (macaques)</td><td class="colsep0 rowsep0" align="left">MPTP-induced Parkinson’s model (0.01 mg/kg, im)</td><td class="colsep0 rowsep0" align="left">Improvement in Parkinsonian scores (but less than that with L-DOPA)</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">6-Hydroxydopamine hemilesioned rat model (0.3, 1, and 3 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Relieved akinesia and attenuated motor asymmetry in hemiparkinsonian rats</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">148</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">6-Hydroxydopamine hemilesioned rat model (0.01, 0.1, and 1 mg/kg, ip)</td><td class="colsep0 rowsep0" align="left">Relieved akinesia and improved motor performance in hemiparkinsonian rats</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pain (Chronic, inflammatory)</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Carrageenan-induced inflammatory pain model (0.1, 0.3, 1, 3, 5 mg/kg, iv)</td><td class="colsep0 rowsep0" align="left">Increase in paw withdrawal latencies at 3 and 5 mg/kg doses</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">139</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Formalin-induced inflammatory pain model (3 mg/kg, po)</td><td class="colsep0 rowsep0" align="left">Decreased licking response up to 45 min after administration</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">152</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Rats</td><td class="colsep0 rowsep0" align="left">Hyperalgesia in the single prolonged stress model of post-traumatic stress disorder (6 mg/kg, ip once daily, 21 d)</td><td class="colsep0 rowsep0" align="left">Decreased mechanical allodynia, thermal hyperalgesia</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">164</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Preclinical assays in non-human primates not reported.</p></div></div></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">NOP Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> </h3><div class="NLM_p"><b>Ro64-6198 (8)</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) was among the first small-molecule NOP agonists reported, from a series of 1,3,8-triazaspirodecanones disclosed by Hoffman La-Roche,<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> and has been the most widely studied non-peptide NOP agonist. It has subnanomolar binding affinity for NOP, 100-fold binding selectivity over MOP, and negligible affinity for KOP or DOP (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69, 70)</a> Its potency as a full agonist at NOP is comparable to that of the endogenous agonist N/OFQ.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69, 70)</a> Compound <b>8</b> has been invaluable as a pharmacological tool to validate NOP receptor agonists as a potential treatment of several conditions such as anxiety, substance abuse, pain, and cough. Importantly, however, characterization of the in vivo pharmacology of <b>8</b>, after systemic administration, in several pharmacological tests <i>and in different species</i> has been very informative for identifying the issues and challenges for translational development of NOP agonists as therapeutics. One of the first indications of the potential clinical utility of NOP agonists came from the demonstration that <b>8</b> and its congeners (e.g., <b>9</b>, Ro65-6570,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, also see below) showed significant anxiolytic activity in many different assay paradigms,<a onclick="showRef(event, 'ref50 ref69'); return false;" href="javascript:void(0);" class="ref ref50 ref69">(50, 69)</a> later independently confirmed in a report from Schering-Plough researchers, who characterized the anxiolytic properties of <b>8</b> across three different rodent species (rat, mouse and guinea pig), and a variety of conditioned and unconditioned tests of anxiety.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p">While these studies clearly established the anxiolytic potential of <b>8</b> after systemic administration, they also revealed several issues regarding systemic effects of NOP agonists that confound behavioral assays, particularly in rodents.</div><div class="NLM_p">(i) For example, in mice, compound <b>8</b> showed significant anxiolytic activity only at doses at which it adversely affected general neurological functions such as rotarod performance, locomotor activity, and body temperature.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> A detailed study of the effect of <b>8</b> on rodent neurological functions previously showed that at doses of 3 mg/kg and above, in mice, compound <b>8</b>, given intraperitoneally, produced marked suppressive effects on body posture, rotarod performance, grip strength, and righting reflex.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Together, these studies showed that in mice, there is no dose separation between anxiolytic doses and doses that disrupt general behavior. This is also observed with other selective NOP agonists studied in mouse anxiety assays such as <b>13</b> (SCH655842)<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Interestingly, there seems to be some influence of the mouse <i>strain</i> on the severity of these adverse behavioral effects, as no decrease in locomotor or other activity was observed in ICR mice, using a different selective NOP agonist <b>16</b> (SR16835)<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), at doses at which it inhibited morphine-conditioned place preference (see below).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Similarly, no adverse effects on activity were observed at anxiolytic doses with the Pfizer NOP agonist <b>10</b> (MCOPPB)<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) in ddY mice, a general purpose inbred mouse strain used in Japan.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The anxiety studies with <b>8</b> were all conducted in mice with a C57Bl/6 background and consistently showed dose-dependent disruptive effects on mouse behavior (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref71 ref72 ref76'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref76">(71, 72, 76)</a> It appears that the C57Bl/6 mice are sensitive to the adverse neurological effects of NOP agonists. Interestingly, in studies in isolated tissue preparations, <b>8</b> mimicked the effect of N/OFQ in Swiss mouse vas deferens, but this effect was not reversed by NOP antagonists or by opioid antagonist naloxone, suggesting that in this mouse strain also, <b>8</b> appears to have effects mediated by an uncharacterized biological target.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">(ii) In rats, however, compound <b>8</b> and other NOP agonists mentioned above show distinct and consistent dose separation of at least >3-fold between the doses at which anxiolytic effects are observed in a variety of assay paradigms and those at which decreased activity is observed. Compound <b>8</b> not only showed significant anxiolytic activity comparable to benzodiazepines in several rat anxiety assays but also showed a better side-effect profile than benzodiazepines at efficacious doses, pointing to potential therapeutic utility as a novel approach for anxiolytics.<a onclick="showRef(event, 'ref50 ref71 ref76'); return false;" href="javascript:void(0);" class="ref ref50 ref71 ref76">(50, 71, 76)</a> Moreover, unlike the case with C57Bl/6 mice, the disruptive neurological effects of <b>8</b> in rats were only observed at doses of 10 mg/kg and above.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_p">Another dimension to species differences in the pharmacological profile of <b>8</b> was revealed in the studies by Ko et al. in non-human primates (NHP), which showed that <b>8</b>, given systemically (sc or iv), did not cause sedation or other adverse effects at doses at which it exhibited significant antinociceptive efficacy.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78, 79)</a> However, the anxiolytic potential of <b>8</b> (or any other NOP agonist) has not been reported in non-human primates.</div><div class="NLM_p">Compound <b>8</b> has also been useful in highlighting the complexities of the role of the NOP–N/OFQ system in modulation of pain pathways. It is well documented that the effect of NOP agonists in pain modulation in animal models varies with the assay, route of administration, and species.<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(80-82)</a> Compound <b>8</b> has been investigated in animal models of various pain modalities and shows differential effects depending on the route of administration and the type of pain assay (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, recent developments in the characterization of the NOP ligands in <i>non-human primates</i> reveals important information suggesting that NOP agonists may have some unique advantages over classical opioid therapy, offering opioid-type analgesia without the classical opioid liabilities such as itch, constipation, sedation, and dependence.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a></div><div class="NLM_p">As expected of a NOP agonist, compound <b>8</b>, given ip, suppressed the antinociceptive effect of an acute injection of morphine in the mouse warm water tail immersion test but did not, by itself, increase the latency of response to this thermal stimulus.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> These results were in line with the observations by Hoffman La-Roche researchers who first reported the pharmacological characterization of <b>8</b> in rat anxiolytic assays but found no effect of this compound on pain thresholds in rat tail-flick assay or on tactile allodynia measured with Von Frey hairs.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Further characterization of <b>8</b> in other acute pain paradigms in C57BL/6 mice showed that it <i>increased</i> pain sensitivity in the tail-flick test at the 1 and 3 mg/kg doses given ip but showed antinociceptive effects in the hot-plate test and shock threshold tests.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">In contrast to these effects in <i>rodent</i> acute pain assays, <b>8</b>, administered systemically (sc) to <i>non-human primates</i>, showed significant antinociceptive efficacy against an acute noxious stimulus (50 °C water) tail-immersion test<a onclick="showRef(event, 'ref78 ref86'); return false;" href="javascript:void(0);" class="ref ref78 ref86">(78, 86)</a> and also inhibited capsaicin-induced allodynia manifested as reduced warm water tail-flick latency when capsaicin was injected into the monkey tail.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Clearly, the effect of systemic administration of NOP agonist <b>8</b> was <i>different</i> between rodents and non-human primates. Since the effect of systemic administration is a net effect of central (supraspinal and spinal) and peripheral action, it is possible that in rodents, the supraspinal NOP-receptor mediated hyperalgesia is countered by spinal and peripheral antinociceptive effects of NOP agonists (such as <b>8</b>), resulting in a net outcome of “no effect” on antinociception in rodents after systemic administration, as was observed with <b>8</b>. The fact that in primates, systemic <b>8</b> consistently shows significant antinociceptive activity, points to a differential role of NOP–N/OFQ in the modulation of pain pathways in rodents versus primates and at different physiological sites (supraspinal, spinal and peripheral) in the two species. Indeed, a recent report by the Ko group shows that, <i>unlike</i> the hyperalgesic effect of icv N/OFQ in rodents, supraspinal administration of N/OFQ to non-human primates via an intracisternal injection produced robust antinociceptive effects without increasing scratching response.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> These provocative results suggest that supraspinal actions of N/OFQ and its involvement in regulating pain may be different in rodents versus non-human primates, and possibly humans, and offer the possibility of obtaining antinociceptive efficacies in humans, using NOP agonists, without the confounding side effects such as itch that accompanies traditional opioids like morphine.</div><div class="NLM_p">On the other hand, the intrathecal (it.) route of administration has been explored in larger animals such as NHPs, with peptides such as N/OFQ and a synthetic peptide agonist UFP-112,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> which showed significant acute thermal antinociception in the warm water test and capsaicin-induced allodynia (see <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref88 ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref88 ref89 ref90">(88-90)</a> However, small-molecule NOP agonists such as <b>8</b> have not yet been reported to be administered intrathecally to non-human primates.</div><div class="NLM_p">In chronic pain models in rodents, such as the rat sciatic nerve injury model, <b>8</b> showed antiallodynic and antinociceptive effects only upon intrathecal and intraplantar (local peripheral) administration but not systemic (sc) administration.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> In non-human primates, however, systemic administration (sc) of <b>8</b> shows significant antinociceptive effects against carrageenan-induced hyperalgesia (a model of inflammatory pain), with potencies similar to μ opioid agonists but without producing the itch and respiratory depression effects typically associated with μ opioid-type analgesics.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Taken together, the results of the extensive characterization of <b>8</b> in acute and chronic pain models in rodents and primates via various routes of administration suggest that selective NOP agonists may have clinical utility as analgesics in humans, providing efficacies similar to opioids but without opioid-associated side effects such as pruritis, respiratory depression, and dependence (see below).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">Given that the NOP–N/OFQ system is in the opioid family and is present in areas of the brain associated with reward processing, NOP ligands have been investigated for their rewarding and motivational properties. Early studies with <b>8</b> showed that it did not induce a place preference in rats, up to doses of 3.2 mg/kg, when administered systemically.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> However, a more recent study in rats showed that <b>8</b>, at doses 2.5 mg/kg and 3.16 mg/kg, produced a significant place preference, reversible by the D2 antagonist haloperidol but not by naloxone or the NOP antagonist J-113397<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> (<b>18</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), suggesting a dopaminergic effect of <b>8</b>.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The reasons for this discrepancy are not known but could be attributed to several factors, including the chemical supply of <b>8</b> itself, given that these two studies were conducted in different laboratories. Compound <b>8</b> (0.3, 1, and 3.2 mg/kg) was shown not to significantly modify the threshold for intracranial self-stimulation (ICSS) in animals implanted with electrodes into the ventral tegmental area, in contrast to cocaine, which, expectedly, rapidly decreased the ICSS threshold.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> These studies further confirmed that compound <b>8</b> was devoid of reward-stimulating effects characteristic of pyschostimulants such as cocaine.</div><div class="NLM_p">On the other hand, <b>8</b> was shown to produce a discriminative stimulus effect in rats, reversible by the NOP antagonist <b>18</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), and weakly generalized to morphine but not κ or δ agonists.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> This discriminative stimulus was not as strong as that produced by μ opioid agonists, suggesting that NOP agonists are likely to be devoid of reinforcing or euphorigenic effects. In non-human primates, <b>8</b> did not produce reinforcing effects at doses at which it showed significant antinociceptive effects.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> For potential clinical utility as analgesics, as discussed above, NOP agonists may provide opioid-like efficacies without the abuse liabilities of classical opioids.</div><div class="NLM_p">The natural peptide agonist N/OFQ reduces basal and drug-induced dopamine release in the nucleus accumbens,<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> pointing to the potential of NOP agonists in reducing drug-induced dopamine release and consequently the rewarding effects of abused drugs.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Indeed, <b>8</b> (and other small-molecule NOP agonists, see below) was shown to decrease the acute rewarding effects of morphine in the conditioned place preference paradigm in C57BL/6 mice at a dose of 1 mg/kg, at which it does not produce nonspecific effects on locomotion or activity of the animals.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Compound <b>8</b> has, however, not been tested for its effect on morphine drug reward in rats, nor has it been tested for effects on drug reward induced by psychostimulants such as cocaine. However, icv, N/OFQ itself has been shown to block the conditioned place preference induced by cocaine, amphetamine, and methamphetamine in mice and rats.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a> On the other hand, <b>8</b> has been shown to block the acquisition and reinstatement of alcohol place preference in NMRI mice at the 1 mg/kg dose sc without nonspecific effects on activity.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> The inhibitory effect of <b>8</b> on alcohol-induced rewarding effects was further confirmed in rats, where it was shown to reduce alcohol self-administration and deprivation-induced relapse-like alcohol drinking in Wistar rats when administered ip at doses up to 1 mg/kg.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> However, in genetically modified alcohol-preferring rats, <b>8</b>, at 1 mg/kg administered ip, actually increased alcohol consumption.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> This effect was not observed with other NOP agonists and was inhibited by naloxone, hence attributed to a residual μ opioid agonist activity of <b>8</b>. Notably, recently, another nonpeptidic NOP agonist <b>15</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> (MT-7716, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) was shown to decrease ethanol-seeking in alcohol-preferring rats.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Therefore, the potential of NOP agonists to reduce alcohol reward needs further investigation.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and in vitro pharmacological profiles of known NOP agonists. Note that the in vitro data from the cited references are from different laboratories and use different radioligands and protocols for the assays and therefore cannot be directly compared.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although <b>8</b> has been extensively characterized in vivo and shown to have good brain penetration,<a onclick="showRef(event, 'ref50 ref71'); return false;" href="javascript:void(0);" class="ref ref50 ref71">(50, 71)</a> it was not further developed for any of the above indications likely because its oral bioavailability in multiple preclinical species was poor (1% in cynomolgous monkeys and 4% in rodent species).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_p"><b>Ro65-6570 (9)</b> was another congener from the same family of 1,3,8-triazaspirodecanones as <b>8</b>, reported by Hoffman La-Roche, but not as extensively characterized. Compound <b>9</b> differs from <b>8</b> only in the structure of the piperidine nitrogen substituent (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref68 ref102'); return false;" href="javascript:void(0);" class="ref ref68 ref102">(68, 102)</a> Interestingly, this small structural change results in a significant difference in binding affinity for the NOP and MOP receptor (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), compared to <b>8</b>, such that its selectivity for NOP is lower than that of <b>8</b> (∼10-fold, compared to 100-fold for <b>8</b>).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Nevertheless, both compounds are full agonists at the NOP receptor. While it has not been directly compared with <b>8</b> in any study, compound <b>9</b> was reported to show dose-dependent anxiolytic effects in the elevated plus maze test in rats in doses (1 and 3.2 mg/kg ip) at which it did not affect motor performance.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> However, its low selectivity versus the μ opioid receptor may be responsible for the “increase” in locomotor activity observed with 3 and 6 mg/kg doses in rats, as well as increase in cocaine-induced hyperactivity, when <b>9</b> was administered prior to cocaine in the conditioned place preference paradigm.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In the same study, <b>9</b> was also shown to produce a significant place preference alone, at doses of 3 mg/kg and 6 mg/kg, at which it produced an increase in locomotor activity while having no effect on the expression of cocaine place preference. While this study did not report the effect of <b>9</b> on the <i>acquisition</i> (development) of cocaine CPP, a later study showed that <b>9</b> increased the minimal effective doses of morphine, heroin, oxycodone, and cocaine, but not amphetamine, to produce a place preference when it was administered as a 15 min pretreatment but not when administered 30 s before these drugs.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> These results show that while NOP agonists reduce the rewarding effects of opioids and psychostimulants, the attenuation of rewarding effects is more consistent with the opioid class of abused drugs. The discrepancy between the effect of <b>9</b> on CPP induced by psychostimulants cocaine versus amphetamine is not entirely clear and points to the need to study the efficacy of well-characterized selective NOP agonists for their effects on psychostimulant reward.</div><div class="NLM_p">Unlike <b>8</b>, compound <b>9</b> has not been extensively evaluated in antinociceptive assays, possibly because of its lower selectivity profile. However, consistent with observations with <b>8</b>,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> compound <b>9</b> showed robust peripheral antihyperalgesic activity when administered intraplantarly to rats with diabetic polyneuropathy, showing efficacy similar to that of morphine administered by the same route.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Similar to <b>8</b>, compound <b>9</b> also did not show significant antihyperalgesic efficacy, with dose separation from confounding side effects, when administered <i>systemically</i> to rats.<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105, 106)</a> Nevertheless, these results with both NOP agonists <b>8</b> and <b>9</b> further attest that NOP agonists may be useful for relief of peripheral pain associated with chronic pain conditions such as diabetic neuropathy and open up possibilities for development of peripherally targeted NOP agonists which may be devoid of centrally mediated side effects such as suppression of locomotor activity at higher doses.</div><div class="NLM_p"><b>SCH 221510 (12) and SCH 655842 (13)</b> belong to a class of <i>N</i>-benzhydrylnortropane-based NOP agonists (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) developed by Schering-Plough Corporation.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> These two NOP agonists were characterized extensively by Schering-Plough in rodent models of anxiety,<a onclick="showRef(event, 'ref73 ref108'); return false;" href="javascript:void(0);" class="ref ref73 ref108">(73, 108)</a> both in rat and in mouse, and found to have robust anxiolytic profiles in a variety of anxiety paradigms, similar to that observed with <b>8</b>. Notably, the anxiolytic efficacy of <b>12</b> and <b>13</b> was observed at doses at which there was no nonspecific disruption of activity, as was observed with classical benzodiazepines. As seen with agonist <b>8</b>,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> there appeared to be a better dose separation between efficacy and reduction in activity in the rat, compared to mouse.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Although both SCH agonists were reported to have good oral bioavailability and modest brain penetration (average rat brain-to-plasma ratio for <b>13</b> of 0.43–0.59), neither of these compounds were advanced into clinical trials. While it is not expressly discussed or reported, it is possible that its pharmacokinetic profile (e.g., modest brain penetration observed with <b>13</b>) precludes an effective therapeutic window between anxiolytic effects and target-based side effects.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> As discussed below, others have investigated different NOP agonists (e.g., <b>10</b>,<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> by Pfizer, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) as anxiolytics but have not progressed these NOP agonists into clinical trials for this indication. The clinical activity of the only NOP agonist that was advanced into Phase I trials for anxiety (viz. <b>5</b>) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) has not been reported thus far.</div><div class="NLM_p">Compound <b>12</b>, however, is now commercially available as a selective NOP agonist research tool, and its availability has spawned investigations into the utility of NOP agonists for several indications, including those investigated with compound <b>8</b> (such as drug abuse, pain) and others such as gastrointestinal disorders. Sukhtankar et al. have shown that, in rats, <b>12</b> is not reinforcing on its own but attenuates self-administration of the opioid remifentanil. Interestingly, this effect of decreasing opioid reinforcing effects was only observed when <b>12</b> was administered intracisternally (directly into the brain) to rats but not when administered systemically (sc).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Following sc administration, <b>12</b> was found to cause adverse behavioral abnormalities in rats at doses of 30 mg/kg and above. Even though <b>12</b> was shown to have oral efficacy in anxiety assays, it seems likely that its further development was negatively impacted by its poor distribution into the brain.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_p">Unlike agonist <b>8</b>, compound <b>12</b> has not been evaluated for efficacy as an antinociceptive in rodents. However, a recent study in primates showed that NOP agonists <b>8</b> and <b>12</b> enhanced opioid buprenorphine antinociception synergistically without causing a concomitant increase in respiratory depression or itch.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> A further confirmation of the antinociceptive efficacy of <b>12</b> in primates comes from a recent study by Kangas and Bergman, who utilized a novel operant paradigm to evaluate antinociceptive efficacies of compounds and showed that compound <b>12</b>, injected intramuscularly, showed antinociceptive efficacy exceeding that of morphine, as a significant increase in the thermal threshold and pull duration of a thermode-driven operant food reward in a novel thermal threshold antinociceptive assay (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> These results with <b>12</b> further confirm the notion that NOP agonists have the potential to have potent antinociceptive activity in non-human primates and therefore likely in humans.</div><div class="NLM_p">Among recent therapeutic applications explored in animal models with compound <b>12</b> as a NOP agonist tool compound are reports that NOP agonists show significant antinociceptive and anti-inflammatory efficacy in mouse models of intestinal disorders such as inflammatory bowel disease (IBD)<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> and diarrhea-predominant IBD.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Interestingly, only the ip and oral routes of administration were effective for the antinociceptive effects of <b>12</b>; direct intracolonic administration did not have an effect on the intestinal swelling observed in these animals.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> It has been speculated that N/OFQ and therefore NOP agonists may play a role in neurogenic inflammation and pain, such as that in IBD.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> These interesting findings, however, warrant further investigation before these applications can be translated to the clinic.</div><div class="NLM_p"><b>SCH486757 (4)</b>,<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> a NOP agonist, also belongs to the <i>N</i>-benzhydrylnortropane series of NOP ligands developed by Schering-Plough (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). This was the first small-molecule NOP agonist to enter human clinical testing.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> This compound and a close analog <b>14</b> (SCH225288, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>)<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> are high affinity NOP full agonists and were extensively characterized in experimental models of cough (guinea pig capsaicin-induced cough and cat mechanical-induced cough) and shown to be more potent than commonly used antitussives codeine and dextromethorphan.<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116, 117)</a> Indeed, the natural peptide N/OFQ, given intravenously, has also been shown to inhibit cough in experimental models at doses that do not affect general activity in the animal.<a onclick="showRef(event, 'ref118 ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref118 ref119 ref120">(118-120)</a> Interestingly, compound <b>8</b> was also tested in the same models of experimental cough and found to be effective when administered ip up to 3 mg/kg.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> The authors hypothesized that the antitussive action of N/OFQ and <b>8</b> could be mediated by a peripheral mechanism and proposed that oral NOP agonists that do not penetrate the blood–brain barrier may provide a novel approach for the treatment of cough, without central effects on activity. Further support for this hypothesis came from the work of Lee et al.,<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> who showed that the inhibition of acid-induced cough effect by nociceptin results from the inhibition of acid-induced transient receptor potential vanilloid-1 (TRPV1) activation in peripheral C-fibers.</div><div class="NLM_p">Compound <b>4</b> was advanced into Phase Ib/II clinical trials in patients with subacute cough;<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> however, the development of this NOP agonist was terminated due to a lack of significant efficacy and therapeutic window. The high doses at which cough suppression was observed also resulted in significant somnolence in patients. It is possible that <b>4</b> was not sufficiently excluded from the blood–brain barrier at the high dose at which antitussive efficacy was observed, resulting in an unwanted effect of sleepiness.</div><div class="NLM_p"><b>MT-7716 (15)</b><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> is a NOP agonist belonging to the benzimidazolone class (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), similar to the well-known NOP antagonist <b>18</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Compound <b>15</b> is a high-affinity and potent NOP full agonist with greater affinity and selectivity than compound <b>8</b>. It was recently shown to decrease alcohol drinking in the genetically alcohol-preferring Marchigian Sardinian P rats (msP rats) after chronic treatment (po, twice daily dosing) for 14 days, an effect that lasted after the drug was discontinued.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Compound <b>15</b> also significantly inhibited stress- and cue-induced reinstatement of alcohol drinking in these rats.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> When administered to Wistar rats made dependent on ethanol and withdrawn from ethanol, compound <b>15</b> (3 and 10 mg/kg po) decreased the expression of withdrawal signs up to 4 h after administration.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Interestingly, <b>15</b> appeared to preferentially decrease alcohol drinking and reinstatement in postdependent Wistar rats but was ineffective in nondependent rats.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> On the other hand, compound <b>8</b> was found to inhibit reinstatement of deprivation-induced alcohol seeking in Wistar rats that were nondependent.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> The reason for this difference between the two NOP agonists is unclear but likely has to do with their overall profiles of NOP efficacy and selectivity, their pharmacokinetics, and brain penetration. Notably, compound <b>15</b>, previously characterized as W212393,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> was shown to have significant affinity at SERT, albeit with a 20-fold lower affinity than for NOP.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> However, the differences between the effect of <b>15</b> in postdependent versus nondependent rats suggest that alcohol dependence leads to neuroadaptations in the N/OFQ–NOP system and that NOP agonists offer a potential approach to treat alcohol dependence, particularly relapse.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div><div class="NLM_p"><b>SR16835 (16, now named AT-202) and SR14150 (17, now named AT-200)</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) are NOP agonists from the dihydroindolinone class of NOP ligands.<a onclick="showRef(event, 'ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref125 ref126">(125, 126)</a> The NOP binding affinities for <b>16</b> and <b>17</b>, while not in the subnanomolar range as for compounds <b>8</b> and <b>15</b>, are comparable to those of the SCH series (compounds <b>4</b>, <b>12</b>–<b>14</b>) and the Pfizer agonists <b>10</b> and <b>11</b><a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Compound <b>16</b> is a NOP full agonist, whereas <b>17</b> shows partial agonist activity at NOP (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Interestingly, both these compounds, administered systemically, show significant antinociceptive and antiallodynic activity in a mouse spinal nerve ligation model of neuropathic pain, which is reversed by a NOP antagonist but not an opioid antagonist.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Notably, even though both these NOP agonists have modest selectivity versus the MOP receptor, their antinociceptive efficacy in the chronic pain model is mediated only via their NOP agonist efficacy, since an opioid antagonist did not affect the overall efficacy when coadministered.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> A further confirmation of the potential antinociceptive efficacy of NOP agonists in chronic pain comes from a recent study in which <b>17</b> was shown to have antinociceptive and antiallodynic activity, superior to morphine, in a transgenic mouse model of sickle-cell disease in which the transgenic sickle mice develop spontaneous hyperalgesia akin to the pain observed in patients with sickle cell disease.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The potent antinociceptive efficacy of <b>17</b> in this animal model was reversed only by the selective NOP antagonist <b>19</b> (SB-612111, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>)<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> but not by the opioid antagonist naloxone. Moreover, the antinociceptive efficacy of <b>17</b> did not diminish over a 7-day daily treatment, in contrast to that of morphine. As expected of NOP agonists, both <b>17</b> and <b>16</b> show no abuse liabilities, as determined in mouse conditioned place preference assays.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><div class="NLM_p last">The antinociceptive action of <b>16</b> and <b>17</b> mediated by their NOP agonist efficacy in chronic pain is consistent with the efficacy observed with NOP agonists <b>8</b> and <b>11</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) in rodent peripheral neuropathy models and suggests that spinal and peripheral NOP receptors provide inhibitory control in pain pathways activated in these conditions. Further mechanistic studies are needed to shed light on this, however. In the light of the efficacies observed with NOP agonists in non-human primates, it is clear that NOP agonists may have the potential of antinociceptive efficacies in human chronic pain conditions, offering therapeutic efficacy equal to or superior to that of traditional opioids.</div></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Perspective on the Therapeutic Potential of NOP Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From the extensive pharmacological characterization of a variety of NOP agonists from different chemical classes, a few common themes emerge that suggest that NOP agonists still hold significant promise as therapeutics in several clinical indications, where the NOP agonist pharmacological profile offers unique advantages over current approaches. Two such applications are (i) treatment of neuropathic, inflammatory and other chronic pain conditions and (ii) substance abuse medications, particularly to prevent stress-induced relapse and maintain abstinence.</div><div id="sec1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Treatment of Chronic, Neuropathic, and Inflammatory Pain</h3><div class="NLM_p last">As discussed above, studies in rodent and non-human primate models of pain show that NOP agonists, administered systemically or spinally, show significant antinociceptive activity in neuropathic and inflammatory pain, with efficacies similar to that of opioids but without the usual opioid-induced side effects such as itch, respiratory depression, and abuse liability. One might argue that the locomotor-inhibiting activity of NOP agonism may lead to undesired sedative effects; however, NOP agonists <b>8</b> and <b>12</b> showed no sedative effects in non-human primates at antinociceptive doses.<a onclick="showRef(event, 'ref78 ref111'); return false;" href="javascript:void(0);" class="ref ref78 ref111">(78, 111)</a> Given that the antinociceptive activity of NOP agonists and N/OFQ is likely through a spinally mediated mechanism and the sedative properties are mediated via a supraspinal mechanism, it may be possible to design NOP agonists with limited penetration into the brain. Such NOP agonists may also be useful for peripheral neuropathic pain as well as pain conditions such as IBD.</div></div><div id="sec1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Treatment of Substance Abuse</h3><div class="NLM_p last">Studies with NOP agonists discussed above indicate that they reduce the rewarding effects of drugs of abuse. From the different classes of abused substances, the data for alcohol dependence appear to be the most compelling.<a onclick="showRef(event, 'ref37 ref100 ref123 ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref37 ref100 ref123 ref130 ref131">(37, 100, 123, 130, 131)</a> Notwithstanding the inhibitory effect of NOP agonism on dopamine release in the nucleus accumbens and dopamine neurotransmission, the anti-CRF effect of NOP agonists in the central amygdala<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132, 133)</a> may be particularly relevant for the therapeutic use of NOP agonists in preventing relapse and maintaining abstinence. Further, NOP agonism was also shown to reduce alcohol withdrawal symptoms in rats.<a onclick="showRef(event, 'ref100 ref131'); return false;" href="javascript:void(0);" class="ref ref100 ref131">(100, 131)</a> Even for psychostimulants, studies with NOP agonist <b>16</b> show that it blocks stress- and drug prime-induced reinstatement of cocaine conditioned place preference in mice at doses at which there is no effect on locomotor activity.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Clearly, NOP agonism appears to be a promising approach for substance abuse treatment that should be evaluated in the clinic. Studies in non-human primates may also provide a suitable translational model to evaluate NOP agonists for cocaine abuse treatment, although such studies have yet to be reported.</div></div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">NOP Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32823" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32823" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There has been a significantly higher interest in pharmaceutical companies for developing NOP antagonists than has been for NOP agonists. The potential therapeutic indications explored are depression, cognitive impairment, obesity, and Parkinson’s disease, to name a few.<a onclick="showRef(event, 'ref38 ref66 ref135'); return false;" href="javascript:void(0);" class="ref ref38 ref66 ref135">(38, 66, 135)</a> As seen in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, NOP antagonists from Lilly and Merck were advanced to Phase II clinical trials for major depressive disorder and schizophrenia-associated cognitive impairment, respectively, although no further information on the development of these compounds is available. After the discovery of the NOP–N/OFQ receptor/endogenous peptide system, both peptide (e.g., UFP-101) and small-molecule (<b>18</b>, <b>19</b>) NOP antagonist ligands (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) were reported in the literature and significantly aided the characterization of NOP-mediated pharmacology.<a onclick="showRef(event, 'ref136 ref137 ref138 ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref136 ref137 ref138 ref139 ref140 ref141">(136-141)</a> These NOP antagonist tool compounds continue to be used today, are commercially available, and serve as invaluable tools to study NOP pharmacology and therapeutic potential. The intense effort in pharmaceutical companies around developing small-molecule NOP antagonists also culminated in the development of radioligand and PET tracers (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) to aid clinical trials and human receptor occupany studies for NOP antagonists that entered the clinic (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These tool compounds and radiotracers are briefly described below. It is interesting to note that in contrast to NOP agonists, which have been explored in many pharmacological paradigms for uncovering their therapeutic potential (anxiolytic, drug abuse treatment, pain, cough, GI disorders), there are very few explorations of NOP antagonists in pathophysiological states that indicate their therapeutic potential. As discussed below, NOP antagonist tool compounds have primarily been used as “pharmacological knockouts” to confirm the involvement of the NOP–N/OFQ system in disease states or to confirm the mechanism of action of NOP agonists. The exceptions to this are reports of the effect of NOP antagonists in inhibiting parkinsonian symptoms in rodent and primate models of Parkinson’s disease<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> and the antidepressant effects of NOP antagonists in rodent models.<a onclick="showRef(event, 'ref38 ref142 ref143 ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref38 ref142 ref143 ref144 ref145">(38, 142-145)</a> As noted in the discussion above and seen in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, small-molecule NOP antagonists have had a much higher success rate of entering the clinic compared to small-molecule NOP agonists, albeit the outcomes of the clinical trials with NOP antagonists are not disseminated or published yet.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures and in vitro pharmacological profiles of NOP antagonists widely used as tool compounds. Note that the in vitro data from the cited references are from different laboratories and use different radioligands and protocols for the assays and therefore cannot be directly compared.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><b>J-113397 (18)</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was the very first small-molecule NOP ligand and antagonist to be reported, by researchers at Banyu Japan.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Since, unlike peptidic NOP antagonists available at that time, <b>18</b> could be administered systemically, there were several reports independently characterizing <b>18</b> in vitro and in vivo.<a onclick="showRef(event, 'ref103 ref138 ref146'); return false;" href="javascript:void(0);" class="ref ref103 ref138 ref146">(103, 138, 146)</a> These consistently reported that <b>18</b> was a high affinity, competitive antagonist at NOP but had modest selectivity (∼15-fold, see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) versus the μ opioid receptor. Nevertheless, it was active when administered systemically and reversed the hyperalgesic effect of icv N/OFQ quite effectively.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Interestingly, when administered sc, <b>18</b> was found to be rewarding in mice and stimulated accumbal dopamine release by a non-NOP receptor-mediated mechanism,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> suggesting that its in vivo effects may be a composite of actions at the NOP receptor and another undetermined target. Nevertheless, compound <b>18</b> has been a very popular NOP antagonist that is still used in pharmacological studies to block actions mediated by the NOP receptor.</div><div class="NLM_p">Compound <b>18</b> was also very instrumental in the seminal results from the Morari group that showed NOP receptor blockade attenuates Parkinson-like symptoms in rodent and in non-human primate models of Parkinson’s disease.<a onclick="showRef(event, 'ref20 ref148 ref149'); return false;" href="javascript:void(0);" class="ref ref20 ref148 ref149">(20, 148, 149)</a> These results were recapitulated, at least in rodent models, with other NOP antagonists, such as 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methylethyl)-1,2,3,6-tetrahydropyridin-4-yl]-3-ethyl-1,3-dihydrobenzoimidazol-2-one (GF-4),<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> 2-[3-[4-(2-chloro-6-fluorophenyl)piperidin-1-ylmethyl]-2-(morpholine-4-carbonyl)indol-1-yl]acetamide (Nik-21273),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and 1-(1-cyclooctylmethyl-5-hydroxymethyl-1,2,3,6-tetrahydropyridin-4-yl)-3-ethyl-1,3-dihydrobenzoimidazol-2-one (Trap-101),<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> suggesting that NOP antagonists may represent a novel approach to treat symptoms in Parkinson’s disease. Although NOP antagonists such as <b>18</b> were determined to enhance the effect of levodopa, findings which were validated in non-human primate models of Parkinson’s disease,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> no NOP antagonist has been developed to progress into human clinical trials for Parkinson’s disease symptom management.</div><div class="NLM_p">Compound <b>18</b> was also the first small-molecule NOP antagonist to be tested in the mouse forced swim test, an assay usually employed to investigate an antidepressant-like profile.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Compound <b>18</b>, administered ip at 20 mg/kg, showed a significant reduction in mouse immobility time,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> an effect that was absent in NOP–/– mice.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> In the same study, <b>18</b> was shown to have no effect on general locomotor activity of mice in an open field test, indicating that the reduction in immobility time was not due to increase in locomotion.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> This antidepressant-like activity of <b>18</b> was later confirmed with other NOP antagonists such as <b>19</b> and peptide UFP-101.<a onclick="showRef(event, 'ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref141 ref142">(141, 142)</a> Interestingly, NOP–/– mice have also been characterized to possess an antidepressant-like phenotype.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> These studies have provided an important basis for the translation of NOP-targeted pharmacology into the clinical setting, since NOP antagonist <b>2</b> (LY2940094) was advanced to Phase II clinical trials for major depressive disorder (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and discussion above).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p"><b>SB-612111 (19)</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) is a high affinity, highly selective NOP antagonist reported by GSK.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> It is significantly more selective for NOP versus the other opioid receptors than is <b>18</b> when compared in the same study (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Compound <b>19</b> has been widely used to reverse the effects of N/OFQ. When administered systemically (ip or sc), <b>19</b> effectively reverses hyperalgesia produced by an icv injection of N/OFQ<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> as well as antinociception produced by an intrathecal injection of N/OFQ.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Compound <b>19</b> was also shown to have antihyperalgesic effects to thermal hyperalgesia in the rat carageenan inflammatory pain model and reverse the expression of morphine tolerance.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Interestingly, the aminoquinoline NOP antagonist JTC-801 (<b>7</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) also showed an antihyperalgesic effect in the rat formalin model.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> On the other hand, NOP antagonist <b>18</b> has not been evaluated in models of nociception. None of the above-mentioned antagonists or their congeners have successfully been investigated for their clinical potential as antinociceptives or antihyperalgesic agents for chronic or inflammatory pain. The clinical trials of <b>7</b>, on the other hand, were discontinued, and its antinociceptive activity was speculated to be due to a non-NOP-mediated effect.</div><div class="NLM_p">Compound <b>19</b> was also shown to ameliorate parkinsonian symptoms in the 6-hydroxydopamine hemilesioned rat model of Parkinson’s disease and synergize with L-DOPA to provide motor benefit in parkinsonian rats.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Further, Rizzi et al. showed that <b>19</b> decreased immobility time in the forced swim test for antidepressant-like activity, an effect that was abolished in NOP–/– mice,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> confirming the antidepressant potential of NOP antagonists.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Compound <b>19</b> was not further developed and is commercially available as a NOP antagonist tool compound.</div><div class="NLM_p last">The NOP antagonist <b>20</b> (C-24)<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> was reported by researchers at Banyu and later fully characterized by Fischetti et al.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> As expected of a small-molecule NOP antagonist, systemic administration of up to 10 mg/kg of <b>20</b> inhibited the effect of N/OFQ in analgesia assays.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Compound <b>20</b> was also used as the bound ligand for crystallization of the NOP receptor GPCR.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a></div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">NOP Antagonist PET and Radioligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Perhaps one of the more useful developments in the NOP field, signaling the translation of NOP-targeted ligands into clinical trials, has been the development of PET tracers, which have been used to guide clinical trials of NOP antagonists from Lilly and Merck (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). PET tracers are valuable for clinical development because they can enable quantitation of the target, receptor occupancy by the test compound, and pharmacodynamic assessments, particularly during Phase I clinical trials. Development of a suitable CNS PET tracer involves significant effort in medicinal chemistry and optimization due to the demanding criteria of a CNS-penetrant PET tracer. Multiple parameters have to be simultaneously optimized, including the choice of the PET isotope and the synthesis route. Previous attempts to make PET radiotracers out of high-affinity NOP ligands <b>8</b> (viz. [<sup>11</sup>C]methyl-Ro 64-6198) and <b>18</b> (viz. [<sup>11</sup>C]CPEB) were not successful due to problems of high nonspecific binding and low brain uptake.<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156, 157)</a></div><div class="NLM_p">Pike and co-workers reported the development of [<sup>11</sup>C] NOP-1A (<b>21</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), a NOP antagonist-based PET tracer, which has subnanomolar affinity for NOP and excellent selectivity versus the opioid receptors and a majority of other CNS targets.<a onclick="showRef(event, 'ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref158 ref159">(158, 159)</a> Compound <b>21</b> was used to label NOP receptor sites in rhesus monkey<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and human brain.<a onclick="showRef(event, 'ref36 ref160'); return false;" href="javascript:void(0);" class="ref ref36 ref160">(36, 160)</a> A <sup>18</sup>F-containing PET tracer, [<sup>18</sup>F]MK0911 (<b>22</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) was recently reported by Merck scientists, which was developed to support the clinical development of NOP antagonist <b>3</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Compound <b>22</b> was also investigated in both rhesus monkeys and humans and showed high specific binding in monkey and human brains, dose-dependently displaced by test NOP antagonists being developed in their studies.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p">Pfizer scientists recently reported the development of a tritiated NOP antagonist radioligand, for use in rodent in vivo imaging and receptor occupancy studies, to support lead optimization and clinical candidate selection. [<sup>3</sup>H]PF-7191 (<b>23</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) was developed after significant SAR and optimization of its physicochemical properties.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Robust labeling of rat binding sites with high NOP receptor expression was observed, which was displaceable with a test NOP antagonist in a dose-dependent manner, indicating the suitability of this radioligand for in vivo receptor occupancy studies.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures and in vitro pharmacological profiles of NOP antagonist-based PET tracers and radioligands recently developed for the NOP receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the 20 years following the discovery of this fourth opioid receptor and its endogenous ligand, the NOP–N/OFQ research field has been actively engaged, using state-of-the-art approaches on all fronts, pharmacologic, genetic, drug discovery, and tracer discovery, to understand the role of this system in normal function and in pathophysiological states. Given the widespread distribution of the NOP–N/OFQ system in areas of the brain and periphery, it is clear that this system plays an important role in several physiological processes. At the same time, this also poses a challenge in targeting the NOP receptor for therapeutic applications. Nevertheless, the discussion above shows that the NOP-targeted therapies may have key advantages over existing approaches in several therapeutic areas, notably chronic pain and substance abuse for NOP agonists and psychiatric disorders for NOP antagonists. Other therapeutic areas under active investigation include treatment of gastrointestinal, inflammatory disorders, and possibly Parkinson’s disease symptom management.</div><div class="NLM_p last">The NOP–N/OFQ field is at the cusp of an exciting time because of the entry and successful progression of NOP-targeted compounds into the clinic (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). It is hoped that the findings from these clinical investigations will be disseminated to benefit ongoing research into the validating the NOP receptor system as a viable clinical target.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01499" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nurulain T. Zaveri</span> - <span class="hlFld-Affiliation affiliation">Astraea Therapeutics, 320 Logue Avenue, Suite 142, Mountain View, California 94043, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#630d1611160f020a0d2302101711020602170b061102130616170a00104d000c0e"><span class="__cf_email__" data-cfemail="543a21262138353d3a1435272026353135203c312635243121203d37277a373b39">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The author declares no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Nurulain T. Zaveri</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=BIO-d48e3035-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nurulain T. Zaveri</b>, Ph.D., is founder, President, and Chief Scientific Officer of Astraea Therapeutics, a preclinical-stage company founded in 2009, focused on the development of small-molecule therapeutics for the treatment of CNS disorders. She has a Bachelor’s degree in Pharmacy and obtained her Ph.D. in Medicinal Chemistry in 1994 from Duquesne University. Prior to Astraea, she was Principal Investigator and Drug Discovery Program Director at a nonprofit research institute for 15 years. Her drug discovery research has spanned a variety of molecular targets in oncology and CNS disorders, such as nuclear receptors, GPCRs, enzyme modulators, ion channels, and natural products. Her current work is focused on the discovery, optimization, and development of small-molecule therapeutics for two major molecular targets important in CNS and neurodegenerative diseases.</p></figure></div><div class="ack" id="ACK-d48e3040-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Support from the National Institutes of Health through Grants R01DA014026, R01DA027811, R43NS070664, and R43HL115984 is gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i16" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i16"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i17" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i17"> Abbreviations Used</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CPP</td><td class="NLM_def"><p class="first last">conditioned place preference</p></td></tr><tr><td class="NLM_term">DOP</td><td class="NLM_def"><p class="first last">δ opioid receptor</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">inflammatory bowel disease</p></td></tr><tr><td class="NLM_term">ICSS</td><td class="NLM_def"><p class="first last">intracranial self-stimulation</p></td></tr><tr><td class="NLM_term">icv</td><td class="NLM_def"><p class="first last">intracerebroventricular</p></td></tr><tr><td class="NLM_term">im</td><td class="NLM_def"><p class="first last">intramuscular</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">it.</td><td class="NLM_def"><p class="first last">intrathecal</p></td></tr><tr><td class="NLM_term">IUPHAR</td><td class="NLM_def"><p class="first last">International Union of Basic and Clinical Pharmacology</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">KOP</td><td class="NLM_def"><p class="first last">κ opioid receptor</p></td></tr><tr><td class="NLM_term">MOP</td><td class="NLM_def"><p class="first last">μ opioid receptor</p></td></tr><tr><td class="NLM_term">MPTP</td><td class="NLM_def"><p class="first last">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</p></td></tr><tr><td class="NLM_term">N/OFQ</td><td class="NLM_def"><p class="first last">nociceptin/orphaninFQ peptide</p></td></tr><tr><td class="NLM_term">NOP</td><td class="NLM_def"><p class="first last">nociceptin/orphaninFQ peptide receptor</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">peroral</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 164 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailleux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moisand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caput, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J. C.</span><span> </span><span class="NLM_article-title">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)80235-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2980235-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=8137918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1994&pages=33-38&author=C.+Mollereauauthor=M.+Parmentierauthor=P.+Mailleuxauthor=J.+L.+Butourauthor=C.+Moisandauthor=P.+Chalonauthor=D.+Caputauthor=G.+Vassartauthor=J.+C.+Meunier&title=ORL1%2C+a+novel+member+of+the+opioid+receptor+family.+Cloning%2C+functional+expression+and+localization&doi=10.1016%2F0014-5793%2894%2980235-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span></div><div class="casAuthors">Mollereau, Catherine; Parmentier, Marc; Mailleux, Pierre; Butour, Jean Luc; Moisand, Christiane; Chalon, Pascale; Caput, Daniel; Vassart, Gilbert; Meunier, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-8</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Selective PCR amplification of human and mouse genomic DNAs with oligonucleotides encoding highly conserved regions of the β-opioid and somatostatin receptors generated a human DNA probe (hOP01, 761 bp) and its murine counterpart (mOP86, 447 bp).  Probe hOP01 was used to screen a cDNA library from human brainstem.  A clone (named hORL1) was isolated, sequenced and found to encode a protein of 370 amino acids whose primary structure displays the seven putative membrane-spanning domains of a G protein-coupled membrane receptor.  The hORL1 receptor is most closely related to opioid receptors not only on structural (sequence) but also on functional grounds: hORL1 is 49-50% identical to the murine μ-, δ- and κ-opioid receptors and, in CHO-K1 cells stably transfected with a pRc/CMV:hORL1 construct, ORL1 mediates inhibition of adenylyl cyclase by etorphine, a universal (nonselective) opiate agonist.  Yet, hORL1 appears not to be a typical opioid receptor.  Neither is it a somatostatin or σ (N-allylnormetazocine) receptor.  The mRNAs hybridizing with synthetic oligonucleotides complementary to mOP86 are present in many regions of the mouse brain and spinal cord, particularly in limbic (amygdala, hippocampus, septum, habenula, ...) and hypothalamic structures.  The authors conclude that the hORL1 receptor is a new member of the opioid receptor family with a potential role in modulating a no. of brain functions, including instinctive behaviors and emotions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWFR7ExrwbJrVg90H21EOLACvtfcHk0ljJ4XUpvS8E1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D&md5=7a7190c4703811558b3ce3e60e9df7e8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980235-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980235-1%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DMailleux%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DChalon%26aufirst%3DP.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26atitle%3DORL1%252C%2520a%2520novel%2520member%2520of%2520the%2520opioid%2520receptor%2520family.%2520Cloning%252C%2520functional%2520expression%2520and%2520localization%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D341%26spage%3D33%26epage%3D38%26doi%3D10.1016%2F0014-5793%2894%2980235-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortrud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)00561-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2900561-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1994&pages=284-288&author=J.+R.+Bunzowauthor=C.+Saezauthor=M.+Mortrudauthor=C.+Bouvierauthor=J.+T.+Williamsauthor=M.+Lowauthor=D.+K.+Grandy&title=Molecular+cloning+and+tissue+distribution+of+a+putative+member+of+the+rat+opioid+receptor+gene+family+that+is+not+a+mu%2C+delta+or+kappa+opioid+receptor+type&doi=10.1016%2F0014-5793%2894%2900561-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900561-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900561-3%26sid%3Dliteratum%253Aachs%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DSaez%26aufirst%3DC.%26aulast%3DMortrud%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DLow%26aufirst%3DM.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DMolecular%2520cloning%2520and%2520tissue%2520distribution%2520of%2520a%2520putative%2520member%2520of%2520the%2520rat%2520opioid%2520receptor%2520gene%2520family%2520that%2520is%2520not%2520a%2520mu%252C%2520delta%2520or%2520kappa%2520opioid%2520receptor%2520type%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D347%26spage%3D284%26epage%3D288%26doi%3D10.1016%2F0014-5793%2894%2900561-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Fukuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span> </span><span class="NLM_article-title">cDNA cloning and regional distribution of a novel member of the opioid receptor family</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)80603-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2980603-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=1994&pages=42-46&author=K.+Fukudaauthor=S.+Katoauthor=K.+Moriauthor=M.+Nishiauthor=H.+Takeshimaauthor=N.+Iwabeauthor=T.+Miyataauthor=T.+Houtaniauthor=T.+Sugimoto&title=cDNA+cloning+and+regional+distribution+of+a+novel+member+of+the+opioid+receptor+family&doi=10.1016%2F0014-5793%2894%2980603-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980603-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980603-9%26sid%3Dliteratum%253Aachs%26aulast%3DFukuda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DNishi%26aufirst%3DM.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DIwabe%26aufirst%3DN.%26aulast%3DMiyata%26aufirst%3DT.%26aulast%3DHoutani%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DT.%26atitle%3DcDNA%2520cloning%2520and%2520regional%2520distribution%2520of%2520a%2520novel%2520member%2520of%2520the%2520opioid%2520receptor%2520family%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D343%26spage%3D42%26epage%3D46%26doi%3D10.1016%2F0014-5793%2894%2980603-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persico, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozenberger, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eppler, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhl, G. R.</span><span> </span><span class="NLM_article-title">cDNA cloning of an orphan opiate receptor gene family member and its splice variant</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)00557-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2900557-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1994&pages=75-79&author=J.+B.+Wangauthor=P.+S.+Johnsonauthor=Y.+Imaiauthor=A.+M.+Persicoauthor=B.+A.+Ozenbergerauthor=C.+M.+Epplerauthor=G.+R.+Uhl&title=cDNA+cloning+of+an+orphan+opiate+receptor+gene+family+member+and+its+splice+variant&doi=10.1016%2F0014-5793%2894%2900557-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900557-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900557-5%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DJohnson%26aufirst%3DP.%2BS.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DPersico%26aufirst%3DA.%2BM.%26aulast%3DOzenberger%26aufirst%3DB.%2BA.%26aulast%3DEppler%26aufirst%3DC.%2BM.%26aulast%3DUhl%26aufirst%3DG.%2BR.%26atitle%3DcDNA%2520cloning%2520of%2520an%2520orphan%2520opiate%2520receptor%2520gene%2520family%2520member%2520and%2520its%2520splice%2520variant%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D348%26spage%3D75%26epage%3D79%26doi%3D10.1016%2F0014-5793%2894%2900557-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Pan, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan-Moro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standifer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1995&pages=1180-1188&author=Y.+X.+Panauthor=J.+Chengauthor=J.+Xuauthor=G.+Rossiauthor=E.+Jacobsonauthor=J.+Ryan-Moroauthor=A.+I.+Brooksauthor=G.+E.+Deanauthor=K.+M.+Standiferauthor=G.+W.+Pasternak&title=Cloning+and+functional+characterization+through+antisense+mapping+of+a+kappa+3-related+opioid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%2BX.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DE.%26aulast%3DRyan-Moro%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DA.%2BI.%26aulast%3DDean%26aufirst%3DG.%2BE.%26aulast%3DStandifer%26aufirst%3DK.%2BM.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DCloning%2520and%2520functional%2520characterization%2520through%2520antisense%2520mapping%2520of%2520a%2520kappa%25203-related%2520opioid%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1995%26volume%3D47%26spage%3D1180%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Meunier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suaudeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moisand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvinerie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsarrat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span> </span><span class="NLM_article-title">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1038/377532a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2F377532a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=7566152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=532-535&author=J.+C.+Meunierauthor=C.+Mollereauauthor=L.+Tollauthor=C.+Suaudeauauthor=C.+Moisandauthor=P.+Alvinerieauthor=J.+L.+Butourauthor=J.+C.+Guillemotauthor=P.+Ferraraauthor=B.+Monsarratauthor=H.+Mazarguilauthor=G.+Vassartauthor=M.+Parmentierauthor=J.+Costentin&title=Isolation+and+structure+of+the+endogenous+agonist+of+opioid+receptor-like+ORL1+receptor&doi=10.1038%2F377532a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span></div><div class="casAuthors">Meunier, Jean-Claude; Mollereau, Catherine; Toll, Lawrence; Suaudeau, Charles; Moisand, Christiane; Alvinerie, Paul; Butour, Jean-Luc; Guillemot, Jean-Claude; Ferrara, Pascual; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">6549</span>),
    <span class="NLM_cas:pages">532-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The ORL1 receptor, an orphan receptor whose human and murine complementary DNAs have recently been characterized, structurally resembles opioid receptors and is neg. coupled with adenylate cyclase.  ORL1 transcripts are particularly abundant in the central nervous system.  Here the authors report the isolation, on the basis of its ability to inhibit the cyclase in a stable recombinant CHO(ORL1+) cell line, of a neuropeptide that resembles dynorphin A and whose amino acid sequences is Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln.  A rat-brain cDNA encodes the peptide flanked by Lys-Arg proteolytic cleavage motifs.  The synthetic heptadecapeptide potently inhibits adenylate cyclase in CHO(ORL1+) cells in culture and induces hyperalgesia when administered intracerebroventricularly to mice.  Taken together, these data indicate that the newly discovered heptadecapeptide is an endogenous agonist of the ORL1 receptor and that it may be endowed with pro-nociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Ma-3fqZODbVg90H21EOLACvtfcHk0ljrOAXG1FSXvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D&md5=664f5b56671b66e3c7caee4d2acc4a5b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F377532a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F377532a0%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DSuaudeau%26aufirst%3DC.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DAlvinerie%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DGuillemot%26aufirst%3DJ.%2BC.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DMonsarrat%26aufirst%3DB.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DIsolation%2520and%2520structure%2520of%2520the%2520endogenous%2520agonist%2520of%2520opioid%2520receptor-like%2520ORL1%2520receptor%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D532%26epage%3D535%26doi%3D10.1038%2F377532a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nothacker, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henningsen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.1126/science.270.5237.792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1126%2Fscience.270.5237.792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=7481766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=792-794&author=R.+K.+Reinscheidauthor=H.+P.+Nothackerauthor=A.+Boursonauthor=A.+Ardatiauthor=R.+A.+Henningsenauthor=J.+R.+Bunzowauthor=D.+K.+Grandyauthor=H.+Langenauthor=F.+J.+Monsmaauthor=O.+Civelli&title=Orphanin+FQ%3A+a+neuropeptide+that+activates+an+opioidlike+G+protein-coupled+receptor&doi=10.1126%2Fscience.270.5237.792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span></div><div class="casAuthors">Reinscheid, Rainer K.; Nothacker, Hans-Peter; Bourson, Anne; Ardati, Ali; Henningsen, Robert A.; Bunzow, James R.; Grady, David K.; Langen, Hanno; Monsma, Frederick J., Jr.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">5237</span>),
    <span class="NLM_cas:pages">792-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A heptadecapeptide was identified and purified from porcine brain tissue as a ligand for an orphan heterotrimeric GTP-binding protein (G protein)- coupled receptor (LC132) that is similar in sequence to opioid receptors.  This peptide, orphanin FQ, has a primary structure reminiscent of that of opioid peptides.  Nanomolar concns. of orphanin FQ inhibited forskolin-stimulated adenylyl cyclase activity in cells transfected with LC132.  This inhibitory activity was not affected by the addn. of opioid ligands, nor did the peptide activate opioid receptors.  Orphanin FQ bound to its receptor in a saturable manner and with high affinity.  When injected intracerebroventricularly into mice, orphanin FQ caused a decrease in locomotor activity but did not induce analgesia in the hot-plate test.  However, the peptide produced hyperalgesia in the tail-flick assay.  Thus, orphanin FQ may act as a transmitter in the brain by modulating nociceptive and locomotor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpERb2sP0w_6bVg90H21EOLACvtfcHk0ljrOAXG1FSXvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D&md5=64b046d1497af57d0841c0de710dcad5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.270.5237.792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.270.5237.792%26sid%3Dliteratum%253Aachs%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DNothacker%26aufirst%3DH.%2BP.%26aulast%3DBourson%26aufirst%3DA.%26aulast%3DArdati%26aufirst%3DA.%26aulast%3DHenningsen%26aufirst%3DR.%2BA.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLangen%26aufirst%3DH.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DOrphanin%2520FQ%253A%2520a%2520neuropeptide%2520that%2520activates%2520an%2520opioidlike%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D792%26epage%3D794%26doi%3D10.1126%2Fscience.270.5237.792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouledous, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapalu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambois, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moisand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J. C.</span><span> </span><span class="NLM_article-title">Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=324-331&author=C.+Mollereauauthor=L.+Mouledousauthor=S.+Lapaluauthor=G.+Camboisauthor=C.+Moisandauthor=J.+L.+Butourauthor=J.+C.+Meunier&title=Distinct+mechanisms+for+activation+of+the+opioid+receptor-like+1+and+kappa-opioid+receptors+by+nociceptin+and+dynorphin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DMouledous%26aufirst%3DL.%26aulast%3DLapalu%26aufirst%3DS.%26aulast%3DCambois%26aufirst%3DG.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26atitle%3DDistinct%2520mechanisms%2520for%2520activation%2520of%2520the%2520opioid%2520receptor-like%25201%2520and%2520kappa-opioid%2520receptors%2520by%2520nociceptin%2520and%2520dynorphin%2520A%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D55%26spage%3D324%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Yu, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C. W.</span><span> </span><span class="NLM_article-title">Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus</span> <span class="citation_source-journal">Hippocampus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1002/(SICI)1098-1063(1997)7:1<88::AID-HIPO9>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=88-94&author=T.+P.+Yuauthor=J.+Feinauthor=T.+Phanauthor=C.+J.+Evansauthor=C.+W.+Xie&title=Orphanin+FQ+inhibits+synaptic+transmission+and+long-term+potentiation+in+rat+hippocampus&doi=10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1063%25281997%25297%253A1%253C88%253A%253AAID-HIPO9%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DT.%2BP.%26aulast%3DFein%26aufirst%3DJ.%26aulast%3DPhan%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DC.%2BJ.%26aulast%3DXie%26aufirst%3DC.%2BW.%26atitle%3DOrphanin%2520FQ%2520inhibits%2520synaptic%2520transmission%2520and%2520long-term%2520potentiation%2520in%2520rat%2520hippocampus%26jtitle%3DHippocampus%26date%3D1997%26volume%3D7%26spage%3D88%26epage%3D94%26doi%3D10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hawes, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span> </span><span class="NLM_article-title">Cellular actions of nociceptin: transduction mechanisms</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1016/S0196-9781(00)00232-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0196-9781%2800%2900232-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=961-967&author=B.+E.+Hawesauthor=M.+P.+Grazianoauthor=D.+G.+Lambert&title=Cellular+actions+of+nociceptin%3A+transduction+mechanisms&doi=10.1016%2FS0196-9781%2800%2900232-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900232-1%26sid%3Dliteratum%253Aachs%26aulast%3DHawes%26aufirst%3DB.%2BE.%26aulast%3DGraziano%26aufirst%3DM.%2BP.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCellular%2520actions%2520of%2520nociceptin%253A%2520transduction%2520mechanisms%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D961%26epage%3D967%26doi%3D10.1016%2FS0196-9781%2800%2900232-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Briscini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span> </span><span class="NLM_article-title">Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/S0014-2999(02)01833-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2802%2901833-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12106803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2002&pages=59-65&author=L.+Brisciniauthor=L.+Corradiniauthor=E.+Onginiauthor=R.+Bertorelli&title=Up-regulation+of+ORL-1+receptors+in+spinal+tissue+of+allodynic+rats+after+sciatic+nerve+injury&doi=10.1016%2FS0014-2999%2802%2901833-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury</span></div><div class="casAuthors">Briscini, Luca; Corradini, Laura; Ongini, Ennio; Bertorelli, Rosalia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-65</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Nociceptin, acting through the opioid receptor-like 1 (ORL1) receptor, produces anti-nociception in several models of neuropathy.  We examd. the involvement of the ORL1 receptor system in the allodynia developed after sciatic nerve ligation.  Allodyniac rats were selected by the von Frey hair and treated intrathecally with nociception or morphine.  The peptide induced dose-dependent anti-allodynic activities, while morphine was effective at the higher dose only.  By the semi-quant. reverse transcription-polymerase chain reaction (RT-PCR) assay, the two described ORL1 receptor isoforms were up-regulated in the allodynic animals, but unmodified in non-allodynic rats.  Both short and long ORL1 receptor mRNA isoforms increased in the ipsilateral lumbar enlargement (by 50% and 100%, resp.), while 50% and 60% increases were found in the ipsilateral L5-L6 dorsal root ganglia, resp.  No significant changes were obsd. for either the nociception precursor or μ-opioid receptor expression.  Thus, the ORL1 receptor system seems to regulate the mechano-allodynia that developed after nerve damage, suggesting its potential role in the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2Ql1yMFL4rVg90H21EOLACvtfcHk0lhpGQXwI6RbgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFWjs78%253D&md5=86c920a656ceda72780aaf8d876b832e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901833-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901833-2%26sid%3Dliteratum%253Aachs%26aulast%3DBriscini%26aufirst%3DL.%26aulast%3DCorradini%26aufirst%3DL.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DBertorelli%26aufirst%3DR.%26atitle%3DUp-regulation%2520of%2520ORL-1%2520receptors%2520in%2520spinal%2520tissue%2520of%2520allodynic%2520rats%2520after%2520sciatic%2520nerve%2520injury%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D447%26spage%3D59%26epage%3D65%26doi%3D10.1016%2FS0014-2999%2802%2901833-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenach, J. C.</span><span> </span><span class="NLM_article-title">Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">970</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/S0006-8993(03)02293-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0006-8993%2803%2902293-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12706252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFeqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=970&publication_year=2003&pages=110-118&author=W.+Maauthor=J.+C.+Eisenach&title=Chronic+constriction+injury+of+sciatic+nerve+induces+the+up-regulation+of+descending+inhibitory+noradrenergic+innervation+to+the+lumbar+dorsal+horn+of+mice&doi=10.1016%2FS0006-8993%2803%2902293-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice</span></div><div class="casAuthors">Ma, Weiya; Eisenach, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">970</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">110-118</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Peripheral nerve injury in rodents results in hypersensitivity to mech. and thermal stimuli accompanied by reduced antinociceptive efficacy of opioids and, in some models, sensitivity to sympathetic blockade.  α2-Adrenergic receptor agonists increase in potency and efficacy after nerve injury in rodents and effectively relieve neuropathic pain in humans who do not get pain relief from opioids.  However, the underlying mechanisms are unclear.  It has been well known that the major noradrenergic innervation of the spinal dorsal horn originates from the locus coeruleus nucleus (LC) in the brainstem.  Therefore, the aim of this study is to examine whether peripheral nerve injury that causes neuropathic pain modulates the noradrenergic innervation to the lumbar dorsal horn, in order to det. the possible anatomical substrates underlying increased potency and efficacy of noradrenergic receptor agonists in alleviating neuropathic pain.  At 2 wk after chronic constriction injury (CCI) of the sciatic nerve, a remarkable increase in tyrosine-hydroxylase (TH) and dopamine β-hydroxylase (DβH) immunoreactive (IR) axonal terminals was obsd. in the ipsilateral L4-L6 dorsal horn.  Consistently, greater nos. of both TH- and DβH-IR neurons were detected in the ipsilateral LC.  Interestingly, in the lower lumbar and upper sacral spinal dorsal horn, numerous TH-IR neurons were obsd. in the superficial dorsal horn (primarily lamina I).  CCI of the sciatic nerve did not change the no. of these TH-IR cells.  These findings suggest that augmented descending inhibitory noradrenergic innervation to the dorsal horn could be one of the mechanisms underlying the increased effectiveness in the anti-allodynic effect elicited by α2-adrenergic receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCSiYg-eRHSbVg90H21EOLACvtfcHk0lhpGQXwI6RbgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFeqtLs%253D&md5=961f4a46808293a06ad6625fedd8acb7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2803%2902293-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252803%252902293-5%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DEisenach%26aufirst%3DJ.%2BC.%26atitle%3DChronic%2520constriction%2520injury%2520of%2520sciatic%2520nerve%2520induces%2520the%2520up-regulation%2520of%2520descending%2520inhibitory%2520noradrenergic%2520innervation%2520to%2520the%2520lumbar%2520dorsal%2520horn%2520of%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2003%26volume%3D970%26spage%3D110%26epage%3D118%26doi%3D10.1016%2FS0006-8993%2803%2902293-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mika, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weihe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M. K.</span><span> </span><span class="NLM_article-title">Relationship of pronociceptin/orphanin FQ and the nociceptin receptor ORL1 with Substance P and calcitonin gene-related peptide expression in dorsal root ganglion of the rat</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span><span class="refDoi"> DOI: 10.1016/S0304-3940(03)00786-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2803%2900786-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=190-194&author=J.+Mikaauthor=Y.+Liauthor=E.+Weiheauthor=M.+K.+Schafer&title=Relationship+of+pronociceptin%2Forphanin+FQ+and+the+nociceptin+receptor+ORL1+with+Substance+P+and+calcitonin+gene-related+peptide+expression+in+dorsal+root+ganglion+of+the+rat&doi=10.1016%2FS0304-3940%2803%2900786-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2803%2900786-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252803%252900786-9%26sid%3Dliteratum%253Aachs%26aulast%3DMika%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeihe%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26atitle%3DRelationship%2520of%2520pronociceptin%252Forphanin%2520FQ%2520and%2520the%2520nociceptin%2520receptor%2520ORL1%2520with%2520Substance%2520P%2520and%2520calcitonin%2520gene-related%2520peptide%2520expression%2520in%2520dorsal%2520root%2520ganglion%2520of%2520the%2520rat%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D348%26spage%3D190%26epage%3D194%26doi%3D10.1016%2FS0304-3940%2803%2900786-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, C.</span><span> </span><span class="NLM_article-title">Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing</span> <span class="citation_source-journal">J. Peripher. Nerv. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1111/j.1529-8027.2006.0093.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1529-8027.2006.0093.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16930285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKqsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=232-240&author=Y.+Chenauthor=C.+Sommer&title=Nociceptin+and+its+receptor+in+rat+dorsal+root+ganglion+neurons+in+neuropathic+and+inflammatory+pain+models%3A+implications+on+pain+processing&doi=10.1111%2Fj.1529-8027.2006.0093.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing</span></div><div class="casAuthors">Chen, Yong; Sommer, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Peripheral Nervous System</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-240</span>CODEN:
                <span class="NLM_cas:coden">JPNSFO</span>;
        ISSN:<span class="NLM_cas:issn">1085-9489</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Nociceptin (NC), by activating its receptor, the opioid receptor-like 1 (ORL1) receptor, exerts an effect on a no. of functions in the nervous system including locomotion, learning and memory, and processing of pain signals.  Data on the expression of NC and ORL1 receptor in dorsal root ganglion (DRG) neurons and on its modulation after nerve injury and inflammation are controversial.  We therefore sought to investigate the immunoreactivity (IR) of NC and ORL1 receptor in DRG neurons in two pain models, a pure neuropathic pain model, namely partial sciatic nerve transection (PST), and an inflammatory pain model, complete Freund's adjuvant (CFA) injection into the hindpaw.  In intact DRG neurons, both NC and ORL1 receptor IR were present in mainly small- and medium-sized neurons, NC IR in 31% and ORL1 receptor IR in 33% of all neuronal profiles.  Both NC and ORL1 receptor IR were upregulated 7 days after nerve injury (to 56 and 55%) and inflammation (to 53 and 48%), resp.  Activating transcription factor 3 (ATF3), a neuronal marker of nerve injury, was induced in DRG neurons 7 and 14 days after PST and 7 days after CFA injection.  Double labeling with ATF3 revealed expression of NC and ORL1 receptor in intact as well as in injured primary afferent neurons.  Thus, NC and the ORL1 receptor may be involved in the modulation of neuropathic and inflammatory pain at the level of the primary afferent neuron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXOyqSirpvFbVg90H21EOLACvtfcHk0lhpGQXwI6RbgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKqsrbN&md5=5493c46d6861da702f11bf8666e66b63</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1529-8027.2006.0093.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1529-8027.2006.0093.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSommer%26aufirst%3DC.%26atitle%3DNociceptin%2520and%2520its%2520receptor%2520in%2520rat%2520dorsal%2520root%2520ganglion%2520neurons%2520in%2520neuropathic%2520and%2520inflammatory%2520pain%2520models%253A%2520implications%2520on%2520pain%2520processing%26jtitle%3DJ.%2520Peripher.%2520Nerv.%2520Syst.%26date%3D2006%26volume%3D11%26spage%3D232%26epage%3D240%26doi%3D10.1111%2Fj.1529-8027.2006.0093.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, C.</span><span> </span><span class="NLM_article-title">Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span><span class="refDoi"> DOI: 10.1002/jnr.21272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2Fjnr.21272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17387690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=1478-1488&author=Y.+Chenauthor=C.+Sommer&title=Activation+of+the+nociceptin+opioid+system+in+rat+sensory+neurons+produces+antinociceptive+effects+in+inflammatory+pain%3A+involvement+of+inflammatory+mediators&doi=10.1002%2Fjnr.21272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators</span></div><div class="casAuthors">Chen, Yong; Sommer, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1478-1488</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Despite a large body of literature on the nociceptin (NC) opioid system in pain modulation, the mechanism of action of NC remains largely unexplored.  Here, the authors investigated the role and mode of action of the spinal NC system in inflammatory pain.  Preemptive intrathecal administration of NC attenuated thermal hyperalgesia and mech. allodynia in rats with intraplantar complete Freund's adjuvant (CFA) injection.  By using immunohistochem. in L4 dorsal root ganglion (DRG) neurons, a marked increase of NC and ORL1 receptor immunoreactivity was detected following CFA.  Intrathecal administration of NC attenuated the CFA-induced increases of calcitonin gene-related peptide, transient receptor potential vanilloid-1, and tumor necrosis factor-α in DRG neurons.  Real-time reverse transcription-polymerase chain reaction showed that NC reduced the up-regulation of inducible nitric oxide synthase mRNA but not that of neuronal nitric oxide synthase mRNA in spinal cord segments after CFA.  Furthermore, [Nphe1]NC(1-13)NH2, a selective opioid receptor-like 1 (ORL1) receptor antagonist, significantly antagonized the effects of NC on pain modulation and on the expression of inflammatory mediators, indicating a specific NC action through the ORL1 receptor.  Together, these findings reveal novel mechanisms by which the NC system produces analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdWPGzi_94D7Vg90H21EOLACvtfcHk0lhLiRoF6P34QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVWlur0%253D&md5=d58f1d30a2c74adaacc35abe63f8dad1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21272%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSommer%26aufirst%3DC.%26atitle%3DActivation%2520of%2520the%2520nociceptin%2520opioid%2520system%2520in%2520rat%2520sensory%2520neurons%2520produces%2520antinociceptive%2520effects%2520in%2520inflammatory%2520pain%253A%2520involvement%2520of%2520inflammatory%2520mediators%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2007%26volume%3D85%26spage%3D1478%26epage%3D1488%26doi%3D10.1002%2Fjnr.21272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serie, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seybold, V. S.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1016/S0304-3940(98)00430-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2898%2900430-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1998&pages=21-24&author=Y.+Jiaauthor=D.+R.+Lindenauthor=J.+R.+Serieauthor=V.+S.+Seybold&title=Nociceptin%2Forphanin+FQ+binding+increases+in+superficial+laminae+of+the+rat+spinal+cord+during+persistent+peripheral+inflammation&doi=10.1016%2FS0304-3940%2898%2900430-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2898%2900430-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252898%252900430-3%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DLinden%26aufirst%3DD.%2BR.%26aulast%3DSerie%26aufirst%3DJ.%2BR.%26aulast%3DSeybold%26aufirst%3DV.%2BS.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520binding%2520increases%2520in%2520superficial%2520laminae%2520of%2520the%2520rat%2520spinal%2520cord%2520during%2520persistent%2520peripheral%2520inflammation%26jtitle%3DNeurosci.%2520Lett.%26date%3D1998%26volume%3D250%26spage%3D21%26epage%3D24%26doi%3D10.1016%2FS0304-3940%2898%2900430-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarubbo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biguzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lettieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quatrale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candeletti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romualdi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1732</span><span class="refDoi"> DOI: 10.1002/mds.23271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2Fmds.23271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20589874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC3cjntlyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=1723-1732&author=M.+Martiauthor=S.+Sarubboauthor=F.+Latiniauthor=M.+Cavalloauthor=R.+Eleopraauthor=S.+Biguzziauthor=C.+Lettieriauthor=C.+Contiauthor=M.+Simonatoauthor=S.+Zucchiniauthor=R.+Quatraleauthor=M.+Sensiauthor=S.+Candelettiauthor=P.+Romualdiauthor=M.+Morari&title=Brain+interstitial+nociceptin%2Forphanin+FQ+levels+are+elevated+in+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.23271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease</span></div><div class="casAuthors">Marti Matteo; Sarubbo Silvio; Latini Francesco; Cavallo Michele; Eleopra Roberto; Biguzzi Sara; Lettieri Christian; Conti Carlo; Simonato Michele; Zucchini Silvia; Quatrale Rocco; Sensi Mariachiara; Candeletti Sanzio; Romualdi Patrizia; Morari Michele</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders : official journal of the Movement Disorder Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1723-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Expression and release of nociceptin/orphanin FQ (N/OFQ) are elevated in the substantia nigra reticulata of 6-hydroxydopamine-hemilesioned rats, suggesting a pathogenic role for N/OFQ in Parkinson's disease.  In this study, we investigated whether elevation of N/OFQ expression in 6-hydroxydopamine-hemilesioned rats selectively occurs in substantia nigra and whether hypomotility following acute haloperidol administration is accompanied by a rise in nigral N/OFQ levels.  Moreover, to prove a link between N/OFQ and idiopathic Parkinson's disease in humans, we measured N/OFQ levels in the cerebrospinal fluid of parkinsonian patients undergoing surgery for deep brain stimulation.  In situ hybridization demonstrated that dopamine depletion was associated with increase of N/OFQ expression in substantia nigra (compacta +160%, reticulata +105%) and subthalamic nucleus (+45%), as well as reduction in caudate putamen (-20%).  No change was observed in globus pallidus, nucleus accumbens, thalamus, and motor cortex.  Microdialysis coupled to the bar test allowed to demonstrate that acute administration of haloperidol (0.8 and 3 mg/kg) increased nigral N/OFQ levels (maximally of +47% and +53%, respectively) in parallel with akinesia.  A correlation with preclinical studies was found by analyzing N/OFQ levels in humans.  Indeed, N/OFQ levels were found to be approximately 3.5-fold elevated in the cerebrospinal fluid of parkinsonian patients (148 fmol/ml) compared with nonparkinsonian neurologic controls (41 fmol/ml).  These data represent the first clinical evidence linking N/OFQ to idiopathic Parkinson's disease in humans.  They strengthen the pathogenic role of N/OFQ in the modulation of parkinsonism across species and provide a rationale for developing N/OFQ receptor antagonists as antiparkinsonian drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1HYQVGZGxJFWTCLT8lX9SfW6udTcc2eZuCDIfZYySQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjntlyhuw%253D%253D&md5=ca6bc5c0248c9c288061d9c7cb55e221</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmds.23271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.23271%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DSarubbo%26aufirst%3DS.%26aulast%3DLatini%26aufirst%3DF.%26aulast%3DCavallo%26aufirst%3DM.%26aulast%3DEleopra%26aufirst%3DR.%26aulast%3DBiguzzi%26aufirst%3DS.%26aulast%3DLettieri%26aufirst%3DC.%26aulast%3DConti%26aufirst%3DC.%26aulast%3DSimonato%26aufirst%3DM.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DQuatrale%26aufirst%3DR.%26aulast%3DSensi%26aufirst%3DM.%26aulast%3DCandeletti%26aufirst%3DS.%26aulast%3DRomualdi%26aufirst%3DP.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DBrain%2520interstitial%2520nociceptin%252Forphanin%2520FQ%2520levels%2520are%2520elevated%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2010%26volume%3D25%26spage%3D1723%26epage%3D1732%26doi%3D10.1002%2Fmds.23271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malfacini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calò, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02219.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1476-5381.2012.02219.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22994368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlCrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=863-879&author=M.+Martiauthor=F.+Melaauthor=M.+Budriauthor=M.+Voltaauthor=D.+Malfaciniauthor=S.+Molinariauthor=N.+T.+Zaveriauthor=S.+Ronzoniauthor=P.+Petrilloauthor=G.+Cal%C3%B2author=M.+Morari&title=Acute+and+chronic+antiparkinsonian+effects+of+the+novel+nociceptin%2Forphanin+FQ+receptor+antagonist+NiK-21273+in+comparison+with+SB-612111&doi=10.1111%2Fj.1476-5381.2012.02219.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111</span></div><div class="casAuthors">Marti, M.; Mela, F.; Budri, M.; Volta, M.; Malfacini, D.; Molinari, S.; Zaveri, N. T.; Ronzoni, S.; Petrillo, P.; Calo, G.; Morari, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">863-879</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor antagonists have been proposed as a novel therapeutic approach to Parkinson's disease.  Main limitations of previous studies were the use of structurally similar compds. and the evaluation of their acute effects only.  We report here on the acute and long-term antiparkinsonian effects of the novel compd. 2-[3-[4-(2-chloro-6-fluoro-phenyl)-piperidin-1-ylmethyl]-2-(morpholine-4-carbonyl)-indol-1-yl]-acetamide (NiK-21273) in comparison with the potent and selective NOP receptor antagonist SB-612111.  Basic pharmacol. properties of NiK-21273 were studied in cell lines and isolated tissues (mouse and rat vas deferens).  Antiparkinsonian effects were studied in reserpinized mice and 6-hydroxydopamine hemilesioned rats under both acute and chronic administration protocols.  In vitro, NiK-21273 behaved as a potent (pA2 7.7) and selective NOP receptor antagonist.  In vivo, it reduced hypokinesia in reserpinized mice at 0.1 and 1 but not 10 mg·kg-1, whereas SB-612111 (0.01-1 mg·kg-1) provided a dose-dependent antiparkinsonian effect.  NiK-21273 ameliorated motor performance in 6-hydroxydopamine hemilesioned rats at 0.5 and 5 but not 15 mg·kg-1.  SB-612111 replicated these effects in the 0.01-1 mg·kg-1 range without loss of efficacy.  Both antagonists synergized with L-DOPA at subthreshold doses.  Chronic administration of NiK-21273 provided delayed improvement in baseline activity at 0.5 and 1.5 mg·kg-1, although tolerance to the higher dose was obsd.  Conversely, SB-612111 (1 mg·kg-1) maintained its effects over time without modifying baseline activity.  NOP receptor antagonists provide motor benefit in parkinsonism models although the "therapeutic" window and long-term effects may vary between compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraKmOpwrHrPrVg90H21EOLACvtfcHk0lhLiRoF6P34QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlCrtbc%253D&md5=88649abb548dc7148ce42dadf9cbc596</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02219.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02219.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMela%26aufirst%3DF.%26aulast%3DBudri%26aufirst%3DM.%26aulast%3DVolta%26aufirst%3DM.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DPetrillo%26aufirst%3DP.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DAcute%2520and%2520chronic%2520antiparkinsonian%2520effects%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520NiK-21273%2520in%2520comparison%2520with%2520SB-612111%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D863%26epage%3D879%26doi%3D10.1111%2Fj.1476-5381.2012.02219.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Visanji, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bie, R. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCreary, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. H.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1922</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span><span class="refDoi"> DOI: 10.1002/mds.22086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2Fmds.22086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=1922-1925&author=N.+P.+Visanjiauthor=R.+M.+A.+de+Bieauthor=T.+H.+Johnstonauthor=A.+C.+McCrearyauthor=J.+M.+Brotchieauthor=S.+H.+Fox&title=The+nociceptin%2Forphanin+FQ+%28NOP%29+receptor+antagonist+J-113397+enhances+the+effects+of+levodopa+in+the+MPTP-lesioned+nonhuman+primate+model+of+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.22086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fmds.22086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.22086%26sid%3Dliteratum%253Aachs%26aulast%3DVisanji%26aufirst%3DN.%2BP.%26aulast%3Dde%2BBie%26aufirst%3DR.%2BM.%2BA.%26aulast%3DJohnston%26aufirst%3DT.%2BH.%26aulast%3DMcCreary%26aufirst%3DA.%2BC.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26aulast%3DFox%26aufirst%3DS.%2BH.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%2520antagonist%2520J-113397%2520enhances%2520the%2520effects%2520of%2520levodopa%2520in%2520the%2520MPTP-lesioned%2520nonhuman%2520primate%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3D1922%26epage%3D1925%26doi%3D10.1002%2Fmds.22086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Viaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Pernaute, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span><span class="refDoi"> DOI: 10.1016/j.nbd.2008.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.nbd.2008.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18413287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlShs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=430-438&author=R.+Viaroauthor=R.+Sanchez-Pernauteauthor=M.+Martiauthor=C.+Trapellaauthor=O.+Isacsonauthor=M.+Morari&title=Nociceptin%2Forphanin+FQ+receptor+blockade+attenuates+MPTP-induced+parkinsonism&doi=10.1016%2Fj.nbd.2008.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism</span></div><div class="casAuthors">Viaro, Riccardo; Sanchez-Pernaute, Rosario; Marti, Matteo; Trapella, Claudio; Isacson, Ole; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">430-438</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Endogenous nociceptin/orphanin FQ (N/OFQ) inhibits the activity of dopamine neurons in the substantia nigra and affects motor behavior.  In this study we investigated whether a N/OFQ receptor (NOP) antagonist, J-113397, can modify movement in naive mice and nonhuman primates and attenuate motor deficits in MPTP-treated parkinsonian animals.  J-113397 facilitated motor activity in naive mice at low doses (0.1-1 mg/kg) and inhibited it at higher ones (10 mg/kg).  Likewise, in MPTP-treated mice, J-113397 reversed motor deficit at 0.01 mg/kg but worsened hypokinesia at higher doses (1 mg/kg).  In naive nonhuman primates, J-113397, ineffective up to 1 mg/kg, produced inconsistent motor improvements at 3 mg/kg.  Conversely, in parkinsonian primates J-113397 (0.01 mg/kg) reversed parkinsonism, being most effective against hypokinesia.  We conclude that endogenous N/OFQ modulates motor activity in mice and nonhuman primates and contributes to parkinsonian symptoms in MPTP-treated animals.  NOP receptor antagonists may represent a novel approach to Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW6b77UNWC3rVg90H21EOLACvtfcHk0ljuQHeVFspEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlShs7s%253D&md5=52c63df34902638af353e5de9146eb0d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DViaro%26aufirst%3DR.%26aulast%3DSanchez-Pernaute%26aufirst%3DR.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DIsacson%26aufirst%3DO.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520blockade%2520attenuates%2520MPTP-induced%2520parkinsonism%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2008%26volume%3D30%26spage%3D430%26epage%3D438%26doi%3D10.1016%2Fj.nbd.2008.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chau, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. I.</span><span> </span><span class="NLM_article-title">The neural circuitry of reward and its relevance to psychiatric disorders</span> <span class="citation_source-journal">Curr. Psychiatry Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1007/s11920-004-0026-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs11920-004-0026-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15355762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD2cvkslyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=391-399&author=D.+T.+Chauauthor=R.+M.+Rothauthor=A.+I.+Green&title=The+neural+circuitry+of+reward+and+its+relevance+to+psychiatric+disorders&doi=10.1007%2Fs11920-004-0026-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The neural circuitry of reward and its relevance to psychiatric disorders</span></div><div class="casAuthors">Chau David T; Roth Robert M; Green Alan I</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-9</span>
        ISSN:<span class="NLM_cas:issn">1523-3812</span>.
    </div><div class="casAbstract">Scientific interest in how the brain processes reward has burgeoned during the past 50 years since the discovery that rats will do tasks such as pressing a lever to obtain electrical stimulation of the brain.  This interest was additionally encouraged by the observation of an association between reward and dopamine activity in the mesocorticolimbic system.  In this article, we will discuss the complex nature of reward processing and recent animal studies and human functional neuroimaging studies to elucidate the current understanding of the neural substrates of reward processing and its components.  Lastly, we will review recent theoretical and empirical work investigating the role of brain reward circuitry in several psychiatric disorders, including substance use disorders, schizophrenia, pathologic gambling, major depressive disorder, and attention-deficit/hyperactivity disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSa5E42Hae79UHdcurJClFcfW6udTcc2eZSeCICa81suLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvkslyjsg%253D%253D&md5=9d95dbf7a7eaf1b3c0f8c04245780934</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs11920-004-0026-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-004-0026-8%26sid%3Dliteratum%253Aachs%26aulast%3DChau%26aufirst%3DD.%2BT.%26aulast%3DRoth%26aufirst%3DR.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BI.%26atitle%3DThe%2520neural%2520circuitry%2520of%2520reward%2520and%2520its%2520relevance%2520to%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2004%26volume%3D6%26spage%3D391%26epage%3D399%26doi%3D10.1007%2Fs11920-004-0026-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Di Giannuario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span> </span><span class="NLM_article-title">Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span><span class="refDoi"> DOI: 10.1016/S0196-9781(00)00250-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0196-9781%2800%2900250-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1125-1130&author=A.+Di+Giannuarioauthor=S.+Pieretti&title=Nociceptin+differentially+affects+morphine-induced+dopamine+release+from+the+nucleus+accumbens+and+nucleus+caudate+in+rats&doi=10.1016%2FS0196-9781%2800%2900250-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900250-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900250-3%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiannuario%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26atitle%3DNociceptin%2520differentially%2520affects%2520morphine-induced%2520dopamine%2520release%2520from%2520the%2520nucleus%2520accumbens%2520and%2520nucleus%2520caudate%2520in%2520rats%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D1125%26epage%3D1130%26doi%3D10.1016%2FS0196-9781%2800%2900250-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Di Giannuario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loizzo, A.</span><span> </span><span class="NLM_article-title">Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1016/S0304-3940(99)00579-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2899%2900579-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1999&pages=183-186&author=A.+Di+Giannuarioauthor=S.+Pierettiauthor=A.+Catalaniauthor=A.+Loizzo&title=Orphanin+FQ+reduces+morphine-induced+dopamine+release+in+the+nucleus+accumbens%3A+a+microdialysis+study+in+rats&doi=10.1016%2FS0304-3940%2899%2900579-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2899%2900579-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252899%252900579-0%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiannuario%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DCatalani%26aufirst%3DA.%26aulast%3DLoizzo%26aufirst%3DA.%26atitle%3DOrphanin%2520FQ%2520reduces%2520morphine-induced%2520dopamine%2520release%2520in%2520the%2520nucleus%2520accumbens%253A%2520a%2520microdialysis%2520study%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D272%26spage%3D183%26epage%3D186%26doi%3D10.1016%2FS0304-3940%2899%2900579-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1016/0306-4522(96)00322-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0306-4522%2896%2900322-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1996&pages=1-4&author=N.+P.+Murphyauthor=H.+T.+Lyauthor=N.+T.+Maidment&title=Intracerebroventricular+orphanin+FQ%2Fnociceptin+suppresses+dopamine+release+in+the+nucleus+accumbens+of+anaesthetized+rats&doi=10.1016%2F0306-4522%2896%2900322-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0306-4522%2896%2900322-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-4522%252896%252900322-3%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DLy%26aufirst%3DH.%2BT.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DIntracerebroventricular%2520orphanin%2520FQ%252Fnociceptin%2520suppresses%2520dopamine%2520release%2520in%2520the%2520nucleus%2520accumbens%2520of%2520anaesthetized%2520rats%26jtitle%3DNeuroscience%26date%3D1996%26volume%3D75%26spage%3D1%26epage%3D4%26doi%3D10.1016%2F0306-4522%2896%2900322-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0730179.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1046%2Fj.1471-4159.1999.0730179.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10386969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK1MXktVeltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1999&pages=179-186&author=N.+P.+Murphyauthor=N.+T.+Maidment&title=Orphanin+FQ%2Fnociceptin+modulation+of+mesolimbic+dopamine+transmission+determined+by+microdialysis&doi=10.1046%2Fj.1471-4159.1999.0730179.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis</span></div><div class="casAuthors">Murphy, Niall P.; Maidment, Nigel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-186</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Orphanin FQ has been reported to suppress extracellular dopamine levels in the nucleus accumbens after intracerebroventricular administration.  This study sought to provide evidence for an intra-ventral tegmental site of action for this effect using a dual-probe microdialysis exptl. design.  Orphanin FQ was applied to the ventral tegmental area of anesthetized rats by reverse dialysis while extracellular dopamine was sampled with a second dialysis probe in the nucleus accumbens.  Orphanin FQ at a probe concn. of 1 mM (but not at 0.1 mM) significantly reduced nucleus accumbens dialyzate dopamine levels.  The receptor-inactive analog, des-Phe1-orphanin FQ (1 mM), produced a small but significant increase in nucleus accumbens dialyzate dopamine levels.  Simultaneous measurement of ventral tegmental area dialyzate amino acid content revealed significant increases in both GABA and glutamate during infusion of orphanin FQ (1 mM).  To det. if increased GABA overflow mediates the action of orphanin FQ on mesolimbic neurons, orphanin FQ (10 nmol) was microinjected directly into the ventral tegmental area in the presence or absence of the GABAA receptor antagonist, bicuculline (1 nmol).  Bicuculline transiently blocked the suppressive action of orphanin FQ on accumbens dialyzate dopamine levels.  These data indicate that orphanin FQ decreases dopamine transmission in the nucleus accumbens by inhibiting dopamine neuronal activity in the ventral tegmental area through a mechanism that may involve an increased overflow of GABA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroKLZTv4fKdbVg90H21EOLACvtfcHk0lhqxQJRjnQ1Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVeltrs%253D&md5=2c8d95426c38f026d4d4a9738998f582</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0730179.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0730179.x%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520modulation%2520of%2520mesolimbic%2520dopamine%2520transmission%2520determined%2520by%2520microdialysis%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D73%26spage%3D179%26epage%3D186%26doi%3D10.1046%2Fj.1471-4159.1999.0730179.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin blocks acquisition of morphine place preference</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">832</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1016/S0006-8993(99)01425-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0006-8993%2899%2901425-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10375664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1SjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=832&publication_year=1999&pages=168-170&author=N.+P.+Murphyauthor=Y.+Leeauthor=N.+T.+Maidment&title=Orphanin+FQ%2Fnociceptin+blocks+acquisition+of+morphine+place+preference&doi=10.1016%2FS0006-8993%2899%2901425-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ/nociceptin blocks acquisition of morphine place preference</span></div><div class="casAuthors">Murphy, Niall P.; Lee, Yohan; Maidment, Nigel T.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">832</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">168-170</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Orphanin FQ/nociceptin (OFQ/N) suppresses the activity of the dopaminergic mesolimbic reward pathway yet reportedly fails to produce conditioned place aversion or preference.  The present study sought to det. if this peptide could attenuate the development of morphine place preference.  Male rats were administered OFQ/N (3 to 30 nmol intracerebroventricularly) during the induction of morphine (3 mg/kg s.c.) place preference.  Animals receiving 3 or 10 nmol (but not 30 nmol) OFQ/N showed significant redns. in the development of place preference to morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJtrwGN6HjhLVg90H21EOLACvtfcHk0lhqxQJRjnQ1Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1SjsLw%253D&md5=3cabd70eb0bd15736fa905cae8a1dcb1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2899%2901425-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252899%252901425-0%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520blocks%2520acquisition%2520of%2520morphine%2520place%2520preference%26jtitle%3DBrain%2520Res.%26date%3D1999%26volume%3D832%26spage%3D168%26epage%3D170%26doi%3D10.1016%2FS0006-8993%2899%2901425-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kotlinska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberring, J.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1097/00008877-200205000-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00008877-200205000-00006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=229-235&author=J.+Kotlinskaauthor=J.+Wichmannauthor=A.+Legowskaauthor=K.+Rolkaauthor=J.+Silberring&title=Orphanin+FQ%2Fnociceptin+but+not+Ro+65-6570+inhibits+the+expression+of+cocaine-induced+conditioned+place+preference&doi=10.1097%2F00008877-200205000-00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1097%2F00008877-200205000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008877-200205000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DKotlinska%26aufirst%3DJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DLegowska%26aufirst%3DA.%26aulast%3DRolka%26aufirst%3DK.%26aulast%3DSilberring%26aufirst%3DJ.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520but%2520not%2520Ro%252065-6570%2520inhibits%2520the%2520expression%2520of%2520cocaine-induced%2520conditioned%2520place%2520preference%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2002%26volume%3D13%26spage%3D229%26epage%3D235%26doi%3D10.1097%2F00008877-200205000-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Sakoori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, N. P.</span><span> </span><span class="NLM_article-title">Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1007/s00213-003-1643-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-003-1643-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=14624329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=129-136&author=K.+Sakooriauthor=N.+P.+Murphy&title=Central+administration+of+nociceptin%2Forphanin+FQ+blocks+the+acquisition+of+conditioned+place+preference+to+morphine+and+cocaine%2C+but+not+conditioned+place+aversion+to+naloxone+in+mice&doi=10.1007%2Fs00213-003-1643-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice</span></div><div class="casAuthors">Sakoori, Kazuto; Murphy, Niall P.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-136</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Previous studies have suggested that nociceptin (known also as orphanin FQ) suppresses the rewarding potential of morphine and alc. in the rat.  However, little is known of the effect of nociceptin on the rewarding properties of these and other drugs in the mouse.  The objective was to det. the effect of nociceptin on opiate or psychostimulant-induced conditioned place preference, or naloxone-induced conditioned place aversion in mice.  C57BL6 mice were implanted with chronically indwelling intracranial cannulae targeted at the lateral cerebroventricle through which nociceptin (0.06, 0.6, or 6 nmol) could be administered.  Animals were conditioned in an unbiased balanced paradigm to study the effect of nociceptin administration alone, or the effect of nociceptin on the acquisition of place conditioning to morphine, cocaine, or naloxone (all 7.6 mg/kg s.c.).  Administration of 0.06 nmol nociceptin alone stimulated locomotion during conditioning sessions, but had no hedonic effects.  In contrast, administration of 6 nmol nociceptin alone markedly reduced basal locomotion during the conditioning sessions and induced a mild place aversion.  Both morphine and cocaine induced robust place preferences, the acquisition of which was dose dependently suppressed by administration of nociceptin at doses of 0.6 nmol and above.  Conditioning with naloxone produced a robust place aversion that was only weakly blocked by the max. dose of nociceptin tested.  Nociceptin blocks the rewarding properties of drugs in both narcotic analgesic and psychostimulant classes in the mouse.  In contrast, nociceptin has only a minor effect on the neg. affective state experienced following naloxone administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw8LFQBUAxxrVg90H21EOLACvtfcHk0ljHZ-0f_Y96tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbw%253D&md5=074461fbdecbf8aab19aa49ec19faf7d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00213-003-1643-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-003-1643-3%26sid%3Dliteratum%253Aachs%26aulast%3DSakoori%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26atitle%3DCentral%2520administration%2520of%2520nociceptin%252Forphanin%2520FQ%2520blocks%2520the%2520acquisition%2520of%2520conditioned%2520place%2520preference%2520to%2520morphine%2520and%2520cocaine%252C%2520but%2520not%2520conditioned%2520place%2520aversion%2520to%2520naloxone%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2004%26volume%3D172%26spage%3D129%26epage%3D136%26doi%3D10.1007%2Fs00213-003-1643-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zhao, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. W.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin blocks methamphetamine place preference in rats</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2383</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span><span class="refDoi"> DOI: 10.1097/00001756-200312190-00019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00001756-200312190-00019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=2383-2385&author=R.+J.+Zhaoauthor=R.+S.+Wooauthor=M.+S.+Jeongauthor=B.+S.+Shinauthor=D.+G.+Kimauthor=K.+W.+Kim&title=Orphanin+FQ%2Fnociceptin+blocks+methamphetamine+place+preference+in+rats&doi=10.1097%2F00001756-200312190-00019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F00001756-200312190-00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200312190-00019%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%2BJ.%26aulast%3DWoo%26aufirst%3DR.%2BS.%26aulast%3DJeong%26aufirst%3DM.%2BS.%26aulast%3DShin%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BG.%26aulast%3DKim%26aufirst%3DK.%2BW.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520blocks%2520methamphetamine%2520place%2520preference%2520in%2520rats%26jtitle%3DNeuroReport%26date%3D2003%26volume%3D14%26spage%3D2383%26epage%3D2385%26doi%3D10.1097%2F00001756-200312190-00019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kotlinska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dylag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberring, J.</span><span> </span><span class="NLM_article-title">Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span><span class="refDoi"> DOI: 10.1016/S0014-2999(03)02081-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2803%2902081-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12921868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Kju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2003&pages=233-239&author=J.+Kotlinskaauthor=P.+Rafalskiauthor=G.+Bialaauthor=T.+Dylagauthor=K.+Rolkaauthor=J.+Silberring&title=Nociceptin+inhibits+acquisition+of+amphetamine-induced+place+preference+and+sensitization+to+stereotypy+in+rats&doi=10.1016%2FS0014-2999%2803%2902081-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats</span></div><div class="casAuthors">Kotlinska, Jolanta; Rafalski, Piotr; Biala, Grazyna; Dylag, Tomasz; Rolka, Krzysztof; Silberring, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">233-239</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Nociceptin (also called orphanin FQ), a 17-amino-acid peptide, is the natural ligand of the nociceptin opioid peptide (NOP) receptor.  This peptide shows similarities, in its structure, to opioid peptides, mainly to dynorphin A.  However, unlike opioid peptides, it does not produce a conditioned place preference or aversion but inhibits rewarding effect of drugs of abuse.  The present study was designed to examine the ability of nociceptin to block the acquisition of amphetamine-induced place preference, and the development of amphetamine-induced sensitization to stereotypy in rats.  Our expts. indicated that repeated administration of nociceptin at increasing doses during conditioning significantly attenuated the reinforcing effect of amphetamine in conditioned place preference paradigm.  Nociceptin did not change the acute effect of amphetamine-induced stereotypy but prevented the development of sensitization to stereotypy measured on the challenge day.  Our results suggest the involvement of nociceptin in long-lasting neuronal adaptation after repeated amphetamine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhqVzPd9SudLVg90H21EOLACvtfcHk0ljHZ-0f_Y96tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Kju7g%253D&md5=4cd98cbdcbb47593a4f55fb2cd9b165d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2902081-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252902081-8%26sid%3Dliteratum%253Aachs%26aulast%3DKotlinska%26aufirst%3DJ.%26aulast%3DRafalski%26aufirst%3DP.%26aulast%3DBiala%26aufirst%3DG.%26aulast%3DDylag%26aufirst%3DT.%26aulast%3DRolka%26aufirst%3DK.%26aulast%3DSilberring%26aufirst%3DJ.%26atitle%3DNociceptin%2520inhibits%2520acquisition%2520of%2520amphetamine-induced%2520place%2520preference%2520and%2520sensitization%2520to%2520stereotypy%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D474%26spage%3D233%26epage%3D239%26doi%3D10.1016%2FS0014-2999%2803%2902081-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Florin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Nicollet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span> </span><span class="NLM_article-title">Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1016/S0304-3940(97)00470-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2897%2900470-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1997&pages=33-36&author=S.+Florinauthor=I.+Leroux-Nicolletauthor=J.+C.+Meunierauthor=J.+Costentin&title=Autoradiographic+localization+of+%5B3H%5Dnociceptin+binding+sites+from+telencephalic+to+mesencephalic+regions+of+the+mouse+brain&doi=10.1016%2FS0304-3940%2897%2900470-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2897%2900470-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252897%252900470-9%26sid%3Dliteratum%253Aachs%26aulast%3DFlorin%26aufirst%3DS.%26aulast%3DLeroux-Nicollet%26aufirst%3DI.%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DAutoradiographic%2520localization%2520of%2520%255B3H%255Dnociceptin%2520binding%2520sites%2520from%2520telencephalic%2520to%2520mesencephalic%2520regions%2520of%2520the%2520mouse%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D230%26spage%3D33%26epage%3D36%26doi%3D10.1016%2FS0304-3940%2897%2900470-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Florin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span> </span><span class="NLM_article-title">Autoradiographic localization of [3H]nociceptin binding sites in the rat brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">880</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/S0006-8993(00)02669-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0006-8993%2800%2902669-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11032985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntF2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=880&publication_year=2000&pages=11-16&author=S.+Florinauthor=J.-C.+Meunierauthor=J.+Costentin&title=Autoradiographic+localization+of+%5B3H%5Dnociceptin+binding+sites+in+the+rat+brain&doi=10.1016%2FS0006-8993%2800%2902669-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiographic localization of [3H]nociceptin binding sites in the rat brain</span></div><div class="casAuthors">Florin, S.; Meunier, J.-C.; Costentin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">880</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">11-16</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The binding sites of nociceptin (also named orphanin FQ), the endogenous ligand of ORL1 (opiate receptor like 1), were localized in rat brain, using an autoradiog. procedure.  High levels of binding were obsd. in the cingulate, retrosplenial, perirhinal, insular and occipital cortex, anterior and posteromedial cortical amygdaloid nuclei, basolateral amygdaloid nucleus, amygdaloid complex, posterior hippocampus, dorsal endopiriform, central medial thalamic, paraventricular, rhomboid thalamic, suprachiasmatic, ventromedial hypothalamic nuclei, mammillary complex, superficial gray layer of the superior colliculus, locus coeruleus, dorsal raphe nucleus.  More moderate labeling was obsd. in the prefrontal, fronto-parietal, temporal, piriform cortex, dentate gyrus, anterior olfactory nucleus, olfactory tubercle, shell of nucleus accumbens, claustrum, lateral septum, laterodorsal thalamic, medial habenular, subthalamic, reuniens thalamic nuclei, subiculum, periaqueductal gray matter and pons.  A lower binding site d. was obsd. in the anterior and medial hippocampus, olfactory bulb, caudate putamen, the core of the nucleus accumbens, medial septum, ventrolateral, ventroposterolateral and mediodorsal thalamic nuclei, lateral and medial geniculate nuclei, hypothalamic area, substantia nigra, ventral tegmentum area and interpedoncular nucleus.  A moderate and similar labeling was found in the dorsal and ventral horn of the spinal cord.  No labeling was apparent in the corpus callosum.  Thus, it appears that the ORL1 receptor is particularly abundant in the cerebral cortex, limbic system of the rat brain and some areas involved in pain perception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VMorOlDoubVg90H21EOLACvtfcHk0liAnNCtkgMpUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntF2hu7o%253D&md5=36c30c2bcd826b6b96da78997a3c8891</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902669-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902669-X%26sid%3Dliteratum%253Aachs%26aulast%3DFlorin%26aufirst%3DS.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DAutoradiographic%2520localization%2520of%2520%255B3H%255Dnociceptin%2520binding%2520sites%2520in%2520the%2520rat%2520brain%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D880%26spage%3D11%26epage%3D16%26doi%3D10.1016%2FS0006-8993%2800%2902669-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bridge, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainwright, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, K. R.</span><span> </span><span class="NLM_article-title">Autoradiographic localization of (125)i[Tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1016/S0306-4522(02)00927-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0306-4522%2802%2900927-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2003&pages=513-523&author=K.+E.+Bridgeauthor=A.+Wainwrightauthor=K.+Reillyauthor=K.+R.+Oliver&title=Autoradiographic+localization+of+%28125%29i%5BTyr%2814%29%5D+nociceptin%2Forphanin+FQ+binding+sites+in+macaque+primate+CNS&doi=10.1016%2FS0306-4522%2802%2900927-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2802%2900927-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252802%252900927-2%26sid%3Dliteratum%253Aachs%26aulast%3DBridge%26aufirst%3DK.%2BE.%26aulast%3DWainwright%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DK.%26aulast%3DOliver%26aufirst%3DK.%2BR.%26atitle%3DAutoradiographic%2520localization%2520of%2520%2528125%2529i%255BTyr%252814%2529%255D%2520nociceptin%252Forphanin%2520FQ%2520binding%2520sites%2520in%2520macaque%2520primate%2520CNS%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D118%26spage%3D513%26epage%3D523%26doi%3D10.1016%2FS0306-4522%2802%2900927-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladding, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedregal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span> </span><span class="NLM_article-title">Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span><span class="refDoi"> DOI: 10.2967/jnumed.111.091181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2967%2Fjnumed.111.091181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1638-1645&author=Y.+Kimuraauthor=M.+Fujitaauthor=J.+Hongauthor=T.+G.+Lohithauthor=R.+L.+Gladdingauthor=S.+S.+Zoghbiauthor=J.+A.+Tauscherauthor=N.+Goeblauthor=K.+S.+Rashauthor=Z.+Chenauthor=C.+Pedregalauthor=V.+N.+Barthauthor=V.+W.+Pikeauthor=R.+B.+Innis&title=Brain+and+whole-body+imaging+in+rhesus+monkeys+of+11C-NOP-1A%2C+a+promising+PET+radioligand+for+nociceptin%2Forphanin+FQ+peptide+receptors&doi=10.2967%2Fjnumed.111.091181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.091181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.091181%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DGladding%26aufirst%3DR.%2BL.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DTauscher%26aufirst%3DJ.%2BA.%26aulast%3DGoebl%26aufirst%3DN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26atitle%3DBrain%2520and%2520whole-body%2520imaging%2520in%2520rhesus%2520monkeys%2520of%252011C-NOP-1A%252C%2520a%2520promising%2520PET%2520radioligand%2520for%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1638%26epage%3D1645%26doi%3D10.2967%2Fjnumed.111.091181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Berthele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworzak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadrack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assmus, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zieglgansberger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolle, T. R.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-nociceptin ligand-binding and nociceptin opioid receptor mRNA expression in the human brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1016/S0306-4522(03)00484-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0306-4522%2803%2900484-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2003&pages=629-640&author=A.+Bertheleauthor=S.+Platzerauthor=D.+Dworzakauthor=J.+Schadrackauthor=B.+Mahalauthor=A.+Buttnerauthor=H.+P.+Assmusauthor=K.+Wursterauthor=W.+Zieglgansbergerauthor=B.+Conradauthor=T.+R.+Tolle&title=%5B3H%5D-nociceptin+ligand-binding+and+nociceptin+opioid+receptor+mRNA+expression+in+the+human+brain&doi=10.1016%2FS0306-4522%2803%2900484-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2803%2900484-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252803%252900484-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerthele%26aufirst%3DA.%26aulast%3DPlatzer%26aufirst%3DS.%26aulast%3DDworzak%26aufirst%3DD.%26aulast%3DSchadrack%26aufirst%3DJ.%26aulast%3DMahal%26aufirst%3DB.%26aulast%3DButtner%26aufirst%3DA.%26aulast%3DAssmus%26aufirst%3DH.%2BP.%26aulast%3DWurster%26aufirst%3DK.%26aulast%3DZieglgansberger%26aufirst%3DW.%26aulast%3DConrad%26aufirst%3DB.%26aulast%3DTolle%26aufirst%3DT.%2BR.%26atitle%3D%255B3H%255D-nociceptin%2520ligand-binding%2520and%2520nociceptin%2520opioid%2520receptor%2520mRNA%2520expression%2520in%2520the%2520human%2520brain%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D121%26spage%3D629%26epage%3D640%26doi%3D10.1016%2FS0306-4522%2803%2900484-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araneta, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span> </span><span class="NLM_article-title">Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand <sup>11</sup>C-NOP-1A</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.2967/jnumed.111.097162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2967%2Fjnumed.111.097162" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=385-392&author=T.+G.+Lohithauthor=S.+S.+Zoghbiauthor=C.+L.+Morseauthor=M.+F.+Aranetaauthor=V.+N.+Barthauthor=N.+A.+Goeblauthor=J.+T.+Tauscherauthor=V.+W.+Pikeauthor=R.+B.+Innisauthor=M.+Fujita&title=Brain+and+whole-body+imaging+of+nociceptin%2Forphanin+FQ+peptide+receptor+in+humans+using+the+PET+ligand+11C-NOP-1A&doi=10.2967%2Fjnumed.111.097162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.097162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.097162%26sid%3Dliteratum%253Aachs%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMorse%26aufirst%3DC.%2BL.%26aulast%3DAraneta%26aufirst%3DM.%2BF.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DGoebl%26aufirst%3DN.%2BA.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DFujita%26aufirst%3DM.%26atitle%3DBrain%2520and%2520whole-body%2520imaging%2520of%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520in%2520humans%2520using%2520the%2520PET%2520ligand%252011C-NOP-1A%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D385%26epage%3D392%26doi%3D10.2967%2Fjnumed.111.097162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorick-Kehn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintar, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansonoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span> </span><span class="NLM_article-title">The biology of nociceptin/orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pharmthera.2013.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24189487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=283-299&author=J.+M.+Witkinauthor=M.+A.+Statnickauthor=L.+M.+Rorick-Kehnauthor=J.+E.+Pintarauthor=M.+Ansonoffauthor=Y.+Chenauthor=R.+C.+Tuckerauthor=R.+Ciccocioppo&title=The+biology+of+nociceptin%2Forphanin+FQ+%28N%2FOFQ%29+related+to+obesity%2C+stress%2C+anxiety%2C+mood%2C+and+drug+dependence&doi=10.1016%2Fj.pharmthera.2013.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence</span></div><div class="casAuthors">Witkin, Jeffrey M.; Statnick, Michael A.; Rorick-Kehn, Linda M.; Pintar, John E.; Ansonoff, Michael; Chen, Yanyun; Tucker, R. Craig; Ciccocioppo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-299</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nociceptin/Orphanin FQ (N/OFQ) is a 17 amino acid peptide that was deorphanized in 1995.  The generation of specific agonists, antagonists and receptor deficient mice and rats has enabled progress in elucidating the biol. functions of N/OFQ.  Addnl., radio-imaging technologies have been advanced for investigation of this system in animals and humans.  Together with traditional neurobehavioral techniques, these tools have been utilized to identify the biol. significance of the N/OFQ system and its interacting partners.  The present review focuses on the role of N/OFQ in the regulation of feeding, body wt. homeostasis, stress, the stress-related psychiatric disorders of depression and anxiety, and in drug and alc. dependence.  Crit. evaluation of the current scientific preclin. literature suggests that small mol. modulators of nociceptin opioid peptide receptors (NOP) might be useful in the treatment of diseases related to these biol. functions.  In particular, the literature data suggest that antagonism of NOP receptors will produce anti-obesity and antidepressant activities in humans.  However, there are also contradictory data discussed.  The current literature on the role of N/OFQ in anxiety and addiction, on the other hand points primarily to a role of agonist modulation being potentially therapeutic.  Some drug-like mols. that function either as agonists or antagonists of NOP receptors have been optimized for human clin. study to test some of these hypotheses.  The discovery of PET ligands for NOP receptors, combined with the pharmacol. tools and burgeoning preclin. data set discussed here bodes well for a rapid advancement of clin. understanding and potential therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTjRy74bFqVLVg90H21EOLACvtfcHk0liAnNCtkgMpUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtbzI&md5=7dd059d26483dbe6bcd58741f60f5ec3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DRorick-Kehn%26aufirst%3DL.%2BM.%26aulast%3DPintar%26aufirst%3DJ.%2BE.%26aulast%3DAnsonoff%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTucker%26aufirst%3DR.%2BC.%26aulast%3DCiccocioppo%26aufirst%3DR.%26atitle%3DThe%2520biology%2520of%2520nociceptin%252Forphanin%2520FQ%2520%2528N%252FOFQ%2529%2520related%2520to%2520obesity%252C%2520stress%252C%2520anxiety%252C%2520mood%252C%2520and%2520drug%2520dependence%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D141%26spage%3D283%26epage%3D299%26doi%3D10.1016%2Fj.pharmthera.2013.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pharmthera.2013.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=23711793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyqtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=10-25&author=E.+C.+Gavioliauthor=G.+Calo&title=Nociceptin%2Forphanin+FQ+receptor+antagonists+as+innovative+antidepressant+drugs&doi=10.1016%2Fj.pharmthera.2013.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs</span></div><div class="casAuthors">Gavioli, Elaine Cristina; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-25</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) were identified in the mid 90s as a novel peptidergic system structurally related to opioids.  A growing body of preclin. evidence suggests that blockade of NOP receptors evokes antidepressant-like actions.  These have been explored using a range of compds. (peptide and non peptide antagonists), across different species (rat and mouse) and assays (behavioral despair and chronic mild stress) suggesting a robust and consistent antidepressant-like effect.  Moreover, rats and mice knockout for the NOP receptor gene display an antidepressant-like phenotype in behavioral despair assays.  Electrophysiol., immunohistochem. and neurochem. studies point to an important role played by monoaminergic systems, particularly 5-HTergic, in mediating the antidepressant-like properties of NOP antagonists.  However other putative mechanisms of action, including modulation of the CRF system, circadian rhythm and a possible neuroendocrine-immune control might be involved.  A close relationship between the N/OFQ-NOP receptor system and stress responses is well described in the literature.  Stressful situations also alter endocrine, behavioral and neurochem. parameters in rats and chronic administration of a NOP antagonist restored these alterations.  Interestingly, clin. findings showed that plasma N/OFQ levels were significantly altered in major and post-partum depression, and bipolar disease patients.  Collectively, data in the literature support the notion that blockade of NOP receptor signaling could be a novel and interesting strategy for the development of innovative antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMWQXmH9Ke-7Vg90H21EOLACvtfcHk0liwKLZt4_YLDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyqtLnI&md5=fc03fe69957a97dec69feb0b8fef3648</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520antagonists%2520as%2520innovative%2520antidepressant%2520drugs%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D140%26spage%3D10%26epage%3D25%26doi%3D10.1016%2Fj.pharmthera.2013.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Schröder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T.</span><span> </span><span class="NLM_article-title">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3800</span><span class="refDoi"> DOI: 10.1111/bph.12744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fbph.12744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24762001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3777-3800&author=W.+Schr%C3%B6derauthor=D.+G.+Lambertauthor=M.+C.+Koauthor=T.+Koch&title=Functional+plasticity+of+the+N%2FOFQ-NOP+receptor+system+determines+analgesic+properties+of+NOP+receptor+agonists&doi=10.1111%2Fbph.12744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span></div><div class="casAuthors">Schroder W; Lambert D G; Ko M C; Koch T</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3777-800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite high sequence similarity between NOP (nociceptin/orphanin FQ opioid peptide) and opioid receptors, marked differences in endogenous ligand selectivity, signal transduction, phosphorylation, desensitization, internalization and trafficking have been identified; underscoring the evolutionary difference between NOP and opioid receptors.  Activation of NOP receptors affects nociceptive transmission in a site-specific manner, with antinociceptive effects prevailing after peripheral and spinal activation, and pronociceptive effects after supraspinal activation in rodents.  The net effect of systemically administered NOP receptor agonists on nociception is proposed to depend on the relative contribution of peripheral, spinal and supraspinal activation, and this may depend on experimental conditions.  Functional expression and regulation of NOP receptors at peripheral and central sites of the nociceptive pathway exhibits a high degree of plasticity under conditions of neuropathic and inflammatory pain.  In rodents, systemically administered NOP receptor agonists exerted antihypersensitive effects in models of neuropathic and inflammatory pain.  However, they were largely ineffective in acute pain while concomitantly evoking severe motor side effects.  In contrast, systemic administration of NOP receptor agonists to non-human primates (NHPs) exerted potent and efficacious antinociception in the absence of motor and sedative side effects.  The reason for this species difference with respect to antinociceptive efficacy and tolerability is not clear.  Moreover, co-activation of NOP and μ-opioid peptide (MOP) receptors synergistically produced antinociception in NHPs.  Hence, both selective NOP receptor as well as NOP/MOP receptor agonists may hold potential for clinical use as analgesics effective in conditions of acute and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKk8UmQyPtHQ8IxFYvehhofW6udTcc2eYjZPmj5Rskx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D&md5=04241ff79c2ff0853c7a4513961d0648</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fbph.12744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12744%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DT.%26atitle%3DFunctional%2520plasticity%2520of%2520the%2520N%252FOFQ-NOP%2520receptor%2520system%2520determines%2520analgesic%2520properties%2520of%2520NOP%2520receptor%2520agonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3777%26epage%3D3800%26doi%3D10.1111%2Fbph.12744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Mogil, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=381-415&author=J.+S.+Mogilauthor=G.+W.+Pasternak&title=The+molecular+and+behavioral+pharmacology+of+the+orphanin+FQ%2Fnociceptin+peptide+and+receptor+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DThe%2520molecular%2520and%2520behavioral%2520pharmacology%2520of%2520the%2520orphanin%2520FQ%252Fnociceptin%2520peptide%2520and%2520receptor%2520family%26jtitle%3DPharmacol.%2520Rev.%26date%3D2001%26volume%3D53%26spage%3D381%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Linz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzschentke, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautrois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kögel, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englberger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, S.</span><span> </span><span class="NLM_article-title">Cebranopadol: A novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1124/jpet.114.213694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.114.213694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24713140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=535-548&author=K.+Linzauthor=T.+Christophauthor=T.+M.+Tzschentkeauthor=T.+Kochauthor=K.+Schieneauthor=M.+Gautroisauthor=W.+Schr%C3%B6derauthor=B.+Y.+K%C3%B6gelauthor=H.+Beierauthor=W.+Englbergerauthor=S.+Schunkauthor=J.+De+Vryauthor=U.+Jahnelauthor=S.+Frosch&title=Cebranopadol%3A+A+novel+potent+analgesic+nociceptin%2Forphanin+FQ+peptide+and+opioid+receptor+agonist&doi=10.1124%2Fjpet.114.213694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span></div><div class="casAuthors">Linz, Klaus; Christoph, Thomas; Tzschentke, Thomas M.; Koch, Thomas; Schiene, Klaus; Gautrois, Michael; Schroeder, Wolfgang; Koegel, Babette Y.; Beier, Horst; Englberger, Werner; Schunk, Stefan; De Vry, Jean; Jahnel, Ulrich; Frosch, Stefanie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-548, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cebranopadol (trans-6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine) is a novel analgesic nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonist [Ki (nM)/EC50 (nM)/relative efficacy (%): human NOP receptor 0.9/13.0/89; human mu-opioid peptide (MOP) receptor 0.7/1.2/104; human kappa-opioid peptide receptor 2.6/17/67; human delta-opioid peptide receptor 18/110/105].  Cebranopadol exhibits highly potent and efficacious antinociceptive and antihypersensitive effects in several rat models of acute and chronic pain (tail-flick, rheumatoid arthritis, bone cancer, spinal nerve ligation, diabetic neuropathy) with ED50 values of 0.5-5.6 μg/kg after i.v. and 25.1 μg/kg after oral administration.  In comparison with selective MOP receptor agonists, cebranopadol was more potent in models of chronic neuropathic than acute nociceptive pain.  Cebranopadol's duration of action is long (up to 7 h after i.v. 12 μg/kg; >9 h after oral 55 μg/kg in the rat tail-flick test).  The antihypersensitive activity of cebranopadol in the spinal nerve ligation model was partially reversed by pretreatment with the selective NOP receptor antagonist J-1133'7[1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one] or the opioid receptor antagonist naloxone, indicating that both NOP and opioid receptor agonism are involved in this activity.  Development of analgesic tolerance in the chronic constriction injury model was clearly delayed compared with that from an equianalgesic dose of morphine (complete tolerance on day 26 vs. day 11, resp.).  Unlike morphine, cebranopadol did not disrupt motor coordination and respiration at doses within and exceeding the analgesic dose range.  Cebranopadol, by its combination of agonism at NOP and opioid receptors, affords highly potent and efficacious analgesia in various pain models with a favorable side effect profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvDj3QJY4fYrVg90H21EOLACvtfcHk0liwKLZt4_YLDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE&md5=c3fcc301bf4dde5706565d9187578df4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213694%26sid%3Dliteratum%253Aachs%26aulast%3DLinz%26aufirst%3DK.%26aulast%3DChristoph%26aufirst%3DT.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DKoch%26aufirst%3DT.%26aulast%3DSchiene%26aufirst%3DK.%26aulast%3DGautrois%26aufirst%3DM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DK%25C3%25B6gel%26aufirst%3DB.%2BY.%26aulast%3DBeier%26aufirst%3DH.%26aulast%3DEnglberger%26aufirst%3DW.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DJahnel%26aufirst%3DU.%26aulast%3DFrosch%26aufirst%3DS.%26atitle%3DCebranopadol%253A%2520A%2520novel%2520potent%2520analgesic%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D535%26epage%3D548%26doi%3D10.1124%2Fjpet.114.213694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowbotham, D. J.</span><span> </span><span class="NLM_article-title">Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist</span> <span class="citation_source-journal">Br. J. Anaesth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span><span class="refDoi"> DOI: 10.1093/bja/aeu332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1093%2Fbja%2Faeu332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25248647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jvFCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2015&pages=364-366&author=D.+G.+Lambertauthor=M.+F.+Birdauthor=D.+J.+Rowbotham&title=Cebranopadol%3A+a+first+in-class+example+of+a+nociceptin%2Forphanin+FQ+receptor+and+opioid+receptor+agonist&doi=10.1093%2Fbja%2Faeu332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist</span></div><div class="casAuthors">Lambert D G; Bird M F; Rowbotham D J</div><div class="citationInfo"><span class="NLM_cas:title">British journal of anaesthesia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">364-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtYUFOxkJ7ocAKB7Fa-xrUfW6udTcc2eb3dK7xBLoYnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jvFCqtA%253D%253D&md5=a649b9bc2fe0ebb8e3ac2bef59ff8499</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fbja%2Faeu332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252Faeu332%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DRowbotham%26aufirst%3DD.%2BJ.%26atitle%3DCebranopadol%253A%2520a%2520first%2520in-class%2520example%2520of%2520a%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2015%26volume%3D114%26spage%3D364%26epage%3D366%26doi%3D10.1093%2Fbja%2Faeu332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Sałat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulig, K.</span><span> </span><span class="NLM_article-title">Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1036985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543784.2015.1036985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=837-844&author=K.+Sa%C5%82atauthor=A.+Jakubowskaauthor=K.+Kulig&title=Cebranopadol%3A+a+first-in-class+potent+analgesic+agent+with+agonistic+activity+at+nociceptin%2Forphanin+FQ+and+opioid+receptors&doi=10.1517%2F13543784.2015.1036985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1036985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1036985%26sid%3Dliteratum%253Aachs%26aulast%3DSa%25C5%2582at%26aufirst%3DK.%26aulast%3DJakubowska%26aufirst%3DA.%26aulast%3DKulig%26aufirst%3DK.%26atitle%3DCebranopadol%253A%2520a%2520first-in-class%2520potent%2520analgesic%2520agent%2520with%2520agonistic%2520activity%2520at%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D837%26epage%3D844%26doi%3D10.1517%2F13543784.2015.1036985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Post, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krikke-Workel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span> </span><span class="NLM_article-title">A selective nociceptin receptor antagonist to treat depression: Evidence from preclinical and clinical studies</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1038/npp.2015.348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnpp.2015.348" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Postauthor=T.+S.+Smartauthor=J.+Krikke-Workelauthor=G.+R.+Dawsonauthor=C.+J.+Harmerauthor=M.+Browningauthor=K.+Jacksonauthor=R.+Kakarauthor=R.+Mohsauthor=M.+Statnickauthor=K.+Waffordauthor=A.+McCarthyauthor=V.+Barthauthor=J.+M.+Witkin&title=A+selective+nociceptin+receptor+antagonist+to+treat+depression%3A+Evidence+from+preclinical+and+clinical+studies&doi=10.1038%2Fnpp.2015.348"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.348%26sid%3Dliteratum%253Aachs%26aulast%3DPost%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DT.%2BS.%26aulast%3DKrikke-Workel%26aufirst%3DJ.%26aulast%3DDawson%26aufirst%3DG.%2BR.%26aulast%3DHarmer%26aufirst%3DC.%2BJ.%26aulast%3DBrowning%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DKakar%26aufirst%3DR.%26aulast%3DMohs%26aufirst%3DR.%26aulast%3DStatnick%26aufirst%3DM.%26aulast%3DWafford%26aufirst%3DK.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DBarth%26aufirst%3DV.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26atitle%3DA%2520selective%2520nociceptin%2520receptor%2520antagonist%2520to%2520treat%2520depression%253A%2520Evidence%2520from%2520preclinical%2520and%2520clinical%2520studies%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26doi%3D10.1038%2Fnpp.2015.348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span>Eli Lilly & Co. Study of the efficacy and safety of LY2940094 in participants with major depressive disorder (MDD). <a href="https://clinicaltrials.gov/ct2/show/NCT01724112" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01724112</a>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>NCT01724112, Phase 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eli+Lilly+%26+Co.+Study+of+the+efficacy+and+safety+of+LY2940094+in+participants+with+major+depressive+disorder+%28MDD%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01724112%2C+2014%3B+NCT01724112%2C+Phase+2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span>Eli Lilly & Co. A Study of LY2940094 in participants with alcohol dependence. <a href="https://clinicaltrials.gov/ct2/show/NCT01798303" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01798303</a>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>NCT0198303, Phase 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eli+Lilly+%26+Co.+A+Study+of+LY2940094+in+participants+with+alcohol+dependence.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01798303%2C+2014%3B+NCT0198303%2C+Phase+2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Satoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma-Kanoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span> </span><span class="NLM_article-title">Identification of an orally active opioid receptor-like 1 (ORL1) receptor antagonist 4-{3-[(2R)-2,3-dihydroxypropyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-1-[(1S,3S ,4R)-spiro[bicyclo[2.2.1]heptane-2,1′-cyclopropan]-3-ylmethyl]piperidine as clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4091</span><span class="NLM_x">–</span> <span class="NLM_lpage">4094</span><span class="refDoi"> DOI: 10.1021/jm900581g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900581g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4091-4094&author=A.+Satohauthor=T.+Sagaraauthor=H.+Sakohauthor=M.+Hashimotoauthor=H.+Nakashimaauthor=T.+Katoauthor=Y.+Gotoauthor=S.+Mizutaniauthor=T.+Azuma-Kanohauthor=T.+Taniauthor=S.+Okudaauthor=O.+Okamotoauthor=S.+Ozakiauthor=Y.+Iwasawaauthor=H.+Ohtaauthor=H.+Kawamoto&title=Identification+of+an+orally+active+opioid+receptor-like+1+%28ORL1%29+receptor+antagonist+4-%7B3-%5B%282R%29-2%2C3-dihydroxypropyl%5D-2-oxo-2%2C3-dihydro-1H-benzimidazol-1-yl%7D-1-%5B%281S%2C3S+%2C4R%29-spiro%5Bbicyclo%5B2.2.1%5Dheptane-2%2C1%E2%80%B2-cyclopropan%5D-3-ylmethyl%5Dpiperidine+as+clinical+candidate&doi=10.1021%2Fjm900581g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900581g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900581g%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DA.%26aulast%3DSagara%26aufirst%3DT.%26aulast%3DSakoh%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DAzuma-Kanoh%26aufirst%3DT.%26aulast%3DTani%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DKawamoto%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520an%2520orally%2520active%2520opioid%2520receptor-like%25201%2520%2528ORL1%2529%2520receptor%2520antagonist%25204-%257B3-%255B%25282R%2529-2%252C3-dihydroxypropyl%255D-2-oxo-2%252C3-dihydro-1H-benzimidazol-1-yl%257D-1-%255B%25281S%252C3S%2520%252C4R%2529-spiro%255Bbicyclo%255B2.2.1%255Dheptane-2%252C1%25E2%2580%25B2-cyclopropan%255D-3-ylmethyl%255Dpiperidine%2520as%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4091%26epage%3D4094%26doi%3D10.1021%2Fjm900581g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span>Merck, Sharp and Dohme Corp. Treatment of cognitive impairment in men with schizophrenia (MK5757-005) (COMPLETED). <a href="https://clinicaltrials.gov/ct2/show/results/NCT00848484" class="extLink">https://clinicaltrials.gov/ct2/show/results/NCT00848484</a>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>NCT00848484, Phase 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck%2C+Sharp+and+Dohme+Corp.+Treatment+of+cognitive+impairment+in+men+with+schizophrenia+%28MK5757-005%29+%28COMPLETED%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT00848484%2C+2015%3B+NCT00848484%2C+Phase+2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nothacker, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">14854</span><span class="NLM_x">–</span> <span class="NLM_lpage">14858</span><span class="refDoi"> DOI: 10.1073/pnas.94.26.14854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1073%2Fpnas.94.26.14854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=14854-14858&author=F.+Jenckauthor=J.+L.+Moreauauthor=J.+R.+Martinauthor=G.+J.+Kilpatrickauthor=R.+K.+Reinscheidauthor=F.+J.+Monsmaauthor=H.+P.+Nothackerauthor=O.+Civelli&title=Orphanin+FQ+acts+as+an+anxiolytic+to+attenuate+behavioral+responses+to+stress&doi=10.1073%2Fpnas.94.26.14854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.26.14854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.26.14854%26sid%3Dliteratum%253Aachs%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DNothacker%26aufirst%3DH.%2BP.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DOrphanin%2520FQ%2520acts%2520as%2520an%2520anxiolytic%2520to%2520attenuate%2520behavioral%2520responses%2520to%2520stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D14854%26epage%3D14858%26doi%3D10.1073%2Fpnas.94.26.14854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouagazzal, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roever, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G.</span><span> </span><span class="NLM_article-title">A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">4938</span><span class="NLM_x">–</span> <span class="NLM_lpage">4943</span><span class="refDoi"> DOI: 10.1073/pnas.090514397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1073%2Fpnas.090514397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4938-4943&author=F.+Jenckauthor=J.+Wichmannauthor=F.+M.+Dautzenbergauthor=J.+L.+Moreauauthor=A.+M.+Ouagazzalauthor=J.+R.+Martinauthor=K.+Lundstromauthor=A.+M.+Cesuraauthor=S.+M.+Poliauthor=S.+Roeverauthor=S.+Kolczewskiauthor=G.+Adamauthor=G.+Kilpatrick&title=A+synthetic+agonist+at+the+orphanin+FQ%2Fnociceptin+receptor+ORL1%3A+anxiolytic+profile+in+the+rat&doi=10.1073%2Fpnas.090514397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.090514397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.090514397%26sid%3Dliteratum%253Aachs%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DOuagazzal%26aufirst%3DA.%2BM.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DLundstrom%26aufirst%3DK.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DRoever%26aufirst%3DS.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DKilpatrick%26aufirst%3DG.%26atitle%3DA%2520synthetic%2520agonist%2520at%2520the%2520orphanin%2520FQ%252Fnociceptin%2520receptor%2520ORL1%253A%2520anxiolytic%2520profile%2520in%2520the%2520rat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4938%26epage%3D4943%26doi%3D10.1073%2Fpnas.090514397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Canuso, C. M.; Hutchison, J.; Manitpisitkul, P.; Moyer, J. A.</span><span> </span><span class="NLM_article-title">NOP agonism: A novel mechanism for the treatment of anxiety and depression</span>. American Society of Clinical Psychopharmacology NCDEU Meeting, Phoenix, AZ, May 29, 2012; <span class="NLM_publisher-name">American Society of Clinical Psychopharmacology</span>: <span class="NLM_publisher-loc">Phoenix, AZ</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">19</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Canuso%2C+C.+M.%3B+Hutchison%2C+J.%3B+Manitpisitkul%2C+P.%3B+Moyer%2C+J.+A.+NOP+agonism%3A+A+novel+mechanism+for+the+treatment+of+anxiety+and+depression.+American+Society+of+Clinical+Psychopharmacology+NCDEU+Meeting%2C+Phoenix%2C+AZ%2C+May+29%2C+2012%3B+American+Society+of+Clinical+Psychopharmacology%3A+Phoenix%2C+AZ%2C+2012%3B+p+19."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCanuso%26aufirst%3DC.%2BM.%26atitle%3DNOP%2520agonism%253A%2520A%2520novel%2520mechanism%2520for%2520the%2520treatment%2520of%2520anxiety%2520and%2520depression%26pub%3DAmerican%2520Society%2520of%2520Clinical%2520Psychopharmacology%26date%3D2012%26spage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo', G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0704894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0704894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12237257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Ciu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=369-374&author=A.+Rizziauthor=D.+Rizziauthor=G.+Marzolaauthor=D.+Regoliauthor=B.+D.+Larsenauthor=J.+S.+Petersenauthor=G.+Calo%27&title=Pharmacological+characterization+of+the+novel+nociceptin%2Forphanin+FQ+receptor+ligand%2C+ZP120%3A+in+vitro+and+in+vivo+studies+in+mice&doi=10.1038%2Fsj.bjp.0704894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand ZP120: in vitro and in vivo studies in mice</span></div><div class="casAuthors">Rizzi, Anna; Rizzi, Daniela; Marzola, Giuliano; Regoli, Domenico; Larsen, Bjarne Due; Petersen, Jorgen Soberg; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-374</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This study reports the pharmacol. characterization of ZP120, a novel ligand of the nociceptin/orphanin FQ (N/OFQ) peptide receptor, NOP.  In vitro, ZP120 mimicked the inhibitory effects of N/OFQ on contractions of the elec. stimulated mouse vas deferens, showing, however, higher potency (pEC50 8.88 vs 7.74), lower maximal effects (Emax 69% vs 91%), and slower onset of action.  Like N/OFQ, the effects of ZP120 were not modified by 1 μM naloxone, but they were antagonized by the NOP receptor-selective antagonist J-113397 (pA2 7.80 vs. ZP120, 7.81 vs. N/OFQ).  In vivo, ZP120 mimicked the effects of N/OFQ, producing pronociceptive effects in the tail withdrawal assay and decreased locomotor activity after intracerebroventricular, but not after i.v., administration to mice.  ZP120 elicited similar maximal effects as N/OFQ, but it was about 10-fold more potent and its effects lasted longer.  In conclusion, the novel NOP receptor ligand ZP120 is a highly potent and selective partial agonist of the NOP receptor with prolonged effects in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVlVZ3fJ-6mrVg90H21EOLACvtfcHk0liMO5FBqtyyPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Ciu7w%253D&md5=33cc5383382632191e292640a6d5383b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704894%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DLarsen%26aufirst%3DB.%2BD.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26aulast%3DCalo%2527%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligand%252C%2520ZP120%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D369%26epage%3D374%26doi%3D10.1038%2Fsj.bjp.0704894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Kapusta, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorkildsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenigs, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinge, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span> </span><span class="NLM_article-title">Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1124/jpet.105.083436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.105.083436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15855355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVSis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=652-660&author=D.+R.+Kapustaauthor=C.+Thorkildsenauthor=V.+A.+Kenigsauthor=E.+Meierauthor=M.+M.+Vingeauthor=C.+Quistauthor=J.+S.+Petersen&title=Pharmacodynamic+characterization+of+ZP120+%28Ac-RYYRWKKKKKKK-NH2%29%2C+a+novel%2C+functionally+selective+nociceptin%2Forphanin+FQ+peptide+receptor+partial+agonist+with+sodium-potassium-sparing+aquaretic+activity&doi=10.1124%2Fjpet.105.083436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity</span></div><div class="casAuthors">Kapusta, Daniel R.; Thorkildsen, Christian; Kenigs, Velga A.; Meier, Eddi; Vinge, Mette M.; Quist, Charlotte; Petersen, Jorgen Soberg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">652-660</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In conscious rats, i.v. administration of the hexapeptide Ac-RYYRWK-NH2, a partial agonist of the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor, produces a selective water diuresis without marked cardiovascular or behavioral effects.  The present study examd. the in vitro and in vivo pharmacodynamic profile of the novel and potentially metabolically stable NOP receptor ligand ZP120 (Ac-RYYRWKKKKKKK-NH2), which was created by conjugation of a structure-inducing probe (SIP) (i.e., K6 sequence) to Ac-RYYRWK-NH2.  In cells transfected with human NOP receptors, both Ac-RYYRWK-NH2 and ZP120 displaced [3H]N/OFQ (both peptides, pKi = 9.6), and similar to N/OFQ inhibited forskolin-induced cAMP formation (Ac-RYYRWK-NH2, pEC50 = 9.2; ZP120, 9.3; N/OFQ, 9.7).  In the mouse vas deferens assay (MVD), Ac-RYYRWK-NH2 and ZP120 behaved as partial agonists, inhibiting elec. induced contractions with similar pEC50 values (9.0 and 8.6 resp.) but with submaximal efficacy compared with N/OFQ.  In MVD, both peptides blocked the responses to N/OFQ, with ZP120 being approx. 50-fold more potent than Ac-RYYRWK-NH2.  In vivo, dose-response studies in rats showed that at doses (i.v. bolus or i.v. infusion) that produced a sodium-potassium-sparing aquaresis, ZP120 and Ac-RYYRWK-NH2 elicited a mild vasodilatory response without reflex tachycardia.  However, the renal responses to ZP120 were of greater magnitude and duration.  Finally, each peptide blocked the bradycardia and hypotension to N/OFQ in conscious rats, but the effect of ZP120 was of much greater duration.  Together, these findings demonstrate that ZP120 is a novel, functionally selective SIP-modified NOP receptor partial agonist with increased biol. activity and sodium-potassium-sparing aquaretic activity, the actions of which may be useful in the management of hyponatremia/hypokalemia in water-retaining states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovm0GvXih8VLVg90H21EOLACvtfcHk0lhV6dtJRfSWtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVSis78%253D&md5=547f88e32841320ee1ac37672a827938</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.083436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.083436%26sid%3Dliteratum%253Aachs%26aulast%3DKapusta%26aufirst%3DD.%2BR.%26aulast%3DThorkildsen%26aufirst%3DC.%26aulast%3DKenigs%26aufirst%3DV.%2BA.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DVinge%26aufirst%3DM.%2BM.%26aulast%3DQuist%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26atitle%3DPharmacodynamic%2520characterization%2520of%2520ZP120%2520%2528Ac-RYYRWKKKKKKK-NH2%2529%252C%2520a%2520novel%252C%2520functionally%2520selective%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520partial%2520agonist%2520with%2520sodium-potassium-sparing%2520aquaretic%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D652%26epage%3D660%26doi%3D10.1124%2Fjpet.105.083436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Fischetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/j.peptides.2008.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.peptides.2008.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=248-255&author=C.+Fischettiauthor=A.+Rizziauthor=E.+C.+Gavioliauthor=G.+Marzolaauthor=C.+Trapellaauthor=R.+Guerriniauthor=J.+S.+Petersenauthor=G.+Calo&title=Further+studies+on+the+pharmacological+features+of+the+nociceptin%2Forphanin+FQ+receptor+ligand+ZP120&doi=10.1016%2Fj.peptides.2008.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2008.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2008.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DFurther%2520studies%2520on%2520the%2520pharmacological%2520features%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligand%2520ZP120%26jtitle%3DPeptides%26date%3D2009%26volume%3D30%26spage%3D248%26epage%3D255%26doi%3D10.1016%2Fj.peptides.2008.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">van Deurs, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadrup, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonassen, T. E.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ peptide receptor agonist Ac-RYYRWKKKKKKK-NH2 (ZP120) induces antinatriuresis in rats by stimulation of amiloride-sensitive sodium reabsorption</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1124/jpet.108.144774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.108.144774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19028991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Khu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=533-539&author=U.+S.+van+Deursauthor=N.+Hadrupauthor=J.+S.+Petersenauthor=S.+Christensenauthor=T.+E.+Jonassen&title=Nociceptin%2Forphanin+FQ+peptide+receptor+agonist+Ac-RYYRWKKKKKKK-NH2+%28ZP120%29+induces+antinatriuresis+in+rats+by+stimulation+of+amiloride-sensitive+sodium+reabsorption&doi=10.1124%2Fjpet.108.144774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ peptide receptor agonist Ac-RYYRWKKKKKKK-NH2 (ZP120) induces antinatriuresis in rats by stimulation of amiloride-sensitive sodium reabsorption</span></div><div class="casAuthors">van Deurs, Ulla S. K.; Hadrup, Niels; Petersen, Joergen Soeberg; Christensen, Sten; Jonassen, Thomas E. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">533-539</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of the present study was to examine the mechanisms responsible for the antinatriuretic effect of the selective, peripherally acting, nociceptin/orphanin FQ peptide (NOP) receptor partial agonist Ac-RYYRWKKKKKKK-NH2 (ZP120).  Using immunohistochem., we showed that in the cortex NOP receptors are expressed in the distal convoluted tubules, the connecting tubules, and the collecting ducts.  Using clearance techniques, we evaluated renal excretory function during acute administration of ZP120 (1 nmol/kg/min) in chronically catheterized, conscious rats (n = 8/group).  To examine the hypothesis that ZP120 induces direct renal effects by modifying the activity of sodium transporters in the distal convoluted tubules or in the collecting ducts, ZP120-induced antinatriuresis was examd. during coadministration of an inhibitor of the NaCl cotransporter, bendroflumethiazide, or a blocker of the epithelial sodium channel, amiloride, resp.  ZP120 produced a marked antinatriuresis [fractional excretion of sodium (FENa): ZP120, 0.3±0.1% vs. control, 0.9±0.1%; p < 0.05] in sodium-replete rats.  The natriuretic response to amiloride was significantly increased in ZP120-treated rats compared with controls (ΔFENa: ZP120, 1.1±0.2% vs. control, 0.5±0.2%; p < 0.01), whereas the effect of BFTZ was equal in ZP120-treated rats and controls.  These results suggest that ZP120 exerts a direct renal NOP receptor-mediated stimulatory effect on the epithelial sodium channel in the collecting ducts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMyLz1TuMz7Vg90H21EOLACvtfcHk0lhV6dtJRfSWtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Khu7Y%253D&md5=5299f0567a06d09bd32c1a4a82fa0b61</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.144774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.144774%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDeurs%26aufirst%3DU.%2BS.%26aulast%3DHadrup%26aufirst%3DN.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DJonassen%26aufirst%3DT.%2BE.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520agonist%2520Ac-RYYRWKKKKKKK-NH2%2520%2528ZP120%2529%2520induces%2520antinatriuresis%2520in%2520rats%2520by%2520stimulation%2520of%2520amiloride-sensitive%2520sodium%2520reabsorption%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D533%26epage%3D539%26doi%3D10.1124%2Fjpet.108.144774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span>SERODUS PHARMA Pipeline SER100TRISH. <a href="http://www.serodus.com/Pipeline/SER100TRISH" class="extLink">http://www.serodus.com/Pipeline/SER100TRISH</a> (accessed September 20,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SERODUS+PHARMA+Pipeline+SER100TRISH.+http%3A%2F%2Fwww.serodus.com%2FPipeline%2FSER100TRISH+%28accessed+September+20%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Woodcock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span> </span><span class="NLM_article-title">The efficacy of a NOP1 agonist (SCH486757) in subacute cough</span> <span class="citation_source-journal">Lung</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1007/s00408-009-9197-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00408-009-9197-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2010&pages=47-52&issue=Suppl.+1&author=A.+Woodcockauthor=R.+L.+McLeodauthor=J.+Sadehauthor=J.+A.+Smith&title=The+efficacy+of+a+NOP1+agonist+%28SCH486757%29+in+subacute+cough&doi=10.1007%2Fs00408-009-9197-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs00408-009-9197-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00408-009-9197-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoodcock%26aufirst%3DA.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DSadeh%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520efficacy%2520of%2520a%2520NOP1%2520agonist%2520%2528SCH486757%2529%2520in%2520subacute%2520cough%26jtitle%3DLung%26date%3D2010%26volume%3D188%26issue%3DSuppl.%25201%26spage%3D47%26epage%3D52%26doi%3D10.1007%2Fs00408-009-9197-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeh, J.</span><span> </span><span class="NLM_article-title">Where are the new cough treatments: a debriefing of recent clinical proof-of-concept trials with the NOP agonist SCH 486757</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1159/000328782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1159%2F000328782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2011&pages=50-54&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=J.+Sadeh&title=Where+are+the+new+cough+treatments%3A+a+debriefing+of+recent+clinical+proof-of-concept+trials+with+the+NOP+agonist+SCH+486757&doi=10.1159%2F000328782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1159%2F000328782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000328782%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DSadeh%26aufirst%3DJ.%26atitle%3DWhere%2520are%2520the%2520new%2520cough%2520treatments%253A%2520a%2520debriefing%2520of%2520recent%2520clinical%2520proof-of-concept%2520trials%2520with%2520the%2520NOP%2520agonist%2520SCH%2520486757%26jtitle%3DPharmacology%26date%3D2011%26volume%3D88%26spage%3D50%26epage%3D54%26doi%3D10.1159%2F000328782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span>JTC 801 Japan Tobacco discontinued, Japan, UK,(pain). <a href="http://business.highbeam.com/436989/article-1G1-109477099/jtc-801-japan-tobacco-discontinued-japan-uk" class="extLink">http://business.highbeam.com/436989/article-1G1-109477099/jtc-801-japan-tobacco-discontinued-japan-uk</a> (accessed June 30,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=JTC+801+Japan+Tobacco+discontinued%2C+Japan%2C+UK%2C%28pain%29.+http%3A%2F%2Fbusiness.highbeam.com%2F436989%2Farticle-1G1-109477099%2Fjtc-801-japan-tobacco-discontinued-japan-uk+%28accessed+June+30%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Lazzeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaguti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beneforti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, D.</span><span> </span><span class="NLM_article-title">Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2098</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span><span class="refDoi"> DOI: 10.1016/j.juro.2006.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.juro.2006.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17070267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=2098-2102&author=M.+Lazzeriauthor=G.+Caloauthor=M.+Spinelliauthor=S.+Malagutiauthor=R.+Guerriniauthor=S.+Salvadoriauthor=P.+Benefortiauthor=D.+Regoliauthor=D.+Turini&title=Daily+intravesical+instillation+of+1+mg+nociceptin%2Forphanin+FQ+for+the+control+of+neurogenic+detrusor+overactivity%3A+a+multicenter%2C+placebo+controlled%2C+randomized+exploratory+study&doi=10.1016%2Fj.juro.2006.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study</span></div><div class="casAuthors">Lazzeri, Massimo; Calo, Girolamo; Spinelli, Michele; Malaguti, Silvia; Guerrini, Remo; Salvadori, Severo; Beneforti, Patrizia; Regoli, Domenico; Turini, Damiano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2098-2102</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: We studied the feasibility, safety and efficacy of daily intravesical instillation of 1 mg of the endogenous peptide nociceptin/orphanin FQ in a selected group of patients who perform clean intermittent self-catheterization for neurogenic detrusor over activity incontinence.  Materials and Methods: A total of 18 patients with neurogenic detrusor overactivity incontinence and on clean intermittent self-catheterization were prospectively randomized to receive 1 mg nociceptin/orphanin FQ in 10 cc saline (9) or placebo (saline) soln. (9) at the first morning catheterization for 10 days.  All patients completed a voiding diary using a frequency/vol. chart according to International Continence Society guidelines, and reported daily incontinence frequency.  Mean changes in incontinence episode frequency and voiding diary mean bladder capacity from baseline throughout treatment were the primary outcome variables.  Urodynamic parameters (cystomanometric bladder capacity, max. bladder pressure) were also recorded at baseline and during the study.  Results: The 2 groups were well balanced and all patients completed the study.  The urodynamic parameters recorded during the study showed an increase in cystomanometric bladder capacity and a decrease in max. bladder pressure compared to baseline only in patients assigned to the nociceptin/orphanin FQ group.  Mean daily urine leakage episodes during nociceptin/orphanin FQ treatment were 0.94 vs a pretreatment baseline of 2.18 (p <0.05), while no significant changes were reported in the placebo group (2.06 vs 2.43 baseline).  The total mean voiding diary bladder capacity increased from 171 ± 70 to 294 ± 107 mL in patients receiving nociceptin/orphanin FQ, while voiding diary mean bladder capacity remained unchanged in patients receiving placebo (from 182 ± 55 to 178 ± 23 mL).  No significant problems related to feasibility of the procedure as well as significant side effects were reported by patients.  Conclusions: This study showed that intravesical nociceptin/orphanin FQ but not placebo inhibited the micturition reflex in patients with neurogenic detrusor overactivity incontinence, and demonstrated the clin. efficacy of nociceptin/orphanin FQ during 10 days of treatment.  These findings support the use of nociceptin/orphanin FQ peptide receptor agonists as an innovative therapeutic approach for controlling detrusor overactivity incontinence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJMcvtQcA4brVg90H21EOLACvtfcHk0liZqi9ga_9B7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbN&md5=f6344f49e36299e104eb679d9cc1026b</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DMalaguti%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBeneforti%26aufirst%3DP.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTurini%26aufirst%3DD.%26atitle%3DDaily%2520intravesical%2520instillation%2520of%25201%2520mg%2520nociceptin%252Forphanin%2520FQ%2520for%2520the%2520control%2520of%2520neurogenic%2520detrusor%2520overactivity%253A%2520a%2520multicenter%252C%2520placebo%2520controlled%252C%2520randomized%2520exploratory%2520study%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D2098%26epage%3D2102%26doi%3D10.1016%2Fj.juro.2006.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Lazzeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beneforti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanollo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, D.</span><span> </span><span class="NLM_article-title">Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">2237</span><span class="NLM_x">–</span> <span class="NLM_lpage">2240</span><span class="refDoi"> DOI: 10.1016/S0022-5347(05)65541-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0022-5347%2805%2965541-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11696742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFKm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=2237-2240&author=M.+Lazzeriauthor=G.+Caloauthor=M.+Spinelliauthor=R.+Guerriniauthor=P.+Benefortiauthor=S.+Sandriauthor=A.+Zanolloauthor=D.+Regoliauthor=D.+Turini&title=Urodynamic+and+clinical+evidence+of+acute+inhibitory+effects+of+intravesical+nociceptin%2Forphanin+FQ+on+detrusor+overactivity+in+humans%3A+a+pilot+study&doi=10.1016%2FS0022-5347%2805%2965541-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study</span></div><div class="casAuthors">Lazzeri, Massimo; Calo, Girolamo; Spinelli, Michele; Guerrini, Remo; Beneforti, Patrizia; Sandri, Sandro; Zanollo, Alberto; Regoli, Domenico; Turini, Damiano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2237-2240</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Management of neurogenic incontinence is complex and available treatments are not satisfactory.  Nociceptin/orphanin FQ, a recently discovered neuropeptide, has been reported to inhibit the voiding reflex in the rat.  These exptl. prompted the authors to investigate the urodynamic and clin. effects of intravesical instillation of nociceptin/orphanin FQ in humans.  The authors' study involved 5 normal subjects (group 1) with a mean age of 40.4 yr (range 21 to 54) and 9 patients (group 2) 40.4 yr (24 to 54).  All patients in group 2 presented with detrusor hyperreflexia refractory to std. therapy.  They were invited to undergo a filling cystometrogram with saline soln. and after 30 min, a new one with a soln. contg. 1 μM. nociceptin/orphanin FQ.  The urodynamic parameters that were recorded included bladder capacity, vol. threshold for the appearance of detrusor hyperreflexia and max. bladder pressure.  Clin. and urodynamic follow-up was performed after 15 days.  The data were statistically analyzed with 1-way anal. of variance followed by the Dunnett test for multiple comparison considered statistically significant with.  Intravesical instillation of 1 μM. nociceptin/orphanin FQ in group 1 did not produce significant functional changes.  This infusion in group 2 produced a statistically significant increase in mean bladder capacity and vol. threshold for the appearance of detrusor hyperreflexia from 164 to 301 and 93 to 231 mL.  Mean max. bladder pressure decreased from 79 to 54 cm. water but was not statistically significant.  After 15 days an absence of clin. improvement was noticed in group 2, and the urodynamic control did not show any significant changes compared to the values before nociceptin/orphanin FQ treatment.  No severe symptomatic reactions were obsd. during infusion of 1 μM. nociceptin/orphanin FQ.  The results demonstrate that nociceptin/orphanin FQ is able to elicit a robust inhibitory effect on voiding reflex in group 2 but not 1.  The ideal dosage, route of administration of nociceptin/orphanin FQ and treatment interval are not yet established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU83s3zAsTY7Vg90H21EOLACvtfcHk0liZqi9ga_9B7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFKm&md5=3877595544e45918b2f7193f3d5c0345</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2805%2965541-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252805%252965541-3%26sid%3Dliteratum%253Aachs%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBeneforti%26aufirst%3DP.%26aulast%3DSandri%26aufirst%3DS.%26aulast%3DZanollo%26aufirst%3DA.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTurini%26aufirst%3DD.%26atitle%3DUrodynamic%2520and%2520clinical%2520evidence%2520of%2520acute%2520inhibitory%2520effects%2520of%2520intravesical%2520nociceptin%252Forphanin%2520FQ%2520on%2520detrusor%2520overactivity%2520in%2520humans%253A%2520a%2520pilot%2520study%26jtitle%3DJ.%2520Urol.%26date%3D2001%26volume%3D166%26spage%3D2237%26epage%3D2240%26doi%3D10.1016%2FS0022-5347%2805%2965541-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lazzeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beneforti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, D.</span><span> </span><span class="NLM_article-title">Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">946</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span><span class="refDoi"> DOI: 10.1016/S0090-4295(02)02587-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0090-4295%2802%2902587-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=946-950&author=M.+Lazzeriauthor=G.+Caloauthor=M.+Spinelliauthor=R.+Guerriniauthor=S.+Salvadoriauthor=P.+Benefortiauthor=S.+Sandriauthor=D.+Regoliauthor=D.+Turini&title=Urodynamic+effects+of+intravesical+nociceptin%2Forphanin+FQ+in+neurogenic+detrusor+overactivity%3A+a+randomized%2C+placebo-controlled%2C+double-blind+study&doi=10.1016%2FS0090-4295%2802%2902587-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0090-4295%2802%2902587-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-4295%252802%252902587-6%26sid%3Dliteratum%253Aachs%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBeneforti%26aufirst%3DP.%26aulast%3DSandri%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTurini%26aufirst%3DD.%26atitle%3DUrodynamic%2520effects%2520of%2520intravesical%2520nociceptin%252Forphanin%2520FQ%2520in%2520neurogenic%2520detrusor%2520overactivity%253A%2520a%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520study%26jtitle%3DUrology%26date%3D2003%26volume%3D61%26spage%3D946%26epage%3D950%26doi%3D10.1016%2FS0090-4295%2802%2902587-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Zaveri, N.</span><span> </span><span class="NLM_article-title">Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1016/S0024-3205(03)00387-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0024-3205%2803%2900387-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=663-678&author=N.+Zaveri&title=Peptide+and+nonpeptide+ligands+for+the+nociceptin%2Forphanin+FQ+receptor+ORL1%3A+research+tools+and+potential+therapeutic+agents&doi=10.1016%2FS0024-3205%2803%2900387-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2803%2900387-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252803%252900387-4%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%26atitle%3DPeptide%2520and%2520nonpeptide%2520ligands%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ORL1%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D663%26epage%3D678%26doi%3D10.1016%2FS0024-3205%2803%2900387-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Ronzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, G. A. M.</span><span> </span><span class="NLM_article-title">Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1517/13543776.11.4.525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543776.11.4.525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1emu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=525-546&author=S.+Ronzoniauthor=I.+Perettoauthor=G.+A.+M.+Giardina&title=Lead+generation+and+lead+optimisation+approaches+in+the+discovery+of+selective%2C+non-peptide+ORL-1+receptor+agonists+and+antagonists&doi=10.1517%2F13543776.11.4.525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists</span></div><div class="casAuthors">Ronzoni, Silvano; Peretto, Ilaria; Giardina, Giuseppe A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-546</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 104 refs.  The discovery of the opioid receptor like-1 (ORL-1) receptor and of its endogenous agonist nociceptin/orphanin FQ has attracted great interest in the scientific community giving rise, in the last five years, to a flurry of biol. studies aimed at elucidating the role of this new receptor.  Hence, the involvement of the ORL-1 receptor in many important processes, such as antinociception, learning and memory, feeding and anxiety, has been well documented.  However, a clear understanding of the potential therapeutic value assocd. with the modulation of the ORL-1 receptor needs the development of selective non-peptide agonists and antagonists allowing systemic routes of administration.  This review addresses the advances made by several research groups in the discovery of such compds. and discusses the medicinal chem. strategies which, starting from the first non-selective ligands NalBzoH and lofentanil, led to the disclosure of highly potent and selective agonists and antagonists, such as Ro 64-6198, J-113397 and JTC-801.  Efforts have also focussed on the pharmacol. characterization of the newly discovered non-peptide tools, which represent a significant step forward in the understanding of the involvement of the ORL-1 receptor in a no. of possible pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgQVIuVN7IW7Vg90H21EOLACvtfcHk0liVjKoUCOge0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1emu7c%253D&md5=577714ac0d0d15d639a2d934a1eb77c2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F13543776.11.4.525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.11.4.525%26sid%3Dliteratum%253Aachs%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26atitle%3DLead%2520generation%2520and%2520lead%2520optimisation%2520approaches%2520in%2520the%2520discovery%2520of%2520selective%252C%2520non-peptide%2520ORL-1%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2001%26volume%3D11%26spage%3D525%26epage%3D546%26doi%3D10.1517%2F13543776.11.4.525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Bignan, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span> </span><span class="NLM_article-title">Recent advances towards the discovery of ORL-1 receptor agonists and antagonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1517/13543776.15.4.357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543776.15.4.357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1ymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=357-388&author=G.+C.+Bignanauthor=P.+J.+Connollyauthor=S.+A.+Middleton&title=Recent+advances+towards+the+discovery+of+ORL-1+receptor+agonists+and+antagonists&doi=10.1517%2F13543776.15.4.357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances towards the discovery of ORL-1 receptor agonists and antagonists</span></div><div class="casAuthors">Bignan, Gilles C.; Connolly, Peter J.; Middleton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-388</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Since their discovery a decade ago, remarkable progress was made toward understanding the biol. function and significance of the opioid receptor-like-1 (ORL-1) receptor and its endogenous peptide ligand, nociceptin.  The human nociceptin receptor, herein referred to as ORL-1, but also known as OP4 (the 4th member of opioid peptide receptor family) or nociceptin/orphanin FQ peptide (NOP) receptor, was first identified as an orphan opioid receptor with close homol. to the classical μ-, κ-, and δ-opioid receptors.  ORL-1 does not bind endogenous ligands of the other opioid receptors with high affinity, but instead prefers the 17 amino acid peptide nociceptin.  The obvious homologies of ORL-1 to opioid receptors, and its ligand nociceptin to opioid peptide ligands, led to a period of intense investigation that resulted in a no. of significant reports describing the biol. of the receptor and ligand.  The emerging pharmacol. evidence from these reports suggests that ORL-1 agonists may be clin. useful for treatment of stress, anxiety, substance abuse (opioid and alc.), anorexia, cachexia, cough, asthma, and possibly neuropathic pain/allodynia.  The peripheral effects of nociceptin suggest that agonists may have utility in the treatment of gastrointestinal motility disorders, water retention, and hypertension.  ORL-1 antagonists may be useful in enhancing cognitive function and treating locomotor disorders such as Parkinsonism.  In addn. to research into the fundamental biol. of ORL-1 and nociceptin, noteworthy advances were made in the discovery of new peptide and non-peptide agonists and antagonists of the ORL-1 receptor leading to a better understanding of its involvement in a variety of biol. processes.  This review highlights the rationale for the development of ORL-1 ligands and recent progress made by different research groups towards the development of peptidic and non-peptidic ORL-1 agonists or antagonists over the last 4 years.  To add perspective on the com. potential of this research area, the development status of advanced new mols. is addressed together with any pharmacol. characterization of these entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF-D3T_o_24bVg90H21EOLACvtfcHk0liVjKoUCOge0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1ymsLw%253D&md5=288edcbf10ec87a04cec5b8e33380fb3</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1517%2F13543776.15.4.357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.15.4.357%26sid%3Dliteratum%253Aachs%26aulast%3DBignan%26aufirst%3DG.%2BC.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26atitle%3DRecent%2520advances%2520towards%2520the%2520discovery%2520of%2520ORL-1%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2005%26volume%3D15%26spage%3D357%26epage%3D388%26doi%3D10.1517%2F13543776.15.4.357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Lambert, D. G.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1038/nrd2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnrd2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18670432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=694-710&author=D.+G.+Lambert&title=The+nociceptin%2Forphanin+FQ+receptor%3A+a+target+with+broad+therapeutic+potential&doi=10.1038%2Fnrd2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span></div><div class="casAuthors">Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">694-710</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, Lambert describes the physiol. and potential clin. applications of nociceptin/orphanin FQ and its receptor.  This peptide-receptor system has been implicated in a wide range of biol. functions such as pain, drug abuse, cardiovascular control and immunity.  Identification of the enigmatic nociceptin/orphanin FQ peptide (N/OFQ) in 1995 represented the first successful use of reverse pharmacol. and led to deorphanization of the N/OFQ receptor (NOP).  Subsequently, the N/OFQ-NOP system has been implicated in a wide range of biol. functions, including pain, drug abuse, cardiovascular control and immunity.  Although this could be considered a hurdle for the development of pharmaceuticals selective for a specific disease indication, NOP represents a viable drug target.  This article describes potential clin. indications and highlights the current status of the very limited no. of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuID92HZwUB7Vg90H21EOLACvtfcHk0liVjKoUCOge0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D&md5=46c1952ed4a0ac1aa7779276bda5bba6</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnrd2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2572%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%253A%2520a%2520target%2520with%2520broad%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D694%26epage%3D710%26doi%3D10.1038%2Fnrd2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Largent-Milnes, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span> </span><span class="NLM_article-title">Recently patented and promising ORL-1 ligands: where have we been and where are we going?</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1517/13543771003602004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543771003602004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20180617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisValur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=291-305&author=T.+M.+Largent-Milnesauthor=T.+W.+Vanderah&title=Recently+patented+and+promising+ORL-1+ligands%3A+where+have+we+been+and+where+are+we+going%3F&doi=10.1517%2F13543771003602004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Recently patented and promising ORL-1 ligands: where have we been and where are we going?</span></div><div class="casAuthors">Largent-Milnes, Tally M.; Vanderah, Todd W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-305</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The interactions of nociceptin/orphanin FQ (N/OFQ) and the opioid receptor-like receptor 1 (nociceptin opioid peptide - NOP) have been implicated in a variety of systems including cardiovascular, respiratory, immune, and the central and peripheral nervous systems.  To elucidate the endogenous role of the N/OFQ-NOP system through the use of knockout and knockdown animal prepns., though most advances have been made using a host of synthetic agonists and antagonists.  This review gives a brief history of the receptor-ligand discovery, the development of these agonists and antagonists within the last 10 years as published, and the therapeutic indications thereof focusing on pain.  The use of NOP ligands in pain has been controversial at best; however, there are indications that both agonists and antagonists have a place in the clin. setting for acute and chronic pain.  NOP ligands have potential as novel therapeutics, interestingly, when incorporated into a rationally-designed multi-target agent.  The discovery of N/OFQ and NOP opened a new option for the treatment of pain with the potential for a decreased side effect profile.  Numerous compds. have been designed to target this system, the most promising of which have mixed profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL_skezB-GNbVg90H21EOLACvtfcHk0liVjKoUCOge0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisValur0%253D&md5=63c937f182ea33d61b83784ab8866749</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1517%2F13543771003602004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003602004%26sid%3Dliteratum%253Aachs%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DRecently%2520patented%2520and%2520promising%2520ORL-1%2520ligands%253A%2520where%2520have%2520we%2520been%2520and%2520where%2520are%2520we%2520going%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D291%26epage%3D305%26doi%3D10.1517%2F13543771003602004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Rover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span> </span><span class="NLM_article-title">High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.1021/jm991129q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991129q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1329-1338&author=S.+Roverauthor=G.+Adamauthor=A.+M.+Cesuraauthor=G.+Galleyauthor=F.+Jenckauthor=F.+J.+Monsmaauthor=J.+Wichmannauthor=F.+M.+Dautzenberg&title=High-affinity%2C+non-peptide+agonists+for+the+ORL1+%28orphanin+FQ%2Fnociceptin%29+receptor&doi=10.1021%2Fjm991129q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm991129q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991129q%26sid%3Dliteratum%253Aachs%26aulast%3DRover%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DGalley%26aufirst%3DG.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26atitle%3DHigh-affinity%252C%2520non-peptide%2520agonists%2520for%2520the%2520ORL1%2520%2528orphanin%2520FQ%252Fnociceptin%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1329%26epage%3D1338%26doi%3D10.1021%2Fjm991129q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span><span class="refDoi"> DOI: 10.1016/S0223-5234(00)00171-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0223-5234%2800%2900171-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=839-851&author=J.+Wichmannauthor=G.+Adamauthor=S.+Roverauthor=M.+Hennigauthor=M.+Scaloneauthor=A.+M.+Cesuraauthor=F.+M.+Dautzenbergauthor=F.+Jenck&title=Synthesis+of+%281S%2C3aS%29-8-%282%2C3%2C3a%2C4%2C5%2C+6-hexahydro-1H-phenalen-1-yl%29-1-phenyl-1%2C3%2C8-triaza-spiro%5B4.+5%5Ddecan-4-one%2C+a+potent+and+selective+orphanin+FQ+%28OFQ%29+receptor+agonist+with+anxiolytic-like+properties&doi=10.1016%2FS0223-5234%2800%2900171-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2800%2900171-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252800%252900171-9%26sid%3Dliteratum%253Aachs%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DRover%26aufirst%3DS.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520%25281S%252C3aS%2529-8-%25282%252C3%252C3a%252C4%252C5%252C%25206-hexahydro-1H-phenalen-1-yl%2529-1-phenyl-1%252C3%252C8-triaza-spiro%255B4.%25205%255Ddecan-4-one%252C%2520a%2520potent%2520and%2520selective%2520orphanin%2520FQ%2520%2528OFQ%2529%2520receptor%2520agonist%2520with%2520anxiolytic-like%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2000%26volume%3D35%26spage%3D839%26epage%3D851%26doi%3D10.1016%2FS0223-5234%2800%2900171-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higelin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Py-Lang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzeisen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11454946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVKqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2001&pages=812-819&author=F.+M.+Dautzenbergauthor=J.+Wichmannauthor=J.+Higelinauthor=G.+Py-Langauthor=C.+Kratzeisenauthor=P.+Malherbeauthor=G.+J.+Kilpatrickauthor=F.+Jenck&title=Pharmacological+characterization+of+the+novel+nonpeptide+orphanin+FQ%2Fnociceptin+receptor+agonist+Ro+64-6198%3A+rapid+and+reversible+desensitization+of+the+ORL1+receptor+in+vitro+and+lack+of+tolerance+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo</span></div><div class="casAuthors">Dautzenberg, Frank M.; Wichmann, Jurgen; Higelin, Jacqueline; Py-Lang, Gabrielle; Kratzeisen, Claudia; Malherbe, Pari; Kilpatrick, Gavin J.; Jenck, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">812-819</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The novel nonpeptide orphanin FQ/nociceptin (OFQ/N) ligand {(1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1- phenyl-1,3,8-triaza-spiro[4,5]decan-4-one} (Ro 64-6198) was characterized in vitro and in vivo for its agonistic potential.  Ro 64-6198 was 130- to 3500-fold selective for the OFQ/N receptor (ORL1) compared with opiate receptors.  In the cAMP inhibition assay, Ro 64-6198 was a full agonist at the ORL1 and a partial agonist at the mu opiate receptor.  When human embryonic kidney 293 cells stably expressing the human ORL1 receptor were pre-exposed (30 min) to either OFQ/N or Ro 64-6198, the ability of both agonists to inhibit forskolin-mediated cAMP accumulation was strongly reduced, indicating a functional desensitization of the second messenger cascade.  However, acidic washes of OFQ/N-exposed cells fully restored the sensitivity of the ORL1 receptor for agonists.  In contrast, the cAMP response in Ro 64-6198-exposed cells remained impaired after acidic washes, suggesting sustained receptor internalization at 30 min.  In agreement with this finding, the no. of cell-surface ORL1 receptors was significantly reduced after Ro 64-6198 pre-exposure, and this effect could be blocked with high sucrose concns.  When Ro 64-6198 was chronically administered to rats, no signs of tolerance to its anxiolytic-like effects were detected following 15 days of daily drug exposure.  In agreement with the behavioral results, Ro 64-6198 was able to reduce brain ORL1 binding sites in both acutely and chronically treated rats.  Full recovery of ORL1 binding sites was obsd. 24 h after Ro 64-6198 administration with a t1/2 of ∼5.5 h.  These data show that nonpeptide agonists at the ORL1 receptor have a good clin. potential as anxiolytics without causing tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqprX8RN_LX6bVg90H21EOLACvtfcHk0lgU1ion-KBumQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVKqt70%253D&md5=e7cc837ea26d5eb3ab8ced4d21e36b7f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DHigelin%26aufirst%3DJ.%26aulast%3DPy-Lang%26aufirst%3DG.%26aulast%3DKratzeisen%26aufirst%3DC.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520novel%2520nonpeptide%2520orphanin%2520FQ%252Fnociceptin%2520receptor%2520agonist%2520Ro%252064-6198%253A%2520rapid%2520and%2520reversible%2520desensitization%2520of%2520the%2520ORL1%2520receptor%2520in%2520vitro%2520and%2520lack%2520of%2520tolerance%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D298%26spage%3D812%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCool, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazdoba, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pond, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1007/s00213-005-0041-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-005-0041-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16025321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOitb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=132-143&author=G.+B.+Vartyauthor=L.+A.+Hydeauthor=R.+A.+Hodgsonauthor=S.+X.+Luauthor=M.+F.+McCoolauthor=T.+M.+Kazdobaauthor=R.+A.+Del+Vecchioauthor=D.+H.+Guthrieauthor=A.+J.+Pondauthor=M.+E.+Grzelakauthor=X.+Xuauthor=W.+A.+Korfmacherauthor=D.+Tulshianauthor=E.+M.+Parkerauthor=G.+A.+Higgins&title=Characterization+of+the+nociceptin+receptor+%28ORL-1%29+agonist%2C+Ro64-6198%2C+in+tests+of+anxiety+across+multiple+species&doi=10.1007%2Fs00213-005-0041-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species</span></div><div class="casAuthors">Varty, G. B.; Hyde, L. A.; Hodgson, R. A.; Lu, S. X.; McCool, M. F.; Kazdoba, T. M.; Vecchio, R. A.; Guthrie, D. H.; Pond, A. J.; Grzelak, M. E.; Xu, X.; Korfmacher, W. A.; Tulshian, D.; Parker, E. M.; Higgins, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-143</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Previous studies have demonstrated behaviors indicative of anxiolysis in rats pretreated with the nociceptin receptor (opioid receptor like-1, ORL-1) agonist, Ro64-6198.  The aim of this study was to examine the effects of Ro64-6198 in anxiety models across three species: rat, guinea pig, and mouse.  In addn., the receptor specificity of Ro64-6198 was studied, using the ORL-1 receptor antagonist, J-113397, and ORL-1 receptor knockout (KO) mice.  Finally, neurol. studies examd. potential side effects of Ro64-6198 in the rat and mouse.  Ro64-6198 (3 - 10 mg/kg) increased punished responding in a rat conditioned lick suppression test similarly to chlordiazepoxide (6 mg/kg).  This effect of Ro64-6198 was attenuated by J-113397 (10 mg/kg), but not the mu opioid antagonist, naltrexone (3 mg/kg).  In addn., Ro64-6198 ( 1 - 3 mg/kg) reduced isolation-induced vocalizations in rat and guinea pig pups.  Ro64-6198 (3 mg/kg) increased the proportion of punished responding in a mouse Geller-Seifter test in wild-type (WT) but not ORL-1 KO mice, whereas diazepam (1 - 5.6 mg/kg) was effective in both genotypes.  In rats, Ro64-6198 reduced locomotor activity (LMA) and body temp. and impaired rotarod, beam walking, and fixed-ratio (FR) performance at doses of 10-30 mg/kg, i.e., three to ten times higher than an anxiolytic dose.  In WT mice, Ro64-6198 (3 - 10 mg/kg) reduced LMA and rotarod performance, body temp., and FR responding, but these same measures were unaffected in ORL-1 KO mice.  Haloperidol (0.3 - 3 mg/kg) reduced these measures to a similar extent in both genotypes.  These studies confirm the potent, ORL-1 receptor-mediated, anxiolytic-like effects of Ro64-6198, extending the findings across three species.  Ro64-6198 has target-based side effects, although the magnitude of these effects varies across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDj40L9WM_abVg90H21EOLACvtfcHk0lgU1ion-KBumQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOitb%252FO&md5=851b297d2d33661509cb723adf922b01</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-0041-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-0041-4%26sid%3Dliteratum%253Aachs%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DMcCool%26aufirst%3DM.%2BF.%26aulast%3DKazdoba%26aufirst%3DT.%2BM.%26aulast%3DDel%2BVecchio%26aufirst%3DR.%2BA.%26aulast%3DGuthrie%26aufirst%3DD.%2BH.%26aulast%3DPond%26aufirst%3DA.%2BJ.%26aulast%3DGrzelak%26aufirst%3DM.%2BE.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DKorfmacher%26aufirst%3DW.%2BA.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DCharacterization%2520of%2520the%2520nociceptin%2520receptor%2520%2528ORL-1%2529%2520agonist%252C%2520Ro64-6198%252C%2520in%2520tests%2520of%2520anxiety%2520across%2520multiple%2520species%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2005%26volume%3D182%26spage%3D132%26epage%3D143%26doi%3D10.1007%2Fs00213-005-0041-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly-Evers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span> </span><span class="NLM_article-title">Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/S0028-3908(01)00048-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0028-3908%2801%2900048-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=97-107&author=G.+A.+Higginsauthor=A.+J.+Grottickauthor=T.+M.+Ballardauthor=J.+G.+Richardsauthor=J.+Messerauthor=H.+Takeshimaauthor=M.+Pauly-Eversauthor=F.+Jenckauthor=G.+Adamauthor=J.+Wichmann&title=Influence+of+the+selective+ORL1+receptor+agonist%2C+Ro64-6198%2C+on+rodent+neurological+function&doi=10.1016%2FS0028-3908%2801%2900048-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2801%2900048-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252801%252900048-X%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DBallard%26aufirst%3DT.%2BM.%26aulast%3DRichards%26aufirst%3DJ.%2BG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DPauly-Evers%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DWichmann%26aufirst%3DJ.%26atitle%3DInfluence%2520of%2520the%2520selective%2520ORL1%2520receptor%2520agonist%252C%2520Ro64-6198%252C%2520on%2520rodent%2520neurological%2520function%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D97%26epage%3D107%26doi%3D10.1016%2FS0028-3908%2801%2900048-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazdoba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCool, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bercovici, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span> </span><span class="NLM_article-title">The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxami de (SCH 655842): comparison of efficacy and side effects across rodent species</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">661</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2011.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2011.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21545797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=661&publication_year=2011&pages=63-71&author=S.+X.+Luauthor=G.+A.+Higginsauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=R.+A.+Del+Vecchioauthor=D.+H.+Guthrieauthor=T.+Kazdobaauthor=M.+F.+McCoolauthor=C.+A.+Morganauthor=A.+Bercoviciauthor=G.+D.+Hoauthor=D.+Tulshianauthor=E.+M.+Parkerauthor=J.+C.+Hunterauthor=G.+B.+Varty&title=The+anxiolytic-like+profile+of+the+nociceptin+receptor+agonist%2C+endo-8-%5Bbis%282-chlorophenyl%29methyl%5D-3-phenyl-8-azabicyclo%5B3.2.1%5Doctane-3-carboxami+de+%28SCH+655842%29%3A+comparison+of+efficacy+and+side+effects+across+rodent+species&doi=10.1016%2Fj.ejphar.2011.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): Comparison of efficacy and side effects across rodent species</span></div><div class="casAuthors">Lu, Sherry X.; Higgins, Guy A.; Hodgson, Robert A.; Hyde, Lynn A.; Del Vecchio, Robert A.; Guthrie, Donald H.; Kazdoba, Tatiana; McCool, Martha F.; Morgan, Cynthia A.; Bercovici, Ana; Ho, Ginny D.; Tulshian, Deen; Parker, Eric M.; Hunter, John C.; Varty, Geoffrey B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">661</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endogenous opioid-like peptide, nociceptin, produces anxiolytic-like effects that are mediated via the nociceptin (NOP) receptor.  Similarly, synthetic, non-peptide NOP agonists produce robust anxiolytic-like effects although these effects are limited by marked side effects.  In the present studies, the effects of a novel NOP receptor agonist, SCH 655842(I), were examd. in rodent models sensitive to anxiolytic drugs and tests measuring potential adverse affects.  Oral administration of SCH 655842 produced robust, anxiolytic-like effects in three species, i.e., rat, guinea pig, and mouse.  Specifically, SCH 655842 was effective in rat conditioned lick suppression (3-10 mg/kg) and fear-potentiated startle (3-10 mg/kg) tests, a guinea pig pup vocalization test (1-3 mg/kg), as well as in mouse Geller-Seifter (30 mg/kg) and marble burying (30 mg/kg) tests.  The anxiolytic-like effect of SCH 655842 in the conditioned lick suppression test was attenuated by the NOP antagonist, J-113397.  In mice, SCH 655842 reduced locomotor activity and body temp. at doses similar to the anxiolytic-like dose and these effects were absent in NOP receptor knockout mice.  In rats, SCH 655842 did not produce adverse behavioral effects up to doses of 70-100 mg/kg.  Pharmacokinetic studies in the rat confirmed dose-related increases in plasma and brain levels of SCH 655842 across a wide oral dose range.  Taken together, SCH 655842 may represent a NOP receptor agonist with improved tolerability compared to other members of this class although further studies are necessary to establish whether this extends to higher species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKYNN1RUmobVg90H21EOLACvtfcHk0li8wAwiDLR9zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVagt7k%253D&md5=34a603291c8e13ebbcaf0a520abbd543</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DDel%2BVecchio%26aufirst%3DR.%2BA.%26aulast%3DGuthrie%26aufirst%3DD.%2BH.%26aulast%3DKazdoba%26aufirst%3DT.%26aulast%3DMcCool%26aufirst%3DM.%2BF.%26aulast%3DMorgan%26aufirst%3DC.%2BA.%26aulast%3DBercovici%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26atitle%3DThe%2520anxiolytic-like%2520profile%2520of%2520the%2520nociceptin%2520receptor%2520agonist%252C%2520endo-8-%255Bbis%25282-chlorophenyl%2529methyl%255D-3-phenyl-8-azabicyclo%255B3.2.1%255Doctane-3-carboxami%2520de%2520%2528SCH%2520655842%2529%253A%2520comparison%2520of%2520efficacy%2520and%2520side%2520effects%2520across%2520rodent%2520species%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D661%26spage%3D63%26epage%3D71%26doi%3D10.1016%2Fj.ejphar.2011.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Toll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span> </span><span class="NLM_article-title">Comparison of the anti-nociceptive and anti-rewarding profiles of novel bifunctional nociceptin/orphanin FQ receptor (NOPr)-mu opioid receptor (MOPr) ligands: Implications for therapeutic applications</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span><span class="refDoi"> DOI: 10.1124/jpet.109.157446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.109.157446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19773529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=954-964&author=L.+Tollauthor=T.+V.+Khroyanauthor=W.+E.+Polgarauthor=F.+Jiangauthor=C.+Olsenauthor=N.+T.+Zaveri&title=Comparison+of+the+anti-nociceptive+and+anti-rewarding+profiles+of+novel+bifunctional+nociceptin%2Forphanin+FQ+receptor+%28NOPr%29-mu+opioid+receptor+%28MOPr%29+ligands%3A+Implications+for+therapeutic+applications&doi=10.1124%2Fjpet.109.157446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/μ-opioid receptor ligands: implications for therapeutic applications</span></div><div class="casAuthors">Toll, Lawrence; Khroyan, Taline V.; Polgar, Willma E.; Jiang, Faming; Olsen, Cris; Zaveri, Nurulain T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">954-964</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The nociceptin receptor (NOPr), a member of the opioid receptor family, is a target for the treatment of pain and drug abuse.  Nociceptin/orphanin FQ (N/OFQ), the endogenous peptide for NOPr, not only modulates opioid antinociception, but also blocks the rewarding effects of several abused drugs, such as morphine, cocaine, and amphetamine.  We hypothesized that NOPr agonists, with bifunctional activity at the μ-opioid receptor (MOPr), may function as nonaddicting analgesics or as drug abuse medications.  Bifunctional small-mol. NOPr agonists possessing different selectivities and efficacies at MOPr were evaluated in an acute thermal antinociception assay, and for their ability to induce conditioned place preference (CPP) and their effect on morphine-induced CPP.  1-(1-Cyclooctylpiperidin-4-yl)-indolin-2-one (SR14150), a high-affinity NOPr partial agonist, with low MOPr affinity and efficacy, produced analgesia that was naloxone-reversible.  SR14150 did not induce CPP alone, nor did it attenuate morphine-induced CPP.  3-Ethyl-1-(1-(4-isopropylcyclohexyl)piperidin-4-yl)-indolin-2-one (SR16507), which has high affinity for both NOPr and MOPr, full agonist activity at NOPr, and partial agonist activity at MOPr, was also a potent analgesic and produced CPP alone, but also modestly attenuated morphine CPP.  1-(1-(2,3,3A,4,5,6-hexahydro-1H-phenalen-1-yl)piperidin-4-yl)-indolin-2-one (SR16835), a NOPr full agonist and low-affinity MOPr partial agonist, was not antinociceptive, did not produce CPP alone, but attenuated morphine CPP.  Our results suggest that NOPr full-agonist activity is required to modulate opioid-induced reward, whereas a bifunctional NOPr/MOPr partial agonist profile may be suitable as a nonaddicting analgesic.  The opioid-modulating effects of the NOPr ligands may be used effectively to produce better medications for treatment of drug abuse and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSq0nyX8esa7Vg90H21EOLACvtfcHk0li8wAwiDLR9zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLrI&md5=d9386f73b81e02a7afddf8efe6cba83a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.157446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.157446%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DComparison%2520of%2520the%2520anti-nociceptive%2520and%2520anti-rewarding%2520profiles%2520of%2520novel%2520bifunctional%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520%2528NOPr%2529-mu%2520opioid%2520receptor%2520%2528MOPr%2529%2520ligands%253A%2520Implications%2520for%2520therapeutic%2520applications%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D954%26epage%3D964%26doi%3D10.1124%2Fjpet.109.157446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Hirao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toide, K.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1254/jphs.FP0071742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1254%2Fjphs.FP0071742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18319566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlWlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=361-368&author=A.+Hiraoauthor=A.+Imaiauthor=Y.+Sugieauthor=Y.+Yamadaauthor=S.+Hayashiauthor=K.+Toide&title=Pharmacological+characterization+of+the+newly+synthesized+nociceptin%2Forphanin+FQ-receptor+agonist+1-%5B1-%281-methylcyclooctyl%29-4-piperidinyl%5D-2-%5B%283R%29-3-piperidinyl%5D-1H-benzimidazole+as+an+anxiolytic+agent&doi=10.1254%2Fjphs.FP0071742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent</span></div><div class="casAuthors">Hirao, Akiko; Imai, Aki; Sugie, Yutaka; Yamada, Yoshinari; Hayashi, Shigeo; Toide, Katsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-368</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ peptide (NOP)-receptor agonists have been shown to produce anxiolytic-like effects in rodents subjected to various behavioral assays.  Recently, we developed a new nonpeptide agonist of the NOP receptor, 1-[1-(1-methylcyclooctyl)-4-piperidin-yl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole (MCOPPB), as an anxiolytic agent.  MCOPPB has a high affinity for the human NOP receptor (pKi = 10.07±0.01) and selectivity for the NOP receptor over other members of the opioid receptor family: 12-, 270- and >1000-fold more selective for the NOP receptor than for the μ-, κ-, and δ-receptor, resp.  In an ex vivo binding study, MCOPPB (10 mg/kg, p.o.) inhibited signaling through the NOP receptor in the mouse brain, suggesting that it penetrated into the brain after it was orally administered.  In the mouse Vogel conflict test, MCOPPB (10 mg/kg, p.o.) and diazepam (3 mg/kg, p.o.) elicited anxiolytic-like effects, although MCOPPB produced a bell-shaped response curve.  In addn., MCOPPB (10 mg/kg, p.o.) was still effective as an anxiolytic agent even after repeated administration for 5 days.  MCOPPB at an oral dose of 10 mg/kg did not affect locomotor activity or memory, nor did it contribute to ethanol-induced hypnosis.  On the other hand, the benzodiazepine-type anxiolytic agent diazepam caused memory deficits and enhanced ethanol-induced hypnosis.  These findings suggest that MCOPPB - a compd. with few adverse effects on the central nervous system - is a potential therapeutic agent for the treatment of anxiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJQVq7TInA-bVg90H21EOLACvtfcHk0li3f3098MHNzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlWlsrk%253D&md5=a33af41c65b5bf322c260d3dfc3a6f0c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0071742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0071742%26sid%3Dliteratum%253Aachs%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DA.%26aulast%3DSugie%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DToide%26aufirst%3DK.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520newly%2520synthesized%2520nociceptin%252Forphanin%2520FQ-receptor%2520agonist%25201-%255B1-%25281-methylcyclooctyl%2529-4-piperidinyl%255D-2-%255B%25283R%2529-3-piperidinyl%255D-1H-benzimidazole%2520as%2520an%2520anxiolytic%2520agent%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D106%26spage%3D361%26epage%3D368%26doi%3D10.1254%2Fjphs.FP0071742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Goeldner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span> </span><span class="NLM_article-title">Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1007/s00213-012-2636-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-012-2636-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22249359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC38vgsFaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2012&pages=203-214&author=C.+Goeldnerauthor=W.+Spoorenauthor=J.+Wichmannauthor=E.+P.+Prinssen&title=Further+characterization+of+the+prototypical+nociceptin%2Forphanin+FQ+peptide+receptor+agonist+Ro+64-6198+in+rodent+models+of+conflict+anxiety+and+despair&doi=10.1007%2Fs00213-012-2636-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair</span></div><div class="casAuthors">Goeldner Celia; Spooren Will; Wichmann Jurgen; Prinssen Eric P</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Ro 64-6198, the prototypical non-peptide nociceptin/orphanin FQ peptide (NOP) receptor agonist, has potent anxiolytic-like effects in several preclinical models and species.  However the effects of Ro 64-6198 on distinctive anxiety-provoking conditions related to unconditioned conflict behavior as well as its role in despair-like behavior remain to be addressed.  OBJECTIVE:  Here we examined the effects of Ro 64-6198 on unconditioned conflict anxiety using stimuli with different salience and on regulation of autonomic reactivity and compared these to the effects of benzodiazepine receptor agonists.  We also addressed the potential effects of Ro 64-6198 on despair-like behavior.  MATERIALS AND METHODS:  Ro 64-6198 (0.1 to 10 mg/kg i.p.) and either diazepam or chlordiazepoxide were tested in the Vogel conflict punished drinking test (VCT) in Sprague Dawley rats, in the social approach-avoidance (SAA) test in Lewis rats, in the novelty-induced hypophagia (NIH) in C57BL/6J mice, and in stress-induced hyperthermia in NMRI mice, as well as in the forced swim test (FST) in Sprague Dawley rats and the tail suspension test (TST) in C57BL/6J mice.  RESULTS:  Ro 64-6198 (0.3 to 3 mg/kg) dose-dependently produced anxiolytic-like effects in the VCT, SAA, NIH, and SIH, similar to benzodiazepine receptor agonists.  Ro 64-6198 did not alter immobility time in the FST and TST.  CONCLUSIONS:  Ro 64-6198 produced marked anxiolytic-like effects in response to a variety of mild to strong anxiogenic stimuli, whereas it did not facilitate depression-related behaviors.  This data extend previous literature suggesting that NOP receptors are a viable target for the treatment of anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTc5QfO7mWeQ9enUz0lpNqnfW6udTcc2eZXCpK8T8sN2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgsFaisQ%253D%253D&md5=ead95ba6b48a6b6c2712de728f8c98f2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2636-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2636-x%26sid%3Dliteratum%253Aachs%26aulast%3DGoeldner%26aufirst%3DC.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26atitle%3DFurther%2520characterization%2520of%2520the%2520prototypical%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520agonist%2520Ro%252064-6198%2520in%2520rodent%2520models%2520of%2520conflict%2520anxiety%2520and%2520despair%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2012%26volume%3D222%26spage%3D203%26epage%3D214%26doi%3D10.1007%2Fs00213-012-2636-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Rizzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1007/s002100100399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs002100100399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11383716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2001&pages=551-555&author=D.+Rizziauthor=R.+Bigoniauthor=A.+Rizziauthor=F.+Jenckauthor=J.+Wichmannauthor=R.+Guerriniauthor=D.+Regoliauthor=G.+Calo&title=Effects+of+Ro+64-6198+in+nociceptin%2Forphanin+FQ-sensitive+isolated+tissues&doi=10.1007%2Fs002100100399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues</span></div><div class="casAuthors">Rizzi, Daniela; Bigoni, Raffaella; Rizzi, Anna; Jenck, Francois; Wichmann, Juergen; Guerrini, Remo; Regoli, Domenico; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">551-555</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The pharmacol. profile of the non-peptide OP4 receptor (ORL1, LC132) agonist, Ro 64-6198, was investigated, in three elec. stimulated nociceptin/orphanin FQ (NC)-sensitive prepns., namely the mouse and rat vas deferens and the guinea pig ileum.  Ro 64-6198 mimicked the inhibitory effect of NC in the three prepns., while showing slow kinetics of action and a slowly reversible effect compared to the fast and immediately and completely reversible effect of the natural peptide.  Ro 64-6198 displayed similar pEC50 and Emax values as NC in the mouse and rat vas deferens while it was 100-fold less potent but more efficacious (higher Emax) than NC in the guinea pig ileum.  In the rat vas deferens the effects of Ro 64-6198 were antagonized by [Nphe1]NC(1-13)NH2 and J-113397 with pKB values (6.30 and 8.05, resp.) similar to those obtained against NC (6.20 and 7.77, resp.).  Naloxone (1 μM) was inactive.  In the guinea pig ileum a clear shift of the concn. response curve to Ro 64-6198 was obtained only using a cocktail of antagonists (naloxone +[Nphe1]NC(1-13)NH2 or naloxone +J-113397).  In the mouse vas deferens the antagonists were inactive against Ro 64-6198 either when tested alone or in combination.  Therefore, Ro 64-6198 behaved as a selective OP4 receptor agonist only in the rat tissue.  These results suggest a physiol. heterogeneity in OP4 receptors across tissues and species and may explain why, when tested in vivo, Ro 64-6198 mimics the potent anxiolytic effect of NC better in the rat than in the mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVodqqFXQa67Vg90H21EOLACvtfcHk0li3f3098MHNzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGhurg%253D&md5=00bf787239b428a78b75d619090faa99</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2Fs002100100399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100100399%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DEffects%2520of%2520Ro%252064-6198%2520in%2520nociceptin%252Forphanin%2520FQ-sensitive%2520isolated%2520tissues%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2001%26volume%3D363%26spage%3D551%26epage%3D555%26doi%3D10.1007%2Fs002100100399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galuska, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span> </span><span class="NLM_article-title">Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2096</span><span class="refDoi"> DOI: 10.1038/npp.2009.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnpp.2009.33" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=2088-2096&author=M.+C.+Koauthor=J.+H.+Woodsauthor=W.+E.+Fantegrossiauthor=C.+M.+Galuskaauthor=J.+Wichmannauthor=E.+P.+Prinssen&title=Behavioral+effects+of+a+synthetic+agonist+selective+for+nociceptin%2Forphanin+FQ+peptide+receptors+in+monkeys&doi=10.1038%2Fnpp.2009.33"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.33%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DGaluska%26aufirst%3DC.%2BM.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26atitle%3DBehavioral%2520effects%2520of%2520a%2520synthetic%2520agonist%2520selective%2520for%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptors%2520in%2520monkeys%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D2088%26epage%3D2096%26doi%3D10.1038%2Fnpp.2009.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Podlesnik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1007/s00213-010-2012-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-010-2012-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20852848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2011&pages=53-60&author=C.+A.+Podlesnikauthor=M.+C.+Koauthor=G.+Wingerauthor=J.+Wichmannauthor=E.+P.+Prinssenauthor=J.+H.+Woods&title=The+effects+of+nociceptin%2Forphanin+FQ+receptor+agonist+Ro+64-6198+and+diazepam+on+antinociception+and+remifentanil+self-administration+in+rhesus+monkeys&doi=10.1007%2Fs00213-010-2012-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys</span></div><div class="casAuthors">Podlesnik, Christopher A.; Ko, Mei-Chuan; Winger, Gail; Wichmann, Juergen; Prinssen, Eric P.; Woods, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: The synthetic nonpeptide NOP (nociceptin/orphanin FQ peptide) receptor agonist Ro 64-6198 produces antinociception in rhesus monkeys.  In rodents, it has much more variable effects on pain responses, but has response rate-increasing effects on punished operant behavior and decreases drug reward.  Objectives: The aim of this study was to compare Ro 64-6198 with the benzodiazepine diazepam in tests of analgesia, drug self-administration, and response-increasing effects in rhesus monkeys.  Results: Ro 64-6198 (0.001-0.01 mg/kg, i.v.) produced antinociception against an acute noxious stimulus (50°C water) in the absence of sedation, whereas diazepam (0.32-3.2 mg/kg, i.v.) did not have analgesic effects without sedation.  Diazepam (1.0-5.6 mg/kg, i.v.) and the largest dose of Ro 64-6198 (0.32 mg/kg, i.v.) decreased lever pressing maintained by i.v. self-administration of the mu-opioid agonist, remifentanil, but neither effect could be distinguished from sedative effects.  Although neither drug consistently increased responding during nonreinforcement, such effects were obsd. more frequently following diazepam administration.  The effects of Ro 64-6198 on lever pressing were blocked by the NOP-receptor antagonist, J-113397, but not by the benzodiazepine antagonist, flumazenil.  Conclusions: These findings suggest that the effects of Ro 64-6198 on operant lever pressing are mediated by NOP receptors and that larger doses are required to impact operant behavior when compared directly with those that produce antinociception.  Therefore, the present findings support previous literature suggesting NOP receptors are a viable target for pain management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTxXlqJKBd7Vg90H21EOLACvtfcHk0lgPD4dwfOVayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht7jE&md5=9f0697809104bb9de44ef42f9952b68d</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-2012-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-2012-7%26sid%3Dliteratum%253Aachs%26aulast%3DPodlesnik%26aufirst%3DC.%2BA.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DWinger%26aufirst%3DG.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%2520Ro%252064-6198%2520and%2520diazepam%2520on%2520antinociception%2520and%2520remifentanil%2520self-administration%2520in%2520rhesus%2520monkeys%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2011%26volume%3D213%26spage%3D53%26epage%3D60%26doi%3D10.1007%2Fs00213-010-2012-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy?</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1124/jpet.102.046979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.102.046979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12721334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGlt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=423-429&author=H.+U.+Zeilhoferauthor=G.+Calo&title=Nociceptin%2Forphanin+FQ+and+its+receptor-potential+targets+for+pain+therapy%3F&doi=10.1124%2Fjpet.102.046979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy?</span></div><div class="casAuthors">Zeilhofer, Hanns Ulrich; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">423-429</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The neuropeptide nociceptin, also called orphanin FQ (N/OFQ), is the endogenous agonist of the N/OFQ peptide receptor (NOP receptor).  Both N/OFQ and the NOP receptor share a high degree of homol. with classical opioid peptides and opioid receptors, resp., and use similar signal transduction pathways as classical opioids.  The NOP receptor has thus been regarded as the fourth member of the opioid receptor family.  Despite this close relationship, 7 yr of research have demonstrated that the N/OFQ system has a distinct pharmacol. profile and serves different physiol. functions.  In particular, its role in the control of pain and analgesia at different levels of integration appears quite different from that of classical opioids.  The recent development of specific antagonists at the NOP receptor and of NOP receptor or N/OFQ precursor knock-out mice have generated new insights into the role of N/OFQ in pain processing and help to evaluate the N/OFQ-NOP system as a potential target for new analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1rfljDkKAbVg90H21EOLACvtfcHk0lgPD4dwfOVayA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGlt7k%253D&md5=98bb8d88169e52d9c74b2c005eb3f058</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.046979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.046979%26sid%3Dliteratum%253Aachs%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520and%2520its%2520receptor-potential%2520targets%2520for%2520pain%2520therapy%253F%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D423%26epage%3D429%26doi%3D10.1124%2Fjpet.102.046979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Whiteside, G. T.; Kyle, D. J.</span><span> </span><span class="NLM_article-title">A review of the NOP (ORL-1)-nociceptin/orphanin FQ system covering receptor structure, distribution, role in analgesia and reward and interactions with other receptors</span>. In  <span class="citation_source-book">Research and Development of Opioid-Related Ligands</span>; American Chemical Society Symposium Series, 1131; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bk-2013-1131.ch016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=327-368&author=G.+T.+Whiteside&author=D.+J.+Kyle&title=Research+and+Development+of+Opioid-Related+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fbk-2013-1131.ch016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1021%252Fbk-2013-1131.ch016%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26atitle%3DA%2520review%2520of%2520the%2520NOP%2520%2528ORL-1%2529-nociceptin%252Forphanin%2520FQ%2520system%2520covering%2520receptor%2520structure%252C%2520distribution%252C%2520role%2520in%2520analgesia%2520and%2520reward%2520and%2520interactions%2520with%2520other%2520receptors%26btitle%3DResearch%2520and%2520Development%2520of%2520Opioid-Related%2520Ligands%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013%26spage%3D327%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Sukhtankar, D.; Ko, M.-C.</span><span> </span><span class="NLM_article-title">Pharmacological investigation of NOP-related ligands as analgesics without abuse liability</span>. In  <span class="citation_source-book">Research and Development of Opioid-Related Ligands</span>; American Chemical Society Symposium Series, 1131; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bk-2013-1131.ch018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=393-416&author=D.+Sukhtankar&author=M.-C.+Ko&title=Research+and+Development+of+Opioid-Related+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fbk-2013-1131.ch018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1021%252Fbk-2013-1131.ch018%26sid%3Dliteratum%253Aachs%26aulast%3DSukhtankar%26aufirst%3DD.%26atitle%3DPharmacological%2520investigation%2520of%2520NOP-related%2520ligands%2520as%2520analgesics%2520without%2520abuse%2520liability%26btitle%3DResearch%2520and%2520Development%2520of%2520Opioid-Related%2520Ligands%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013%26spage%3D393%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Lin, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1021/cn300124f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300124f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=214-224&author=A.+P.+Linauthor=M.+C.+Ko&title=The+therapeutic+potential+of+nociceptin%2Forphanin+FQ+receptor+agonists+as+analgesics+without+abuse+liability&doi=10.1021%2Fcn300124f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The Therapeutic Potential of Nociceptin/Orphanin FQ Receptor Agonists as Analgesics without Abuse Liability</span></div><div class="casAuthors">Lin, Ann P.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">214-224</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although mu opioid (MOP) receptor agonists are the most commonly used analgesics for the treatment of moderate to severe pain in the clinic, the side effects of MOP agonists such as abuse liability limit their value as a medication.  Research to identify novel analgesics without adverse effects is pivotal to advance the health care of humans.  The nociceptin/orphanin FQ peptide (NOP) receptor, the fourth opioid receptor subtype, mediates distinctive actions in nonhuman primates which suggests the possibility that activity at this receptor may result in strong analgesia in the absence of virtually all of the side effects assocd. with MOP agonists.  The present review highlights the recent progress of pharmacol. studies of NOP-related ligands in primates.  Selective NOP agonists, either peptidic or nonpeptidic, produce full analgesia in various assays in primates, when delivered systemically or intrathecally.  Yet small mol. NOP agonists do not serve as reinforcers, indicating a lack of abuse liability.  Given that NOP agonists have low abuse liability and that coactivation of NOP and MOP receptors produces synergistic antinociception, it is worth developing bifunctional NOP/MOP ligands.  The outcomes of these studies and recent developments provide new perspectives to establish a translational bridge for understanding the biobehavioral functions of NOP receptors in primates and for facilitating the development of NOP-related ligands as a new generation of analgesics without abuse liability in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof3wFSa_bAsbVg90H21EOLACvtfcHk0lg1QzjHz5v2EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtbzF&md5=1dd123d0591387b291faf4571e9fe024</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fcn300124f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300124f%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%2BP.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonists%2520as%2520analgesics%2520without%2520abuse%2520liability%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D214%26epage%3D224%26doi%3D10.1021%2Fcn300124f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Kotlinska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talarek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dylag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberring, J.</span><span> </span><span class="NLM_article-title">Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span><span class="refDoi"> DOI: 10.1097/00001756-200303240-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00001756-200303240-00015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=601-604&author=J.+Kotlinskaauthor=J.+Wichmannauthor=P.+Rafalskiauthor=S.+Talarekauthor=T.+Dylagauthor=J.+Silberring&title=Non-peptidergic+OP4+receptor+agonist+inhibits+morphine+antinociception+but+does+not+influence+morphine+dependence&doi=10.1097%2F00001756-200303240-00015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1097%2F00001756-200303240-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200303240-00015%26sid%3Dliteratum%253Aachs%26aulast%3DKotlinska%26aufirst%3DJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DRafalski%26aufirst%3DP.%26aulast%3DTalarek%26aufirst%3DS.%26aulast%3DDylag%26aufirst%3DT.%26aulast%3DSilberring%26aufirst%3DJ.%26atitle%3DNon-peptidergic%2520OP4%2520receptor%2520agonist%2520inhibits%2520morphine%2520antinociception%2520but%2520does%2520not%2520influence%2520morphine%2520dependence%26jtitle%3DNeuroReport%26date%3D2003%26volume%3D14%26spage%3D601%26epage%3D604%26doi%3D10.1097%2F00001756-200303240-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Reiss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekeshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouagazzal, A. M.</span><span> </span><span class="NLM_article-title">Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2007.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2007.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18031727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2008&pages=141-148&author=D.+Reissauthor=J.+Wichmannauthor=H.+Tekeshimaauthor=B.+L.+Kiefferauthor=A.+M.+Ouagazzal&title=Effects+of+nociceptin%2Forphanin+FQ+receptor+%28NOP%29+agonist%2C+Ro64-6198%2C+on+reactivity+to+acute+pain+in+mice%3A+comparison+to+morphine&doi=10.1016%2Fj.ejphar.2007.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: Comparison to morphine</span></div><div class="casAuthors">Reiss, David; Wichmann, Juergen; Tekeshima, Hiroshi; Kieffer, Brigitte L.; Ouagazzal, Abdel-Mouttalib</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of the present study was to clarify the role of nociceptin system in pain modulation.  The effects of the synthetic nociceptin (NOP) receptor agonist, Ro64-6198 ((1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one), on reactivity to acute noxious stimuli were assessed in C57BL/6N (B6) mice in tail-flick, hot-plate and shock threshold tests.  The mu receptor agonist, morphine, was used in each study for comparison.  In the tail-flick test, morphine (4 and 8 mg/kg, i.p.) produced analgesia, while Ro64-6198 (0.3, 1 and 3 mg/kg, i.p.) increased pain sensitivity.  The effects of Ro64-6198 were seen in naive but not in mice previously habituated to testing conditions, indicating that increased pain sensitivity may be due to inhibition of stress-induced analgesia.  In the hot-plate and the shock threshold tests, Ro64-6198 produced analgesia in B6 mice, like morphine.  These effects were reproduced in wild-type but not in NOP receptor knockout mice.  Finally, when injected conjointly at subthreshold doses, Ro64-6198 (1 mg/kg) and morphine (1 mg/kg) acted in additive manner to reduce pain sensitivity in the hot-plate test.  Together these results show that systemic activation of NOP receptors produced bidirectional changes in pain sensitivity depending on the exptl. conditions.  They also suggest that central NOP and mu receptors may inhibit reactivity to acute noxious stimuli via independent neural mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-0HEOUghLgbVg90H21EOLACvtfcHk0lg1QzjHz5v2EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVKhug%253D%253D&md5=ab099dd29e1c0354911ffe73be96069b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DReiss%26aufirst%3DD.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DTekeshima%26aufirst%3DH.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DOuagazzal%26aufirst%3DA.%2BM.%26atitle%3DEffects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520%2528NOP%2529%2520agonist%252C%2520Ro64-6198%252C%2520on%2520reactivity%2520to%2520acute%2520pain%2520in%2520mice%253A%2520comparison%2520to%2520morphine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D579%26spage%3D141%26epage%3D148%26doi%3D10.1016%2Fj.ejphar.2007.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Sukhtankar, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1007/s00213-013-3341-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-013-3341-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24217900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ltF2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=1377-1387&author=D.+D.+Sukhtankarauthor=H.+Leeauthor=K.+C.+Riceauthor=M.+C.+Ko&title=Differential+effects+of+opioid-related+ligands+and+NSAIDs+in+nonhuman+primate+models+of+acute+and+inflammatory+pain&doi=10.1007%2Fs00213-013-3341-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain</span></div><div class="casAuthors">Sukhtankar Devki D; Lee Heeseung; Rice Kenner C; Ko Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1377-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Carrageenan-induced hyperalgesia is a widely used pain model in rodents.  However, characteristics of carrageenan-induced hyperalgesia and effects of analgesic drugs under these conditions are unknown in nonhuman primates.  OBJECTIVE:  The aims of this study were to develop carrageenan-induced hyperalgesia in rhesus monkeys and determine the efficacy and potency of agonists selective for the four opioid receptor subtypes in this model versus acute pain, as compared to non-steroidal anti-inflammatory drugs (NSAIDs).  RESULTS:  Tail injection of carrageenan produced long-lasting thermal hyperalgesia in monkeys.  Systemically administered agonists selective for opioid receptor subtypes, i.e., fentanyl (mu/MOP), U-50488H (kappa/KOP), SNC80 (delta/DOP) and Ro 64-6198 (nociceptin/orphanin FQ/NOP) dose-dependently attenuated carrageenan-induced thermal hyperalgesia with different potencies.  In absence of carrageenan, these agonists, except SNC80, blocked acute thermal nociception.  Opioid-related ligands, especially Ro 64-6198, were much more potent for their antihyperalgesic than antinociceptive effects.  Both effects were mediated by the corresponding receptor mechanisms.  Only fentanyl produced scratching at antihyperalgesic and antinociceptive doses consistent with its pruritic effects in humans, illustrating a translational profile of MOP agonists in nonhuman primates.  Similar to SNC80, systemically administered NSAIDs ketorolac and naproxen dose-dependently attenuated carrageenan-induced hyperalgesia but not acute nociception.  CONCLUSION:  Using two different pain modalities in nonhuman primates, effectiveness of clinically available analgesics like fentanyl, ketorolac and naproxen was distinguished and their efficacies and potencies were compared with the selective KOP, DOP, and NOP agonists.  The opioid-related ligands displayed differential pharmacological properties in regulating hyperalgesia and acute nociception in the same subjects.  Such preclinical primate models can be used to investigate novel analgesic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTq_91slIeoEEQ0lWbKiCflfW6udTcc2ebp8jUZ25__Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ltF2ruw%253D%253D&md5=89d4b44a8d3c186f53063767502641ea</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3341-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3341-0%26sid%3Dliteratum%253Aachs%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DDifferential%2520effects%2520of%2520opioid-related%2520ligands%2520and%2520NSAIDs%2520in%2520nonhuman%2520primate%2520models%2520of%2520acute%2520and%2520inflammatory%2520pain%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2014%26volume%3D231%26spage%3D1377%26epage%3D1387%26doi%3D10.1007%2Fs00213-013-3341-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhtankar, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendenhall, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">3302</span><span class="NLM_x">–</span> <span class="NLM_lpage">3312</span><span class="refDoi"> DOI: 10.1111/bph.13124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fbph.13124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25752320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3302-3312&author=H.+Dingauthor=K.+Hayashidaauthor=T.+Sutoauthor=D.+D.+Sukhtankarauthor=M.+Kimuraauthor=V.+Mendenhallauthor=M.+C.+Ko&title=Supraspinal+actions+of+nociceptin%2Forphanin+FQ%2C+morphine+and+substance+P+in+regulating+pain+and+itch+in+non-human+primates&doi=10.1111%2Fbph.13124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates</span></div><div class="casAuthors">Ding, H.; Hayashida, K.; Suto, T.; Sukhtankar, D. D.; Kimura, M.; Mendenhall, V.; Ko, M. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3302-3312</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor agonists display a promising analgesic profile in preclin. studies.  However, supraspinal N/OFQ produced hyperalgesia in rodents and such effects have not been addressed in primates.  Thus, the aim of this study was to investigate the effects of centrally administered ligands on regulating pain and itch in non-human primates.  In particular, nociceptive thresholds affected by intracisternal N/OFQ were compared with those of morphine and substance P, known to provide analgesia and mediate hyperalgesia, resp., in humans.  Exptl. Approach : Intrathecal catheters were installed to allow intracisternal and lumbar intrathecal administration in awake and unanaesthetized rhesus monkeys.  Nociceptive responses were measured using the warm water tail-withdrawal assay.  Itch scratching responses were scored from videotapes recording behavioral activities of monkeys in their home cages.  Antagonist studies were conducted to validate the receptor mechanisms underlying intracisternally elicited behavioral responses.  Key Results : Intracisternal morphine (100 nmol) elicited more head scratches than those after intrathecal morphine.  Distinct dermatomal scratching locations between the two routes suggest a corresponding activation of supraspinal and spinal μ receptors.  Unlike intracisternal substance P, which induced hyperalgesia, intracisternal N/OFQ (100 nmol) produced antinociceptive effects mediated by NOP receptors.  Neither peptide increased scratching responses.  Conclusions and Implications : Taken together, these results demonstrated differential actions of ligands in the primate supraspinal region in regulating pain and itch.  This study not only improves scientific understanding of the N/OFQ-NOP receptor system in pain processing but also supports the therapeutic potential of NOP-related ligands as analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrvMfam5d_dLVg90H21EOLACvtfcHk0ljoVsd2a88Gfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rE&md5=7445642e93ca057d2bea07b08d294d7e</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fbph.13124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13124%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DHayashida%26aufirst%3DK.%26aulast%3DSuto%26aufirst%3DT.%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DMendenhall%26aufirst%3DV.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DSupraspinal%2520actions%2520of%2520nociceptin%252Forphanin%2520FQ%252C%2520morphine%2520and%2520substance%2520P%2520in%2520regulating%2520pain%2520and%2520itch%2520in%2520non-human%2520primates%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3302%26epage%3D3312%26doi%3D10.1111%2Fbph.13124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, N. N.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span><span class="refDoi"> DOI: 10.1016/j.jpain.2008.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.jpain.2008.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19231294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=509-514&author=M.+C.+Koauthor=N.+N.+Naughton&title=Antinociceptive+effects+of+nociceptin%2Forphanin+FQ+administered+intrathecally+in+monkeys&doi=10.1016%2Fj.jpain.2008.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive Effects of Nociceptin/Orphanin FQ Administered Intrathecally in Monkeys</span></div><div class="casAuthors">Ko, Mei-Chuan; Naughton, Norah N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) is the endogenous peptide for the NOP receptors.  Depending on the doses, intrathecal administration of N/OFQ has dual actions (ie, hyperalgesia and antinociception) in rodents.  However, the pharmacol. profile of intrathecal N/OFQ is not fully known in primates.  The aim of this study was to investigate behavioral effects of intrathecal N/OFQ over a wide dose range and to compare its effects with ligands known to produce hyperalgesia or antinociception in monkeys.  Intrathecal N/OFQ from 1 fmol to 1 nmol did not produce any hyperalgesic or scratching responses.  In contrast, intrathecal substance P 100 nmol produced hyperalgesia, and intrathecal DAMGO 10 nmol produced antinociception.  At the dose range between 10 nmol and 1 μmol, intrathecal N/OFQ dose-dependently produced thermal antinociception against a noxious stimulus in 2 intensities.  More importantly, N/OFQ in combined with intrathecal morphine dose-dependently potentiated morphine-induced antinociception without inhibiting morphine-induced itch/scratching.  Taken together, this study is the first to provide a unique functional profile of intrathecal N/OFQ over a wide dose range in primates.  Intrathecal N/OFQ produces thermal antinociception without anti-morphine actions or scratching responses, indicating that N/OFQ or NOP receptor agonists represent a promising target as spinal analgesics.  Perspective: Intrathecal administration of N/OFQ only produced thermal antinociception, not hyperalgesia, in monkeys.  In addn., intrathecal N/OFQ does not have anti-morphine actions or itch/scratching responses.  This study strongly supports the therapeutic potential of N/OFQ or NOP receptor agonists as spinal analgesics for clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwKwjiq-tA7Vg90H21EOLACvtfcHk0ljoVsd2a88Gfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKmu7o%253D&md5=6ec599eae9dafd60b054a7fc502ce16e</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2008.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2008.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DNaughton%26aufirst%3DN.%2BN.%26atitle%3DAntinociceptive%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520administered%2520intrathecally%2520in%2520monkeys%26jtitle%3DJ.%2520Pain%26date%3D2009%26volume%3D10%26spage%3D509%26epage%3D514%26doi%3D10.1016%2Fj.jpain.2008.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, R. T.</span><span> </span><span class="NLM_article-title">Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1264</span><span class="refDoi"> DOI: 10.1124/jpet.106.106120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.106.106120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16766718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFygt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=1257-1264&author=M.+C.+Koauthor=H.+Weiauthor=J.+H.+Woodsauthor=R.+T.+Kennedy&title=Effects+of+intrathecally+administered+nociceptin%2Forphanin+FQ+in+monkeys%3A+behavioral+and+mass+spectrometric+studies&doi=10.1124%2Fjpet.106.106120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies</span></div><div class="casAuthors">Ko, M. C. Holden; Wei, Hui; Woods, James H.; Kennedy, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1257-1264</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) is a heptadecapeptide that is an endogenous ligand for the N/OFQ peptide (NOP) receptor.  This study was to investigate the behavioral responses of N/OFQ and its major fragment N/OFQ(2-17) in monkeys following i.t. administration.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was used to quantify the amts. of N/OFQ and N/OFQ(2-17) in the cerebrospinal fluid at specific time points when effects of i.t. N/OFQ were sustained and disappeared.  Intrathecal administration of N/OFQ dose dependently (10-100 nmol) produced long-lasting antinociception against a noxious stimulus, 50° water, and did not elicit itch/scratching responses in monkeys.  S.c. pretreatment with a selective NOP receptor antagonist, (+)J-113397 [(1-[3R,4R)-1-cyclooctymethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3,-dihydro-2H-benzimidazol-2-one] (0.1 mg/kg), completely blocked i.t. N/OFQ (100 nmol)-induced antinociception.  In contrast, a classic opioid receptor antagonist, naltrexone (0.01 and 1 mg/kg), failed to reverse i.t. N/OFQ-induced antinociception.  MALDI-TOF-MS showed that the amt. of N/OFQ(2-17) was 4-fold higher than that of N/OFQ at 1.5 h after i.t. administration of 100 nmol N/OFQ.  Intrathecal N/OFQ-induced antinociception disappeared at 4.5 h, which corresponded to nearly undetectable cerebrospinal fluid levels of N/OFQ.  No other metabolite of N/OFQ was detected at appreciable levels at either the 1.5- or 4.5-h time points.  Although significant amts. of N/OFQ(2-17) were detected at the 1.5- and 4.5-h time points, 100 nmol N/OFQ(2-17) i.t. was inactive in changing the monkeys' nociceptive threshold.  These results provide the first functional evidence of spinal N/OFQ-induced antinociception in primates and indicate that activation of spinal NOP receptors may be a potential target for spinal analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDK5E2U9CJLVg90H21EOLACvtfcHk0lgID90t-TLzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFygt7o%253D&md5=1316933db560b47f728508da1e15339e</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106120%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DR.%2BT.%26atitle%3DEffects%2520of%2520intrathecally%2520administered%2520nociceptin%252Forphanin%2520FQ%2520in%2520monkeys%253A%2520behavioral%2520and%2520mass%2520spectrometric%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D1257%26epage%3D1264%26doi%3D10.1124%2Fjpet.106.106120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.pain.2009.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pain.2009.10.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=107-113&author=E.+Huauthor=G.+Caloauthor=R.+Guerriniauthor=M.+C.+Ko&title=Long-lasting+antinociceptive+spinal+effects+in+primates+of+the+novel+nociceptin%2Forphanin+FQ+receptor+agonist+UFP-112&doi=10.1016%2Fj.pain.2009.10.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DLong-lasting%2520antinociceptive%2520spinal%2520effects%2520in%2520primates%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%2520UFP-112%26jtitle%3DPain%26date%3D2010%26volume%3D148%26spage%3D107%26epage%3D113%26doi%3D10.1016%2Fj.pain.2009.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Obara, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przewlocki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przewlocka, B.</span><span> </span><span class="NLM_article-title">Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.pain.2005.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pain.2005.03.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2005&pages=17-25&author=I.+Obaraauthor=R.+Przewlockiauthor=B.+Przewlocka&title=Spinal+and+local+peripheral+antiallodynic+activity+of+Ro64-6198+in+neuropathic+pain+in+the+rat&doi=10.1016%2Fj.pain.2005.03.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DObara%26aufirst%3DI.%26aulast%3DPrzewlocki%26aufirst%3DR.%26aulast%3DPrzewlocka%26aufirst%3DB.%26atitle%3DSpinal%2520and%2520local%2520peripheral%2520antiallodynic%2520activity%2520of%2520Ro64-6198%2520in%2520neuropathic%2520pain%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D2005%26volume%3D116%26spage%3D17%26epage%3D25%26doi%3D10.1016%2Fj.pain.2005.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Le Pen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1097/00001756-200203250-00018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00001756-200203250-00018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=451-454&author=G.+Le+Penauthor=J.+Wichmannauthor=J.+L.+Moreauauthor=F.+Jenck&title=The+orphanin+receptor+agonist+RO+64-6198+does+not+induce+place+conditioning+in+rats&doi=10.1097%2F00001756-200203250-00018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1097%2F00001756-200203250-00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200203250-00018%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPen%26aufirst%3DG.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DThe%2520orphanin%2520receptor%2520agonist%2520RO%252064-6198%2520does%2520not%2520induce%2520place%2520conditioning%2520in%2520rats%26jtitle%3DNeuroReport%26date%3D2002%26volume%3D13%26spage%3D451%26epage%3D454%26doi%3D10.1097%2F00001756-200203250-00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruckmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzschentke, T. M.</span><span> </span><span class="NLM_article-title">Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">645</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2010.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2010.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20674566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=645&publication_year=2010&pages=119-126&author=K.+Ruttenauthor=J.+De+Vryauthor=W.+Bruckmannauthor=T.+M.+Tzschentke&title=Effects+of+the+NOP+receptor+agonist+Ro65-6570+on+the+acquisition+of+opiate-+and+psychostimulant-induced+conditioned+place+preference+in+rats&doi=10.1016%2Fj.ejphar.2010.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats</span></div><div class="casAuthors">Rutten, Kris; De Vry, Jean; Bruckmann, Walter; Tzschentke, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">645</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">119-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of the Nociceptin/Orphanin FQ (NOP) receptor may have anti-abuse effects.  The present study examd. the consequence of NOP receptor activation on the rewarding effect of opiates and psychostimulants in the conditioned place preference task in rats.  First, the motivational effect of the NOP receptor agonists Ro64-6198 (0.316-3.16 mg/kg i.p.) and Ro65-6570 (1-10 mg/kg i.p.) when administered alone, was assessed.  Ro65-6570 was selected for further drug combination studies since, unlike Ro64-6198, it was devoid of an intrinsic motivational effect.  Next, the minimal ED to induce reward for the opiates heroin (0.1-3.16 mg/kg i.p.), morphine (1-10 mg/kg i.p.), hydrocodone (0.316-10 mg/kg i.p.), tilidine (1-31.6 mg/kg i.p.), hydromorphone (0.1-10 mg/kg i.p.), and oxycodone (0.0316-10 mg/kg i.p.), as well as for the psychostimulants cocaine (3.16-31.6 mg/kg i.p.) and dexamphetamine (0.316-3.16 mg/kg i.p.) in combination with Ro65-6570 (0 or 3.16 mg/kg i.p.) was detd.  All drugs produced conditioned place preference, and for opiates and cocaine, but not for dexamphetamine, the minimal ED was higher when combined with Ro65-6570 (3.16 mg/kg i.p.).  Attenuation of the rewarding effect of tilidine (3.16 mg/kg i.p.) and oxycodone (1 mg/kg i.p.) by Ro65-6570 (3.16 mg/kg i.p.) could be reversed by pre-treatment with the NOP receptor antagonist J-113397 (4.64 mg/kg i.p.), suggesting that the attenuating effect of Ro65-6570 on opiates is due to activation of the NOP receptor.  Taken together, the present study suggests that activation of NOP receptors effectively attenuates the rewarding effect of opiates, but may be less effective in reducing psychostimulant-induced reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoex7t1LgsV-bVg90H21EOLACvtfcHk0lgID90t-TLzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7rE&md5=9b5b20acbcf02e41d73036713298f2fb</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DBruckmann%26aufirst%3DW.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26atitle%3DEffects%2520of%2520the%2520NOP%2520receptor%2520agonist%2520Ro65-6570%2520on%2520the%2520acquisition%2520of%2520opiate-%2520and%2520psychostimulant-induced%2520conditioned%2520place%2520preference%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D645%26spage%3D119%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2010.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Recker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a μ, κ, and δ opioid receptor agonist cue</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span><span class="refDoi"> DOI: 10.1124/jpet.104.071423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.104.071423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15226383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=652-658&author=M.+D.+Reckerauthor=G.+A.+Higgins&title=The+opioid+receptor+like-1+receptor+agonist+Ro+64-6198+%281S%2C3aS-8-2%2C3%2C3a%2C4%2C5%2C6-hexahydro-1H-phenalen-1-yl-1-phenyl-1%2C3%2C8-triaza-spiro%5B4.5%5Ddecan-4-one%29+produces+a+discriminative+stimulus+in+rats+distinct+from+that+of+a+%CE%BC%2C+%CE%BA%2C+and+%CE%B4+opioid+receptor+agonist+cue&doi=10.1124%2Fjpet.104.071423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a μ, κ, and δ opioid receptor agonist cue</span></div><div class="casAuthors">Recker, Matthew D.; Higgins, Guy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">652-658</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Male Wistar rats were trained to discriminate either the opioid receptor like (ORL)-1 receptor agonist Ro 64-6198 or morphine from saline using a two-choice, food reinforced, operant procedure.  Acquisition of Ro 64-6198 discrimination was relatively slow (mean trials to criterion 113±6), and a final 4 mg/kg dose (initial training dose 2 mg/kg) was required to establish appropriate stimulus control.  In comparison, a sep. group of rats attained a morphine (2 mg/kg) discrimination in 44±4 trials.  In tests of substitution, Ro 64-6198 produced a dose-related generalization to its own cue (ED50 of 1.1 mg/kg i.p.), yet only weakly generalized to the morphine cue (19% at 10 mg/kg i.p.).  In contrast, morphine generalized completely to the morphine cue (ED50 of 0.7 mg/kg s.c.), yet only partially generalized to the Ro 64-6198 cue (40% at 6 mg/kg s.c.).  The κ opioid receptor agonist U50,488 [trans-3,4-dichloro-N-methyl-N(2-[1-pyrrolidinyl]cyclohexyl)benzeneacetamide methanesulfonate] (0.3-6 mg/kg s.c.) and the δ opioid receptor agonist SNC-80 [(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] (0.3-6 mg/kg i.p.) failed to evoke significant generalization to either cue.  The μ opioid receptor agonists codeine (0.3-20 mg/kg) and buprenorphine (0.01-1 mg/kg) completely generalized to the morphine cue, but only buprenorphine partially generalized to the Ro 64-6198 cue.  Naloxone pretreatment completely blocked the morphine cue (ED50 of 0.005 mg/kg s.c.), yet only weakly attenuated the Ro 64-6198 cue at 0.3 mg/kg.  Finally, the selective ORL-1 antagonist J-113397 [1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one] completely blocked the Ro 64-6198 cue at a dose (30 mg/kg i.p.) that had no effect against the morphine cue.  The present studies demonstrate that rats may be trained to discriminate Ro 64-6198 from saline, and the pharmacol. characteristics of this cue are most consistent with ORL-1 receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfR6PHUG626LVg90H21EOLACvtfcHk0lgID90t-TLzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKrurw%253D&md5=76bc4df5ac9442790df632c46d641fae</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.071423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.071423%26sid%3Dliteratum%253Aachs%26aulast%3DRecker%26aufirst%3DM.%2BD.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DThe%2520opioid%2520receptor%2520like-1%2520receptor%2520agonist%2520Ro%252064-6198%2520%25281S%252C3aS-8-2%252C3%252C3a%252C4%252C5%252C6-hexahydro-1H-phenalen-1-yl-1-phenyl-1%252C3%252C8-triaza-spiro%255B4.5%255Ddecan-4-one%2529%2520produces%2520a%2520discriminative%2520stimulus%2520in%2520rats%2520distinct%2520from%2520that%2520of%2520a%2520%25CE%25BC%252C%2520%25CE%25BA%252C%2520and%2520%25CE%25B4%2520opioid%2520receptor%2520agonist%2520cue%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D652%26epage%3D658%26doi%3D10.1124%2Fjpet.104.071423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Zaveri, N. T.</span><span> </span><span class="NLM_article-title">The Nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span><span class="refDoi"> DOI: 10.2174/156802611795371341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2174%2F156802611795371341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21050175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFKrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1151-1156&author=N.+T.+Zaveri&title=The+Nociceptin%2Forphanin+FQ+receptor+%28NOP%29+as+a+target+for+drug+abuse+medications&doi=10.2174%2F156802611795371341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications</span></div><div class="casAuthors">Zaveri, Nurulain T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1151-1156</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several studies show that the nociceptin receptor NOP plays a role in the regulation of reward and motivation pathways related to substance abuse.  Administration of the NOP's natural peptide ligand, Nociceptin/Orphanin FQ (N/OFQ) or synthetic agonist Ro 64-6198 has been shown to block rewarding effects of cocaine, morphine, amphetamines and alc., in various behavioral models of drug reward and reinforcement, such as conditioned place preference and drug self-administration.  Administration of N/OFQ has been shown to reduce drug-stimulated levels of dopamine in mesolimbic pathways.  The NOP-N/OFQ system has been particularly well examd. in the development of alc. abuse in animal models.  Furthermore, the efficacy of the mixed-action opioid buprenorphine, in attenuating alc. consumption in human addicts and in alc.-preferring animal models, at higher doses, has been attributed to its partial agonist activity at the NOP receptor.  These studies suggest that NOP receptor agonists may have potential as drug abuse medications.  However, the pathophysiol. of addiction is complex and drug addiction pharmacotherapy needs to address the various phases of substance addiction (craving, withdrawal, relapse).  Further studies are needed to clearly establish how NOP agonists may attenuate the drug addiction process and provide therapeutic benefit.  Addiction to multiple abused drugs (polydrug addiction) is now commonplace and presents a treatment challenge, given the limited pharmacotherapies currently approved.  Polydrug addiction may not be adequately treated by a single agent with a single mechanism of action.  As with the case of buprenorphine, a mixed-action profile of NOP/opioid activity may provide a more effective drug to treat addiction to various abused substances and/or polydrug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1aSFoIdRD7bVg90H21EOLACvtfcHk0lihQru2uAIdVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFKrs7s%253D&md5=1154eba7c8b2241122a0d72c0b34baff</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.2174%2F156802611795371341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795371341%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DThe%2520Nociceptin%252Forphanin%2520FQ%2520receptor%2520%2528NOP%2529%2520as%2520a%2520target%2520for%2520drug%2520abuse%2520medications%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D1151%26epage%3D1156%26doi%3D10.2174%2F156802611795371341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.neuropharm.2005.04.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=439-446&author=J.+R.+Shoblockauthor=J.+Wichmannauthor=N.+T.+Maidment&title=The+effect+of+a+systemically+active+ORL-1+agonist%2C+Ro+64-6198%2C+on+the+acquisition%2C+expression%2C+extinction%2C+and+reinstatement+of+morphine+conditioned+place+preference&doi=10.1016%2Fj.neuropharm.2005.04.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DThe%2520effect%2520of%2520a%2520systemically%2520active%2520ORL-1%2520agonist%252C%2520Ro%252064-6198%252C%2520on%2520the%2520acquisition%252C%2520expression%252C%2520extinction%252C%2520and%2520reinstatement%2520of%2520morphine%2520conditioned%2520place%2520preference%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D439%26epage%3D446%26doi%3D10.1016%2Fj.neuropharm.2005.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Kuzmin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terenius, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogren, S. O.</span><span> </span><span class="NLM_article-title">Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span><span class="refDoi"> DOI: 10.1124/jpet.102.041350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.102.041350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12490606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Sgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=310-318&author=A.+Kuzminauthor=J.+Sandinauthor=L.+Tereniusauthor=S.+O.+Ogren&title=Acquisition%2C+expression%2C+and+reinstatement+of+ethanol-induced+conditioned+place+preference+in+mice%3A+effects+of+opioid+receptor-like+1+receptor+agonists+and+naloxone&doi=10.1124%2Fjpet.102.041350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: Effects of opioid receptor-like 1 receptor agonists and naloxone</span></div><div class="casAuthors">Kuzmin, A.; Sandin, J.; Terenius, L.; Ogren, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">310-318</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability of the two opioid receptor-like receptor 1 (ORL1) agonists nociceptin (5 nmol i.c.v.) and synthetic (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8- triaza-spiro[4.5]decan-4-one hydrochloride (Ro 64-6198; 0.1, 0.3, and 1.0 mg/kg i.p.) and the opioid antagonist naloxone (0.1, 1.0, and 10.0 mg/kg s.c.) to modify ethanol-induced conditioned place preference was examd. in NMRI male mice.  The ORL1 agonists were found to significantly reduce the acquisition, expression, and ethanol-induced reinstatement of conditioned place preference.  Unlike the ORL1 agonists, naloxone at the doses relevant for opioid receptor blockade failed to significantly influence the acquisition of ethanol-induced conditioned place preference.  However, naloxone at 1.0 but not 0.1 mg/kg s.c. potently blocked the expression of ethanol-induced conditioned place preference and significantly inhibited ethanol-induced reinstatement of the conditioned place preference after extinction.  Sep. expts. indicated that nociceptin and Ro 64-6198 are both devoid of reinforcing or aversive properties.  Naloxone, however, at 1.0 and 10.0 mg/kg, produced conditioned place aversion, indicating motivational properties of its own.  Both nociceptin and Ro 64-6198 reduced locomotor activity after acute administration.  However, tolerance developed very quickly to this effect and already after three i.c.v. (or i.p.) injections, there was no significant redn. of locomotor activity.  It is concluded that ORL1 agonists can modulate the acquisition, expression, and reinstatement of the conditioned reinforcing effects of ethanol with no reinforcing or aversive properties of their own.  This property might be a potential advantage in the treatment of alcoholism compared with nonselective opioid antagonist naltrexone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps1o4YcdLO17Vg90H21EOLACvtfcHk0lihQru2uAIdVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Sgtw%253D%253D&md5=5aa918ad64be2022d3b8c00c9b8a9897</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.041350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.041350%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmin%26aufirst%3DA.%26aulast%3DSandin%26aufirst%3DJ.%26aulast%3DTerenius%26aufirst%3DL.%26aulast%3DOgren%26aufirst%3DS.%2BO.%26atitle%3DAcquisition%252C%2520expression%252C%2520and%2520reinstatement%2520of%2520ethanol-induced%2520conditioned%2520place%2520preference%2520in%2520mice%253A%2520effects%2520of%2520opioid%2520receptor-like%25201%2520receptor%2520agonists%2520and%2520naloxone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D310%26epage%3D318%26doi%3D10.1124%2Fjpet.102.041350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Kuzmin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreek, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakalkin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljequist, S.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span><span class="refDoi"> DOI: 10.1038/sj.npp.1301169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.npp.1301169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=902-910&author=A.+Kuzminauthor=M.+J.+Kreekauthor=G.+Bakalkinauthor=S.+Liljequist&title=The+nociceptin%2Forphanin+FQ+receptor+agonist+Ro+64-6198+reduces+alcohol+self-administration+and+prevents+relapse-like+alcohol+drinking&doi=10.1038%2Fsj.npp.1301169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301169%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmin%26aufirst%3DA.%26aulast%3DKreek%26aufirst%3DM.%2BJ.%26aulast%3DBakalkin%26aufirst%3DG.%26aulast%3DLiljequist%26aufirst%3DS.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%2520Ro%252064-6198%2520reduces%2520alcohol%2520self-administration%2520and%2520prevents%2520relapse-like%2520alcohol%2520drinking%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D902%26epage%3D910%26doi%3D10.1038%2Fsj.npp.1301169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Economidou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fardon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span> </span><span class="NLM_article-title">Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3299</span><span class="NLM_x">–</span> <span class="NLM_lpage">3306</span><span class="refDoi"> DOI: 10.1016/j.peptides.2006.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.peptides.2006.09.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=3299-3306&author=D.+Economidouauthor=A.+Fedeliauthor=R.+M.+Fardonauthor=F.+Weissauthor=M.+Massiauthor=R.+Ciccocioppo&title=Effect+of+novel+nociceptin%2Forphanin+FQ-NOP+receptor+ligands+on+ethanol+drinking+in+alcohol-preferring+msP+rats&doi=10.1016%2Fj.peptides.2006.09.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2006.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2006.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DEconomidou%26aufirst%3DD.%26aulast%3DFedeli%26aufirst%3DA.%26aulast%3DFardon%26aufirst%3DR.%2BM.%26aulast%3DWeiss%26aufirst%3DF.%26aulast%3DMassi%26aufirst%3DM.%26aulast%3DCiccocioppo%26aufirst%3DR.%26atitle%3DEffect%2520of%2520novel%2520nociceptin%252Forphanin%2520FQ-NOP%2520receptor%2520ligands%2520on%2520ethanol%2520drinking%2520in%2520alcohol-preferring%2520msP%2520rats%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D3299%26epage%3D3306%26doi%3D10.1016%2Fj.peptides.2006.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopponi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Economidou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teshima, K.</span><span> </span><span class="NLM_article-title">Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2610</span><span class="refDoi"> DOI: 10.1038/npp.2014.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnpp.2014.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2601-2610&author=R.+Ciccocioppoauthor=S.+Stopponiauthor=D.+Economidouauthor=M.+Kuriyamaauthor=H.+Kinoshitaauthor=M.+Heiligauthor=M.+Robertoauthor=F.+Weissauthor=K.+Teshima&title=Chronic+treatment+with+novel+brain-penetrating+selective+NOP+receptor+agonist+MT-7716+reduces+alcohol+drinking+and+seeking+in+the+rat&doi=10.1038%2Fnpp.2014.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.113%26sid%3Dliteratum%253Aachs%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DStopponi%26aufirst%3DS.%26aulast%3DEconomidou%26aufirst%3DD.%26aulast%3DKuriyama%26aufirst%3DM.%26aulast%3DKinoshita%26aufirst%3DH.%26aulast%3DHeilig%26aufirst%3DM.%26aulast%3DRoberto%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DF.%26aulast%3DTeshima%26aufirst%3DK.%26atitle%3DChronic%2520treatment%2520with%2520novel%2520brain-penetrating%2520selective%2520NOP%2520receptor%2520agonist%2520MT-7716%2520reduces%2520alcohol%2520drinking%2520and%2520seeking%2520in%2520the%2520rat%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2601%26epage%3D2610%26doi%3D10.1038%2Fnpp.2014.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Heinig, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomae, A.</span><span> </span><span class="NLM_article-title">Bioanalytics and pharmacokinetics of the nociceptin/orphanin FQ peptide receptor agonist RO0646198 in Wistar rats and cynomolgus monkeys</span> <span class="citation_source-journal">J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">878</span><span class="NLM_x">, </span> <span class="NLM_fpage">2101</span><span class="NLM_x">–</span> <span class="NLM_lpage">2105</span><span class="refDoi"> DOI: 10.1016/j.jchromb.2010.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.jchromb.2010.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20627230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVaktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=878&publication_year=2010&pages=2101-2105&author=K.+Heinigauthor=N.+Kratochwilauthor=F.+Bucheliauthor=A.+Thomae&title=Bioanalytics+and+pharmacokinetics+of+the+nociceptin%2Forphanin+FQ+peptide+receptor+agonist+RO0646198+in+Wistar+rats+and+cynomolgus+monkeys&doi=10.1016%2Fj.jchromb.2010.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalytics and pharmacokinetics of the nociceptin/orphanin FQ peptide receptor agonist RO0646198 in Wistar rats and Cynomolgus monkeys</span></div><div class="casAuthors">Heinig, Katja; Kratochwil, Nicole; Bucheli, Franz; Thomae, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">878</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2101-2105</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This manuscript describes the detn. of the nociceptin/orphanin FQ peptide (NOP) receptor agonist RO0646198 in rat and Cynomolgus monkey plasma using liq. chromatog. coupled to tandem mass spectrometry.  The structural analog RO0658791 served as internal std.  After protein pptn. with ethanol, clean up and enrichment was carried out by online solid-phase extn. on a 10 mm C18 trapping column.  Gradient sepn. was performed on a 50 mm C18 anal. column, followed by electrospray ionization and detection in pos. ion selected reaction monitoring (SRM) mode.  The total run time was 2.5 min.  The lower limit of quantification (LLOQ) was 10 pg/mL.  Precisions were below 19% and accuracies were between 86% and 118%.  The recoveries were above 90%, and no significant matrix effect was obsd.  The method was successfully applied to low dose pharmacokinetic studies.  The bioavailability after oral dosing was below 5% for rats and below 1% in Cynomolgus monkeys, limiting the application of RO0646198 in the clinic to parenteral routes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNxapLsKFIdrVg90H21EOLACvtfcHk0lgb-WL-mXcudA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVaktL0%253D&md5=1f6b1f89024f7e41559f126a0485e06d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2010.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2010.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DHeinig%26aufirst%3DK.%26aulast%3DKratochwil%26aufirst%3DN.%26aulast%3DBucheli%26aufirst%3DF.%26aulast%3DThomae%26aufirst%3DA.%26atitle%3DBioanalytics%2520and%2520pharmacokinetics%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520agonist%2520RO0646198%2520in%2520Wistar%2520rats%2520and%2520cynomolgus%2520monkeys%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2010%26volume%3D878%26spage%3D2101%26epage%3D2105%26doi%3D10.1016%2Fj.jchromb.2010.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span><span class="refDoi"> DOI: 10.1016/S0960-894X(99)00385-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0960-894X%2899%2900385-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2343-2348&author=J.+Wichmannauthor=G.+Adamauthor=S.+Roverauthor=A.+M.+Cesuraauthor=F.+M.+Dautzenbergauthor=F.+Jenck&title=8-acenaphthen-1-yl-1-phenyl-1%2C3%2C8-triaza-spiro%5B4.5%5Ddecan-4-one+derivatives+as+orphanin+FQ+receptor+agonists&doi=10.1016%2FS0960-894X%2899%2900385-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900385-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900385-6%26sid%3Dliteratum%253Aachs%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DRover%26aufirst%3DS.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3D8-acenaphthen-1-yl-1-phenyl-1%252C3%252C8-triaza-spiro%255B4.5%255Ddecan-4-one%2520derivatives%2520as%2520orphanin%2520FQ%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2343%26epage%3D2348%26doi%3D10.1016%2FS0960-894X%2899%2900385-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Hashiba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo', G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowbotham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span> </span><span class="NLM_article-title">Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1007/s002100000327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs002100000327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11191833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2001&pages=28-33&author=E.+Hashibaauthor=C.+Harrisonauthor=G.+Calo%27author=R.+Guerriniauthor=D.+J.+Rowbothamauthor=G.+Smithauthor=D.+G.+Lambert&title=Characterisation+and+comparison+of+novel+ligands+for+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1007%2Fs002100000327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor</span></div><div class="casAuthors">Hashiba, E.; Harrison, C.; Calo, G.; Guerrini, R.; Rowbotham, D. J.; Smith, G.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-33</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Studies of nociceptin/orphanin FQ (NC) have been hampered by the paucity of available ligands with activity at the nociceptin receptor (NCR).  In this study the authors have compared the agonist profile of NC and a novel NCR agonist, Ro65-6570, in a series of radioligand binding studies and effects on forskolin-stimulated cAMP formation in Chinese hamster ovary (CHO) cells expressing the recombinant human NCR (CHOhNCR).  In addn., the authors report the effects of three antagonists, [Nphe1]NC(1-13)NH2, J-113397 and III-BTD, on these responses.  In radioligand binding studies Ro65-6570, [Nphe1]NC(1-13)NH2, J-113397 and III-BTD displaced [3H]NC with similar pKi values (8.4-8.8).  This compares with a pKD of 10.2 for NC in a direct satn. expt. [Nphe1]NC(1-13)NH2 and J-113397 showed at least 100-fold selectivity over classical opioid receptors.  Both NC and Ro65-6570 produced a concn.-dependent inhibition of cAMP formation with pEC50 values of 9.56 and 8.68, resp.  Maximum inhibition achieved was 100%. [Nphe1]NC(1-13)NH2, J-113397 and III-BTD produced a parallel rightward shift in the concn.-response curves to both NC and Ro65-6570 with pKB values of 6.5, 7.5 and 7.7, resp.  Importantly, all three antagonists were devoid of residual agonist activity.  Collectively, these data indicate the value of Ro65-6570, [Nphe1]NC(1-13)NH2, J-113397 and III-BTD in studies of the physiol. role played by NC.  However, due to the relatively poor selectivity of Ro65-6570 and III-BTD caution should be exercised when using tissues that co-express μ-opioid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpOzyrD2lFlLVg90H21EOLACvtfcHk0lgb-WL-mXcudA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVyjuw%253D%253D&md5=8fb498095229c20260a01a36414b211b</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1007%2Fs002100000327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000327%26sid%3Dliteratum%253Aachs%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DHarrison%26aufirst%3DC.%26aulast%3DCalo%2527%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRowbotham%26aufirst%3DD.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCharacterisation%2520and%2520comparison%2520of%2520novel%2520ligands%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2001%26volume%3D363%26spage%3D28%26epage%3D33%26doi%3D10.1007%2Fs002100000327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Schiene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzschentke, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, T.</span><span> </span><span class="NLM_article-title">Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and μ-opioid receptor agonism</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">754</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.01.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2015.01.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25697471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1Sjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=754&publication_year=2015&pages=61-65&author=K.+Schieneauthor=T.+M.+Tzschentkeauthor=W.+Schr%C3%B6derauthor=T.+Christoph&title=Mechanical+hyperalgesia+in+rats+with+diabetic+polyneuropathy+is+selectively+inhibited+by+local+peripheral+nociceptin%2Forphanin+FQ+receptor+and+%CE%BC-opioid+receptor+agonism&doi=10.1016%2Fj.ejphar.2015.01.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and μ-opioid receptor agonism</span></div><div class="casAuthors">Schiene, Klaus; Tzschentke, Thomas M.; Schroeder, Wolfgang; Christoph, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">754</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-65</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peripheral receptors may contribute to the effects of systemically administered centrally available analgesics.  In the present study, we analyzed the effect of local peripheral injection of the nociceptin/orphanin FQ peptide (NOP) receptor agonist Ro65-6570 and compared it to the μ-opioid peptide (MOP) receptor agonist morphine in streptozotocin-induced diabetic polyneuropathy in rats.  Ro65-6570 and morphine were injected intraplantarly into the hind paw of diabetic rats, and mech. withdrawal thresholds were detd. in both paws (ipsi- and contralateral to the injection site).  Ro65-6570 in the dose range of 7.1-71.4 nmol/animal showed antihyperalgesic effects with maximal efficacy of 57.1±15.4% maximal possible effect (MPE) at the dose of 23.8 nmol/animal.  Intraplantar administration of morphine showed dose-dependent antihyperalgesic effects in the dose range of 25.8-257.8 nmol/animal in a similar efficacy range with a maximal efficacy of 76.0±12.1% MPE at the dose of 257.8 nmol/animal.  Both compds. did not induce overt confounding side effects across the tested dose range.  The NOP receptor antagonist J-113397 and the MOP receptor antagonist naloxone, intraplantarly co-administered with the resp. agonists, selectively and completely prevented the antihyperalgesic action of the resp. NOP and MOP receptor agonist.  These results indicate that the activation of peripheral NOP and MOP receptors by Ro65-6570 and morphine, resp., mediated antihyperalgesic effects in rats with diabetic polyneuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpXaH_biV0SbVg90H21EOLACvtfcHk0lhaSPsZUk183w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1Sjs7c%253D&md5=b5dec6ffd8f78e713f353e385be2bc49</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.01.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.01.049%26sid%3Dliteratum%253Aachs%26aulast%3DSchiene%26aufirst%3DK.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DChristoph%26aufirst%3DT.%26atitle%3DMechanical%2520hyperalgesia%2520in%2520rats%2520with%2520diabetic%2520polyneuropathy%2520is%2520selectively%2520inhibited%2520by%2520local%2520peripheral%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520and%2520%25CE%25BC-opioid%2520receptor%2520agonism%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D754%26spage%3D61%26epage%3D65%26doi%3D10.1016%2Fj.ejphar.2015.01.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Schiene, K.; Christoph, T.; Kögel, B.; Tzschentke, T.</span><span> </span><span class="NLM_article-title">Antinociceptive, antihyperalgesic and antiallodynic activity of the NOP receptor agonist Ro65-6570 in rodent models of pain</span>. EFIC, 8th “Pain in Europe” Congress, 2013; <span class="NLM_publisher-name">EFIC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schiene%2C+K.%3B+Christoph%2C+T.%3B+K%C3%B6gel%2C+B.%3B+Tzschentke%2C+T.+Antinociceptive%2C+antihyperalgesic+and+antiallodynic+activity+of+the+NOP+receptor+agonist+Ro65-6570+in+rodent+models+of+pain.+EFIC%2C+8th+%E2%80%9CPain+in+Europe%E2%80%9D+Congress%2C+2013%3B+EFIC%2C+2013%3B+pp+9%E2%80%9312."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSchiene%26aufirst%3DK.%26atitle%3DAntinociceptive%252C%2520antihyperalgesic%2520and%2520antiallodynic%2520activity%2520of%2520the%2520NOP%2520receptor%2520agonist%2520Ro65-6570%2520in%2520rodent%2520models%2520of%2520pain%26pub%3DEFIC%26date%3D2013%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Byford, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. K.</span><span> </span><span class="NLM_article-title">The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1213/01.ane.0000250403.88649.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1213%2F01.ane.0000250403.88649.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17179266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD28jjvFeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=174-179&author=A.+J.+Byfordauthor=A.+Andersonauthor=P.+S.+Jonesauthor=R.+Palinauthor=A.+K.+Houghton&title=The+hypnotic%2C+electroencephalographic%2C+and+antinociceptive+properties+of+nonpeptide+ORL1+receptor+agonists+after+intravenous+injection+in+rodents&doi=10.1213%2F01.ane.0000250403.88649.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents</span></div><div class="casAuthors">Byford Alan J; Anderson Alison; Jones Philip S; Palin Ronald; Houghton Andrea K</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia and analgesia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Agonists at the opioid receptor-like receptor 1 (ORL1) induce motor impairment, sedation, and loss of righting reflex (LRR) in rodents.  This receptor may provide a novel target in the field of anesthesia.  METHODS:  We examined the hypnotic, electroencephalographic (EEG), and antinociceptive effects of two IV administered nonpeptide ORL1 agonists, (Ro 65-6570 and Org 26383), using LRR in mice and rats, percent EEG burst suppression in rats, and formalin paw test in mice.  RESULTS:  In mice, Ro 65-6570 and Org 26383 produced LRR (hypnotic dose 0.6 and 3.7 micromol/kg for Ro 65-6570 and Org 26383, respectively).  Naloxone had no significant effect on sleep times produced by both compounds.  In rats, Ro 65-6570 (0.6-2.4 micromol/kg) and Org 26383 (4-8 micromol/kg) produced LRR and burst suppression activity in the EEG.  Both sleep times and burst suppression activity were significantly reduced with a selective ORL1 antagonist.  In mice, dose-dependent inhibition of formalin-induced nociceptive behaviors occurred (Phase 1 ED50 0.4 and 1.8 micromol/kg and Phase 2 ED50 0.4 and 4.2 micromol/kg for Ro 65-6570 and Org 26383, respectively).  CONCLUSIONS:  These results show that Ro 65-6570 and Org 26383 (probably via the ORL1 receptor) behave as IV hypnotics and analgesics in mice and rats, and that the hypnotic and antinociceptive doses are similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCEQgPogiM-IUSrryheKE6fW6udTcc2eZa_1Y_l2d7ebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jjvFeltA%253D%253D&md5=2429954774972a87a9a3c8f102691528</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1213%2F01.ane.0000250403.88649.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252F01.ane.0000250403.88649.51%26sid%3Dliteratum%253Aachs%26aulast%3DByford%26aufirst%3DA.%2BJ.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DP.%2BS.%26aulast%3DPalin%26aufirst%3DR.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26atitle%3DThe%2520hypnotic%252C%2520electroencephalographic%252C%2520and%2520antinociceptive%2520properties%2520of%2520nonpeptide%2520ORL1%2520receptor%2520agonists%2520after%2520intravenous%2520injection%2520in%2520rodents%26jtitle%3DAnesth.%2520Analg.%26date%3D2007%26volume%3D104%26spage%3D174%26epage%3D179%26doi%3D10.1213%2F01.ane.0000250403.88649.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bercovici, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torhan, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2519</span><span class="NLM_x">–</span> <span class="NLM_lpage">2523</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.bmcl.2009.03.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2519-2523&author=G.+D.+Hoauthor=J.+Anthesauthor=A.+Bercoviciauthor=J.+P.+Caldwellauthor=K.+C.+Chengauthor=X.+Cuiauthor=A.+Fawziauthor=X.+Fernandezauthor=W.+J.+Greenleeauthor=J.+Heyauthor=W.+Korfmacherauthor=S.+X.+Luauthor=R.+L.+McLeodauthor=F.+Ngauthor=A.+S.+Torhanauthor=Z.+Tanauthor=D.+Tulshianauthor=G.+B.+Vartyauthor=X.+Xuauthor=H.+Zhang&title=The+discovery+of+tropane+derivatives+as+nociceptin+receptor+ligands+for+the+management+of+cough+and+anxiety&doi=10.1016%2Fj.bmcl.2009.03.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DAnthes%26aufirst%3DJ.%26aulast%3DBercovici%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DFawzi%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DHey%26aufirst%3DJ.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DNg%26aufirst%3DF.%26aulast%3DTorhan%26aufirst%3DA.%2BS.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520of%2520tropane%2520derivatives%2520as%2520nociceptin%2520receptor%2520ligands%2520for%2520the%2520management%2520of%2520cough%2520and%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2519%26epage%3D2523%26doi%3D10.1016%2Fj.bmcl.2009.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G. J.</span><span> </span><span class="NLM_article-title">The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span><span class="refDoi"> DOI: 10.1124/jpet.108.136937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.108.136937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18492950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVWqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=672-682&author=G.+B.+Vartyauthor=S.+X.+Luauthor=C.+A.+Morganauthor=M.+E.+Cohen-Williamsauthor=R.+A.+Hodgsonauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=A.+B.+Fawziauthor=M.+P.+Grazianoauthor=G.+D.+Hoauthor=J.+Matasiauthor=D.+Tulshianauthor=V.+L.+Coffinauthor=G.+J.+Carey&title=The+anxiolytic-like+effects+of+the+novel%2C+orally+active+nociceptin+opioid+receptor+agonist+8-%5Bbis%282-methylphenyl%29methyl%5D-3-phenyl-8-azabicyclo%5B3.2.1%5Doctan-3-ol+%28SCH+221510%29&doi=10.1124%2Fjpet.108.136937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)</span></div><div class="casAuthors">Varty, Geoffrey B.; Lu, Sherry X.; Morgan, Cynthia A.; Cohen-Williams, Mary E.; Hodgson, Robert A.; Smith-Torhan, April; Zhang, Hongtao; Fawzi, Ahmad B.; Graziano, Michael P.; Ho, Ginny D.; Matasi, Julius; Tulshian, Deen; Coffin, Vicki L.; Carey, Galen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">672-682</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Orphanin FQ/nociceptin (OFQ/N) is the endogenously occurring peptide ligand for the nociceptin opioid receptor (NOP) that produces anxiolytic-like effects in mice and rats.  The present study assessed the anxiolytic-like activity of 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510), a novel potent piperidine NOP agonist (EC50 = 12 nM) that binds with high affinity (Ki = 0.3 nM) and functional selectivity (>50-fold over the μ-, κ-, and δ-opioid receptors).  The anxiolytic-like activity and side-effect profile of SCH 221510 were assessed in a variety of models and the benzodiazepine, chlordiazepoxide (CDP), was included for comparison.  The effects of chronic dosing of SCH 221510 were also assessed.  Furthermore, the specificity of the anxiolytic-like effect of SCH 221510 was investigated with the NOP receptor antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and the opioid receptor antagonist naltrexone.  Like CDP (1-30 mg/kg i.p.), SCH 221510 (1-30 mg/kg p.o.) produced anxiolytic-like effects in the elevated plus-maze (rat and gerbil), Vogel conflict (rat), conditioned lick suppression (rat), fear-potentiated startle (rat), and pup sepn.-induced vocalization (guinea pig) assays.  In the Vogel conflict, the anxiolytic-like effect of SCH 221510 (10 mg/kg) was attenuated by J-113397 (3-10 mg/kg p.o.), but not naltrexone (3-30 mg/kg i.p.).  Addnl., the anxiolytic-like effects of SCH 221510 did not change appreciably following 14-day b.i.d. dosing in rats (10 mg/kg).  Furthermore, unlike CDP, SCH 221510 (3-30 mg/kg) produced anxiolytic-like activity at doses that did not disrupt overt behavior.  Collectively, these data suggest that NOP agonists such as SCH 221510 may have an anxiolytic-like profile similar to benzodiazepines, with a reduced side-effect liability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr61zPPj5Ve3rVg90H21EOLACvtfcHk0liqz4JgPXtZ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVWqsLs%253D&md5=f4cc72e8df4266b67ed4b61ac9c632ad</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136937%26sid%3Dliteratum%253Aachs%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DMorgan%26aufirst%3DC.%2BA.%26aulast%3DCohen-Williams%26aufirst%3DM.%2BE.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DGraziano%26aufirst%3DM.%2BP.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DMatasi%26aufirst%3DJ.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DCoffin%26aufirst%3DV.%2BL.%26aulast%3DCarey%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520anxiolytic-like%2520effects%2520of%2520the%2520novel%252C%2520orally%2520active%2520nociceptin%2520opioid%2520receptor%2520agonist%25208-%255Bbis%25282-methylphenyl%2529methyl%255D-3-phenyl-8-azabicyclo%255B3.2.1%255Doctan-3-ol%2520%2528SCH%2520221510%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D672%26epage%3D682%26doi%3D10.1124%2Fjpet.108.136937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, E.</span><span> </span><span class="NLM_article-title">Novel non-peptide nociceptin/orphanin FQ receptor agonist, 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: design, synthesis, and structure-activity relationship of oral receptor occupancy in the brain for orally potent antianxiety drug</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span><span class="refDoi"> DOI: 10.1021/jm7012979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7012979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=610-625&author=S.+Hayashiauthor=A.+Hiraoauthor=A.+Imaiauthor=H.+Nakamuraauthor=Y.+Murataauthor=K.+Ohashiauthor=E.+Nakata&title=Novel+non-peptide+nociceptin%2Forphanin+FQ+receptor+agonist%2C+1-%5B1-%281-methylcyclooctyl%29-4-piperidinyl%5D-2-%5B%283R%29-3-piperidinyl%5D-1H-benzimidazole%3A+design%2C+synthesis%2C+and+structure-activity+relationship+of+oral+receptor+occupancy+in+the+brain+for+orally+potent+antianxiety+drug&doi=10.1021%2Fjm7012979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm7012979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7012979%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DOhashi%26aufirst%3DK.%26aulast%3DNakata%26aufirst%3DE.%26atitle%3DNovel%2520non-peptide%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%252C%25201-%255B1-%25281-methylcyclooctyl%2529-4-piperidinyl%255D-2-%255B%25283R%2529-3-piperidinyl%255D-1H-benzimidazole%253A%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520oral%2520receptor%2520occupancy%2520in%2520the%2520brain%2520for%2520orally%2520potent%2520antianxiety%2520drug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D610%26epage%3D625%26doi%3D10.1021%2Fjm7012979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Sukhtankar, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagorio, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M.-C.</span><span> </span><span class="NLM_article-title">Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">745</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2014.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2014.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25446568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=745&publication_year=2014&pages=182-189&author=D.+D.+Sukhtankarauthor=C.+H.+Lagorioauthor=M.-C.+Ko&title=Effects+of+the+NOP+agonist+SCH221510+on+producing+and+attenuating+reinforcing+effects+as+measured+by+drug+self-administration+in+rats&doi=10.1016%2Fj.ejphar.2014.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats</span></div><div class="casAuthors">Sukhtankar, Devki D.; Lagorio, Carla H.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">745</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">182-189</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ peptide (NOP) receptor agonists attenuate morphine-induced conditioned place preference in rodents.  However, it is not known whether NOP agonists have reinforcing properties or can inhibit mu opioid receptor (MOP)-mediated reinforcement as measured by drug self-administration in rodents.  Further understanding the behavioral effects of NOP agonists could suggest them as having potential in attenuating reinforcing effects of opioids.  In the first part of the study, reinforcing properties of selective NOP agonist SCH221510 were detd. and compared with the full MOP agonist remifentanil under fixed-ratio 5 (FR5) and progressive-ratio (PR) schedules of drug self-administration.  In the second part, effects of systemic and intracisternal pretreatment of SCH221510 were detd. and compared with MOP antagonist naltrexone in attenuating reinforcing effects of remifentanil and a non-drug reinforcer (sucrose pellets).  Remifentanil self-administration (0.3-10 μg/kg/infusion) generated a biphasic dose-response curve, characteristic of drugs with reinforcing properties.  SCH221510 (3-300 μg/kg/infusion) self-administration resulted in flat dose-response curves and early break-points under the PR, indicative of drugs lacking reinforcing value.  Intracisternally, but not systemically, administered SCH221510 (0.3-3 μg) attenuated remifentanil self-administration, comparable with systemic naltrexone (0.03-0.3 mg/kg).  SCH221510 (1-3 μg), unlike naltrexone (0.03-1 mg/kg), attenuated responding for sucrose pellets.  Both effects of SCH221510 were reversed by the NOP antagonist J-113397 (0.3-3 μg).  These results suggest that SCH221510 does not function as a reinforcer in rats, and that it can attenuate the reinforcing value of MOP agonists; therefore, the potential utility of NOP agonists for the treatment of drug addiction warrants further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUdaBr_X6zKLVg90H21EOLACvtfcHk0liqz4JgPXtZ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtb3N&md5=ef3acd92713cc8257facef3a7f60367c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DLagorio%26aufirst%3DC.%2BH.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DEffects%2520of%2520the%2520NOP%2520agonist%2520SCH221510%2520on%2520producing%2520and%2520attenuating%2520reinforcing%2520effects%2520as%2520measured%2520by%2520drug%2520self-administration%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D745%26spage%3D182%26epage%3D189%26doi%3D10.1016%2Fj.ejphar.2014.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Cremeans, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Roles of mu-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1124/jpet.112.194308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.112.194308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22743574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagsb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=72-81&author=C.+M.+Cremeansauthor=E.+Gruleyauthor=D.+J.+Kyleauthor=M.+C.+Ko&title=Roles+of+mu-opioid+receptors+and+nociceptin%2Forphanin+FQ+peptide+receptors+in+buprenorphine-induced+physiological+responses+in+primates&doi=10.1124%2Fjpet.112.194308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates</span></div><div class="casAuthors">Cremeans, Colette M.; Gruley, Erin; Kyle, Donald J.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Buprenorphine is known as a μ-opioid peptide (MOP) receptor agonist, but its antinociception is compromised by the activation of nociceptin/orphanin FQ peptide (NOP) receptors in rodents.  The aim of this study was to investigate the roles of MOP and NOP receptors in regulating buprenorphine-induced physiol. responses in primates (rhesus monkeys).  The effects of MOP antagonist (naltrexone), NOP antagonist [(±)-1-[(3R*,4R*)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397)], and NOP agonists [(1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one (Ro 64-6198) and 3-endo-8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)] on buprenorphine were studied in three functional assays for measuring analgesia, respiratory depression, and itch in primates.  Over the dose range of 0.01 to 0.1 mg/kg, buprenorphine dose-dependently produced antinociception, respiratory depression, and itch/scratching responses, and there was a ceiling effect at higher doses (0.1-1 mg/kg).  Naltrexone (0.03 mg/kg) produced similar degrees of rightward shifts of buprenorphine's dose-response curves for all three endpoints.  Mean pKB values of naltrexone (8.1-8.3) confirmed that MOP receptors mediated mainly buprenorphine-induced antinociception, respiratory depression, and itch/scratching.  In contrast, J-113397 (0.1 mg/kg) did not change buprenorphine-induced physiol. responses, indicating that there were no functional NOP receptors in buprenorphine-induced effects.  More importantly, both NOP agonists, Ro 64-6198 and SCH 221510, enhanced buprenorphine-induced antinociception without respiratory depression and itch/scratching.  The dose-addn. anal. revealed that buprenorphine in combination with the NOP agonist synergistically produced antinociceptive effects.  These findings provided functional evidence that the activation of NOP receptors did not attenuate buprenorphine-induced antinociception in primates; instead, the coactivation of MOP and NOP receptors produced synergistic antinociception without other side effects.  This study strongly supports the therapeutic potential of mixed MOP/NOP agonists as innovative analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAFWzdMLHCurVg90H21EOLACvtfcHk0liqz4JgPXtZ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagsb%252FP&md5=62e9b5453a946496111f9cdddae5f2df</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194308%26sid%3Dliteratum%253Aachs%26aulast%3DCremeans%26aufirst%3DC.%2BM.%26aulast%3DGruley%26aufirst%3DE.%26aulast%3DKyle%26aufirst%3DD.%2BJ.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DRoles%2520of%2520mu-opioid%2520receptors%2520and%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptors%2520in%2520buprenorphine-induced%2520physiological%2520responses%2520in%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D72%26epage%3D81%26doi%3D10.1124%2Fjpet.112.194308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Kangas, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span> </span><span class="NLM_article-title">Operant nociception in nonhuman primates</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1828</span><span class="refDoi"> DOI: 10.1016/j.pain.2014.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pain.2014.06.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=1821-1828&author=B.+D.+Kangasauthor=J.+Bergman&title=Operant+nociception+in+nonhuman+primates&doi=10.1016%2Fj.pain.2014.06.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2014.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2014.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DKangas%26aufirst%3DB.%2BD.%26aulast%3DBergman%26aufirst%3DJ.%26atitle%3DOperant%2520nociception%2520in%2520nonhuman%2520primates%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D1821%26epage%3D1828%26doi%3D10.1016%2Fj.pain.2014.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Fichna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobczak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrowiecka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cygankiewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenac, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sałaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Małecka-Panas, E.</span><span> </span><span class="NLM_article-title">Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1550</span><span class="refDoi"> DOI: 10.1111/nmo.12390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fnmo.12390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25041572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslCqtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1539-1550&author=J.+Fichnaauthor=M.+Sobczakauthor=A.+Mokrowieckaauthor=A.+Cygankiewiczauthor=P.+Zakrzewskiauthor=N.+Cenacauthor=M.+Sa%C5%82agaauthor=J.+P.+Timmermansauthor=N.+Vergnolleauthor=E.+Ma%C5%82ecka-Panas&title=Activation+of+the+endogenous+nociceptin+system+by+selective+nociceptin+receptor+agonist+SCH+221510+produces+antitransit+and+antinociceptive+effect%3A+a+novel+strategy+for+treatment+of+diarrhea-predominant+IBS&doi=10.1111%2Fnmo.12390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS</span></div><div class="casAuthors">Fichna, J.; Sobczak, M.; Mokrowiecka, A.; Cygankiewicz, A. I.; Zakrzewski, P. K.; Cenac, N.; Salaga, M.; Timmermans, J.-P.; Vergnolle, N.; Malecka-Panas, E.; Krajewska, W. M.; Storr, M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology & Motility</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1539-1550</span>CODEN:
                <span class="NLM_cas:coden">NMOTEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-1925</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : Diarrhea-predominant irritable bowel syndrome (IBS-D) is a functional gastrointestinal (GI) disorder, defined by the presence of loose stools and abdominal pain.  In search for a novel anti-IBS-D therapy, here we investigated the nociceptin receptor (NOP)-dependent effects in the GI tract.  Methods : A novel potent and selective NOP agonist SCH 221510 was used in the study.  The effect of NOP activation on mouse intestinal motility was characterized in vitro and in vivo, in physiol. conditions and in animal models of hypermotility and diarrhea.  Well-established mouse models of visceral pain were used to characterize the antinociceptive effect of the NOP activation.  To provide addnl. evidence that the endogenous nociceptin system is a relevant target for IBS, NOP expression and nociceptin levels were quantified in serum and colonic biopsies from IBS-D patients.  Key Results : SCH 221510 produced a potent NOP-mediated inhibitory effect on mouse intestinal motility in vitro and in vivo in physiol. conditions.  The NOP agonist displayed an antidiarrheal and analgesic action after oral administration in animal models mimicking the symptoms of IBS-D.  Studies on human samples revealed a strong decrease in endogenous nociceptin system expression in IBS-D patients compared with healthy controls.  Conclusions & Inferences : Collectively, mouse and human data suggest that the endogenous nociceptin system is involved in IBS-D and may become a target for anti-IBS-D treatments using potent and selective synthetic NOP agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaT-LhZszp7bVg90H21EOLACvtfcHk0ljw0G_sY5c2IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslCqtbvN&md5=44e2f664d0336baeee3a5f0f675325e2</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fnmo.12390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnmo.12390%26sid%3Dliteratum%253Aachs%26aulast%3DFichna%26aufirst%3DJ.%26aulast%3DSobczak%26aufirst%3DM.%26aulast%3DMokrowiecka%26aufirst%3DA.%26aulast%3DCygankiewicz%26aufirst%3DA.%26aulast%3DZakrzewski%26aufirst%3DP.%26aulast%3DCenac%26aufirst%3DN.%26aulast%3DSa%25C5%2582aga%26aufirst%3DM.%26aulast%3DTimmermans%26aufirst%3DJ.%2BP.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DMa%25C5%2582ecka-Panas%26aufirst%3DE.%26atitle%3DActivation%2520of%2520the%2520endogenous%2520nociceptin%2520system%2520by%2520selective%2520nociceptin%2520receptor%2520agonist%2520SCH%2520221510%2520produces%2520antitransit%2520and%2520antinociceptive%2520effect%253A%2520a%2520novel%2520strategy%2520for%2520treatment%2520of%2520diarrhea-predominant%2520IBS%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2014%26volume%3D26%26spage%3D1539%26epage%3D1550%26doi%3D10.1111%2Fnmo.12390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Sobczak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrowiecka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cygankiewicz, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewski, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malecka-Panas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewska, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fichna, J.</span><span> </span><span class="NLM_article-title">Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1124/jpet.113.209825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.113.209825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24345466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFajt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=401-409&author=M.+Sobczakauthor=A.+Mokrowieckaauthor=A.+I.+Cygankiewiczauthor=P.+K.+Zakrzewskiauthor=M.+Salagaauthor=M.+Storrauthor=R.+Kordekauthor=E.+Malecka-Panasauthor=W.+M.+Krajewskaauthor=J.+Fichna&title=Anti-inflammatory+and+antinociceptive+action+of+an+orally+available+nociceptin+receptor+agonist+SCH+221510+in+a+mouse+model+of+inflammatory+bowel+diseases&doi=10.1124%2Fjpet.113.209825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases</span></div><div class="casAuthors">Sobczak, Marta; Mokrowiecka, Anna; Cygankiewicz, Adam I.; Zakrzewski, Piotr K.; Salaga, Maciej; Storr, Martin; Kordek, Radzislaw; Malecka-Panas, Ewa; Krajewska, Wanda M.; Fichna, Jakub</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-409, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The nociceptin receptors (NOPs) are expressed in the gastrointestinal (GI) tract on muscle cell membranes and neurons, as well as the immune cells that infiltrate the mucosa.  The involvement of NOPs in the pathophysiol. of GI inflammation has been suggested, but due to the lack of selective NOP agonists, it never fully elucidated.  Our aim was to characterize the anti-inflammatory and antinociceptive effect of the NOP agonist, SCH 221510 [3-endo-8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo [3.2.1]octan-3-ol], as a potential therapeutic strategy in the treatment of inflammatory bowel diseases (IBD).  The anti-inflammatory action of SCH 221510 was detd. after i.p., oral, and intracolonic administration of SCH 221510 (0.1-3.0 mg/kg once or twice daily) in mice treated with 2,4,6-trinitrobenzenesulfonic acid (TNBS).  Antinociceptive action of SCH 221510 was evaluated in the mouse model of mustard oil (MO)-induced abdominal pain.  Relative NOP mRNA expression was assessed in patients with IBD using real-time reverse transcriptase-polymerase chain reaction.  We found that the expression of NOP mRNA was significantly decreased in patients with IBD.  The administration (0.1 and 1.0 mg/kg i.p. twice daily and 3 mg/kg p.o. twice daily) of SCH 221510 attenuated TNBS colitis in mice.  This effect was blocked by a selective NOP antagonist [J-113397 [(±)-1-[(3R*,4R*)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one]].  The intracolonic injections of SCH 221510 did not improve colitis in mice.  The antinociceptive effect of SCH 221510 was obsd. after oral administration of SCH 221510 in MO-induced pain tests in mice with acute colitis.  In conclusion, our results show a potent anti-inflammatory and antinociceptive effect upon selective activation of NOP receptors and suggest that the NOP agonist SCH 221510 is a promising drug candidate for future treatment of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBm0-RxSsif7Vg90H21EOLACvtfcHk0ljw0G_sY5c2IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFajt78%253D&md5=7e19d27d66bee05478f88fcc538618b3</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.209825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.209825%26sid%3Dliteratum%253Aachs%26aulast%3DSobczak%26aufirst%3DM.%26aulast%3DMokrowiecka%26aufirst%3DA.%26aulast%3DCygankiewicz%26aufirst%3DA.%2BI.%26aulast%3DZakrzewski%26aufirst%3DP.%2BK.%26aulast%3DSalaga%26aufirst%3DM.%26aulast%3DStorr%26aufirst%3DM.%26aulast%3DKordek%26aufirst%3DR.%26aulast%3DMalecka-Panas%26aufirst%3DE.%26aulast%3DKrajewska%26aufirst%3DW.%2BM.%26aulast%3DFichna%26aufirst%3DJ.%26atitle%3DAnti-inflammatory%2520and%2520antinociceptive%2520action%2520of%2520an%2520orally%2520available%2520nociceptin%2520receptor%2520agonist%2520SCH%2520221510%2520in%2520a%2520mouse%2520model%2520of%2520inflammatory%2520bowel%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D401%26epage%3D409%26doi%3D10.1124%2Fjpet.113.209825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Agostini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, C.</span><span> </span><span class="NLM_article-title">The endogenous nociceptin/orphanin FQ-NOP receptor system as a potential therapeutic target for intestinal disorders</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1519</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span><span class="refDoi"> DOI: 10.1111/nmo.12460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fnmo.12460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25307525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2M7pvVGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1519-1526&author=S.+Agostiniauthor=C.+Petrella&title=The+endogenous+nociceptin%2Forphanin+FQ-NOP+receptor+system+as+a+potential+therapeutic+target+for+intestinal+disorders&doi=10.1111%2Fnmo.12460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">The endogenous nociceptin/orphanin FQ-NOP receptor system as a potential therapeutic target for intestinal disorders</span></div><div class="casAuthors">Agostini S; Petrella C</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1519-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In 1995, by reverse pharmacology approach, used here for the first time in the history of pharmacology, nociceptin/orphanin FQ (N/OFQ) has been discovered as the endogenous ligand of a preidentified receptor named opioid receptor like 1.  Subsequent studies showed that N/OFQ and its receptor (N/OFQergic system) are widely distributed in central and peripheral nervous systems as well as in peripheral organs of human and animals, and represent a system that is involved in a very large range of biological functions such as pain perception, intestinal motility and secretion, immune modulation, stress.  From the time of its discovery to now, a high number of NOP agonists and antagonists have been synthesized and tested in various pathologies.  Nevertheless, none of the molecules targeting N/OFQergic system have currently succeeded in going through clinical trials concerning gut pathologies, indicating that further studies are required.  The work from Dr.  Fichna et al., published in the present issue of Neurogastroenterology and Motility, adds another brick in the wall of understanding the role of N/OFQergic system in IBS-D pathology by the pharmacological evaluation of a new NOP receptor agonist, SCH 221510, in animal models of intestinal alterations (diarrhea and visceral hyperalgesia).  Interestingly, authors report clinical data confirming the involvement of N/OFQergic system in IBS-D patients and, consequently, suggest this system as a valuable therapeutic target for IBS-D pathology.  This minireview aims to give a brief summary of experimental and clinical studies focusing on the N/OFQergic system as pharmacological target for the therapeutic treatment of intestinal pathologies such as IBS and IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-VaHzP8O5fr0AGQpJZWpJfW6udTcc2eZSoG44gn_P1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7pvVGluw%253D%253D&md5=bca183007a694ce0cc7c01a8cbd0defd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1111%2Fnmo.12460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnmo.12460%26sid%3Dliteratum%253Aachs%26aulast%3DAgostini%26aufirst%3DS.%26aulast%3DPetrella%26aufirst%3DC.%26atitle%3DThe%2520endogenous%2520nociceptin%252Forphanin%2520FQ-NOP%2520receptor%2520system%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520intestinal%2520disorders%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2014%26volume%3D26%26spage%3D1519%26epage%3D1526%26doi%3D10.1111%2Fnmo.12460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veals, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainhaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Heek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[bis(2-chlorophenyl)methyl]-3-(2-pyrimidinyl)-8-azabicyclo[3.2.1]octan-3-ol) in preclinical models</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">630</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2009.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20006596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=630&publication_year=2010&pages=112-120&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=D.+C.+Bolserauthor=G.+B.+Vartyauthor=M.+Baptistaauthor=X.+Fernandezauthor=L.+E.+Parraauthor=J.+C.+Zimmerauthor=C.+H.+Ericksonauthor=G.+D.+Hoauthor=Y.+Jiaauthor=F.+W.+Ngauthor=W.+Korfmacherauthor=X.+Xuauthor=J.+Vealsauthor=A.+Smith-Torhanauthor=S.+Wainhausauthor=A.+B.+Fawziauthor=T.+M.+Austinauthor=M.+van+Heekauthor=J.+A.+Hey&title=Pharmacological+profile+of+the+NOP+agonist+and+cough+suppressing+agent+SCH+486757+%288-%5Bbis%282-chlorophenyl%29methyl%5D-3-%282-pyrimidinyl%29-8-azabicyclo%5B3.2.1%5Doctan-3-ol%29+in+preclinical+models&doi=10.1016%2Fj.ejphar.2009.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models</span></div><div class="casAuthors">McLeod, Robbie L.; Tulshian, Deen B.; Bolser, Donald C.; Varty, Geoffrey B.; Baptista, Marco; Fernandez, Xiomara; Parra, Leonard E.; Zimmer, Jennifer C.; Erickson, Christine H.; Ho, Ginny D.; Jia, Yanlin; Ng, Fay W.; Korfmacher, Walter; Xu, Xiaoying; Veals, John; Smith-Torhan, April; Wainhaus, Samuel; Fawzi, Ahmad B.; Austin, Theodore M.; van Heek, Margaret; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">630</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">112-120</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe the pharmacol. and pharmacokinetic profiles of SCH 486757, a nociceptin/orphanin FQ peptide (NOP) receptor agonist that has recently entered human clin. trials for cough.  SCH 486757 selectively binds human NOP receptor (K i = 4.6 ± 0.61 nM) over classical opioid receptors.  In a guinea pig capsaicin cough model, SCH 486757 (0.01-1 mg/kg) suppressed cough at 2, 4, and 6 h post oral administration with a max. efficacy occurring at 4 h equiv. to codeine, hydrocodone, dextromethorphan and baclofen.  The antitussive effects of SCH 486757 (3.0 mg/kg, p.o.) was blocked by the NOP receptor antagonist J113397 (12 mg/kg, i.p.) but not by naltrexone (10 mg/kg, p.o.).  SCH 486757 does not produce tolerance to its antitussive activity after a 5-day BID dosing regimen.  After acute and chronic dosing paradigms, SCH 486757 (1 mg/kg) inhibited capsaicin-evoked coughing by 46 ± 9% and 40 ± 11%, resp.  In a feline mech.-evoked cough model, SCH 486757 produces a max. inhibition of cough and expiratory abdominal electromyogram amplitude of 59 and 61%, resp.  SCH 486757 did not significantly affect inspiratory electromyogram amplitude.  We examd. the abuse potential of SCH 486757 (10 mg/kg, p.o.) in a rat conditioned place preference procedure which is sensitive to classical drugs of abuse, such as amphetamine and morphine.  SCH 486757 was without effect in this model.  Finally, SCH 486757 displays a good oral pharmacokinetic profile in the guinea pig, rat and dog.  We conclude that SCH 486757 has a favorable antitussive profile in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyYZy_0Vw2_LVg90H21EOLACvtfcHk0lj4nf2lZ5I3FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ymt7c%253D&md5=04a736ea082b03a3e7ff9a4eb687d6fc</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DBaptista%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DZimmer%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DF.%2BW.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DVeals%26aufirst%3DJ.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DWainhaus%26aufirst%3DS.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DAustin%26aufirst%3DT.%2BM.%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520NOP%2520agonist%2520and%2520cough%2520suppressing%2520agent%2520SCH%2520486757%2520%25288-%255Bbis%25282-chlorophenyl%2529methyl%255D-3-%25282-pyrimidinyl%2529-8-azabicyclo%255B3.2.1%255Doctan-3-ol%2529%2520in%2520preclinical%2520models%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D630%26spage%3D112%26epage%3D120%26doi%3D10.1016%2Fj.ejphar.2009.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayappa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1159/000235601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1159%2F000235601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19696521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2009&pages=153-161&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=G.+D.+Hoauthor=X.+Fernandezauthor=D.+C.+Bolserauthor=L.+E.+Parraauthor=J.+C.+Zimmerauthor=C.+H.+Ericksonauthor=A.+B.+Fawziauthor=H.+Jayappaauthor=C.+Lehrauthor=J.+Erskineauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Effect+of+a+novel+NOP+receptor+agonist+%28SCH+225288%29+on+guinea+pig+irritant-evoked%2C+feline+mechanically+induced+and+canine+infectious+tracheobronchitis+cough&doi=10.1159%2F000235601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a Novel NOP Receptor Agonist (SCH 225288) on Guinea Pig Irritant-Evoked, Feline Mechanically Induced and Canine Infectious Tracheobronchitis Cough</span></div><div class="casAuthors">McLeod, Robbie L.; Tulshian, Deen B.; Ho, Ginny D.; Fernandez, Xiomara; Bolser, Donald C.; Parra, Leonard E.; Zimmer, Jennifer C.; Erickson, Christine H.; Fawzi, Ahmad B.; Jayappa, Huchappa; Lehr, Craig; Erskine, Jason; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Previous studies have demonstrated that nociceptin/orphanin FQ (N/OFQ), the endogenous peptide ligand for the G-protein-coupled NOP receptor, inhibits cough in exptl. models.  SCH 225288 is a nonpeptide, orally active NOP agonist that may provide the foundation for the development of novel treatments for cough.  Methods: First we characterized the selectivity of SCH 225288 in human receptor binding assays.  Afterwards, the antitussive activity of SCH 225288 was studied in three mechanistically distinct cough models.  Specifically, we obsd. the cough-suppressant effect of SCH 225288 in a guinea pig capsaicin irritant-evoked cough model, a feline mech. induced cough model and finally in a canine Bordetella bronchiseptica disease model.  Results: SCH 225288 selectively binds human NOP receptor (Ki = 0.38 ± 0.02 nmol/l) over classical opioid receptors (COR).  In a guinea pig capsaicin cough model, SCH 225288 (0.1-1 mg/kg) suppressed cough at 2, 4, and 6 h after oral administration.  The antitussive effect of SCH 225288 (3.0 mg/kg, p.o.) was blocked by the NOP antagonist J113397 (12 mg/kg, i.p.) but not by the classical opioid receptor (COR) antagonist, naltrexone (3.0 mg/kg, i.p.).  In the anesthetized cat, we evaluated the effects of SCH 225288 given either i.v. or via the intravertebral artery against the increases in cough no. and respiratory expiratory and inspiratory muscle (rectus abdominis and parasternal) electromyog. (EMG) activities due to perturbations of the intrathoracic trachea.  SCH 225288 (0.03-3.0 mg/kg, i.v.) inhibited both cough no. and abdominal EMG amplitudes.  Similarly, SCH 225288 (0.001-0.3 mg/kg) administered intra-arterially also diminished cough no. and abdominal EMG amplitudes.  No significant effect of the drug was noted on parasternal EMG activity.  Finally, we studied the antitussive actions of SCH 225288 (1.0 mg/kg) in a canine B. bronchiseptica disease model.  In this model, dogs were challenged intranasally with B. bronchiseptica.  Comparisons were made between a vehicle group, an SCH 225288 (1.0 mg/kg, p.o., q.d.) and a butorphanol (0.6 mg/kg, p.o., b.i.d.) group on the mean change in cough scores from baseline values and days 6-9 after B. bronchiseptica challenge.  SCH 225288 (1.0 mg/kg, p.o., q.d.) displayed a pos. antitussive tendency (p = 0.06) to inhibit B. bronchiseptica cough whereas butorphanol (0.6 mg/kg, p.o., b.i.d.) was devoid of antitussive activity.  Conclusions: Taken together, the present data show that SCH 225288 is a potent and effective antitussive agent in animal models of cough.  Furthermore, these findings indicate that NOP agonists represent a promising new therapeutic approach for the treatment of cough without the side effect liabilities assocd. with opioid antitussives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodplJfyEx3gLVg90H21EOLACvtfcHk0lj4nf2lZ5I3FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE&md5=4c78dd41fcc5ff00100526d8da04d2ef</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1159%2F000235601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000235601%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DZimmer%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DJayappa%26aufirst%3DH.%26aulast%3DLehr%26aufirst%3DC.%26aulast%3DErskine%26aufirst%3DJ.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DEffect%2520of%2520a%2520novel%2520NOP%2520receptor%2520agonist%2520%2528SCH%2520225288%2529%2520on%2520guinea%2520pig%2520irritant-evoked%252C%2520feline%2520mechanically%2520induced%2520and%2520canine%2520infectious%2520tracheobronchitis%2520cough%26jtitle%3DPharmacology%26date%3D2009%26volume%3D84%26spage%3D153%26epage%3D161%26doi%3D10.1159%2F000235601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuss, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0703954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0703954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11250866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1175-1178&author=R.+L.+McLeodauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=C.+H.+Ericksonauthor=G.+J.+Careyauthor=D.+B.+Tulshianauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=R.+W.+Eganauthor=F.+M.+Cussauthor=J.+A.+Hey&title=Nociceptin+inhibits+cough+in+the+guinea-pig+by+activation+of+ORL%281%29+receptors&doi=10.1038%2Fsj.bjp.0703954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin inhibits cough in the guinea-pig by activation of ORL1 receptors</span></div><div class="casAuthors">McLeod, Robbie L.; Parra, Leonard E.; Mutter, Jennifer C.; Erickson, Christine H.; Carey, Galen J.; Tulshian, Deen B.; Fawzi, Ahmad B.; Smith-Torhan, April; Egan, Robert W.; Cuss, Francis M.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1175-1178</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We studied the central and peripheral antitussive effect of ORL1 receptor activation with nociceptin/orphanin FQ in conscious guinea pigs.  In guinea pig cough studies, nociceptin/orphanin FQ (10, 30, and 90 μg) given directly into the CNS by an intracerebroventricular (i.c.v.) route inhibited cough elicited by capsaicin exposure by approx. 23, 29 and 52%, resp.  The antitussive activity of nociceptin/orphanin FQ (90 μg, i.c.v.) was blocked by the selective ORL1 antagonist [Phe1γ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 (180 μg, i.c.v.) and J 113397 (10 mg kg-1, i.p.) but not by the opioid antagonist, naltrexone (3 mg kg-1, i.p.).  Furthermore, i.v. nociceptin/orphanin FQ (1.0 and 3.0 mg kg-1) also inhibited cough approx. by 25 and 42%, resp.  These findings indicate that selective ORL1 agonists display the potential to inhibit cough by both a central and peripheral mechanism, and potentially represent a novel therapeutic approach for the treatment of cough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH9gaplu1T_LVg90H21EOLACvtfcHk0lixZ3l-F6uZYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D&md5=48746f19039e43c21957cbaed2383962</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703954%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DCarey%26aufirst%3DG.%2BJ.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DCuss%26aufirst%3DF.%2BM.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DNociceptin%2520inhibits%2520cough%2520in%2520the%2520guinea-pig%2520by%2520activation%2520of%2520ORL%25281%2529%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D1175%26epage%3D1178%26doi%3D10.1038%2Fsj.bjp.0703954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Antitussive action of nociceptin in the cat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/S0014-2999(01)01244-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2801%2901244-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11698070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2001&pages=107-111&author=D.+C.+Bolserauthor=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=J.+A.+Hey&title=Antitussive+action+of+nociceptin+in+the+cat&doi=10.1016%2FS0014-2999%2801%2901244-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive action of nociceptin in the cat</span></div><div class="casAuthors">Bolser, Donald C.; McLeod, Robbie L.; Tulshian, Deen B.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-111</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Expts. were conducted to det. the influence of the specific ORL1 receptor agonist, nociceptin, on the cough reflex in the cat.  Cats were anesthetized and allowed to breathe spontaneously.  Cough was elicited by mech. stimulation of the intrathoracic airway.  I.v. administration of nociceptin (0.001-3.0 mg kg-1) inhibited cough no. and the magnitude of abdominal muscle electromyogram (EMG) discharge during cough in a dose-dependent manner.  Nociceptin had no effect on the magnitude of the inspiratory muscle EMG during cough.  These effects of nociceptin were antagonized by pretreatment with the ORL1 receptor antagonist, 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397, 0.1 mg kg-1, i.v.).  We conclude that i.v. nociceptin inhibits cough in the cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZOPz-HZOatLVg90H21EOLACvtfcHk0lixZ3l-F6uZYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWhsr4%253D&md5=c3ec258f55a3c7baa8663d4463ed0a08</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901244-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901244-4%26sid%3Dliteratum%253Aachs%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520action%2520of%2520nociceptin%2520in%2520the%2520cat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D430%26spage%3D107%26epage%3D111%26doi%3D10.1016%2FS0014-2999%2801%2901244-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Antitussive effect of nociceptin/orphanin FQ in experimental cough models</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1006/pupt.2002.0357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1006%2Fpupt.2002.0357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12099766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=213-216&author=R.+L.+McLeodauthor=D.+C.+Bolserauthor=Y.+Jiaauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=X.+Wangauthor=D.+B.+Tulshianauthor=R.+W.+Eganauthor=J.+A.+Hey&title=Antitussive+effect+of+nociceptin%2Forphanin+FQ+in+experimental+cough+models&doi=10.1006%2Fpupt.2002.0357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive Effect of Nociceptin/Orphanin FQ in Experimental Cough Models</span></div><div class="casAuthors">McLeod, Robbie L.; Bolser, Donald C.; Jia, Yanlin; Parra, Leonard E.; Mutter, Jennifer C.; Wang, Xin; Tulshian, Deen B.; Egan, Robert W.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-216</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cough is an important defensive pulmonary reflex that removes irritants, fluids or foreign materials from the airways.  However, often cough is non-productive and requires suppression.  Opioid μ receptor agonists, such as codeine are commonly used as antitussive agents and are among the most widely administered drugs in the world.  Codeine suppresses the responsiveness of one or more components of the central reflex pathway for cough and is an efficacious antitussive drug for cough due to diverse etiologies.  However, opioids produce side effects that include sedation, addiction potential and constipation.  Therefore, novel cough suppressant therapies should maintain or improve upon the antitussive efficacy profile of opioids.  Moreover, these novel therapies should have a safety profile significantly better than current antitussive therapies.  Presently, we discuss preclin. findings showing that activation of the 'opioid-like' receptor (NOP1) inhibits cough in the guinea pig and cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK5SQIUqfLVLVg90H21EOLACvtfcHk0lixZ3l-F6uZYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D&md5=88453aa1b1f2ed62697ffe6c96781954</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1006%2Fpupt.2002.0357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fpupt.2002.0357%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520effect%2520of%2520nociceptin%252Forphanin%2520FQ%2520in%2520experimental%2520cough%2520models%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2002%26volume%3D15%26spage%3D213%26epage%3D216%26doi%3D10.1006%2Fpupt.2002.0357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselgof, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.1159/000077448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1159%2F000077448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15161996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2004&pages=143-149&author=R.+L.+McLeodauthor=Y.+Jiaauthor=X.+Fernandezauthor=L.+E.+Parraauthor=X.+Wangauthor=D.+B.+Tulshianauthor=E.+J.+Kiselgofauthor=Z.+Tanauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Antitussive+profile+of+the+NOP+agonist+Ro-64-6198+in+the+guinea+pig&doi=10.1159%2F000077448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span></div><div class="casAuthors">McLeod, Robbie L.; Jia, Yanlin; Fernandez, Xiomara; Parra, Leonard E.; Wang, Xin; Tulshian, Deen B.; Kiselgof, Eugenia J.; Tan, Zheng; Fawzi, Ahmad B.; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">We have previously shown that N/OFQ, the endogenous peptide ligand for the "opioid-like" NOP receptor, inhibits cough in guinea pigs and cats.  In the present study we sought to continue our characterization of the cough-suppressant effects of NOP stimulation by profiling the pulmonary and antitussive effects of a novel non-peptide NOP agonist, Ro-64-6198, in guinea pigs.  In receptor-binding assays, we confirmed that Ro-64-6198 selectively binds to NOP receptors over other opioid receptors.  The Ki values for Ro-64-6198 at NOP, MOP, KOP and DOP receptors was 0.3, 36, 214 and 3,787 nmol/l, resp.  In GTPγS-binding assays, Ro-64-6198 displayed >900-fold functional selectivity at NOP relative to MOP receptors.  We evaluated the effects of Ro-64-6198 (3 and 10 μmol/l) in isolated guinea pig nodose ganglia cells on the increases in intracellular Ca2+ concn. evoked by capsaicin stimulation (1×10-8-1×10-6 mol/l).  Similar to previously reported data with N/OFQ, Ro-64-6198 (3 and 10 μmol/l) significantly attenuated Ca2+ responses in nodose ganglia cells produced by exposure to capsaicin.  The effect of Ro-64-6198 (3 μmol/l) on capsaicin-induced intracellular Ca2+ responses was blocked by the NOP antagonist, J113397 (3 μmol/l).  In guinea pig in vivo studies, aerosolized capsaicin (10-300 μmol/l) produced a dose-dependent increase in cough no.  Ro-64-6198 given i.p. significantly inhibited cough due to capsaicin (300 μmol/l) exposure.  In a duration study we found that the max. antitussive effect (42±8% inhibition) of Ro-64-6198 (3 mg/kg) was obsd. at 1 h after i.p. administration.  Also at 1 h after administration, Ro-64-6198 (0.003-3.0 mg/kg, i.p.) produced a dose-dependent inhibition of cough.  The antitussive effect of Ro-64-6198 (3 mg/kg, i.p.) was blocked by J113397 (12 mg/kg, i.p.) but not by the classical opioid antagonist naltrexone (10 mg/kg, i.p.).  Although the antitussive action of Ro-64-6198 may be mediated by a central and/or a peripheral site of action, we hypothesize that selective oral NOP agonists that do not penetrate the blood-brain barrier may provide a novel approach for the treatment of cough.  Moreover, because these drugs do not interact at MOP receptors, they may be devoid of codeine-like side effects such as respiratory depression, sedation, constipation or proclivities for addictive liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjdJxKiezFwbVg90H21EOLACvtfcHk0ljsnWO9AyC53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D&md5=303c3df4646580491f2bde89650c5bfa</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1159%2F000077448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000077448%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DKiselgof%26aufirst%3DE.%2BJ.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520profile%2520of%2520the%2520NOP%2520agonist%2520Ro-64-6198%2520in%2520the%2520guinea%2520pig%26jtitle%3DPharmacology%26date%3D2004%26volume%3D71%26spage%3D143%26epage%3D149%26doi%3D10.1159%2F000077448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Lee, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undem, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. J.</span><span> </span><span class="NLM_article-title">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1164/rccm.200507-1043OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1164%2Frccm.200507-1043OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16239621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=271-275&author=M.+G.+Leeauthor=B.+J.+Undemauthor=C.+Brownauthor=M.+J.+Carr&title=Effect+of+nociceptin+in+acid-evoked+cough+and+airway+sensory+nerve+activation+in+guinea+pigs&doi=10.1164%2Frccm.200507-1043OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span></div><div class="casAuthors">Lee, Min-Goo; Undem, Bradley J.; Brown, Claire; Carr, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-275</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Nociceptin/orphanin FQ has been reported to inhibit capsaicin- and mech. provoked cough in animal models, but the mechanism of this effect has not been elucidated.  Objectives: The objectives of this study were to det. whether nociceptin inhibits acid-evoked cough in conscious animals and to evaluate the mechanism of this effect.  Methods: We tested the effect of nociceptin on acid-induced cough in conscious guinea pigs and acid-induced nerve activation in airway-specific vagal sensory neurons using calcium imaging techniques and the gramicidin-perforated patch clamp technique.  Measurements and Main Results: Nociceptin (3 mg/kg, i.p.) effectively inhibited acid-evoked cough in guinea pigs by nearly 70%.  Acid (pH 5) increased intracellular free calcium in acutely dissocd. vagal jugular ganglionic neurons.  The acid-induced increase in intracellular calcium was inhibited by a selective transient receptor potential vanilloid-1 antagonist, 5-iodo-resiniferatoxin (1 μM, ∼80% redn.).  The inhibitory effect of 5-iodo-resiniferatoxin on acid-induced increases in calcium was mimicked by nociceptin (0.1 μM).  In gramicidin-perforated patch clamp recordings on airway-specific capsaicin-sensitive jugular ganglion neurons, acid (pH 5) induced two distinct inward currents.  A transient current was evoked that was inhibited by amiloride and a sustained current was evoked that was inhibited by 5-iodo-resiniferatoxin.  Nociceptin selectively inhibited only the sustained component of acid-induced inward current.  Conclusion: These results indicate that the inhibitory effect of nociceptin on acid-induced cough may result from a direct inhibitory effect on peripheral C-fiber activity caused by the selective inhibition of acid-induced transient receptor potential vanilloid-1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7nu8PLku7c7Vg90H21EOLACvtfcHk0ljsnWO9AyC53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D&md5=915d140a2cc8650708e1fe6291863482</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1164%2Frccm.200507-1043OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200507-1043OC%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DUndem%26aufirst%3DB.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DCarr%26aufirst%3DM.%2BJ.%26atitle%3DEffect%2520of%2520nociceptin%2520in%2520acid-evoked%2520cough%2520and%2520airway%2520sensory%2520nerve%2520activation%2520in%2520guinea%2520pigs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D271%26epage%3D275%26doi%3D10.1164%2Frccm.200507-1043OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">de Guglielmo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Fardon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span> </span><span class="NLM_article-title">MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span><span class="refDoi"> DOI: 10.1111/adb.12157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fadb.12157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24930632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFahu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=643-651&author=G.+de+Guglielmoauthor=R.+Martin-Fardonauthor=K.+Teshimaauthor=R.+Ciccocioppoauthor=F.+Weiss&title=MT-7716%2C+a+potent+NOP+receptor+agonist%2C+preferentially+reduces+ethanol+seeking+and+reinforcement+in+post-dependent+rats&doi=10.1111%2Fadb.12157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats</span></div><div class="casAuthors">de Guglielmo, Giordano; Martin-Fardon, Remi; Teshima, Koji; Ciccocioppo, Roberto; Weiss, Friedbert</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-651</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Dysregulation of the nociceptin (N/OFQ) system has been implicated in alc. abuse and alcoholism, and growing evidence suggests that targeting this system may be beneficial for treating alcoholism.  To further explore the treatment target potential of the N/OFQ system, the novel non-peptide, small-mol. N/OFQ (NOP) agonist MT-7716, (R)-2-{3-[1-(Acenaphthen-1-yl)piperidin-4-yl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-N-methylacetamide hydrochloride hydrate, was examd. for its effects on ethanol self-administration and stress-induced reinstatement of alc. seeking in non-dependent and post-dependent rats.  Male Wistar rats were trained to self-administer ethanol and then made ethanol dependent via repeated intragastric ethanol intubation.  The effects of MT-7716 (0.3 and 1 mg/kg; PO) on alc. self-administration were detd. 2 wk following dependence induction, when baseline self-administration was restored.  Effects of MT-7716 on stress-induced reinstatement were tested in sep. cohorts of rats, 1 and 3 wk post-withdrawal.  MT-7716 reduced alc. self-administration and stress-induced reinstatement of alc. seeking in post-dependent rats, but was ineffective in non-dependent animals.  Moreover, the prevention of stress-induced reinstatement by MT-7716 was more pronounced at 3 wk post-dependence.  The results further confirm treatment target potential for the NOP receptor and identify non-peptide NOP agonists as promising potential treatment drugs for alc. abuse and relapse prevention.  The findings also support dysregulation of the N/OFQ system as a factor in alc. seeking and reinforcement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIN08ElzbvDbVg90H21EOLACvtfcHk0ljsnWO9AyC53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFahu70%253D&md5=9499774fae9de0e6535d7796c2934335</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1111%2Fadb.12157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12157%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGuglielmo%26aufirst%3DG.%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DTeshima%26aufirst%3DK.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DF.%26atitle%3DMT-7716%252C%2520a%2520potent%2520NOP%2520receptor%2520agonist%252C%2520preferentially%2520reduces%2520ethanol%2520seeking%2520and%2520reinforcement%2520in%2520post-dependent%2520rats%26jtitle%3DAddict.%2520Biol.%26date%3D2015%26volume%3D20%26spage%3D643%26epage%3D651%26doi%3D10.1111%2Fadb.12157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Teshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashimori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span> </span><span class="NLM_article-title">Nonphotic entrainment of the circadian body temperature rhythm by the selective ORL1 receptor agonist W-212393 in rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0706311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15980870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslaltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=33-40&author=K.+Teshimaauthor=M.+Minoguchiauthor=S.+Tounaiauthor=A.+Ashimoriauthor=J.+Eguchiauthor=C.+N.+Allenauthor=S.+Shibata&title=Nonphotic+entrainment+of+the+circadian+body+temperature+rhythm+by+the+selective+ORL1+receptor+agonist+W-212393+in+rats&doi=10.1038%2Fsj.bjp.0706311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Nonphotic entrainment of the circadian body temperature rhythm by the selective ORL1 receptor agonist W-212393 in rats</span></div><div class="casAuthors">Teshima, Koji; Minoguchi, Masanori; Tounai, Sayuri; Ashimori, Atsuyuki; Eguchi, Junichi; Allen, Charles N.; Shibata, Shigenobu</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We synthesized a small-mol. opioid receptor-like 1 (ORL1) receptor agonist, 2-{3-[1-((1R)-acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide (W-212393), and investigated its effect on the circadian body temp. rhythm of rats.  W-212393 has high affinity for ORL1 receptors in the rat cerebral cortex and human ORL1 receptors expressed in HEK293 cells with Ki values of 0.76 and 0.50 nM, resp.  W-212393 concn.-dependently stimulated GTPγ35S binding and its efficacy was similar to nociceptin/orphanin FQ (N/OFQ), suggesting that W-212393 is a full agonist at ORL1 receptors.  W-212393 dose-dependently occupied ORL1 receptors following intraventricular or i.p. administration, suggesting that W-212393 is a brain-penetrating compd.  W-212393 (100 nM) and N/OFQ (100 nM) significantly suppressed the activity of spontaneously firing rat suprachiasmatic nucleus neurons.  These suppressive effects were blocked by an ORL1 receptor antagonist, J-113397 (1 μM).  W-212393 (3 mg kg-1, i.p.) induced a significant phase advance at circadian time 6 (CT6) and CT9, but not at other CTs.  The magnitude of the W-212393 (0.3-3 mg kg-1, i.p.)-induced phase advance was dose-dependent and greater than those produced by 8-hydroxy-2-(di-n-propylamino)tetralin (0.3-3 mg kg-1, i.p.) or melatonin (0.3-3 mg kg-1, i.p.).  The W-212393 (3 mg kg-1, i.p.)-induced phase advance was antagonized by J-113397 (10 mg kg-1, i.p.).  W-212393 (3 mg kg-1, i.p.) significantly accelerated the re-entrainment of the body temp. rhythm to a 6 h advanced light-dark cycle.  These results indicate that activation of ORL1 receptors contributes to the circadian entrainment and W-212393 may represent an interesting agent for the study of circadian rhythms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONSr62_au4rVg90H21EOLACvtfcHk0ljsnWO9AyC53Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslaltbk%253D&md5=dffa9f3cb188d94ed8c8451e8586482f</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706311%26sid%3Dliteratum%253Aachs%26aulast%3DTeshima%26aufirst%3DK.%26aulast%3DMinoguchi%26aufirst%3DM.%26aulast%3DTounai%26aufirst%3DS.%26aulast%3DAshimori%26aufirst%3DA.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DC.%2BN.%26aulast%3DShibata%26aufirst%3DS.%26atitle%3DNonphotic%2520entrainment%2520of%2520the%2520circadian%2520body%2520temperature%2520rhythm%2520by%2520the%2520selective%2520ORL1%2520receptor%2520agonist%2520W-212393%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D146%26spage%3D33%26epage%3D40%26doi%3D10.1038%2Fsj.bjp.0706311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2973</span><span class="NLM_x">–</span> <span class="NLM_lpage">2976</span><span class="refDoi"> DOI: 10.1021/jm034249d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034249d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Sjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2973-2976&author=N.+T.+Zaveriauthor=F.+Jiangauthor=C.+M.+Olsenauthor=J.+R.+Deschampsauthor=D.+Parrishauthor=W.+Polgarauthor=L.+Toll&title=A+novel+series+of+piperidin-4-yl-1%2C3-dihydroindol-2-ones+as+agonist+and+antagonist+ligands+at+the+nociceptin+receptor&doi=10.1021%2Fjm034249d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor</span></div><div class="casAuthors">Zaveri, Nurulain T.; Jiang, Faming; Olsen, Cris M.; Deschamps, Jeffrey R.; Parrish, Damon; Polgar, Willma; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2973-2976</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N-(4-piperidinyl)-2-indolinones were discovered as a new structural class of nociceptin receptor (NOP) ligands.  Unlike other previously reported classes of NOP receptor ligands, modifications of the piperidine N substituents afforded both potent agonists and antagonists, with modest selectivities over other opioid receptors.  The SAR revealed in this new series will provide important insights for the development of pharmacophores for agonist and antagonist actions at the NOP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouCteePy22mbVg90H21EOLACvtfcHk0lgIBlExCkL_sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Sjs7s%253D&md5=f7988bb47141c9055b43c47eadf06bba</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm034249d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034249d%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%2BM.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DParrish%26aufirst%3DD.%26aulast%3DPolgar%26aufirst%3DW.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DA%2520novel%2520series%2520of%2520piperidin-4-yl-1%252C3-dihydroindol-2-ones%2520as%2520agonist%2520and%2520antagonist%2520ligands%2520at%2520the%2520nociceptin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2973%26epage%3D2976%26doi%3D10.1021%2Fjm034249d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Zaveri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">E345</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1208/aapsj070234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1208%2Faapsj070234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16353914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ylt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=E345-352&author=N.+Zaveriauthor=F.+Jiangauthor=C.+Olsenauthor=W.+Polgarauthor=L.+Toll&title=Small-molecule+agonists+and+antagonists+of+the+opioid+receptor-like+receptor+%28ORL1%2C+NOP%29%3A+ligand-based+analysis+of+structural+factors+influencing+intrinsic+activity+at+NOP&doi=10.1208%2Faapsj070234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP</span></div><div class="casAuthors">Zaveri, Nurulain; Jiang, Faming; Olsen, Cris; Polgar, Willma; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">E345-E352</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">American Association of Pharmaceutical Scientists</span>)
        </div><div class="casAbstract">A review.  The recently discovered fourth member of the opioid receptor family, the nociceptin receptor (NOP) and its endogenous ligand, the heptadecapeptide nociceptin, are involved in several central nervous system pathways, such as nociception, reward, tolerance, and feeding.  The discovery of small-mol. ligands for NOP is being actively pursued for several therapeutic applications.  This review presents a brief overview of the several recently reported NOP ligands, classified as NOP agonists and antagonists, with an emphasis on the anal. of the structural features that may be important for modulating the agonist/antagonist profile (intrinsic activity) of these ligands.  Structure-activity relationships in our own series of dihydroindolinone-based NOP ligands and those of the various reported ligands indicate that the lipophilic substituent on the common basic nitrogen present in all NOP ligands plays a role in detg. the agonist/antagonist profile of the NOP ligand.  This anal. provides a basis for the rational drug design of NOP ligands of desired intrinsic activity and provides a framework for developing pharmacophore models for high affinity binding and intrinsic activity at the NOP receptor.  Since NOP agonists and antagonists both have therapeutic value, rational approaches for obtaining both within a high-affinity binding class of compds. are very useful for designing potent and selective NOP ligands with the desired profile of intrinsic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4wQ41VBI3hrVg90H21EOLACvtfcHk0lgIBlExCkL_sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ylt7bJ&md5=edfd4b8d20d0e33e6f64d970092d5604</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1208%2Faapsj070234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Faapsj070234%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%26aulast%3DPolgar%26aufirst%3DW.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DSmall-molecule%2520agonists%2520and%2520antagonists%2520of%2520the%2520opioid%2520receptor-like%2520receptor%2520%2528ORL1%252C%2520NOP%2529%253A%2520ligand-based%2520analysis%2520of%2520structural%2520factors%2520influencing%2520intrinsic%2520activity%2520at%2520NOP%26jtitle%3DAAPS%2520J.%26date%3D2005%26volume%3D7%26spage%3DE345%26epage%3D352%26doi%3D10.1208%2Faapsj070234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, K.</span><span> </span><span class="NLM_article-title">Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7675</span><span class="NLM_x">–</span> <span class="NLM_lpage">7699</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.bmc.2010.07.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7675-7699&author=S.+Hayashiauthor=E.+Nakataauthor=A.+Moritaauthor=K.+Mizunoauthor=K.+Yamamuraauthor=A.+Katoauthor=K.+Ohashi&title=Discovery+of+%7B1-%5B4-%282-%7Bhexahydropyrrolo%5B3%2C4-c%5Dpyrrol-2%281H%29-yl%7D-1H-benzimidazol-1-yl%29piperidin-1-yl%5Dcyclooctyl%7Dmethanol%2C+systemically+potent+novel+non-peptide+agonist+of+nociceptin%2Forphanin+FQ+receptor+as+analgesic+for+the+treatment+of+neuropathic+pain%3A+design%2C+synthesis%2C+and+structure-activity+relationships&doi=10.1016%2Fj.bmc.2010.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DNakata%26aufirst%3DE.%26aulast%3DMorita%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DOhashi%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520%257B1-%255B4-%25282-%257Bhexahydropyrrolo%255B3%252C4-c%255Dpyrrol-2%25281H%2529-yl%257D-1H-benzimidazol-1-yl%2529piperidin-1-yl%255Dcyclooctyl%257Dmethanol%252C%2520systemically%2520potent%2520novel%2520non-peptide%2520agonist%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520as%2520analgesic%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%253A%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7675%26epage%3D7699%26doi%3D10.1016%2Fj.bmc.2010.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orduna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenegro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: Studies with bifunctional NOP/mu receptor agonists in the sciatic nerve ligation chronic pain model in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1124/jpet.111.184663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.111.184663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21859931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=687-693&author=T.+V.+Khroyanauthor=W.+E.+Polgarauthor=J.+Ordunaauthor=J.+Montenegroauthor=F.+Jiangauthor=N.+T.+Zaveriauthor=L.+Toll&title=Differential+effects+of+nociceptin%2Forphanin+FQ+%28NOP%29+receptor+agonists+in+acute+versus+chronic+pain%3A+Studies+with+bifunctional+NOP%2Fmu+receptor+agonists+in+the+sciatic+nerve+ligation+chronic+pain+model+in+mice&doi=10.1124%2Fjpet.111.184663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in mice</span></div><div class="casAuthors">Khroyan, Taline V.; Polgar, Willma E.; Orduna, Juan; Montenegro, Jose; Jiang, Faming; Zaveri, Nurulain T.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-693</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1-(1-Cyclooctylpiperidin-4-yl)-indolin-2-one (SR14150) and 1-(1-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)piperidinl-4-yl)-indolin-2-one (SR16835) are moderately selective nociceptin/orphanin FQ (NOP) receptor agonists.  In the [35S]guanosine 5'-O-(3-thiotriphosphate) assay in vitro, SR14150 is a partial agonist at both the NOP and μ-opioid receptors, whereas SR16835 is a full agonist at the NOP receptor and has low efficacy at μ receptors.  These compds. were tested for antinociceptive and antiallodynic activity, using mice in chronic pain, subsequent to spinal nerve ligation (SNL) surgery.  When administered s.c. to mice after SNL surgery, SR14150 but not SR16835 increased tail-flick latency, which was blocked by the opioid antagonist naloxone, but not by the NOP receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).  In contrast, both SR14150 and SR16835 had antiallodynic activity when mech. allodynia was measured with von Frey monofilaments.  This effect was completely blocked by SB-612111 but not by naloxone.  On the other hand, morphine antinociception and antiallodynia were both blocked by naloxone and potentiated by SB-612111.  These results indicate that, in mice, circuitry mediating antinociceptive activity in acute and chronic pain states is different.  It is possible that during a chronic pain state, an up-regulated NOP system in the spinal cord leads to NOP receptor-mediated antiallodynia, which is blocked by NOP antagonists.  However, supraspinal up-regulation could lead to an attenuation of morphine antinociception and antiallodynia, which can be alleviated by an NOP receptor antagonist.  Thus, although neither NOP agonists nor antagonists are effective as analgesics in acute pain, they may have efficacy as analgesics, either alone or in combination with morphine, for treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0K9DfQCAq7Vg90H21EOLACvtfcHk0lg7XsenN2G2-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL&md5=d5e03c7d72ac9feab468aa8cdc8ba89d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.184663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.184663%26sid%3Dliteratum%253Aachs%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DOrduna%26aufirst%3DJ.%26aulast%3DMontenegro%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DDifferential%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%2520agonists%2520in%2520acute%2520versus%2520chronic%2520pain%253A%2520Studies%2520with%2520bifunctional%2520NOP%252Fmu%2520receptor%2520agonists%2520in%2520the%2520sciatic%2520nerve%2520ligation%2520chronic%2520pain%2520model%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D687%26epage%3D693%26doi%3D10.1124%2Fjpet.111.184663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Vang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, K.</span><span> </span><span class="NLM_article-title">Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span><span class="refDoi"> DOI: 10.3324/haematol.2015.128736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.3324%2Fhaematol.2015.128736" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=1517-1525&author=D.+Vangauthor=J.+A.+Paulauthor=J.+Nguyenauthor=H.+Tranauthor=L.+Vincentauthor=D.+Yasudaauthor=N.+T.+Zaveriauthor=K.+Gupta&title=Small-molecule+nociceptin+receptor+agonist+ameliorates+mast+cell+activation+and+pain+in+sickle+mice&doi=10.3324%2Fhaematol.2015.128736"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2015.128736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2015.128736%26sid%3Dliteratum%253Aachs%26aulast%3DVang%26aufirst%3DD.%26aulast%3DPaul%26aufirst%3DJ.%2BA.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DH.%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DGupta%26aufirst%3DK.%26atitle%3DSmall-molecule%2520nociceptin%2520receptor%2520agonist%2520ameliorates%2520mast%2520cell%2520activation%2520and%2520pain%2520in%2520sickle%2520mice%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3D1517%26epage%3D1525%26doi%3D10.3324%2Fhaematol.2015.128736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ system as a target for treating alcoholism</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.2174/187152710790966713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2174%2F187152710790966713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20201819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=87-93&author=N.+P.+Murphy&title=The+nociceptin%2Forphanin+FQ+system+as+a+target+for+treating+alcoholism&doi=10.2174%2F187152710790966713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ system as a target for treating alcoholism</span></div><div class="casAuthors">Murphy, Niall P.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-93</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nociceptin (known also as orphanin FQ) is the most recently discovered member of the endogenous opioid peptide family, albeit nearly 15 years ago.  Nociceptin renders or influences many behavioral, psychol. and neurobiol. processes, including memory, anxiety, stress and reward.  Since its discovery, results of a steady stream of studies have suggested that endogenous nociceptin might be involved in responses to addictive drugs, and that targeting the nociceptin system may be beneficial in treating addictions.  The current review summarizes and critically appraises those studies, particularly those that point to an application in treating alcoholism.  Overall, most studies suggest that the endogenous nociceptin system has a physiol. role in mediating or regulating behavioral responses to alc., and that activating nociceptin receptors suppresses ongoing alc. consumption or reinstatement of responding for alc.  These findings encourage the development of therapies targeted at the nociceptin system for the treatment of alcoholism in humans, though a minor no. of studies showing continuous activation of the nociceptin receptor can produce increased, rather than reduced, alc. consumption emphasize the necessity of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTCxdiYsUYh7Vg90H21EOLACvtfcHk0lg7XsenN2G2-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsL4%253D&md5=6a9f671254319083b3f6b6b47a636a2e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.2174%2F187152710790966713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710790966713%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520system%2520as%2520a%2520target%2520for%2520treating%2520alcoholism%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D87%26epage%3D93%26doi%3D10.2174%2F187152710790966713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Economidou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopponi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braconi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubaldi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Fardon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span> </span><span class="NLM_article-title">Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat</span> <span class="citation_source-journal">Alcohol.: Clin. Exp. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.1111/j.1530-0277.2010.01392.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1530-0277.2010.01392.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21223310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslWitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=747-755&author=D.+Economidouauthor=A.+Cippitelliauthor=S.+Stopponiauthor=S.+Braconiauthor=S.+Clementiauthor=M.+Ubaldiauthor=R.+Martin-Fardonauthor=F.+Weissauthor=M.+Massiauthor=R.+Ciccocioppo&title=Activation+of+brain+NOP+receptors+attenuates+acute+and+protracted+alcohol+withdrawal+symptoms+in+the+rat&doi=10.1111%2Fj.1530-0277.2010.01392.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat</span></div><div class="casAuthors">Economidou, Daina; Cippitelli, Andrea; Stopponi, Serena; Braconi, Simone; Clementi, Stefano; Ubaldi, Massimo; Martin-Fardon, Remi; Weiss, Friedbert; Massi, Maurizio; Ciccocioppo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Alcoholism: Clinical & Experimental Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">747-755</span>CODEN:
                <span class="NLM_cas:coden">ACRSDM</span>;
        ISSN:<span class="NLM_cas:issn">0145-6008</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alc. withdrawal refers to a cluster of symptoms that may occur from suddenly ceasing the use of alc. after chronic or prolonged ingestion.  These symptoms make alc. abstinence difficult and increase the risk of relapse in recovering alcoholics.  In previous studies, we demonstrated that treatment with Nociceptin/orphanin FQ (N/OFQ) significantly reduces alc. consumption and attenuates alc.-seeking behavior induced by environmental conditioning factors or by stress in rats.  In this study, we evaluated whether activation of brain NOP receptors may also attenuate alc. withdrawal signs in rats.  For this purpose, animals were subjected to a 6-day chronic alc. intoxication (by intragastric administration), and at 8, 10, and 12 h following cessation of alc. exposure, they were treated intracerebroventricularly (ICV) with N/OFQ (0.0, 1.0, and 3.0 μg/rat).  Somatic withdrawal signs were scored after ICV treatment.  In a subsequent expt., to evaluate N/OFQ effects on alc. withdrawal-induced anxiety, another group of rats was subjected to ethanol intoxication and after 1 wk was tested for anxiety behavior in the elevated plus maze (EPM).  In the last expt., an addnl. group of rats was tested for anxiety elicited by acute ethanol intoxication (hangover anxiety).  For this purpose, animals received an acute dose (3.0 g/kg) of 20% alc. and 12 h later were tested in the EPM following ICV N/OFQ (0.0, 1.0, and 2.0 μg/rat).  Results showed that N/OFQ significantly reduced the expression of somatic withdrawal signs and reversed anxiety-like behaviors assocd. with both chronic and acute alc. intoxication.  N/OFQ did not affect anxiety scores in nondependent animals.  These findings suggest that the N/OFQ-NOP receptor system may represent a promising target for the development of new treatments to ameliorate alc. withdrawal symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwXXBZYFgBs7Vg90H21EOLACvtfcHk0lg7XsenN2G2-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslWitbY%253D&md5=f8b05fee52e9711e3e859bb672dc1296</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1530-0277.2010.01392.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1530-0277.2010.01392.x%26sid%3Dliteratum%253Aachs%26aulast%3DEconomidou%26aufirst%3DD.%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DStopponi%26aufirst%3DS.%26aulast%3DBraconi%26aufirst%3DS.%26aulast%3DClementi%26aufirst%3DS.%26aulast%3DUbaldi%26aufirst%3DM.%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DF.%26aulast%3DMassi%26aufirst%3DM.%26aulast%3DCiccocioppo%26aufirst%3DR.%26atitle%3DActivation%2520of%2520brain%2520NOP%2520receptors%2520attenuates%2520acute%2520and%2520protracted%2520alcohol%2520withdrawal%2520symptoms%2520in%2520the%2520rat%26jtitle%3DAlcohol.%253A%2520Clin.%2520Exp.%2520Res.%26date%3D2011%26volume%3D35%26spage%3D747%26epage%3D755%26doi%3D10.1111%2Fj.1530-0277.2010.01392.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Martin-Fardon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorrilla, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span> </span><span class="NLM_article-title">Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1314</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1016/j.brainres.2009.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.brainres.2009.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20026088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlelsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1314&publication_year=2010&pages=145-161&author=R.+Martin-Fardonauthor=E.+P.+Zorrillaauthor=R.+Ciccocioppoauthor=F.+Weiss&title=Role+of+innate+and+drug-induced+dysregulation+of+brain+stress+and+arousal+systems+in+addiction%3A+Focus+on+corticotropin-releasing+factor%2C+nociceptin%2Forphanin+FQ%2C+and+orexin%2Fhypocretin&doi=10.1016%2Fj.brainres.2009.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin</span></div><div class="casAuthors">Martin-Fardon, Remi; Zorrilla, Eric P.; Ciccocioppo, Roberto; Weiss, Friedbert</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1314</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-161</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Stress-like symptoms are an integral part of acute and protracted drug withdrawal, and several lines of evidence have shown that dysregulation of brain stress systems, including the extrahypothalamic corticotropin-releasing factor (CRF) system, following long-term drug use is of major importance in maintaining drug and alc. addiction.  Recently, two other neuropeptide systems have attracted interest, the nociceptin/orphanin FQ (N/OFQ) and orexin/hypocretin (Orx/Hcrt) systems.  N/OFQ participates in a wide range of physiol. responses, and the hypothalamic Orx/Hcrt system helps regulate several physiol. processes, including feeding, energy metab., and arousal.  Moreover, these two systems have been suggested to participate in psychiatric disorders, including anxiety and drug addiction.  Dysregulation of these systems by chronic drug exposure has been hypothesized to play a role in the maintenance of addiction and dependence.  Recent evidence demonstrated that interactions between CRF-N/OFQ and CRF-Orx/Hcrt systems may be functionally relevant for the control of stress-related addictive behavior.  The present review discusses recent findings that support the hypotheses of the participation and dysregulation of these systems in drug addiction and evaluates the current understanding of interactions among these stress-regulatory peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8stmOMuATrVg90H21EOLACvtfcHk0lgBMONLgZULJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlelsrc%253D&md5=de20d863e8252166cdca6230d6e28800</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DZorrilla%26aufirst%3DE.%2BP.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DF.%26atitle%3DRole%2520of%2520innate%2520and%2520drug-induced%2520dysregulation%2520of%2520brain%2520stress%2520and%2520arousal%2520systems%2520in%2520addiction%253A%2520Focus%2520on%2520corticotropin-releasing%2520factor%252C%2520nociceptin%252Forphanin%2520FQ%252C%2520and%2520orexin%252Fhypocretin%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1314%26spage%3D145%26epage%3D161%26doi%3D10.1016%2Fj.brainres.2009.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Rodi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cifani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, C.</span><span> </span><span class="NLM_article-title">Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1007/s00213-007-0985-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-007-0985-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=523-531&author=D.+Rodiauthor=S.+Zucchiniauthor=M.+Simonatoauthor=C.+Cifaniauthor=M.+Massiauthor=C.+Polidori&title=Functional+antagonism+between+nociceptin%2Forphanin+FQ+%28N%2FOFQ%29+and+corticotropin-releasing+factor+%28CRF%29+in+the+rat+brain%3A+evidence+for+involvement+of+the+bed+nucleus+of+the+stria+terminalis&doi=10.1007%2Fs00213-007-0985-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0985-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0985-7%26sid%3Dliteratum%253Aachs%26aulast%3DRodi%26aufirst%3DD.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DSimonato%26aufirst%3DM.%26aulast%3DCifani%26aufirst%3DC.%26aulast%3DMassi%26aufirst%3DM.%26aulast%3DPolidori%26aufirst%3DC.%26atitle%3DFunctional%2520antagonism%2520between%2520nociceptin%252Forphanin%2520FQ%2520%2528N%252FOFQ%2529%2520and%2520corticotropin-releasing%2520factor%2520%2528CRF%2529%2520in%2520the%2520rat%2520brain%253A%2520evidence%2520for%2520involvement%2520of%2520the%2520bed%2520nucleus%2520of%2520the%2520stria%2520terminalis%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D523%26epage%3D531%26doi%3D10.1007%2Fs00213-007-0985-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Khroyan, T. V.; Polgar, W.; Toll, L.; Jiang, F.; Zaveri, N. T.</span><span> </span><span class="NLM_article-title">AT-202, a nociceptin receptor agonist, blocks drug- and stress-induced reinstatement of extinguished cocaine conditioned place preference</span>. Society for Neuroscience Annual Meeting, San Diego, CA, 2013; <span class="NLM_publisher-name">Society for Neuroscience</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>No. 733.724.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Khroyan%2C+T.+V.%3B+Polgar%2C+W.%3B+Toll%2C+L.%3B+Jiang%2C+F.%3B+Zaveri%2C+N.+T.+AT-202%2C+a+nociceptin+receptor+agonist%2C+blocks+drug-+and+stress-induced+reinstatement+of+extinguished+cocaine+conditioned+place+preference.+Society+for+Neuroscience+Annual+Meeting%2C+San+Diego%2C+CA%2C+2013%3B+Society+for+Neuroscience%2C+2013%3B+No.+733.724."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26atitle%3DAT-202%252C%2520a%2520nociceptin%2520receptor%2520agonist%252C%2520blocks%2520drug-%2520and%2520stress-induced%2520reinstatement%2520of%2520extinguished%2520cocaine%2520conditioned%2520place%2520preference%26pub%3DSociety%2520for%2520Neuroscience%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Przydzial, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heisler, L. K.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ peptide receptor as a therapeutic target for obesity</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.2174/138955708784912139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2174%2F138955708784912139" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=796-811&author=M.+J.+Przydzialauthor=L.+K.+Heisler&title=Nociceptin%2Forphanin+FQ+peptide+receptor+as+a+therapeutic+target+for+obesity&doi=10.2174%2F138955708784912139"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.2174%2F138955708784912139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955708784912139%26sid%3Dliteratum%253Aachs%26aulast%3DPrzydzial%26aufirst%3DM.%2BJ.%26aulast%3DHeisler%26aufirst%3DL.%2BK.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520as%2520a%2520therapeutic%2520target%2520for%2520obesity%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D796%26epage%3D811%26doi%3D10.2174%2F138955708784912139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burmeister, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapusta, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span> </span><span class="NLM_article-title">UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2005.tb00264.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1527-3458.2005.tb00264.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=97-112&author=G.+Caloauthor=R.+Guerriniauthor=A.+Rizziauthor=S.+Salvadoriauthor=M.+Burmeisterauthor=D.+R.+Kapustaauthor=D.+G.+Lambertauthor=D.+Regoli&title=UFP-101%2C+a+peptide+antagonist+selective+for+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1111%2Fj.1527-3458.2005.tb00264.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2005.tb00264.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2005.tb00264.x%26sid%3Dliteratum%253Aachs%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBurmeister%26aufirst%3DM.%26aulast%3DKapusta%26aufirst%3DD.%2BR.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DUFP-101%252C%2520a%2520peptide%2520antagonist%2520selective%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D97%26epage%3D112%26doi%3D10.1111%2Fj.1527-3458.2005.tb00264.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5063</span><span class="refDoi"> DOI: 10.1021/jm990517p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990517p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5061-5063&author=H.+Kawamotoauthor=S.+Ozakiauthor=Y.+Itohauthor=M.+Miyajiauthor=S.+Araiauthor=H.+Nakashimaauthor=T.+Katoauthor=H.+Ohtaauthor=Y.+Iwasawa&title=Discovery+of+the+first+potent+and+selective+small+molecule+opioid+receptor-like+%28ORL1%29+antagonist%3A+1-%5B%283R%2C4R%29-1-cyclooctylmethyl-3-+hydroxymethyl-4-piperidyl%5D-3-ethyl-1%2C+3-dihydro-2H-benzimidazol-2-one+%28J-113397%29&doi=10.1021%2Fjm990517p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm990517p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990517p%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520and%2520selective%2520small%2520molecule%2520opioid%2520receptor-like%2520%2528ORL1%2529%2520antagonist%253A%25201-%255B%25283R%252C4R%2529-1-cyclooctylmethyl-3-%2520hydroxymethyl-4-piperidyl%255D-3-ethyl-1%252C%25203-dihydro-2H-benzimidazol-2-one%2520%2528J-113397%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5061%26epage%3D5063%26doi%3D10.1021%2Fjm990517p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span> </span><span class="NLM_article-title">In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/S0014-2999(00)00520-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2800%2900520-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10940356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2000&pages=45-53&author=S.+Ozakiauthor=H.+Kawamotoauthor=Y.+Itohauthor=M.+Miyajiauthor=T.+Azumaauthor=D.+Ichikawaauthor=H.+Nambuauthor=T.+Iguchiauthor=Y.+Iwasawaauthor=H.+Ohta&title=In+vitro+and+in+vivo+pharmacological+characterization+of+J-113397%2C+a+potent+and+selective+non-peptidyl+ORL1+receptor+antagonist&doi=10.1016%2FS0014-2999%2800%2900520-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist</span></div><div class="casAuthors">Ozaki, S.; Kawamoto, H.; Itoh, Y.; Miyaji, M.; Azuma, T.; Ichikawa, D.; Nambu, H.; Iguchi, T.; Iwasawa, Y.; Ohta, H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) was found to be the first potent nonpeptidyl ORL1 receptor antagonist (Ki: cloned human ORL1=1.8 nM) with high selectivity over other opioid receptors (Ki: 1000 nM for human μ-opioid receptor, °10,000 nM for human δ-opioid receptor, and 640 nM for human κ-opioid receptor).  In vitro, J-113397 inhibited nociceptin/orphanin FQ-stimulated [35S]guanosine 5'-O-(γ-thio)triphosphate (GTPγS) binding to Chinese Hamster Ovary (CHO) cells expressing ORL1 (CHO-ORL1) with an IC50 value of 5.3 nM but had no effect on [35S]GTPγS binding by itself.  Schild plot anal. of the [35S]GTPγS binding assay and cAMP assay using CHO-ORL1 indicated competitive antagonism of J-113397 on the ORL1 receptor.  In CHO cells expressing μ-, δ- or κ-opioid receptors, J-113397 had no effects on [35S]GTPγS binding up to a concn. of 100 nM, indicating selective antagonism of the compd. on the ORL1 receptor.  In vivo, J-113397, when administered s.c., dose-dependently inhibited hyperalgesia elicited by intracerebroventricular (i.c.v.) administration of nociceptin/orphanin FQ in a tail-flick test with mice.  An in vitro binding study using mouse brains indicated that J-113397 possesses high affinity for the mouse ORL1 receptor (Ki: 1.1 nM) as well as the human receptor.  In summary, J-113397 is the first potent, selective ORL1 receptor antagonist that may be useful in elucidating the physiol. roles of nociceptin/orphanin FQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbOSgVDC0RqLVg90H21EOLACvtfcHk0ljBNSsqTJNTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCgtbc%253D&md5=5c6bc44e82e4164b11dbf1c11bd7710f</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900520-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900520-3%26sid%3Dliteratum%253Aachs%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DM.%26aulast%3DAzuma%26aufirst%3DT.%26aulast%3DIchikawa%26aufirst%3DD.%26aulast%3DNambu%26aufirst%3DH.%26aulast%3DIguchi%26aufirst%3DT.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DH.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%2520of%2520J-113397%252C%2520a%2520potent%2520and%2520selective%2520non-peptidyl%2520ORL1%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D402%26spage%3D45%26epage%3D53%26doi%3D10.1016%2FS0014-2999%2800%2900520-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Zaratin, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbacchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheideler, M. A.</span><span> </span><span class="NLM_article-title">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1124/jpet.103.055848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.103.055848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=14593080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=454-461&author=P.+F.+Zaratinauthor=G.+Petroneauthor=M.+Sbacchiauthor=M.+Garnierauthor=C.+Fossatiauthor=P.+Petrilloauthor=S.+Ronzoniauthor=G.+A.+Giardinaauthor=M.+A.+Scheideler&title=Modification+of+nociception+and+morphine+tolerance+by+the+selective+opiate+receptor-like+orphan+receptor+antagonist+%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol+%28SB-612111%29&doi=10.1124%2Fjpet.103.055848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)</span></div><div class="casAuthors">Zaratin, Paola F.; Petrone, Giuseppe; Sbacchi, Massimo; Garnier, Martine; Fossati, Claudia; Petrillo, Paola; Ronzoni, Silvio; Giardina, Giuseppe A. M.; Scheideler, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-461</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SB-612111 is a novel human opiate receptor-like orphan receptor (ORL-1) antagonist that has high affinity for the clonal human ORL-1 receptor (hORL-1 Ki = 0.33 nM), selectivity vs. μ- (174-fold), δ- (6391-fold), and κ (486-fold)-opioid receptors and is able to inhibit nociceptin signaling via hORL-1 in a whole cell gene reporter assay.  SB-612111 has no measurable antinociceptive effects in vivo in the mouse hot-plate test after i.v. administration but is able to antagonize the antimorphine action of nociceptin [ED50 = 0.69 mg/kg, 95% confidence limit (CL) = 0.34-1.21].  SB-62111 administration can also reverse tolerance to morphine in this model, established via repeated morphine administration.  In addn., i.v. SB-612111 can antagonize nociceptin-induced thermal hyperalgesia in a dose-dependent manner (ED50 = 0.62 mg/kg i.v., 95% CL = 0.22-1.89) and is effective per se at reversing thermal hyperalgesia in the rat carrageenan inflammatory pain model.  These data show that an ORL-1 receptor antagonist may be a useful adjunct to chronic pain therapy with opioids and can be used to treat conditions in which thermal hyperalgesia is a significant component of the pain response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZbUKJ64ZkmbVg90H21EOLACvtfcHk0ljBNSsqTJNTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D&md5=c56ae72c9113af5aeb7168b9a1646b7b</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.055848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.055848%26sid%3Dliteratum%253Aachs%26aulast%3DZaratin%26aufirst%3DP.%2BF.%26aulast%3DPetrone%26aufirst%3DG.%26aulast%3DSbacchi%26aufirst%3DM.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DFossati%26aufirst%3DC.%26aulast%3DPetrillo%26aufirst%3DP.%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%26aulast%3DScheideler%26aufirst%3DM.%2BA.%26atitle%3DModification%2520of%2520nociception%2520and%2520morphine%2520tolerance%2520by%2520the%2520selective%2520opiate%2520receptor-like%2520orphan%2520receptor%2520antagonist%2520%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%2520%2528SB-612111%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D454%26epage%3D461%26doi%3D10.1124%2Fjpet.103.055848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Spagnolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrà, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calò, G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ Receptor antagonist SB-612111 [(–)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1124/jpet.106.116764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.106.116764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17329552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=961-967&author=B.+Spagnoloauthor=G.+Carr%C3%A0author=M.+Fantinauthor=C.+Fischettiauthor=C.+Hebbesauthor=J.+McDonaldauthor=T.+A.+Barnesauthor=A.+Rizziauthor=C.+Trapellaauthor=G.+Fantonauthor=M.+Morariauthor=D.+G.+Lambertauthor=D.+Regoliauthor=G.+Cal%C3%B2&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+Receptor+antagonist+SB-612111+%5B%28%E2%80%93%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol%5D%3A+In+vitro+studies&doi=10.1124%2Fjpet.106.116764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies</span></div><div class="casAuthors">Spagnolo, Barbara; Carra, Giacomo; Fantin, Martina; Fischetti, Carmela; Hebbes, Chris; McDonald, John; Barnes, Timothy A.; Rizzi, Anna; Trapella, Claudio; Fanton, Giulia; Morari, Michele; Lambert, Dave G.; Regoli, Domenico; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The compd. SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol] was recently identified as a selective antagonist for the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  In the present study, the in vitro pharmacol. profile of SB-612111 at human recombinant NOP receptors expressed in Chinese hamster ovary (CHO) cells [receptor binding, guanosine 5'-O-(3-[35S]thio)triphosphate (GTPγ[35S]) binding, and cAMP level expts.] as well as at native NOP receptors expressed in peripheral (mouse and rat vas deferens, guinea pig ileum) and central (mouse cerebral cortex synaptosomes releasing [3H]5-HT) prepns. was evaluated and compared with that of the std. nonpeptide antagonist (±)J-113397 [(±)-trans-1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one].  SB-612111 produced a concn.-dependent displacement of [3H]N/OFQ binding to CHOhNOP cell membranes, showing higher affinity and NOP selectivity over classical opioid receptors than (±)J-113397.  SB-612111 and (±)J-113397 competitively antagonized the effects of N/OFQ on GTPγ[35S] binding in CHOhNOP cell membranes (pKB, 9.70 and 8.71, resp.) and on cAMP accumulation in CHOhNOP cells (pKB, 8.63 and 7.95, resp.), being per se inactive.  In isolated peripheral tissues of mice, rats, and guinea pigs and in mouse cerebral cortex synaptosomes preloaded with [3H]5-HT, SB-612111 competitively antagonized the inhibitory effects of N/OFQ, with pA2 values in the range of 8.20 to 8.50.  In parallel expts., (±)J-113397 was found to be 2- to 9-fold less potent than SB-612111.  In the elec. stimulated tissues, 1 μM SB-612111 did not modify the effects of classical opioid receptor agonists.  In conclusion, the results of the present study demonstrated that SB-612111 is among the most potent and NOP-selective nonpeptide antagonists identified to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozelFgTfoi5rVg90H21EOLACvtfcHk0ljBNSsqTJNTQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D&md5=49c903afa586c64284535b50692bb877</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116764%26sid%3Dliteratum%253Aachs%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DFantin%26aufirst%3DM.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DHebbes%26aufirst%3DC.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DBarnes%26aufirst%3DT.%2BA.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DFanton%26aufirst%3DG.%26aulast%3DMorari%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520Receptor%2520antagonist%2520SB-612111%2520%255B%2528%25E2%2580%2593%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%255D%253A%2520In%2520vitro%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D961%26epage%3D967%26doi%3D10.1124%2Fjpet.106.116764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spagnolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrah ydro-5H-benzocyclohepten-5-ol]: in vivo studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1124/jpet.106.116780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.106.116780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17329551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=968-974&author=A.+Rizziauthor=E.+C.+Gavioliauthor=G.+Marzolaauthor=B.+Spagnoloauthor=S.+Zucchiniauthor=R.+Ciccocioppoauthor=C.+Trapellaauthor=D.+Regoliauthor=G.+Calo&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+receptor+antagonist+SB-612111+%5B%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrah+ydro-5H-benzocyclohepten-5-ol%5D%3A+in+vivo+studies&doi=10.1124%2Fjpet.106.116780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies</span></div><div class="casAuthors">Rizzi, Anna; Gavioli, Elaine C.; Marzola, Giuliano; Spagnolo, Barbara; Zucchini, Silvia; Ciccocioppo, Roberto; Trapella, Claudio; Regoli, Domenico; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">968-974</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The excellent pharmacol. profile displayed by the selective nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol] in vitro prompted us to investigate the actions of this compd. in vivo.  In the mouse tail withdrawal assay, SB-612111 given i.p. up to 3 mg/kg did not modify per se tail withdrawal latencies but was able to prevent the pronociceptive and the antinociceptive action of 1 nmol of N/OFQ given i.c.v. and i.t., resp.  In food intake studies performed in sated mice, SB-612111 (1 mg/kg i.p.) had no effect on food consumption but fully prevented the orexigenic effect of 1 nmol of N/OFQ i.c.v.  In 17-h food-deprived mice, the opioid receptor antagonist naltrexone (1 mg/kg s.c.), but not SB-612111 (1 and 10 mg/kg i.p.), produced a statistically significant redn. of food intake.  In the mouse forced swimming and tail suspension tests, SB-612111 (1-10 mg/kg) reduced immobility time.  The antidepressant-like effect elicited by SB-612111 in the forced swimming test was reversed by the i.c.v. injection of 1 nmol of N/OFQ and no longer evident in mice knockout for the NOP receptor gene.  In conclusion, the present findings demonstrate that SB-612111 behaves in vivo as a potent and selective NOP antagonist and suggest that the N-OFQ-NOP receptor endogenous system plays an important role in regulating mood-related behaviors.  The use of SB-612111 in future pathophysiol. studies will certainly contribute to define the therapeutic potential of selective NOP receptor antagonists in different disease areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8kC-dXIn8n7Vg90H21EOLACvtfcHk0lg2yQlX1YPb9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsr0%253D&md5=8a60d569531dc17d0168f30578945d8f</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116780%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520SB-612111%2520%255B%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrah%2520ydro-5H-benzocyclohepten-5-ol%255D%253A%2520in%2520vivo%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D968%26epage%3D974%26doi%3D10.1124%2Fjpet.106.116780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lima, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1990</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.2003.02603.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1046%2Fj.1460-9568.2003.02603.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12752799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD3s3mvVKnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=1987-1990&author=E.+C.+Gavioliauthor=G.+Marzolaauthor=R.+Guerriniauthor=R.+Bertorelliauthor=S.+Zucchiniauthor=T.+C.+De+Limaauthor=G.+A.+Raeauthor=S.+Salvadoriauthor=D.+Regoliauthor=G.+Calo&title=Blockade+of+nociceptin%2Forphanin+FQ-NOP+receptor+signalling+produces+antidepressant-like+effects%3A+pharmacological+and+genetic+evidences+from+the+mouse+forced+swimming+test&doi=10.1046%2Fj.1460-9568.2003.02603.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test</span></div><div class="casAuthors">Gavioli E C; Marzola G; Guerrini R; Bertorelli R; Zucchini S; De Lima T C M; Rae G A; Salvadori S; Regoli D; Calo G</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1987-90</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ), the endogenous ligand of the NOP receptor, regulates several central functions such as pain transmission, learning and memory, fear and anxiety and feeding and locomotor activity.  It has been recently reported that NOP receptor antagonists induce antidepressant-like effects in the mouse forced swimming test (FST), i.e. reduce immobility time.  This assay was used in the present study for further investigating the involvement of the NOP receptor in depression states.  In male Swiss mice, intracerebroventricular injection (i.c.v) of the novel NOP receptor antagonist, UFP-101 (1-10 nmol) dose-dependently reduced the immobility time (control 192 +/- 14 s, UFP-101 91 +/- 15 s).  The effect of 3 or 10 nmol UFP-101 was fully or partially reversed, respectively, by the coadministration of 1 nmol N/OFQ, which was inactive per se.  NOP receptor knockout mice showed a reduced immobility time compared with their wild-type littermates (wild-type 215 +/- 10 s, knockout 143 +/- 12 s).  Moreover, i.c.v. injected UFP-101 (10 nmol) significantly reduced immobility time in wild-type mice but not in NOP receptor knockout animals.  In conclusion, these results, obtained using a combined pharmacological and genetic approach, indicate that blockade of the N/OFQ-NOP receptor signalling in the brain produces antidepressant-like effects in the mouse FST.  These findings support the NOP receptor as a candidate target for the development of innovative antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcToguwyRgrVcczK395ZObgVfW6udTcc2ebonwgBOFfkbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3mvVKnsA%253D%253D&md5=4870bca0e7d871f06bbd29c4becd114f</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2003.02603.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2003.02603.x%26sid%3Dliteratum%253Aachs%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DDe%2BLima%26aufirst%3DT.%2BC.%26aulast%3DRae%26aufirst%3DG.%2BA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DBlockade%2520of%2520nociceptin%252Forphanin%2520FQ-NOP%2520receptor%2520signalling%2520produces%2520antidepressant-like%2520effects%253A%2520pharmacological%2520and%2520genetic%2520evidences%2520from%2520the%2520mouse%2520forced%2520swimming%2520test%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2003%26volume%3D17%26spage%3D1987%26epage%3D1990%26doi%3D10.1046%2Fj.1460-9568.2003.02603.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1007/s00210-006-0035-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00210-006-0035-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16491387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2006&pages=319-330&author=E.+C.+Gavioliauthor=G.+Calo&title=Antidepressant-+and+anxiolytic-like+effects+of+nociceptin%2Forphanin+FQ+receptor+ligands&doi=10.1007%2Fs00210-006-0035-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands</span></div><div class="casAuthors">Gavioli, Elaine C.; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review with refs.  Many studies point toward the nociceptin/orphanin FQ (N/OFQ) and the N/OFQ peptide receptor (NOP) as targets for the development of innovative drugs for treating affective disorders.  It has been reported that the activation of NOP receptors produces anxiolytic-like effects in rodents in a large series of behavioral assays, i.e., elevated plus maze, light-dark aversion, operant conflict, fear-potentiated startle, pup ultrasonic vocalizations, and hole board tests.  In contrast, the blockade of N/OFQ signaling obtained with NOP-selective antagonists promotes antidepressant-like effects in the forced swimming and tail suspension tests.  In these assays, N/OFQ is inactive per se, but reverses the antidepressant-like effects of NOP antagonists.  NOP receptor knockout mice show an antidepressant-like phenotype, and NOP antagonists are inactive in these animals.  Thus, the activation of the NOP receptor seems to evoke anxiolytic-like effects while its blockade antidepressant-like effects.  This appears to be a rather unique behavioral profile since the activation or the blockade of a given neuropeptide receptor produces, in most of the cases, both antidepressant- and anxiolytic-like effects.  This particular behavioral profile, the possible mechanisms of action, and the therapeutic potential of NOP receptor ligands for the treatment of depression and anxiety disorders are discussed in this review article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre33WhTL5HRLVg90H21EOLACvtfcHk0lg2yQlX1YPb9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslOkurc%253D&md5=22c592813d6edd1ed75e0eed734aab12</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1007%2Fs00210-006-0035-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-006-0035-8%26sid%3Dliteratum%253Aachs%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DAntidepressant-%2520and%2520anxiolytic-like%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2006%26volume%3D372%26spage%3D319%26epage%3D330%26doi%3D10.1007%2Fs00210-006-0035-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Redrobe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirion, R.</span><span> </span><span class="NLM_article-title">Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1007/s00210-001-0511-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00210-001-0511-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11819035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2002&pages=164-167&author=J.+Redrobeauthor=G.+Caloauthor=D.+Regoliauthor=R.+Quirion&title=Nociceptin+receptor+antagonists+display+antidepressant-like+properties+in+the+mouse+forced+swimming+test&doi=10.1007%2Fs00210-001-0511-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test</span></div><div class="casAuthors">Redrobe, John P.; Calo, Girolamo; Regoli, Domenico; Quirion, Remi</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-167</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The present study investigated the effects of nociceptin, the peptide nociceptin receptor antagonist, [Nphe1]-nociceptin (1-13)-NH2, and the non-peptide antagonist, J-113397, in the mouse forced swimming test, an animal model used for the screening of potential antidepressant drugs.  Addnl. studies were performed with naloxone to exclude effects on traditional opioid receptors.  Intracerebroventricular (ICV) administration of nociceptin (0.01-1 nmole) was devoid of any activity in the mouse forced swimming test, as was i.p. administration of naloxone (1-10 mg/kg).  ICV treatment with [Nphe1]-nociceptin (1-13)-NH2 (25 nmole and 50 nmole) induced significant antidepressant-like activity (P<0.01), as did administration of J-113397 (20 mg/kg, i.p; P<0.05).  Open field anal. revealed that acute treatment with these mols. did not induce significant changes in locomotor activity at the doses tested.  These results suggest that nociceptin, and its receptor, may play a role in depressive disorders and that the nociceptin system could represent a novel target for the development of new antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaZDJ1e6MlPLVg90H21EOLACvtfcHk0lhu0D_DaNlxLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cqtg%253D%253D&md5=a184571c1dfa13124ca5e2a90d2e07fe</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs00210-001-0511-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-001-0511-0%26sid%3Dliteratum%253Aachs%26aulast%3DRedrobe%26aufirst%3DJ.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DQuirion%26aufirst%3DR.%26atitle%3DNociceptin%2520receptor%2520antagonists%2520display%2520antidepressant-like%2520properties%2520in%2520the%2520mouse%2520forced%2520swimming%2520test%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2002%26volume%3D365%26spage%3D164%26epage%3D167%26doi%3D10.1007%2Fs00210-001-0511-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Vitale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggieri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filaferro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigeri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tascedda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cifani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1007/s00213-009-1646-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-009-1646-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19711054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD1MjisVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=173-189&author=G.+Vitaleauthor=V.+Ruggieriauthor=M.+Filaferroauthor=C.+Frigeriauthor=S.+Alboniauthor=F.+Tasceddaauthor=N.+Brunelloauthor=R.+Guerriniauthor=C.+Cifaniauthor=M.+Massi&title=Chronic+treatment+with+the+selective+NOP+receptor+antagonist+%5BNphe+1%2C+Arg+14%2C+Lys+15%5DN%2FOFQ-NH+2+%28UFP-101%29+reverses+the+behavioural+and+biochemical+effects+of+unpredictable+chronic+mild+stress+in+rats&doi=10.1007%2Fs00213-009-1646-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats</span></div><div class="casAuthors">Vitale Giovanni; Ruggieri Valentina; Filaferro Monica; Frigeri Claudio; Alboni Silvia; Tascedda Fabio; Brunello Nicoletta; Guerrini Remo; Cifani Carlo; Massi Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The present study was designed to assess the antidepressant effects of UFP-101, a selective nociceptin/orphanin FQ peptide (NOP) receptor antagonist, in a validated animal model of depression: the chronic mild stress (CMS).  MATERIALS AND METHODS AND RESULTS:  UFP-101 (5, 10 and 20 nmol/rat; i.c.v., once a day for 21 days) dose- and time-dependently reinstated sucrose consumption in stressed animals without affecting the same parameter in non-stressed ones.  In the forced swimming test, UFP-101 reduced immobility of stressed rats from day 8 of treatment.  After a 3-week treatment, rats were killed for biochemical evaluations.  UFP-101 abolished increase in serum corticosterone induced by CMS and reverted changes in central 5-HT/5-HIAA ratio.  The behavioural and biochemical effects of UFP-101 mimicked those of imipramine, the reference antidepressant drug, administered at the dose of 15 mg/kg (i.p.).  Co-administration of nociceptin/orphanin FQ (5 nmol/rat, from day 12 to 21) prevented the effects of UFP-101.  Brain-derived neurotrophic factor mRNA and protein in hippocampus were not reduced by CMS nor did UFP-101 modify these parameters.  DISCUSSION AND CONCLUSION:  This study demonstrated that chronic treatment with UFP-101 produces antidepressant-like effects in rats subjected to CMS supporting the proposal that NOP receptors represent a candidate target for the development of innovative antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzV7J6V2CUwe98rul4nhSdfW6udTcc2eaDAanDEId_Prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjisVGmug%253D%253D&md5=5831db52990da8f9a637fc3b28b34882</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1646-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1646-9%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DG.%26aulast%3DRuggieri%26aufirst%3DV.%26aulast%3DFilaferro%26aufirst%3DM.%26aulast%3DFrigeri%26aufirst%3DC.%26aulast%3DAlboni%26aufirst%3DS.%26aulast%3DTascedda%26aufirst%3DF.%26aulast%3DBrunello%26aufirst%3DN.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCifani%26aufirst%3DC.%26aulast%3DMassi%26aufirst%3DM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520selective%2520NOP%2520receptor%2520antagonist%2520%255BNphe%25201%252C%2520Arg%252014%252C%2520Lys%252015%255DN%252FOFQ-NH%25202%2520%2528UFP-101%2529%2520reverses%2520the%2520behavioural%2520and%2520biochemical%2520effects%2520of%2520unpredictable%2520chronic%2520mild%2520stress%2520in%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2009%26volume%3D207%26spage%3D173%26epage%3D189%26doi%3D10.1007%2Fs00213-009-1646-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Bigoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Risi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashiba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span> </span><span class="NLM_article-title">In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span><span class="refDoi"> DOI: 10.1007/s002100000220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs002100000220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10832612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFGjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2000&pages=565-568&author=R.+Bigoniauthor=G.+Caloauthor=A.+Rizziauthor=R.+Guerriniauthor=C.+De+Risiauthor=Y.+Hashimotoauthor=E.+Hashibaauthor=D.+G.+Lambertauthor=D.+Regoli&title=In+vitro+characterization+of+J-113397%2C+a+non-peptide+nociceptin%2Forphanin+FQ+receptor+antagonist&doi=10.1007%2Fs002100000220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist</span></div><div class="casAuthors">Bigoni, R.; Calo, G.; Rizzi, A.; Guerrini, R.; De Risi, C.; Hashimoto, Y.; Hashiba, E.; Lambert, D. G.; Regoli, D.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-568</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The lack of availability of a selective, highly potent, competitive antagonist for the nociceptin receptor (OP4) devoid of residual agonistic activity has hampered studies in this area.  The authors report here the in vitro pharmacol. properties of the novel non-peptide OP4 antagonist, J-113397, which was recently discovered by Banyu Pharmaceutical investigators.  The compd. was synthesized as a racemic mixt. in the authors labs.  J-113397 was shown to antagonize (pA2 7.52) the nociceptin-induced inhibition of cAMP formation in cells expressing the recombinant human OP4 receptor (CHOhOP4) and to displace [125I]Tyr14nociceptin from CHOhOP4 membranes with a pKi of 8.56.  It also competitively antagonized the contractile actions of nociceptin in the mouse colon (pA2 8.07) and the inhibitory effect of nociceptin in elec. stimulated prepns. such as the mouse vas deferens (pA2 7.85), the guinea pig ileum (7.75), and the rat vas deferens (7.77).  At high concns. (10 mM), the compd. was devoid of agonist activity in the mouse vas deferens and CHOhOP4, while it contracted the mouse colon and increased the twitch response of the rat vas deferens, and produced a naloxone-sensitive inhibition of the elec. evoked twitches in the guinea pig ileum.  PA2 values for the new antagonist against deltorphin I in the mouse vas deferens (OP1 receptors), or against dermorphin in the guinea pig ileum (OP3 receptors), etorphine in the rat vas deferens (OP receptors), U69593 in the rabbit vas deferens (OP2 receptors) and endomorphin 1 in the mouse colon (OP3 receptors) were lower than 6.  Taken together, these data indicate that J-113397 is a high-affinity, selective and competitive antagonist of the OP4 receptor; this novel pharmacol. tool will be of great value in studies directed at evaluating the physiol. roles of the nociceptin/OP4 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbXASA1Y0rlbVg90H21EOLACvtfcHk0lhu0D_DaNlxLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFGjurc%253D&md5=a88542f84bb42988f9f31b9aa2ea5875</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs002100000220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000220%26sid%3Dliteratum%253Aachs%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DDe%2BRisi%26aufirst%3DC.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520J-113397%252C%2520a%2520non-peptide%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D361%26spage%3D565%26epage%3D568%26doi%3D10.1007%2Fs002100000220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Koizumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midorikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, N. P.</span><span> </span><span class="NLM_article-title">The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0705906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15289286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVenurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=53-62&author=M.+Koizumiauthor=K.+Sakooriauthor=N.+Midorikawaauthor=N.+P.+Murphy&title=The+NOP+%28ORL1%29+receptor+antagonist+Compound+B+stimulates+mesolimbic+dopamine+release+and+is+rewarding+in+mice+by+a+non-NOP-receptor-mediated+mechanism&doi=10.1038%2Fsj.bjp.0705906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism</span></div><div class="casAuthors">Koizumi, Miwako; Sakoori, Kazuto; Midorikawa, Naoko; Murphy, Niall P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Compd. B (1-[(3R, 4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one, CompB) is a nociceptin/orphanin FQ (N/OFQ) antagonist showing high selectivity for the NOP (ORL1) receptor over classical opioid receptors.  We studied the effect of s.c. CompB administration on the release of mesolimbic dopamine (DA) and the expression of hedonia in mice.  2 CompB (0.3-30 mg kg-1) dose dependently stimulated mesolimbic DA release as measured by in vivo freely moving microdialysis, without any change in locomotor activity.  However, intracerebroventricular administered N/OFQ (endogenous agonist of the NOP receptor, 6 nmol) did not influence CompB- (10 mg kg-1) induced DA release, despite clearly suppressing release when administered alone.  3 Studies using NOP receptor knockout mice and no-net-flux microdialysis revealed mildly, but not statistically significantly higher endogenous DA levels in mice lacking the NOP receptor compared to wild-type mice.  Administration of CompB (10 mg kg-1) induced identical increases in mesolimbic DA release in wild-type and NOP receptor knockout mice.  4 CompB was rewarding in approx. the same dose range in which CompB induced major increases in mesolimbic DA release when assayed using a conditioned place preference paradigm.  The rewarding effect of CompB (30 mg kg-1) was maintained in NOP receptor knockout mice.  5 These results show that CompB stimulates mesolimbic DA release and is rewarding by an action independent of the NOP receptor, the precise site of which is unclear.  Consequently, caution should be exercised when interpreting the results of studies using this drug, particularly when administered by a peripheral route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkJ-Aw4Re64LVg90H21EOLACvtfcHk0lg5aoWMr3h_sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVenurk%253D&md5=b4a0a886721035d0589671e879740abc</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705906%26sid%3Dliteratum%253Aachs%26aulast%3DKoizumi%26aufirst%3DM.%26aulast%3DSakoori%26aufirst%3DK.%26aulast%3DMidorikawa%26aufirst%3DN.%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26atitle%3DThe%2520NOP%2520%2528ORL1%2529%2520receptor%2520antagonist%2520Compound%2520B%2520stimulates%2520mesolimbic%2520dopamine%2520release%2520and%2520is%2520rewarding%2520in%2520mice%2520by%2520a%2520non-NOP-receptor-mediated%2520mechanism%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D53%26epage%3D62%26doi%3D10.1038%2Fsj.bjp.0705906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Benedetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romualdi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candeletti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9591</span><span class="NLM_x">–</span> <span class="NLM_lpage">9601</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2546-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1523%2FJNEUROSCI.2546-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16237164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=9591-9601&author=M.+Martiauthor=F.+Melaauthor=M.+Fantinauthor=S.+Zucchiniauthor=J.+M.+Brownauthor=J.+Wittaauthor=M.+Di+Benedettoauthor=B.+Buzasauthor=R.+K.+Reinscheidauthor=S.+Salvadoriauthor=R.+Guerriniauthor=P.+Romualdiauthor=S.+Candelettiauthor=M.+Simonatoauthor=B.+M.+Coxauthor=M.+Morari&title=Blockade+of+nociceptin%2Forphanin+FQ+transmission+attenuates+symptoms+and+neurodegeneration+associated+with+Parkinson%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.2546-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease</span></div><div class="casAuthors">Marti, Matteo; Mela, Flora; Fantin, Martina; Zucchini, Silvia; Brown, Jeffrey M.; Witta, Jassir; Di Benedetto, Manuela; Buzas, Beata; Reinscheid, Rainer K.; Salvadori, Severo; Guerrini, Remo; Romualdi, Patrizia; Candeletti, Sanzio; Simonato, Michele; Cox, Brian M.; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">9591-9601</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The opioid-like neuropeptide nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) are expressed in the substantia nigra (SN), a brain area contg. dopamine neurons that degenerate in Parkinson's disease.  Endogenous N/OFQ facilitates nigral glutamate release and inhibits nigrostriatal dopamine transmission and motor behavior.  Here, we present evidence suggesting that endogenous N/OFQ may contribute to Parkinson's disease.  Pharmacol. blockade of the SN N/OFQ-NOP receptor system attenuated parkinsonian-like akinesia/hypokinesia in 6-hydroxydopamine hemi-lesioned or haloperidol-treated rats, whereas deletion of the NOP receptor gene conferred mice partial protection from haloperidol-induced motor depression.  The antiparkinsonian action of NOP receptor antagonists was assocd. with redn. of glutamate release in the SN.  In 6-hydroxydopamine hemilesioned rats, enhancement of N/OFQ expression and release was detected in the lesioned compared with the unlesioned SN, indicating that parkinsonism may be assocd. with over-activation of the N/OFQ-NOP receptor system in the SN.  Finally, deletion of the N/OFQ gene conferred mice partial protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced loss of SN dopamine neurons.  Based on these data, we propose that NOP receptor antagonists may represent a novel approach for combined (symptomatic and neuroprotective) therapy of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcXWmE9x6-rrVg90H21EOLACvtfcHk0lg5aoWMr3h_sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrjF&md5=893032d6983e5bc603cf446dd290b6b9</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2546-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2546-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMela%26aufirst%3DF.%26aulast%3DFantin%26aufirst%3DM.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DWitta%26aufirst%3DJ.%26aulast%3DDi%2BBenedetto%26aufirst%3DM.%26aulast%3DBuzas%26aufirst%3DB.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRomualdi%26aufirst%3DP.%26aulast%3DCandeletti%26aufirst%3DS.%26aulast%3DSimonato%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DB.%2BM.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DBlockade%2520of%2520nociceptin%252Forphanin%2520FQ%2520transmission%2520attenuates%2520symptoms%2520and%2520neurodegeneration%2520associated%2520with%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D9591%26epage%3D9601%26doi%3D10.1523%2FJNEUROSCI.2546-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronesi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercuri, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">6659</span><span class="NLM_x">–</span> <span class="NLM_lpage">6666</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0987-04.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1523%2FJNEUROSCI.0987-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15282268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=6659-6666&author=M.+Martiauthor=F.+Melaauthor=C.+Veronesiauthor=R.+Guerriniauthor=S.+Salvadoriauthor=M.+Federiciauthor=N.+B.+Mercuriauthor=A.+Rizziauthor=G.+Franchiauthor=L.+Beaniauthor=C.+Bianchiauthor=M.+Morari&title=Blockade+of+nociceptin%2Forphanin+FQ+receptor+signaling+in+rat+substantia+nigra+pars+reticulata+stimulates+nigrostriatal+dopaminergic+transmission+and+motor+behavior&doi=10.1523%2FJNEUROSCI.0987-04.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior</span></div><div class="casAuthors">Marti, Matteo; Mela, Flora; Veronesi, Carlo; Guerrini, Remo; Salvadori, Severo; Federici, Mauro; Mercuri, Nicola B.; Rizzi, Anna; Franchi, Gianfranco; Beani, Lorenzo; Bianchi, Clementina; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">6659-6666</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A multidisciplinary approach was followed to investigate whether the opioid-like peptide nociceptin/orphanin FQ (N/OFQ) regulates the nigrostriatal dopaminergic pathway and motor behavior.  Nigrostriatal dopaminergic cells, which express N/OFQ peptide (NOP) receptors, are located in the substantia nigra pars compacta and extend their dendrites in the substantia nigra pars reticulata, thereby modulating the basal ganglia output neurons.  In vitro electrophysiol. recordings demonstrated that N/OFQ hyperpolarized the dopaminergic cells of the substantia nigra pars compacta and inhibited their firing activity.  In vivo dual-probe microdialysis showed that N/OFQ perfused in the substantia nigra pars reticulata reduced dopamine release in the ipsilateral striatum, whereas UFP-101 ([Nphe1,Arg14,Lys15]N/OFQ(1-13)-NH2) (a selective NOP receptor peptide antagonist) stimulated it.  N/OFQ microinjected in the substantia nigra pars reticulata impaired rat performance on a rotarod app., whereas UFP-101 enhanced it.  Electromyog. revealed that N/OFQ and UFP-101 oppositely affected muscle tone, inducing relaxation and contraction of triceps, resp.  The selective NOP receptor nonpeptide antagonist J-113397 (1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H benzimidazol-2-one), either injected intranigrally or given systemically, also elevated striatal dopamine release and facilitated motor activity, confirming that these effects were caused by blockade of endogenous N/OFQ signaling.  The inhibitory role played by endogenous N/OFQ on motor activity was addnl. strengthened by the finding that mice lacking the NOP receptor gene outperformed wild-type mice on the rotarod.  The authors conclude that NOP receptors in the substantia nigra pars reticulata, activated by endogenous N/OFQ, drive a physiol. inhibitory control on motor behavior, possibly via modulation of the nigrostriatal dopaminergic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKEHVGKjAkn7Vg90H21EOLACvtfcHk0lg5aoWMr3h_sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCksLo%253D&md5=84f7e383d4b524170a75b3d581848903</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0987-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0987-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMela%26aufirst%3DF.%26aulast%3DVeronesi%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DMercuri%26aufirst%3DN.%2BB.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DFranchi%26aufirst%3DG.%26aulast%3DBeani%26aufirst%3DL.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DBlockade%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520signaling%2520in%2520rat%2520substantia%2520nigra%2520pars%2520reticulata%2520stimulates%2520nigrostriatal%2520dopaminergic%2520transmission%2520and%2520motor%2520behavior%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D6659%26epage%3D6666%26doi%3D10.1523%2FJNEUROSCI.0987-04.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Volta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-y l]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4)</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1194</span><span class="NLM_x">–</span> <span class="NLM_lpage">1204</span><span class="refDoi"> DOI: 10.1016/j.peptides.2010.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.peptides.2010.03.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1194-1204&author=M.+Voltaauthor=M.+Martiauthor=J.+McDonaldauthor=S.+Molinariauthor=V.+Camardaauthor=M.+Pelaauthor=C.+Trapellaauthor=M.+Morari&title=Pharmacological+profile+and+antiparkinsonian+properties+of+the+novel+nociceptin%2Forphanin+FQ+receptor+antagonist+1-%5B1-cyclooctylmethyl-5-%281-hydroxy-1-methyl-ethyl%29-1%2C2%2C3%2C6-tetrahydro-pyridin-4-y+l%5D-3-ethyl-1%2C3-dihydro-benzoimidazol-2-one+%28GF-4%29&doi=10.1016%2Fj.peptides.2010.03.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2010.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2010.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DVolta%26aufirst%3DM.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DPela%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DPharmacological%2520profile%2520and%2520antiparkinsonian%2520properties%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%25201-%255B1-cyclooctylmethyl-5-%25281-hydroxy-1-methyl-ethyl%2529-1%252C2%252C3%252C6-tetrahydro-pyridin-4-y%2520l%255D-3-ethyl-1%252C3-dihydro-benzoimidazol-2-one%2520%2528GF-4%2529%26jtitle%3DPeptides%26date%3D2010%26volume%3D31%26spage%3D1194%26epage%3D1204%26doi%3D10.1016%2Fj.peptides.2010.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05735.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1471-4159.2008.05735.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19014386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1SrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=1683-1696&author=M.+Martiauthor=C.+Trapellaauthor=M.+Morari&title=The+novel+nociceptin%2Forphanin+FQ+receptor+antagonist+Trap-101+alleviates+experimental+parkinsonism+through+inhibition+of+the+nigro-thalamic+pathway%3A+positive+interaction+with+L-DOPA&doi=10.1111%2Fj.1471-4159.2008.05735.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA</span></div><div class="casAuthors">Marti, Matteo; Trapella, Claudio; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1683-1696</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In this study we investigated whether the recently discovered antagonist of the nociceptin/orphanin FQ (N/OFQ) opioid peptide (NOP) receptor, 1-[1-(cyclooctylmethyl)-1,2,3,6-tetrahydro-5-(hydroxymethyl)-4-pyridinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (Trap-101) changed motor activity in naive rats and mice, and alleviated parkinsonism in 6-hydroxydopamine hemilesioned rats.  In naive rats, Trap-101 stimulated motor activity at 10 mg/kg and inhibited it at 30 mg/Kg.  Such dual action was also obsd. in wild-type but not NOP receptor knockout mice suggesting specific involvement of NOP receptors.  Trap-101 alleviated akinesia/bradykinesia and improved overall gait ability in hemiparkinsonian rats, being effective starting at 1 mg/Kg and without worsening motor deficit at 30 mg/Kg.  To investigate the circuitry involved in the Trap-101 action, behavioral tests were performed in rats undergoing microdialysis.  The anti-akinetic/anti-bradykinetic effects of Trap-101, given systemically (10 mg/Kg) or perfused in substantia nigra reticulata (10 μM), were assocd. with reduced glutamate and enhanced GABA release in substantia nigra, and reduced GABA release in ipsilateral ventro-medial thalamus.  When combined with ineffective doses of L-DOPA (0.1 mg/Kg), Trap-101 evoked larger neurochem. and behavioral responses.  These data show that Trap-101 is an effective NOP receptor antagonist in vivo and confirm that NOP receptor antagonists alleviate parkinsonism through blockade of nigral NOP receptors and impairment of nigro-thalamic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn1My6a_g6WLVg90H21EOLACvtfcHk0lh_SYbgWimg0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1SrtA%253D%253D&md5=5cc7eea58031e06842f19b8b7750dede</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05735.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05735.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DThe%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520Trap-101%2520alleviates%2520experimental%2520parkinsonism%2520through%2520inhibition%2520of%2520the%2520nigro-thalamic%2520pathway%253A%2520positive%2520interaction%2520with%2520L-DOPA%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D107%26spage%3D1683%26epage%3D1696%26doi%3D10.1111%2Fj.1471-4159.2008.05735.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Shinkai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, I.</span><span> </span><span class="NLM_article-title">4-Aminoquinolines: novel nociceptin antagonists with analgesic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4667</span><span class="NLM_x">–</span> <span class="NLM_lpage">4677</span><span class="refDoi"> DOI: 10.1021/jm0002073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0002073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4667-4677&author=H.+Shinkaiauthor=T.+Itoauthor=T.+Iidaauthor=Y.+Kitaoauthor=H.+Yamadaauthor=I.+Uchida&title=4-Aminoquinolines%3A+novel+nociceptin+antagonists+with+analgesic+activity&doi=10.1021%2Fjm0002073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm0002073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002073%26sid%3Dliteratum%253Aachs%26aulast%3DShinkai%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DT.%26aulast%3DKitao%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DUchida%26aufirst%3DI.%26atitle%3D4-Aminoquinolines%253A%2520novel%2520nociceptin%2520antagonists%2520with%2520analgesic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4667%26epage%3D4677%26doi%3D10.1021%2Fjm0002073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai-Otsuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagara, T.</span><span> </span><span class="NLM_article-title">Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span><span class="refDoi"> DOI: 10.1021/jm0509851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0509851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=847-849&author=Y.+Gotoauthor=S.+Arai-Otsukiauthor=Y.+Tachibanaauthor=D.+Ichikawaauthor=S.+Ozakiauthor=H.+Takahashiauthor=Y.+Iwasawaauthor=O.+Okamotoauthor=S.+Okudaauthor=H.+Ohtaauthor=T.+Sagara&title=Identification+of+a+novel+spiropiperidine+opioid+receptor-like+1+antagonist+class+by+a+focused+library+approach+featuring+3D-pharmacophore+similarity&doi=10.1021%2Fjm0509851"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm0509851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509851%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DArai-Otsuki%26aufirst%3DS.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DIchikawa%26aufirst%3DD.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DSagara%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520novel%2520spiropiperidine%2520opioid%2520receptor-like%25201%2520antagonist%2520class%2520by%2520a%2520focused%2520library%2520approach%2520featuring%25203D-pharmacophore%2520similarity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D847%26epage%3D849%26doi%3D10.1021%2Fjm0509851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Fischetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">614</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.04.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2009.04.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19445927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVGisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=614&publication_year=2009&pages=50-57&author=C.+Fischettiauthor=V.+Camardaauthor=A.+Rizziauthor=M.+Pelaauthor=C.+Trapellaauthor=R.+Guerriniauthor=J.+McDonaldauthor=D.+G.+Lambertauthor=S.+Salvadoriauthor=D.+Regoliauthor=G.+Calo&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+receptor+non+peptide+antagonist+Compound+24&doi=10.1016%2Fj.ejphar.2009.04.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24</span></div><div class="casAuthors">Fischetti, Carmela; Camarda, Valeria; Rizzi, Anna; Pela, Michela; Trapella, Claudio; Guerrini, Remo; McDonald, John; Lambert, David G.; Salvadori, Severo; Regoli, Domenico; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">614</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">50-57</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compd. 24, 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide was recently identified as a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) ligand.  In this study, the in vitro and in vivo pharmacol. profiles of Compd. 24 were investigated.  In vitro studies were performed measuring receptor and [35S]GTPγS binding and calcium mobilization in cells expressing the recombinant NOP receptor as well as using N/OFQ sensitive tissues.  In vivo studies were conducted using the tail withdrawal assay in mice.  Compd. 24 produced a concn.-dependent displacement of [3H]N/OFQ binding to CHOhNOP cell membranes showing high affinity (pKi 9.62) and selectivity (1000 fold) over classical opioid receptors.  Compd. 24 antagonized with high potency the following in vitro effects of N/OFQ: stimulation of [35S]GTPγS binding in CHOhNOP cell membranes (pA2 9.98), calcium mobilization in CHOhNOP cells expressing the Gαqi5 chimeric protein (pKB 8.73), inhibition of elec. evoked twitches in the mouse (pA2 8.44) and rat (pKB 8.28) vas deferens, and in the guinea pig ileum (pKB 9.12).  In elec. stimulated tissues, Compd. 24 up to 1 μM did not modify the effects of classical opioid receptor agonists.  Finally in vivo, in the mouse tail withdrawal assay, Compd. 24 at 10 mg/kg antagonized the pronociceptive and antinociceptive effects of 1 nmol N/OFQ given supraspinally and spinally, resp.  Under the same exptl. conditions Compd. 24 did not affect the antinociceptive action of 3 nmol endomorphin-1 injected intrathecally.  The present study demonstrated that Compd. 24 is a pure, competitive, and highly potent non-peptide NOP receptor selective antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhw3JL9BZux7Vg90H21EOLACvtfcHk0ljCfLs1wT-uyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVGisLY%253D&md5=8888668284839078d49db38556e0065c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.04.054%26sid%3Dliteratum%253Aachs%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DPela%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520non%2520peptide%2520antagonist%2520Compound%252024%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D614%26spage%3D50%26epage%3D57%26doi%3D10.1016%2Fj.ejphar.2009.04.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Thompson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1038/nature11085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnature11085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22596163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=395-399&author=A.+A.+Thompsonauthor=W.+Liuauthor=E.+Chunauthor=V.+Katritchauthor=H.+Wuauthor=E.+Vardyauthor=X.+P.+Huangauthor=C.+Trapellaauthor=R.+Guerriniauthor=G.+Caloauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+nociceptin%2Forphanin+FQ+receptor+in+complex+with+a+peptide+mimetic&doi=10.1038%2Fnature11085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span></div><div class="casAuthors">Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia.  Unlike the classical' opioid receptors, δ, κ and μ (δ-OR, κ-OR and μ-OR), which were delineated by pharmacol. criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by mol. cloning and characterization of an orphan GPCR.  Although it shares high sequence similarity with classical opioid GPCR subtypes (∼60%), NOP has a markedly distinct pharmacol., featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands.  Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compd.-24 (C-24), revealing at. details of ligand-receptor recognition and selectivity.  Compd.-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close deriv. of N/OFQ, and provides important clues to the binding of these peptides.  The x-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors κ and μ, and these are probably due to a small no. of residues that vary between these receptors.  The NOP-compd.-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0_U24fZ4r7Vg90H21EOLACvtfcHk0ljCfLs1wT-uyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D&md5=56819d10685f8a389710e9005d595d5b</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fnature11085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11085%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520in%2520complex%2520with%2520a%2520peptide%2520mimetic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature11085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihyd ro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.1016/S0969-8051(02)00352-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0969-8051%2802%2900352-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12493543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD38jjtFentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=51-59&author=M.+Ogawaauthor=K.+Hatanoauthor=Y.+Kawasumiauthor=K.+Ishiwataauthor=K.+Kawamuraauthor=S.+Ozakiauthor=K.+Ito&title=Synthesis+and+evaluation+of+1-%5B%283R%2C4R%29-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%5D-3-%5B11C%5Dethyl-1%2C3-dihyd+ro-2H-benzimidazol-2-one+as+a+brain+ORL1+receptor+imaging+agent+for+positron+emission+tomography&doi=10.1016%2FS0969-8051%2802%2900352-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography</span></div><div class="casAuthors">Ogawa Mikako; Hatano Kentaro; Kawasumi Yasuhiro; Ishiwata Kiichi; Kawamura Kazunori; Ozaki Satoshi; Ito Kengo</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-9</span>
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    </div><div class="casAbstract">1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[(11)C]ethyl-1,3-dihydro-2H-benzimidazol-2-one ([(11)C]CPEB) was synthesized by [(11)C]N-ethylation and evaluated as a potential brain ORL1 receptor imaging agent by positron emission tomography.  The uptake of [(11)C]CPEB in the mouse brain was 1.9% dose/g, 2 min post-injection, and gradually decreased with time.  Receptor-specific binding was observed, however, the contribution of other receptors was observed and the non-specific binding of [(11)C]CPEB was too high for imaging receptors in vivo.  Therefore, [(11)C]CPEB is not a suitable tracer for in vivo ORL1 receptor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6Aa6vKzKALDDnmmyUf5qOfW6udTcc2eZrFp26fBXwgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jjtFentQ%253D%253D&md5=d8a206c1856b024091f426524047be0f</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900352-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900352-9%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DHatano%26aufirst%3DK.%26aulast%3DKawasumi%26aufirst%3DY.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201-%255B%25283R%252C4R%2529-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%255D-3-%255B11C%255Dethyl-1%252C3-dihyd%2520ro-2H-benzimidazol-2-one%2520as%2520a%2520brain%2520ORL1%2520receptor%2520imaging%2520agent%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D51%26epage%3D59%26doi%3D10.1016%2FS0969-8051%2802%2900352-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1016/S0969-8051(01)00260-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0969-8051%2801%2900260-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11711314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1Olur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=941-947&author=M.+Ogawaauthor=K.+Hatanoauthor=Y.+Kawasumiauthor=J.+Wichmannauthor=K.+Ito&title=Synthesis+and+in+vivo+evaluation+of+%5B11C%5Dmethyl-Ro+64-6198+as+an+ORL1+receptor+imaging+agent&doi=10.1016%2FS0969-8051%2801%2900260-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent</span></div><div class="casAuthors">Ogawa, Mikako; Hatano, Kentaro; Kawasumi, Yasuhiro; Wichmann, Jurgen; Ito, Kengo</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">941-947</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-3-N-[11C]methyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one ([11C]methyl-Ro 64-6198), a N-methylated analog of Ro 64-6198, was synthesized and evaluated as a potential radiopharmaceutical for investigating brain nociceptin/orphanin FQ receptors (ORL1 receptors) by positron emission tomog.  A racemate of methyl-Ro 64-6198, Ro 66-7931, showed a high affinity and selectivity for the ORL1 receptor in vitro.  An in vivo distribution study in mice demonstrated moderate brain uptake, however, only slight difference was obsd. among brain regions.  Furthermore, pretreating with nociceptin or Ro 66-7931 did not affect the accumulation.  Therefore, despite its high affinity, [11C]methyl-Ro 64-6198 does not appear to be a suitable tracer for in vivo ORL1 receptor imaging studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfqCua3bEUp7Vg90H21EOLACvtfcHk0lgzFIGvDW3xkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1Olur4%253D&md5=b3e2e97125f1064c370e2fc4b909d38d</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900260-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900260-8%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DHatano%26aufirst%3DK.%26aulast%3DKawasumi%26aufirst%3DY.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255Dmethyl-Ro%252064-6198%2520as%2520an%2520ORL1%2520receptor%2520imaging%2520agent%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D941%26epage%3D947%26doi%3D10.1016%2FS0969-8051%2801%2900260-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedregal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gackenheimer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2687</span><span class="NLM_x">–</span> <span class="NLM_lpage">2700</span><span class="refDoi"> DOI: 10.1021/jm101487v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101487v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2687-2700&author=V.+W.+Pikeauthor=K.+S.+Rashauthor=Z.+Chenauthor=C.+Pedregalauthor=M.+A.+Statnickauthor=Y.+Kimuraauthor=J.+Hongauthor=S.+S.+Zoghbiauthor=M.+Fujitaauthor=M.+A.+Toledoauthor=N.+Diazauthor=S.+L.+Gackenheimerauthor=J.+T.+Tauscherauthor=V.+N.+Barthauthor=R.+B.+Innis&title=Synthesis+and+evaluation+of+radioligands+for+imaging+brain+nociceptin%2Forphanin+FQ+peptide+%28NOP%29+receptors+with+positron+emission+tomography&doi=10.1021%2Fjm101487v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span></div><div class="casAuthors">Pike, Victor W.; Rash, Karen S.; Chen, Zhaogen; Pedregal, Concepcion; Statnick, Michael A.; Kimura, Yasuyuki; Hong, Jinsoo; Zoghbi, Sami S.; Fujita, Masahiro; Toledo, Miguel A.; Diaz, Nuria; Gackenheimer, Susan L.; Tauscher, Johannes T.; Barth, Vanessa N.; Innis, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2687-2700</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) coupled to an effective radioligand could provide an important tool for understanding possible links between neuropsychiatric disorders and brain NOP (nociceptin/orphanin FQ peptide) receptors.  We sought to develop such a PET radioligand.  High-affinity NOP ligands were synthesized based on a 3-(2'-fluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)-2(2-halobenzyl)-N-alkylpropanamide scaffold and from exptl. screens in rats, with ex vivo LC-MS/MS measures, three ligands were identified for labeling with carbon-11 and evaluation with PET in monkey.  Each ligand was labeled by 11C-methylation of an N-demethyl precursor and studied in monkey under baseline and NOP receptor-preblock conditions.  The three radioligands, [11C](S)-I (X = F, Cl, R = H; X = F, R = iPr) gave similar results.  Baseline scans showed high entry of radioactivity into the brain to give a distribution reflecting that expected for NOP receptors.  Preblock expts. showed high early peak levels of brain radioactivity, which rapidly declined to a much lower level than seen in baseline scans, thereby indicating a high level of receptor-specific binding in baseline expts.  Overall, [11C](S)-I (X = F, R = iPr) showed the most favorable receptor-specific signal and kinetics and is now selected for evaluation in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLbdZG2H-gRLVg90H21EOLACvtfcHk0lgzFIGvDW3xkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D&md5=7519fa250770248d3c73c58e20eca3f1</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm101487v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101487v%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DToledo%26aufirst%3DM.%2BA.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DGackenheimer%26aufirst%3DS.%2BL.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520radioligands%2520for%2520imaging%2520brain%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520%2528NOP%2529%2520receptors%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2687%26epage%3D2700%26doi%3D10.1021%2Fjm101487v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Pedregal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafuente, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Grau, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span> </span><span class="NLM_article-title">Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4955</span><span class="NLM_x">–</span> <span class="NLM_lpage">4967</span><span class="refDoi"> DOI: 10.1021/jm201629q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201629q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4955-4967&author=C.+Pedregalauthor=E.+M.+Joshiauthor=M.+A.+Toledoauthor=C.+Lafuenteauthor=N.+Diazauthor=M.+A.+Martinez-Grauauthor=A.+Jimenezauthor=A.+Benitoauthor=A.+Navarroauthor=Z.+Chenauthor=D.+R.+Mudraauthor=S.+D.+Kahlauthor=K.+S.+Rashauthor=M.+A.+Statnickauthor=V.+N.+Barth&title=Development+of+LC-MS%2FMS-based+receptor+occupancy+tracers+and+positron+emission+tomography+radioligands+for+the+nociceptin%2Forphanin+FQ+%28NOP%29+receptor&doi=10.1021%2Fjm201629q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Development of LC-MS/MS-Based Receptor Occupancy Tracers and Positron Emission Tomography Radioligands for the Nociceptin/Orphanin FQ (NOP) Receptor</span></div><div class="casAuthors">Pedregal, Concepcion; Joshi, Elizabeth M.; Toledo, Miguel A.; Lafuente, Celia; Diaz, Nuria; Martinez-Grau, Maria A.; Jimenez, Alma; Benito, Ana; Navarro, Antonio; Chen, Zhaogen; Mudra, Daniel R.; Kahl, Steven D.; Rash, Karen S.; Statnick, Michael A.; Barth, Vanessa N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4955-4967</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Currently, a lack of sufficient tools has limited the understanding of the relation between neuropsychiatric disorders and the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor.  Herein, we describe the discovery and development of an antagonist NOP receptor occupancy (RO) tracer and a novel positron emission tomog. (PET) radioligand suitable to probe the NOP receptor in human clin. studies.  A thorough structure-activity relation (SAR) around the high-affinity 3-(2'-fluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)-2-(2-halobenzyl)-N-alkylpropanamide scaffold identified a series of subnanomolar, highly selective NOP antagonists.  Subsequently, these unlabeled NOP ligands were evaluated in vivo by liq. chromatog.-tandem mass spectrometry (LC-MS/MS) in rat to det. brain uptake, kinetics and specific binding.  Three compds. were selected for evaluation in nonhuman primates as PET tracers.  Carbon-11 labeling yielded [11C]I, which exhibited minimal generation of central nervous system (CNS) penetrant radiometabolites, improved brain uptake, and was an excellent PET radioligand in both rat and monkey.  Currently [11C]I is being evaluated as a PET radiotracer for the NOP receptor in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9BUDm4qd1VrVg90H21EOLACvtfcHk0lgzFIGvDW3xkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqu7c%253D&md5=37ba5b3497d5300a487c179a668a9055</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm201629q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201629q%26sid%3Dliteratum%253Aachs%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DE.%2BM.%26aulast%3DToledo%26aufirst%3DM.%2BA.%26aulast%3DLafuente%26aufirst%3DC.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DMartinez-Grau%26aufirst%3DM.%2BA.%26aulast%3DJimenez%26aufirst%3DA.%26aulast%3DBenito%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26atitle%3DDevelopment%2520of%2520LC-MS%252FMS-based%2520receptor%2520occupancy%2520tracers%2520and%2520positron%2520emission%2520tomography%2520radioligands%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4955%26epage%3D4967%26doi%3D10.1021%2Fjm201629q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araneta, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span> </span><span class="NLM_article-title">Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2013.10.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.neuroimage.2013.10.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24225488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=89-95&author=T.+G.+Lohithauthor=S.+S.+Zoghbiauthor=C.+L.+Morseauthor=M.+D.+Aranetaauthor=V.+N.+Barthauthor=N.+A.+Goeblauthor=J.+T.+Tauscherauthor=V.+W.+Pikeauthor=R.+B.+Innisauthor=M.+Fujita&title=Retest+imaging+of+%5B11C%5DNOP-1A+binding+to+nociceptin%2Forphanin+FQ+peptide+%28NOP%29+receptors+in+the+brain+of+healthy+humans&doi=10.1016%2Fj.neuroimage.2013.10.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans</span></div><div class="casAuthors">Lohith, Talakad G.; Zoghbi, Sami S.; Morse, Cheryl L.; Araneta, Maria D. Ferraris; Barth, Vanessa N.; Goebl, Nancy A.; Tauscher, Johannes T.; Pike, Victor W.; Innis, Robert B.; Fujita, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">[11C]NOP-1A is a novel high-affinity PET ligand for imaging nociceptin/orphanin FQ peptide (NOP) receptors.  Here, we report reproducibility and reliability measures of binding parameter ests. for [11C]NOP-1A binding in the brain of healthy humans.  After i.v. injection of [11C]NOP-1A, PET scans were conducted twice on eleven healthy volunteers on the same (10/11 subjects) or different (1/11 subjects) days.  Subjects underwent serial sampling of radial arterial blood to measure parent radioligand concns.  Distribution vol. (VT; a measure of receptor d.) was detd. by compartmental (one- and two-tissue) modeling in large regions and by simpler regression methods (graphical Logan and bilinear MA1) in both large regions and voxel data.  Retest variability and intraclass correlation coeff. (ICC) of VT were detd. as measures of reproducibility and reliability resp.  Regional [11C]NOP-1A uptake in the brain was high, with a peak radioactivity concn. of 4-7 SUV (standardized uptake value) and a rank order of putamen > cingulate cortex > cerebellum.  Brain time-activity curves fitted well in 10 of 11 subjects by unconstrained two-tissue compartmental model.  The retest variability of VT was moderately good across brain regions except cerebellum, and was similar across different modeling methods, averaging 12% for large regions and 14% for voxel-based methods.  The retest reliability of VT was also moderately good in most brain regions, except thalamus and cerebellum, and was similar across different modeling methods averaging 0.46 for large regions and 0.48 for voxels having gray matter probability > 20%.  The lowest retest variability and highest retest reliability of VT were achieved by compartmental modeling for large regions, and by the parametric Logan method for voxel-based methods.  Moderately good reproducibility and reliability measures of VT for [11C]NOP-1A make it a useful PET ligand for comparing NOP receptor binding between different subject groups or under different conditions in the same subject.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3eP0iGbS2IbVg90H21EOLACvtfcHk0lh9F6ysTcrLfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyks7s%253D&md5=41e71bf10ab8b68cb8fcae116cd30582</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2013.10.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2013.10.068%26sid%3Dliteratum%253Aachs%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMorse%26aufirst%3DC.%2BL.%26aulast%3DAraneta%26aufirst%3DM.%2BD.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DGoebl%26aufirst%3DN.%2BA.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DFujita%26aufirst%3DM.%26atitle%3DRetest%2520imaging%2520of%2520%255B11C%255DNOP-1A%2520binding%2520to%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520%2528NOP%2529%2520receptors%2520in%2520the%2520brain%2520of%2520healthy%2520humans%26jtitle%3DNeuroImage%26date%3D2014%26volume%3D87%26spage%3D89%26epage%3D95%26doi%3D10.1016%2Fj.neuroimage.2013.10.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohórquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depré, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lepeleire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynders, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span> </span><span class="NLM_article-title">Evaluation of [18F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2012.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.neuroimage.2012.11.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=1-10&author=E.+D.+Hostetlerauthor=S.+Sanabria-Boh%C3%B3rquezauthor=W.+Engauthor=A.+D.+Joshiauthor=S.+Patelauthor=R.+E.+Gibsonauthor=S.+O%E2%80%99Malleyauthor=S.+M.+Krauseauthor=C.+Ryanauthor=K.+Riffelauthor=S.+Biauthor=O.+Okamotoauthor=H.+Kawamotoauthor=S.+Ozakiauthor=H.+Ohtaauthor=T.+de+Grootauthor=G.+Bormansauthor=M.+Depr%C3%A9author=J.+de+Hoonauthor=I.+De+Lepeleireauthor=T.+Reyndersauthor=J.+J.+Cookauthor=H.+D.+Burnsauthor=M.+Eganauthor=W.+Choauthor=K.+van+Laereauthor=R.+J.+Hargreaves&title=Evaluation+of+%5B18F%5DMK-0911%2C+a+positron+emission+tomography+%28PET%29+tracer+for+opioid+receptor-like+1+%28ORL1%29%2C+in+rhesus+monkey+and+human&doi=10.1016%2Fj.neuroimage.2012.11.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2012.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2012.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DSanabria-Boh%25C3%25B3rquez%26aufirst%3DS.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DKrause%26aufirst%3DS.%2BM.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3Dde%2BGroot%26aufirst%3DT.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DDepr%25C3%25A9%26aufirst%3DM.%26aulast%3Dde%2BHoon%26aufirst%3DJ.%26aulast%3DDe%2BLepeleire%26aufirst%3DI.%26aulast%3DReynders%26aufirst%3DT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DBurns%26aufirst%3DH.%2BD.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DW.%26aulast%3Dvan%2BLaere%26aufirst%3DK.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520%255B18F%255DMK-0911%252C%2520a%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520tracer%2520for%2520opioid%2520receptor-like%25201%2520%2528ORL1%2529%252C%2520in%2520rhesus%2520monkey%2520and%2520human%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D68%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.neuroimage.2012.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drozda, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of [3H]PF-7191, a highly specific nociceptin opioid peptide (NOP) receptor radiotracer for in vivo receptor occupancy (RO) studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5219</span><span class="NLM_x">–</span> <span class="NLM_lpage">5223</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.bmcl.2014.09.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5219-5223&author=L.+Zhangauthor=E.+Drummondauthor=M.+A.+Brodneyauthor=J.+Cianfrognaauthor=S.+E.+Drozdaauthor=S.+Grimwoodauthor=M.+A.+Vanase-Frawleyauthor=A.+Villalobos&title=Design%2C+synthesis+and+evaluation+of+%5B3H%5DPF-7191%2C+a+highly+specific+nociceptin+opioid+peptide+%28NOP%29+receptor+radiotracer+for+in+vivo+receptor+occupancy+%28RO%29+studies&doi=10.1016%2Fj.bmcl.2014.09.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.069%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDrummond%26aufirst%3DE.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520%255B3H%255DPF-7191%252C%2520a%2520highly%2520specific%2520nociceptin%2520opioid%2520peptide%2520%2528NOP%2529%2520receptor%2520radiotracer%2520for%2520in%2520vivo%2520receptor%2520occupancy%2520%2528RO%2529%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5219%26epage%3D5223%26doi%3D10.1016%2Fj.bmcl.2014.09.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Micheli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare Mannelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calò, G.</span><span> </span><span class="NLM_article-title">Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">754</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2015.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25704616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVahs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=754&publication_year=2015&pages=73-81&author=L.+Micheliauthor=L.+Di+Cesare+Mannelliauthor=R.+Guerriniauthor=C.+Trapellaauthor=M.+Zanardelliauthor=R.+Ciccocioppoauthor=A.+Rizziauthor=C.+Ghelardiniauthor=G.+Cal%C3%B2&title=Acute+and+subchronic+antinociceptive+effects+of+nociceptin%2Forphanin+FQ+receptor+agonists+infused+by+intrathecal+route+in+rats&doi=10.1016%2Fj.ejphar.2015.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats</span></div><div class="casAuthors">Micheli, Laura; Di Cesare Mannelli, Lorenzo; Guerrini, Remo; Trapella, Claudio; Zanardelli, Matteo; Ciccocioppo, Roberto; Rizzi, Anna; Ghelardini, Carla; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">754</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-81</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Severe pain occurs in the context of many diseases and conditions and is a leading cause of disability.  Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand of the N/OFQ peptide (NOP) receptor.  This peptidergic system controls pain transmission and in particular spinally administered N/OFQ has robust antinociceptive properties.The aim of this study was to investigate the spinal antinociceptive properties of NOP peptide agonists after acute and subchronic treatment in rats.  Doses unable to alter motor coordination were selected.  UFP-112 (full NOP agonist) and UFP-113 (partial NOP agonist) were administered intrathecally (i.t.) by spinal catheterization.  Acute injection of UFP-112 induced antinociceptive response at lower dosages (0.03-1 nmol i.t.) compared to morphine and similar to N/OFQ.  UFP-113 was effective in a 0.001-1 nmol i.t. dose range.  The antinociceptive effects of NOP ligands were no longer evident in rats knockout for the NOP gene, while those of morphine were maintained.  The continuous spinal infusion (by osmotic pumps) of 0.1 nmol/h UFP-112 and UFP-113 showed antinociceptive action comparable to 1-3 nmol/h morphine or N/OFQ.  The antinociceptive effect of morphine progressively decreased and was no longer significant after 6 days of treatment.  Similar results were obtained with N/OFQ, UFP-112, and UFP-113.  The acute i.t. injection of morphine in animals tolerant to N/OFQ and UFP-112 evoked analgesic effects.  Neither morphine nor N/OFQ induced antinociceptive effects in morphine- and UFP-113-tolerant rats.  In conclusion this study highlights the analgesic efficacy and potency of UFP-112 and UFP-113 underlining the relevance of NOP system in analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmvrfiXAFrbVg90H21EOLACvtfcHk0lh9F6ysTcrLfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVahs7w%253D&md5=bf03685287fc82e25a0bbc5be96133c8</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DZanardelli%26aufirst%3DM.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DAcute%2520and%2520subchronic%2520antinociceptive%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonists%2520infused%2520by%2520intrathecal%2520route%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D754%26spage%3D73%26epage%3D81%26doi%3D10.1016%2Fj.ejphar.2015.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson-Durand, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standifer, K. M.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1111/bph.12701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fbph.12701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24666365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFaqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=571-582&author=Y.+Zhangauthor=C.+D.+Simpson-Durandauthor=K.+M.+Standifer&title=Nociceptin%2Forphanin+FQ+peptide+receptor+antagonist+JTC-801+reverses+pain+and+anxiety+symptoms+in+a+rat+model+of+post-traumatic+stress+disorder&doi=10.1111%2Fbph.12701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder</span></div><div class="casAuthors">Zhang, Y.; Simpson-Durand, C. D.; Standifer, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-582</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Single-prolonged stress (SPS), a rat model of post-traumatic stress disorder (PTSD), also induces long-lasting hyperalgesia assocd. with hypocortisolism and elevated nociceptin/orphanin FQ (N/OFQ) levels in serum and CSF.  Here, we detd. the effect of JTC-801 (N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride), a nociceptin/orphanin FQ peptide (NOP) receptor antagonist, on symptoms of pain and anxiety in rats after SPS exposure, and examd. N/OFQ-NOP receptor system changes.  Exptl. Approach : Male Sprague Dawley rats received JTC-801 (6 mg kg-1 i.p., once daily) during days 7-21 of SPS.  The ability of JTC-801 to inhibit N/OFQ-stimulated [35S]-GTPγS binding was confirmed in rat brain membranes.  Anxiety-like behavior and pain sensitivity were monitored by changes in elevated plus maze performance and withdrawal responses to thermal and mech. stimuli.  Serum corticosterone and N/OFQ content in CSF, serum and brain tissues were detd. by RIA; NOP receptor protein and gene expression in amygdala, hippocampus and periaqueductal gray (PAG) were examd. by immunoblotting and real-time PCR resp.  Key Results : JTC-801 treatment reversed SPS-induced mech. allodynia, thermal hyperalgesia, anxiety-like behavior and hypocortisolism.  Elevated N/OFQ levels in serum, CSF, PAG and hippocampus at day 21 of SPS were blocked by JTC-801; daily JTC-801 treatment also reversed NOP receptor protein and mRNA up-regulation in amygdala and PAG.  Conclusion and Implications : JTC-801 reversed SPS-induced anxiety- and pain-like behaviors, and NOP receptor system up-regulation.  These findings suggest that N/OFQ plays an important role in hyperalgesia and allodynia maintenance after SPS.  NOP receptor antagonists may provide effective treatment for co-morbid PTSD and pain.  Linked Articles : This article is part of a themed section on Opioids: New Pathways to Functional Selectivity.  To view the other articles in this section visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRucLJKwtOs7Vg90H21EOLACvtfcHk0lhM1oDpDZJkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFaqt7vE&md5=4cb9b24c0543a7ab9ac65b049e27ac7d</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fbph.12701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12701%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSimpson-Durand%26aufirst%3DC.%2BD.%26aulast%3DStandifer%26aufirst%3DK.%2BM.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520antagonist%2520JTC-801%2520reverses%2520pain%2520and%2520anxiety%2520symptoms%2520in%2520a%2520rat%2520model%2520of%2520post-traumatic%2520stress%2520disorder%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D571%26epage%3D582%26doi%3D10.1111%2Fbph.12701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Soumen Chakraborty, Rajendra Uprety, Amal E. Daibani, Valerie L. Rouzic, Amanda Hunkele, Kevin Appourchaux, Shainnel O. Eans, Nitin Nuthikattu, Rahul Jilakara, Lisa Thammavong, Gavril W. Pasternak, Ying-Xian Pan, Jay P. McLaughlin, Tao Che, <span class="NLM_string-name hlFld-ContribAuthor">Susruta Majumdar</span>. </span><span class="cited-content_cbyCitation_article-title">Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (14)
                                     , 2661-2678. <a href="https://doi.org/10.1021/acschemneuro.1c00149" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00149%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DKratom%252BAlkaloids%252Bas%252BProbes%252Bfor%252BOpioid%252BReceptor%252BFunction%25253A%252BPharmacological%252BCharacterization%252Bof%252BMinor%252BIndole%252Band%252BOxindole%252BAlkaloids%252Bfrom%252BKratom%26aulast%3DChakraborty%26aufirst%3DSoumen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15032021%26date%3D28062021%26date%3D02072021%26volume%3D12%26issue%3D14%26spage%3D2661%26epage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Uma Gayathri Kamakolanu, Michael E. Meyer, Dennis Yasuda, Willma E. Polgar, Matteo Marti, Daniela Mercatelli, Clarissa Anna Pisanò, Alberto Brugnoli, Michele Morari, <span class="NLM_string-name hlFld-ContribAuthor">Nurulain T. Zaveri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson’s Disease Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2688-2704. <a href="https://doi.org/10.1021/acs.jmedchem.9b02134" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02134%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BNociceptin%252BReceptor%252BPartial%252BAgonists%252BThat%252BAfford%252BSymptom%252BAblation%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%252BModels%26aulast%3DKamakolanu%26aufirst%3DUma%2BGayathri%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D03022020%26date%3D17012020%26volume%3D63%26issue%3D5%26spage%3D2688%26epage%3D2704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Wenzhong Yan, John D. McCorvy, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9841-9878. <a href="https://doi.org/10.1021/acs.jmedchem.8b00435" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiased%252BLigands%252Bof%252BG%252BProtein-Coupled%252BReceptors%252B%252528GPCRs%252529%25253A%252BStructure%2525E2%252580%252593Functional%252BSelectivity%252BRelationships%252B%252528SFSRs%252529%252Band%252BTherapeutic%252BPotential%26aulast%3DTan%26aufirst%3DLiang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19032018%26date%3D10072018%26date%3D25062018%26volume%3D61%26issue%3D22%26spage%3D9841%26epage%3D9878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dilip
K. Tosh, Antonella Ciancetta, Philip Mannes, Eugene Warnick, Aaron Janowsky, Amy J. Eshleman, Elizabeth Gizewski, Tarsis F. Brust, Laura M. Bohn, John A. Auchampach, Zhan-Guo Gao, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth A. Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (10)
                                     , 12658-12678. <a href="https://doi.org/10.1021/acsomega.8b01237" title="DOI URL">https://doi.org/10.1021/acsomega.8b01237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01237%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DRepurposing%252Bof%252Ba%252BNucleoside%252BScaffold%252Bfrom%252BAdenosine%252BReceptor%252BAgonists%252Bto%252BOpioid%252BReceptor%252BAntagonists%26aulast%3DTosh%26aufirst%3DDilip%2BK.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04062018%26date%3D19092018%26volume%3D3%26issue%3D10%26spage%3D12658%26epage%3D12678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph B  O'Brien</span>, <span class="hlFld-ContribAuthor ">David L  Roman</span>. </span><span class="cited-content_cbyCitation_article-title">Novel treatments for chronic pain: moving beyond opioids. </span><span class="cited-content_cbyCitation_journal-name">Translational Research</span><span> <strong>2021,</strong> <em>234 </em>, 1-19. <a href="https://doi.org/10.1016/j.trsl.2021.03.008" title="DOI URL">https://doi.org/10.1016/j.trsl.2021.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trsl.2021.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trsl.2021.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Research%26atitle%3DNovel%252Btreatments%252Bfor%252Bchronic%252Bpain%25253A%252Bmoving%252Bbeyond%252Bopioids%26aulast%3DO%2527Brien%26aufirst%3DJoseph%2BB%26date%3D2021%26volume%3D234%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna Maria  Borruto</span>, <span class="hlFld-ContribAuthor ">Yannick  Fotio</span>, <span class="hlFld-ContribAuthor ">Serena  Stopponi</span>, <span class="hlFld-ContribAuthor ">Michele  Petrella</span>, <span class="hlFld-ContribAuthor ">Sara  De Carlo</span>, <span class="hlFld-ContribAuthor ">Ana  Domi</span>, <span class="hlFld-ContribAuthor ">Massimo  Ubaldi</span>, <span class="hlFld-ContribAuthor ">Friedbert  Weiss</span>, <span class="hlFld-ContribAuthor ">Roberto  Ciccocioppo</span>. </span><span class="cited-content_cbyCitation_article-title">NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2021,</strong> <em>125 </em><a href="https://doi.org/10.1038/s41386-021-01096-1" title="DOI URL">https://doi.org/10.1038/s41386-021-01096-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-021-01096-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-021-01096-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DNOP%252Breceptor%252Bantagonism%252Battenuates%252Breinstatement%252Bof%252Balcohol-seeking%252Bthrough%252Bmodulation%252Bof%252Bthe%252Bmesolimbic%252Bcircuitry%252Bin%252Bmale%252Band%252Bfemale%252Balcohol-preferring%252Brats%26aulast%3DBorruto%26aufirst%3DAnna%2BMaria%26date%3D2021%26date%3D2021%26volume%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Kelly M.  Standifer</span>. </span><span class="cited-content_cbyCitation_article-title">Exacerbated Headache-Related Pain in the Single Prolonged Stress Preclinical Model of Post-traumatic Stress Disorder. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Neurobiology</span><span> <strong>2021,</strong> <em>41 </em>
                                    (5)
                                     , 1009-1018. <a href="https://doi.org/10.1007/s10571-020-00962-8" title="DOI URL">https://doi.org/10.1007/s10571-020-00962-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10571-020-00962-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10571-020-00962-8%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Neurobiology%26atitle%3DExacerbated%252BHeadache-Related%252BPain%252Bin%252Bthe%252BSingle%252BProlonged%252BStress%252BPreclinical%252BModel%252Bof%252BPost-traumatic%252BStress%252BDisorder%26aulast%3DZhang%26aufirst%3DYong%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D5%26spage%3D1009%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rob  Hill</span>, <span class="hlFld-ContribAuthor ">Meritxell  Canals</span>. </span><span class="cited-content_cbyCitation_article-title">Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>31 </em>, 107961. <a href="https://doi.org/10.1016/j.pharmthera.2021.107961" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2021.107961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2021.107961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2021.107961%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DExperimental%252Bconsiderations%252Bfor%252Bthe%252Bassessment%252Bof%252Bin%252Bvivo%252Band%252Bin%252Bvitro%252Bopioid%252Bpharmacology%26aulast%3DHill%26aufirst%3DRob%26date%3D2021%26volume%3D31%26spage%3D107961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jolien  De Neve</span>, <span class="hlFld-ContribAuthor ">Thomas M. A.  Barlow</span>, <span class="hlFld-ContribAuthor ">Dirk  Tourwé</span>, <span class="hlFld-ContribAuthor ">Frédéric  Bihel</span>, <span class="hlFld-ContribAuthor ">Frédéric  Simonin</span>, <span class="hlFld-ContribAuthor ">Steven  Ballet</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (6)
                                     , 828-870. <a href="https://doi.org/10.1039/D1MD00041A" title="DOI URL">https://doi.org/10.1039/D1MD00041A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00041A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00041A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DComprehensive%252Boverview%252Bof%252Bbiased%252Bpharmacology%252Bat%252Bthe%252Bopioid%252Breceptors%25253A%252Bbiased%252Bligands%252Band%252Bbias%252Bfactors%26aulast%3DDe%2BNeve%26aufirst%3DJolien%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D6%26spage%3D828%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael E.  Meyer</span>, <span class="hlFld-ContribAuthor ">Arpit  Doshi</span>, <span class="hlFld-ContribAuthor ">Dennis  Yasuda</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based SAR in the Design of Selective or Bifunctional Nociceptin (NOP) Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">The AAPS Journal</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     <a href="https://doi.org/10.1208/s12248-021-00589-7" title="DOI URL">https://doi.org/10.1208/s12248-021-00589-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12248-021-00589-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12248-021-00589-7%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520AAPS%2520Journal%26atitle%3DStructure-Based%252BSAR%252Bin%252Bthe%252BDesign%252Bof%252BSelective%252Bor%252BBifunctional%252BNociceptin%252B%252528NOP%252529%252BReceptor%252BAgonists%26aulast%3DMeyer%26aufirst%3DMichael%2BE.%26date%3D2021%26date%3D2021%26volume%3D23%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Hou</span>, <span class="hlFld-ContribAuthor ">Fangfang  Xu</span>, <span class="hlFld-ContribAuthor ">Xingrong  Peng</span>, <span class="hlFld-ContribAuthor ">Han  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiuli  Zhang</span>, <span class="hlFld-ContribAuthor ">Minghua  Qiu</span>, <span class="hlFld-ContribAuthor ">Jixia  Wang</span>, <span class="hlFld-ContribAuthor ">Yanfang  Liu</span>, <span class="hlFld-ContribAuthor ">Xinmiao  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Label-free cell phenotypic study of opioid receptors and discovery of novel mu opioid ligands from natural products. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2021,</strong> <em>270 </em>, 113872. <a href="https://doi.org/10.1016/j.jep.2021.113872" title="DOI URL">https://doi.org/10.1016/j.jep.2021.113872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2021.113872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2021.113872%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DLabel-free%252Bcell%252Bphenotypic%252Bstudy%252Bof%252Bopioid%252Breceptors%252Band%252Bdiscovery%252Bof%252Bnovel%252Bmu%252Bopioid%252Bligands%252Bfrom%252Bnatural%252Bproducts%26aulast%3DHou%26aufirst%3DTao%26date%3D2021%26volume%3D270%26spage%3D113872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jannicke Irina  Nesman</span>, <span class="hlFld-ContribAuthor ">Ouyang  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Luo</span>, <span class="hlFld-ContribAuthor ">Ru-Rong  Ji</span>, <span class="hlFld-ContribAuthor ">Charles N.  Serhan</span>, <span class="hlFld-ContribAuthor ">Trond Vidar  Hansen</span>. </span><span class="cited-content_cbyCitation_article-title">A new synthetic protectin D1 analog 3-oxa-PD1
              n-3 DPA
              reduces neuropathic pain and chronic itch in mice. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (12)
                                     , 2744-2752. <a href="https://doi.org/10.1039/D0OB02136A" title="DOI URL">https://doi.org/10.1039/D0OB02136A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02136A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02136A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bnew%252Bsynthetic%252Bprotectin%252BD1%252Banalog%252B3-oxa-PD1%252Bn-3%252BDPA%252Breduces%252Bneuropathic%252Bpain%252Band%252Bchronic%252Bitch%252Bin%252Bmice%26aulast%3DNesman%26aufirst%3DJannicke%2BIrina%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D12%26spage%3D2744%26epage%3D2752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Starnowska-Sokół</span>. </span><span class="cited-content_cbyCitation_article-title">A hybrid for pain, i.e. bifunctional analgesics in neuropathy. </span><span class="cited-content_cbyCitation_journal-name">BÓL</span><span> <strong>2021,</strong> <em>21 </em>
                                    (4)
                                     , 17-24. <a href="https://doi.org/10.5604/01.3001.0014.8073" title="DOI URL">https://doi.org/10.5604/01.3001.0014.8073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5604/01.3001.0014.8073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5604%2F01.3001.0014.8073%26sid%3Dliteratum%253Aachs%26jtitle%3DB%25C3%2593L%26atitle%3DA%252Bhybrid%252Bfor%252Bpain%25252C%252Bi.e.%252Bbifunctional%252Banalgesics%252Bin%252Bneuropathy%26aulast%3DStarnowska-Sok%25C3%25B3%25C5%2582%26aufirst%3DJoanna%26date%3D2021%26volume%3D21%26issue%3D4%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karol  Wtorek</span>, <span class="hlFld-ContribAuthor ">Anna  Janecka</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/cbdv.202000871" title="DOI URL">https://doi.org/10.1002/cbdv.202000871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.202000871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.202000871%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DPotential%252Bof%252BNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BAnalogs%252Bfor%252BDrug%252BDevelopment%26aulast%3DWtorek%26aufirst%3DKarol%26date%3D2021%26date%3D2020%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.Yu.  Shamakina</span>, <span class="hlFld-ContribAuthor ">F.Sh.  Shagiakhmetov</span>, <span class="hlFld-ContribAuthor ">P.K.  Anokhin</span>, <span class="hlFld-ContribAuthor ">V.S.  Kohan</span>, <span class="hlFld-ContribAuthor ">T.V.  Davidova</span>. </span><span class="cited-content_cbyCitation_article-title">The role of nociceptin in opioid regulation of brain functions. </span><span class="cited-content_cbyCitation_journal-name">Biomeditsinskaya Khimiya</span><span> <strong>2021,</strong> <em>67 </em>
                                    (1)
                                     , 5-16. <a href="https://doi.org/10.18097/pbmc20216701005" title="DOI URL">https://doi.org/10.18097/pbmc20216701005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18097/pbmc20216701005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18097%2Fpbmc20216701005%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomeditsinskaya%2520Khimiya%26atitle%3DThe%252Brole%252Bof%252Bnociceptin%252Bin%252Bopioid%252Bregulation%252Bof%252Bbrain%252Bfunctions%26aulast%3DShamakina%26aufirst%3DI.Yu.%26date%3D2021%26date%3D2021%26volume%3D67%26issue%3D1%26spage%3D5%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norikazu  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Shiroh  Kishioka</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Ko</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potentials of safe opioid analgesics targeting nociceptin/orphanin FQ peptide receptor. </span><span class="cited-content_cbyCitation_journal-name">Folia Pharmacologica Japonica</span><span> <strong>2021,</strong> <em>156 </em>
                                    (3)
                                     , 139-144. <a href="https://doi.org/10.1254/fpj.20106" title="DOI URL">https://doi.org/10.1254/fpj.20106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1254/fpj.20106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1254%2Ffpj.20106%26sid%3Dliteratum%253Aachs%26jtitle%3DFolia%2520Pharmacologica%2520Japonica%26atitle%3DTherapeutic%252Bpotentials%252Bof%252Bsafe%252Bopioid%252Banalgesics%252Btargeting%252Bnociceptin%25252Forphanin%252BFQ%252Bpeptide%252Breceptor%26aulast%3DKiguchi%26aufirst%3DNorikazu%26date%3D2021%26volume%3D156%26issue%3D3%26spage%3D139%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norikazu  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Huiping  Ding</span>, <span class="hlFld-ContribAuthor ">Shiroh  Kishioka</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Ko</span>. </span><span class="cited-content_cbyCitation_article-title">Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (31)
                                     , 2878-2888. <a href="https://doi.org/10.2174/1568026620666200508082615" title="DOI URL">https://doi.org/10.2174/1568026620666200508082615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200508082615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200508082615%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BReceptor-Related%252BLigands%252Bas%252BNovel%252BAnalgesics%26aulast%3DKiguchi%26aufirst%3DNorikazu%26date%3D2020%26volume%3D20%26issue%3D31%26spage%3D2878%26epage%3D2888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana  Lemos Duarte</span>, <span class="hlFld-ContribAuthor ">Lakshmi A.  Devi</span>. </span><span class="cited-content_cbyCitation_article-title">Post-translational Modifications of Opioid Receptors. </span><span class="cited-content_cbyCitation_journal-name">Trends in Neurosciences</span><span> <strong>2020,</strong> <em>43 </em>
                                    (6)
                                     , 417-432. <a href="https://doi.org/10.1016/j.tins.2020.03.011" title="DOI URL">https://doi.org/10.1016/j.tins.2020.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tins.2020.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tins.2020.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Neurosciences%26atitle%3DPost-translational%252BModifications%252Bof%252BOpioid%252BReceptors%26aulast%3DLemos%2BDuarte%26aufirst%3DMariana%26date%3D2020%26volume%3D43%26issue%3D6%26spage%3D417%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norikazu  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Huiping  Ding</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Ko</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroscience Research</span><span> <strong>2020,</strong> <em>18 </em><a href="https://doi.org/10.1002/jnr.24624" title="DOI URL">https://doi.org/10.1002/jnr.24624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jnr.24624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjnr.24624%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroscience%2520Research%26atitle%3DTherapeutic%252Bpotentials%252Bof%252BNOP%252Band%252BMOP%252Breceptor%252Bcoactivation%252Bfor%252Bthe%252Btreatment%252Bof%252Bpain%252Band%252Bopioid%252Babuse%26aulast%3DKiguchi%26aufirst%3DNorikazu%26date%3D2020%26date%3D2020%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Link</span>, <span class="hlFld-ContribAuthor ">Xinnan  Niu</span>, <span class="hlFld-ContribAuthor ">Connie M.  Weaver</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Jennings</span>, <span class="hlFld-ContribAuthor ">Dexter T.  Duncan</span>, <span class="hlFld-ContribAuthor ">K. Jill  McAfee</span>, <span class="hlFld-ContribAuthor ">Morgan  Sammons</span>, <span class="hlFld-ContribAuthor ">Vince R.  Gerbasi</span>, <span class="hlFld-ContribAuthor ">Adam R.  Farley</span>, <span class="hlFld-ContribAuthor ">Tracey C.  Fleischer</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Browne</span>, <span class="hlFld-ContribAuthor ">Parimal  Samir</span>, <span class="hlFld-ContribAuthor ">Allison  Galassie</span>, <span class="hlFld-ContribAuthor ">Braden  Boone</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Identification of Protein Interactions in Eukaryotic mRNA Translation. </span><span class="cited-content_cbyCitation_journal-name">PROTEOMICS</span><span> <strong>2020,</strong> <em>20 </em>
                                    (7)
                                     , 1900177. <a href="https://doi.org/10.1002/pmic.201900177" title="DOI URL">https://doi.org/10.1002/pmic.201900177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pmic.201900177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpmic.201900177%26sid%3Dliteratum%253Aachs%26jtitle%3DPROTEOMICS%26atitle%3DTargeted%252BIdentification%252Bof%252BProtein%252BInteractions%252Bin%252BEukaryotic%252BmRNA%252BTranslation%26aulast%3DLink%26aufirst%3DAndrew%2BJ.%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D7%26spage%3D1900177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Athanasios  Fountas</span>, <span class="hlFld-ContribAuthor ">Stan  Van Uum</span>, <span class="hlFld-ContribAuthor ">Niki  Karavitaki</span>. </span><span class="cited-content_cbyCitation_article-title">Opioid-induced endocrinopathies. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Diabetes & Endocrinology</span><span> <strong>2020,</strong> <em>8 </em>
                                    (1)
                                     , 68-80. <a href="https://doi.org/10.1016/S2213-8587(19)30254-2" title="DOI URL">https://doi.org/10.1016/S2213-8587(19)30254-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S2213-8587(19)30254-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS2213-8587%2819%2930254-2%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Diabetes%2520%2526%2520Endocrinology%26atitle%3DOpioid-induced%252Bendocrinopathies%26aulast%3DFountas%26aufirst%3DAthanasios%26date%3D2020%26volume%3D8%26issue%3D1%26spage%3D68%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Mercatelli</span>, <span class="hlFld-ContribAuthor ">Erwan  Bezard</span>, <span class="hlFld-ContribAuthor ">Roberto  Eleopra</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Michele  Morari</span>. </span><span class="cited-content_cbyCitation_article-title">Managing Parkinson's disease: moving ON with NOP. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (1)
                                     , 28-47. <a href="https://doi.org/10.1111/bph.14893" title="DOI URL">https://doi.org/10.1111/bph.14893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14893%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DManaging%252BParkinson%252527s%252Bdisease%25253A%252Bmoving%252BON%252Bwith%252BNOP%26aulast%3DMercatelli%26aufirst%3DDaniela%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D1%26spage%3D28%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin S.  Hong</span>, <span class="hlFld-ContribAuthor ">Maria T.  Moran</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Eaton</span>, <span class="hlFld-ContribAuthor ">Lori M.  Grafton</span>. </span><span class="cited-content_cbyCitation_article-title">Neurologic, Cognitive, and Behavioral Consequences of Opioid Overdose: a Review. </span><span class="cited-content_cbyCitation_journal-name">Current Physical Medicine and Rehabilitation Reports</span><span> <strong>2019,</strong> <em>7 </em>
                                    (4)
                                     , 305-313. <a href="https://doi.org/10.1007/s40141-019-00247-2" title="DOI URL">https://doi.org/10.1007/s40141-019-00247-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40141-019-00247-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40141-019-00247-2%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Physical%2520Medicine%2520and%2520Rehabilitation%2520Reports%26atitle%3DNeurologic%25252C%252BCognitive%25252C%252Band%252BBehavioral%252BConsequences%252Bof%252BOpioid%252BOverdose%25253A%252Ba%252BReview%26aulast%3DHong%26aufirst%3DJustin%2BS.%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D4%26spage%3D305%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Cumming</span>, <span class="hlFld-ContribAuthor ">János  Marton</span>, <span class="hlFld-ContribAuthor ">Tuomas O.  Lilius</span>, <span class="hlFld-ContribAuthor ">Dag Erlend  Olberg</span>, <span class="hlFld-ContribAuthor ">Axel  Rominger</span>. </span><span class="cited-content_cbyCitation_article-title">A Survey of Molecular Imaging of Opioid Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (22)
                                     , 4190. <a href="https://doi.org/10.3390/molecules24224190" title="DOI URL">https://doi.org/10.3390/molecules24224190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24224190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24224190%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BSurvey%252Bof%252BMolecular%252BImaging%252Bof%252BOpioid%252BReceptors%26aulast%3DCumming%26aufirst%3DPaul%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D22%26spage%3D4190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline A.  Browne</span>, <span class="hlFld-ContribAuthor ">Irwin  Lucki</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting opioid dysregulation in depression for the development of novel therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>201 </em>, 51-76. <a href="https://doi.org/10.1016/j.pharmthera.2019.04.009" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTargeting%252Bopioid%252Bdysregulation%252Bin%252Bdepression%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnovel%252Btherapeutics%26aulast%3DBrowne%26aufirst%3DCaroline%2BA.%26date%3D2019%26volume%3D201%26spage%3D51%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn M.  Flynn</span>, <span class="hlFld-ContribAuthor ">Phillip M.  Epperly</span>, <span class="hlFld-ContribAuthor ">April T.  Davenport</span>, <span class="hlFld-ContribAuthor ">Gerta  Cami-Kobeci</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Husbands</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Ko</span>, <span class="hlFld-ContribAuthor ">Paul W.  Czoty</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of stimulation of mu opioid and nociceptin/orphanin FQ peptide (NOP) receptors on alcohol drinking in rhesus monkeys. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (8)
                                     , 1476-1484. <a href="https://doi.org/10.1038/s41386-019-0390-z" title="DOI URL">https://doi.org/10.1038/s41386-019-0390-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-019-0390-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-019-0390-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DEffects%252Bof%252Bstimulation%252Bof%252Bmu%252Bopioid%252Band%252Bnociceptin%25252Forphanin%252BFQ%252Bpeptide%252B%252528NOP%252529%252Breceptors%252Bon%252Balcohol%252Bdrinking%252Bin%252Brhesus%252Bmonkeys%26aulast%3DFlynn%26aufirst%3DShawn%2BM.%26date%3D2019%26date%3D2019%26volume%3D44%26issue%3D8%26spage%3D1476%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norikazu  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Huiping  Ding</span>, <span class="hlFld-ContribAuthor ">Gerta  Cami-Kobeci</span>, <span class="hlFld-ContribAuthor ">Devki D.  Sukhtankar</span>, <span class="hlFld-ContribAuthor ">Paul W.  Czoty</span>, <span class="hlFld-ContribAuthor ">Heather B.  DeLoid</span>, <span class="hlFld-ContribAuthor ">Fang-Chi  Hsu</span>, <span class="hlFld-ContribAuthor ">Lawrence  Toll</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Husbands</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Ko</span>. </span><span class="cited-content_cbyCitation_article-title">BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Anaesthesia</span><span> <strong>2019,</strong> <em>122 </em>
                                    (6)
                                     , e146-e156. <a href="https://doi.org/10.1016/j.bja.2018.10.065" title="DOI URL">https://doi.org/10.1016/j.bja.2018.10.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bja.2018.10.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bja.2018.10.065%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Anaesthesia%26atitle%3DBU10038%252Bas%252Ba%252Bsafe%252Bopioid%252Banalgesic%252Bwith%252Bfewer%252Bside-effects%252Bafter%252Bsystemic%252Band%252Bintrathecal%252Badministration%252Bin%252Bprimates%26aulast%3DKiguchi%26aufirst%3DNorikazu%26date%3D2019%26volume%3D122%26issue%3D6%26spage%3De146%26epage%3De156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana Paula Aquistapase  Dagnino</span>, <span class="hlFld-ContribAuthor ">Rodrigo Braccini Madeira  da Silva</span>, <span class="hlFld-ContribAuthor ">Pedro Cesar  Chagastelles</span>, <span class="hlFld-ContribAuthor ">Talita Carneiro Brandão  Pereira</span>, <span class="hlFld-ContribAuthor ">Gianina Teribele  Venturin</span>, <span class="hlFld-ContribAuthor ">Samuel  Greggio</span>, <span class="hlFld-ContribAuthor ">Jaderson  Costa da Costa</span>, <span class="hlFld-ContribAuthor ">Maurício Reis  Bogo</span>, <span class="hlFld-ContribAuthor ">Maria Martha  Campos</span>. </span><span class="cited-content_cbyCitation_article-title">Nociceptin/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia. </span><span class="cited-content_cbyCitation_journal-name">Pain</span><span> <strong>2019,</strong> <em>160 </em>
                                    (6)
                                     , 1383-1401. <a href="https://doi.org/10.1097/j.pain.0000000000001513" title="DOI URL">https://doi.org/10.1097/j.pain.0000000000001513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/j.pain.0000000000001513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2Fj.pain.0000000000001513%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%26atitle%3DNociceptin%25252Forphanin%252BFQ%252Breceptor%252Bmodulates%252Bpainful%252Band%252Bfatigue%252Bsymptoms%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bfibromyalgia%26aulast%3DDagnino%26aufirst%3DAna%2BPaula%2BAquistapase%26date%3D2019%26date%3D2019%26volume%3D160%26issue%3D6%26spage%3D1383%26epage%3D1401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Massaly</span>, <span class="hlFld-ContribAuthor ">Jose A  Morón</span>. </span><span class="cited-content_cbyCitation_article-title">Pain And Opioid Systems, Implications In The Opioid Epidemic. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Behavioral Sciences</span><span> <strong>2019,</strong> <em>26 </em>, 69-74. <a href="https://doi.org/10.1016/j.cobeha.2018.10.002" title="DOI URL">https://doi.org/10.1016/j.cobeha.2018.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cobeha.2018.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cobeha.2018.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Behavioral%2520Sciences%26atitle%3DPain%252BAnd%252BOpioid%252BSystems%25252C%252BImplications%252BIn%252BThe%252BOpioid%252BEpidemic%26aulast%3DMassaly%26aufirst%3DNicolas%26date%3D2019%26volume%3D26%26spage%3D69%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anika  Mann</span>, <span class="hlFld-ContribAuthor ">Lionel  Moulédous</span>, <span class="hlFld-ContribAuthor ">Carine  Froment</span>, <span class="hlFld-ContribAuthor ">Patrick R.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Pooja  Dasgupta</span>, <span class="hlFld-ContribAuthor ">Thomas  Günther</span>, <span class="hlFld-ContribAuthor ">Gloria  Brunori</span>, <span class="hlFld-ContribAuthor ">Brigitte L.  Kieffer</span>, <span class="hlFld-ContribAuthor ">Lawrence  Toll</span>, <span class="hlFld-ContribAuthor ">Michael R.  Bruchas</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Stefan  Schulz</span>. </span><span class="cited-content_cbyCitation_article-title">Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2019,</strong> <em>12 </em>
                                    (574)
                                     , eaau8072. <a href="https://doi.org/10.1126/scisignal.aau8072" title="DOI URL">https://doi.org/10.1126/scisignal.aau8072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.aau8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.aau8072%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DAgonist-selective%252BNOP%252Breceptor%252Bphosphorylation%252Bcorrelates%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Band%252Breveals%252Bdifferential%252Bpost-activation%252Bsignaling%252Bby%252Bchemically%252Bdiverse%252Bagonists%26aulast%3DMann%26aufirst%3DAnika%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D574%26spage%3Deaau8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt  Rasmussen</span>, <span class="hlFld-ContribAuthor ">David A.  White</span>, <span class="hlFld-ContribAuthor ">Jane B.  Acri</span>. </span><span class="cited-content_cbyCitation_article-title">NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (4)
                                     , 657-659. <a href="https://doi.org/10.1038/s41386-018-0292-5" title="DOI URL">https://doi.org/10.1038/s41386-018-0292-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0292-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0292-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DNIDA%2525E2%252580%252599s%252Bmedication%252Bdevelopment%252Bpriorities%252Bin%252Bresponse%252Bto%252Bthe%252BOpioid%252BCrisis%25253A%252Bten%252Bmost%252Bwanted%26aulast%3DRasmussen%26aufirst%3DKurt%26date%3D2019%26date%3D2018%26volume%3D44%26issue%3D4%26spage%3D657%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna I.  Erdei</span>, <span class="hlFld-ContribAuthor ">Adina  Borbély</span>, <span class="hlFld-ContribAuthor ">Anna  Magyar</span>, <span class="hlFld-ContribAuthor ">Edina  Szűcs</span>, <span class="hlFld-ContribAuthor ">Ferenc  Ötvös</span>, <span class="hlFld-ContribAuthor ">Dávid  Gombos</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Al-Khrasani</span>, <span class="hlFld-ContribAuthor ">Azzurra  Stefanucci</span>, <span class="hlFld-ContribAuthor ">Marilisa Pia  Dimmito</span>, <span class="hlFld-ContribAuthor ">Grazia  Luisi</span>, <span class="hlFld-ContribAuthor ">Adriano  Mollica</span>, <span class="hlFld-ContribAuthor ">Sándor  Benyhe</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides. </span><span class="cited-content_cbyCitation_journal-name">Peptides</span><span> <strong>2019,</strong> <em>112 </em>, 106-113. <a href="https://doi.org/10.1016/j.peptides.2018.11.010" title="DOI URL">https://doi.org/10.1016/j.peptides.2018.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.peptides.2018.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.peptides.2018.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptides%26atitle%3DBiochemical%252Band%252Bpharmacological%252Binvestigation%252Bof%252Bnovel%252Bnociceptin%25252FOFQ%252Banalogues%252Band%252BN%25252FOFQ-RYYRIK%252Bhybrid%252Bpeptides%26aulast%3DErdei%26aufirst%3DAnna%2BI.%26date%3D2019%26volume%3D112%26spage%3D106%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norikazu  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Ko</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of NOP-Related Ligands in Nonhuman Primates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 323-343. <a href="https://doi.org/10.1007/164_2019_211" title="DOI URL">https://doi.org/10.1007/164_2019_211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2019_211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2019_211%26sid%3Dliteratum%253Aachs%26atitle%3DEffects%252Bof%252BNOP-Related%252BLigands%252Bin%252BNonhuman%252BPrimates%26aulast%3DKiguchi%26aufirst%3DNorikazu%26date%3D2019%26date%3D2019%26spage%3D323%26epage%3D343%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BReceptor%26aulast%3DKo%26aufirst%3DMei-Chuan%26date%3D2019%26volume%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Michael E.  Meyer</span>. </span><span class="cited-content_cbyCitation_article-title">NOP-Targeted Nonpeptide Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 37-67. <a href="https://doi.org/10.1007/164_2019_213" title="DOI URL">https://doi.org/10.1007/164_2019_213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2019_213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2019_213%26sid%3Dliteratum%253Aachs%26atitle%3DNOP-Targeted%252BNonpeptide%252BLigands%26aulast%3DZaveri%26aufirst%3DNurulain%2BT.%26date%3D2019%26date%3D2019%26spage%3D37%26epage%3D67%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BReceptor%26aulast%3DKo%26aufirst%3DMei-Chuan%26date%3D2019%26volume%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuel  Schembri</span>. </span><span class="cited-content_cbyCitation_article-title">Are Opioids Effective in Relieving Neuropathic Pain?. </span><span class="cited-content_cbyCitation_journal-name">SN Comprehensive Clinical Medicine</span><span> <strong>2019,</strong> <em>1 </em>
                                    (1)
                                     , 30-46. <a href="https://doi.org/10.1007/s42399-018-0009-4" title="DOI URL">https://doi.org/10.1007/s42399-018-0009-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s42399-018-0009-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs42399-018-0009-4%26sid%3Dliteratum%253Aachs%26jtitle%3DSN%2520Comprehensive%2520Clinical%2520Medicine%26atitle%3DAre%252BOpioids%252BEffective%252Bin%252BRelieving%252BNeuropathic%252BPain%25253F%26aulast%3DSchembri%26aufirst%3DEmanuel%26date%3D2019%26date%3D2018%26volume%3D1%26issue%3D1%26spage%3D30%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan  Zhang</span>, <span class="hlFld-ContribAuthor ">Frank  Stüber</span>, <span class="hlFld-ContribAuthor ">Christoph  Lippuner</span>, <span class="hlFld-ContribAuthor ">Marcel  Schiff</span>, <span class="hlFld-ContribAuthor ">Ulrike M  Stamer</span>. </span><span class="cited-content_cbyCitation_article-title">ERK and p38 contribute to the regulation of nociceptin and the nociceptin receptor in human peripheral blood leukocytes. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pain</span><span> <strong>2019,</strong> <em>15 </em>, 174480691982892. <a href="https://doi.org/10.1177/1744806919828921" title="DOI URL">https://doi.org/10.1177/1744806919828921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1744806919828921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1744806919828921%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pain%26atitle%3DERK%252Band%252Bp38%252Bcontribute%252Bto%252Bthe%252Bregulation%252Bof%252Bnociceptin%252Band%252Bthe%252Bnociceptin%252Breceptor%252Bin%252Bhuman%252Bperipheral%252Bblood%252Bleukocytes%26aulast%3DZhang%26aufirst%3DLan%26date%3D2019%26date%3D2019%26volume%3D15%26spage%3D174480691982892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Paul V.  Marquez</span>, <span class="hlFld-ContribAuthor ">Michael E.  Meyer</span>, <span class="hlFld-ContribAuthor ">Abdul  Hamid</span>, <span class="hlFld-ContribAuthor ">Kabirullah  Lutfy</span>. </span><span class="cited-content_cbyCitation_article-title">The Nociceptin Receptor (NOP) Agonist AT-312 Blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in Mice. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fpsyt.2018.00638" title="DOI URL">https://doi.org/10.3389/fpsyt.2018.00638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2018.00638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2018.00638%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DThe%252BNociceptin%252BReceptor%252B%252528NOP%252529%252BAgonist%252BAT-312%252BBlocks%252BAcquisition%252Bof%252BMorphine-%252Band%252BCocaine-Induced%252BConditioned%252BPlace%252BPreference%252Bin%252BMice%26aulast%3DZaveri%26aufirst%3DNurulain%2BT.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.  Calo</span>, <span class="hlFld-ContribAuthor ">D.G.  Lambert</span>. </span><span class="cited-content_cbyCitation_article-title">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Anaesthesia</span><span> <strong>2018,</strong> <em>121 </em>
                                    (5)
                                     , 1105-1114. <a href="https://doi.org/10.1016/j.bja.2018.06.024" title="DOI URL">https://doi.org/10.1016/j.bja.2018.06.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bja.2018.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bja.2018.06.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Anaesthesia%26atitle%3DNociceptin%25252Forphanin%252BFQ%252Breceptor%252Bligands%252Band%252Btranslational%252Bchallenges%25253A%252Bfocus%252Bon%252Bcebranopadol%252Bas%252Ban%252Binnovative%252Banalgesic%26aulast%3DCalo%26aufirst%3DG.%26date%3D2018%26volume%3D121%26issue%3D5%26spage%3D1105%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ean-Jeong  Seo</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>, <span class="hlFld-ContribAuthor ">Alexander  Panossian</span>. </span><span class="cited-content_cbyCitation_article-title">Curcumin downregulates expression of opioid-related nociceptin receptor gene (OPRL1) in isolated neuroglia cells. </span><span class="cited-content_cbyCitation_journal-name">Phytomedicine</span><span> <strong>2018,</strong> <em>50 </em>, 285-299. <a href="https://doi.org/10.1016/j.phymed.2018.09.202" title="DOI URL">https://doi.org/10.1016/j.phymed.2018.09.202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phymed.2018.09.202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phymed.2018.09.202%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytomedicine%26atitle%3DCurcumin%252Bdownregulates%252Bexpression%252Bof%252Bopioid-related%252Bnociceptin%252Breceptor%252Bgene%252B%252528OPRL1%252529%252Bin%252Bisolated%252Bneuroglia%252Bcells%26aulast%3DSeo%26aufirst%3DEan-Jeong%26date%3D2018%26volume%3D50%26spage%3D285%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Davide  Malfacini</span>, <span class="hlFld-ContribAuthor ">Katharina  Simon</span>, <span class="hlFld-ContribAuthor ">Claudio  Trapella</span>, <span class="hlFld-ContribAuthor ">Remo  Guerrini</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Evi  Kostenis</span>, <span class="hlFld-ContribAuthor ">Girolamo  Calo’</span>, . </span><span class="cited-content_cbyCitation_article-title">NOP receptor pharmacological profile – A dynamic mass redistribution study. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (8)
                                     , e0203021. <a href="https://doi.org/10.1371/journal.pone.0203021" title="DOI URL">https://doi.org/10.1371/journal.pone.0203021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0203021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0203021%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNOP%252Breceptor%252Bpharmacological%252Bprofile%252B%2525E2%252580%252593%252BA%252Bdynamic%252Bmass%252Bredistribution%252Bstudy%26aulast%3DMalfacini%26aufirst%3DDavide%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D8%26spage%3De0203021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huiping  Ding</span>, <span class="hlFld-ContribAuthor ">Norikazu  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Dennis  Yasuda</span>, <span class="hlFld-ContribAuthor ">Pankaj R.  Daga</span>, <span class="hlFld-ContribAuthor ">Willma E.  Polgar</span>, <span class="hlFld-ContribAuthor ">James J.  Lu</span>, <span class="hlFld-ContribAuthor ">Paul W.  Czoty</span>, <span class="hlFld-ContribAuthor ">Shiroh  Kishioka</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Ko</span>. </span><span class="cited-content_cbyCitation_article-title">A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2018,</strong> <em>10 </em>
                                    (456)
                                     , eaar3483. <a href="https://doi.org/10.1126/scitranslmed.aar3483" title="DOI URL">https://doi.org/10.1126/scitranslmed.aar3483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aar3483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aar3483%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DA%252Bbifunctional%252Bnociceptin%252Band%252Bmu%252Bopioid%252Breceptor%252Bagonist%252Bis%252Banalgesic%252Bwithout%252Bopioid%252Bside%252Beffects%252Bin%252Bnonhuman%252Bprimates%26aulast%3DDing%26aufirst%3DHuiping%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D456%26spage%3Deaar3483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel  Darcq</span>, <span class="hlFld-ContribAuthor ">Brigitte Lina  Kieffer</span>. </span><span class="cited-content_cbyCitation_article-title">Opioid receptors: drivers to addiction?. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Neuroscience</span><span> <strong>2018,</strong> <em>19 </em>
                                    (8)
                                     , 499-514. <a href="https://doi.org/10.1038/s41583-018-0028-x" title="DOI URL">https://doi.org/10.1038/s41583-018-0028-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41583-018-0028-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41583-018-0028-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Neuroscience%26atitle%3DOpioid%252Breceptors%25253A%252Bdrivers%252Bto%252Baddiction%25253F%26aulast%3DDarcq%26aufirst%3DEmmanuel%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D8%26spage%3D499%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. Matthew  Walentiny</span>, <span class="hlFld-ContribAuthor ">Jason M.  Wiebelhaus</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Beardsley</span>. </span><span class="cited-content_cbyCitation_article-title">Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice. </span><span class="cited-content_cbyCitation_journal-name">Drug and Alcohol Dependence</span><span> <strong>2018,</strong> <em>187 </em>, 335-342. <a href="https://doi.org/10.1016/j.drugalcdep.2018.02.035" title="DOI URL">https://doi.org/10.1016/j.drugalcdep.2018.02.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drugalcdep.2018.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drugalcdep.2018.02.035%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520and%2520Alcohol%2520Dependence%26atitle%3DNociceptin%25252Forphanin%252BFQ%252Breceptors%252Bmodulate%252Bthe%252Bdiscriminative%252Bstimulus%252Beffects%252Bof%252Boxycodone%252Bin%252BC57BL%25252F6%252Bmice%26aulast%3DWalentiny%26aufirst%3DD.%2BMatthew%26date%3D2018%26volume%3D187%26spage%3D335%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ludovico  Arcuri</span>, <span class="hlFld-ContribAuthor ">Salvatore  Novello</span>, <span class="hlFld-ContribAuthor ">Martina  Frassineti</span>, <span class="hlFld-ContribAuthor ">Daniela  Mercatelli</span>, <span class="hlFld-ContribAuthor ">Clarissa Anna  Pisanò</span>, <span class="hlFld-ContribAuthor ">Ilaria  Morella</span>, <span class="hlFld-ContribAuthor ">Stefania  Fasano</span>, <span class="hlFld-ContribAuthor ">Blair V  Journigan</span>, <span class="hlFld-ContribAuthor ">Michael E  Meyer</span>, <span class="hlFld-ContribAuthor ">Willma E  Polgar</span>, <span class="hlFld-ContribAuthor ">Riccardo  Brambilla</span>, <span class="hlFld-ContribAuthor ">Nurulain T  Zaveri</span>, <span class="hlFld-ContribAuthor ">Michele  Morari</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2018,</strong> <em>175 </em>
                                    (5)
                                     , 782-796. <a href="https://doi.org/10.1111/bph.14123" title="DOI URL">https://doi.org/10.1111/bph.14123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14123%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DAnti-Parkinsonian%252Band%252Banti-dyskinetic%252Bprofiles%252Bof%252Btwo%252Bnovel%252Bpotent%252Band%252Bselective%252Bnociceptin%25252Forphanin%252BFQ%252Breceptor%252Bagonists%26aulast%3DArcuri%26aufirst%3DLudovico%26date%3D2018%26date%3D2018%26volume%3D175%26issue%3D5%26spage%3D782%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Paul V.  Marquez</span>, <span class="hlFld-ContribAuthor ">Michael E.  Meyer</span>, <span class="hlFld-ContribAuthor ">Willma E.  Polgar</span>, <span class="hlFld-ContribAuthor ">Abdul  Hamid</span>, <span class="hlFld-ContribAuthor ">Kabirullah  Lutfy</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice. </span><span class="cited-content_cbyCitation_journal-name">Alcoholism: Clinical and Experimental Research</span><span> <strong>2018,</strong> <em>42 </em>
                                    (2)
                                     , 461-471. <a href="https://doi.org/10.1111/acer.13575" title="DOI URL">https://doi.org/10.1111/acer.13575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/acer.13575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Facer.13575%26sid%3Dliteratum%253Aachs%26jtitle%3DAlcoholism%253A%2520Clinical%2520and%2520Experimental%2520Research%26atitle%3DA%252BNovel%252Band%252BSelective%252BNociceptin%252BReceptor%252B%252528NOP%252529%252BAgonist%252B%2525281-%2525281-%252528%252528cis%252529-4-isopropylcyclohexyl%252529piperidin-4-yl%252529-1H-indol-2-yl%252529methanol%252B%252528AT-312%252529%252BDecreases%252BAcquisition%252Bof%252BEthanol-Induced%252BConditioned%252BPlace%252BPreference%252Bin%252BMice%26aulast%3DZaveri%26aufirst%3DNurulain%2BT.%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D2%26spage%3D461%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lionel  Moulédous</span>. </span><span class="cited-content_cbyCitation_article-title">The Nociceptin/Orphanin FQ System and the Regulation of Memory. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 259-278. <a href="https://doi.org/10.1007/164_2018_185" title="DOI URL">https://doi.org/10.1007/164_2018_185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2018_185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2018_185%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BNociceptin%25252FOrphanin%252BFQ%252BSystem%252Band%252Bthe%252BRegulation%252Bof%252BMemory%26aulast%3DMoul%25C3%25A9dous%26aufirst%3DLionel%26date%3D2018%26date%3D2018%26spage%3D259%26epage%3D278%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BReceptor%26aulast%3DKo%26aufirst%3DMei-Chuan%26date%3D2019%26volume%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey M.  Witkin</span>, <span class="hlFld-ContribAuthor ">Tanya L.  Wallace</span>, <span class="hlFld-ContribAuthor ">William J.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Approaches for NOP Receptor Antagonists in Neurobehavioral Disorders: Clinical Studies in Major Depressive Disorder and Alcohol Use Disorder with BTRX-246040 (LY2940094). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 399-415. <a href="https://doi.org/10.1007/164_2018_186" title="DOI URL">https://doi.org/10.1007/164_2018_186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2018_186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2018_186%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BApproaches%252Bfor%252BNOP%252BReceptor%252BAntagonists%252Bin%252BNeurobehavioral%252BDisorders%25253A%252BClinical%252BStudies%252Bin%252BMajor%252BDepressive%252BDisorder%252Band%252BAlcohol%252BUse%252BDisorder%252Bwith%252BBTRX-246040%252B%252528LY2940094%252529%26aulast%3DWitkin%26aufirst%3DJeffrey%2BM.%26date%3D2018%26date%3D2019%26spage%3D399%26epage%3D415%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BReceptor%26aulast%3DKo%26aufirst%3DMei-Chuan%26date%3D2019%26volume%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delia  Preti</span>, <span class="hlFld-ContribAuthor ">Girolamo  Caló</span>, <span class="hlFld-ContribAuthor ">Remo  Guerrini</span>. </span><span class="cited-content_cbyCitation_article-title">NOP-Targeted Peptide Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 17-36. <a href="https://doi.org/10.1007/164_2018_198" title="DOI URL">https://doi.org/10.1007/164_2018_198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2018_198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2018_198%26sid%3Dliteratum%253Aachs%26atitle%3DNOP-Targeted%252BPeptide%252BLigands%26aulast%3DPreti%26aufirst%3DDelia%26date%3D2018%26date%3D2019%26spage%3D17%26epage%3D36%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DThe%252BNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BReceptor%26aulast%3DKo%26aufirst%3DMei-Chuan%26date%3D2019%26volume%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heath B.  McAnally</span>. </span><span class="cited-content_cbyCitation_article-title">Attenuating the Agent: Reducing Opioid “Virulence”. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 99-118. <a href="https://doi.org/10.1007/978-3-319-47497-7_5" title="DOI URL">https://doi.org/10.1007/978-3-319-47497-7_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-47497-7_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-47497-7_5%26sid%3Dliteratum%253Aachs%26atitle%3DAttenuating%252Bthe%252BAgent%25253A%252BReducing%252BOpioid%252B%2525E2%252580%25259CVirulence%2525E2%252580%25259D%26aulast%3DMcAnally%26aufirst%3DHeath%2BB.%26date%3D2018%26date%3D2017%26spage%3D99%26epage%3D118%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DOpioid%252BDependence%26aulast%3DMcAnally%26aufirst%3DHeath%2BB.%26date%3D2018%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Yulia B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XVI, 2016. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 173-254. <a href="https://doi.org/10.1016/bs.aihch.2018.02.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2018.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2018.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2018.02.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXVI%25252C%252B2016%26aulast%3DBelen%25E2%2580%2599kii%26aufirst%3DLeonid%2BI.%26date%3D2018%26spage%3D173%26epage%3D254%26pub%3DElsevier%26date%3D2018%26volume%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Girolamo  Calo’</span>, <span class="hlFld-ContribAuthor ">Anna  Rizzi</span>, <span class="hlFld-ContribAuthor ">Chiara  Ruzza</span>, <span class="hlFld-ContribAuthor ">Federica  Ferrari</span>, <span class="hlFld-ContribAuthor ">Salvatore  Pacifico</span>, <span class="hlFld-ContribAuthor ">Elaine C.  Gavioli</span>, <span class="hlFld-ContribAuthor ">Severo  Salvadori</span>, <span class="hlFld-ContribAuthor ">Remo  Guerrini</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors. </span><span class="cited-content_cbyCitation_journal-name">Peptides</span><span> <strong>2018,</strong> <em>99 </em>, 195-204. <a href="https://doi.org/10.1016/j.peptides.2017.10.004" title="DOI URL">https://doi.org/10.1016/j.peptides.2017.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.peptides.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.peptides.2017.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DPeptides%26atitle%3DPeptide%252Bwelding%252Btechnology%252B%2525E2%252580%252593%252BA%252Bsimple%252Bstrategy%252Bfor%252Bgenerating%252Binnovative%252Bligands%252Bfor%252BG%252Bprotein%252Bcoupled%252Breceptors%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DGirolamo%26date%3D2018%26volume%3D99%26spage%3D195%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaoula  Rekik</span>, <span class="hlFld-ContribAuthor ">Raquel  Faria Da Silva</span>, <span class="hlFld-ContribAuthor ">Morgane  Colom</span>, <span class="hlFld-ContribAuthor ">Salvatore  Pacifico</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Girolamo  Calo'</span>, <span class="hlFld-ContribAuthor ">Claire  Rampon</span>, <span class="hlFld-ContribAuthor ">Bernard  Frances</span>, <span class="hlFld-ContribAuthor ">Lionel  Mouledous</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>125 </em>, 39-49. <a href="https://doi.org/10.1016/j.neuropharm.2017.07.006" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DActivation%252Bof%252Bnociceptin%25252Forphanin%252BFQ%252Breceptors%252Binhibits%252Bcontextual%252Bfear%252Bmemory%252Breconsolidation%26aulast%3DRekik%26aufirst%3DKhaoula%26date%3D2017%26volume%3D125%26spage%3D39%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Ferrari</span>, <span class="hlFld-ContribAuthor ">Davide  Malfacini</span>, <span class="hlFld-ContribAuthor ">Blair V.  Journigan</span>, <span class="hlFld-ContribAuthor ">Mark F.  Bird</span>, <span class="hlFld-ContribAuthor ">Claudio  Trapella</span>, <span class="hlFld-ContribAuthor ">Remo  Guerrini</span>, <span class="hlFld-ContribAuthor ">David G.  Lambert</span>, <span class="hlFld-ContribAuthor ">Girolamo  Calo'</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2017,</strong> <em>5 </em>
                                    (4)
                                     , e00333. <a href="https://doi.org/10.1002/prp2.333" title="DOI URL">https://doi.org/10.1002/prp2.333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.333%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DIn%252Bvitro%252Bpharmacological%252Bcharacterization%252Bof%252Ba%252Bnovel%252Bunbiased%252BNOP%252Breceptor-selective%252Bnonpeptide%252Bagonist%252BAT-403%26aulast%3DFerrari%26aufirst%3DFederica%26date%3D2017%26date%3D2017%26volume%3D5%26issue%3D4%26spage%3De00333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. B.  Raffa</span>, <span class="hlFld-ContribAuthor ">G.  Burdge</span>, <span class="hlFld-ContribAuthor ">J.  Gambrah</span>, <span class="hlFld-ContribAuthor ">H. E.  Kinecki</span>, <span class="hlFld-ContribAuthor ">F.  Lin</span>, <span class="hlFld-ContribAuthor ">B.  Lu</span>, <span class="hlFld-ContribAuthor ">J. T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">V.  Phan</span>, <span class="hlFld-ContribAuthor ">A.  Ruan</span>, <span class="hlFld-ContribAuthor ">M. A.  Sesay</span>, <span class="hlFld-ContribAuthor ">T. N.  Watkins</span>. </span><span class="cited-content_cbyCitation_article-title">Cebranopadol: novel dual opioid/NOP receptor agonist analgesic. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Pharmacy and Therapeutics</span><span> <strong>2017,</strong> <em>42 </em>
                                    (1)
                                     , 8-17. <a href="https://doi.org/10.1111/jcpt.12461" title="DOI URL">https://doi.org/10.1111/jcpt.12461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcpt.12461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcpt.12461%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Pharmacy%2520and%2520Therapeutics%26atitle%3DCebranopadol%25253A%252Bnovel%252Bdual%252Bopioid%25252FNOP%252Breceptor%252Bagonist%252Banalgesic%26aulast%3DRaffa%26aufirst%3DR.%2BB.%26date%3D2017%26date%3D2016%26volume%3D42%26issue%3D1%26spage%3D8%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Ferrari</span>, <span class="hlFld-ContribAuthor ">Maria Camilla  Cerlesi</span>, <span class="hlFld-ContribAuthor ">Davide  Malfacini</span>, <span class="hlFld-ContribAuthor ">Laila  Asth</span>, <span class="hlFld-ContribAuthor ">Elaine C.  Gavioli</span>, <span class="hlFld-ContribAuthor ">Blair V.  Journigan</span>, <span class="hlFld-ContribAuthor ">Uma Gayathri  Kamakolanu</span>, <span class="hlFld-ContribAuthor ">Michael E.  Meyer</span>, <span class="hlFld-ContribAuthor ">Dennis  Yasuda</span>, <span class="hlFld-ContribAuthor ">Willma E.  Polgar</span>, <span class="hlFld-ContribAuthor ">Anna  Rizzi</span>, <span class="hlFld-ContribAuthor ">Remo  Guerrini</span>, <span class="hlFld-ContribAuthor ">Chiara  Ruzza</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Girolamo  Calo</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2016,</strong> <em>793 </em>, 1-13. <a href="https://doi.org/10.1016/j.ejphar.2016.10.025" title="DOI URL">https://doi.org/10.1016/j.ejphar.2016.10.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2016.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2016.10.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DIn%252Bvitro%252Bfunctional%252Bcharacterization%252Bof%252Bnovel%252Bnociceptin%25252Forphanin%252BFQ%252Breceptor%252Bagonists%252Bin%252Brecombinant%252Band%252Bnative%252Bpreparations%26aulast%3DFerrari%26aufirst%3DFederica%26date%3D2016%26volume%3D793%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and in vitro pharmacological profiles of known NOP agonists. Note that the in vitro data from the cited references are from different laboratories and use different radioligands and protocols for the assays and therefore cannot be directly compared.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures and in vitro pharmacological profiles of NOP antagonists widely used as tool compounds. Note that the in vitro data from the cited references are from different laboratories and use different radioligands and protocols for the assays and therefore cannot be directly compared.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/medium/jm-2015-014997_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures and in vitro pharmacological profiles of NOP antagonist-based PET tracers and radioligands recently developed for the NOP receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.5b01499/20160811/images/large/jm-2015-014997_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01499&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 164 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailleux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moisand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caput, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J. C.</span><span> </span><span class="NLM_article-title">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)80235-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2980235-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=8137918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1994&pages=33-38&author=C.+Mollereauauthor=M.+Parmentierauthor=P.+Mailleuxauthor=J.+L.+Butourauthor=C.+Moisandauthor=P.+Chalonauthor=D.+Caputauthor=G.+Vassartauthor=J.+C.+Meunier&title=ORL1%2C+a+novel+member+of+the+opioid+receptor+family.+Cloning%2C+functional+expression+and+localization&doi=10.1016%2F0014-5793%2894%2980235-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span></div><div class="casAuthors">Mollereau, Catherine; Parmentier, Marc; Mailleux, Pierre; Butour, Jean Luc; Moisand, Christiane; Chalon, Pascale; Caput, Daniel; Vassart, Gilbert; Meunier, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-8</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Selective PCR amplification of human and mouse genomic DNAs with oligonucleotides encoding highly conserved regions of the β-opioid and somatostatin receptors generated a human DNA probe (hOP01, 761 bp) and its murine counterpart (mOP86, 447 bp).  Probe hOP01 was used to screen a cDNA library from human brainstem.  A clone (named hORL1) was isolated, sequenced and found to encode a protein of 370 amino acids whose primary structure displays the seven putative membrane-spanning domains of a G protein-coupled membrane receptor.  The hORL1 receptor is most closely related to opioid receptors not only on structural (sequence) but also on functional grounds: hORL1 is 49-50% identical to the murine μ-, δ- and κ-opioid receptors and, in CHO-K1 cells stably transfected with a pRc/CMV:hORL1 construct, ORL1 mediates inhibition of adenylyl cyclase by etorphine, a universal (nonselective) opiate agonist.  Yet, hORL1 appears not to be a typical opioid receptor.  Neither is it a somatostatin or σ (N-allylnormetazocine) receptor.  The mRNAs hybridizing with synthetic oligonucleotides complementary to mOP86 are present in many regions of the mouse brain and spinal cord, particularly in limbic (amygdala, hippocampus, septum, habenula, ...) and hypothalamic structures.  The authors conclude that the hORL1 receptor is a new member of the opioid receptor family with a potential role in modulating a no. of brain functions, including instinctive behaviors and emotions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWFR7ExrwbJrVg90H21EOLACvtfcHk0lgxDXq7U55uqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D&md5=7a7190c4703811558b3ce3e60e9df7e8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980235-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980235-1%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DMailleux%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DChalon%26aufirst%3DP.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26atitle%3DORL1%252C%2520a%2520novel%2520member%2520of%2520the%2520opioid%2520receptor%2520family.%2520Cloning%252C%2520functional%2520expression%2520and%2520localization%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D341%26spage%3D33%26epage%3D38%26doi%3D10.1016%2F0014-5793%2894%2980235-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortrud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span> </span><span class="NLM_article-title">Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)00561-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2900561-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1994&pages=284-288&author=J.+R.+Bunzowauthor=C.+Saezauthor=M.+Mortrudauthor=C.+Bouvierauthor=J.+T.+Williamsauthor=M.+Lowauthor=D.+K.+Grandy&title=Molecular+cloning+and+tissue+distribution+of+a+putative+member+of+the+rat+opioid+receptor+gene+family+that+is+not+a+mu%2C+delta+or+kappa+opioid+receptor+type&doi=10.1016%2F0014-5793%2894%2900561-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900561-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900561-3%26sid%3Dliteratum%253Aachs%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DSaez%26aufirst%3DC.%26aulast%3DMortrud%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DLow%26aufirst%3DM.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26atitle%3DMolecular%2520cloning%2520and%2520tissue%2520distribution%2520of%2520a%2520putative%2520member%2520of%2520the%2520rat%2520opioid%2520receptor%2520gene%2520family%2520that%2520is%2520not%2520a%2520mu%252C%2520delta%2520or%2520kappa%2520opioid%2520receptor%2520type%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D347%26spage%3D284%26epage%3D288%26doi%3D10.1016%2F0014-5793%2894%2900561-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Fukuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houtani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, T.</span><span> </span><span class="NLM_article-title">cDNA cloning and regional distribution of a novel member of the opioid receptor family</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)80603-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2980603-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=1994&pages=42-46&author=K.+Fukudaauthor=S.+Katoauthor=K.+Moriauthor=M.+Nishiauthor=H.+Takeshimaauthor=N.+Iwabeauthor=T.+Miyataauthor=T.+Houtaniauthor=T.+Sugimoto&title=cDNA+cloning+and+regional+distribution+of+a+novel+member+of+the+opioid+receptor+family&doi=10.1016%2F0014-5793%2894%2980603-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980603-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980603-9%26sid%3Dliteratum%253Aachs%26aulast%3DFukuda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DNishi%26aufirst%3DM.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DIwabe%26aufirst%3DN.%26aulast%3DMiyata%26aufirst%3DT.%26aulast%3DHoutani%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DT.%26atitle%3DcDNA%2520cloning%2520and%2520regional%2520distribution%2520of%2520a%2520novel%2520member%2520of%2520the%2520opioid%2520receptor%2520family%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D343%26spage%3D42%26epage%3D46%26doi%3D10.1016%2F0014-5793%2894%2980603-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persico, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozenberger, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eppler, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhl, G. R.</span><span> </span><span class="NLM_article-title">cDNA cloning of an orphan opiate receptor gene family member and its splice variant</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/0014-5793(94)00557-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0014-5793%2894%2900557-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1994&pages=75-79&author=J.+B.+Wangauthor=P.+S.+Johnsonauthor=Y.+Imaiauthor=A.+M.+Persicoauthor=B.+A.+Ozenbergerauthor=C.+M.+Epplerauthor=G.+R.+Uhl&title=cDNA+cloning+of+an+orphan+opiate+receptor+gene+family+member+and+its+splice+variant&doi=10.1016%2F0014-5793%2894%2900557-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2900557-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252900557-5%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BB.%26aulast%3DJohnson%26aufirst%3DP.%2BS.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DPersico%26aufirst%3DA.%2BM.%26aulast%3DOzenberger%26aufirst%3DB.%2BA.%26aulast%3DEppler%26aufirst%3DC.%2BM.%26aulast%3DUhl%26aufirst%3DG.%2BR.%26atitle%3DcDNA%2520cloning%2520of%2520an%2520orphan%2520opiate%2520receptor%2520gene%2520family%2520member%2520and%2520its%2520splice%2520variant%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D348%26spage%3D75%26epage%3D79%26doi%3D10.1016%2F0014-5793%2894%2900557-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Pan, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan-Moro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standifer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1995&pages=1180-1188&author=Y.+X.+Panauthor=J.+Chengauthor=J.+Xuauthor=G.+Rossiauthor=E.+Jacobsonauthor=J.+Ryan-Moroauthor=A.+I.+Brooksauthor=G.+E.+Deanauthor=K.+M.+Standiferauthor=G.+W.+Pasternak&title=Cloning+and+functional+characterization+through+antisense+mapping+of+a+kappa+3-related+opioid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%2BX.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DE.%26aulast%3DRyan-Moro%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DA.%2BI.%26aulast%3DDean%26aufirst%3DG.%2BE.%26aulast%3DStandifer%26aufirst%3DK.%2BM.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DCloning%2520and%2520functional%2520characterization%2520through%2520antisense%2520mapping%2520of%2520a%2520kappa%25203-related%2520opioid%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D1995%26volume%3D47%26spage%3D1180%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Meunier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suaudeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moisand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvinerie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemot, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsarrat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarguil, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span> </span><span class="NLM_article-title">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1038/377532a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2F377532a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=7566152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=532-535&author=J.+C.+Meunierauthor=C.+Mollereauauthor=L.+Tollauthor=C.+Suaudeauauthor=C.+Moisandauthor=P.+Alvinerieauthor=J.+L.+Butourauthor=J.+C.+Guillemotauthor=P.+Ferraraauthor=B.+Monsarratauthor=H.+Mazarguilauthor=G.+Vassartauthor=M.+Parmentierauthor=J.+Costentin&title=Isolation+and+structure+of+the+endogenous+agonist+of+opioid+receptor-like+ORL1+receptor&doi=10.1038%2F377532a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span></div><div class="casAuthors">Meunier, Jean-Claude; Mollereau, Catherine; Toll, Lawrence; Suaudeau, Charles; Moisand, Christiane; Alvinerie, Paul; Butour, Jean-Luc; Guillemot, Jean-Claude; Ferrara, Pascual; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">6549</span>),
    <span class="NLM_cas:pages">532-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The ORL1 receptor, an orphan receptor whose human and murine complementary DNAs have recently been characterized, structurally resembles opioid receptors and is neg. coupled with adenylate cyclase.  ORL1 transcripts are particularly abundant in the central nervous system.  Here the authors report the isolation, on the basis of its ability to inhibit the cyclase in a stable recombinant CHO(ORL1+) cell line, of a neuropeptide that resembles dynorphin A and whose amino acid sequences is Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln.  A rat-brain cDNA encodes the peptide flanked by Lys-Arg proteolytic cleavage motifs.  The synthetic heptadecapeptide potently inhibits adenylate cyclase in CHO(ORL1+) cells in culture and induces hyperalgesia when administered intracerebroventricularly to mice.  Taken together, these data indicate that the newly discovered heptadecapeptide is an endogenous agonist of the ORL1 receptor and that it may be endowed with pro-nociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Ma-3fqZODbVg90H21EOLACvtfcHk0lh9337A-MVXEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D&md5=664f5b56671b66e3c7caee4d2acc4a5b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F377532a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F377532a0%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DSuaudeau%26aufirst%3DC.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DAlvinerie%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DGuillemot%26aufirst%3DJ.%2BC.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DMonsarrat%26aufirst%3DB.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DIsolation%2520and%2520structure%2520of%2520the%2520endogenous%2520agonist%2520of%2520opioid%2520receptor-like%2520ORL1%2520receptor%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D532%26epage%3D535%26doi%3D10.1038%2F377532a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nothacker, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henningsen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunzow, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandy, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.1126/science.270.5237.792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1126%2Fscience.270.5237.792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=7481766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=792-794&author=R.+K.+Reinscheidauthor=H.+P.+Nothackerauthor=A.+Boursonauthor=A.+Ardatiauthor=R.+A.+Henningsenauthor=J.+R.+Bunzowauthor=D.+K.+Grandyauthor=H.+Langenauthor=F.+J.+Monsmaauthor=O.+Civelli&title=Orphanin+FQ%3A+a+neuropeptide+that+activates+an+opioidlike+G+protein-coupled+receptor&doi=10.1126%2Fscience.270.5237.792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span></div><div class="casAuthors">Reinscheid, Rainer K.; Nothacker, Hans-Peter; Bourson, Anne; Ardati, Ali; Henningsen, Robert A.; Bunzow, James R.; Grady, David K.; Langen, Hanno; Monsma, Frederick J., Jr.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">5237</span>),
    <span class="NLM_cas:pages">792-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A heptadecapeptide was identified and purified from porcine brain tissue as a ligand for an orphan heterotrimeric GTP-binding protein (G protein)- coupled receptor (LC132) that is similar in sequence to opioid receptors.  This peptide, orphanin FQ, has a primary structure reminiscent of that of opioid peptides.  Nanomolar concns. of orphanin FQ inhibited forskolin-stimulated adenylyl cyclase activity in cells transfected with LC132.  This inhibitory activity was not affected by the addn. of opioid ligands, nor did the peptide activate opioid receptors.  Orphanin FQ bound to its receptor in a saturable manner and with high affinity.  When injected intracerebroventricularly into mice, orphanin FQ caused a decrease in locomotor activity but did not induce analgesia in the hot-plate test.  However, the peptide produced hyperalgesia in the tail-flick assay.  Thus, orphanin FQ may act as a transmitter in the brain by modulating nociceptive and locomotor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpERb2sP0w_6bVg90H21EOLACvtfcHk0ljsk_QcR-CeOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D&md5=64b046d1497af57d0841c0de710dcad5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.270.5237.792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.270.5237.792%26sid%3Dliteratum%253Aachs%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DNothacker%26aufirst%3DH.%2BP.%26aulast%3DBourson%26aufirst%3DA.%26aulast%3DArdati%26aufirst%3DA.%26aulast%3DHenningsen%26aufirst%3DR.%2BA.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLangen%26aufirst%3DH.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DOrphanin%2520FQ%253A%2520a%2520neuropeptide%2520that%2520activates%2520an%2520opioidlike%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D792%26epage%3D794%26doi%3D10.1126%2Fscience.270.5237.792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mollereau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouledous, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapalu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambois, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moisand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J. C.</span><span> </span><span class="NLM_article-title">Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=324-331&author=C.+Mollereauauthor=L.+Mouledousauthor=S.+Lapaluauthor=G.+Camboisauthor=C.+Moisandauthor=J.+L.+Butourauthor=J.+C.+Meunier&title=Distinct+mechanisms+for+activation+of+the+opioid+receptor-like+1+and+kappa-opioid+receptors+by+nociceptin+and+dynorphin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DMouledous%26aufirst%3DL.%26aulast%3DLapalu%26aufirst%3DS.%26aulast%3DCambois%26aufirst%3DG.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26atitle%3DDistinct%2520mechanisms%2520for%2520activation%2520of%2520the%2520opioid%2520receptor-like%25201%2520and%2520kappa-opioid%2520receptors%2520by%2520nociceptin%2520and%2520dynorphin%2520A%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D55%26spage%3D324%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Yu, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C. W.</span><span> </span><span class="NLM_article-title">Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus</span> <span class="citation_source-journal">Hippocampus</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1002/(SICI)1098-1063(1997)7:1<88::AID-HIPO9>3.0.CO;2-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=88-94&author=T.+P.+Yuauthor=J.+Feinauthor=T.+Phanauthor=C.+J.+Evansauthor=C.+W.+Xie&title=Orphanin+FQ+inhibits+synaptic+transmission+and+long-term+potentiation+in+rat+hippocampus&doi=10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1063%25281997%25297%253A1%253C88%253A%253AAID-HIPO9%253E3.0.CO%253B2-3%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DT.%2BP.%26aulast%3DFein%26aufirst%3DJ.%26aulast%3DPhan%26aufirst%3DT.%26aulast%3DEvans%26aufirst%3DC.%2BJ.%26aulast%3DXie%26aufirst%3DC.%2BW.%26atitle%3DOrphanin%2520FQ%2520inhibits%2520synaptic%2520transmission%2520and%2520long-term%2520potentiation%2520in%2520rat%2520hippocampus%26jtitle%3DHippocampus%26date%3D1997%26volume%3D7%26spage%3D88%26epage%3D94%26doi%3D10.1002%2F%28SICI%291098-1063%281997%297%3A1%3C88%3A%3AAID-HIPO9%3E3.0.CO%3B2-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hawes, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span> </span><span class="NLM_article-title">Cellular actions of nociceptin: transduction mechanisms</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1016/S0196-9781(00)00232-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0196-9781%2800%2900232-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=961-967&author=B.+E.+Hawesauthor=M.+P.+Grazianoauthor=D.+G.+Lambert&title=Cellular+actions+of+nociceptin%3A+transduction+mechanisms&doi=10.1016%2FS0196-9781%2800%2900232-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900232-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900232-1%26sid%3Dliteratum%253Aachs%26aulast%3DHawes%26aufirst%3DB.%2BE.%26aulast%3DGraziano%26aufirst%3DM.%2BP.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCellular%2520actions%2520of%2520nociceptin%253A%2520transduction%2520mechanisms%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D961%26epage%3D967%26doi%3D10.1016%2FS0196-9781%2800%2900232-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Briscini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span> </span><span class="NLM_article-title">Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/S0014-2999(02)01833-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2802%2901833-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12106803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38XltFWjs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2002&pages=59-65&author=L.+Brisciniauthor=L.+Corradiniauthor=E.+Onginiauthor=R.+Bertorelli&title=Up-regulation+of+ORL-1+receptors+in+spinal+tissue+of+allodynic+rats+after+sciatic+nerve+injury&doi=10.1016%2FS0014-2999%2802%2901833-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury</span></div><div class="casAuthors">Briscini, Luca; Corradini, Laura; Ongini, Ennio; Bertorelli, Rosalia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-65</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Nociceptin, acting through the opioid receptor-like 1 (ORL1) receptor, produces anti-nociception in several models of neuropathy.  We examd. the involvement of the ORL1 receptor system in the allodynia developed after sciatic nerve ligation.  Allodyniac rats were selected by the von Frey hair and treated intrathecally with nociception or morphine.  The peptide induced dose-dependent anti-allodynic activities, while morphine was effective at the higher dose only.  By the semi-quant. reverse transcription-polymerase chain reaction (RT-PCR) assay, the two described ORL1 receptor isoforms were up-regulated in the allodynic animals, but unmodified in non-allodynic rats.  Both short and long ORL1 receptor mRNA isoforms increased in the ipsilateral lumbar enlargement (by 50% and 100%, resp.), while 50% and 60% increases were found in the ipsilateral L5-L6 dorsal root ganglia, resp.  No significant changes were obsd. for either the nociception precursor or μ-opioid receptor expression.  Thus, the ORL1 receptor system seems to regulate the mechano-allodynia that developed after nerve damage, suggesting its potential role in the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh2Ql1yMFL4rVg90H21EOLACvtfcHk0ljsk_QcR-CeOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltFWjs78%253D&md5=86c920a656ceda72780aaf8d876b832e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901833-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901833-2%26sid%3Dliteratum%253Aachs%26aulast%3DBriscini%26aufirst%3DL.%26aulast%3DCorradini%26aufirst%3DL.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DBertorelli%26aufirst%3DR.%26atitle%3DUp-regulation%2520of%2520ORL-1%2520receptors%2520in%2520spinal%2520tissue%2520of%2520allodynic%2520rats%2520after%2520sciatic%2520nerve%2520injury%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D447%26spage%3D59%26epage%3D65%26doi%3D10.1016%2FS0014-2999%2802%2901833-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenach, J. C.</span><span> </span><span class="NLM_article-title">Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">970</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/S0006-8993(03)02293-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0006-8993%2803%2902293-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12706252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFeqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=970&publication_year=2003&pages=110-118&author=W.+Maauthor=J.+C.+Eisenach&title=Chronic+constriction+injury+of+sciatic+nerve+induces+the+up-regulation+of+descending+inhibitory+noradrenergic+innervation+to+the+lumbar+dorsal+horn+of+mice&doi=10.1016%2FS0006-8993%2803%2902293-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice</span></div><div class="casAuthors">Ma, Weiya; Eisenach, James C.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">970</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">110-118</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Peripheral nerve injury in rodents results in hypersensitivity to mech. and thermal stimuli accompanied by reduced antinociceptive efficacy of opioids and, in some models, sensitivity to sympathetic blockade.  α2-Adrenergic receptor agonists increase in potency and efficacy after nerve injury in rodents and effectively relieve neuropathic pain in humans who do not get pain relief from opioids.  However, the underlying mechanisms are unclear.  It has been well known that the major noradrenergic innervation of the spinal dorsal horn originates from the locus coeruleus nucleus (LC) in the brainstem.  Therefore, the aim of this study is to examine whether peripheral nerve injury that causes neuropathic pain modulates the noradrenergic innervation to the lumbar dorsal horn, in order to det. the possible anatomical substrates underlying increased potency and efficacy of noradrenergic receptor agonists in alleviating neuropathic pain.  At 2 wk after chronic constriction injury (CCI) of the sciatic nerve, a remarkable increase in tyrosine-hydroxylase (TH) and dopamine β-hydroxylase (DβH) immunoreactive (IR) axonal terminals was obsd. in the ipsilateral L4-L6 dorsal horn.  Consistently, greater nos. of both TH- and DβH-IR neurons were detected in the ipsilateral LC.  Interestingly, in the lower lumbar and upper sacral spinal dorsal horn, numerous TH-IR neurons were obsd. in the superficial dorsal horn (primarily lamina I).  CCI of the sciatic nerve did not change the no. of these TH-IR cells.  These findings suggest that augmented descending inhibitory noradrenergic innervation to the dorsal horn could be one of the mechanisms underlying the increased effectiveness in the anti-allodynic effect elicited by α2-adrenergic receptor agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCSiYg-eRHSbVg90H21EOLACvtfcHk0lhrWQDKTUMIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFeqtLs%253D&md5=961f4a46808293a06ad6625fedd8acb7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2803%2902293-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252803%252902293-5%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DEisenach%26aufirst%3DJ.%2BC.%26atitle%3DChronic%2520constriction%2520injury%2520of%2520sciatic%2520nerve%2520induces%2520the%2520up-regulation%2520of%2520descending%2520inhibitory%2520noradrenergic%2520innervation%2520to%2520the%2520lumbar%2520dorsal%2520horn%2520of%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2003%26volume%3D970%26spage%3D110%26epage%3D118%26doi%3D10.1016%2FS0006-8993%2803%2902293-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mika, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weihe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M. K.</span><span> </span><span class="NLM_article-title">Relationship of pronociceptin/orphanin FQ and the nociceptin receptor ORL1 with Substance P and calcitonin gene-related peptide expression in dorsal root ganglion of the rat</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span><span class="refDoi"> DOI: 10.1016/S0304-3940(03)00786-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2803%2900786-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=190-194&author=J.+Mikaauthor=Y.+Liauthor=E.+Weiheauthor=M.+K.+Schafer&title=Relationship+of+pronociceptin%2Forphanin+FQ+and+the+nociceptin+receptor+ORL1+with+Substance+P+and+calcitonin+gene-related+peptide+expression+in+dorsal+root+ganglion+of+the+rat&doi=10.1016%2FS0304-3940%2803%2900786-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2803%2900786-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252803%252900786-9%26sid%3Dliteratum%253Aachs%26aulast%3DMika%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeihe%26aufirst%3DE.%26aulast%3DSchafer%26aufirst%3DM.%2BK.%26atitle%3DRelationship%2520of%2520pronociceptin%252Forphanin%2520FQ%2520and%2520the%2520nociceptin%2520receptor%2520ORL1%2520with%2520Substance%2520P%2520and%2520calcitonin%2520gene-related%2520peptide%2520expression%2520in%2520dorsal%2520root%2520ganglion%2520of%2520the%2520rat%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D348%26spage%3D190%26epage%3D194%26doi%3D10.1016%2FS0304-3940%2803%2900786-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, C.</span><span> </span><span class="NLM_article-title">Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing</span> <span class="citation_source-journal">J. Peripher. Nerv. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1111/j.1529-8027.2006.0093.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1529-8027.2006.0093.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16930285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKqsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=232-240&author=Y.+Chenauthor=C.+Sommer&title=Nociceptin+and+its+receptor+in+rat+dorsal+root+ganglion+neurons+in+neuropathic+and+inflammatory+pain+models%3A+implications+on+pain+processing&doi=10.1111%2Fj.1529-8027.2006.0093.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing</span></div><div class="casAuthors">Chen, Yong; Sommer, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Peripheral Nervous System</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">232-240</span>CODEN:
                <span class="NLM_cas:coden">JPNSFO</span>;
        ISSN:<span class="NLM_cas:issn">1085-9489</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Nociceptin (NC), by activating its receptor, the opioid receptor-like 1 (ORL1) receptor, exerts an effect on a no. of functions in the nervous system including locomotion, learning and memory, and processing of pain signals.  Data on the expression of NC and ORL1 receptor in dorsal root ganglion (DRG) neurons and on its modulation after nerve injury and inflammation are controversial.  We therefore sought to investigate the immunoreactivity (IR) of NC and ORL1 receptor in DRG neurons in two pain models, a pure neuropathic pain model, namely partial sciatic nerve transection (PST), and an inflammatory pain model, complete Freund's adjuvant (CFA) injection into the hindpaw.  In intact DRG neurons, both NC and ORL1 receptor IR were present in mainly small- and medium-sized neurons, NC IR in 31% and ORL1 receptor IR in 33% of all neuronal profiles.  Both NC and ORL1 receptor IR were upregulated 7 days after nerve injury (to 56 and 55%) and inflammation (to 53 and 48%), resp.  Activating transcription factor 3 (ATF3), a neuronal marker of nerve injury, was induced in DRG neurons 7 and 14 days after PST and 7 days after CFA injection.  Double labeling with ATF3 revealed expression of NC and ORL1 receptor in intact as well as in injured primary afferent neurons.  Thus, NC and the ORL1 receptor may be involved in the modulation of neuropathic and inflammatory pain at the level of the primary afferent neuron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXOyqSirpvFbVg90H21EOLACvtfcHk0lhrWQDKTUMIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKqsrbN&md5=5493c46d6861da702f11bf8666e66b63</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1529-8027.2006.0093.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1529-8027.2006.0093.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSommer%26aufirst%3DC.%26atitle%3DNociceptin%2520and%2520its%2520receptor%2520in%2520rat%2520dorsal%2520root%2520ganglion%2520neurons%2520in%2520neuropathic%2520and%2520inflammatory%2520pain%2520models%253A%2520implications%2520on%2520pain%2520processing%26jtitle%3DJ.%2520Peripher.%2520Nerv.%2520Syst.%26date%3D2006%26volume%3D11%26spage%3D232%26epage%3D240%26doi%3D10.1111%2Fj.1529-8027.2006.0093.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommer, C.</span><span> </span><span class="NLM_article-title">Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1478</span><span class="NLM_x">–</span> <span class="NLM_lpage">1488</span><span class="refDoi"> DOI: 10.1002/jnr.21272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2Fjnr.21272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17387690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2007&pages=1478-1488&author=Y.+Chenauthor=C.+Sommer&title=Activation+of+the+nociceptin+opioid+system+in+rat+sensory+neurons+produces+antinociceptive+effects+in+inflammatory+pain%3A+involvement+of+inflammatory+mediators&doi=10.1002%2Fjnr.21272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators</span></div><div class="casAuthors">Chen, Yong; Sommer, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1478-1488</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Despite a large body of literature on the nociceptin (NC) opioid system in pain modulation, the mechanism of action of NC remains largely unexplored.  Here, the authors investigated the role and mode of action of the spinal NC system in inflammatory pain.  Preemptive intrathecal administration of NC attenuated thermal hyperalgesia and mech. allodynia in rats with intraplantar complete Freund's adjuvant (CFA) injection.  By using immunohistochem. in L4 dorsal root ganglion (DRG) neurons, a marked increase of NC and ORL1 receptor immunoreactivity was detected following CFA.  Intrathecal administration of NC attenuated the CFA-induced increases of calcitonin gene-related peptide, transient receptor potential vanilloid-1, and tumor necrosis factor-α in DRG neurons.  Real-time reverse transcription-polymerase chain reaction showed that NC reduced the up-regulation of inducible nitric oxide synthase mRNA but not that of neuronal nitric oxide synthase mRNA in spinal cord segments after CFA.  Furthermore, [Nphe1]NC(1-13)NH2, a selective opioid receptor-like 1 (ORL1) receptor antagonist, significantly antagonized the effects of NC on pain modulation and on the expression of inflammatory mediators, indicating a specific NC action through the ORL1 receptor.  Together, these findings reveal novel mechanisms by which the NC system produces analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdWPGzi_94D7Vg90H21EOLACvtfcHk0lhrWQDKTUMIdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVWlur0%253D&md5=d58f1d30a2c74adaacc35abe63f8dad1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21272%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DSommer%26aufirst%3DC.%26atitle%3DActivation%2520of%2520the%2520nociceptin%2520opioid%2520system%2520in%2520rat%2520sensory%2520neurons%2520produces%2520antinociceptive%2520effects%2520in%2520inflammatory%2520pain%253A%2520involvement%2520of%2520inflammatory%2520mediators%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2007%26volume%3D85%26spage%3D1478%26epage%3D1488%26doi%3D10.1002%2Fjnr.21272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serie, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seybold, V. S.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">250</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1016/S0304-3940(98)00430-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2898%2900430-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1998&pages=21-24&author=Y.+Jiaauthor=D.+R.+Lindenauthor=J.+R.+Serieauthor=V.+S.+Seybold&title=Nociceptin%2Forphanin+FQ+binding+increases+in+superficial+laminae+of+the+rat+spinal+cord+during+persistent+peripheral+inflammation&doi=10.1016%2FS0304-3940%2898%2900430-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2898%2900430-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252898%252900430-3%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DY.%26aulast%3DLinden%26aufirst%3DD.%2BR.%26aulast%3DSerie%26aufirst%3DJ.%2BR.%26aulast%3DSeybold%26aufirst%3DV.%2BS.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520binding%2520increases%2520in%2520superficial%2520laminae%2520of%2520the%2520rat%2520spinal%2520cord%2520during%2520persistent%2520peripheral%2520inflammation%26jtitle%3DNeurosci.%2520Lett.%26date%3D1998%26volume%3D250%26spage%3D21%26epage%3D24%26doi%3D10.1016%2FS0304-3940%2898%2900430-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarubbo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biguzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lettieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quatrale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candeletti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romualdi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1732</span><span class="refDoi"> DOI: 10.1002/mds.23271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2Fmds.23271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20589874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC3cjntlyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=1723-1732&author=M.+Martiauthor=S.+Sarubboauthor=F.+Latiniauthor=M.+Cavalloauthor=R.+Eleopraauthor=S.+Biguzziauthor=C.+Lettieriauthor=C.+Contiauthor=M.+Simonatoauthor=S.+Zucchiniauthor=R.+Quatraleauthor=M.+Sensiauthor=S.+Candelettiauthor=P.+Romualdiauthor=M.+Morari&title=Brain+interstitial+nociceptin%2Forphanin+FQ+levels+are+elevated+in+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.23271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease</span></div><div class="casAuthors">Marti Matteo; Sarubbo Silvio; Latini Francesco; Cavallo Michele; Eleopra Roberto; Biguzzi Sara; Lettieri Christian; Conti Carlo; Simonato Michele; Zucchini Silvia; Quatrale Rocco; Sensi Mariachiara; Candeletti Sanzio; Romualdi Patrizia; Morari Michele</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders : official journal of the Movement Disorder Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1723-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Expression and release of nociceptin/orphanin FQ (N/OFQ) are elevated in the substantia nigra reticulata of 6-hydroxydopamine-hemilesioned rats, suggesting a pathogenic role for N/OFQ in Parkinson's disease.  In this study, we investigated whether elevation of N/OFQ expression in 6-hydroxydopamine-hemilesioned rats selectively occurs in substantia nigra and whether hypomotility following acute haloperidol administration is accompanied by a rise in nigral N/OFQ levels.  Moreover, to prove a link between N/OFQ and idiopathic Parkinson's disease in humans, we measured N/OFQ levels in the cerebrospinal fluid of parkinsonian patients undergoing surgery for deep brain stimulation.  In situ hybridization demonstrated that dopamine depletion was associated with increase of N/OFQ expression in substantia nigra (compacta +160%, reticulata +105%) and subthalamic nucleus (+45%), as well as reduction in caudate putamen (-20%).  No change was observed in globus pallidus, nucleus accumbens, thalamus, and motor cortex.  Microdialysis coupled to the bar test allowed to demonstrate that acute administration of haloperidol (0.8 and 3 mg/kg) increased nigral N/OFQ levels (maximally of +47% and +53%, respectively) in parallel with akinesia.  A correlation with preclinical studies was found by analyzing N/OFQ levels in humans.  Indeed, N/OFQ levels were found to be approximately 3.5-fold elevated in the cerebrospinal fluid of parkinsonian patients (148 fmol/ml) compared with nonparkinsonian neurologic controls (41 fmol/ml).  These data represent the first clinical evidence linking N/OFQ to idiopathic Parkinson's disease in humans.  They strengthen the pathogenic role of N/OFQ in the modulation of parkinsonism across species and provide a rationale for developing N/OFQ receptor antagonists as antiparkinsonian drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS1HYQVGZGxJFWTCLT8lX9SfW6udTcc2eYvPjeZ8FkELrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjntlyhuw%253D%253D&md5=ca6bc5c0248c9c288061d9c7cb55e221</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fmds.23271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.23271%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DSarubbo%26aufirst%3DS.%26aulast%3DLatini%26aufirst%3DF.%26aulast%3DCavallo%26aufirst%3DM.%26aulast%3DEleopra%26aufirst%3DR.%26aulast%3DBiguzzi%26aufirst%3DS.%26aulast%3DLettieri%26aufirst%3DC.%26aulast%3DConti%26aufirst%3DC.%26aulast%3DSimonato%26aufirst%3DM.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DQuatrale%26aufirst%3DR.%26aulast%3DSensi%26aufirst%3DM.%26aulast%3DCandeletti%26aufirst%3DS.%26aulast%3DRomualdi%26aufirst%3DP.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DBrain%2520interstitial%2520nociceptin%252Forphanin%2520FQ%2520levels%2520are%2520elevated%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2010%26volume%3D25%26spage%3D1723%26epage%3D1732%26doi%3D10.1002%2Fmds.23271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malfacini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calò, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02219.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1476-5381.2012.02219.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22994368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlCrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=863-879&author=M.+Martiauthor=F.+Melaauthor=M.+Budriauthor=M.+Voltaauthor=D.+Malfaciniauthor=S.+Molinariauthor=N.+T.+Zaveriauthor=S.+Ronzoniauthor=P.+Petrilloauthor=G.+Cal%C3%B2author=M.+Morari&title=Acute+and+chronic+antiparkinsonian+effects+of+the+novel+nociceptin%2Forphanin+FQ+receptor+antagonist+NiK-21273+in+comparison+with+SB-612111&doi=10.1111%2Fj.1476-5381.2012.02219.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111</span></div><div class="casAuthors">Marti, M.; Mela, F.; Budri, M.; Volta, M.; Malfacini, D.; Molinari, S.; Zaveri, N. T.; Ronzoni, S.; Petrillo, P.; Calo, G.; Morari, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">863-879</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor antagonists have been proposed as a novel therapeutic approach to Parkinson's disease.  Main limitations of previous studies were the use of structurally similar compds. and the evaluation of their acute effects only.  We report here on the acute and long-term antiparkinsonian effects of the novel compd. 2-[3-[4-(2-chloro-6-fluoro-phenyl)-piperidin-1-ylmethyl]-2-(morpholine-4-carbonyl)-indol-1-yl]-acetamide (NiK-21273) in comparison with the potent and selective NOP receptor antagonist SB-612111.  Basic pharmacol. properties of NiK-21273 were studied in cell lines and isolated tissues (mouse and rat vas deferens).  Antiparkinsonian effects were studied in reserpinized mice and 6-hydroxydopamine hemilesioned rats under both acute and chronic administration protocols.  In vitro, NiK-21273 behaved as a potent (pA2 7.7) and selective NOP receptor antagonist.  In vivo, it reduced hypokinesia in reserpinized mice at 0.1 and 1 but not 10 mg·kg-1, whereas SB-612111 (0.01-1 mg·kg-1) provided a dose-dependent antiparkinsonian effect.  NiK-21273 ameliorated motor performance in 6-hydroxydopamine hemilesioned rats at 0.5 and 5 but not 15 mg·kg-1.  SB-612111 replicated these effects in the 0.01-1 mg·kg-1 range without loss of efficacy.  Both antagonists synergized with L-DOPA at subthreshold doses.  Chronic administration of NiK-21273 provided delayed improvement in baseline activity at 0.5 and 1.5 mg·kg-1, although tolerance to the higher dose was obsd.  Conversely, SB-612111 (1 mg·kg-1) maintained its effects over time without modifying baseline activity.  NOP receptor antagonists provide motor benefit in parkinsonism models although the "therapeutic" window and long-term effects may vary between compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraKmOpwrHrPrVg90H21EOLACvtfcHk0ljeAHIXLoWcSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlCrtbc%253D&md5=88649abb548dc7148ce42dadf9cbc596</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02219.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02219.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMela%26aufirst%3DF.%26aulast%3DBudri%26aufirst%3DM.%26aulast%3DVolta%26aufirst%3DM.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DPetrillo%26aufirst%3DP.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DAcute%2520and%2520chronic%2520antiparkinsonian%2520effects%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520NiK-21273%2520in%2520comparison%2520with%2520SB-612111%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D863%26epage%3D879%26doi%3D10.1111%2Fj.1476-5381.2012.02219.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Visanji, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bie, R. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCreary, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, S. H.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ (NOP) receptor antagonist J-113397 enhances the effects of levodopa in the MPTP-lesioned nonhuman primate model of Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1922</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span><span class="refDoi"> DOI: 10.1002/mds.22086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1002%2Fmds.22086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=1922-1925&author=N.+P.+Visanjiauthor=R.+M.+A.+de+Bieauthor=T.+H.+Johnstonauthor=A.+C.+McCrearyauthor=J.+M.+Brotchieauthor=S.+H.+Fox&title=The+nociceptin%2Forphanin+FQ+%28NOP%29+receptor+antagonist+J-113397+enhances+the+effects+of+levodopa+in+the+MPTP-lesioned+nonhuman+primate+model+of+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.22086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fmds.22086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.22086%26sid%3Dliteratum%253Aachs%26aulast%3DVisanji%26aufirst%3DN.%2BP.%26aulast%3Dde%2BBie%26aufirst%3DR.%2BM.%2BA.%26aulast%3DJohnston%26aufirst%3DT.%2BH.%26aulast%3DMcCreary%26aufirst%3DA.%2BC.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26aulast%3DFox%26aufirst%3DS.%2BH.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%2520antagonist%2520J-113397%2520enhances%2520the%2520effects%2520of%2520levodopa%2520in%2520the%2520MPTP-lesioned%2520nonhuman%2520primate%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2008%26volume%3D23%26spage%3D1922%26epage%3D1925%26doi%3D10.1002%2Fmds.22086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Viaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Pernaute, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span><span class="refDoi"> DOI: 10.1016/j.nbd.2008.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.nbd.2008.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18413287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlShs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2008&pages=430-438&author=R.+Viaroauthor=R.+Sanchez-Pernauteauthor=M.+Martiauthor=C.+Trapellaauthor=O.+Isacsonauthor=M.+Morari&title=Nociceptin%2Forphanin+FQ+receptor+blockade+attenuates+MPTP-induced+parkinsonism&doi=10.1016%2Fj.nbd.2008.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism</span></div><div class="casAuthors">Viaro, Riccardo; Sanchez-Pernaute, Rosario; Marti, Matteo; Trapella, Claudio; Isacson, Ole; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">430-438</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Endogenous nociceptin/orphanin FQ (N/OFQ) inhibits the activity of dopamine neurons in the substantia nigra and affects motor behavior.  In this study we investigated whether a N/OFQ receptor (NOP) antagonist, J-113397, can modify movement in naive mice and nonhuman primates and attenuate motor deficits in MPTP-treated parkinsonian animals.  J-113397 facilitated motor activity in naive mice at low doses (0.1-1 mg/kg) and inhibited it at higher ones (10 mg/kg).  Likewise, in MPTP-treated mice, J-113397 reversed motor deficit at 0.01 mg/kg but worsened hypokinesia at higher doses (1 mg/kg).  In naive nonhuman primates, J-113397, ineffective up to 1 mg/kg, produced inconsistent motor improvements at 3 mg/kg.  Conversely, in parkinsonian primates J-113397 (0.01 mg/kg) reversed parkinsonism, being most effective against hypokinesia.  We conclude that endogenous N/OFQ modulates motor activity in mice and nonhuman primates and contributes to parkinsonian symptoms in MPTP-treated animals.  NOP receptor antagonists may represent a novel approach to Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW6b77UNWC3rVg90H21EOLACvtfcHk0lj1q8FE5Qo5bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlShs7s%253D&md5=52c63df34902638af353e5de9146eb0d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DViaro%26aufirst%3DR.%26aulast%3DSanchez-Pernaute%26aufirst%3DR.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DIsacson%26aufirst%3DO.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520blockade%2520attenuates%2520MPTP-induced%2520parkinsonism%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2008%26volume%3D30%26spage%3D430%26epage%3D438%26doi%3D10.1016%2Fj.nbd.2008.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chau, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. I.</span><span> </span><span class="NLM_article-title">The neural circuitry of reward and its relevance to psychiatric disorders</span> <span class="citation_source-journal">Curr. Psychiatry Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1007/s11920-004-0026-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs11920-004-0026-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15355762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD2cvkslyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=391-399&author=D.+T.+Chauauthor=R.+M.+Rothauthor=A.+I.+Green&title=The+neural+circuitry+of+reward+and+its+relevance+to+psychiatric+disorders&doi=10.1007%2Fs11920-004-0026-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The neural circuitry of reward and its relevance to psychiatric disorders</span></div><div class="casAuthors">Chau David T; Roth Robert M; Green Alan I</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-9</span>
        ISSN:<span class="NLM_cas:issn">1523-3812</span>.
    </div><div class="casAbstract">Scientific interest in how the brain processes reward has burgeoned during the past 50 years since the discovery that rats will do tasks such as pressing a lever to obtain electrical stimulation of the brain.  This interest was additionally encouraged by the observation of an association between reward and dopamine activity in the mesocorticolimbic system.  In this article, we will discuss the complex nature of reward processing and recent animal studies and human functional neuroimaging studies to elucidate the current understanding of the neural substrates of reward processing and its components.  Lastly, we will review recent theoretical and empirical work investigating the role of brain reward circuitry in several psychiatric disorders, including substance use disorders, schizophrenia, pathologic gambling, major depressive disorder, and attention-deficit/hyperactivity disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSa5E42Hae79UHdcurJClFcfW6udTcc2eay_GXTq36f_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvkslyjsg%253D%253D&md5=9d95dbf7a7eaf1b3c0f8c04245780934</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs11920-004-0026-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-004-0026-8%26sid%3Dliteratum%253Aachs%26aulast%3DChau%26aufirst%3DD.%2BT.%26aulast%3DRoth%26aufirst%3DR.%2BM.%26aulast%3DGreen%26aufirst%3DA.%2BI.%26atitle%3DThe%2520neural%2520circuitry%2520of%2520reward%2520and%2520its%2520relevance%2520to%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2004%26volume%3D6%26spage%3D391%26epage%3D399%26doi%3D10.1007%2Fs11920-004-0026-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Di Giannuario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span> </span><span class="NLM_article-title">Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span><span class="refDoi"> DOI: 10.1016/S0196-9781(00)00250-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0196-9781%2800%2900250-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1125-1130&author=A.+Di+Giannuarioauthor=S.+Pieretti&title=Nociceptin+differentially+affects+morphine-induced+dopamine+release+from+the+nucleus+accumbens+and+nucleus+caudate+in+rats&doi=10.1016%2FS0196-9781%2800%2900250-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900250-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900250-3%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiannuario%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26atitle%3DNociceptin%2520differentially%2520affects%2520morphine-induced%2520dopamine%2520release%2520from%2520the%2520nucleus%2520accumbens%2520and%2520nucleus%2520caudate%2520in%2520rats%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D1125%26epage%3D1130%26doi%3D10.1016%2FS0196-9781%2800%2900250-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Di Giannuario, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loizzo, A.</span><span> </span><span class="NLM_article-title">Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1016/S0304-3940(99)00579-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2899%2900579-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1999&pages=183-186&author=A.+Di+Giannuarioauthor=S.+Pierettiauthor=A.+Catalaniauthor=A.+Loizzo&title=Orphanin+FQ+reduces+morphine-induced+dopamine+release+in+the+nucleus+accumbens%3A+a+microdialysis+study+in+rats&doi=10.1016%2FS0304-3940%2899%2900579-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2899%2900579-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252899%252900579-0%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGiannuario%26aufirst%3DA.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DCatalani%26aufirst%3DA.%26aulast%3DLoizzo%26aufirst%3DA.%26atitle%3DOrphanin%2520FQ%2520reduces%2520morphine-induced%2520dopamine%2520release%2520in%2520the%2520nucleus%2520accumbens%253A%2520a%2520microdialysis%2520study%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D272%26spage%3D183%26epage%3D186%26doi%3D10.1016%2FS0304-3940%2899%2900579-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1016/0306-4522(96)00322-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2F0306-4522%2896%2900322-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1996&pages=1-4&author=N.+P.+Murphyauthor=H.+T.+Lyauthor=N.+T.+Maidment&title=Intracerebroventricular+orphanin+FQ%2Fnociceptin+suppresses+dopamine+release+in+the+nucleus+accumbens+of+anaesthetized+rats&doi=10.1016%2F0306-4522%2896%2900322-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0306-4522%2896%2900322-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-4522%252896%252900322-3%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DLy%26aufirst%3DH.%2BT.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DIntracerebroventricular%2520orphanin%2520FQ%252Fnociceptin%2520suppresses%2520dopamine%2520release%2520in%2520the%2520nucleus%2520accumbens%2520of%2520anaesthetized%2520rats%26jtitle%3DNeuroscience%26date%3D1996%26volume%3D75%26spage%3D1%26epage%3D4%26doi%3D10.1016%2F0306-4522%2896%2900322-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.1999.0730179.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1046%2Fj.1471-4159.1999.0730179.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10386969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK1MXktVeltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1999&pages=179-186&author=N.+P.+Murphyauthor=N.+T.+Maidment&title=Orphanin+FQ%2Fnociceptin+modulation+of+mesolimbic+dopamine+transmission+determined+by+microdialysis&doi=10.1046%2Fj.1471-4159.1999.0730179.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis</span></div><div class="casAuthors">Murphy, Niall P.; Maidment, Nigel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">179-186</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Orphanin FQ has been reported to suppress extracellular dopamine levels in the nucleus accumbens after intracerebroventricular administration.  This study sought to provide evidence for an intra-ventral tegmental site of action for this effect using a dual-probe microdialysis exptl. design.  Orphanin FQ was applied to the ventral tegmental area of anesthetized rats by reverse dialysis while extracellular dopamine was sampled with a second dialysis probe in the nucleus accumbens.  Orphanin FQ at a probe concn. of 1 mM (but not at 0.1 mM) significantly reduced nucleus accumbens dialyzate dopamine levels.  The receptor-inactive analog, des-Phe1-orphanin FQ (1 mM), produced a small but significant increase in nucleus accumbens dialyzate dopamine levels.  Simultaneous measurement of ventral tegmental area dialyzate amino acid content revealed significant increases in both GABA and glutamate during infusion of orphanin FQ (1 mM).  To det. if increased GABA overflow mediates the action of orphanin FQ on mesolimbic neurons, orphanin FQ (10 nmol) was microinjected directly into the ventral tegmental area in the presence or absence of the GABAA receptor antagonist, bicuculline (1 nmol).  Bicuculline transiently blocked the suppressive action of orphanin FQ on accumbens dialyzate dopamine levels.  These data indicate that orphanin FQ decreases dopamine transmission in the nucleus accumbens by inhibiting dopamine neuronal activity in the ventral tegmental area through a mechanism that may involve an increased overflow of GABA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroKLZTv4fKdbVg90H21EOLACvtfcHk0ljE92g3EELY1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVeltrs%253D&md5=2c8d95426c38f026d4d4a9738998f582</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1999.0730179.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1999.0730179.x%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520modulation%2520of%2520mesolimbic%2520dopamine%2520transmission%2520determined%2520by%2520microdialysis%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D73%26spage%3D179%26epage%3D186%26doi%3D10.1046%2Fj.1471-4159.1999.0730179.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin blocks acquisition of morphine place preference</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">832</span><span class="NLM_x">, </span> <span class="NLM_fpage">168</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.1016/S0006-8993(99)01425-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0006-8993%2899%2901425-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10375664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1SjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=832&publication_year=1999&pages=168-170&author=N.+P.+Murphyauthor=Y.+Leeauthor=N.+T.+Maidment&title=Orphanin+FQ%2Fnociceptin+blocks+acquisition+of+morphine+place+preference&doi=10.1016%2FS0006-8993%2899%2901425-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ/nociceptin blocks acquisition of morphine place preference</span></div><div class="casAuthors">Murphy, Niall P.; Lee, Yohan; Maidment, Nigel T.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">832</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">168-170</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Orphanin FQ/nociceptin (OFQ/N) suppresses the activity of the dopaminergic mesolimbic reward pathway yet reportedly fails to produce conditioned place aversion or preference.  The present study sought to det. if this peptide could attenuate the development of morphine place preference.  Male rats were administered OFQ/N (3 to 30 nmol intracerebroventricularly) during the induction of morphine (3 mg/kg s.c.) place preference.  Animals receiving 3 or 10 nmol (but not 30 nmol) OFQ/N showed significant redns. in the development of place preference to morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJtrwGN6HjhLVg90H21EOLACvtfcHk0ljE92g3EELY1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1SjsLw%253D&md5=3cabd70eb0bd15736fa905cae8a1dcb1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2899%2901425-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252899%252901425-0%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520blocks%2520acquisition%2520of%2520morphine%2520place%2520preference%26jtitle%3DBrain%2520Res.%26date%3D1999%26volume%3D832%26spage%3D168%26epage%3D170%26doi%3D10.1016%2FS0006-8993%2899%2901425-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kotlinska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberring, J.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1097/00008877-200205000-00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00008877-200205000-00006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=229-235&author=J.+Kotlinskaauthor=J.+Wichmannauthor=A.+Legowskaauthor=K.+Rolkaauthor=J.+Silberring&title=Orphanin+FQ%2Fnociceptin+but+not+Ro+65-6570+inhibits+the+expression+of+cocaine-induced+conditioned+place+preference&doi=10.1097%2F00008877-200205000-00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1097%2F00008877-200205000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008877-200205000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DKotlinska%26aufirst%3DJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DLegowska%26aufirst%3DA.%26aulast%3DRolka%26aufirst%3DK.%26aulast%3DSilberring%26aufirst%3DJ.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520but%2520not%2520Ro%252065-6570%2520inhibits%2520the%2520expression%2520of%2520cocaine-induced%2520conditioned%2520place%2520preference%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2002%26volume%3D13%26spage%3D229%26epage%3D235%26doi%3D10.1097%2F00008877-200205000-00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Sakoori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, N. P.</span><span> </span><span class="NLM_article-title">Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1007/s00213-003-1643-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-003-1643-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=14624329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2004&pages=129-136&author=K.+Sakooriauthor=N.+P.+Murphy&title=Central+administration+of+nociceptin%2Forphanin+FQ+blocks+the+acquisition+of+conditioned+place+preference+to+morphine+and+cocaine%2C+but+not+conditioned+place+aversion+to+naloxone+in+mice&doi=10.1007%2Fs00213-003-1643-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice</span></div><div class="casAuthors">Sakoori, Kazuto; Murphy, Niall P.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-136</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Previous studies have suggested that nociceptin (known also as orphanin FQ) suppresses the rewarding potential of morphine and alc. in the rat.  However, little is known of the effect of nociceptin on the rewarding properties of these and other drugs in the mouse.  The objective was to det. the effect of nociceptin on opiate or psychostimulant-induced conditioned place preference, or naloxone-induced conditioned place aversion in mice.  C57BL6 mice were implanted with chronically indwelling intracranial cannulae targeted at the lateral cerebroventricle through which nociceptin (0.06, 0.6, or 6 nmol) could be administered.  Animals were conditioned in an unbiased balanced paradigm to study the effect of nociceptin administration alone, or the effect of nociceptin on the acquisition of place conditioning to morphine, cocaine, or naloxone (all 7.6 mg/kg s.c.).  Administration of 0.06 nmol nociceptin alone stimulated locomotion during conditioning sessions, but had no hedonic effects.  In contrast, administration of 6 nmol nociceptin alone markedly reduced basal locomotion during the conditioning sessions and induced a mild place aversion.  Both morphine and cocaine induced robust place preferences, the acquisition of which was dose dependently suppressed by administration of nociceptin at doses of 0.6 nmol and above.  Conditioning with naloxone produced a robust place aversion that was only weakly blocked by the max. dose of nociceptin tested.  Nociceptin blocks the rewarding properties of drugs in both narcotic analgesic and psychostimulant classes in the mouse.  In contrast, nociceptin has only a minor effect on the neg. affective state experienced following naloxone administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw8LFQBUAxxrVg90H21EOLACvtfcHk0ljABEFWggsCWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyktbw%253D&md5=074461fbdecbf8aab19aa49ec19faf7d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00213-003-1643-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-003-1643-3%26sid%3Dliteratum%253Aachs%26aulast%3DSakoori%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26atitle%3DCentral%2520administration%2520of%2520nociceptin%252Forphanin%2520FQ%2520blocks%2520the%2520acquisition%2520of%2520conditioned%2520place%2520preference%2520to%2520morphine%2520and%2520cocaine%252C%2520but%2520not%2520conditioned%2520place%2520aversion%2520to%2520naloxone%2520in%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2004%26volume%3D172%26spage%3D129%26epage%3D136%26doi%3D10.1007%2Fs00213-003-1643-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zhao, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. W.</span><span> </span><span class="NLM_article-title">Orphanin FQ/nociceptin blocks methamphetamine place preference in rats</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2383</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span><span class="refDoi"> DOI: 10.1097/00001756-200312190-00019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00001756-200312190-00019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=2383-2385&author=R.+J.+Zhaoauthor=R.+S.+Wooauthor=M.+S.+Jeongauthor=B.+S.+Shinauthor=D.+G.+Kimauthor=K.+W.+Kim&title=Orphanin+FQ%2Fnociceptin+blocks+methamphetamine+place+preference+in+rats&doi=10.1097%2F00001756-200312190-00019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2F00001756-200312190-00019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200312190-00019%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%2BJ.%26aulast%3DWoo%26aufirst%3DR.%2BS.%26aulast%3DJeong%26aufirst%3DM.%2BS.%26aulast%3DShin%26aufirst%3DB.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BG.%26aulast%3DKim%26aufirst%3DK.%2BW.%26atitle%3DOrphanin%2520FQ%252Fnociceptin%2520blocks%2520methamphetamine%2520place%2520preference%2520in%2520rats%26jtitle%3DNeuroReport%26date%3D2003%26volume%3D14%26spage%3D2383%26epage%3D2385%26doi%3D10.1097%2F00001756-200312190-00019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kotlinska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dylag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberring, J.</span><span> </span><span class="NLM_article-title">Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span><span class="refDoi"> DOI: 10.1016/S0014-2999(03)02081-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2803%2902081-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12921868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Kju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2003&pages=233-239&author=J.+Kotlinskaauthor=P.+Rafalskiauthor=G.+Bialaauthor=T.+Dylagauthor=K.+Rolkaauthor=J.+Silberring&title=Nociceptin+inhibits+acquisition+of+amphetamine-induced+place+preference+and+sensitization+to+stereotypy+in+rats&doi=10.1016%2FS0014-2999%2803%2902081-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats</span></div><div class="casAuthors">Kotlinska, Jolanta; Rafalski, Piotr; Biala, Grazyna; Dylag, Tomasz; Rolka, Krzysztof; Silberring, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">233-239</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Nociceptin (also called orphanin FQ), a 17-amino-acid peptide, is the natural ligand of the nociceptin opioid peptide (NOP) receptor.  This peptide shows similarities, in its structure, to opioid peptides, mainly to dynorphin A.  However, unlike opioid peptides, it does not produce a conditioned place preference or aversion but inhibits rewarding effect of drugs of abuse.  The present study was designed to examine the ability of nociceptin to block the acquisition of amphetamine-induced place preference, and the development of amphetamine-induced sensitization to stereotypy in rats.  Our expts. indicated that repeated administration of nociceptin at increasing doses during conditioning significantly attenuated the reinforcing effect of amphetamine in conditioned place preference paradigm.  Nociceptin did not change the acute effect of amphetamine-induced stereotypy but prevented the development of sensitization to stereotypy measured on the challenge day.  Our results suggest the involvement of nociceptin in long-lasting neuronal adaptation after repeated amphetamine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhqVzPd9SudLVg90H21EOLACvtfcHk0ljABEFWggsCWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Kju7g%253D&md5=4cd98cbdcbb47593a4f55fb2cd9b165d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2902081-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252902081-8%26sid%3Dliteratum%253Aachs%26aulast%3DKotlinska%26aufirst%3DJ.%26aulast%3DRafalski%26aufirst%3DP.%26aulast%3DBiala%26aufirst%3DG.%26aulast%3DDylag%26aufirst%3DT.%26aulast%3DRolka%26aufirst%3DK.%26aulast%3DSilberring%26aufirst%3DJ.%26atitle%3DNociceptin%2520inhibits%2520acquisition%2520of%2520amphetamine-induced%2520place%2520preference%2520and%2520sensitization%2520to%2520stereotypy%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D474%26spage%3D233%26epage%3D239%26doi%3D10.1016%2FS0014-2999%2803%2902081-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Florin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroux-Nicollet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span> </span><span class="NLM_article-title">Autoradiographic localization of [3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">230</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span><span class="refDoi"> DOI: 10.1016/S0304-3940(97)00470-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0304-3940%2897%2900470-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=1997&pages=33-36&author=S.+Florinauthor=I.+Leroux-Nicolletauthor=J.+C.+Meunierauthor=J.+Costentin&title=Autoradiographic+localization+of+%5B3H%5Dnociceptin+binding+sites+from+telencephalic+to+mesencephalic+regions+of+the+mouse+brain&doi=10.1016%2FS0304-3940%2897%2900470-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2897%2900470-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252897%252900470-9%26sid%3Dliteratum%253Aachs%26aulast%3DFlorin%26aufirst%3DS.%26aulast%3DLeroux-Nicollet%26aufirst%3DI.%26aulast%3DMeunier%26aufirst%3DJ.%2BC.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DAutoradiographic%2520localization%2520of%2520%255B3H%255Dnociceptin%2520binding%2520sites%2520from%2520telencephalic%2520to%2520mesencephalic%2520regions%2520of%2520the%2520mouse%2520brain%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D230%26spage%3D33%26epage%3D36%26doi%3D10.1016%2FS0304-3940%2897%2900470-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Florin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meunier, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span> </span><span class="NLM_article-title">Autoradiographic localization of [3H]nociceptin binding sites in the rat brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">880</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/S0006-8993(00)02669-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0006-8993%2800%2902669-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11032985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntF2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=880&publication_year=2000&pages=11-16&author=S.+Florinauthor=J.-C.+Meunierauthor=J.+Costentin&title=Autoradiographic+localization+of+%5B3H%5Dnociceptin+binding+sites+in+the+rat+brain&doi=10.1016%2FS0006-8993%2800%2902669-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Autoradiographic localization of [3H]nociceptin binding sites in the rat brain</span></div><div class="casAuthors">Florin, S.; Meunier, J.-C.; Costentin, J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">880</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">11-16</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The binding sites of nociceptin (also named orphanin FQ), the endogenous ligand of ORL1 (opiate receptor like 1), were localized in rat brain, using an autoradiog. procedure.  High levels of binding were obsd. in the cingulate, retrosplenial, perirhinal, insular and occipital cortex, anterior and posteromedial cortical amygdaloid nuclei, basolateral amygdaloid nucleus, amygdaloid complex, posterior hippocampus, dorsal endopiriform, central medial thalamic, paraventricular, rhomboid thalamic, suprachiasmatic, ventromedial hypothalamic nuclei, mammillary complex, superficial gray layer of the superior colliculus, locus coeruleus, dorsal raphe nucleus.  More moderate labeling was obsd. in the prefrontal, fronto-parietal, temporal, piriform cortex, dentate gyrus, anterior olfactory nucleus, olfactory tubercle, shell of nucleus accumbens, claustrum, lateral septum, laterodorsal thalamic, medial habenular, subthalamic, reuniens thalamic nuclei, subiculum, periaqueductal gray matter and pons.  A lower binding site d. was obsd. in the anterior and medial hippocampus, olfactory bulb, caudate putamen, the core of the nucleus accumbens, medial septum, ventrolateral, ventroposterolateral and mediodorsal thalamic nuclei, lateral and medial geniculate nuclei, hypothalamic area, substantia nigra, ventral tegmentum area and interpedoncular nucleus.  A moderate and similar labeling was found in the dorsal and ventral horn of the spinal cord.  No labeling was apparent in the corpus callosum.  Thus, it appears that the ORL1 receptor is particularly abundant in the cerebral cortex, limbic system of the rat brain and some areas involved in pain perception.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VMorOlDoubVg90H21EOLACvtfcHk0ljABEFWggsCWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntF2hu7o%253D&md5=36c30c2bcd826b6b96da78997a3c8891</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902669-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902669-X%26sid%3Dliteratum%253Aachs%26aulast%3DFlorin%26aufirst%3DS.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DAutoradiographic%2520localization%2520of%2520%255B3H%255Dnociceptin%2520binding%2520sites%2520in%2520the%2520rat%2520brain%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D880%26spage%3D11%26epage%3D16%26doi%3D10.1016%2FS0006-8993%2800%2902669-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bridge, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainwright, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, K. R.</span><span> </span><span class="NLM_article-title">Autoradiographic localization of (125)i[Tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1016/S0306-4522(02)00927-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0306-4522%2802%2900927-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2003&pages=513-523&author=K.+E.+Bridgeauthor=A.+Wainwrightauthor=K.+Reillyauthor=K.+R.+Oliver&title=Autoradiographic+localization+of+%28125%29i%5BTyr%2814%29%5D+nociceptin%2Forphanin+FQ+binding+sites+in+macaque+primate+CNS&doi=10.1016%2FS0306-4522%2802%2900927-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2802%2900927-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252802%252900927-2%26sid%3Dliteratum%253Aachs%26aulast%3DBridge%26aufirst%3DK.%2BE.%26aulast%3DWainwright%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DK.%26aulast%3DOliver%26aufirst%3DK.%2BR.%26atitle%3DAutoradiographic%2520localization%2520of%2520%2528125%2529i%255BTyr%252814%2529%255D%2520nociceptin%252Forphanin%2520FQ%2520binding%2520sites%2520in%2520macaque%2520primate%2520CNS%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D118%26spage%3D513%26epage%3D523%26doi%3D10.1016%2FS0306-4522%2802%2900927-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladding, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedregal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span> </span><span class="NLM_article-title">Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1638</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span><span class="refDoi"> DOI: 10.2967/jnumed.111.091181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2967%2Fjnumed.111.091181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1638-1645&author=Y.+Kimuraauthor=M.+Fujitaauthor=J.+Hongauthor=T.+G.+Lohithauthor=R.+L.+Gladdingauthor=S.+S.+Zoghbiauthor=J.+A.+Tauscherauthor=N.+Goeblauthor=K.+S.+Rashauthor=Z.+Chenauthor=C.+Pedregalauthor=V.+N.+Barthauthor=V.+W.+Pikeauthor=R.+B.+Innis&title=Brain+and+whole-body+imaging+in+rhesus+monkeys+of+11C-NOP-1A%2C+a+promising+PET+radioligand+for+nociceptin%2Forphanin+FQ+peptide+receptors&doi=10.2967%2Fjnumed.111.091181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.091181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.091181%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DGladding%26aufirst%3DR.%2BL.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DTauscher%26aufirst%3DJ.%2BA.%26aulast%3DGoebl%26aufirst%3DN.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26atitle%3DBrain%2520and%2520whole-body%2520imaging%2520in%2520rhesus%2520monkeys%2520of%252011C-NOP-1A%252C%2520a%2520promising%2520PET%2520radioligand%2520for%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1638%26epage%3D1645%26doi%3D10.2967%2Fjnumed.111.091181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Berthele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworzak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadrack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assmus, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zieglgansberger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolle, T. R.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-nociceptin ligand-binding and nociceptin opioid receptor mRNA expression in the human brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1016/S0306-4522(03)00484-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0306-4522%2803%2900484-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2003&pages=629-640&author=A.+Bertheleauthor=S.+Platzerauthor=D.+Dworzakauthor=J.+Schadrackauthor=B.+Mahalauthor=A.+Buttnerauthor=H.+P.+Assmusauthor=K.+Wursterauthor=W.+Zieglgansbergerauthor=B.+Conradauthor=T.+R.+Tolle&title=%5B3H%5D-nociceptin+ligand-binding+and+nociceptin+opioid+receptor+mRNA+expression+in+the+human+brain&doi=10.1016%2FS0306-4522%2803%2900484-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0306-4522%2803%2900484-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0306-4522%252803%252900484-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerthele%26aufirst%3DA.%26aulast%3DPlatzer%26aufirst%3DS.%26aulast%3DDworzak%26aufirst%3DD.%26aulast%3DSchadrack%26aufirst%3DJ.%26aulast%3DMahal%26aufirst%3DB.%26aulast%3DButtner%26aufirst%3DA.%26aulast%3DAssmus%26aufirst%3DH.%2BP.%26aulast%3DWurster%26aufirst%3DK.%26aulast%3DZieglgansberger%26aufirst%3DW.%26aulast%3DConrad%26aufirst%3DB.%26aulast%3DTolle%26aufirst%3DT.%2BR.%26atitle%3D%255B3H%255D-nociceptin%2520ligand-binding%2520and%2520nociceptin%2520opioid%2520receptor%2520mRNA%2520expression%2520in%2520the%2520human%2520brain%26jtitle%3DNeuroscience%26date%3D2003%26volume%3D121%26spage%3D629%26epage%3D640%26doi%3D10.1016%2FS0306-4522%2803%2900484-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araneta, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span> </span><span class="NLM_article-title">Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand <sup>11</sup>C-NOP-1A</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.2967/jnumed.111.097162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2967%2Fjnumed.111.097162" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=385-392&author=T.+G.+Lohithauthor=S.+S.+Zoghbiauthor=C.+L.+Morseauthor=M.+F.+Aranetaauthor=V.+N.+Barthauthor=N.+A.+Goeblauthor=J.+T.+Tauscherauthor=V.+W.+Pikeauthor=R.+B.+Innisauthor=M.+Fujita&title=Brain+and+whole-body+imaging+of+nociceptin%2Forphanin+FQ+peptide+receptor+in+humans+using+the+PET+ligand+11C-NOP-1A&doi=10.2967%2Fjnumed.111.097162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.097162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.097162%26sid%3Dliteratum%253Aachs%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMorse%26aufirst%3DC.%2BL.%26aulast%3DAraneta%26aufirst%3DM.%2BF.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DGoebl%26aufirst%3DN.%2BA.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DFujita%26aufirst%3DM.%26atitle%3DBrain%2520and%2520whole-body%2520imaging%2520of%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520in%2520humans%2520using%2520the%2520PET%2520ligand%252011C-NOP-1A%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D385%26epage%3D392%26doi%3D10.2967%2Fjnumed.111.097162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorick-Kehn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintar, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansonoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span> </span><span class="NLM_article-title">The biology of nociceptin/orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pharmthera.2013.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24189487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2014&pages=283-299&author=J.+M.+Witkinauthor=M.+A.+Statnickauthor=L.+M.+Rorick-Kehnauthor=J.+E.+Pintarauthor=M.+Ansonoffauthor=Y.+Chenauthor=R.+C.+Tuckerauthor=R.+Ciccocioppo&title=The+biology+of+nociceptin%2Forphanin+FQ+%28N%2FOFQ%29+related+to+obesity%2C+stress%2C+anxiety%2C+mood%2C+and+drug+dependence&doi=10.1016%2Fj.pharmthera.2013.10.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence</span></div><div class="casAuthors">Witkin, Jeffrey M.; Statnick, Michael A.; Rorick-Kehn, Linda M.; Pintar, John E.; Ansonoff, Michael; Chen, Yanyun; Tucker, R. Craig; Ciccocioppo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-299</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nociceptin/Orphanin FQ (N/OFQ) is a 17 amino acid peptide that was deorphanized in 1995.  The generation of specific agonists, antagonists and receptor deficient mice and rats has enabled progress in elucidating the biol. functions of N/OFQ.  Addnl., radio-imaging technologies have been advanced for investigation of this system in animals and humans.  Together with traditional neurobehavioral techniques, these tools have been utilized to identify the biol. significance of the N/OFQ system and its interacting partners.  The present review focuses on the role of N/OFQ in the regulation of feeding, body wt. homeostasis, stress, the stress-related psychiatric disorders of depression and anxiety, and in drug and alc. dependence.  Crit. evaluation of the current scientific preclin. literature suggests that small mol. modulators of nociceptin opioid peptide receptors (NOP) might be useful in the treatment of diseases related to these biol. functions.  In particular, the literature data suggest that antagonism of NOP receptors will produce anti-obesity and antidepressant activities in humans.  However, there are also contradictory data discussed.  The current literature on the role of N/OFQ in anxiety and addiction, on the other hand points primarily to a role of agonist modulation being potentially therapeutic.  Some drug-like mols. that function either as agonists or antagonists of NOP receptors have been optimized for human clin. study to test some of these hypotheses.  The discovery of PET ligands for NOP receptors, combined with the pharmacol. tools and burgeoning preclin. data set discussed here bodes well for a rapid advancement of clin. understanding and potential therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTjRy74bFqVLVg90H21EOLACvtfcHk0ljemvbv7CZEug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOhtbzI&md5=7dd059d26483dbe6bcd58741f60f5ec3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DRorick-Kehn%26aufirst%3DL.%2BM.%26aulast%3DPintar%26aufirst%3DJ.%2BE.%26aulast%3DAnsonoff%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTucker%26aufirst%3DR.%2BC.%26aulast%3DCiccocioppo%26aufirst%3DR.%26atitle%3DThe%2520biology%2520of%2520nociceptin%252Forphanin%2520FQ%2520%2528N%252FOFQ%2529%2520related%2520to%2520obesity%252C%2520stress%252C%2520anxiety%252C%2520mood%252C%2520and%2520drug%2520dependence%26jtitle%3DPharmacol.%2520Ther.%26date%3D2014%26volume%3D141%26spage%3D283%26epage%3D299%26doi%3D10.1016%2Fj.pharmthera.2013.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2013.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pharmthera.2013.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=23711793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyqtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=10-25&author=E.+C.+Gavioliauthor=G.+Calo&title=Nociceptin%2Forphanin+FQ+receptor+antagonists+as+innovative+antidepressant+drugs&doi=10.1016%2Fj.pharmthera.2013.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs</span></div><div class="casAuthors">Gavioli, Elaine Cristina; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-25</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) were identified in the mid 90s as a novel peptidergic system structurally related to opioids.  A growing body of preclin. evidence suggests that blockade of NOP receptors evokes antidepressant-like actions.  These have been explored using a range of compds. (peptide and non peptide antagonists), across different species (rat and mouse) and assays (behavioral despair and chronic mild stress) suggesting a robust and consistent antidepressant-like effect.  Moreover, rats and mice knockout for the NOP receptor gene display an antidepressant-like phenotype in behavioral despair assays.  Electrophysiol., immunohistochem. and neurochem. studies point to an important role played by monoaminergic systems, particularly 5-HTergic, in mediating the antidepressant-like properties of NOP antagonists.  However other putative mechanisms of action, including modulation of the CRF system, circadian rhythm and a possible neuroendocrine-immune control might be involved.  A close relationship between the N/OFQ-NOP receptor system and stress responses is well described in the literature.  Stressful situations also alter endocrine, behavioral and neurochem. parameters in rats and chronic administration of a NOP antagonist restored these alterations.  Interestingly, clin. findings showed that plasma N/OFQ levels were significantly altered in major and post-partum depression, and bipolar disease patients.  Collectively, data in the literature support the notion that blockade of NOP receptor signaling could be a novel and interesting strategy for the development of innovative antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMWQXmH9Ke-7Vg90H21EOLACvtfcHk0lgKZqIdqIbaAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyqtLnI&md5=fc03fe69957a97dec69feb0b8fef3648</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2013.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2013.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520antagonists%2520as%2520innovative%2520antidepressant%2520drugs%26jtitle%3DPharmacol.%2520Ther.%26date%3D2013%26volume%3D140%26spage%3D10%26epage%3D25%26doi%3D10.1016%2Fj.pharmthera.2013.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Schröder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T.</span><span> </span><span class="NLM_article-title">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">3777</span><span class="NLM_x">–</span> <span class="NLM_lpage">3800</span><span class="refDoi"> DOI: 10.1111/bph.12744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fbph.12744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24762001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3777-3800&author=W.+Schr%C3%B6derauthor=D.+G.+Lambertauthor=M.+C.+Koauthor=T.+Koch&title=Functional+plasticity+of+the+N%2FOFQ-NOP+receptor+system+determines+analgesic+properties+of+NOP+receptor+agonists&doi=10.1111%2Fbph.12744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span></div><div class="casAuthors">Schroder W; Lambert D G; Ko M C; Koch T</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3777-800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite high sequence similarity between NOP (nociceptin/orphanin FQ opioid peptide) and opioid receptors, marked differences in endogenous ligand selectivity, signal transduction, phosphorylation, desensitization, internalization and trafficking have been identified; underscoring the evolutionary difference between NOP and opioid receptors.  Activation of NOP receptors affects nociceptive transmission in a site-specific manner, with antinociceptive effects prevailing after peripheral and spinal activation, and pronociceptive effects after supraspinal activation in rodents.  The net effect of systemically administered NOP receptor agonists on nociception is proposed to depend on the relative contribution of peripheral, spinal and supraspinal activation, and this may depend on experimental conditions.  Functional expression and regulation of NOP receptors at peripheral and central sites of the nociceptive pathway exhibits a high degree of plasticity under conditions of neuropathic and inflammatory pain.  In rodents, systemically administered NOP receptor agonists exerted antihypersensitive effects in models of neuropathic and inflammatory pain.  However, they were largely ineffective in acute pain while concomitantly evoking severe motor side effects.  In contrast, systemic administration of NOP receptor agonists to non-human primates (NHPs) exerted potent and efficacious antinociception in the absence of motor and sedative side effects.  The reason for this species difference with respect to antinociceptive efficacy and tolerability is not clear.  Moreover, co-activation of NOP and μ-opioid peptide (MOP) receptors synergistically produced antinociception in NHPs.  Hence, both selective NOP receptor as well as NOP/MOP receptor agonists may hold potential for clinical use as analgesics effective in conditions of acute and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKk8UmQyPtHQ8IxFYvehhofW6udTcc2eZTgEliLF4yDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D&md5=04241ff79c2ff0853c7a4513961d0648</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fbph.12744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12744%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DT.%26atitle%3DFunctional%2520plasticity%2520of%2520the%2520N%252FOFQ-NOP%2520receptor%2520system%2520determines%2520analgesic%2520properties%2520of%2520NOP%2520receptor%2520agonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3777%26epage%3D3800%26doi%3D10.1111%2Fbph.12744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Mogil, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G. W.</span><span> </span><span class="NLM_article-title">The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=381-415&author=J.+S.+Mogilauthor=G.+W.+Pasternak&title=The+molecular+and+behavioral+pharmacology+of+the+orphanin+FQ%2Fnociceptin+peptide+and+receptor+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26aulast%3DPasternak%26aufirst%3DG.%2BW.%26atitle%3DThe%2520molecular%2520and%2520behavioral%2520pharmacology%2520of%2520the%2520orphanin%2520FQ%252Fnociceptin%2520peptide%2520and%2520receptor%2520family%26jtitle%3DPharmacol.%2520Rev.%26date%3D2001%26volume%3D53%26spage%3D381%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Linz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzschentke, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautrois, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kögel, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englberger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahnel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, S.</span><span> </span><span class="NLM_article-title">Cebranopadol: A novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.1124/jpet.114.213694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.114.213694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24713140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=535-548&author=K.+Linzauthor=T.+Christophauthor=T.+M.+Tzschentkeauthor=T.+Kochauthor=K.+Schieneauthor=M.+Gautroisauthor=W.+Schr%C3%B6derauthor=B.+Y.+K%C3%B6gelauthor=H.+Beierauthor=W.+Englbergerauthor=S.+Schunkauthor=J.+De+Vryauthor=U.+Jahnelauthor=S.+Frosch&title=Cebranopadol%3A+A+novel+potent+analgesic+nociceptin%2Forphanin+FQ+peptide+and+opioid+receptor+agonist&doi=10.1124%2Fjpet.114.213694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span></div><div class="casAuthors">Linz, Klaus; Christoph, Thomas; Tzschentke, Thomas M.; Koch, Thomas; Schiene, Klaus; Gautrois, Michael; Schroeder, Wolfgang; Koegel, Babette Y.; Beier, Horst; Englberger, Werner; Schunk, Stefan; De Vry, Jean; Jahnel, Ulrich; Frosch, Stefanie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-548, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cebranopadol (trans-6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine) is a novel analgesic nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonist [Ki (nM)/EC50 (nM)/relative efficacy (%): human NOP receptor 0.9/13.0/89; human mu-opioid peptide (MOP) receptor 0.7/1.2/104; human kappa-opioid peptide receptor 2.6/17/67; human delta-opioid peptide receptor 18/110/105].  Cebranopadol exhibits highly potent and efficacious antinociceptive and antihypersensitive effects in several rat models of acute and chronic pain (tail-flick, rheumatoid arthritis, bone cancer, spinal nerve ligation, diabetic neuropathy) with ED50 values of 0.5-5.6 μg/kg after i.v. and 25.1 μg/kg after oral administration.  In comparison with selective MOP receptor agonists, cebranopadol was more potent in models of chronic neuropathic than acute nociceptive pain.  Cebranopadol's duration of action is long (up to 7 h after i.v. 12 μg/kg; >9 h after oral 55 μg/kg in the rat tail-flick test).  The antihypersensitive activity of cebranopadol in the spinal nerve ligation model was partially reversed by pretreatment with the selective NOP receptor antagonist J-1133'7[1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one] or the opioid receptor antagonist naloxone, indicating that both NOP and opioid receptor agonism are involved in this activity.  Development of analgesic tolerance in the chronic constriction injury model was clearly delayed compared with that from an equianalgesic dose of morphine (complete tolerance on day 26 vs. day 11, resp.).  Unlike morphine, cebranopadol did not disrupt motor coordination and respiration at doses within and exceeding the analgesic dose range.  Cebranopadol, by its combination of agonism at NOP and opioid receptors, affords highly potent and efficacious analgesia in various pain models with a favorable side effect profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvDj3QJY4fYrVg90H21EOLACvtfcHk0lgKZqIdqIbaAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE&md5=c3fcc301bf4dde5706565d9187578df4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213694%26sid%3Dliteratum%253Aachs%26aulast%3DLinz%26aufirst%3DK.%26aulast%3DChristoph%26aufirst%3DT.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DKoch%26aufirst%3DT.%26aulast%3DSchiene%26aufirst%3DK.%26aulast%3DGautrois%26aufirst%3DM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DK%25C3%25B6gel%26aufirst%3DB.%2BY.%26aulast%3DBeier%26aufirst%3DH.%26aulast%3DEnglberger%26aufirst%3DW.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DJahnel%26aufirst%3DU.%26aulast%3DFrosch%26aufirst%3DS.%26atitle%3DCebranopadol%253A%2520A%2520novel%2520potent%2520analgesic%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D535%26epage%3D548%26doi%3D10.1124%2Fjpet.114.213694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowbotham, D. J.</span><span> </span><span class="NLM_article-title">Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist</span> <span class="citation_source-journal">Br. J. Anaesth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span><span class="refDoi"> DOI: 10.1093/bja/aeu332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1093%2Fbja%2Faeu332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25248647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jvFCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2015&pages=364-366&author=D.+G.+Lambertauthor=M.+F.+Birdauthor=D.+J.+Rowbotham&title=Cebranopadol%3A+a+first+in-class+example+of+a+nociceptin%2Forphanin+FQ+receptor+and+opioid+receptor+agonist&doi=10.1093%2Fbja%2Faeu332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist</span></div><div class="casAuthors">Lambert D G; Bird M F; Rowbotham D J</div><div class="citationInfo"><span class="NLM_cas:title">British journal of anaesthesia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">364-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtYUFOxkJ7ocAKB7Fa-xrUfW6udTcc2eaENL9ykoVFtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jvFCqtA%253D%253D&md5=a649b9bc2fe0ebb8e3ac2bef59ff8499</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fbja%2Faeu332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbja%252Faeu332%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DRowbotham%26aufirst%3DD.%2BJ.%26atitle%3DCebranopadol%253A%2520a%2520first%2520in-class%2520example%2520of%2520a%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2015%26volume%3D114%26spage%3D364%26epage%3D366%26doi%3D10.1093%2Fbja%2Faeu332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Sałat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakubowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulig, K.</span><span> </span><span class="NLM_article-title">Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1517/13543784.2015.1036985</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543784.2015.1036985" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=837-844&author=K.+Sa%C5%82atauthor=A.+Jakubowskaauthor=K.+Kulig&title=Cebranopadol%3A+a+first-in-class+potent+analgesic+agent+with+agonistic+activity+at+nociceptin%2Forphanin+FQ+and+opioid+receptors&doi=10.1517%2F13543784.2015.1036985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1517%2F13543784.2015.1036985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2015.1036985%26sid%3Dliteratum%253Aachs%26aulast%3DSa%25C5%2582at%26aufirst%3DK.%26aulast%3DJakubowska%26aufirst%3DA.%26aulast%3DKulig%26aufirst%3DK.%26atitle%3DCebranopadol%253A%2520a%2520first-in-class%2520potent%2520analgesic%2520agent%2520with%2520agonistic%2520activity%2520at%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2015%26volume%3D24%26spage%3D837%26epage%3D844%26doi%3D10.1517%2F13543784.2015.1036985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Post, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krikke-Workel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span> </span><span class="NLM_article-title">A selective nociceptin receptor antagonist to treat depression: Evidence from preclinical and clinical studies</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1038/npp.2015.348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnpp.2015.348" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Postauthor=T.+S.+Smartauthor=J.+Krikke-Workelauthor=G.+R.+Dawsonauthor=C.+J.+Harmerauthor=M.+Browningauthor=K.+Jacksonauthor=R.+Kakarauthor=R.+Mohsauthor=M.+Statnickauthor=K.+Waffordauthor=A.+McCarthyauthor=V.+Barthauthor=J.+M.+Witkin&title=A+selective+nociceptin+receptor+antagonist+to+treat+depression%3A+Evidence+from+preclinical+and+clinical+studies&doi=10.1038%2Fnpp.2015.348"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.348%26sid%3Dliteratum%253Aachs%26aulast%3DPost%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DT.%2BS.%26aulast%3DKrikke-Workel%26aufirst%3DJ.%26aulast%3DDawson%26aufirst%3DG.%2BR.%26aulast%3DHarmer%26aufirst%3DC.%2BJ.%26aulast%3DBrowning%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DKakar%26aufirst%3DR.%26aulast%3DMohs%26aufirst%3DR.%26aulast%3DStatnick%26aufirst%3DM.%26aulast%3DWafford%26aufirst%3DK.%26aulast%3DMcCarthy%26aufirst%3DA.%26aulast%3DBarth%26aufirst%3DV.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26atitle%3DA%2520selective%2520nociceptin%2520receptor%2520antagonist%2520to%2520treat%2520depression%253A%2520Evidence%2520from%2520preclinical%2520and%2520clinical%2520studies%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26doi%3D10.1038%2Fnpp.2015.348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span>Eli Lilly & Co. Study of the efficacy and safety of LY2940094 in participants with major depressive disorder (MDD). <a href="https://clinicaltrials.gov/ct2/show/NCT01724112" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01724112</a>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>NCT01724112, Phase 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eli+Lilly+%26+Co.+Study+of+the+efficacy+and+safety+of+LY2940094+in+participants+with+major+depressive+disorder+%28MDD%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01724112%2C+2014%3B+NCT01724112%2C+Phase+2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span>Eli Lilly & Co. A Study of LY2940094 in participants with alcohol dependence. <a href="https://clinicaltrials.gov/ct2/show/NCT01798303" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01798303</a>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>NCT0198303, Phase 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eli+Lilly+%26+Co.+A+Study+of+LY2940094+in+participants+with+alcohol+dependence.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01798303%2C+2014%3B+NCT0198303%2C+Phase+2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Satoh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma-Kanoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span> </span><span class="NLM_article-title">Identification of an orally active opioid receptor-like 1 (ORL1) receptor antagonist 4-{3-[(2R)-2,3-dihydroxypropyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-1-[(1S,3S ,4R)-spiro[bicyclo[2.2.1]heptane-2,1′-cyclopropan]-3-ylmethyl]piperidine as clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4091</span><span class="NLM_x">–</span> <span class="NLM_lpage">4094</span><span class="refDoi"> DOI: 10.1021/jm900581g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900581g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4091-4094&author=A.+Satohauthor=T.+Sagaraauthor=H.+Sakohauthor=M.+Hashimotoauthor=H.+Nakashimaauthor=T.+Katoauthor=Y.+Gotoauthor=S.+Mizutaniauthor=T.+Azuma-Kanohauthor=T.+Taniauthor=S.+Okudaauthor=O.+Okamotoauthor=S.+Ozakiauthor=Y.+Iwasawaauthor=H.+Ohtaauthor=H.+Kawamoto&title=Identification+of+an+orally+active+opioid+receptor-like+1+%28ORL1%29+receptor+antagonist+4-%7B3-%5B%282R%29-2%2C3-dihydroxypropyl%5D-2-oxo-2%2C3-dihydro-1H-benzimidazol-1-yl%7D-1-%5B%281S%2C3S+%2C4R%29-spiro%5Bbicyclo%5B2.2.1%5Dheptane-2%2C1%E2%80%B2-cyclopropan%5D-3-ylmethyl%5Dpiperidine+as+clinical+candidate&doi=10.1021%2Fjm900581g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm900581g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900581g%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DA.%26aulast%3DSagara%26aufirst%3DT.%26aulast%3DSakoh%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DAzuma-Kanoh%26aufirst%3DT.%26aulast%3DTani%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DKawamoto%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520an%2520orally%2520active%2520opioid%2520receptor-like%25201%2520%2528ORL1%2529%2520receptor%2520antagonist%25204-%257B3-%255B%25282R%2529-2%252C3-dihydroxypropyl%255D-2-oxo-2%252C3-dihydro-1H-benzimidazol-1-yl%257D-1-%255B%25281S%252C3S%2520%252C4R%2529-spiro%255Bbicyclo%255B2.2.1%255Dheptane-2%252C1%25E2%2580%25B2-cyclopropan%255D-3-ylmethyl%255Dpiperidine%2520as%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4091%26epage%3D4094%26doi%3D10.1021%2Fjm900581g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>Merck, Sharp and Dohme Corp. Treatment of cognitive impairment in men with schizophrenia (MK5757-005) (COMPLETED). <a href="https://clinicaltrials.gov/ct2/show/results/NCT00848484" class="extLink">https://clinicaltrials.gov/ct2/show/results/NCT00848484</a>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span>NCT00848484, Phase 2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Merck%2C+Sharp+and+Dohme+Corp.+Treatment+of+cognitive+impairment+in+men+with+schizophrenia+%28MK5757-005%29+%28COMPLETED%29.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT00848484%2C+2015%3B+NCT00848484%2C+Phase+2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nothacker, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Civelli, O.</span><span> </span><span class="NLM_article-title">Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">14854</span><span class="NLM_x">–</span> <span class="NLM_lpage">14858</span><span class="refDoi"> DOI: 10.1073/pnas.94.26.14854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1073%2Fpnas.94.26.14854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=14854-14858&author=F.+Jenckauthor=J.+L.+Moreauauthor=J.+R.+Martinauthor=G.+J.+Kilpatrickauthor=R.+K.+Reinscheidauthor=F.+J.+Monsmaauthor=H.+P.+Nothackerauthor=O.+Civelli&title=Orphanin+FQ+acts+as+an+anxiolytic+to+attenuate+behavioral+responses+to+stress&doi=10.1073%2Fpnas.94.26.14854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.26.14854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.26.14854%26sid%3Dliteratum%253Aachs%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DNothacker%26aufirst%3DH.%2BP.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DOrphanin%2520FQ%2520acts%2520as%2520an%2520anxiolytic%2520to%2520attenuate%2520behavioral%2520responses%2520to%2520stress%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D14854%26epage%3D14858%26doi%3D10.1073%2Fpnas.94.26.14854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouagazzal, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roever, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G.</span><span> </span><span class="NLM_article-title">A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">4938</span><span class="NLM_x">–</span> <span class="NLM_lpage">4943</span><span class="refDoi"> DOI: 10.1073/pnas.090514397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1073%2Fpnas.090514397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4938-4943&author=F.+Jenckauthor=J.+Wichmannauthor=F.+M.+Dautzenbergauthor=J.+L.+Moreauauthor=A.+M.+Ouagazzalauthor=J.+R.+Martinauthor=K.+Lundstromauthor=A.+M.+Cesuraauthor=S.+M.+Poliauthor=S.+Roeverauthor=S.+Kolczewskiauthor=G.+Adamauthor=G.+Kilpatrick&title=A+synthetic+agonist+at+the+orphanin+FQ%2Fnociceptin+receptor+ORL1%3A+anxiolytic+profile+in+the+rat&doi=10.1073%2Fpnas.090514397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.090514397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.090514397%26sid%3Dliteratum%253Aachs%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DOuagazzal%26aufirst%3DA.%2BM.%26aulast%3DMartin%26aufirst%3DJ.%2BR.%26aulast%3DLundstrom%26aufirst%3DK.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DRoever%26aufirst%3DS.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DKilpatrick%26aufirst%3DG.%26atitle%3DA%2520synthetic%2520agonist%2520at%2520the%2520orphanin%2520FQ%252Fnociceptin%2520receptor%2520ORL1%253A%2520anxiolytic%2520profile%2520in%2520the%2520rat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4938%26epage%3D4943%26doi%3D10.1073%2Fpnas.090514397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Canuso, C. M.; Hutchison, J.; Manitpisitkul, P.; Moyer, J. A.</span><span> </span><span class="NLM_article-title">NOP agonism: A novel mechanism for the treatment of anxiety and depression</span>. American Society of Clinical Psychopharmacology NCDEU Meeting, Phoenix, AZ, May 29, 2012; <span class="NLM_publisher-name">American Society of Clinical Psychopharmacology</span>: <span class="NLM_publisher-loc">Phoenix, AZ</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">19</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Canuso%2C+C.+M.%3B+Hutchison%2C+J.%3B+Manitpisitkul%2C+P.%3B+Moyer%2C+J.+A.+NOP+agonism%3A+A+novel+mechanism+for+the+treatment+of+anxiety+and+depression.+American+Society+of+Clinical+Psychopharmacology+NCDEU+Meeting%2C+Phoenix%2C+AZ%2C+May+29%2C+2012%3B+American+Society+of+Clinical+Psychopharmacology%3A+Phoenix%2C+AZ%2C+2012%3B+p+19."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCanuso%26aufirst%3DC.%2BM.%26atitle%3DNOP%2520agonism%253A%2520A%2520novel%2520mechanism%2520for%2520the%2520treatment%2520of%2520anxiety%2520and%2520depression%26pub%3DAmerican%2520Society%2520of%2520Clinical%2520Psychopharmacology%26date%3D2012%26spage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo', G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0704894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0704894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12237257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1Ciu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2002&pages=369-374&author=A.+Rizziauthor=D.+Rizziauthor=G.+Marzolaauthor=D.+Regoliauthor=B.+D.+Larsenauthor=J.+S.+Petersenauthor=G.+Calo%27&title=Pharmacological+characterization+of+the+novel+nociceptin%2Forphanin+FQ+receptor+ligand%2C+ZP120%3A+in+vitro+and+in+vivo+studies+in+mice&doi=10.1038%2Fsj.bjp.0704894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand ZP120: in vitro and in vivo studies in mice</span></div><div class="casAuthors">Rizzi, Anna; Rizzi, Daniela; Marzola, Giuliano; Regoli, Domenico; Larsen, Bjarne Due; Petersen, Jorgen Soberg; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-374</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This study reports the pharmacol. characterization of ZP120, a novel ligand of the nociceptin/orphanin FQ (N/OFQ) peptide receptor, NOP.  In vitro, ZP120 mimicked the inhibitory effects of N/OFQ on contractions of the elec. stimulated mouse vas deferens, showing, however, higher potency (pEC50 8.88 vs 7.74), lower maximal effects (Emax 69% vs 91%), and slower onset of action.  Like N/OFQ, the effects of ZP120 were not modified by 1 μM naloxone, but they were antagonized by the NOP receptor-selective antagonist J-113397 (pA2 7.80 vs. ZP120, 7.81 vs. N/OFQ).  In vivo, ZP120 mimicked the effects of N/OFQ, producing pronociceptive effects in the tail withdrawal assay and decreased locomotor activity after intracerebroventricular, but not after i.v., administration to mice.  ZP120 elicited similar maximal effects as N/OFQ, but it was about 10-fold more potent and its effects lasted longer.  In conclusion, the novel NOP receptor ligand ZP120 is a highly potent and selective partial agonist of the NOP receptor with prolonged effects in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVlVZ3fJ-6mrVg90H21EOLACvtfcHk0liY6GBYIfYLQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1Ciu7w%253D&md5=33cc5383382632191e292640a6d5383b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704894%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DLarsen%26aufirst%3DB.%2BD.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26aulast%3DCalo%2527%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligand%252C%2520ZP120%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D137%26spage%3D369%26epage%3D374%26doi%3D10.1038%2Fsj.bjp.0704894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Kapusta, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorkildsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenigs, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinge, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span> </span><span class="NLM_article-title">Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1124/jpet.105.083436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.105.083436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15855355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVSis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=652-660&author=D.+R.+Kapustaauthor=C.+Thorkildsenauthor=V.+A.+Kenigsauthor=E.+Meierauthor=M.+M.+Vingeauthor=C.+Quistauthor=J.+S.+Petersen&title=Pharmacodynamic+characterization+of+ZP120+%28Ac-RYYRWKKKKKKK-NH2%29%2C+a+novel%2C+functionally+selective+nociceptin%2Forphanin+FQ+peptide+receptor+partial+agonist+with+sodium-potassium-sparing+aquaretic+activity&doi=10.1124%2Fjpet.105.083436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity</span></div><div class="casAuthors">Kapusta, Daniel R.; Thorkildsen, Christian; Kenigs, Velga A.; Meier, Eddi; Vinge, Mette M.; Quist, Charlotte; Petersen, Jorgen Soberg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">652-660</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In conscious rats, i.v. administration of the hexapeptide Ac-RYYRWK-NH2, a partial agonist of the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor, produces a selective water diuresis without marked cardiovascular or behavioral effects.  The present study examd. the in vitro and in vivo pharmacodynamic profile of the novel and potentially metabolically stable NOP receptor ligand ZP120 (Ac-RYYRWKKKKKKK-NH2), which was created by conjugation of a structure-inducing probe (SIP) (i.e., K6 sequence) to Ac-RYYRWK-NH2.  In cells transfected with human NOP receptors, both Ac-RYYRWK-NH2 and ZP120 displaced [3H]N/OFQ (both peptides, pKi = 9.6), and similar to N/OFQ inhibited forskolin-induced cAMP formation (Ac-RYYRWK-NH2, pEC50 = 9.2; ZP120, 9.3; N/OFQ, 9.7).  In the mouse vas deferens assay (MVD), Ac-RYYRWK-NH2 and ZP120 behaved as partial agonists, inhibiting elec. induced contractions with similar pEC50 values (9.0 and 8.6 resp.) but with submaximal efficacy compared with N/OFQ.  In MVD, both peptides blocked the responses to N/OFQ, with ZP120 being approx. 50-fold more potent than Ac-RYYRWK-NH2.  In vivo, dose-response studies in rats showed that at doses (i.v. bolus or i.v. infusion) that produced a sodium-potassium-sparing aquaresis, ZP120 and Ac-RYYRWK-NH2 elicited a mild vasodilatory response without reflex tachycardia.  However, the renal responses to ZP120 were of greater magnitude and duration.  Finally, each peptide blocked the bradycardia and hypotension to N/OFQ in conscious rats, but the effect of ZP120 was of much greater duration.  Together, these findings demonstrate that ZP120 is a novel, functionally selective SIP-modified NOP receptor partial agonist with increased biol. activity and sodium-potassium-sparing aquaretic activity, the actions of which may be useful in the management of hyponatremia/hypokalemia in water-retaining states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovm0GvXih8VLVg90H21EOLACvtfcHk0liY6GBYIfYLQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVSis78%253D&md5=547f88e32841320ee1ac37672a827938</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.083436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.083436%26sid%3Dliteratum%253Aachs%26aulast%3DKapusta%26aufirst%3DD.%2BR.%26aulast%3DThorkildsen%26aufirst%3DC.%26aulast%3DKenigs%26aufirst%3DV.%2BA.%26aulast%3DMeier%26aufirst%3DE.%26aulast%3DVinge%26aufirst%3DM.%2BM.%26aulast%3DQuist%26aufirst%3DC.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26atitle%3DPharmacodynamic%2520characterization%2520of%2520ZP120%2520%2528Ac-RYYRWKKKKKKK-NH2%2529%252C%2520a%2520novel%252C%2520functionally%2520selective%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520partial%2520agonist%2520with%2520sodium-potassium-sparing%2520aquaretic%2520activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D652%26epage%3D660%26doi%3D10.1124%2Fjpet.105.083436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Fischetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1016/j.peptides.2008.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.peptides.2008.10.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=248-255&author=C.+Fischettiauthor=A.+Rizziauthor=E.+C.+Gavioliauthor=G.+Marzolaauthor=C.+Trapellaauthor=R.+Guerriniauthor=J.+S.+Petersenauthor=G.+Calo&title=Further+studies+on+the+pharmacological+features+of+the+nociceptin%2Forphanin+FQ+receptor+ligand+ZP120&doi=10.1016%2Fj.peptides.2008.10.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2008.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2008.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DFurther%2520studies%2520on%2520the%2520pharmacological%2520features%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligand%2520ZP120%26jtitle%3DPeptides%26date%3D2009%26volume%3D30%26spage%3D248%26epage%3D255%26doi%3D10.1016%2Fj.peptides.2008.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">van Deurs, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadrup, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonassen, T. E.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ peptide receptor agonist Ac-RYYRWKKKKKKK-NH2 (ZP120) induces antinatriuresis in rats by stimulation of amiloride-sensitive sodium reabsorption</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1124/jpet.108.144774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.108.144774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19028991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Khu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2009&pages=533-539&author=U.+S.+van+Deursauthor=N.+Hadrupauthor=J.+S.+Petersenauthor=S.+Christensenauthor=T.+E.+Jonassen&title=Nociceptin%2Forphanin+FQ+peptide+receptor+agonist+Ac-RYYRWKKKKKKK-NH2+%28ZP120%29+induces+antinatriuresis+in+rats+by+stimulation+of+amiloride-sensitive+sodium+reabsorption&doi=10.1124%2Fjpet.108.144774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ peptide receptor agonist Ac-RYYRWKKKKKKK-NH2 (ZP120) induces antinatriuresis in rats by stimulation of amiloride-sensitive sodium reabsorption</span></div><div class="casAuthors">van Deurs, Ulla S. K.; Hadrup, Niels; Petersen, Joergen Soeberg; Christensen, Sten; Jonassen, Thomas E. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">533-539</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The aim of the present study was to examine the mechanisms responsible for the antinatriuretic effect of the selective, peripherally acting, nociceptin/orphanin FQ peptide (NOP) receptor partial agonist Ac-RYYRWKKKKKKK-NH2 (ZP120).  Using immunohistochem., we showed that in the cortex NOP receptors are expressed in the distal convoluted tubules, the connecting tubules, and the collecting ducts.  Using clearance techniques, we evaluated renal excretory function during acute administration of ZP120 (1 nmol/kg/min) in chronically catheterized, conscious rats (n = 8/group).  To examine the hypothesis that ZP120 induces direct renal effects by modifying the activity of sodium transporters in the distal convoluted tubules or in the collecting ducts, ZP120-induced antinatriuresis was examd. during coadministration of an inhibitor of the NaCl cotransporter, bendroflumethiazide, or a blocker of the epithelial sodium channel, amiloride, resp.  ZP120 produced a marked antinatriuresis [fractional excretion of sodium (FENa): ZP120, 0.3±0.1% vs. control, 0.9±0.1%; p < 0.05] in sodium-replete rats.  The natriuretic response to amiloride was significantly increased in ZP120-treated rats compared with controls (ΔFENa: ZP120, 1.1±0.2% vs. control, 0.5±0.2%; p < 0.01), whereas the effect of BFTZ was equal in ZP120-treated rats and controls.  These results suggest that ZP120 exerts a direct renal NOP receptor-mediated stimulatory effect on the epithelial sodium channel in the collecting ducts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRMyLz1TuMz7Vg90H21EOLACvtfcHk0lgoOhMX_61JFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Khu7Y%253D&md5=5299f0567a06d09bd32c1a4a82fa0b61</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.144774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.144774%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDeurs%26aufirst%3DU.%2BS.%26aulast%3DHadrup%26aufirst%3DN.%26aulast%3DPetersen%26aufirst%3DJ.%2BS.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DJonassen%26aufirst%3DT.%2BE.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520agonist%2520Ac-RYYRWKKKKKKK-NH2%2520%2528ZP120%2529%2520induces%2520antinatriuresis%2520in%2520rats%2520by%2520stimulation%2520of%2520amiloride-sensitive%2520sodium%2520reabsorption%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D328%26spage%3D533%26epage%3D539%26doi%3D10.1124%2Fjpet.108.144774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span>SERODUS PHARMA Pipeline SER100TRISH. <a href="http://www.serodus.com/Pipeline/SER100TRISH" class="extLink">http://www.serodus.com/Pipeline/SER100TRISH</a> (accessed September 20,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SERODUS+PHARMA+Pipeline+SER100TRISH.+http%3A%2F%2Fwww.serodus.com%2FPipeline%2FSER100TRISH+%28accessed+September+20%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Woodcock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. A.</span><span> </span><span class="NLM_article-title">The efficacy of a NOP1 agonist (SCH486757) in subacute cough</span> <span class="citation_source-journal">Lung</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1007/s00408-009-9197-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00408-009-9197-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2010&pages=47-52&issue=Suppl.+1&author=A.+Woodcockauthor=R.+L.+McLeodauthor=J.+Sadehauthor=J.+A.+Smith&title=The+efficacy+of+a+NOP1+agonist+%28SCH486757%29+in+subacute+cough&doi=10.1007%2Fs00408-009-9197-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2Fs00408-009-9197-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00408-009-9197-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoodcock%26aufirst%3DA.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DSadeh%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520efficacy%2520of%2520a%2520NOP1%2520agonist%2520%2528SCH486757%2529%2520in%2520subacute%2520cough%26jtitle%3DLung%26date%3D2010%26volume%3D188%26issue%3DSuppl.%25201%26spage%3D47%26epage%3D52%26doi%3D10.1007%2Fs00408-009-9197-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeh, J.</span><span> </span><span class="NLM_article-title">Where are the new cough treatments: a debriefing of recent clinical proof-of-concept trials with the NOP agonist SCH 486757</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span><span class="refDoi"> DOI: 10.1159/000328782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1159%2F000328782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2011&pages=50-54&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=J.+Sadeh&title=Where+are+the+new+cough+treatments%3A+a+debriefing+of+recent+clinical+proof-of-concept+trials+with+the+NOP+agonist+SCH+486757&doi=10.1159%2F000328782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1159%2F000328782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000328782%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DSadeh%26aufirst%3DJ.%26atitle%3DWhere%2520are%2520the%2520new%2520cough%2520treatments%253A%2520a%2520debriefing%2520of%2520recent%2520clinical%2520proof-of-concept%2520trials%2520with%2520the%2520NOP%2520agonist%2520SCH%2520486757%26jtitle%3DPharmacology%26date%3D2011%26volume%3D88%26spage%3D50%26epage%3D54%26doi%3D10.1159%2F000328782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span>JTC 801 Japan Tobacco discontinued, Japan, UK,(pain). <a href="http://business.highbeam.com/436989/article-1G1-109477099/jtc-801-japan-tobacco-discontinued-japan-uk" class="extLink">http://business.highbeam.com/436989/article-1G1-109477099/jtc-801-japan-tobacco-discontinued-japan-uk</a> (accessed June 30,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=JTC+801+Japan+Tobacco+discontinued%2C+Japan%2C+UK%2C%28pain%29.+http%3A%2F%2Fbusiness.highbeam.com%2F436989%2Farticle-1G1-109477099%2Fjtc-801-japan-tobacco-discontinued-japan-uk+%28accessed+June+30%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Lazzeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaguti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beneforti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, D.</span><span> </span><span class="NLM_article-title">Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2098</span><span class="NLM_x">–</span> <span class="NLM_lpage">2102</span><span class="refDoi"> DOI: 10.1016/j.juro.2006.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.juro.2006.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17070267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=2098-2102&author=M.+Lazzeriauthor=G.+Caloauthor=M.+Spinelliauthor=S.+Malagutiauthor=R.+Guerriniauthor=S.+Salvadoriauthor=P.+Benefortiauthor=D.+Regoliauthor=D.+Turini&title=Daily+intravesical+instillation+of+1+mg+nociceptin%2Forphanin+FQ+for+the+control+of+neurogenic+detrusor+overactivity%3A+a+multicenter%2C+placebo+controlled%2C+randomized+exploratory+study&doi=10.1016%2Fj.juro.2006.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study</span></div><div class="casAuthors">Lazzeri, Massimo; Calo, Girolamo; Spinelli, Michele; Malaguti, Silvia; Guerrini, Remo; Salvadori, Severo; Beneforti, Patrizia; Regoli, Domenico; Turini, Damiano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2098-2102</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: We studied the feasibility, safety and efficacy of daily intravesical instillation of 1 mg of the endogenous peptide nociceptin/orphanin FQ in a selected group of patients who perform clean intermittent self-catheterization for neurogenic detrusor over activity incontinence.  Materials and Methods: A total of 18 patients with neurogenic detrusor overactivity incontinence and on clean intermittent self-catheterization were prospectively randomized to receive 1 mg nociceptin/orphanin FQ in 10 cc saline (9) or placebo (saline) soln. (9) at the first morning catheterization for 10 days.  All patients completed a voiding diary using a frequency/vol. chart according to International Continence Society guidelines, and reported daily incontinence frequency.  Mean changes in incontinence episode frequency and voiding diary mean bladder capacity from baseline throughout treatment were the primary outcome variables.  Urodynamic parameters (cystomanometric bladder capacity, max. bladder pressure) were also recorded at baseline and during the study.  Results: The 2 groups were well balanced and all patients completed the study.  The urodynamic parameters recorded during the study showed an increase in cystomanometric bladder capacity and a decrease in max. bladder pressure compared to baseline only in patients assigned to the nociceptin/orphanin FQ group.  Mean daily urine leakage episodes during nociceptin/orphanin FQ treatment were 0.94 vs a pretreatment baseline of 2.18 (p <0.05), while no significant changes were reported in the placebo group (2.06 vs 2.43 baseline).  The total mean voiding diary bladder capacity increased from 171 ± 70 to 294 ± 107 mL in patients receiving nociceptin/orphanin FQ, while voiding diary mean bladder capacity remained unchanged in patients receiving placebo (from 182 ± 55 to 178 ± 23 mL).  No significant problems related to feasibility of the procedure as well as significant side effects were reported by patients.  Conclusions: This study showed that intravesical nociceptin/orphanin FQ but not placebo inhibited the micturition reflex in patients with neurogenic detrusor overactivity incontinence, and demonstrated the clin. efficacy of nociceptin/orphanin FQ during 10 days of treatment.  These findings support the use of nociceptin/orphanin FQ peptide receptor agonists as an innovative therapeutic approach for controlling detrusor overactivity incontinence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJMcvtQcA4brVg90H21EOLACvtfcHk0lgoOhMX_61JFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SgurbN&md5=f6344f49e36299e104eb679d9cc1026b</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DMalaguti%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBeneforti%26aufirst%3DP.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTurini%26aufirst%3DD.%26atitle%3DDaily%2520intravesical%2520instillation%2520of%25201%2520mg%2520nociceptin%252Forphanin%2520FQ%2520for%2520the%2520control%2520of%2520neurogenic%2520detrusor%2520overactivity%253A%2520a%2520multicenter%252C%2520placebo%2520controlled%252C%2520randomized%2520exploratory%2520study%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D2098%26epage%3D2102%26doi%3D10.1016%2Fj.juro.2006.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Lazzeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beneforti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanollo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, D.</span><span> </span><span class="NLM_article-title">Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">2237</span><span class="NLM_x">–</span> <span class="NLM_lpage">2240</span><span class="refDoi"> DOI: 10.1016/S0022-5347(05)65541-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0022-5347%2805%2965541-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11696742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38XktFKm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2001&pages=2237-2240&author=M.+Lazzeriauthor=G.+Caloauthor=M.+Spinelliauthor=R.+Guerriniauthor=P.+Benefortiauthor=S.+Sandriauthor=A.+Zanolloauthor=D.+Regoliauthor=D.+Turini&title=Urodynamic+and+clinical+evidence+of+acute+inhibitory+effects+of+intravesical+nociceptin%2Forphanin+FQ+on+detrusor+overactivity+in+humans%3A+a+pilot+study&doi=10.1016%2FS0022-5347%2805%2965541-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study</span></div><div class="casAuthors">Lazzeri, Massimo; Calo, Girolamo; Spinelli, Michele; Guerrini, Remo; Beneforti, Patrizia; Sandri, Sandro; Zanollo, Alberto; Regoli, Domenico; Turini, Damiano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2237-2240</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Management of neurogenic incontinence is complex and available treatments are not satisfactory.  Nociceptin/orphanin FQ, a recently discovered neuropeptide, has been reported to inhibit the voiding reflex in the rat.  These exptl. prompted the authors to investigate the urodynamic and clin. effects of intravesical instillation of nociceptin/orphanin FQ in humans.  The authors' study involved 5 normal subjects (group 1) with a mean age of 40.4 yr (range 21 to 54) and 9 patients (group 2) 40.4 yr (24 to 54).  All patients in group 2 presented with detrusor hyperreflexia refractory to std. therapy.  They were invited to undergo a filling cystometrogram with saline soln. and after 30 min, a new one with a soln. contg. 1 μM. nociceptin/orphanin FQ.  The urodynamic parameters that were recorded included bladder capacity, vol. threshold for the appearance of detrusor hyperreflexia and max. bladder pressure.  Clin. and urodynamic follow-up was performed after 15 days.  The data were statistically analyzed with 1-way anal. of variance followed by the Dunnett test for multiple comparison considered statistically significant with.  Intravesical instillation of 1 μM. nociceptin/orphanin FQ in group 1 did not produce significant functional changes.  This infusion in group 2 produced a statistically significant increase in mean bladder capacity and vol. threshold for the appearance of detrusor hyperreflexia from 164 to 301 and 93 to 231 mL.  Mean max. bladder pressure decreased from 79 to 54 cm. water but was not statistically significant.  After 15 days an absence of clin. improvement was noticed in group 2, and the urodynamic control did not show any significant changes compared to the values before nociceptin/orphanin FQ treatment.  No severe symptomatic reactions were obsd. during infusion of 1 μM. nociceptin/orphanin FQ.  The results demonstrate that nociceptin/orphanin FQ is able to elicit a robust inhibitory effect on voiding reflex in group 2 but not 1.  The ideal dosage, route of administration of nociceptin/orphanin FQ and treatment interval are not yet established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU83s3zAsTY7Vg90H21EOLACvtfcHk0lhhqSzcd-pJAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktFKm&md5=3877595544e45918b2f7193f3d5c0345</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2805%2965541-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252805%252965541-3%26sid%3Dliteratum%253Aachs%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBeneforti%26aufirst%3DP.%26aulast%3DSandri%26aufirst%3DS.%26aulast%3DZanollo%26aufirst%3DA.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTurini%26aufirst%3DD.%26atitle%3DUrodynamic%2520and%2520clinical%2520evidence%2520of%2520acute%2520inhibitory%2520effects%2520of%2520intravesical%2520nociceptin%252Forphanin%2520FQ%2520on%2520detrusor%2520overactivity%2520in%2520humans%253A%2520a%2520pilot%2520study%26jtitle%3DJ.%2520Urol.%26date%3D2001%26volume%3D166%26spage%3D2237%26epage%3D2240%26doi%3D10.1016%2FS0022-5347%2805%2965541-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lazzeri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beneforti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, D.</span><span> </span><span class="NLM_article-title">Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">946</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span><span class="refDoi"> DOI: 10.1016/S0090-4295(02)02587-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0090-4295%2802%2902587-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=946-950&author=M.+Lazzeriauthor=G.+Caloauthor=M.+Spinelliauthor=R.+Guerriniauthor=S.+Salvadoriauthor=P.+Benefortiauthor=S.+Sandriauthor=D.+Regoliauthor=D.+Turini&title=Urodynamic+effects+of+intravesical+nociceptin%2Forphanin+FQ+in+neurogenic+detrusor+overactivity%3A+a+randomized%2C+placebo-controlled%2C+double-blind+study&doi=10.1016%2FS0090-4295%2802%2902587-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0090-4295%2802%2902587-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-4295%252802%252902587-6%26sid%3Dliteratum%253Aachs%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBeneforti%26aufirst%3DP.%26aulast%3DSandri%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTurini%26aufirst%3DD.%26atitle%3DUrodynamic%2520effects%2520of%2520intravesical%2520nociceptin%252Forphanin%2520FQ%2520in%2520neurogenic%2520detrusor%2520overactivity%253A%2520a%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520study%26jtitle%3DUrology%26date%3D2003%26volume%3D61%26spage%3D946%26epage%3D950%26doi%3D10.1016%2FS0090-4295%2802%2902587-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Zaveri, N.</span><span> </span><span class="NLM_article-title">Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">678</span><span class="refDoi"> DOI: 10.1016/S0024-3205(03)00387-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0024-3205%2803%2900387-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=663-678&author=N.+Zaveri&title=Peptide+and+nonpeptide+ligands+for+the+nociceptin%2Forphanin+FQ+receptor+ORL1%3A+research+tools+and+potential+therapeutic+agents&doi=10.1016%2FS0024-3205%2803%2900387-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2803%2900387-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252803%252900387-4%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%26atitle%3DPeptide%2520and%2520nonpeptide%2520ligands%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ORL1%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D663%26epage%3D678%26doi%3D10.1016%2FS0024-3205%2803%2900387-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Ronzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, G. A. M.</span><span> </span><span class="NLM_article-title">Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1517/13543776.11.4.525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543776.11.4.525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1emu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=525-546&author=S.+Ronzoniauthor=I.+Perettoauthor=G.+A.+M.+Giardina&title=Lead+generation+and+lead+optimisation+approaches+in+the+discovery+of+selective%2C+non-peptide+ORL-1+receptor+agonists+and+antagonists&doi=10.1517%2F13543776.11.4.525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonists</span></div><div class="casAuthors">Ronzoni, Silvano; Peretto, Ilaria; Giardina, Giuseppe A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-546</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 104 refs.  The discovery of the opioid receptor like-1 (ORL-1) receptor and of its endogenous agonist nociceptin/orphanin FQ has attracted great interest in the scientific community giving rise, in the last five years, to a flurry of biol. studies aimed at elucidating the role of this new receptor.  Hence, the involvement of the ORL-1 receptor in many important processes, such as antinociception, learning and memory, feeding and anxiety, has been well documented.  However, a clear understanding of the potential therapeutic value assocd. with the modulation of the ORL-1 receptor needs the development of selective non-peptide agonists and antagonists allowing systemic routes of administration.  This review addresses the advances made by several research groups in the discovery of such compds. and discusses the medicinal chem. strategies which, starting from the first non-selective ligands NalBzoH and lofentanil, led to the disclosure of highly potent and selective agonists and antagonists, such as Ro 64-6198, J-113397 and JTC-801.  Efforts have also focussed on the pharmacol. characterization of the newly discovered non-peptide tools, which represent a significant step forward in the understanding of the involvement of the ORL-1 receptor in a no. of possible pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgQVIuVN7IW7Vg90H21EOLACvtfcHk0lhhqSzcd-pJAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1emu7c%253D&md5=577714ac0d0d15d639a2d934a1eb77c2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F13543776.11.4.525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.11.4.525%26sid%3Dliteratum%253Aachs%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26atitle%3DLead%2520generation%2520and%2520lead%2520optimisation%2520approaches%2520in%2520the%2520discovery%2520of%2520selective%252C%2520non-peptide%2520ORL-1%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2001%26volume%3D11%26spage%3D525%26epage%3D546%26doi%3D10.1517%2F13543776.11.4.525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Bignan, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span> </span><span class="NLM_article-title">Recent advances towards the discovery of ORL-1 receptor agonists and antagonists</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1517/13543776.15.4.357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543776.15.4.357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1ymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=357-388&author=G.+C.+Bignanauthor=P.+J.+Connollyauthor=S.+A.+Middleton&title=Recent+advances+towards+the+discovery+of+ORL-1+receptor+agonists+and+antagonists&doi=10.1517%2F13543776.15.4.357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances towards the discovery of ORL-1 receptor agonists and antagonists</span></div><div class="casAuthors">Bignan, Gilles C.; Connolly, Peter J.; Middleton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-388</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Since their discovery a decade ago, remarkable progress was made toward understanding the biol. function and significance of the opioid receptor-like-1 (ORL-1) receptor and its endogenous peptide ligand, nociceptin.  The human nociceptin receptor, herein referred to as ORL-1, but also known as OP4 (the 4th member of opioid peptide receptor family) or nociceptin/orphanin FQ peptide (NOP) receptor, was first identified as an orphan opioid receptor with close homol. to the classical μ-, κ-, and δ-opioid receptors.  ORL-1 does not bind endogenous ligands of the other opioid receptors with high affinity, but instead prefers the 17 amino acid peptide nociceptin.  The obvious homologies of ORL-1 to opioid receptors, and its ligand nociceptin to opioid peptide ligands, led to a period of intense investigation that resulted in a no. of significant reports describing the biol. of the receptor and ligand.  The emerging pharmacol. evidence from these reports suggests that ORL-1 agonists may be clin. useful for treatment of stress, anxiety, substance abuse (opioid and alc.), anorexia, cachexia, cough, asthma, and possibly neuropathic pain/allodynia.  The peripheral effects of nociceptin suggest that agonists may have utility in the treatment of gastrointestinal motility disorders, water retention, and hypertension.  ORL-1 antagonists may be useful in enhancing cognitive function and treating locomotor disorders such as Parkinsonism.  In addn. to research into the fundamental biol. of ORL-1 and nociceptin, noteworthy advances were made in the discovery of new peptide and non-peptide agonists and antagonists of the ORL-1 receptor leading to a better understanding of its involvement in a variety of biol. processes.  This review highlights the rationale for the development of ORL-1 ligands and recent progress made by different research groups towards the development of peptidic and non-peptidic ORL-1 agonists or antagonists over the last 4 years.  To add perspective on the com. potential of this research area, the development status of advanced new mols. is addressed together with any pharmacol. characterization of these entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF-D3T_o_24bVg90H21EOLACvtfcHk0lgAtZucdLmwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1ymsLw%253D&md5=288edcbf10ec87a04cec5b8e33380fb3</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1517%2F13543776.15.4.357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.15.4.357%26sid%3Dliteratum%253Aachs%26aulast%3DBignan%26aufirst%3DG.%2BC.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26atitle%3DRecent%2520advances%2520towards%2520the%2520discovery%2520of%2520ORL-1%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2005%26volume%3D15%26spage%3D357%26epage%3D388%26doi%3D10.1517%2F13543776.15.4.357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Lambert, D. G.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">694</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1038/nrd2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnrd2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18670432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=694-710&author=D.+G.+Lambert&title=The+nociceptin%2Forphanin+FQ+receptor%3A+a+target+with+broad+therapeutic+potential&doi=10.1038%2Fnrd2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span></div><div class="casAuthors">Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">694-710</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, Lambert describes the physiol. and potential clin. applications of nociceptin/orphanin FQ and its receptor.  This peptide-receptor system has been implicated in a wide range of biol. functions such as pain, drug abuse, cardiovascular control and immunity.  Identification of the enigmatic nociceptin/orphanin FQ peptide (N/OFQ) in 1995 represented the first successful use of reverse pharmacol. and led to deorphanization of the N/OFQ receptor (NOP).  Subsequently, the N/OFQ-NOP system has been implicated in a wide range of biol. functions, including pain, drug abuse, cardiovascular control and immunity.  Although this could be considered a hurdle for the development of pharmaceuticals selective for a specific disease indication, NOP represents a viable drug target.  This article describes potential clin. indications and highlights the current status of the very limited no. of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuID92HZwUB7Vg90H21EOLACvtfcHk0lgAtZucdLmwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D&md5=46c1952ed4a0ac1aa7779276bda5bba6</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnrd2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2572%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%253A%2520a%2520target%2520with%2520broad%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D694%26epage%3D710%26doi%3D10.1038%2Fnrd2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Largent-Milnes, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderah, T. W.</span><span> </span><span class="NLM_article-title">Recently patented and promising ORL-1 ligands: where have we been and where are we going?</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1517/13543771003602004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1517%2F13543771003602004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20180617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisValur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=291-305&author=T.+M.+Largent-Milnesauthor=T.+W.+Vanderah&title=Recently+patented+and+promising+ORL-1+ligands%3A+where+have+we+been+and+where+are+we+going%3F&doi=10.1517%2F13543771003602004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Recently patented and promising ORL-1 ligands: where have we been and where are we going?</span></div><div class="casAuthors">Largent-Milnes, Tally M.; Vanderah, Todd W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-305</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The interactions of nociceptin/orphanin FQ (N/OFQ) and the opioid receptor-like receptor 1 (nociceptin opioid peptide - NOP) have been implicated in a variety of systems including cardiovascular, respiratory, immune, and the central and peripheral nervous systems.  To elucidate the endogenous role of the N/OFQ-NOP system through the use of knockout and knockdown animal prepns., though most advances have been made using a host of synthetic agonists and antagonists.  This review gives a brief history of the receptor-ligand discovery, the development of these agonists and antagonists within the last 10 years as published, and the therapeutic indications thereof focusing on pain.  The use of NOP ligands in pain has been controversial at best; however, there are indications that both agonists and antagonists have a place in the clin. setting for acute and chronic pain.  NOP ligands have potential as novel therapeutics, interestingly, when incorporated into a rationally-designed multi-target agent.  The discovery of N/OFQ and NOP opened a new option for the treatment of pain with the potential for a decreased side effect profile.  Numerous compds. have been designed to target this system, the most promising of which have mixed profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL_skezB-GNbVg90H21EOLACvtfcHk0lgAtZucdLmwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisValur0%253D&md5=63c937f182ea33d61b83784ab8866749</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1517%2F13543771003602004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003602004%26sid%3Dliteratum%253Aachs%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DRecently%2520patented%2520and%2520promising%2520ORL-1%2520ligands%253A%2520where%2520have%2520we%2520been%2520and%2520where%2520are%2520we%2520going%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D291%26epage%3D305%26doi%3D10.1517%2F13543771003602004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Rover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span> </span><span class="NLM_article-title">High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.1021/jm991129q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991129q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1329-1338&author=S.+Roverauthor=G.+Adamauthor=A.+M.+Cesuraauthor=G.+Galleyauthor=F.+Jenckauthor=F.+J.+Monsmaauthor=J.+Wichmannauthor=F.+M.+Dautzenberg&title=High-affinity%2C+non-peptide+agonists+for+the+ORL1+%28orphanin+FQ%2Fnociceptin%29+receptor&doi=10.1021%2Fjm991129q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm991129q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991129q%26sid%3Dliteratum%253Aachs%26aulast%3DRover%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DGalley%26aufirst%3DG.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26atitle%3DHigh-affinity%252C%2520non-peptide%2520agonists%2520for%2520the%2520ORL1%2520%2528orphanin%2520FQ%252Fnociceptin%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1329%26epage%3D1338%26doi%3D10.1021%2Fjm991129q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span><span class="refDoi"> DOI: 10.1016/S0223-5234(00)00171-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0223-5234%2800%2900171-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=839-851&author=J.+Wichmannauthor=G.+Adamauthor=S.+Roverauthor=M.+Hennigauthor=M.+Scaloneauthor=A.+M.+Cesuraauthor=F.+M.+Dautzenbergauthor=F.+Jenck&title=Synthesis+of+%281S%2C3aS%29-8-%282%2C3%2C3a%2C4%2C5%2C+6-hexahydro-1H-phenalen-1-yl%29-1-phenyl-1%2C3%2C8-triaza-spiro%5B4.+5%5Ddecan-4-one%2C+a+potent+and+selective+orphanin+FQ+%28OFQ%29+receptor+agonist+with+anxiolytic-like+properties&doi=10.1016%2FS0223-5234%2800%2900171-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2800%2900171-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252800%252900171-9%26sid%3Dliteratum%253Aachs%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DRover%26aufirst%3DS.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520%25281S%252C3aS%2529-8-%25282%252C3%252C3a%252C4%252C5%252C%25206-hexahydro-1H-phenalen-1-yl%2529-1-phenyl-1%252C3%252C8-triaza-spiro%255B4.%25205%255Ddecan-4-one%252C%2520a%2520potent%2520and%2520selective%2520orphanin%2520FQ%2520%2528OFQ%2529%2520receptor%2520agonist%2520with%2520anxiolytic-like%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2000%26volume%3D35%26spage%3D839%26epage%3D851%26doi%3D10.1016%2FS0223-5234%2800%2900171-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higelin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Py-Lang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratzeisen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11454946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVKqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2001&pages=812-819&author=F.+M.+Dautzenbergauthor=J.+Wichmannauthor=J.+Higelinauthor=G.+Py-Langauthor=C.+Kratzeisenauthor=P.+Malherbeauthor=G.+J.+Kilpatrickauthor=F.+Jenck&title=Pharmacological+characterization+of+the+novel+nonpeptide+orphanin+FQ%2Fnociceptin+receptor+agonist+Ro+64-6198%3A+rapid+and+reversible+desensitization+of+the+ORL1+receptor+in+vitro+and+lack+of+tolerance+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo</span></div><div class="casAuthors">Dautzenberg, Frank M.; Wichmann, Jurgen; Higelin, Jacqueline; Py-Lang, Gabrielle; Kratzeisen, Claudia; Malherbe, Pari; Kilpatrick, Gavin J.; Jenck, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">812-819</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The novel nonpeptide orphanin FQ/nociceptin (OFQ/N) ligand {(1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1- phenyl-1,3,8-triaza-spiro[4,5]decan-4-one} (Ro 64-6198) was characterized in vitro and in vivo for its agonistic potential.  Ro 64-6198 was 130- to 3500-fold selective for the OFQ/N receptor (ORL1) compared with opiate receptors.  In the cAMP inhibition assay, Ro 64-6198 was a full agonist at the ORL1 and a partial agonist at the mu opiate receptor.  When human embryonic kidney 293 cells stably expressing the human ORL1 receptor were pre-exposed (30 min) to either OFQ/N or Ro 64-6198, the ability of both agonists to inhibit forskolin-mediated cAMP accumulation was strongly reduced, indicating a functional desensitization of the second messenger cascade.  However, acidic washes of OFQ/N-exposed cells fully restored the sensitivity of the ORL1 receptor for agonists.  In contrast, the cAMP response in Ro 64-6198-exposed cells remained impaired after acidic washes, suggesting sustained receptor internalization at 30 min.  In agreement with this finding, the no. of cell-surface ORL1 receptors was significantly reduced after Ro 64-6198 pre-exposure, and this effect could be blocked with high sucrose concns.  When Ro 64-6198 was chronically administered to rats, no signs of tolerance to its anxiolytic-like effects were detected following 15 days of daily drug exposure.  In agreement with the behavioral results, Ro 64-6198 was able to reduce brain ORL1 binding sites in both acutely and chronically treated rats.  Full recovery of ORL1 binding sites was obsd. 24 h after Ro 64-6198 administration with a t1/2 of ∼5.5 h.  These data show that nonpeptide agonists at the ORL1 receptor have a good clin. potential as anxiolytics without causing tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqprX8RN_LX6bVg90H21EOLACvtfcHk0lhuiuA7GynfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVKqt70%253D&md5=e7cc837ea26d5eb3ab8ced4d21e36b7f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DHigelin%26aufirst%3DJ.%26aulast%3DPy-Lang%26aufirst%3DG.%26aulast%3DKratzeisen%26aufirst%3DC.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520novel%2520nonpeptide%2520orphanin%2520FQ%252Fnociceptin%2520receptor%2520agonist%2520Ro%252064-6198%253A%2520rapid%2520and%2520reversible%2520desensitization%2520of%2520the%2520ORL1%2520receptor%2520in%2520vitro%2520and%2520lack%2520of%2520tolerance%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D298%26spage%3D812%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCool, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazdoba, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pond, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span><span class="refDoi"> DOI: 10.1007/s00213-005-0041-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-005-0041-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16025321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOitb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2005&pages=132-143&author=G.+B.+Vartyauthor=L.+A.+Hydeauthor=R.+A.+Hodgsonauthor=S.+X.+Luauthor=M.+F.+McCoolauthor=T.+M.+Kazdobaauthor=R.+A.+Del+Vecchioauthor=D.+H.+Guthrieauthor=A.+J.+Pondauthor=M.+E.+Grzelakauthor=X.+Xuauthor=W.+A.+Korfmacherauthor=D.+Tulshianauthor=E.+M.+Parkerauthor=G.+A.+Higgins&title=Characterization+of+the+nociceptin+receptor+%28ORL-1%29+agonist%2C+Ro64-6198%2C+in+tests+of+anxiety+across+multiple+species&doi=10.1007%2Fs00213-005-0041-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species</span></div><div class="casAuthors">Varty, G. B.; Hyde, L. A.; Hodgson, R. A.; Lu, S. X.; McCool, M. F.; Kazdoba, T. M.; Vecchio, R. A.; Guthrie, D. H.; Pond, A. J.; Grzelak, M. E.; Xu, X.; Korfmacher, W. A.; Tulshian, D.; Parker, E. M.; Higgins, G. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-143</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Previous studies have demonstrated behaviors indicative of anxiolysis in rats pretreated with the nociceptin receptor (opioid receptor like-1, ORL-1) agonist, Ro64-6198.  The aim of this study was to examine the effects of Ro64-6198 in anxiety models across three species: rat, guinea pig, and mouse.  In addn., the receptor specificity of Ro64-6198 was studied, using the ORL-1 receptor antagonist, J-113397, and ORL-1 receptor knockout (KO) mice.  Finally, neurol. studies examd. potential side effects of Ro64-6198 in the rat and mouse.  Ro64-6198 (3 - 10 mg/kg) increased punished responding in a rat conditioned lick suppression test similarly to chlordiazepoxide (6 mg/kg).  This effect of Ro64-6198 was attenuated by J-113397 (10 mg/kg), but not the mu opioid antagonist, naltrexone (3 mg/kg).  In addn., Ro64-6198 ( 1 - 3 mg/kg) reduced isolation-induced vocalizations in rat and guinea pig pups.  Ro64-6198 (3 mg/kg) increased the proportion of punished responding in a mouse Geller-Seifter test in wild-type (WT) but not ORL-1 KO mice, whereas diazepam (1 - 5.6 mg/kg) was effective in both genotypes.  In rats, Ro64-6198 reduced locomotor activity (LMA) and body temp. and impaired rotarod, beam walking, and fixed-ratio (FR) performance at doses of 10-30 mg/kg, i.e., three to ten times higher than an anxiolytic dose.  In WT mice, Ro64-6198 (3 - 10 mg/kg) reduced LMA and rotarod performance, body temp., and FR responding, but these same measures were unaffected in ORL-1 KO mice.  Haloperidol (0.3 - 3 mg/kg) reduced these measures to a similar extent in both genotypes.  These studies confirm the potent, ORL-1 receptor-mediated, anxiolytic-like effects of Ro64-6198, extending the findings across three species.  Ro64-6198 has target-based side effects, although the magnitude of these effects varies across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDj40L9WM_abVg90H21EOLACvtfcHk0lhuiuA7GynfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOitb%252FO&md5=851b297d2d33661509cb723adf922b01</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-0041-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-0041-4%26sid%3Dliteratum%253Aachs%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DMcCool%26aufirst%3DM.%2BF.%26aulast%3DKazdoba%26aufirst%3DT.%2BM.%26aulast%3DDel%2BVecchio%26aufirst%3DR.%2BA.%26aulast%3DGuthrie%26aufirst%3DD.%2BH.%26aulast%3DPond%26aufirst%3DA.%2BJ.%26aulast%3DGrzelak%26aufirst%3DM.%2BE.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DKorfmacher%26aufirst%3DW.%2BA.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DCharacterization%2520of%2520the%2520nociceptin%2520receptor%2520%2528ORL-1%2529%2520agonist%252C%2520Ro64-6198%252C%2520in%2520tests%2520of%2520anxiety%2520across%2520multiple%2520species%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2005%26volume%3D182%26spage%3D132%26epage%3D143%26doi%3D10.1007%2Fs00213-005-0041-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly-Evers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span> </span><span class="NLM_article-title">Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1016/S0028-3908(01)00048-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0028-3908%2801%2900048-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=97-107&author=G.+A.+Higginsauthor=A.+J.+Grottickauthor=T.+M.+Ballardauthor=J.+G.+Richardsauthor=J.+Messerauthor=H.+Takeshimaauthor=M.+Pauly-Eversauthor=F.+Jenckauthor=G.+Adamauthor=J.+Wichmann&title=Influence+of+the+selective+ORL1+receptor+agonist%2C+Ro64-6198%2C+on+rodent+neurological+function&doi=10.1016%2FS0028-3908%2801%2900048-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2801%2900048-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252801%252900048-X%26sid%3Dliteratum%253Aachs%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DBallard%26aufirst%3DT.%2BM.%26aulast%3DRichards%26aufirst%3DJ.%2BG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DTakeshima%26aufirst%3DH.%26aulast%3DPauly-Evers%26aufirst%3DM.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DWichmann%26aufirst%3DJ.%26atitle%3DInfluence%2520of%2520the%2520selective%2520ORL1%2520receptor%2520agonist%252C%2520Ro64-6198%252C%2520on%2520rodent%2520neurological%2520function%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D41%26spage%3D97%26epage%3D107%26doi%3D10.1016%2FS0028-3908%2801%2900048-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazdoba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCool, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bercovici, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span> </span><span class="NLM_article-title">The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxami de (SCH 655842): comparison of efficacy and side effects across rodent species</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">661</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2011.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2011.04.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21545797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=661&publication_year=2011&pages=63-71&author=S.+X.+Luauthor=G.+A.+Higginsauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=R.+A.+Del+Vecchioauthor=D.+H.+Guthrieauthor=T.+Kazdobaauthor=M.+F.+McCoolauthor=C.+A.+Morganauthor=A.+Bercoviciauthor=G.+D.+Hoauthor=D.+Tulshianauthor=E.+M.+Parkerauthor=J.+C.+Hunterauthor=G.+B.+Varty&title=The+anxiolytic-like+profile+of+the+nociceptin+receptor+agonist%2C+endo-8-%5Bbis%282-chlorophenyl%29methyl%5D-3-phenyl-8-azabicyclo%5B3.2.1%5Doctane-3-carboxami+de+%28SCH+655842%29%3A+comparison+of+efficacy+and+side+effects+across+rodent+species&doi=10.1016%2Fj.ejphar.2011.04.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): Comparison of efficacy and side effects across rodent species</span></div><div class="casAuthors">Lu, Sherry X.; Higgins, Guy A.; Hodgson, Robert A.; Hyde, Lynn A.; Del Vecchio, Robert A.; Guthrie, Donald H.; Kazdoba, Tatiana; McCool, Martha F.; Morgan, Cynthia A.; Bercovici, Ana; Ho, Ginny D.; Tulshian, Deen; Parker, Eric M.; Hunter, John C.; Varty, Geoffrey B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">661</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endogenous opioid-like peptide, nociceptin, produces anxiolytic-like effects that are mediated via the nociceptin (NOP) receptor.  Similarly, synthetic, non-peptide NOP agonists produce robust anxiolytic-like effects although these effects are limited by marked side effects.  In the present studies, the effects of a novel NOP receptor agonist, SCH 655842(I), were examd. in rodent models sensitive to anxiolytic drugs and tests measuring potential adverse affects.  Oral administration of SCH 655842 produced robust, anxiolytic-like effects in three species, i.e., rat, guinea pig, and mouse.  Specifically, SCH 655842 was effective in rat conditioned lick suppression (3-10 mg/kg) and fear-potentiated startle (3-10 mg/kg) tests, a guinea pig pup vocalization test (1-3 mg/kg), as well as in mouse Geller-Seifter (30 mg/kg) and marble burying (30 mg/kg) tests.  The anxiolytic-like effect of SCH 655842 in the conditioned lick suppression test was attenuated by the NOP antagonist, J-113397.  In mice, SCH 655842 reduced locomotor activity and body temp. at doses similar to the anxiolytic-like dose and these effects were absent in NOP receptor knockout mice.  In rats, SCH 655842 did not produce adverse behavioral effects up to doses of 70-100 mg/kg.  Pharmacokinetic studies in the rat confirmed dose-related increases in plasma and brain levels of SCH 655842 across a wide oral dose range.  Taken together, SCH 655842 may represent a NOP receptor agonist with improved tolerability compared to other members of this class although further studies are necessary to establish whether this extends to higher species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmKYNN1RUmobVg90H21EOLACvtfcHk0liKr4Cj9J8q4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVagt7k%253D&md5=34a603291c8e13ebbcaf0a520abbd543</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DDel%2BVecchio%26aufirst%3DR.%2BA.%26aulast%3DGuthrie%26aufirst%3DD.%2BH.%26aulast%3DKazdoba%26aufirst%3DT.%26aulast%3DMcCool%26aufirst%3DM.%2BF.%26aulast%3DMorgan%26aufirst%3DC.%2BA.%26aulast%3DBercovici%26aufirst%3DA.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26atitle%3DThe%2520anxiolytic-like%2520profile%2520of%2520the%2520nociceptin%2520receptor%2520agonist%252C%2520endo-8-%255Bbis%25282-chlorophenyl%2529methyl%255D-3-phenyl-8-azabicyclo%255B3.2.1%255Doctane-3-carboxami%2520de%2520%2528SCH%2520655842%2529%253A%2520comparison%2520of%2520efficacy%2520and%2520side%2520effects%2520across%2520rodent%2520species%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D661%26spage%3D63%26epage%3D71%26doi%3D10.1016%2Fj.ejphar.2011.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Toll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span> </span><span class="NLM_article-title">Comparison of the anti-nociceptive and anti-rewarding profiles of novel bifunctional nociceptin/orphanin FQ receptor (NOPr)-mu opioid receptor (MOPr) ligands: Implications for therapeutic applications</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">954</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span><span class="refDoi"> DOI: 10.1124/jpet.109.157446</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.109.157446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19773529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=954-964&author=L.+Tollauthor=T.+V.+Khroyanauthor=W.+E.+Polgarauthor=F.+Jiangauthor=C.+Olsenauthor=N.+T.+Zaveri&title=Comparison+of+the+anti-nociceptive+and+anti-rewarding+profiles+of+novel+bifunctional+nociceptin%2Forphanin+FQ+receptor+%28NOPr%29-mu+opioid+receptor+%28MOPr%29+ligands%3A+Implications+for+therapeutic+applications&doi=10.1124%2Fjpet.109.157446"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/μ-opioid receptor ligands: implications for therapeutic applications</span></div><div class="casAuthors">Toll, Lawrence; Khroyan, Taline V.; Polgar, Willma E.; Jiang, Faming; Olsen, Cris; Zaveri, Nurulain T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">954-964</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The nociceptin receptor (NOPr), a member of the opioid receptor family, is a target for the treatment of pain and drug abuse.  Nociceptin/orphanin FQ (N/OFQ), the endogenous peptide for NOPr, not only modulates opioid antinociception, but also blocks the rewarding effects of several abused drugs, such as morphine, cocaine, and amphetamine.  We hypothesized that NOPr agonists, with bifunctional activity at the μ-opioid receptor (MOPr), may function as nonaddicting analgesics or as drug abuse medications.  Bifunctional small-mol. NOPr agonists possessing different selectivities and efficacies at MOPr were evaluated in an acute thermal antinociception assay, and for their ability to induce conditioned place preference (CPP) and their effect on morphine-induced CPP.  1-(1-Cyclooctylpiperidin-4-yl)-indolin-2-one (SR14150), a high-affinity NOPr partial agonist, with low MOPr affinity and efficacy, produced analgesia that was naloxone-reversible.  SR14150 did not induce CPP alone, nor did it attenuate morphine-induced CPP.  3-Ethyl-1-(1-(4-isopropylcyclohexyl)piperidin-4-yl)-indolin-2-one (SR16507), which has high affinity for both NOPr and MOPr, full agonist activity at NOPr, and partial agonist activity at MOPr, was also a potent analgesic and produced CPP alone, but also modestly attenuated morphine CPP.  1-(1-(2,3,3A,4,5,6-hexahydro-1H-phenalen-1-yl)piperidin-4-yl)-indolin-2-one (SR16835), a NOPr full agonist and low-affinity MOPr partial agonist, was not antinociceptive, did not produce CPP alone, but attenuated morphine CPP.  Our results suggest that NOPr full-agonist activity is required to modulate opioid-induced reward, whereas a bifunctional NOPr/MOPr partial agonist profile may be suitable as a nonaddicting analgesic.  The opioid-modulating effects of the NOPr ligands may be used effectively to produce better medications for treatment of drug abuse and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSq0nyX8esa7Vg90H21EOLACvtfcHk0liKr4Cj9J8q4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsLrI&md5=d9386f73b81e02a7afddf8efe6cba83a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.157446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.157446%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DComparison%2520of%2520the%2520anti-nociceptive%2520and%2520anti-rewarding%2520profiles%2520of%2520novel%2520bifunctional%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520%2528NOPr%2529-mu%2520opioid%2520receptor%2520%2528MOPr%2529%2520ligands%253A%2520Implications%2520for%2520therapeutic%2520applications%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D954%26epage%3D964%26doi%3D10.1124%2Fjpet.109.157446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Hirao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toide, K.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1254/jphs.FP0071742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1254%2Fjphs.FP0071742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18319566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktlWlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=361-368&author=A.+Hiraoauthor=A.+Imaiauthor=Y.+Sugieauthor=Y.+Yamadaauthor=S.+Hayashiauthor=K.+Toide&title=Pharmacological+characterization+of+the+newly+synthesized+nociceptin%2Forphanin+FQ-receptor+agonist+1-%5B1-%281-methylcyclooctyl%29-4-piperidinyl%5D-2-%5B%283R%29-3-piperidinyl%5D-1H-benzimidazole+as+an+anxiolytic+agent&doi=10.1254%2Fjphs.FP0071742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent</span></div><div class="casAuthors">Hirao, Akiko; Imai, Aki; Sugie, Yutaka; Yamada, Yoshinari; Hayashi, Shigeo; Toide, Katsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">361-368</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ peptide (NOP)-receptor agonists have been shown to produce anxiolytic-like effects in rodents subjected to various behavioral assays.  Recently, we developed a new nonpeptide agonist of the NOP receptor, 1-[1-(1-methylcyclooctyl)-4-piperidin-yl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole (MCOPPB), as an anxiolytic agent.  MCOPPB has a high affinity for the human NOP receptor (pKi = 10.07±0.01) and selectivity for the NOP receptor over other members of the opioid receptor family: 12-, 270- and >1000-fold more selective for the NOP receptor than for the μ-, κ-, and δ-receptor, resp.  In an ex vivo binding study, MCOPPB (10 mg/kg, p.o.) inhibited signaling through the NOP receptor in the mouse brain, suggesting that it penetrated into the brain after it was orally administered.  In the mouse Vogel conflict test, MCOPPB (10 mg/kg, p.o.) and diazepam (3 mg/kg, p.o.) elicited anxiolytic-like effects, although MCOPPB produced a bell-shaped response curve.  In addn., MCOPPB (10 mg/kg, p.o.) was still effective as an anxiolytic agent even after repeated administration for 5 days.  MCOPPB at an oral dose of 10 mg/kg did not affect locomotor activity or memory, nor did it contribute to ethanol-induced hypnosis.  On the other hand, the benzodiazepine-type anxiolytic agent diazepam caused memory deficits and enhanced ethanol-induced hypnosis.  These findings suggest that MCOPPB - a compd. with few adverse effects on the central nervous system - is a potential therapeutic agent for the treatment of anxiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJQVq7TInA-bVg90H21EOLACvtfcHk0liKr4Cj9J8q4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktlWlsrk%253D&md5=a33af41c65b5bf322c260d3dfc3a6f0c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0071742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0071742%26sid%3Dliteratum%253Aachs%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DA.%26aulast%3DSugie%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DToide%26aufirst%3DK.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520newly%2520synthesized%2520nociceptin%252Forphanin%2520FQ-receptor%2520agonist%25201-%255B1-%25281-methylcyclooctyl%2529-4-piperidinyl%255D-2-%255B%25283R%2529-3-piperidinyl%255D-1H-benzimidazole%2520as%2520an%2520anxiolytic%2520agent%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D106%26spage%3D361%26epage%3D368%26doi%3D10.1254%2Fjphs.FP0071742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Goeldner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span> </span><span class="NLM_article-title">Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1007/s00213-012-2636-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-012-2636-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22249359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC38vgsFaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=2012&pages=203-214&author=C.+Goeldnerauthor=W.+Spoorenauthor=J.+Wichmannauthor=E.+P.+Prinssen&title=Further+characterization+of+the+prototypical+nociceptin%2Forphanin+FQ+peptide+receptor+agonist+Ro+64-6198+in+rodent+models+of+conflict+anxiety+and+despair&doi=10.1007%2Fs00213-012-2636-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair</span></div><div class="casAuthors">Goeldner Celia; Spooren Will; Wichmann Jurgen; Prinssen Eric P</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Ro 64-6198, the prototypical non-peptide nociceptin/orphanin FQ peptide (NOP) receptor agonist, has potent anxiolytic-like effects in several preclinical models and species.  However the effects of Ro 64-6198 on distinctive anxiety-provoking conditions related to unconditioned conflict behavior as well as its role in despair-like behavior remain to be addressed.  OBJECTIVE:  Here we examined the effects of Ro 64-6198 on unconditioned conflict anxiety using stimuli with different salience and on regulation of autonomic reactivity and compared these to the effects of benzodiazepine receptor agonists.  We also addressed the potential effects of Ro 64-6198 on despair-like behavior.  MATERIALS AND METHODS:  Ro 64-6198 (0.1 to 10 mg/kg i.p.) and either diazepam or chlordiazepoxide were tested in the Vogel conflict punished drinking test (VCT) in Sprague Dawley rats, in the social approach-avoidance (SAA) test in Lewis rats, in the novelty-induced hypophagia (NIH) in C57BL/6J mice, and in stress-induced hyperthermia in NMRI mice, as well as in the forced swim test (FST) in Sprague Dawley rats and the tail suspension test (TST) in C57BL/6J mice.  RESULTS:  Ro 64-6198 (0.3 to 3 mg/kg) dose-dependently produced anxiolytic-like effects in the VCT, SAA, NIH, and SIH, similar to benzodiazepine receptor agonists.  Ro 64-6198 did not alter immobility time in the FST and TST.  CONCLUSIONS:  Ro 64-6198 produced marked anxiolytic-like effects in response to a variety of mild to strong anxiogenic stimuli, whereas it did not facilitate depression-related behaviors.  This data extend previous literature suggesting that NOP receptors are a viable target for the treatment of anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTc5QfO7mWeQ9enUz0lpNqnfW6udTcc2easGSLc02zdkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgsFaisQ%253D%253D&md5=ead95ba6b48a6b6c2712de728f8c98f2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2636-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2636-x%26sid%3Dliteratum%253Aachs%26aulast%3DGoeldner%26aufirst%3DC.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26atitle%3DFurther%2520characterization%2520of%2520the%2520prototypical%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520agonist%2520Ro%252064-6198%2520in%2520rodent%2520models%2520of%2520conflict%2520anxiety%2520and%2520despair%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2012%26volume%3D222%26spage%3D203%26epage%3D214%26doi%3D10.1007%2Fs00213-012-2636-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Rizzi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span><span class="refDoi"> DOI: 10.1007/s002100100399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs002100100399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11383716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGhurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2001&pages=551-555&author=D.+Rizziauthor=R.+Bigoniauthor=A.+Rizziauthor=F.+Jenckauthor=J.+Wichmannauthor=R.+Guerriniauthor=D.+Regoliauthor=G.+Calo&title=Effects+of+Ro+64-6198+in+nociceptin%2Forphanin+FQ-sensitive+isolated+tissues&doi=10.1007%2Fs002100100399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues</span></div><div class="casAuthors">Rizzi, Daniela; Bigoni, Raffaella; Rizzi, Anna; Jenck, Francois; Wichmann, Juergen; Guerrini, Remo; Regoli, Domenico; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">551-555</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The pharmacol. profile of the non-peptide OP4 receptor (ORL1, LC132) agonist, Ro 64-6198, was investigated, in three elec. stimulated nociceptin/orphanin FQ (NC)-sensitive prepns., namely the mouse and rat vas deferens and the guinea pig ileum.  Ro 64-6198 mimicked the inhibitory effect of NC in the three prepns., while showing slow kinetics of action and a slowly reversible effect compared to the fast and immediately and completely reversible effect of the natural peptide.  Ro 64-6198 displayed similar pEC50 and Emax values as NC in the mouse and rat vas deferens while it was 100-fold less potent but more efficacious (higher Emax) than NC in the guinea pig ileum.  In the rat vas deferens the effects of Ro 64-6198 were antagonized by [Nphe1]NC(1-13)NH2 and J-113397 with pKB values (6.30 and 8.05, resp.) similar to those obtained against NC (6.20 and 7.77, resp.).  Naloxone (1 μM) was inactive.  In the guinea pig ileum a clear shift of the concn. response curve to Ro 64-6198 was obtained only using a cocktail of antagonists (naloxone +[Nphe1]NC(1-13)NH2 or naloxone +J-113397).  In the mouse vas deferens the antagonists were inactive against Ro 64-6198 either when tested alone or in combination.  Therefore, Ro 64-6198 behaved as a selective OP4 receptor agonist only in the rat tissue.  These results suggest a physiol. heterogeneity in OP4 receptors across tissues and species and may explain why, when tested in vivo, Ro 64-6198 mimics the potent anxiolytic effect of NC better in the rat than in the mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVodqqFXQa67Vg90H21EOLACvtfcHk0liym1RZ31rTyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGhurg%253D&md5=00bf787239b428a78b75d619090faa99</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2Fs002100100399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100100399%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DJenck%26aufirst%3DF.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DEffects%2520of%2520Ro%252064-6198%2520in%2520nociceptin%252Forphanin%2520FQ-sensitive%2520isolated%2520tissues%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2001%26volume%3D363%26spage%3D551%26epage%3D555%26doi%3D10.1007%2Fs002100100399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantegrossi, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galuska, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span> </span><span class="NLM_article-title">Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2088</span><span class="NLM_x">–</span> <span class="NLM_lpage">2096</span><span class="refDoi"> DOI: 10.1038/npp.2009.33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnpp.2009.33" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=2088-2096&author=M.+C.+Koauthor=J.+H.+Woodsauthor=W.+E.+Fantegrossiauthor=C.+M.+Galuskaauthor=J.+Wichmannauthor=E.+P.+Prinssen&title=Behavioral+effects+of+a+synthetic+agonist+selective+for+nociceptin%2Forphanin+FQ+peptide+receptors+in+monkeys&doi=10.1038%2Fnpp.2009.33"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.33%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26aulast%3DFantegrossi%26aufirst%3DW.%2BE.%26aulast%3DGaluska%26aufirst%3DC.%2BM.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26atitle%3DBehavioral%2520effects%2520of%2520a%2520synthetic%2520agonist%2520selective%2520for%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptors%2520in%2520monkeys%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D2088%26epage%3D2096%26doi%3D10.1038%2Fnpp.2009.33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Podlesnik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span> </span><span class="NLM_article-title">The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1007/s00213-010-2012-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-010-2012-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20852848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2011&pages=53-60&author=C.+A.+Podlesnikauthor=M.+C.+Koauthor=G.+Wingerauthor=J.+Wichmannauthor=E.+P.+Prinssenauthor=J.+H.+Woods&title=The+effects+of+nociceptin%2Forphanin+FQ+receptor+agonist+Ro+64-6198+and+diazepam+on+antinociception+and+remifentanil+self-administration+in+rhesus+monkeys&doi=10.1007%2Fs00213-010-2012-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of nociceptin/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys</span></div><div class="casAuthors">Podlesnik, Christopher A.; Ko, Mei-Chuan; Winger, Gail; Wichmann, Juergen; Prinssen, Eric P.; Woods, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-60</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: The synthetic nonpeptide NOP (nociceptin/orphanin FQ peptide) receptor agonist Ro 64-6198 produces antinociception in rhesus monkeys.  In rodents, it has much more variable effects on pain responses, but has response rate-increasing effects on punished operant behavior and decreases drug reward.  Objectives: The aim of this study was to compare Ro 64-6198 with the benzodiazepine diazepam in tests of analgesia, drug self-administration, and response-increasing effects in rhesus monkeys.  Results: Ro 64-6198 (0.001-0.01 mg/kg, i.v.) produced antinociception against an acute noxious stimulus (50°C water) in the absence of sedation, whereas diazepam (0.32-3.2 mg/kg, i.v.) did not have analgesic effects without sedation.  Diazepam (1.0-5.6 mg/kg, i.v.) and the largest dose of Ro 64-6198 (0.32 mg/kg, i.v.) decreased lever pressing maintained by i.v. self-administration of the mu-opioid agonist, remifentanil, but neither effect could be distinguished from sedative effects.  Although neither drug consistently increased responding during nonreinforcement, such effects were obsd. more frequently following diazepam administration.  The effects of Ro 64-6198 on lever pressing were blocked by the NOP-receptor antagonist, J-113397, but not by the benzodiazepine antagonist, flumazenil.  Conclusions: These findings suggest that the effects of Ro 64-6198 on operant lever pressing are mediated by NOP receptors and that larger doses are required to impact operant behavior when compared directly with those that produce antinociception.  Therefore, the present findings support previous literature suggesting NOP receptors are a viable target for pain management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTxXlqJKBd7Vg90H21EOLACvtfcHk0liym1RZ31rTyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht7jE&md5=9f0697809104bb9de44ef42f9952b68d</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs00213-010-2012-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-010-2012-7%26sid%3Dliteratum%253Aachs%26aulast%3DPodlesnik%26aufirst%3DC.%2BA.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DWinger%26aufirst%3DG.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26atitle%3DThe%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%2520Ro%252064-6198%2520and%2520diazepam%2520on%2520antinociception%2520and%2520remifentanil%2520self-administration%2520in%2520rhesus%2520monkeys%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2011%26volume%3D213%26spage%3D53%26epage%3D60%26doi%3D10.1007%2Fs00213-010-2012-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Zeilhofer, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy?</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span><span class="refDoi"> DOI: 10.1124/jpet.102.046979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.102.046979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12721334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGlt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=423-429&author=H.+U.+Zeilhoferauthor=G.+Calo&title=Nociceptin%2Forphanin+FQ+and+its+receptor-potential+targets+for+pain+therapy%3F&doi=10.1124%2Fjpet.102.046979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy?</span></div><div class="casAuthors">Zeilhofer, Hanns Ulrich; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">423-429</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The neuropeptide nociceptin, also called orphanin FQ (N/OFQ), is the endogenous agonist of the N/OFQ peptide receptor (NOP receptor).  Both N/OFQ and the NOP receptor share a high degree of homol. with classical opioid peptides and opioid receptors, resp., and use similar signal transduction pathways as classical opioids.  The NOP receptor has thus been regarded as the fourth member of the opioid receptor family.  Despite this close relationship, 7 yr of research have demonstrated that the N/OFQ system has a distinct pharmacol. profile and serves different physiol. functions.  In particular, its role in the control of pain and analgesia at different levels of integration appears quite different from that of classical opioids.  The recent development of specific antagonists at the NOP receptor and of NOP receptor or N/OFQ precursor knock-out mice have generated new insights into the role of N/OFQ in pain processing and help to evaluate the N/OFQ-NOP system as a potential target for new analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1rfljDkKAbVg90H21EOLACvtfcHk0ljG9B-JeUqWzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGlt7k%253D&md5=98bb8d88169e52d9c74b2c005eb3f058</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.046979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.046979%26sid%3Dliteratum%253Aachs%26aulast%3DZeilhofer%26aufirst%3DH.%2BU.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520and%2520its%2520receptor-potential%2520targets%2520for%2520pain%2520therapy%253F%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D423%26epage%3D429%26doi%3D10.1124%2Fjpet.102.046979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Whiteside, G. T.; Kyle, D. J.</span><span> </span><span class="NLM_article-title">A review of the NOP (ORL-1)-nociceptin/orphanin FQ system covering receptor structure, distribution, role in analgesia and reward and interactions with other receptors</span>. In  <span class="citation_source-book">Research and Development of Opioid-Related Ligands</span>; American Chemical Society Symposium Series, 1131; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bk-2013-1131.ch016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=327-368&author=G.+T.+Whiteside&author=D.+J.+Kyle&title=Research+and+Development+of+Opioid-Related+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fbk-2013-1131.ch016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1021%252Fbk-2013-1131.ch016%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26atitle%3DA%2520review%2520of%2520the%2520NOP%2520%2528ORL-1%2529-nociceptin%252Forphanin%2520FQ%2520system%2520covering%2520receptor%2520structure%252C%2520distribution%252C%2520role%2520in%2520analgesia%2520and%2520reward%2520and%2520interactions%2520with%2520other%2520receptors%26btitle%3DResearch%2520and%2520Development%2520of%2520Opioid-Related%2520Ligands%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013%26spage%3D327%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Sukhtankar, D.; Ko, M.-C.</span><span> </span><span class="NLM_article-title">Pharmacological investigation of NOP-related ligands as analgesics without abuse liability</span>. In  <span class="citation_source-book">Research and Development of Opioid-Related Ligands</span>; American Chemical Society Symposium Series, 1131; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/bk-2013-1131.ch018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=393-416&author=D.+Sukhtankar&author=M.-C.+Ko&title=Research+and+Development+of+Opioid-Related+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fbk-2013-1131.ch018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1021%252Fbk-2013-1131.ch018%26sid%3Dliteratum%253Aachs%26aulast%3DSukhtankar%26aufirst%3DD.%26atitle%3DPharmacological%2520investigation%2520of%2520NOP-related%2520ligands%2520as%2520analgesics%2520without%2520abuse%2520liability%26btitle%3DResearch%2520and%2520Development%2520of%2520Opioid-Related%2520Ligands%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2013%26spage%3D393%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Lin, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1021/cn300124f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300124f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=214-224&author=A.+P.+Linauthor=M.+C.+Ko&title=The+therapeutic+potential+of+nociceptin%2Forphanin+FQ+receptor+agonists+as+analgesics+without+abuse+liability&doi=10.1021%2Fcn300124f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The Therapeutic Potential of Nociceptin/Orphanin FQ Receptor Agonists as Analgesics without Abuse Liability</span></div><div class="casAuthors">Lin, Ann P.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">214-224</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although mu opioid (MOP) receptor agonists are the most commonly used analgesics for the treatment of moderate to severe pain in the clinic, the side effects of MOP agonists such as abuse liability limit their value as a medication.  Research to identify novel analgesics without adverse effects is pivotal to advance the health care of humans.  The nociceptin/orphanin FQ peptide (NOP) receptor, the fourth opioid receptor subtype, mediates distinctive actions in nonhuman primates which suggests the possibility that activity at this receptor may result in strong analgesia in the absence of virtually all of the side effects assocd. with MOP agonists.  The present review highlights the recent progress of pharmacol. studies of NOP-related ligands in primates.  Selective NOP agonists, either peptidic or nonpeptidic, produce full analgesia in various assays in primates, when delivered systemically or intrathecally.  Yet small mol. NOP agonists do not serve as reinforcers, indicating a lack of abuse liability.  Given that NOP agonists have low abuse liability and that coactivation of NOP and MOP receptors produces synergistic antinociception, it is worth developing bifunctional NOP/MOP ligands.  The outcomes of these studies and recent developments provide new perspectives to establish a translational bridge for understanding the biobehavioral functions of NOP receptors in primates and for facilitating the development of NOP-related ligands as a new generation of analgesics without abuse liability in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof3wFSa_bAsbVg90H21EOLACvtfcHk0ljG9B-JeUqWzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtbzF&md5=1dd123d0591387b291faf4571e9fe024</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fcn300124f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300124f%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%2BP.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonists%2520as%2520analgesics%2520without%2520abuse%2520liability%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D214%26epage%3D224%26doi%3D10.1021%2Fcn300124f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Kotlinska, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talarek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dylag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberring, J.</span><span> </span><span class="NLM_article-title">Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span><span class="refDoi"> DOI: 10.1097/00001756-200303240-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00001756-200303240-00015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=601-604&author=J.+Kotlinskaauthor=J.+Wichmannauthor=P.+Rafalskiauthor=S.+Talarekauthor=T.+Dylagauthor=J.+Silberring&title=Non-peptidergic+OP4+receptor+agonist+inhibits+morphine+antinociception+but+does+not+influence+morphine+dependence&doi=10.1097%2F00001756-200303240-00015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1097%2F00001756-200303240-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200303240-00015%26sid%3Dliteratum%253Aachs%26aulast%3DKotlinska%26aufirst%3DJ.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DRafalski%26aufirst%3DP.%26aulast%3DTalarek%26aufirst%3DS.%26aulast%3DDylag%26aufirst%3DT.%26aulast%3DSilberring%26aufirst%3DJ.%26atitle%3DNon-peptidergic%2520OP4%2520receptor%2520agonist%2520inhibits%2520morphine%2520antinociception%2520but%2520does%2520not%2520influence%2520morphine%2520dependence%26jtitle%3DNeuroReport%26date%3D2003%26volume%3D14%26spage%3D601%26epage%3D604%26doi%3D10.1097%2F00001756-200303240-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Reiss, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekeshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouagazzal, A. M.</span><span> </span><span class="NLM_article-title">Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2007.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2007.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18031727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2008&pages=141-148&author=D.+Reissauthor=J.+Wichmannauthor=H.+Tekeshimaauthor=B.+L.+Kiefferauthor=A.+M.+Ouagazzal&title=Effects+of+nociceptin%2Forphanin+FQ+receptor+%28NOP%29+agonist%2C+Ro64-6198%2C+on+reactivity+to+acute+pain+in+mice%3A+comparison+to+morphine&doi=10.1016%2Fj.ejphar.2007.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: Comparison to morphine</span></div><div class="casAuthors">Reiss, David; Wichmann, Juergen; Tekeshima, Hiroshi; Kieffer, Brigitte L.; Ouagazzal, Abdel-Mouttalib</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">579</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The aim of the present study was to clarify the role of nociceptin system in pain modulation.  The effects of the synthetic nociceptin (NOP) receptor agonist, Ro64-6198 ((1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one), on reactivity to acute noxious stimuli were assessed in C57BL/6N (B6) mice in tail-flick, hot-plate and shock threshold tests.  The mu receptor agonist, morphine, was used in each study for comparison.  In the tail-flick test, morphine (4 and 8 mg/kg, i.p.) produced analgesia, while Ro64-6198 (0.3, 1 and 3 mg/kg, i.p.) increased pain sensitivity.  The effects of Ro64-6198 were seen in naive but not in mice previously habituated to testing conditions, indicating that increased pain sensitivity may be due to inhibition of stress-induced analgesia.  In the hot-plate and the shock threshold tests, Ro64-6198 produced analgesia in B6 mice, like morphine.  These effects were reproduced in wild-type but not in NOP receptor knockout mice.  Finally, when injected conjointly at subthreshold doses, Ro64-6198 (1 mg/kg) and morphine (1 mg/kg) acted in additive manner to reduce pain sensitivity in the hot-plate test.  Together these results show that systemic activation of NOP receptors produced bidirectional changes in pain sensitivity depending on the exptl. conditions.  They also suggest that central NOP and mu receptors may inhibit reactivity to acute noxious stimuli via independent neural mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-0HEOUghLgbVg90H21EOLACvtfcHk0liyx97-jEpwYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVKhug%253D%253D&md5=ab099dd29e1c0354911ffe73be96069b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DReiss%26aufirst%3DD.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DTekeshima%26aufirst%3DH.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DOuagazzal%26aufirst%3DA.%2BM.%26atitle%3DEffects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520%2528NOP%2529%2520agonist%252C%2520Ro64-6198%252C%2520on%2520reactivity%2520to%2520acute%2520pain%2520in%2520mice%253A%2520comparison%2520to%2520morphine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D579%26spage%3D141%26epage%3D148%26doi%3D10.1016%2Fj.ejphar.2007.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Sukhtankar, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span><span class="refDoi"> DOI: 10.1007/s00213-013-3341-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-013-3341-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24217900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2c7ltF2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=1377-1387&author=D.+D.+Sukhtankarauthor=H.+Leeauthor=K.+C.+Riceauthor=M.+C.+Ko&title=Differential+effects+of+opioid-related+ligands+and+NSAIDs+in+nonhuman+primate+models+of+acute+and+inflammatory+pain&doi=10.1007%2Fs00213-013-3341-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain</span></div><div class="casAuthors">Sukhtankar Devki D; Lee Heeseung; Rice Kenner C; Ko Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1377-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Carrageenan-induced hyperalgesia is a widely used pain model in rodents.  However, characteristics of carrageenan-induced hyperalgesia and effects of analgesic drugs under these conditions are unknown in nonhuman primates.  OBJECTIVE:  The aims of this study were to develop carrageenan-induced hyperalgesia in rhesus monkeys and determine the efficacy and potency of agonists selective for the four opioid receptor subtypes in this model versus acute pain, as compared to non-steroidal anti-inflammatory drugs (NSAIDs).  RESULTS:  Tail injection of carrageenan produced long-lasting thermal hyperalgesia in monkeys.  Systemically administered agonists selective for opioid receptor subtypes, i.e., fentanyl (mu/MOP), U-50488H (kappa/KOP), SNC80 (delta/DOP) and Ro 64-6198 (nociceptin/orphanin FQ/NOP) dose-dependently attenuated carrageenan-induced thermal hyperalgesia with different potencies.  In absence of carrageenan, these agonists, except SNC80, blocked acute thermal nociception.  Opioid-related ligands, especially Ro 64-6198, were much more potent for their antihyperalgesic than antinociceptive effects.  Both effects were mediated by the corresponding receptor mechanisms.  Only fentanyl produced scratching at antihyperalgesic and antinociceptive doses consistent with its pruritic effects in humans, illustrating a translational profile of MOP agonists in nonhuman primates.  Similar to SNC80, systemically administered NSAIDs ketorolac and naproxen dose-dependently attenuated carrageenan-induced hyperalgesia but not acute nociception.  CONCLUSION:  Using two different pain modalities in nonhuman primates, effectiveness of clinically available analgesics like fentanyl, ketorolac and naproxen was distinguished and their efficacies and potencies were compared with the selective KOP, DOP, and NOP agonists.  The opioid-related ligands displayed differential pharmacological properties in regulating hyperalgesia and acute nociception in the same subjects.  Such preclinical primate models can be used to investigate novel analgesic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTq_91slIeoEEQ0lWbKiCflfW6udTcc2eZ62el-XFGKErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c7ltF2ruw%253D%253D&md5=89d4b44a8d3c186f53063767502641ea</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3341-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3341-0%26sid%3Dliteratum%253Aachs%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DDifferential%2520effects%2520of%2520opioid-related%2520ligands%2520and%2520NSAIDs%2520in%2520nonhuman%2520primate%2520models%2520of%2520acute%2520and%2520inflammatory%2520pain%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2014%26volume%3D231%26spage%3D1377%26epage%3D1387%26doi%3D10.1007%2Fs00213-013-3341-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhtankar, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendenhall, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">3302</span><span class="NLM_x">–</span> <span class="NLM_lpage">3312</span><span class="refDoi"> DOI: 10.1111/bph.13124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fbph.13124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25752320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=3302-3312&author=H.+Dingauthor=K.+Hayashidaauthor=T.+Sutoauthor=D.+D.+Sukhtankarauthor=M.+Kimuraauthor=V.+Mendenhallauthor=M.+C.+Ko&title=Supraspinal+actions+of+nociceptin%2Forphanin+FQ%2C+morphine+and+substance+P+in+regulating+pain+and+itch+in+non-human+primates&doi=10.1111%2Fbph.13124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates</span></div><div class="casAuthors">Ding, H.; Hayashida, K.; Suto, T.; Sukhtankar, D. D.; Kimura, M.; Mendenhall, V.; Ko, M. C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3302-3312</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor agonists display a promising analgesic profile in preclin. studies.  However, supraspinal N/OFQ produced hyperalgesia in rodents and such effects have not been addressed in primates.  Thus, the aim of this study was to investigate the effects of centrally administered ligands on regulating pain and itch in non-human primates.  In particular, nociceptive thresholds affected by intracisternal N/OFQ were compared with those of morphine and substance P, known to provide analgesia and mediate hyperalgesia, resp., in humans.  Exptl. Approach : Intrathecal catheters were installed to allow intracisternal and lumbar intrathecal administration in awake and unanaesthetized rhesus monkeys.  Nociceptive responses were measured using the warm water tail-withdrawal assay.  Itch scratching responses were scored from videotapes recording behavioral activities of monkeys in their home cages.  Antagonist studies were conducted to validate the receptor mechanisms underlying intracisternally elicited behavioral responses.  Key Results : Intracisternal morphine (100 nmol) elicited more head scratches than those after intrathecal morphine.  Distinct dermatomal scratching locations between the two routes suggest a corresponding activation of supraspinal and spinal μ receptors.  Unlike intracisternal substance P, which induced hyperalgesia, intracisternal N/OFQ (100 nmol) produced antinociceptive effects mediated by NOP receptors.  Neither peptide increased scratching responses.  Conclusions and Implications : Taken together, these results demonstrated differential actions of ligands in the primate supraspinal region in regulating pain and itch.  This study not only improves scientific understanding of the N/OFQ-NOP receptor system in pain processing but also supports the therapeutic potential of NOP-related ligands as analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrvMfam5d_dLVg90H21EOLACvtfcHk0liyx97-jEpwYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVaqt7rE&md5=7445642e93ca057d2bea07b08d294d7e</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fbph.13124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13124%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DHayashida%26aufirst%3DK.%26aulast%3DSuto%26aufirst%3DT.%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DMendenhall%26aufirst%3DV.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DSupraspinal%2520actions%2520of%2520nociceptin%252Forphanin%2520FQ%252C%2520morphine%2520and%2520substance%2520P%2520in%2520regulating%2520pain%2520and%2520itch%2520in%2520non-human%2520primates%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D3302%26epage%3D3312%26doi%3D10.1111%2Fbph.13124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, N. N.</span><span> </span><span class="NLM_article-title">Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span><span class="refDoi"> DOI: 10.1016/j.jpain.2008.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.jpain.2008.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19231294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVKmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=509-514&author=M.+C.+Koauthor=N.+N.+Naughton&title=Antinociceptive+effects+of+nociceptin%2Forphanin+FQ+administered+intrathecally+in+monkeys&doi=10.1016%2Fj.jpain.2008.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive Effects of Nociceptin/Orphanin FQ Administered Intrathecally in Monkeys</span></div><div class="casAuthors">Ko, Mei-Chuan; Naughton, Norah N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) is the endogenous peptide for the NOP receptors.  Depending on the doses, intrathecal administration of N/OFQ has dual actions (ie, hyperalgesia and antinociception) in rodents.  However, the pharmacol. profile of intrathecal N/OFQ is not fully known in primates.  The aim of this study was to investigate behavioral effects of intrathecal N/OFQ over a wide dose range and to compare its effects with ligands known to produce hyperalgesia or antinociception in monkeys.  Intrathecal N/OFQ from 1 fmol to 1 nmol did not produce any hyperalgesic or scratching responses.  In contrast, intrathecal substance P 100 nmol produced hyperalgesia, and intrathecal DAMGO 10 nmol produced antinociception.  At the dose range between 10 nmol and 1 μmol, intrathecal N/OFQ dose-dependently produced thermal antinociception against a noxious stimulus in 2 intensities.  More importantly, N/OFQ in combined with intrathecal morphine dose-dependently potentiated morphine-induced antinociception without inhibiting morphine-induced itch/scratching.  Taken together, this study is the first to provide a unique functional profile of intrathecal N/OFQ over a wide dose range in primates.  Intrathecal N/OFQ produces thermal antinociception without anti-morphine actions or scratching responses, indicating that N/OFQ or NOP receptor agonists represent a promising target as spinal analgesics.  Perspective: Intrathecal administration of N/OFQ only produced thermal antinociception, not hyperalgesia, in monkeys.  In addn., intrathecal N/OFQ does not have anti-morphine actions or itch/scratching responses.  This study strongly supports the therapeutic potential of N/OFQ or NOP receptor agonists as spinal analgesics for clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwKwjiq-tA7Vg90H21EOLACvtfcHk0lhoEUWc21HhXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVKmu7o%253D&md5=6ec599eae9dafd60b054a7fc502ce16e</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2008.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2008.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DNaughton%26aufirst%3DN.%2BN.%26atitle%3DAntinociceptive%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520administered%2520intrathecally%2520in%2520monkeys%26jtitle%3DJ.%2520Pain%26date%3D2009%26volume%3D10%26spage%3D509%26epage%3D514%26doi%3D10.1016%2Fj.jpain.2008.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Ko, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, R. T.</span><span> </span><span class="NLM_article-title">Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1257</span><span class="NLM_x">–</span> <span class="NLM_lpage">1264</span><span class="refDoi"> DOI: 10.1124/jpet.106.106120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.106.106120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16766718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFygt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=1257-1264&author=M.+C.+Koauthor=H.+Weiauthor=J.+H.+Woodsauthor=R.+T.+Kennedy&title=Effects+of+intrathecally+administered+nociceptin%2Forphanin+FQ+in+monkeys%3A+behavioral+and+mass+spectrometric+studies&doi=10.1124%2Fjpet.106.106120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies</span></div><div class="casAuthors">Ko, M. C. Holden; Wei, Hui; Woods, James H.; Kennedy, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1257-1264</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) is a heptadecapeptide that is an endogenous ligand for the N/OFQ peptide (NOP) receptor.  This study was to investigate the behavioral responses of N/OFQ and its major fragment N/OFQ(2-17) in monkeys following i.t. administration.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was used to quantify the amts. of N/OFQ and N/OFQ(2-17) in the cerebrospinal fluid at specific time points when effects of i.t. N/OFQ were sustained and disappeared.  Intrathecal administration of N/OFQ dose dependently (10-100 nmol) produced long-lasting antinociception against a noxious stimulus, 50° water, and did not elicit itch/scratching responses in monkeys.  S.c. pretreatment with a selective NOP receptor antagonist, (+)J-113397 [(1-[3R,4R)-1-cyclooctymethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3,-dihydro-2H-benzimidazol-2-one] (0.1 mg/kg), completely blocked i.t. N/OFQ (100 nmol)-induced antinociception.  In contrast, a classic opioid receptor antagonist, naltrexone (0.01 and 1 mg/kg), failed to reverse i.t. N/OFQ-induced antinociception.  MALDI-TOF-MS showed that the amt. of N/OFQ(2-17) was 4-fold higher than that of N/OFQ at 1.5 h after i.t. administration of 100 nmol N/OFQ.  Intrathecal N/OFQ-induced antinociception disappeared at 4.5 h, which corresponded to nearly undetectable cerebrospinal fluid levels of N/OFQ.  No other metabolite of N/OFQ was detected at appreciable levels at either the 1.5- or 4.5-h time points.  Although significant amts. of N/OFQ(2-17) were detected at the 1.5- and 4.5-h time points, 100 nmol N/OFQ(2-17) i.t. was inactive in changing the monkeys' nociceptive threshold.  These results provide the first functional evidence of spinal N/OFQ-induced antinociception in primates and indicate that activation of spinal NOP receptors may be a potential target for spinal analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDK5E2U9CJLVg90H21EOLACvtfcHk0lhoEUWc21HhXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFygt7o%253D&md5=1316933db560b47f728508da1e15339e</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.106120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.106120%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DWoods%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DR.%2BT.%26atitle%3DEffects%2520of%2520intrathecally%2520administered%2520nociceptin%252Forphanin%2520FQ%2520in%2520monkeys%253A%2520behavioral%2520and%2520mass%2520spectrometric%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D1257%26epage%3D1264%26doi%3D10.1124%2Fjpet.106.106120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1016/j.pain.2009.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pain.2009.10.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=107-113&author=E.+Huauthor=G.+Caloauthor=R.+Guerriniauthor=M.+C.+Ko&title=Long-lasting+antinociceptive+spinal+effects+in+primates+of+the+novel+nociceptin%2Forphanin+FQ+receptor+agonist+UFP-112&doi=10.1016%2Fj.pain.2009.10.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2009.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2009.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DLong-lasting%2520antinociceptive%2520spinal%2520effects%2520in%2520primates%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%2520UFP-112%26jtitle%3DPain%26date%3D2010%26volume%3D148%26spage%3D107%26epage%3D113%26doi%3D10.1016%2Fj.pain.2009.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Obara, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przewlocki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przewlocka, B.</span><span> </span><span class="NLM_article-title">Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.pain.2005.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pain.2005.03.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2005&pages=17-25&author=I.+Obaraauthor=R.+Przewlockiauthor=B.+Przewlocka&title=Spinal+and+local+peripheral+antiallodynic+activity+of+Ro64-6198+in+neuropathic+pain+in+the+rat&doi=10.1016%2Fj.pain.2005.03.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2005.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2005.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DObara%26aufirst%3DI.%26aulast%3DPrzewlocki%26aufirst%3DR.%26aulast%3DPrzewlocka%26aufirst%3DB.%26atitle%3DSpinal%2520and%2520local%2520peripheral%2520antiallodynic%2520activity%2520of%2520Ro64-6198%2520in%2520neuropathic%2520pain%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D2005%26volume%3D116%26spage%3D17%26epage%3D25%26doi%3D10.1016%2Fj.pain.2005.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Le Pen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span><span class="refDoi"> DOI: 10.1097/00001756-200203250-00018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1097%2F00001756-200203250-00018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=451-454&author=G.+Le+Penauthor=J.+Wichmannauthor=J.+L.+Moreauauthor=F.+Jenck&title=The+orphanin+receptor+agonist+RO+64-6198+does+not+induce+place+conditioning+in+rats&doi=10.1097%2F00001756-200203250-00018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1097%2F00001756-200203250-00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200203250-00018%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPen%26aufirst%3DG.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3DThe%2520orphanin%2520receptor%2520agonist%2520RO%252064-6198%2520does%2520not%2520induce%2520place%2520conditioning%2520in%2520rats%26jtitle%3DNeuroReport%26date%3D2002%26volume%3D13%26spage%3D451%26epage%3D454%26doi%3D10.1097%2F00001756-200203250-00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruckmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzschentke, T. M.</span><span> </span><span class="NLM_article-title">Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">645</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2010.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2010.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20674566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=645&publication_year=2010&pages=119-126&author=K.+Ruttenauthor=J.+De+Vryauthor=W.+Bruckmannauthor=T.+M.+Tzschentke&title=Effects+of+the+NOP+receptor+agonist+Ro65-6570+on+the+acquisition+of+opiate-+and+psychostimulant-induced+conditioned+place+preference+in+rats&doi=10.1016%2Fj.ejphar.2010.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats</span></div><div class="casAuthors">Rutten, Kris; De Vry, Jean; Bruckmann, Walter; Tzschentke, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">645</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">119-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of the Nociceptin/Orphanin FQ (NOP) receptor may have anti-abuse effects.  The present study examd. the consequence of NOP receptor activation on the rewarding effect of opiates and psychostimulants in the conditioned place preference task in rats.  First, the motivational effect of the NOP receptor agonists Ro64-6198 (0.316-3.16 mg/kg i.p.) and Ro65-6570 (1-10 mg/kg i.p.) when administered alone, was assessed.  Ro65-6570 was selected for further drug combination studies since, unlike Ro64-6198, it was devoid of an intrinsic motivational effect.  Next, the minimal ED to induce reward for the opiates heroin (0.1-3.16 mg/kg i.p.), morphine (1-10 mg/kg i.p.), hydrocodone (0.316-10 mg/kg i.p.), tilidine (1-31.6 mg/kg i.p.), hydromorphone (0.1-10 mg/kg i.p.), and oxycodone (0.0316-10 mg/kg i.p.), as well as for the psychostimulants cocaine (3.16-31.6 mg/kg i.p.) and dexamphetamine (0.316-3.16 mg/kg i.p.) in combination with Ro65-6570 (0 or 3.16 mg/kg i.p.) was detd.  All drugs produced conditioned place preference, and for opiates and cocaine, but not for dexamphetamine, the minimal ED was higher when combined with Ro65-6570 (3.16 mg/kg i.p.).  Attenuation of the rewarding effect of tilidine (3.16 mg/kg i.p.) and oxycodone (1 mg/kg i.p.) by Ro65-6570 (3.16 mg/kg i.p.) could be reversed by pre-treatment with the NOP receptor antagonist J-113397 (4.64 mg/kg i.p.), suggesting that the attenuating effect of Ro65-6570 on opiates is due to activation of the NOP receptor.  Taken together, the present study suggests that activation of NOP receptors effectively attenuates the rewarding effect of opiates, but may be less effective in reducing psychostimulant-induced reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoex7t1LgsV-bVg90H21EOLACvtfcHk0lhoEUWc21HhXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7rE&md5=9b5b20acbcf02e41d73036713298f2fb</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2010.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2010.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DBruckmann%26aufirst%3DW.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26atitle%3DEffects%2520of%2520the%2520NOP%2520receptor%2520agonist%2520Ro65-6570%2520on%2520the%2520acquisition%2520of%2520opiate-%2520and%2520psychostimulant-induced%2520conditioned%2520place%2520preference%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D645%26spage%3D119%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2010.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Recker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a μ, κ, and δ opioid receptor agonist cue</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span><span class="refDoi"> DOI: 10.1124/jpet.104.071423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.104.071423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15226383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVKrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=652-658&author=M.+D.+Reckerauthor=G.+A.+Higgins&title=The+opioid+receptor+like-1+receptor+agonist+Ro+64-6198+%281S%2C3aS-8-2%2C3%2C3a%2C4%2C5%2C6-hexahydro-1H-phenalen-1-yl-1-phenyl-1%2C3%2C8-triaza-spiro%5B4.5%5Ddecan-4-one%29+produces+a+discriminative+stimulus+in+rats+distinct+from+that+of+a+%CE%BC%2C+%CE%BA%2C+and+%CE%B4+opioid+receptor+agonist+cue&doi=10.1124%2Fjpet.104.071423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a μ, κ, and δ opioid receptor agonist cue</span></div><div class="casAuthors">Recker, Matthew D.; Higgins, Guy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">652-658</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Male Wistar rats were trained to discriminate either the opioid receptor like (ORL)-1 receptor agonist Ro 64-6198 or morphine from saline using a two-choice, food reinforced, operant procedure.  Acquisition of Ro 64-6198 discrimination was relatively slow (mean trials to criterion 113±6), and a final 4 mg/kg dose (initial training dose 2 mg/kg) was required to establish appropriate stimulus control.  In comparison, a sep. group of rats attained a morphine (2 mg/kg) discrimination in 44±4 trials.  In tests of substitution, Ro 64-6198 produced a dose-related generalization to its own cue (ED50 of 1.1 mg/kg i.p.), yet only weakly generalized to the morphine cue (19% at 10 mg/kg i.p.).  In contrast, morphine generalized completely to the morphine cue (ED50 of 0.7 mg/kg s.c.), yet only partially generalized to the Ro 64-6198 cue (40% at 6 mg/kg s.c.).  The κ opioid receptor agonist U50,488 [trans-3,4-dichloro-N-methyl-N(2-[1-pyrrolidinyl]cyclohexyl)benzeneacetamide methanesulfonate] (0.3-6 mg/kg s.c.) and the δ opioid receptor agonist SNC-80 [(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] (0.3-6 mg/kg i.p.) failed to evoke significant generalization to either cue.  The μ opioid receptor agonists codeine (0.3-20 mg/kg) and buprenorphine (0.01-1 mg/kg) completely generalized to the morphine cue, but only buprenorphine partially generalized to the Ro 64-6198 cue.  Naloxone pretreatment completely blocked the morphine cue (ED50 of 0.005 mg/kg s.c.), yet only weakly attenuated the Ro 64-6198 cue at 0.3 mg/kg.  Finally, the selective ORL-1 antagonist J-113397 [1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one] completely blocked the Ro 64-6198 cue at a dose (30 mg/kg i.p.) that had no effect against the morphine cue.  The present studies demonstrate that rats may be trained to discriminate Ro 64-6198 from saline, and the pharmacol. characteristics of this cue are most consistent with ORL-1 receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfR6PHUG626LVg90H21EOLACvtfcHk0lgcPMIbAROd7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVKrurw%253D&md5=76bc4df5ac9442790df632c46d641fae</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.071423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.071423%26sid%3Dliteratum%253Aachs%26aulast%3DRecker%26aufirst%3DM.%2BD.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DThe%2520opioid%2520receptor%2520like-1%2520receptor%2520agonist%2520Ro%252064-6198%2520%25281S%252C3aS-8-2%252C3%252C3a%252C4%252C5%252C6-hexahydro-1H-phenalen-1-yl-1-phenyl-1%252C3%252C8-triaza-spiro%255B4.5%255Ddecan-4-one%2529%2520produces%2520a%2520discriminative%2520stimulus%2520in%2520rats%2520distinct%2520from%2520that%2520of%2520a%2520%25CE%25BC%252C%2520%25CE%25BA%252C%2520and%2520%25CE%25B4%2520opioid%2520receptor%2520agonist%2520cue%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D652%26epage%3D658%26doi%3D10.1124%2Fjpet.104.071423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Zaveri, N. T.</span><span> </span><span class="NLM_article-title">The Nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1151</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span><span class="refDoi"> DOI: 10.2174/156802611795371341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2174%2F156802611795371341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21050175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFKrs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1151-1156&author=N.+T.+Zaveri&title=The+Nociceptin%2Forphanin+FQ+receptor+%28NOP%29+as+a+target+for+drug+abuse+medications&doi=10.2174%2F156802611795371341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications</span></div><div class="casAuthors">Zaveri, Nurulain T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1151-1156</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several studies show that the nociceptin receptor NOP plays a role in the regulation of reward and motivation pathways related to substance abuse.  Administration of the NOP's natural peptide ligand, Nociceptin/Orphanin FQ (N/OFQ) or synthetic agonist Ro 64-6198 has been shown to block rewarding effects of cocaine, morphine, amphetamines and alc., in various behavioral models of drug reward and reinforcement, such as conditioned place preference and drug self-administration.  Administration of N/OFQ has been shown to reduce drug-stimulated levels of dopamine in mesolimbic pathways.  The NOP-N/OFQ system has been particularly well examd. in the development of alc. abuse in animal models.  Furthermore, the efficacy of the mixed-action opioid buprenorphine, in attenuating alc. consumption in human addicts and in alc.-preferring animal models, at higher doses, has been attributed to its partial agonist activity at the NOP receptor.  These studies suggest that NOP receptor agonists may have potential as drug abuse medications.  However, the pathophysiol. of addiction is complex and drug addiction pharmacotherapy needs to address the various phases of substance addiction (craving, withdrawal, relapse).  Further studies are needed to clearly establish how NOP agonists may attenuate the drug addiction process and provide therapeutic benefit.  Addiction to multiple abused drugs (polydrug addiction) is now commonplace and presents a treatment challenge, given the limited pharmacotherapies currently approved.  Polydrug addiction may not be adequately treated by a single agent with a single mechanism of action.  As with the case of buprenorphine, a mixed-action profile of NOP/opioid activity may provide a more effective drug to treat addiction to various abused substances and/or polydrug addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1aSFoIdRD7bVg90H21EOLACvtfcHk0lgcPMIbAROd7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFKrs7s%253D&md5=1154eba7c8b2241122a0d72c0b34baff</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.2174%2F156802611795371341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795371341%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DThe%2520Nociceptin%252Forphanin%2520FQ%2520receptor%2520%2528NOP%2529%2520as%2520a%2520target%2520for%2520drug%2520abuse%2520medications%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D1151%26epage%3D1156%26doi%3D10.2174%2F156802611795371341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span> </span><span class="NLM_article-title">The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.neuropharm.2005.04.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=439-446&author=J.+R.+Shoblockauthor=J.+Wichmannauthor=N.+T.+Maidment&title=The+effect+of+a+systemically+active+ORL-1+agonist%2C+Ro+64-6198%2C+on+the+acquisition%2C+expression%2C+extinction%2C+and+reinstatement+of+morphine+conditioned+place+preference&doi=10.1016%2Fj.neuropharm.2005.04.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26atitle%3DThe%2520effect%2520of%2520a%2520systemically%2520active%2520ORL-1%2520agonist%252C%2520Ro%252064-6198%252C%2520on%2520the%2520acquisition%252C%2520expression%252C%2520extinction%252C%2520and%2520reinstatement%2520of%2520morphine%2520conditioned%2520place%2520preference%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D439%26epage%3D446%26doi%3D10.1016%2Fj.neuropharm.2005.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Kuzmin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terenius, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogren, S. O.</span><span> </span><span class="NLM_article-title">Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span><span class="refDoi"> DOI: 10.1124/jpet.102.041350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.102.041350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12490606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Sgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=310-318&author=A.+Kuzminauthor=J.+Sandinauthor=L.+Tereniusauthor=S.+O.+Ogren&title=Acquisition%2C+expression%2C+and+reinstatement+of+ethanol-induced+conditioned+place+preference+in+mice%3A+effects+of+opioid+receptor-like+1+receptor+agonists+and+naloxone&doi=10.1124%2Fjpet.102.041350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: Effects of opioid receptor-like 1 receptor agonists and naloxone</span></div><div class="casAuthors">Kuzmin, A.; Sandin, J.; Terenius, L.; Ogren, S. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">310-318</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability of the two opioid receptor-like receptor 1 (ORL1) agonists nociceptin (5 nmol i.c.v.) and synthetic (1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8- triaza-spiro[4.5]decan-4-one hydrochloride (Ro 64-6198; 0.1, 0.3, and 1.0 mg/kg i.p.) and the opioid antagonist naloxone (0.1, 1.0, and 10.0 mg/kg s.c.) to modify ethanol-induced conditioned place preference was examd. in NMRI male mice.  The ORL1 agonists were found to significantly reduce the acquisition, expression, and ethanol-induced reinstatement of conditioned place preference.  Unlike the ORL1 agonists, naloxone at the doses relevant for opioid receptor blockade failed to significantly influence the acquisition of ethanol-induced conditioned place preference.  However, naloxone at 1.0 but not 0.1 mg/kg s.c. potently blocked the expression of ethanol-induced conditioned place preference and significantly inhibited ethanol-induced reinstatement of the conditioned place preference after extinction.  Sep. expts. indicated that nociceptin and Ro 64-6198 are both devoid of reinforcing or aversive properties.  Naloxone, however, at 1.0 and 10.0 mg/kg, produced conditioned place aversion, indicating motivational properties of its own.  Both nociceptin and Ro 64-6198 reduced locomotor activity after acute administration.  However, tolerance developed very quickly to this effect and already after three i.c.v. (or i.p.) injections, there was no significant redn. of locomotor activity.  It is concluded that ORL1 agonists can modulate the acquisition, expression, and reinstatement of the conditioned reinforcing effects of ethanol with no reinforcing or aversive properties of their own.  This property might be a potential advantage in the treatment of alcoholism compared with nonselective opioid antagonist naltrexone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps1o4YcdLO17Vg90H21EOLACvtfcHk0ljdfuun-fPAAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Sgtw%253D%253D&md5=5aa918ad64be2022d3b8c00c9b8a9897</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.041350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.041350%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmin%26aufirst%3DA.%26aulast%3DSandin%26aufirst%3DJ.%26aulast%3DTerenius%26aufirst%3DL.%26aulast%3DOgren%26aufirst%3DS.%2BO.%26atitle%3DAcquisition%252C%2520expression%252C%2520and%2520reinstatement%2520of%2520ethanol-induced%2520conditioned%2520place%2520preference%2520in%2520mice%253A%2520effects%2520of%2520opioid%2520receptor-like%25201%2520receptor%2520agonists%2520and%2520naloxone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D310%26epage%3D318%26doi%3D10.1124%2Fjpet.102.041350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Kuzmin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreek, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakalkin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liljequist, S.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span><span class="refDoi"> DOI: 10.1038/sj.npp.1301169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.npp.1301169" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=902-910&author=A.+Kuzminauthor=M.+J.+Kreekauthor=G.+Bakalkinauthor=S.+Liljequist&title=The+nociceptin%2Forphanin+FQ+receptor+agonist+Ro+64-6198+reduces+alcohol+self-administration+and+prevents+relapse-like+alcohol+drinking&doi=10.1038%2Fsj.npp.1301169"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301169%26sid%3Dliteratum%253Aachs%26aulast%3DKuzmin%26aufirst%3DA.%26aulast%3DKreek%26aufirst%3DM.%2BJ.%26aulast%3DBakalkin%26aufirst%3DG.%26aulast%3DLiljequist%26aufirst%3DS.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%2520Ro%252064-6198%2520reduces%2520alcohol%2520self-administration%2520and%2520prevents%2520relapse-like%2520alcohol%2520drinking%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D902%26epage%3D910%26doi%3D10.1038%2Fsj.npp.1301169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Economidou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fardon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span> </span><span class="NLM_article-title">Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3299</span><span class="NLM_x">–</span> <span class="NLM_lpage">3306</span><span class="refDoi"> DOI: 10.1016/j.peptides.2006.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.peptides.2006.09.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=3299-3306&author=D.+Economidouauthor=A.+Fedeliauthor=R.+M.+Fardonauthor=F.+Weissauthor=M.+Massiauthor=R.+Ciccocioppo&title=Effect+of+novel+nociceptin%2Forphanin+FQ-NOP+receptor+ligands+on+ethanol+drinking+in+alcohol-preferring+msP+rats&doi=10.1016%2Fj.peptides.2006.09.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2006.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2006.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DEconomidou%26aufirst%3DD.%26aulast%3DFedeli%26aufirst%3DA.%26aulast%3DFardon%26aufirst%3DR.%2BM.%26aulast%3DWeiss%26aufirst%3DF.%26aulast%3DMassi%26aufirst%3DM.%26aulast%3DCiccocioppo%26aufirst%3DR.%26atitle%3DEffect%2520of%2520novel%2520nociceptin%252Forphanin%2520FQ-NOP%2520receptor%2520ligands%2520on%2520ethanol%2520drinking%2520in%2520alcohol-preferring%2520msP%2520rats%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D3299%26epage%3D3306%26doi%3D10.1016%2Fj.peptides.2006.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopponi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Economidou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teshima, K.</span><span> </span><span class="NLM_article-title">Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2610</span><span class="refDoi"> DOI: 10.1038/npp.2014.113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnpp.2014.113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2601-2610&author=R.+Ciccocioppoauthor=S.+Stopponiauthor=D.+Economidouauthor=M.+Kuriyamaauthor=H.+Kinoshitaauthor=M.+Heiligauthor=M.+Robertoauthor=F.+Weissauthor=K.+Teshima&title=Chronic+treatment+with+novel+brain-penetrating+selective+NOP+receptor+agonist+MT-7716+reduces+alcohol+drinking+and+seeking+in+the+rat&doi=10.1038%2Fnpp.2014.113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.113%26sid%3Dliteratum%253Aachs%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DStopponi%26aufirst%3DS.%26aulast%3DEconomidou%26aufirst%3DD.%26aulast%3DKuriyama%26aufirst%3DM.%26aulast%3DKinoshita%26aufirst%3DH.%26aulast%3DHeilig%26aufirst%3DM.%26aulast%3DRoberto%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DF.%26aulast%3DTeshima%26aufirst%3DK.%26atitle%3DChronic%2520treatment%2520with%2520novel%2520brain-penetrating%2520selective%2520NOP%2520receptor%2520agonist%2520MT-7716%2520reduces%2520alcohol%2520drinking%2520and%2520seeking%2520in%2520the%2520rat%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2601%26epage%3D2610%26doi%3D10.1038%2Fnpp.2014.113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Heinig, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucheli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomae, A.</span><span> </span><span class="NLM_article-title">Bioanalytics and pharmacokinetics of the nociceptin/orphanin FQ peptide receptor agonist RO0646198 in Wistar rats and cynomolgus monkeys</span> <span class="citation_source-journal">J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">878</span><span class="NLM_x">, </span> <span class="NLM_fpage">2101</span><span class="NLM_x">–</span> <span class="NLM_lpage">2105</span><span class="refDoi"> DOI: 10.1016/j.jchromb.2010.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.jchromb.2010.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20627230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVaktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=878&publication_year=2010&pages=2101-2105&author=K.+Heinigauthor=N.+Kratochwilauthor=F.+Bucheliauthor=A.+Thomae&title=Bioanalytics+and+pharmacokinetics+of+the+nociceptin%2Forphanin+FQ+peptide+receptor+agonist+RO0646198+in+Wistar+rats+and+cynomolgus+monkeys&doi=10.1016%2Fj.jchromb.2010.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Bioanalytics and pharmacokinetics of the nociceptin/orphanin FQ peptide receptor agonist RO0646198 in Wistar rats and Cynomolgus monkeys</span></div><div class="casAuthors">Heinig, Katja; Kratochwil, Nicole; Bucheli, Franz; Thomae, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">878</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2101-2105</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This manuscript describes the detn. of the nociceptin/orphanin FQ peptide (NOP) receptor agonist RO0646198 in rat and Cynomolgus monkey plasma using liq. chromatog. coupled to tandem mass spectrometry.  The structural analog RO0658791 served as internal std.  After protein pptn. with ethanol, clean up and enrichment was carried out by online solid-phase extn. on a 10 mm C18 trapping column.  Gradient sepn. was performed on a 50 mm C18 anal. column, followed by electrospray ionization and detection in pos. ion selected reaction monitoring (SRM) mode.  The total run time was 2.5 min.  The lower limit of quantification (LLOQ) was 10 pg/mL.  Precisions were below 19% and accuracies were between 86% and 118%.  The recoveries were above 90%, and no significant matrix effect was obsd.  The method was successfully applied to low dose pharmacokinetic studies.  The bioavailability after oral dosing was below 5% for rats and below 1% in Cynomolgus monkeys, limiting the application of RO0646198 in the clinic to parenteral routes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNxapLsKFIdrVg90H21EOLACvtfcHk0ljdfuun-fPAAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVaktL0%253D&md5=1f6b1f89024f7e41559f126a0485e06d</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2010.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2010.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DHeinig%26aufirst%3DK.%26aulast%3DKratochwil%26aufirst%3DN.%26aulast%3DBucheli%26aufirst%3DF.%26aulast%3DThomae%26aufirst%3DA.%26atitle%3DBioanalytics%2520and%2520pharmacokinetics%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520agonist%2520RO0646198%2520in%2520Wistar%2520rats%2520and%2520cynomolgus%2520monkeys%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2010%26volume%3D878%26spage%3D2101%26epage%3D2105%26doi%3D10.1016%2Fj.jchromb.2010.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesura, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenck, F.</span><span> </span><span class="NLM_article-title">8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2348</span><span class="refDoi"> DOI: 10.1016/S0960-894X(99)00385-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0960-894X%2899%2900385-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2343-2348&author=J.+Wichmannauthor=G.+Adamauthor=S.+Roverauthor=A.+M.+Cesuraauthor=F.+M.+Dautzenbergauthor=F.+Jenck&title=8-acenaphthen-1-yl-1-phenyl-1%2C3%2C8-triaza-spiro%5B4.5%5Ddecan-4-one+derivatives+as+orphanin+FQ+receptor+agonists&doi=10.1016%2FS0960-894X%2899%2900385-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900385-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900385-6%26sid%3Dliteratum%253Aachs%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DRover%26aufirst%3DS.%26aulast%3DCesura%26aufirst%3DA.%2BM.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DJenck%26aufirst%3DF.%26atitle%3D8-acenaphthen-1-yl-1-phenyl-1%252C3%252C8-triaza-spiro%255B4.5%255Ddecan-4-one%2520derivatives%2520as%2520orphanin%2520FQ%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2343%26epage%3D2348%26doi%3D10.1016%2FS0960-894X%2899%2900385-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Hashiba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo', G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowbotham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span> </span><span class="NLM_article-title">Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1007/s002100000327</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs002100000327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11191833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVyjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2001&pages=28-33&author=E.+Hashibaauthor=C.+Harrisonauthor=G.+Calo%27author=R.+Guerriniauthor=D.+J.+Rowbothamauthor=G.+Smithauthor=D.+G.+Lambert&title=Characterisation+and+comparison+of+novel+ligands+for+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1007%2Fs002100000327"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor</span></div><div class="casAuthors">Hashiba, E.; Harrison, C.; Calo, G.; Guerrini, R.; Rowbotham, D. J.; Smith, G.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-33</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Studies of nociceptin/orphanin FQ (NC) have been hampered by the paucity of available ligands with activity at the nociceptin receptor (NCR).  In this study the authors have compared the agonist profile of NC and a novel NCR agonist, Ro65-6570, in a series of radioligand binding studies and effects on forskolin-stimulated cAMP formation in Chinese hamster ovary (CHO) cells expressing the recombinant human NCR (CHOhNCR).  In addn., the authors report the effects of three antagonists, [Nphe1]NC(1-13)NH2, J-113397 and III-BTD, on these responses.  In radioligand binding studies Ro65-6570, [Nphe1]NC(1-13)NH2, J-113397 and III-BTD displaced [3H]NC with similar pKi values (8.4-8.8).  This compares with a pKD of 10.2 for NC in a direct satn. expt. [Nphe1]NC(1-13)NH2 and J-113397 showed at least 100-fold selectivity over classical opioid receptors.  Both NC and Ro65-6570 produced a concn.-dependent inhibition of cAMP formation with pEC50 values of 9.56 and 8.68, resp.  Maximum inhibition achieved was 100%. [Nphe1]NC(1-13)NH2, J-113397 and III-BTD produced a parallel rightward shift in the concn.-response curves to both NC and Ro65-6570 with pKB values of 6.5, 7.5 and 7.7, resp.  Importantly, all three antagonists were devoid of residual agonist activity.  Collectively, these data indicate the value of Ro65-6570, [Nphe1]NC(1-13)NH2, J-113397 and III-BTD in studies of the physiol. role played by NC.  However, due to the relatively poor selectivity of Ro65-6570 and III-BTD caution should be exercised when using tissues that co-express μ-opioid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpOzyrD2lFlLVg90H21EOLACvtfcHk0lhxHKksujkGqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVyjuw%253D%253D&md5=8fb498095229c20260a01a36414b211b</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1007%2Fs002100000327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000327%26sid%3Dliteratum%253Aachs%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DHarrison%26aufirst%3DC.%26aulast%3DCalo%2527%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRowbotham%26aufirst%3DD.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCharacterisation%2520and%2520comparison%2520of%2520novel%2520ligands%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2001%26volume%3D363%26spage%3D28%26epage%3D33%26doi%3D10.1007%2Fs002100000327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Schiene, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzschentke, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schröder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, T.</span><span> </span><span class="NLM_article-title">Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and μ-opioid receptor agonism</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">754</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.01.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2015.01.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25697471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjt1Sjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=754&publication_year=2015&pages=61-65&author=K.+Schieneauthor=T.+M.+Tzschentkeauthor=W.+Schr%C3%B6derauthor=T.+Christoph&title=Mechanical+hyperalgesia+in+rats+with+diabetic+polyneuropathy+is+selectively+inhibited+by+local+peripheral+nociceptin%2Forphanin+FQ+receptor+and+%CE%BC-opioid+receptor+agonism&doi=10.1016%2Fj.ejphar.2015.01.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and μ-opioid receptor agonism</span></div><div class="casAuthors">Schiene, Klaus; Tzschentke, Thomas M.; Schroeder, Wolfgang; Christoph, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">754</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61-65</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Peripheral receptors may contribute to the effects of systemically administered centrally available analgesics.  In the present study, we analyzed the effect of local peripheral injection of the nociceptin/orphanin FQ peptide (NOP) receptor agonist Ro65-6570 and compared it to the μ-opioid peptide (MOP) receptor agonist morphine in streptozotocin-induced diabetic polyneuropathy in rats.  Ro65-6570 and morphine were injected intraplantarly into the hind paw of diabetic rats, and mech. withdrawal thresholds were detd. in both paws (ipsi- and contralateral to the injection site).  Ro65-6570 in the dose range of 7.1-71.4 nmol/animal showed antihyperalgesic effects with maximal efficacy of 57.1±15.4% maximal possible effect (MPE) at the dose of 23.8 nmol/animal.  Intraplantar administration of morphine showed dose-dependent antihyperalgesic effects in the dose range of 25.8-257.8 nmol/animal in a similar efficacy range with a maximal efficacy of 76.0±12.1% MPE at the dose of 257.8 nmol/animal.  Both compds. did not induce overt confounding side effects across the tested dose range.  The NOP receptor antagonist J-113397 and the MOP receptor antagonist naloxone, intraplantarly co-administered with the resp. agonists, selectively and completely prevented the antihyperalgesic action of the resp. NOP and MOP receptor agonist.  These results indicate that the activation of peripheral NOP and MOP receptors by Ro65-6570 and morphine, resp., mediated antihyperalgesic effects in rats with diabetic polyneuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpXaH_biV0SbVg90H21EOLACvtfcHk0lhxHKksujkGqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjt1Sjs7c%253D&md5=b5dec6ffd8f78e713f353e385be2bc49</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.01.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.01.049%26sid%3Dliteratum%253Aachs%26aulast%3DSchiene%26aufirst%3DK.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DChristoph%26aufirst%3DT.%26atitle%3DMechanical%2520hyperalgesia%2520in%2520rats%2520with%2520diabetic%2520polyneuropathy%2520is%2520selectively%2520inhibited%2520by%2520local%2520peripheral%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520and%2520%25CE%25BC-opioid%2520receptor%2520agonism%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D754%26spage%3D61%26epage%3D65%26doi%3D10.1016%2Fj.ejphar.2015.01.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Schiene, K.; Christoph, T.; Kögel, B.; Tzschentke, T.</span><span> </span><span class="NLM_article-title">Antinociceptive, antihyperalgesic and antiallodynic activity of the NOP receptor agonist Ro65-6570 in rodent models of pain</span>. EFIC, 8th “Pain in Europe” Congress, 2013; <span class="NLM_publisher-name">EFIC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schiene%2C+K.%3B+Christoph%2C+T.%3B+K%C3%B6gel%2C+B.%3B+Tzschentke%2C+T.+Antinociceptive%2C+antihyperalgesic+and+antiallodynic+activity+of+the+NOP+receptor+agonist+Ro65-6570+in+rodent+models+of+pain.+EFIC%2C+8th+%E2%80%9CPain+in+Europe%E2%80%9D+Congress%2C+2013%3B+EFIC%2C+2013%3B+pp+9%E2%80%9312."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSchiene%26aufirst%3DK.%26atitle%3DAntinociceptive%252C%2520antihyperalgesic%2520and%2520antiallodynic%2520activity%2520of%2520the%2520NOP%2520receptor%2520agonist%2520Ro65-6570%2520in%2520rodent%2520models%2520of%2520pain%26pub%3DEFIC%26date%3D2013%26spage%3D9%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Byford, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. K.</span><span> </span><span class="NLM_article-title">The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents</span> <span class="citation_source-journal">Anesth. Analg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1213/01.ane.0000250403.88649.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1213%2F01.ane.0000250403.88649.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17179266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD28jjvFeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=174-179&author=A.+J.+Byfordauthor=A.+Andersonauthor=P.+S.+Jonesauthor=R.+Palinauthor=A.+K.+Houghton&title=The+hypnotic%2C+electroencephalographic%2C+and+antinociceptive+properties+of+nonpeptide+ORL1+receptor+agonists+after+intravenous+injection+in+rodents&doi=10.1213%2F01.ane.0000250403.88649.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents</span></div><div class="casAuthors">Byford Alan J; Anderson Alison; Jones Philip S; Palin Ronald; Houghton Andrea K</div><div class="citationInfo"><span class="NLM_cas:title">Anesthesia and analgesia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">174-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Agonists at the opioid receptor-like receptor 1 (ORL1) induce motor impairment, sedation, and loss of righting reflex (LRR) in rodents.  This receptor may provide a novel target in the field of anesthesia.  METHODS:  We examined the hypnotic, electroencephalographic (EEG), and antinociceptive effects of two IV administered nonpeptide ORL1 agonists, (Ro 65-6570 and Org 26383), using LRR in mice and rats, percent EEG burst suppression in rats, and formalin paw test in mice.  RESULTS:  In mice, Ro 65-6570 and Org 26383 produced LRR (hypnotic dose 0.6 and 3.7 micromol/kg for Ro 65-6570 and Org 26383, respectively).  Naloxone had no significant effect on sleep times produced by both compounds.  In rats, Ro 65-6570 (0.6-2.4 micromol/kg) and Org 26383 (4-8 micromol/kg) produced LRR and burst suppression activity in the EEG.  Both sleep times and burst suppression activity were significantly reduced with a selective ORL1 antagonist.  In mice, dose-dependent inhibition of formalin-induced nociceptive behaviors occurred (Phase 1 ED50 0.4 and 1.8 micromol/kg and Phase 2 ED50 0.4 and 4.2 micromol/kg for Ro 65-6570 and Org 26383, respectively).  CONCLUSIONS:  These results show that Ro 65-6570 and Org 26383 (probably via the ORL1 receptor) behave as IV hypnotics and analgesics in mice and rats, and that the hypnotic and antinociceptive doses are similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCEQgPogiM-IUSrryheKE6fW6udTcc2eYaFIx3QEg38Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jjvFeltA%253D%253D&md5=2429954774972a87a9a3c8f102691528</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1213%2F01.ane.0000250403.88649.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1213%252F01.ane.0000250403.88649.51%26sid%3Dliteratum%253Aachs%26aulast%3DByford%26aufirst%3DA.%2BJ.%26aulast%3DAnderson%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DP.%2BS.%26aulast%3DPalin%26aufirst%3DR.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26atitle%3DThe%2520hypnotic%252C%2520electroencephalographic%252C%2520and%2520antinociceptive%2520properties%2520of%2520nonpeptide%2520ORL1%2520receptor%2520agonists%2520after%2520intravenous%2520injection%2520in%2520rodents%26jtitle%3DAnesth.%2520Analg.%26date%3D2007%26volume%3D104%26spage%3D174%26epage%3D179%26doi%3D10.1213%2F01.ane.0000250403.88649.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bercovici, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torhan, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2519</span><span class="NLM_x">–</span> <span class="NLM_lpage">2523</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.bmcl.2009.03.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2519-2523&author=G.+D.+Hoauthor=J.+Anthesauthor=A.+Bercoviciauthor=J.+P.+Caldwellauthor=K.+C.+Chengauthor=X.+Cuiauthor=A.+Fawziauthor=X.+Fernandezauthor=W.+J.+Greenleeauthor=J.+Heyauthor=W.+Korfmacherauthor=S.+X.+Luauthor=R.+L.+McLeodauthor=F.+Ngauthor=A.+S.+Torhanauthor=Z.+Tanauthor=D.+Tulshianauthor=G.+B.+Vartyauthor=X.+Xuauthor=H.+Zhang&title=The+discovery+of+tropane+derivatives+as+nociceptin+receptor+ligands+for+the+management+of+cough+and+anxiety&doi=10.1016%2Fj.bmcl.2009.03.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.031%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DAnthes%26aufirst%3DJ.%26aulast%3DBercovici%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DFawzi%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DHey%26aufirst%3DJ.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DNg%26aufirst%3DF.%26aulast%3DTorhan%26aufirst%3DA.%2BS.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DThe%2520discovery%2520of%2520tropane%2520derivatives%2520as%2520nociceptin%2520receptor%2520ligands%2520for%2520the%2520management%2520of%2520cough%2520and%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2519%26epage%3D2523%26doi%3D10.1016%2Fj.bmcl.2009.03.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G. J.</span><span> </span><span class="NLM_article-title">The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span><span class="refDoi"> DOI: 10.1124/jpet.108.136937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.108.136937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=18492950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVWqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=672-682&author=G.+B.+Vartyauthor=S.+X.+Luauthor=C.+A.+Morganauthor=M.+E.+Cohen-Williamsauthor=R.+A.+Hodgsonauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=A.+B.+Fawziauthor=M.+P.+Grazianoauthor=G.+D.+Hoauthor=J.+Matasiauthor=D.+Tulshianauthor=V.+L.+Coffinauthor=G.+J.+Carey&title=The+anxiolytic-like+effects+of+the+novel%2C+orally+active+nociceptin+opioid+receptor+agonist+8-%5Bbis%282-methylphenyl%29methyl%5D-3-phenyl-8-azabicyclo%5B3.2.1%5Doctan-3-ol+%28SCH+221510%29&doi=10.1124%2Fjpet.108.136937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)</span></div><div class="casAuthors">Varty, Geoffrey B.; Lu, Sherry X.; Morgan, Cynthia A.; Cohen-Williams, Mary E.; Hodgson, Robert A.; Smith-Torhan, April; Zhang, Hongtao; Fawzi, Ahmad B.; Graziano, Michael P.; Ho, Ginny D.; Matasi, Julius; Tulshian, Deen; Coffin, Vicki L.; Carey, Galen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">672-682</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Orphanin FQ/nociceptin (OFQ/N) is the endogenously occurring peptide ligand for the nociceptin opioid receptor (NOP) that produces anxiolytic-like effects in mice and rats.  The present study assessed the anxiolytic-like activity of 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510), a novel potent piperidine NOP agonist (EC50 = 12 nM) that binds with high affinity (Ki = 0.3 nM) and functional selectivity (>50-fold over the μ-, κ-, and δ-opioid receptors).  The anxiolytic-like activity and side-effect profile of SCH 221510 were assessed in a variety of models and the benzodiazepine, chlordiazepoxide (CDP), was included for comparison.  The effects of chronic dosing of SCH 221510 were also assessed.  Furthermore, the specificity of the anxiolytic-like effect of SCH 221510 was investigated with the NOP receptor antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and the opioid receptor antagonist naltrexone.  Like CDP (1-30 mg/kg i.p.), SCH 221510 (1-30 mg/kg p.o.) produced anxiolytic-like effects in the elevated plus-maze (rat and gerbil), Vogel conflict (rat), conditioned lick suppression (rat), fear-potentiated startle (rat), and pup sepn.-induced vocalization (guinea pig) assays.  In the Vogel conflict, the anxiolytic-like effect of SCH 221510 (10 mg/kg) was attenuated by J-113397 (3-10 mg/kg p.o.), but not naltrexone (3-30 mg/kg i.p.).  Addnl., the anxiolytic-like effects of SCH 221510 did not change appreciably following 14-day b.i.d. dosing in rats (10 mg/kg).  Furthermore, unlike CDP, SCH 221510 (3-30 mg/kg) produced anxiolytic-like activity at doses that did not disrupt overt behavior.  Collectively, these data suggest that NOP agonists such as SCH 221510 may have an anxiolytic-like profile similar to benzodiazepines, with a reduced side-effect liability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr61zPPj5Ve3rVg90H21EOLACvtfcHk0lgLpKMUOv_01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVWqsLs%253D&md5=f4cc72e8df4266b67ed4b61ac9c632ad</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136937%26sid%3Dliteratum%253Aachs%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DLu%26aufirst%3DS.%2BX.%26aulast%3DMorgan%26aufirst%3DC.%2BA.%26aulast%3DCohen-Williams%26aufirst%3DM.%2BE.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DGraziano%26aufirst%3DM.%2BP.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DMatasi%26aufirst%3DJ.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DCoffin%26aufirst%3DV.%2BL.%26aulast%3DCarey%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520anxiolytic-like%2520effects%2520of%2520the%2520novel%252C%2520orally%2520active%2520nociceptin%2520opioid%2520receptor%2520agonist%25208-%255Bbis%25282-methylphenyl%2529methyl%255D-3-phenyl-8-azabicyclo%255B3.2.1%255Doctan-3-ol%2520%2528SCH%2520221510%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D672%26epage%3D682%26doi%3D10.1124%2Fjpet.108.136937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, E.</span><span> </span><span class="NLM_article-title">Novel non-peptide nociceptin/orphanin FQ receptor agonist, 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: design, synthesis, and structure-activity relationship of oral receptor occupancy in the brain for orally potent antianxiety drug</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span><span class="refDoi"> DOI: 10.1021/jm7012979</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7012979" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=610-625&author=S.+Hayashiauthor=A.+Hiraoauthor=A.+Imaiauthor=H.+Nakamuraauthor=Y.+Murataauthor=K.+Ohashiauthor=E.+Nakata&title=Novel+non-peptide+nociceptin%2Forphanin+FQ+receptor+agonist%2C+1-%5B1-%281-methylcyclooctyl%29-4-piperidinyl%5D-2-%5B%283R%29-3-piperidinyl%5D-1H-benzimidazole%3A+design%2C+synthesis%2C+and+structure-activity+relationship+of+oral+receptor+occupancy+in+the+brain+for+orally+potent+antianxiety+drug&doi=10.1021%2Fjm7012979"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm7012979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7012979%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DHirao%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DOhashi%26aufirst%3DK.%26aulast%3DNakata%26aufirst%3DE.%26atitle%3DNovel%2520non-peptide%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonist%252C%25201-%255B1-%25281-methylcyclooctyl%2529-4-piperidinyl%255D-2-%255B%25283R%2529-3-piperidinyl%255D-1H-benzimidazole%253A%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520oral%2520receptor%2520occupancy%2520in%2520the%2520brain%2520for%2520orally%2520potent%2520antianxiety%2520drug%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D610%26epage%3D625%26doi%3D10.1021%2Fjm7012979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Sukhtankar, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagorio, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M.-C.</span><span> </span><span class="NLM_article-title">Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">745</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2014.10.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2014.10.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25446568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=745&publication_year=2014&pages=182-189&author=D.+D.+Sukhtankarauthor=C.+H.+Lagorioauthor=M.-C.+Ko&title=Effects+of+the+NOP+agonist+SCH221510+on+producing+and+attenuating+reinforcing+effects+as+measured+by+drug+self-administration+in+rats&doi=10.1016%2Fj.ejphar.2014.10.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats</span></div><div class="casAuthors">Sukhtankar, Devki D.; Lagorio, Carla H.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">745</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">182-189</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ peptide (NOP) receptor agonists attenuate morphine-induced conditioned place preference in rodents.  However, it is not known whether NOP agonists have reinforcing properties or can inhibit mu opioid receptor (MOP)-mediated reinforcement as measured by drug self-administration in rodents.  Further understanding the behavioral effects of NOP agonists could suggest them as having potential in attenuating reinforcing effects of opioids.  In the first part of the study, reinforcing properties of selective NOP agonist SCH221510 were detd. and compared with the full MOP agonist remifentanil under fixed-ratio 5 (FR5) and progressive-ratio (PR) schedules of drug self-administration.  In the second part, effects of systemic and intracisternal pretreatment of SCH221510 were detd. and compared with MOP antagonist naltrexone in attenuating reinforcing effects of remifentanil and a non-drug reinforcer (sucrose pellets).  Remifentanil self-administration (0.3-10 μg/kg/infusion) generated a biphasic dose-response curve, characteristic of drugs with reinforcing properties.  SCH221510 (3-300 μg/kg/infusion) self-administration resulted in flat dose-response curves and early break-points under the PR, indicative of drugs lacking reinforcing value.  Intracisternally, but not systemically, administered SCH221510 (0.3-3 μg) attenuated remifentanil self-administration, comparable with systemic naltrexone (0.03-0.3 mg/kg).  SCH221510 (1-3 μg), unlike naltrexone (0.03-1 mg/kg), attenuated responding for sucrose pellets.  Both effects of SCH221510 were reversed by the NOP antagonist J-113397 (0.3-3 μg).  These results suggest that SCH221510 does not function as a reinforcer in rats, and that it can attenuate the reinforcing value of MOP agonists; therefore, the potential utility of NOP agonists for the treatment of drug addiction warrants further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUdaBr_X6zKLVg90H21EOLACvtfcHk0lheaIjNZAjdMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtb3N&md5=ef3acd92713cc8257facef3a7f60367c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.10.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.10.029%26sid%3Dliteratum%253Aachs%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DLagorio%26aufirst%3DC.%2BH.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DEffects%2520of%2520the%2520NOP%2520agonist%2520SCH221510%2520on%2520producing%2520and%2520attenuating%2520reinforcing%2520effects%2520as%2520measured%2520by%2520drug%2520self-administration%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D745%26spage%3D182%26epage%3D189%26doi%3D10.1016%2Fj.ejphar.2014.10.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Cremeans, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyle, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, M. C.</span><span> </span><span class="NLM_article-title">Roles of mu-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1124/jpet.112.194308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.112.194308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22743574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFagsb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2012&pages=72-81&author=C.+M.+Cremeansauthor=E.+Gruleyauthor=D.+J.+Kyleauthor=M.+C.+Ko&title=Roles+of+mu-opioid+receptors+and+nociceptin%2Forphanin+FQ+peptide+receptors+in+buprenorphine-induced+physiological+responses+in+primates&doi=10.1124%2Fjpet.112.194308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates</span></div><div class="casAuthors">Cremeans, Colette M.; Gruley, Erin; Kyle, Donald J.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Buprenorphine is known as a μ-opioid peptide (MOP) receptor agonist, but its antinociception is compromised by the activation of nociceptin/orphanin FQ peptide (NOP) receptors in rodents.  The aim of this study was to investigate the roles of MOP and NOP receptors in regulating buprenorphine-induced physiol. responses in primates (rhesus monkeys).  The effects of MOP antagonist (naltrexone), NOP antagonist [(±)-1-[(3R*,4R*)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397)], and NOP agonists [(1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one (Ro 64-6198) and 3-endo-8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)] on buprenorphine were studied in three functional assays for measuring analgesia, respiratory depression, and itch in primates.  Over the dose range of 0.01 to 0.1 mg/kg, buprenorphine dose-dependently produced antinociception, respiratory depression, and itch/scratching responses, and there was a ceiling effect at higher doses (0.1-1 mg/kg).  Naltrexone (0.03 mg/kg) produced similar degrees of rightward shifts of buprenorphine's dose-response curves for all three endpoints.  Mean pKB values of naltrexone (8.1-8.3) confirmed that MOP receptors mediated mainly buprenorphine-induced antinociception, respiratory depression, and itch/scratching.  In contrast, J-113397 (0.1 mg/kg) did not change buprenorphine-induced physiol. responses, indicating that there were no functional NOP receptors in buprenorphine-induced effects.  More importantly, both NOP agonists, Ro 64-6198 and SCH 221510, enhanced buprenorphine-induced antinociception without respiratory depression and itch/scratching.  The dose-addn. anal. revealed that buprenorphine in combination with the NOP agonist synergistically produced antinociceptive effects.  These findings provided functional evidence that the activation of NOP receptors did not attenuate buprenorphine-induced antinociception in primates; instead, the coactivation of MOP and NOP receptors produced synergistic antinociception without other side effects.  This study strongly supports the therapeutic potential of mixed MOP/NOP agonists as innovative analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAFWzdMLHCurVg90H21EOLACvtfcHk0lijkSpjSFEvdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFagsb%252FP&md5=62e9b5453a946496111f9cdddae5f2df</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.194308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.194308%26sid%3Dliteratum%253Aachs%26aulast%3DCremeans%26aufirst%3DC.%2BM.%26aulast%3DGruley%26aufirst%3DE.%26aulast%3DKyle%26aufirst%3DD.%2BJ.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DRoles%2520of%2520mu-opioid%2520receptors%2520and%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptors%2520in%2520buprenorphine-induced%2520physiological%2520responses%2520in%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D343%26spage%3D72%26epage%3D81%26doi%3D10.1124%2Fjpet.112.194308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Kangas, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, J.</span><span> </span><span class="NLM_article-title">Operant nociception in nonhuman primates</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1828</span><span class="refDoi"> DOI: 10.1016/j.pain.2014.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.pain.2014.06.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2014&pages=1821-1828&author=B.+D.+Kangasauthor=J.+Bergman&title=Operant+nociception+in+nonhuman+primates&doi=10.1016%2Fj.pain.2014.06.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2014.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2014.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DKangas%26aufirst%3DB.%2BD.%26aulast%3DBergman%26aufirst%3DJ.%26atitle%3DOperant%2520nociception%2520in%2520nonhuman%2520primates%26jtitle%3DPain%26date%3D2014%26volume%3D155%26spage%3D1821%26epage%3D1828%26doi%3D10.1016%2Fj.pain.2014.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Fichna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobczak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrowiecka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cygankiewicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenac, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sałaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmermans, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Małecka-Panas, E.</span><span> </span><span class="NLM_article-title">Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1550</span><span class="refDoi"> DOI: 10.1111/nmo.12390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fnmo.12390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25041572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslCqtbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1539-1550&author=J.+Fichnaauthor=M.+Sobczakauthor=A.+Mokrowieckaauthor=A.+Cygankiewiczauthor=P.+Zakrzewskiauthor=N.+Cenacauthor=M.+Sa%C5%82agaauthor=J.+P.+Timmermansauthor=N.+Vergnolleauthor=E.+Ma%C5%82ecka-Panas&title=Activation+of+the+endogenous+nociceptin+system+by+selective+nociceptin+receptor+agonist+SCH+221510+produces+antitransit+and+antinociceptive+effect%3A+a+novel+strategy+for+treatment+of+diarrhea-predominant+IBS&doi=10.1111%2Fnmo.12390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS</span></div><div class="casAuthors">Fichna, J.; Sobczak, M.; Mokrowiecka, A.; Cygankiewicz, A. I.; Zakrzewski, P. K.; Cenac, N.; Salaga, M.; Timmermans, J.-P.; Vergnolle, N.; Malecka-Panas, E.; Krajewska, W. M.; Storr, M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology & Motility</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1539-1550</span>CODEN:
                <span class="NLM_cas:coden">NMOTEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-1925</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : Diarrhea-predominant irritable bowel syndrome (IBS-D) is a functional gastrointestinal (GI) disorder, defined by the presence of loose stools and abdominal pain.  In search for a novel anti-IBS-D therapy, here we investigated the nociceptin receptor (NOP)-dependent effects in the GI tract.  Methods : A novel potent and selective NOP agonist SCH 221510 was used in the study.  The effect of NOP activation on mouse intestinal motility was characterized in vitro and in vivo, in physiol. conditions and in animal models of hypermotility and diarrhea.  Well-established mouse models of visceral pain were used to characterize the antinociceptive effect of the NOP activation.  To provide addnl. evidence that the endogenous nociceptin system is a relevant target for IBS, NOP expression and nociceptin levels were quantified in serum and colonic biopsies from IBS-D patients.  Key Results : SCH 221510 produced a potent NOP-mediated inhibitory effect on mouse intestinal motility in vitro and in vivo in physiol. conditions.  The NOP agonist displayed an antidiarrheal and analgesic action after oral administration in animal models mimicking the symptoms of IBS-D.  Studies on human samples revealed a strong decrease in endogenous nociceptin system expression in IBS-D patients compared with healthy controls.  Conclusions & Inferences : Collectively, mouse and human data suggest that the endogenous nociceptin system is involved in IBS-D and may become a target for anti-IBS-D treatments using potent and selective synthetic NOP agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaT-LhZszp7bVg90H21EOLACvtfcHk0lglRJJ17ffwtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslCqtbvN&md5=44e2f664d0336baeee3a5f0f675325e2</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fnmo.12390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnmo.12390%26sid%3Dliteratum%253Aachs%26aulast%3DFichna%26aufirst%3DJ.%26aulast%3DSobczak%26aufirst%3DM.%26aulast%3DMokrowiecka%26aufirst%3DA.%26aulast%3DCygankiewicz%26aufirst%3DA.%26aulast%3DZakrzewski%26aufirst%3DP.%26aulast%3DCenac%26aufirst%3DN.%26aulast%3DSa%25C5%2582aga%26aufirst%3DM.%26aulast%3DTimmermans%26aufirst%3DJ.%2BP.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DMa%25C5%2582ecka-Panas%26aufirst%3DE.%26atitle%3DActivation%2520of%2520the%2520endogenous%2520nociceptin%2520system%2520by%2520selective%2520nociceptin%2520receptor%2520agonist%2520SCH%2520221510%2520produces%2520antitransit%2520and%2520antinociceptive%2520effect%253A%2520a%2520novel%2520strategy%2520for%2520treatment%2520of%2520diarrhea-predominant%2520IBS%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2014%26volume%3D26%26spage%3D1539%26epage%3D1550%26doi%3D10.1111%2Fnmo.12390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Sobczak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokrowiecka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cygankiewicz, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakrzewski, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kordek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malecka-Panas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewska, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fichna, J.</span><span> </span><span class="NLM_article-title">Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1124/jpet.113.209825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.113.209825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24345466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFajt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2014&pages=401-409&author=M.+Sobczakauthor=A.+Mokrowieckaauthor=A.+I.+Cygankiewiczauthor=P.+K.+Zakrzewskiauthor=M.+Salagaauthor=M.+Storrauthor=R.+Kordekauthor=E.+Malecka-Panasauthor=W.+M.+Krajewskaauthor=J.+Fichna&title=Anti-inflammatory+and+antinociceptive+action+of+an+orally+available+nociceptin+receptor+agonist+SCH+221510+in+a+mouse+model+of+inflammatory+bowel+diseases&doi=10.1124%2Fjpet.113.209825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases</span></div><div class="casAuthors">Sobczak, Marta; Mokrowiecka, Anna; Cygankiewicz, Adam I.; Zakrzewski, Piotr K.; Salaga, Maciej; Storr, Martin; Kordek, Radzislaw; Malecka-Panas, Ewa; Krajewska, Wanda M.; Fichna, Jakub</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">401-409, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The nociceptin receptors (NOPs) are expressed in the gastrointestinal (GI) tract on muscle cell membranes and neurons, as well as the immune cells that infiltrate the mucosa.  The involvement of NOPs in the pathophysiol. of GI inflammation has been suggested, but due to the lack of selective NOP agonists, it never fully elucidated.  Our aim was to characterize the anti-inflammatory and antinociceptive effect of the NOP agonist, SCH 221510 [3-endo-8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo [3.2.1]octan-3-ol], as a potential therapeutic strategy in the treatment of inflammatory bowel diseases (IBD).  The anti-inflammatory action of SCH 221510 was detd. after i.p., oral, and intracolonic administration of SCH 221510 (0.1-3.0 mg/kg once or twice daily) in mice treated with 2,4,6-trinitrobenzenesulfonic acid (TNBS).  Antinociceptive action of SCH 221510 was evaluated in the mouse model of mustard oil (MO)-induced abdominal pain.  Relative NOP mRNA expression was assessed in patients with IBD using real-time reverse transcriptase-polymerase chain reaction.  We found that the expression of NOP mRNA was significantly decreased in patients with IBD.  The administration (0.1 and 1.0 mg/kg i.p. twice daily and 3 mg/kg p.o. twice daily) of SCH 221510 attenuated TNBS colitis in mice.  This effect was blocked by a selective NOP antagonist [J-113397 [(±)-1-[(3R*,4R*)-1-(cyclooctylmethyl)-3-(hydroxymethyl)-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one]].  The intracolonic injections of SCH 221510 did not improve colitis in mice.  The antinociceptive effect of SCH 221510 was obsd. after oral administration of SCH 221510 in MO-induced pain tests in mice with acute colitis.  In conclusion, our results show a potent anti-inflammatory and antinociceptive effect upon selective activation of NOP receptors and suggest that the NOP agonist SCH 221510 is a promising drug candidate for future treatment of IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBm0-RxSsif7Vg90H21EOLACvtfcHk0lglRJJ17ffwtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFajt78%253D&md5=7e19d27d66bee05478f88fcc538618b3</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.209825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.209825%26sid%3Dliteratum%253Aachs%26aulast%3DSobczak%26aufirst%3DM.%26aulast%3DMokrowiecka%26aufirst%3DA.%26aulast%3DCygankiewicz%26aufirst%3DA.%2BI.%26aulast%3DZakrzewski%26aufirst%3DP.%2BK.%26aulast%3DSalaga%26aufirst%3DM.%26aulast%3DStorr%26aufirst%3DM.%26aulast%3DKordek%26aufirst%3DR.%26aulast%3DMalecka-Panas%26aufirst%3DE.%26aulast%3DKrajewska%26aufirst%3DW.%2BM.%26aulast%3DFichna%26aufirst%3DJ.%26atitle%3DAnti-inflammatory%2520and%2520antinociceptive%2520action%2520of%2520an%2520orally%2520available%2520nociceptin%2520receptor%2520agonist%2520SCH%2520221510%2520in%2520a%2520mouse%2520model%2520of%2520inflammatory%2520bowel%2520diseases%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D348%26spage%3D401%26epage%3D409%26doi%3D10.1124%2Fjpet.113.209825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Agostini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, C.</span><span> </span><span class="NLM_article-title">The endogenous nociceptin/orphanin FQ-NOP receptor system as a potential therapeutic target for intestinal disorders</span> <span class="citation_source-journal">Neurogastroenterol. Motil.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1519</span><span class="NLM_x">–</span> <span class="NLM_lpage">1526</span><span class="refDoi"> DOI: 10.1111/nmo.12460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fnmo.12460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25307525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BC2M7pvVGluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2014&pages=1519-1526&author=S.+Agostiniauthor=C.+Petrella&title=The+endogenous+nociceptin%2Forphanin+FQ-NOP+receptor+system+as+a+potential+therapeutic+target+for+intestinal+disorders&doi=10.1111%2Fnmo.12460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">The endogenous nociceptin/orphanin FQ-NOP receptor system as a potential therapeutic target for intestinal disorders</span></div><div class="casAuthors">Agostini S; Petrella C</div><div class="citationInfo"><span class="NLM_cas:title">Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1519-26</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In 1995, by reverse pharmacology approach, used here for the first time in the history of pharmacology, nociceptin/orphanin FQ (N/OFQ) has been discovered as the endogenous ligand of a preidentified receptor named opioid receptor like 1.  Subsequent studies showed that N/OFQ and its receptor (N/OFQergic system) are widely distributed in central and peripheral nervous systems as well as in peripheral organs of human and animals, and represent a system that is involved in a very large range of biological functions such as pain perception, intestinal motility and secretion, immune modulation, stress.  From the time of its discovery to now, a high number of NOP agonists and antagonists have been synthesized and tested in various pathologies.  Nevertheless, none of the molecules targeting N/OFQergic system have currently succeeded in going through clinical trials concerning gut pathologies, indicating that further studies are required.  The work from Dr.  Fichna et al., published in the present issue of Neurogastroenterology and Motility, adds another brick in the wall of understanding the role of N/OFQergic system in IBS-D pathology by the pharmacological evaluation of a new NOP receptor agonist, SCH 221510, in animal models of intestinal alterations (diarrhea and visceral hyperalgesia).  Interestingly, authors report clinical data confirming the involvement of N/OFQergic system in IBS-D patients and, consequently, suggest this system as a valuable therapeutic target for IBS-D pathology.  This minireview aims to give a brief summary of experimental and clinical studies focusing on the N/OFQergic system as pharmacological target for the therapeutic treatment of intestinal pathologies such as IBS and IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-VaHzP8O5fr0AGQpJZWpJfW6udTcc2eaRgbDSZ71YLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7pvVGluw%253D%253D&md5=bca183007a694ce0cc7c01a8cbd0defd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1111%2Fnmo.12460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnmo.12460%26sid%3Dliteratum%253Aachs%26aulast%3DAgostini%26aufirst%3DS.%26aulast%3DPetrella%26aufirst%3DC.%26atitle%3DThe%2520endogenous%2520nociceptin%252Forphanin%2520FQ-NOP%2520receptor%2520system%2520as%2520a%2520potential%2520therapeutic%2520target%2520for%2520intestinal%2520disorders%26jtitle%3DNeurogastroenterol.%2520Motil.%26date%3D2014%26volume%3D26%26spage%3D1519%26epage%3D1526%26doi%3D10.1111%2Fnmo.12460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veals, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainhaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Heek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[bis(2-chlorophenyl)methyl]-3-(2-pyrimidinyl)-8-azabicyclo[3.2.1]octan-3-ol) in preclinical models</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">630</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2009.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20006596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1ymt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=630&publication_year=2010&pages=112-120&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=D.+C.+Bolserauthor=G.+B.+Vartyauthor=M.+Baptistaauthor=X.+Fernandezauthor=L.+E.+Parraauthor=J.+C.+Zimmerauthor=C.+H.+Ericksonauthor=G.+D.+Hoauthor=Y.+Jiaauthor=F.+W.+Ngauthor=W.+Korfmacherauthor=X.+Xuauthor=J.+Vealsauthor=A.+Smith-Torhanauthor=S.+Wainhausauthor=A.+B.+Fawziauthor=T.+M.+Austinauthor=M.+van+Heekauthor=J.+A.+Hey&title=Pharmacological+profile+of+the+NOP+agonist+and+cough+suppressing+agent+SCH+486757+%288-%5Bbis%282-chlorophenyl%29methyl%5D-3-%282-pyrimidinyl%29-8-azabicyclo%5B3.2.1%5Doctan-3-ol%29+in+preclinical+models&doi=10.1016%2Fj.ejphar.2009.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models</span></div><div class="casAuthors">McLeod, Robbie L.; Tulshian, Deen B.; Bolser, Donald C.; Varty, Geoffrey B.; Baptista, Marco; Fernandez, Xiomara; Parra, Leonard E.; Zimmer, Jennifer C.; Erickson, Christine H.; Ho, Ginny D.; Jia, Yanlin; Ng, Fay W.; Korfmacher, Walter; Xu, Xiaoying; Veals, John; Smith-Torhan, April; Wainhaus, Samuel; Fawzi, Ahmad B.; Austin, Theodore M.; van Heek, Margaret; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">630</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">112-120</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe the pharmacol. and pharmacokinetic profiles of SCH 486757, a nociceptin/orphanin FQ peptide (NOP) receptor agonist that has recently entered human clin. trials for cough.  SCH 486757 selectively binds human NOP receptor (K i = 4.6 ± 0.61 nM) over classical opioid receptors.  In a guinea pig capsaicin cough model, SCH 486757 (0.01-1 mg/kg) suppressed cough at 2, 4, and 6 h post oral administration with a max. efficacy occurring at 4 h equiv. to codeine, hydrocodone, dextromethorphan and baclofen.  The antitussive effects of SCH 486757 (3.0 mg/kg, p.o.) was blocked by the NOP receptor antagonist J113397 (12 mg/kg, i.p.) but not by naltrexone (10 mg/kg, p.o.).  SCH 486757 does not produce tolerance to its antitussive activity after a 5-day BID dosing regimen.  After acute and chronic dosing paradigms, SCH 486757 (1 mg/kg) inhibited capsaicin-evoked coughing by 46 ± 9% and 40 ± 11%, resp.  In a feline mech.-evoked cough model, SCH 486757 produces a max. inhibition of cough and expiratory abdominal electromyogram amplitude of 59 and 61%, resp.  SCH 486757 did not significantly affect inspiratory electromyogram amplitude.  We examd. the abuse potential of SCH 486757 (10 mg/kg, p.o.) in a rat conditioned place preference procedure which is sensitive to classical drugs of abuse, such as amphetamine and morphine.  SCH 486757 was without effect in this model.  Finally, SCH 486757 displays a good oral pharmacokinetic profile in the guinea pig, rat and dog.  We conclude that SCH 486757 has a favorable antitussive profile in preclin. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyYZy_0Vw2_LVg90H21EOLACvtfcHk0li-lWxRxWfI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1ymt7c%253D&md5=04a736ea082b03a3e7ff9a4eb687d6fc</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DBaptista%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DZimmer%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DF.%2BW.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DVeals%26aufirst%3DJ.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DWainhaus%26aufirst%3DS.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DAustin%26aufirst%3DT.%2BM.%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520profile%2520of%2520the%2520NOP%2520agonist%2520and%2520cough%2520suppressing%2520agent%2520SCH%2520486757%2520%25288-%255Bbis%25282-chlorophenyl%2529methyl%255D-3-%25282-pyrimidinyl%2529-8-azabicyclo%255B3.2.1%255Doctan-3-ol%2529%2520in%2520preclinical%2520models%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D630%26spage%3D112%26epage%3D120%26doi%3D10.1016%2Fj.ejphar.2009.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayappa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1159/000235601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1159%2F000235601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19696521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2009&pages=153-161&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=G.+D.+Hoauthor=X.+Fernandezauthor=D.+C.+Bolserauthor=L.+E.+Parraauthor=J.+C.+Zimmerauthor=C.+H.+Ericksonauthor=A.+B.+Fawziauthor=H.+Jayappaauthor=C.+Lehrauthor=J.+Erskineauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Effect+of+a+novel+NOP+receptor+agonist+%28SCH+225288%29+on+guinea+pig+irritant-evoked%2C+feline+mechanically+induced+and+canine+infectious+tracheobronchitis+cough&doi=10.1159%2F000235601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a Novel NOP Receptor Agonist (SCH 225288) on Guinea Pig Irritant-Evoked, Feline Mechanically Induced and Canine Infectious Tracheobronchitis Cough</span></div><div class="casAuthors">McLeod, Robbie L.; Tulshian, Deen B.; Ho, Ginny D.; Fernandez, Xiomara; Bolser, Donald C.; Parra, Leonard E.; Zimmer, Jennifer C.; Erickson, Christine H.; Fawzi, Ahmad B.; Jayappa, Huchappa; Lehr, Craig; Erskine, Jason; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Previous studies have demonstrated that nociceptin/orphanin FQ (N/OFQ), the endogenous peptide ligand for the G-protein-coupled NOP receptor, inhibits cough in exptl. models.  SCH 225288 is a nonpeptide, orally active NOP agonist that may provide the foundation for the development of novel treatments for cough.  Methods: First we characterized the selectivity of SCH 225288 in human receptor binding assays.  Afterwards, the antitussive activity of SCH 225288 was studied in three mechanistically distinct cough models.  Specifically, we obsd. the cough-suppressant effect of SCH 225288 in a guinea pig capsaicin irritant-evoked cough model, a feline mech. induced cough model and finally in a canine Bordetella bronchiseptica disease model.  Results: SCH 225288 selectively binds human NOP receptor (Ki = 0.38 ± 0.02 nmol/l) over classical opioid receptors (COR).  In a guinea pig capsaicin cough model, SCH 225288 (0.1-1 mg/kg) suppressed cough at 2, 4, and 6 h after oral administration.  The antitussive effect of SCH 225288 (3.0 mg/kg, p.o.) was blocked by the NOP antagonist J113397 (12 mg/kg, i.p.) but not by the classical opioid receptor (COR) antagonist, naltrexone (3.0 mg/kg, i.p.).  In the anesthetized cat, we evaluated the effects of SCH 225288 given either i.v. or via the intravertebral artery against the increases in cough no. and respiratory expiratory and inspiratory muscle (rectus abdominis and parasternal) electromyog. (EMG) activities due to perturbations of the intrathoracic trachea.  SCH 225288 (0.03-3.0 mg/kg, i.v.) inhibited both cough no. and abdominal EMG amplitudes.  Similarly, SCH 225288 (0.001-0.3 mg/kg) administered intra-arterially also diminished cough no. and abdominal EMG amplitudes.  No significant effect of the drug was noted on parasternal EMG activity.  Finally, we studied the antitussive actions of SCH 225288 (1.0 mg/kg) in a canine B. bronchiseptica disease model.  In this model, dogs were challenged intranasally with B. bronchiseptica.  Comparisons were made between a vehicle group, an SCH 225288 (1.0 mg/kg, p.o., q.d.) and a butorphanol (0.6 mg/kg, p.o., b.i.d.) group on the mean change in cough scores from baseline values and days 6-9 after B. bronchiseptica challenge.  SCH 225288 (1.0 mg/kg, p.o., q.d.) displayed a pos. antitussive tendency (p = 0.06) to inhibit B. bronchiseptica cough whereas butorphanol (0.6 mg/kg, p.o., b.i.d.) was devoid of antitussive activity.  Conclusions: Taken together, the present data show that SCH 225288 is a potent and effective antitussive agent in animal models of cough.  Furthermore, these findings indicate that NOP agonists represent a promising new therapeutic approach for the treatment of cough without the side effect liabilities assocd. with opioid antitussives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodplJfyEx3gLVg90H21EOLACvtfcHk0lg-OJOkQ7j3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE&md5=4c78dd41fcc5ff00100526d8da04d2ef</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1159%2F000235601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000235601%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DZimmer%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DJayappa%26aufirst%3DH.%26aulast%3DLehr%26aufirst%3DC.%26aulast%3DErskine%26aufirst%3DJ.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DEffect%2520of%2520a%2520novel%2520NOP%2520receptor%2520agonist%2520%2528SCH%2520225288%2529%2520on%2520guinea%2520pig%2520irritant-evoked%252C%2520feline%2520mechanically%2520induced%2520and%2520canine%2520infectious%2520tracheobronchitis%2520cough%26jtitle%3DPharmacology%26date%3D2009%26volume%3D84%26spage%3D153%26epage%3D161%26doi%3D10.1159%2F000235601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuss, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0703954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0703954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11250866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1175-1178&author=R.+L.+McLeodauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=C.+H.+Ericksonauthor=G.+J.+Careyauthor=D.+B.+Tulshianauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=R.+W.+Eganauthor=F.+M.+Cussauthor=J.+A.+Hey&title=Nociceptin+inhibits+cough+in+the+guinea-pig+by+activation+of+ORL%281%29+receptors&doi=10.1038%2Fsj.bjp.0703954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin inhibits cough in the guinea-pig by activation of ORL1 receptors</span></div><div class="casAuthors">McLeod, Robbie L.; Parra, Leonard E.; Mutter, Jennifer C.; Erickson, Christine H.; Carey, Galen J.; Tulshian, Deen B.; Fawzi, Ahmad B.; Smith-Torhan, April; Egan, Robert W.; Cuss, Francis M.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1175-1178</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We studied the central and peripheral antitussive effect of ORL1 receptor activation with nociceptin/orphanin FQ in conscious guinea pigs.  In guinea pig cough studies, nociceptin/orphanin FQ (10, 30, and 90 μg) given directly into the CNS by an intracerebroventricular (i.c.v.) route inhibited cough elicited by capsaicin exposure by approx. 23, 29 and 52%, resp.  The antitussive activity of nociceptin/orphanin FQ (90 μg, i.c.v.) was blocked by the selective ORL1 antagonist [Phe1γ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 (180 μg, i.c.v.) and J 113397 (10 mg kg-1, i.p.) but not by the opioid antagonist, naltrexone (3 mg kg-1, i.p.).  Furthermore, i.v. nociceptin/orphanin FQ (1.0 and 3.0 mg kg-1) also inhibited cough approx. by 25 and 42%, resp.  These findings indicate that selective ORL1 agonists display the potential to inhibit cough by both a central and peripheral mechanism, and potentially represent a novel therapeutic approach for the treatment of cough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH9gaplu1T_LVg90H21EOLACvtfcHk0lg-OJOkQ7j3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D&md5=48746f19039e43c21957cbaed2383962</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703954%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DCarey%26aufirst%3DG.%2BJ.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DCuss%26aufirst%3DF.%2BM.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DNociceptin%2520inhibits%2520cough%2520in%2520the%2520guinea-pig%2520by%2520activation%2520of%2520ORL%25281%2529%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D1175%26epage%3D1178%26doi%3D10.1038%2Fsj.bjp.0703954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Antitussive action of nociceptin in the cat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/S0014-2999(01)01244-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2801%2901244-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11698070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2001&pages=107-111&author=D.+C.+Bolserauthor=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=J.+A.+Hey&title=Antitussive+action+of+nociceptin+in+the+cat&doi=10.1016%2FS0014-2999%2801%2901244-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive action of nociceptin in the cat</span></div><div class="casAuthors">Bolser, Donald C.; McLeod, Robbie L.; Tulshian, Deen B.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-111</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Expts. were conducted to det. the influence of the specific ORL1 receptor agonist, nociceptin, on the cough reflex in the cat.  Cats were anesthetized and allowed to breathe spontaneously.  Cough was elicited by mech. stimulation of the intrathoracic airway.  I.v. administration of nociceptin (0.001-3.0 mg kg-1) inhibited cough no. and the magnitude of abdominal muscle electromyogram (EMG) discharge during cough in a dose-dependent manner.  Nociceptin had no effect on the magnitude of the inspiratory muscle EMG during cough.  These effects of nociceptin were antagonized by pretreatment with the ORL1 receptor antagonist, 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397, 0.1 mg kg-1, i.v.).  We conclude that i.v. nociceptin inhibits cough in the cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZOPz-HZOatLVg90H21EOLACvtfcHk0lh7wL99MfB_sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWhsr4%253D&md5=c3ec258f55a3c7baa8663d4463ed0a08</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901244-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901244-4%26sid%3Dliteratum%253Aachs%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520action%2520of%2520nociceptin%2520in%2520the%2520cat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D430%26spage%3D107%26epage%3D111%26doi%3D10.1016%2FS0014-2999%2801%2901244-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolser, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Antitussive effect of nociceptin/orphanin FQ in experimental cough models</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1006/pupt.2002.0357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1006%2Fpupt.2002.0357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12099766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=213-216&author=R.+L.+McLeodauthor=D.+C.+Bolserauthor=Y.+Jiaauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=X.+Wangauthor=D.+B.+Tulshianauthor=R.+W.+Eganauthor=J.+A.+Hey&title=Antitussive+effect+of+nociceptin%2Forphanin+FQ+in+experimental+cough+models&doi=10.1006%2Fpupt.2002.0357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive Effect of Nociceptin/Orphanin FQ in Experimental Cough Models</span></div><div class="casAuthors">McLeod, Robbie L.; Bolser, Donald C.; Jia, Yanlin; Parra, Leonard E.; Mutter, Jennifer C.; Wang, Xin; Tulshian, Deen B.; Egan, Robert W.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-216</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cough is an important defensive pulmonary reflex that removes irritants, fluids or foreign materials from the airways.  However, often cough is non-productive and requires suppression.  Opioid μ receptor agonists, such as codeine are commonly used as antitussive agents and are among the most widely administered drugs in the world.  Codeine suppresses the responsiveness of one or more components of the central reflex pathway for cough and is an efficacious antitussive drug for cough due to diverse etiologies.  However, opioids produce side effects that include sedation, addiction potential and constipation.  Therefore, novel cough suppressant therapies should maintain or improve upon the antitussive efficacy profile of opioids.  Moreover, these novel therapies should have a safety profile significantly better than current antitussive therapies.  Presently, we discuss preclin. findings showing that activation of the 'opioid-like' receptor (NOP1) inhibits cough in the guinea pig and cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK5SQIUqfLVLVg90H21EOLACvtfcHk0lh7wL99MfB_sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D&md5=88453aa1b1f2ed62697ffe6c96781954</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1006%2Fpupt.2002.0357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fpupt.2002.0357%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520effect%2520of%2520nociceptin%252Forphanin%2520FQ%2520in%2520experimental%2520cough%2520models%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2002%26volume%3D15%26spage%3D213%26epage%3D216%26doi%3D10.1006%2Fpupt.2002.0357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">McLeod, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselgof, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawzi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Torhan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hey, J. A.</span><span> </span><span class="NLM_article-title">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.1159/000077448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1159%2F000077448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15161996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2004&pages=143-149&author=R.+L.+McLeodauthor=Y.+Jiaauthor=X.+Fernandezauthor=L.+E.+Parraauthor=X.+Wangauthor=D.+B.+Tulshianauthor=E.+J.+Kiselgofauthor=Z.+Tanauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Antitussive+profile+of+the+NOP+agonist+Ro-64-6198+in+the+guinea+pig&doi=10.1159%2F000077448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span></div><div class="casAuthors">McLeod, Robbie L.; Jia, Yanlin; Fernandez, Xiomara; Parra, Leonard E.; Wang, Xin; Tulshian, Deen B.; Kiselgof, Eugenia J.; Tan, Zheng; Fawzi, Ahmad B.; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">We have previously shown that N/OFQ, the endogenous peptide ligand for the "opioid-like" NOP receptor, inhibits cough in guinea pigs and cats.  In the present study we sought to continue our characterization of the cough-suppressant effects of NOP stimulation by profiling the pulmonary and antitussive effects of a novel non-peptide NOP agonist, Ro-64-6198, in guinea pigs.  In receptor-binding assays, we confirmed that Ro-64-6198 selectively binds to NOP receptors over other opioid receptors.  The Ki values for Ro-64-6198 at NOP, MOP, KOP and DOP receptors was 0.3, 36, 214 and 3,787 nmol/l, resp.  In GTPγS-binding assays, Ro-64-6198 displayed >900-fold functional selectivity at NOP relative to MOP receptors.  We evaluated the effects of Ro-64-6198 (3 and 10 μmol/l) in isolated guinea pig nodose ganglia cells on the increases in intracellular Ca2+ concn. evoked by capsaicin stimulation (1×10-8-1×10-6 mol/l).  Similar to previously reported data with N/OFQ, Ro-64-6198 (3 and 10 μmol/l) significantly attenuated Ca2+ responses in nodose ganglia cells produced by exposure to capsaicin.  The effect of Ro-64-6198 (3 μmol/l) on capsaicin-induced intracellular Ca2+ responses was blocked by the NOP antagonist, J113397 (3 μmol/l).  In guinea pig in vivo studies, aerosolized capsaicin (10-300 μmol/l) produced a dose-dependent increase in cough no.  Ro-64-6198 given i.p. significantly inhibited cough due to capsaicin (300 μmol/l) exposure.  In a duration study we found that the max. antitussive effect (42±8% inhibition) of Ro-64-6198 (3 mg/kg) was obsd. at 1 h after i.p. administration.  Also at 1 h after administration, Ro-64-6198 (0.003-3.0 mg/kg, i.p.) produced a dose-dependent inhibition of cough.  The antitussive effect of Ro-64-6198 (3 mg/kg, i.p.) was blocked by J113397 (12 mg/kg, i.p.) but not by the classical opioid antagonist naltrexone (10 mg/kg, i.p.).  Although the antitussive action of Ro-64-6198 may be mediated by a central and/or a peripheral site of action, we hypothesize that selective oral NOP agonists that do not penetrate the blood-brain barrier may provide a novel approach for the treatment of cough.  Moreover, because these drugs do not interact at MOP receptors, they may be devoid of codeine-like side effects such as respiratory depression, sedation, constipation or proclivities for addictive liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjdJxKiezFwbVg90H21EOLACvtfcHk0lh7wL99MfB_sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D&md5=303c3df4646580491f2bde89650c5bfa</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1159%2F000077448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000077448%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DKiselgof%26aufirst%3DE.%2BJ.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520profile%2520of%2520the%2520NOP%2520agonist%2520Ro-64-6198%2520in%2520the%2520guinea%2520pig%26jtitle%3DPharmacology%26date%3D2004%26volume%3D71%26spage%3D143%26epage%3D149%26doi%3D10.1159%2F000077448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Lee, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undem, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. J.</span><span> </span><span class="NLM_article-title">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1164/rccm.200507-1043OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1164%2Frccm.200507-1043OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16239621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=271-275&author=M.+G.+Leeauthor=B.+J.+Undemauthor=C.+Brownauthor=M.+J.+Carr&title=Effect+of+nociceptin+in+acid-evoked+cough+and+airway+sensory+nerve+activation+in+guinea+pigs&doi=10.1164%2Frccm.200507-1043OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span></div><div class="casAuthors">Lee, Min-Goo; Undem, Bradley J.; Brown, Claire; Carr, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-275</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Nociceptin/orphanin FQ has been reported to inhibit capsaicin- and mech. provoked cough in animal models, but the mechanism of this effect has not been elucidated.  Objectives: The objectives of this study were to det. whether nociceptin inhibits acid-evoked cough in conscious animals and to evaluate the mechanism of this effect.  Methods: We tested the effect of nociceptin on acid-induced cough in conscious guinea pigs and acid-induced nerve activation in airway-specific vagal sensory neurons using calcium imaging techniques and the gramicidin-perforated patch clamp technique.  Measurements and Main Results: Nociceptin (3 mg/kg, i.p.) effectively inhibited acid-evoked cough in guinea pigs by nearly 70%.  Acid (pH 5) increased intracellular free calcium in acutely dissocd. vagal jugular ganglionic neurons.  The acid-induced increase in intracellular calcium was inhibited by a selective transient receptor potential vanilloid-1 antagonist, 5-iodo-resiniferatoxin (1 μM, ∼80% redn.).  The inhibitory effect of 5-iodo-resiniferatoxin on acid-induced increases in calcium was mimicked by nociceptin (0.1 μM).  In gramicidin-perforated patch clamp recordings on airway-specific capsaicin-sensitive jugular ganglion neurons, acid (pH 5) induced two distinct inward currents.  A transient current was evoked that was inhibited by amiloride and a sustained current was evoked that was inhibited by 5-iodo-resiniferatoxin.  Nociceptin selectively inhibited only the sustained component of acid-induced inward current.  Conclusion: These results indicate that the inhibitory effect of nociceptin on acid-induced cough may result from a direct inhibitory effect on peripheral C-fiber activity caused by the selective inhibition of acid-induced transient receptor potential vanilloid-1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7nu8PLku7c7Vg90H21EOLACvtfcHk0lg3dpPlaDms1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D&md5=915d140a2cc8650708e1fe6291863482</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1164%2Frccm.200507-1043OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200507-1043OC%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DUndem%26aufirst%3DB.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DCarr%26aufirst%3DM.%2BJ.%26atitle%3DEffect%2520of%2520nociceptin%2520in%2520acid-evoked%2520cough%2520and%2520airway%2520sensory%2520nerve%2520activation%2520in%2520guinea%2520pigs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D271%26epage%3D275%26doi%3D10.1164%2Frccm.200507-1043OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">de Guglielmo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Fardon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span> </span><span class="NLM_article-title">MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span><span class="refDoi"> DOI: 10.1111/adb.12157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fadb.12157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24930632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFahu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=643-651&author=G.+de+Guglielmoauthor=R.+Martin-Fardonauthor=K.+Teshimaauthor=R.+Ciccocioppoauthor=F.+Weiss&title=MT-7716%2C+a+potent+NOP+receptor+agonist%2C+preferentially+reduces+ethanol+seeking+and+reinforcement+in+post-dependent+rats&doi=10.1111%2Fadb.12157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats</span></div><div class="casAuthors">de Guglielmo, Giordano; Martin-Fardon, Remi; Teshima, Koji; Ciccocioppo, Roberto; Weiss, Friedbert</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">643-651</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Dysregulation of the nociceptin (N/OFQ) system has been implicated in alc. abuse and alcoholism, and growing evidence suggests that targeting this system may be beneficial for treating alcoholism.  To further explore the treatment target potential of the N/OFQ system, the novel non-peptide, small-mol. N/OFQ (NOP) agonist MT-7716, (R)-2-{3-[1-(Acenaphthen-1-yl)piperidin-4-yl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-N-methylacetamide hydrochloride hydrate, was examd. for its effects on ethanol self-administration and stress-induced reinstatement of alc. seeking in non-dependent and post-dependent rats.  Male Wistar rats were trained to self-administer ethanol and then made ethanol dependent via repeated intragastric ethanol intubation.  The effects of MT-7716 (0.3 and 1 mg/kg; PO) on alc. self-administration were detd. 2 wk following dependence induction, when baseline self-administration was restored.  Effects of MT-7716 on stress-induced reinstatement were tested in sep. cohorts of rats, 1 and 3 wk post-withdrawal.  MT-7716 reduced alc. self-administration and stress-induced reinstatement of alc. seeking in post-dependent rats, but was ineffective in non-dependent animals.  Moreover, the prevention of stress-induced reinstatement by MT-7716 was more pronounced at 3 wk post-dependence.  The results further confirm treatment target potential for the NOP receptor and identify non-peptide NOP agonists as promising potential treatment drugs for alc. abuse and relapse prevention.  The findings also support dysregulation of the N/OFQ system as a factor in alc. seeking and reinforcement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIN08ElzbvDbVg90H21EOLACvtfcHk0lg3dpPlaDms1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFahu70%253D&md5=9499774fae9de0e6535d7796c2934335</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1111%2Fadb.12157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12157%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGuglielmo%26aufirst%3DG.%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DTeshima%26aufirst%3DK.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DF.%26atitle%3DMT-7716%252C%2520a%2520potent%2520NOP%2520receptor%2520agonist%252C%2520preferentially%2520reduces%2520ethanol%2520seeking%2520and%2520reinforcement%2520in%2520post-dependent%2520rats%26jtitle%3DAddict.%2520Biol.%26date%3D2015%26volume%3D20%26spage%3D643%26epage%3D651%26doi%3D10.1111%2Fadb.12157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Teshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashimori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span> </span><span class="NLM_article-title">Nonphotic entrainment of the circadian body temperature rhythm by the selective ORL1 receptor agonist W-212393 in rats</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0706311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0706311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15980870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslaltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=33-40&author=K.+Teshimaauthor=M.+Minoguchiauthor=S.+Tounaiauthor=A.+Ashimoriauthor=J.+Eguchiauthor=C.+N.+Allenauthor=S.+Shibata&title=Nonphotic+entrainment+of+the+circadian+body+temperature+rhythm+by+the+selective+ORL1+receptor+agonist+W-212393+in+rats&doi=10.1038%2Fsj.bjp.0706311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Nonphotic entrainment of the circadian body temperature rhythm by the selective ORL1 receptor agonist W-212393 in rats</span></div><div class="casAuthors">Teshima, Koji; Minoguchi, Masanori; Tounai, Sayuri; Ashimori, Atsuyuki; Eguchi, Junichi; Allen, Charles N.; Shibata, Shigenobu</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We synthesized a small-mol. opioid receptor-like 1 (ORL1) receptor agonist, 2-{3-[1-((1R)-acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide (W-212393), and investigated its effect on the circadian body temp. rhythm of rats.  W-212393 has high affinity for ORL1 receptors in the rat cerebral cortex and human ORL1 receptors expressed in HEK293 cells with Ki values of 0.76 and 0.50 nM, resp.  W-212393 concn.-dependently stimulated GTPγ35S binding and its efficacy was similar to nociceptin/orphanin FQ (N/OFQ), suggesting that W-212393 is a full agonist at ORL1 receptors.  W-212393 dose-dependently occupied ORL1 receptors following intraventricular or i.p. administration, suggesting that W-212393 is a brain-penetrating compd.  W-212393 (100 nM) and N/OFQ (100 nM) significantly suppressed the activity of spontaneously firing rat suprachiasmatic nucleus neurons.  These suppressive effects were blocked by an ORL1 receptor antagonist, J-113397 (1 μM).  W-212393 (3 mg kg-1, i.p.) induced a significant phase advance at circadian time 6 (CT6) and CT9, but not at other CTs.  The magnitude of the W-212393 (0.3-3 mg kg-1, i.p.)-induced phase advance was dose-dependent and greater than those produced by 8-hydroxy-2-(di-n-propylamino)tetralin (0.3-3 mg kg-1, i.p.) or melatonin (0.3-3 mg kg-1, i.p.).  The W-212393 (3 mg kg-1, i.p.)-induced phase advance was antagonized by J-113397 (10 mg kg-1, i.p.).  W-212393 (3 mg kg-1, i.p.) significantly accelerated the re-entrainment of the body temp. rhythm to a 6 h advanced light-dark cycle.  These results indicate that activation of ORL1 receptors contributes to the circadian entrainment and W-212393 may represent an interesting agent for the study of circadian rhythms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONSr62_au4rVg90H21EOLACvtfcHk0lg3dpPlaDms1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslaltbk%253D&md5=dffa9f3cb188d94ed8c8451e8586482f</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706311%26sid%3Dliteratum%253Aachs%26aulast%3DTeshima%26aufirst%3DK.%26aulast%3DMinoguchi%26aufirst%3DM.%26aulast%3DTounai%26aufirst%3DS.%26aulast%3DAshimori%26aufirst%3DA.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DC.%2BN.%26aulast%3DShibata%26aufirst%3DS.%26atitle%3DNonphotic%2520entrainment%2520of%2520the%2520circadian%2520body%2520temperature%2520rhythm%2520by%2520the%2520selective%2520ORL1%2520receptor%2520agonist%2520W-212393%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D146%26spage%3D33%26epage%3D40%26doi%3D10.1038%2Fsj.bjp.0706311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschamps, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2973</span><span class="NLM_x">–</span> <span class="NLM_lpage">2976</span><span class="refDoi"> DOI: 10.1021/jm034249d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034249d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Sjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2973-2976&author=N.+T.+Zaveriauthor=F.+Jiangauthor=C.+M.+Olsenauthor=J.+R.+Deschampsauthor=D.+Parrishauthor=W.+Polgarauthor=L.+Toll&title=A+novel+series+of+piperidin-4-yl-1%2C3-dihydroindol-2-ones+as+agonist+and+antagonist+ligands+at+the+nociceptin+receptor&doi=10.1021%2Fjm034249d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor</span></div><div class="casAuthors">Zaveri, Nurulain T.; Jiang, Faming; Olsen, Cris M.; Deschamps, Jeffrey R.; Parrish, Damon; Polgar, Willma; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2973-2976</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N-(4-piperidinyl)-2-indolinones were discovered as a new structural class of nociceptin receptor (NOP) ligands.  Unlike other previously reported classes of NOP receptor ligands, modifications of the piperidine N substituents afforded both potent agonists and antagonists, with modest selectivities over other opioid receptors.  The SAR revealed in this new series will provide important insights for the development of pharmacophores for agonist and antagonist actions at the NOP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouCteePy22mbVg90H21EOLACvtfcHk0li4oHvQ6d4IGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Sjs7s%253D&md5=f7988bb47141c9055b43c47eadf06bba</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm034249d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034249d%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%2BM.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DParrish%26aufirst%3DD.%26aulast%3DPolgar%26aufirst%3DW.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DA%2520novel%2520series%2520of%2520piperidin-4-yl-1%252C3-dihydroindol-2-ones%2520as%2520agonist%2520and%2520antagonist%2520ligands%2520at%2520the%2520nociceptin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2973%26epage%3D2976%26doi%3D10.1021%2Fjm034249d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Zaveri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): ligand-based analysis of structural factors influencing intrinsic activity at NOP</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">E345</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span><span class="refDoi"> DOI: 10.1208/aapsj070234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1208%2Faapsj070234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16353914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ylt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=E345-352&author=N.+Zaveriauthor=F.+Jiangauthor=C.+Olsenauthor=W.+Polgarauthor=L.+Toll&title=Small-molecule+agonists+and+antagonists+of+the+opioid+receptor-like+receptor+%28ORL1%2C+NOP%29%3A+ligand-based+analysis+of+structural+factors+influencing+intrinsic+activity+at+NOP&doi=10.1208%2Faapsj070234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP</span></div><div class="casAuthors">Zaveri, Nurulain; Jiang, Faming; Olsen, Cris; Polgar, Willma; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">E345-E352</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">American Association of Pharmaceutical Scientists</span>)
        </div><div class="casAbstract">A review.  The recently discovered fourth member of the opioid receptor family, the nociceptin receptor (NOP) and its endogenous ligand, the heptadecapeptide nociceptin, are involved in several central nervous system pathways, such as nociception, reward, tolerance, and feeding.  The discovery of small-mol. ligands for NOP is being actively pursued for several therapeutic applications.  This review presents a brief overview of the several recently reported NOP ligands, classified as NOP agonists and antagonists, with an emphasis on the anal. of the structural features that may be important for modulating the agonist/antagonist profile (intrinsic activity) of these ligands.  Structure-activity relationships in our own series of dihydroindolinone-based NOP ligands and those of the various reported ligands indicate that the lipophilic substituent on the common basic nitrogen present in all NOP ligands plays a role in detg. the agonist/antagonist profile of the NOP ligand.  This anal. provides a basis for the rational drug design of NOP ligands of desired intrinsic activity and provides a framework for developing pharmacophore models for high affinity binding and intrinsic activity at the NOP receptor.  Since NOP agonists and antagonists both have therapeutic value, rational approaches for obtaining both within a high-affinity binding class of compds. are very useful for designing potent and selective NOP ligands with the desired profile of intrinsic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4wQ41VBI3hrVg90H21EOLACvtfcHk0li4oHvQ6d4IGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ylt7bJ&md5=edfd4b8d20d0e33e6f64d970092d5604</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1208%2Faapsj070234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Faapsj070234%26sid%3Dliteratum%253Aachs%26aulast%3DZaveri%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DOlsen%26aufirst%3DC.%26aulast%3DPolgar%26aufirst%3DW.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DSmall-molecule%2520agonists%2520and%2520antagonists%2520of%2520the%2520opioid%2520receptor-like%2520receptor%2520%2528ORL1%252C%2520NOP%2529%253A%2520ligand-based%2520analysis%2520of%2520structural%2520factors%2520influencing%2520intrinsic%2520activity%2520at%2520NOP%26jtitle%3DAAPS%2520J.%26date%3D2005%26volume%3D7%26spage%3DE345%26epage%3D352%26doi%3D10.1208%2Faapsj070234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, K.</span><span> </span><span class="NLM_article-title">Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7675</span><span class="NLM_x">–</span> <span class="NLM_lpage">7699</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.bmc.2010.07.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7675-7699&author=S.+Hayashiauthor=E.+Nakataauthor=A.+Moritaauthor=K.+Mizunoauthor=K.+Yamamuraauthor=A.+Katoauthor=K.+Ohashi&title=Discovery+of+%7B1-%5B4-%282-%7Bhexahydropyrrolo%5B3%2C4-c%5Dpyrrol-2%281H%29-yl%7D-1H-benzimidazol-1-yl%29piperidin-1-yl%5Dcyclooctyl%7Dmethanol%2C+systemically+potent+novel+non-peptide+agonist+of+nociceptin%2Forphanin+FQ+receptor+as+analgesic+for+the+treatment+of+neuropathic+pain%3A+design%2C+synthesis%2C+and+structure-activity+relationships&doi=10.1016%2Fj.bmc.2010.07.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DNakata%26aufirst%3DE.%26aulast%3DMorita%26aufirst%3DA.%26aulast%3DMizuno%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DOhashi%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520%257B1-%255B4-%25282-%257Bhexahydropyrrolo%255B3%252C4-c%255Dpyrrol-2%25281H%2529-yl%257D-1H-benzimidazol-1-yl%2529piperidin-1-yl%255Dcyclooctyl%257Dmethanol%252C%2520systemically%2520potent%2520novel%2520non-peptide%2520agonist%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520as%2520analgesic%2520for%2520the%2520treatment%2520of%2520neuropathic%2520pain%253A%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationships%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7675%26epage%3D7699%26doi%3D10.1016%2Fj.bmc.2010.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Khroyan, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orduna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montenegro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toll, L.</span><span> </span><span class="NLM_article-title">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: Studies with bifunctional NOP/mu receptor agonists in the sciatic nerve ligation chronic pain model in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1124/jpet.111.184663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.111.184663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21859931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=687-693&author=T.+V.+Khroyanauthor=W.+E.+Polgarauthor=J.+Ordunaauthor=J.+Montenegroauthor=F.+Jiangauthor=N.+T.+Zaveriauthor=L.+Toll&title=Differential+effects+of+nociceptin%2Forphanin+FQ+%28NOP%29+receptor+agonists+in+acute+versus+chronic+pain%3A+Studies+with+bifunctional+NOP%2Fmu+receptor+agonists+in+the+sciatic+nerve+ligation+chronic+pain+model+in+mice&doi=10.1124%2Fjpet.111.184663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in mice</span></div><div class="casAuthors">Khroyan, Taline V.; Polgar, Willma E.; Orduna, Juan; Montenegro, Jose; Jiang, Faming; Zaveri, Nurulain T.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-693</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">1-(1-Cyclooctylpiperidin-4-yl)-indolin-2-one (SR14150) and 1-(1-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)piperidinl-4-yl)-indolin-2-one (SR16835) are moderately selective nociceptin/orphanin FQ (NOP) receptor agonists.  In the [35S]guanosine 5'-O-(3-thiotriphosphate) assay in vitro, SR14150 is a partial agonist at both the NOP and μ-opioid receptors, whereas SR16835 is a full agonist at the NOP receptor and has low efficacy at μ receptors.  These compds. were tested for antinociceptive and antiallodynic activity, using mice in chronic pain, subsequent to spinal nerve ligation (SNL) surgery.  When administered s.c. to mice after SNL surgery, SR14150 but not SR16835 increased tail-flick latency, which was blocked by the opioid antagonist naloxone, but not by the NOP receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).  In contrast, both SR14150 and SR16835 had antiallodynic activity when mech. allodynia was measured with von Frey monofilaments.  This effect was completely blocked by SB-612111 but not by naloxone.  On the other hand, morphine antinociception and antiallodynia were both blocked by naloxone and potentiated by SB-612111.  These results indicate that, in mice, circuitry mediating antinociceptive activity in acute and chronic pain states is different.  It is possible that during a chronic pain state, an up-regulated NOP system in the spinal cord leads to NOP receptor-mediated antiallodynia, which is blocked by NOP antagonists.  However, supraspinal up-regulation could lead to an attenuation of morphine antinociception and antiallodynia, which can be alleviated by an NOP receptor antagonist.  Thus, although neither NOP agonists nor antagonists are effective as analgesics in acute pain, they may have efficacy as analgesics, either alone or in combination with morphine, for treatment of chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0K9DfQCAq7Vg90H21EOLACvtfcHk0li4oHvQ6d4IGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvL&md5=d5e03c7d72ac9feab468aa8cdc8ba89d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.184663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.184663%26sid%3Dliteratum%253Aachs%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DOrduna%26aufirst%3DJ.%26aulast%3DMontenegro%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DF.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DDifferential%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%2520agonists%2520in%2520acute%2520versus%2520chronic%2520pain%253A%2520Studies%2520with%2520bifunctional%2520NOP%252Fmu%2520receptor%2520agonists%2520in%2520the%2520sciatic%2520nerve%2520ligation%2520chronic%2520pain%2520model%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D687%26epage%3D693%26doi%3D10.1124%2Fjpet.111.184663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Vang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, K.</span><span> </span><span class="NLM_article-title">Small-molecule nociceptin receptor agonist ameliorates mast cell activation and pain in sickle mice</span> <span class="citation_source-journal">Haematologica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span><span class="refDoi"> DOI: 10.3324/haematol.2015.128736</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.3324%2Fhaematol.2015.128736" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=1517-1525&author=D.+Vangauthor=J.+A.+Paulauthor=J.+Nguyenauthor=H.+Tranauthor=L.+Vincentauthor=D.+Yasudaauthor=N.+T.+Zaveriauthor=K.+Gupta&title=Small-molecule+nociceptin+receptor+agonist+ameliorates+mast+cell+activation+and+pain+in+sickle+mice&doi=10.3324%2Fhaematol.2015.128736"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2015.128736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2015.128736%26sid%3Dliteratum%253Aachs%26aulast%3DVang%26aufirst%3DD.%26aulast%3DPaul%26aufirst%3DJ.%2BA.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DH.%26aulast%3DVincent%26aufirst%3DL.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DGupta%26aufirst%3DK.%26atitle%3DSmall-molecule%2520nociceptin%2520receptor%2520agonist%2520ameliorates%2520mast%2520cell%2520activation%2520and%2520pain%2520in%2520sickle%2520mice%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3D1517%26epage%3D1525%26doi%3D10.3324%2Fhaematol.2015.128736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Murphy, N. P.</span><span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ system as a target for treating alcoholism</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.2174/187152710790966713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2174%2F187152710790966713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20201819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=87-93&author=N.+P.+Murphy&title=The+nociceptin%2Forphanin+FQ+system+as+a+target+for+treating+alcoholism&doi=10.2174%2F187152710790966713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ system as a target for treating alcoholism</span></div><div class="casAuthors">Murphy, Niall P.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-93</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Nociceptin (known also as orphanin FQ) is the most recently discovered member of the endogenous opioid peptide family, albeit nearly 15 years ago.  Nociceptin renders or influences many behavioral, psychol. and neurobiol. processes, including memory, anxiety, stress and reward.  Since its discovery, results of a steady stream of studies have suggested that endogenous nociceptin might be involved in responses to addictive drugs, and that targeting the nociceptin system may be beneficial in treating addictions.  The current review summarizes and critically appraises those studies, particularly those that point to an application in treating alcoholism.  Overall, most studies suggest that the endogenous nociceptin system has a physiol. role in mediating or regulating behavioral responses to alc., and that activating nociceptin receptors suppresses ongoing alc. consumption or reinstatement of responding for alc.  These findings encourage the development of therapies targeted at the nociceptin system for the treatment of alcoholism in humans, though a minor no. of studies showing continuous activation of the nociceptin receptor can produce increased, rather than reduced, alc. consumption emphasize the necessity of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTCxdiYsUYh7Vg90H21EOLACvtfcHk0lg0NoiOtlMOtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsL4%253D&md5=6a9f671254319083b3f6b6b47a636a2e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.2174%2F187152710790966713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710790966713%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520system%2520as%2520a%2520target%2520for%2520treating%2520alcoholism%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D87%26epage%3D93%26doi%3D10.2174%2F187152710790966713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Economidou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cippitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stopponi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braconi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clementi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubaldi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Fardon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span> </span><span class="NLM_article-title">Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat</span> <span class="citation_source-journal">Alcohol.: Clin. Exp. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.1111/j.1530-0277.2010.01392.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1530-0277.2010.01392.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=21223310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlslWitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=747-755&author=D.+Economidouauthor=A.+Cippitelliauthor=S.+Stopponiauthor=S.+Braconiauthor=S.+Clementiauthor=M.+Ubaldiauthor=R.+Martin-Fardonauthor=F.+Weissauthor=M.+Massiauthor=R.+Ciccocioppo&title=Activation+of+brain+NOP+receptors+attenuates+acute+and+protracted+alcohol+withdrawal+symptoms+in+the+rat&doi=10.1111%2Fj.1530-0277.2010.01392.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat</span></div><div class="casAuthors">Economidou, Daina; Cippitelli, Andrea; Stopponi, Serena; Braconi, Simone; Clementi, Stefano; Ubaldi, Massimo; Martin-Fardon, Remi; Weiss, Friedbert; Massi, Maurizio; Ciccocioppo, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Alcoholism: Clinical & Experimental Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">747-755</span>CODEN:
                <span class="NLM_cas:coden">ACRSDM</span>;
        ISSN:<span class="NLM_cas:issn">0145-6008</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alc. withdrawal refers to a cluster of symptoms that may occur from suddenly ceasing the use of alc. after chronic or prolonged ingestion.  These symptoms make alc. abstinence difficult and increase the risk of relapse in recovering alcoholics.  In previous studies, we demonstrated that treatment with Nociceptin/orphanin FQ (N/OFQ) significantly reduces alc. consumption and attenuates alc.-seeking behavior induced by environmental conditioning factors or by stress in rats.  In this study, we evaluated whether activation of brain NOP receptors may also attenuate alc. withdrawal signs in rats.  For this purpose, animals were subjected to a 6-day chronic alc. intoxication (by intragastric administration), and at 8, 10, and 12 h following cessation of alc. exposure, they were treated intracerebroventricularly (ICV) with N/OFQ (0.0, 1.0, and 3.0 μg/rat).  Somatic withdrawal signs were scored after ICV treatment.  In a subsequent expt., to evaluate N/OFQ effects on alc. withdrawal-induced anxiety, another group of rats was subjected to ethanol intoxication and after 1 wk was tested for anxiety behavior in the elevated plus maze (EPM).  In the last expt., an addnl. group of rats was tested for anxiety elicited by acute ethanol intoxication (hangover anxiety).  For this purpose, animals received an acute dose (3.0 g/kg) of 20% alc. and 12 h later were tested in the EPM following ICV N/OFQ (0.0, 1.0, and 2.0 μg/rat).  Results showed that N/OFQ significantly reduced the expression of somatic withdrawal signs and reversed anxiety-like behaviors assocd. with both chronic and acute alc. intoxication.  N/OFQ did not affect anxiety scores in nondependent animals.  These findings suggest that the N/OFQ-NOP receptor system may represent a promising target for the development of new treatments to ameliorate alc. withdrawal symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwXXBZYFgBs7Vg90H21EOLACvtfcHk0lg2SKdkacNSwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlslWitbY%253D&md5=f8b05fee52e9711e3e859bb672dc1296</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1530-0277.2010.01392.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1530-0277.2010.01392.x%26sid%3Dliteratum%253Aachs%26aulast%3DEconomidou%26aufirst%3DD.%26aulast%3DCippitelli%26aufirst%3DA.%26aulast%3DStopponi%26aufirst%3DS.%26aulast%3DBraconi%26aufirst%3DS.%26aulast%3DClementi%26aufirst%3DS.%26aulast%3DUbaldi%26aufirst%3DM.%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DF.%26aulast%3DMassi%26aufirst%3DM.%26aulast%3DCiccocioppo%26aufirst%3DR.%26atitle%3DActivation%2520of%2520brain%2520NOP%2520receptors%2520attenuates%2520acute%2520and%2520protracted%2520alcohol%2520withdrawal%2520symptoms%2520in%2520the%2520rat%26jtitle%3DAlcohol.%253A%2520Clin.%2520Exp.%2520Res.%26date%3D2011%26volume%3D35%26spage%3D747%26epage%3D755%26doi%3D10.1111%2Fj.1530-0277.2010.01392.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Martin-Fardon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorrilla, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, F.</span><span> </span><span class="NLM_article-title">Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1314</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span><span class="refDoi"> DOI: 10.1016/j.brainres.2009.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.brainres.2009.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=20026088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlelsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1314&publication_year=2010&pages=145-161&author=R.+Martin-Fardonauthor=E.+P.+Zorrillaauthor=R.+Ciccocioppoauthor=F.+Weiss&title=Role+of+innate+and+drug-induced+dysregulation+of+brain+stress+and+arousal+systems+in+addiction%3A+Focus+on+corticotropin-releasing+factor%2C+nociceptin%2Forphanin+FQ%2C+and+orexin%2Fhypocretin&doi=10.1016%2Fj.brainres.2009.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin</span></div><div class="casAuthors">Martin-Fardon, Remi; Zorrilla, Eric P.; Ciccocioppo, Roberto; Weiss, Friedbert</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1314</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-161</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Stress-like symptoms are an integral part of acute and protracted drug withdrawal, and several lines of evidence have shown that dysregulation of brain stress systems, including the extrahypothalamic corticotropin-releasing factor (CRF) system, following long-term drug use is of major importance in maintaining drug and alc. addiction.  Recently, two other neuropeptide systems have attracted interest, the nociceptin/orphanin FQ (N/OFQ) and orexin/hypocretin (Orx/Hcrt) systems.  N/OFQ participates in a wide range of physiol. responses, and the hypothalamic Orx/Hcrt system helps regulate several physiol. processes, including feeding, energy metab., and arousal.  Moreover, these two systems have been suggested to participate in psychiatric disorders, including anxiety and drug addiction.  Dysregulation of these systems by chronic drug exposure has been hypothesized to play a role in the maintenance of addiction and dependence.  Recent evidence demonstrated that interactions between CRF-N/OFQ and CRF-Orx/Hcrt systems may be functionally relevant for the control of stress-related addictive behavior.  The present review discusses recent findings that support the hypotheses of the participation and dysregulation of these systems in drug addiction and evaluates the current understanding of interactions among these stress-regulatory peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8stmOMuATrVg90H21EOLACvtfcHk0lg2SKdkacNSwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlelsrc%253D&md5=de20d863e8252166cdca6230d6e28800</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Fardon%26aufirst%3DR.%26aulast%3DZorrilla%26aufirst%3DE.%2BP.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DF.%26atitle%3DRole%2520of%2520innate%2520and%2520drug-induced%2520dysregulation%2520of%2520brain%2520stress%2520and%2520arousal%2520systems%2520in%2520addiction%253A%2520Focus%2520on%2520corticotropin-releasing%2520factor%252C%2520nociceptin%252Forphanin%2520FQ%252C%2520and%2520orexin%252Fhypocretin%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1314%26spage%3D145%26epage%3D161%26doi%3D10.1016%2Fj.brainres.2009.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Rodi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cifani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, C.</span><span> </span><span class="NLM_article-title">Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.1007/s00213-007-0985-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-007-0985-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2008&pages=523-531&author=D.+Rodiauthor=S.+Zucchiniauthor=M.+Simonatoauthor=C.+Cifaniauthor=M.+Massiauthor=C.+Polidori&title=Functional+antagonism+between+nociceptin%2Forphanin+FQ+%28N%2FOFQ%29+and+corticotropin-releasing+factor+%28CRF%29+in+the+rat+brain%3A+evidence+for+involvement+of+the+bed+nucleus+of+the+stria+terminalis&doi=10.1007%2Fs00213-007-0985-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1007%2Fs00213-007-0985-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-007-0985-7%26sid%3Dliteratum%253Aachs%26aulast%3DRodi%26aufirst%3DD.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DSimonato%26aufirst%3DM.%26aulast%3DCifani%26aufirst%3DC.%26aulast%3DMassi%26aufirst%3DM.%26aulast%3DPolidori%26aufirst%3DC.%26atitle%3DFunctional%2520antagonism%2520between%2520nociceptin%252Forphanin%2520FQ%2520%2528N%252FOFQ%2529%2520and%2520corticotropin-releasing%2520factor%2520%2528CRF%2529%2520in%2520the%2520rat%2520brain%253A%2520evidence%2520for%2520involvement%2520of%2520the%2520bed%2520nucleus%2520of%2520the%2520stria%2520terminalis%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D196%26spage%3D523%26epage%3D531%26doi%3D10.1007%2Fs00213-007-0985-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Khroyan, T. V.; Polgar, W.; Toll, L.; Jiang, F.; Zaveri, N. T.</span><span> </span><span class="NLM_article-title">AT-202, a nociceptin receptor agonist, blocks drug- and stress-induced reinstatement of extinguished cocaine conditioned place preference</span>. Society for Neuroscience Annual Meeting, San Diego, CA, 2013; <span class="NLM_publisher-name">Society for Neuroscience</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>No. 733.724.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Khroyan%2C+T.+V.%3B+Polgar%2C+W.%3B+Toll%2C+L.%3B+Jiang%2C+F.%3B+Zaveri%2C+N.+T.+AT-202%2C+a+nociceptin+receptor+agonist%2C+blocks+drug-+and+stress-induced+reinstatement+of+extinguished+cocaine+conditioned+place+preference.+Society+for+Neuroscience+Annual+Meeting%2C+San+Diego%2C+CA%2C+2013%3B+Society+for+Neuroscience%2C+2013%3B+No.+733.724."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKhroyan%26aufirst%3DT.%2BV.%26atitle%3DAT-202%252C%2520a%2520nociceptin%2520receptor%2520agonist%252C%2520blocks%2520drug-%2520and%2520stress-induced%2520reinstatement%2520of%2520extinguished%2520cocaine%2520conditioned%2520place%2520preference%26pub%3DSociety%2520for%2520Neuroscience%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Przydzial, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heisler, L. K.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ peptide receptor as a therapeutic target for obesity</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">796</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span><span class="refDoi"> DOI: 10.2174/138955708784912139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.2174%2F138955708784912139" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=796-811&author=M.+J.+Przydzialauthor=L.+K.+Heisler&title=Nociceptin%2Forphanin+FQ+peptide+receptor+as+a+therapeutic+target+for+obesity&doi=10.2174%2F138955708784912139"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.2174%2F138955708784912139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955708784912139%26sid%3Dliteratum%253Aachs%26aulast%3DPrzydzial%26aufirst%3DM.%2BJ.%26aulast%3DHeisler%26aufirst%3DL.%2BK.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520as%2520a%2520therapeutic%2520target%2520for%2520obesity%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D796%26epage%3D811%26doi%3D10.2174%2F138955708784912139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burmeister, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapusta, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span> </span><span class="NLM_article-title">UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1111/j.1527-3458.2005.tb00264.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1527-3458.2005.tb00264.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=97-112&author=G.+Caloauthor=R.+Guerriniauthor=A.+Rizziauthor=S.+Salvadoriauthor=M.+Burmeisterauthor=D.+R.+Kapustaauthor=D.+G.+Lambertauthor=D.+Regoli&title=UFP-101%2C+a+peptide+antagonist+selective+for+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1111%2Fj.1527-3458.2005.tb00264.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2005.tb00264.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2005.tb00264.x%26sid%3Dliteratum%253Aachs%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBurmeister%26aufirst%3DM.%26aulast%3DKapusta%26aufirst%3DD.%2BR.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DUFP-101%252C%2520a%2520peptide%2520antagonist%2520selective%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2005%26volume%3D11%26spage%3D97%26epage%3D112%26doi%3D10.1111%2Fj.1527-3458.2005.tb00264.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span> </span><span class="NLM_article-title">Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5063</span><span class="refDoi"> DOI: 10.1021/jm990517p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990517p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5061-5063&author=H.+Kawamotoauthor=S.+Ozakiauthor=Y.+Itohauthor=M.+Miyajiauthor=S.+Araiauthor=H.+Nakashimaauthor=T.+Katoauthor=H.+Ohtaauthor=Y.+Iwasawa&title=Discovery+of+the+first+potent+and+selective+small+molecule+opioid+receptor-like+%28ORL1%29+antagonist%3A+1-%5B%283R%2C4R%29-1-cyclooctylmethyl-3-+hydroxymethyl-4-piperidyl%5D-3-ethyl-1%2C+3-dihydro-2H-benzimidazol-2-one+%28J-113397%29&doi=10.1021%2Fjm990517p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Fjm990517p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990517p%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520and%2520selective%2520small%2520molecule%2520opioid%2520receptor-like%2520%2528ORL1%2529%2520antagonist%253A%25201-%255B%25283R%252C4R%2529-1-cyclooctylmethyl-3-%2520hydroxymethyl-4-piperidyl%255D-3-ethyl-1%252C%25203-dihydro-2H-benzimidazol-2-one%2520%2528J-113397%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5061%26epage%3D5063%26doi%3D10.1021%2Fjm990517p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span> </span><span class="NLM_article-title">In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/S0014-2999(00)00520-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0014-2999%2800%2900520-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10940356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCgtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2000&pages=45-53&author=S.+Ozakiauthor=H.+Kawamotoauthor=Y.+Itohauthor=M.+Miyajiauthor=T.+Azumaauthor=D.+Ichikawaauthor=H.+Nambuauthor=T.+Iguchiauthor=Y.+Iwasawaauthor=H.+Ohta&title=In+vitro+and+in+vivo+pharmacological+characterization+of+J-113397%2C+a+potent+and+selective+non-peptidyl+ORL1+receptor+antagonist&doi=10.1016%2FS0014-2999%2800%2900520-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist</span></div><div class="casAuthors">Ozaki, S.; Kawamoto, H.; Itoh, Y.; Miyaji, M.; Azuma, T.; Ichikawa, D.; Nambu, H.; Iguchi, T.; Iwasawa, Y.; Ohta, H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) was found to be the first potent nonpeptidyl ORL1 receptor antagonist (Ki: cloned human ORL1=1.8 nM) with high selectivity over other opioid receptors (Ki: 1000 nM for human μ-opioid receptor, °10,000 nM for human δ-opioid receptor, and 640 nM for human κ-opioid receptor).  In vitro, J-113397 inhibited nociceptin/orphanin FQ-stimulated [35S]guanosine 5'-O-(γ-thio)triphosphate (GTPγS) binding to Chinese Hamster Ovary (CHO) cells expressing ORL1 (CHO-ORL1) with an IC50 value of 5.3 nM but had no effect on [35S]GTPγS binding by itself.  Schild plot anal. of the [35S]GTPγS binding assay and cAMP assay using CHO-ORL1 indicated competitive antagonism of J-113397 on the ORL1 receptor.  In CHO cells expressing μ-, δ- or κ-opioid receptors, J-113397 had no effects on [35S]GTPγS binding up to a concn. of 100 nM, indicating selective antagonism of the compd. on the ORL1 receptor.  In vivo, J-113397, when administered s.c., dose-dependently inhibited hyperalgesia elicited by intracerebroventricular (i.c.v.) administration of nociceptin/orphanin FQ in a tail-flick test with mice.  An in vitro binding study using mouse brains indicated that J-113397 possesses high affinity for the mouse ORL1 receptor (Ki: 1.1 nM) as well as the human receptor.  In summary, J-113397 is the first potent, selective ORL1 receptor antagonist that may be useful in elucidating the physiol. roles of nociceptin/orphanin FQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbOSgVDC0RqLVg90H21EOLACvtfcHk0lhvh7ZcQ_su3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCgtbc%253D&md5=5c6bc44e82e4164b11dbf1c11bd7710f</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2800%2900520-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252800%252900520-3%26sid%3Dliteratum%253Aachs%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DM.%26aulast%3DAzuma%26aufirst%3DT.%26aulast%3DIchikawa%26aufirst%3DD.%26aulast%3DNambu%26aufirst%3DH.%26aulast%3DIguchi%26aufirst%3DT.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DH.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%2520of%2520J-113397%252C%2520a%2520potent%2520and%2520selective%2520non-peptidyl%2520ORL1%2520receptor%2520antagonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D402%26spage%3D45%26epage%3D53%26doi%3D10.1016%2FS0014-2999%2800%2900520-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Zaratin, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbacchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronzoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheideler, M. A.</span><span> </span><span class="NLM_article-title">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">454</span><span class="NLM_x">–</span> <span class="NLM_lpage">461</span><span class="refDoi"> DOI: 10.1124/jpet.103.055848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.103.055848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=14593080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=454-461&author=P.+F.+Zaratinauthor=G.+Petroneauthor=M.+Sbacchiauthor=M.+Garnierauthor=C.+Fossatiauthor=P.+Petrilloauthor=S.+Ronzoniauthor=G.+A.+Giardinaauthor=M.+A.+Scheideler&title=Modification+of+nociception+and+morphine+tolerance+by+the+selective+opiate+receptor-like+orphan+receptor+antagonist+%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol+%28SB-612111%29&doi=10.1124%2Fjpet.103.055848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)</span></div><div class="casAuthors">Zaratin, Paola F.; Petrone, Giuseppe; Sbacchi, Massimo; Garnier, Martine; Fossati, Claudia; Petrillo, Paola; Ronzoni, Silvio; Giardina, Giuseppe A. M.; Scheideler, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-461</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SB-612111 is a novel human opiate receptor-like orphan receptor (ORL-1) antagonist that has high affinity for the clonal human ORL-1 receptor (hORL-1 Ki = 0.33 nM), selectivity vs. μ- (174-fold), δ- (6391-fold), and κ (486-fold)-opioid receptors and is able to inhibit nociceptin signaling via hORL-1 in a whole cell gene reporter assay.  SB-612111 has no measurable antinociceptive effects in vivo in the mouse hot-plate test after i.v. administration but is able to antagonize the antimorphine action of nociceptin [ED50 = 0.69 mg/kg, 95% confidence limit (CL) = 0.34-1.21].  SB-62111 administration can also reverse tolerance to morphine in this model, established via repeated morphine administration.  In addn., i.v. SB-612111 can antagonize nociceptin-induced thermal hyperalgesia in a dose-dependent manner (ED50 = 0.62 mg/kg i.v., 95% CL = 0.22-1.89) and is effective per se at reversing thermal hyperalgesia in the rat carrageenan inflammatory pain model.  These data show that an ORL-1 receptor antagonist may be a useful adjunct to chronic pain therapy with opioids and can be used to treat conditions in which thermal hyperalgesia is a significant component of the pain response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZbUKJ64ZkmbVg90H21EOLACvtfcHk0lhvh7ZcQ_su3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D&md5=c56ae72c9113af5aeb7168b9a1646b7b</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.055848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.055848%26sid%3Dliteratum%253Aachs%26aulast%3DZaratin%26aufirst%3DP.%2BF.%26aulast%3DPetrone%26aufirst%3DG.%26aulast%3DSbacchi%26aufirst%3DM.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DFossati%26aufirst%3DC.%26aulast%3DPetrillo%26aufirst%3DP.%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%26aulast%3DScheideler%26aufirst%3DM.%2BA.%26atitle%3DModification%2520of%2520nociception%2520and%2520morphine%2520tolerance%2520by%2520the%2520selective%2520opiate%2520receptor-like%2520orphan%2520receptor%2520antagonist%2520%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%2520%2528SB-612111%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D454%26epage%3D461%26doi%3D10.1124%2Fjpet.103.055848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Spagnolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrà, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebbes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calò, G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ Receptor antagonist SB-612111 [(–)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1124/jpet.106.116764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.106.116764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17329552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=961-967&author=B.+Spagnoloauthor=G.+Carr%C3%A0author=M.+Fantinauthor=C.+Fischettiauthor=C.+Hebbesauthor=J.+McDonaldauthor=T.+A.+Barnesauthor=A.+Rizziauthor=C.+Trapellaauthor=G.+Fantonauthor=M.+Morariauthor=D.+G.+Lambertauthor=D.+Regoliauthor=G.+Cal%C3%B2&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+Receptor+antagonist+SB-612111+%5B%28%E2%80%93%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol%5D%3A+In+vitro+studies&doi=10.1124%2Fjpet.106.116764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies</span></div><div class="casAuthors">Spagnolo, Barbara; Carra, Giacomo; Fantin, Martina; Fischetti, Carmela; Hebbes, Chris; McDonald, John; Barnes, Timothy A.; Rizzi, Anna; Trapella, Claudio; Fanton, Giulia; Morari, Michele; Lambert, Dave G.; Regoli, Domenico; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The compd. SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol] was recently identified as a selective antagonist for the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  In the present study, the in vitro pharmacol. profile of SB-612111 at human recombinant NOP receptors expressed in Chinese hamster ovary (CHO) cells [receptor binding, guanosine 5'-O-(3-[35S]thio)triphosphate (GTPγ[35S]) binding, and cAMP level expts.] as well as at native NOP receptors expressed in peripheral (mouse and rat vas deferens, guinea pig ileum) and central (mouse cerebral cortex synaptosomes releasing [3H]5-HT) prepns. was evaluated and compared with that of the std. nonpeptide antagonist (±)J-113397 [(±)-trans-1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one].  SB-612111 produced a concn.-dependent displacement of [3H]N/OFQ binding to CHOhNOP cell membranes, showing higher affinity and NOP selectivity over classical opioid receptors than (±)J-113397.  SB-612111 and (±)J-113397 competitively antagonized the effects of N/OFQ on GTPγ[35S] binding in CHOhNOP cell membranes (pKB, 9.70 and 8.71, resp.) and on cAMP accumulation in CHOhNOP cells (pKB, 8.63 and 7.95, resp.), being per se inactive.  In isolated peripheral tissues of mice, rats, and guinea pigs and in mouse cerebral cortex synaptosomes preloaded with [3H]5-HT, SB-612111 competitively antagonized the inhibitory effects of N/OFQ, with pA2 values in the range of 8.20 to 8.50.  In parallel expts., (±)J-113397 was found to be 2- to 9-fold less potent than SB-612111.  In the elec. stimulated tissues, 1 μM SB-612111 did not modify the effects of classical opioid receptor agonists.  In conclusion, the results of the present study demonstrated that SB-612111 is among the most potent and NOP-selective nonpeptide antagonists identified to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozelFgTfoi5rVg90H21EOLACvtfcHk0lj5Cm8bTDk48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D&md5=49c903afa586c64284535b50692bb877</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116764%26sid%3Dliteratum%253Aachs%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DFantin%26aufirst%3DM.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DHebbes%26aufirst%3DC.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DBarnes%26aufirst%3DT.%2BA.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DFanton%26aufirst%3DG.%26aulast%3DMorari%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520Receptor%2520antagonist%2520SB-612111%2520%255B%2528%25E2%2580%2593%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%255D%253A%2520In%2520vitro%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D961%26epage%3D967%26doi%3D10.1124%2Fjpet.106.116764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spagnolo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrah ydro-5H-benzocyclohepten-5-ol]: in vivo studies</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">968</span><span class="NLM_x">–</span> <span class="NLM_lpage">974</span><span class="refDoi"> DOI: 10.1124/jpet.106.116780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1124%2Fjpet.106.116780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=17329551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=968-974&author=A.+Rizziauthor=E.+C.+Gavioliauthor=G.+Marzolaauthor=B.+Spagnoloauthor=S.+Zucchiniauthor=R.+Ciccocioppoauthor=C.+Trapellaauthor=D.+Regoliauthor=G.+Calo&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+receptor+antagonist+SB-612111+%5B%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrah+ydro-5H-benzocyclohepten-5-ol%5D%3A+in+vivo+studies&doi=10.1124%2Fjpet.106.116780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies</span></div><div class="casAuthors">Rizzi, Anna; Gavioli, Elaine C.; Marzola, Giuliano; Spagnolo, Barbara; Zucchini, Silvia; Ciccocioppo, Roberto; Trapella, Claudio; Regoli, Domenico; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">968-974</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The excellent pharmacol. profile displayed by the selective nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol] in vitro prompted us to investigate the actions of this compd. in vivo.  In the mouse tail withdrawal assay, SB-612111 given i.p. up to 3 mg/kg did not modify per se tail withdrawal latencies but was able to prevent the pronociceptive and the antinociceptive action of 1 nmol of N/OFQ given i.c.v. and i.t., resp.  In food intake studies performed in sated mice, SB-612111 (1 mg/kg i.p.) had no effect on food consumption but fully prevented the orexigenic effect of 1 nmol of N/OFQ i.c.v.  In 17-h food-deprived mice, the opioid receptor antagonist naltrexone (1 mg/kg s.c.), but not SB-612111 (1 and 10 mg/kg i.p.), produced a statistically significant redn. of food intake.  In the mouse forced swimming and tail suspension tests, SB-612111 (1-10 mg/kg) reduced immobility time.  The antidepressant-like effect elicited by SB-612111 in the forced swimming test was reversed by the i.c.v. injection of 1 nmol of N/OFQ and no longer evident in mice knockout for the NOP receptor gene.  In conclusion, the present findings demonstrate that SB-612111 behaves in vivo as a potent and selective NOP antagonist and suggest that the N-OFQ-NOP receptor endogenous system plays an important role in regulating mood-related behaviors.  The use of SB-612111 in future pathophysiol. studies will certainly contribute to define the therapeutic potential of selective NOP receptor antagonists in different disease areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8kC-dXIn8n7Vg90H21EOLACvtfcHk0lj5Cm8bTDk48w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsr0%253D&md5=8a60d569531dc17d0168f30578945d8f</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116780%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520SB-612111%2520%255B%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrah%2520ydro-5H-benzocyclohepten-5-ol%255D%253A%2520in%2520vivo%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D968%26epage%3D974%26doi%3D10.1124%2Fjpet.106.116780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lima, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1990</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.2003.02603.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1046%2Fj.1460-9568.2003.02603.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12752799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD3s3mvVKnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=1987-1990&author=E.+C.+Gavioliauthor=G.+Marzolaauthor=R.+Guerriniauthor=R.+Bertorelliauthor=S.+Zucchiniauthor=T.+C.+De+Limaauthor=G.+A.+Raeauthor=S.+Salvadoriauthor=D.+Regoliauthor=G.+Calo&title=Blockade+of+nociceptin%2Forphanin+FQ-NOP+receptor+signalling+produces+antidepressant-like+effects%3A+pharmacological+and+genetic+evidences+from+the+mouse+forced+swimming+test&doi=10.1046%2Fj.1460-9568.2003.02603.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test</span></div><div class="casAuthors">Gavioli E C; Marzola G; Guerrini R; Bertorelli R; Zucchini S; De Lima T C M; Rae G A; Salvadori S; Regoli D; Calo G</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1987-90</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ), the endogenous ligand of the NOP receptor, regulates several central functions such as pain transmission, learning and memory, fear and anxiety and feeding and locomotor activity.  It has been recently reported that NOP receptor antagonists induce antidepressant-like effects in the mouse forced swimming test (FST), i.e. reduce immobility time.  This assay was used in the present study for further investigating the involvement of the NOP receptor in depression states.  In male Swiss mice, intracerebroventricular injection (i.c.v) of the novel NOP receptor antagonist, UFP-101 (1-10 nmol) dose-dependently reduced the immobility time (control 192 +/- 14 s, UFP-101 91 +/- 15 s).  The effect of 3 or 10 nmol UFP-101 was fully or partially reversed, respectively, by the coadministration of 1 nmol N/OFQ, which was inactive per se.  NOP receptor knockout mice showed a reduced immobility time compared with their wild-type littermates (wild-type 215 +/- 10 s, knockout 143 +/- 12 s).  Moreover, i.c.v. injected UFP-101 (10 nmol) significantly reduced immobility time in wild-type mice but not in NOP receptor knockout animals.  In conclusion, these results, obtained using a combined pharmacological and genetic approach, indicate that blockade of the N/OFQ-NOP receptor signalling in the brain produces antidepressant-like effects in the mouse FST.  These findings support the NOP receptor as a candidate target for the development of innovative antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcToguwyRgrVcczK395ZObgVfW6udTcc2eZ8LE5NXdD9qLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3mvVKnsA%253D%253D&md5=4870bca0e7d871f06bbd29c4becd114f</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2003.02603.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2003.02603.x%26sid%3Dliteratum%253Aachs%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DDe%2BLima%26aufirst%3DT.%2BC.%26aulast%3DRae%26aufirst%3DG.%2BA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DBlockade%2520of%2520nociceptin%252Forphanin%2520FQ-NOP%2520receptor%2520signalling%2520produces%2520antidepressant-like%2520effects%253A%2520pharmacological%2520and%2520genetic%2520evidences%2520from%2520the%2520mouse%2520forced%2520swimming%2520test%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2003%26volume%3D17%26spage%3D1987%26epage%3D1990%26doi%3D10.1046%2Fj.1460-9568.2003.02603.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Gavioli, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span><span class="refDoi"> DOI: 10.1007/s00210-006-0035-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00210-006-0035-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16491387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2006&pages=319-330&author=E.+C.+Gavioliauthor=G.+Calo&title=Antidepressant-+and+anxiolytic-like+effects+of+nociceptin%2Forphanin+FQ+receptor+ligands&doi=10.1007%2Fs00210-006-0035-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands</span></div><div class="casAuthors">Gavioli, Elaine C.; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review with refs.  Many studies point toward the nociceptin/orphanin FQ (N/OFQ) and the N/OFQ peptide receptor (NOP) as targets for the development of innovative drugs for treating affective disorders.  It has been reported that the activation of NOP receptors produces anxiolytic-like effects in rodents in a large series of behavioral assays, i.e., elevated plus maze, light-dark aversion, operant conflict, fear-potentiated startle, pup ultrasonic vocalizations, and hole board tests.  In contrast, the blockade of N/OFQ signaling obtained with NOP-selective antagonists promotes antidepressant-like effects in the forced swimming and tail suspension tests.  In these assays, N/OFQ is inactive per se, but reverses the antidepressant-like effects of NOP antagonists.  NOP receptor knockout mice show an antidepressant-like phenotype, and NOP antagonists are inactive in these animals.  Thus, the activation of the NOP receptor seems to evoke anxiolytic-like effects while its blockade antidepressant-like effects.  This appears to be a rather unique behavioral profile since the activation or the blockade of a given neuropeptide receptor produces, in most of the cases, both antidepressant- and anxiolytic-like effects.  This particular behavioral profile, the possible mechanisms of action, and the therapeutic potential of NOP receptor ligands for the treatment of depression and anxiety disorders are discussed in this review article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre33WhTL5HRLVg90H21EOLACvtfcHk0ljyiM5vy6jrgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslOkurc%253D&md5=22c592813d6edd1ed75e0eed734aab12</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1007%2Fs00210-006-0035-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-006-0035-8%26sid%3Dliteratum%253Aachs%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DAntidepressant-%2520and%2520anxiolytic-like%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2006%26volume%3D372%26spage%3D319%26epage%3D330%26doi%3D10.1007%2Fs00210-006-0035-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Redrobe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirion, R.</span><span> </span><span class="NLM_article-title">Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1007/s00210-001-0511-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00210-001-0511-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11819035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2002&pages=164-167&author=J.+Redrobeauthor=G.+Caloauthor=D.+Regoliauthor=R.+Quirion&title=Nociceptin+receptor+antagonists+display+antidepressant-like+properties+in+the+mouse+forced+swimming+test&doi=10.1007%2Fs00210-001-0511-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test</span></div><div class="casAuthors">Redrobe, John P.; Calo, Girolamo; Regoli, Domenico; Quirion, Remi</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">164-167</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The present study investigated the effects of nociceptin, the peptide nociceptin receptor antagonist, [Nphe1]-nociceptin (1-13)-NH2, and the non-peptide antagonist, J-113397, in the mouse forced swimming test, an animal model used for the screening of potential antidepressant drugs.  Addnl. studies were performed with naloxone to exclude effects on traditional opioid receptors.  Intracerebroventricular (ICV) administration of nociceptin (0.01-1 nmole) was devoid of any activity in the mouse forced swimming test, as was i.p. administration of naloxone (1-10 mg/kg).  ICV treatment with [Nphe1]-nociceptin (1-13)-NH2 (25 nmole and 50 nmole) induced significant antidepressant-like activity (P<0.01), as did administration of J-113397 (20 mg/kg, i.p; P<0.05).  Open field anal. revealed that acute treatment with these mols. did not induce significant changes in locomotor activity at the doses tested.  These results suggest that nociceptin, and its receptor, may play a role in depressive disorders and that the nociceptin system could represent a novel target for the development of new antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaZDJ1e6MlPLVg90H21EOLACvtfcHk0ljYzdNmZ5QSRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cqtg%253D%253D&md5=a184571c1dfa13124ca5e2a90d2e07fe</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs00210-001-0511-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-001-0511-0%26sid%3Dliteratum%253Aachs%26aulast%3DRedrobe%26aufirst%3DJ.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DQuirion%26aufirst%3DR.%26atitle%3DNociceptin%2520receptor%2520antagonists%2520display%2520antidepressant-like%2520properties%2520in%2520the%2520mouse%2520forced%2520swimming%2520test%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2002%26volume%3D365%26spage%3D164%26epage%3D167%26doi%3D10.1007%2Fs00210-001-0511-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Vitale, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggieri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filaferro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigeri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alboni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tascedda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cifani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1007/s00213-009-1646-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs00213-009-1646-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19711054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD1MjisVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2009&pages=173-189&author=G.+Vitaleauthor=V.+Ruggieriauthor=M.+Filaferroauthor=C.+Frigeriauthor=S.+Alboniauthor=F.+Tasceddaauthor=N.+Brunelloauthor=R.+Guerriniauthor=C.+Cifaniauthor=M.+Massi&title=Chronic+treatment+with+the+selective+NOP+receptor+antagonist+%5BNphe+1%2C+Arg+14%2C+Lys+15%5DN%2FOFQ-NH+2+%28UFP-101%29+reverses+the+behavioural+and+biochemical+effects+of+unpredictable+chronic+mild+stress+in+rats&doi=10.1007%2Fs00213-009-1646-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats</span></div><div class="casAuthors">Vitale Giovanni; Ruggieri Valentina; Filaferro Monica; Frigeri Claudio; Alboni Silvia; Tascedda Fabio; Brunello Nicoletta; Guerrini Remo; Cifani Carlo; Massi Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  The present study was designed to assess the antidepressant effects of UFP-101, a selective nociceptin/orphanin FQ peptide (NOP) receptor antagonist, in a validated animal model of depression: the chronic mild stress (CMS).  MATERIALS AND METHODS AND RESULTS:  UFP-101 (5, 10 and 20 nmol/rat; i.c.v., once a day for 21 days) dose- and time-dependently reinstated sucrose consumption in stressed animals without affecting the same parameter in non-stressed ones.  In the forced swimming test, UFP-101 reduced immobility of stressed rats from day 8 of treatment.  After a 3-week treatment, rats were killed for biochemical evaluations.  UFP-101 abolished increase in serum corticosterone induced by CMS and reverted changes in central 5-HT/5-HIAA ratio.  The behavioural and biochemical effects of UFP-101 mimicked those of imipramine, the reference antidepressant drug, administered at the dose of 15 mg/kg (i.p.).  Co-administration of nociceptin/orphanin FQ (5 nmol/rat, from day 12 to 21) prevented the effects of UFP-101.  Brain-derived neurotrophic factor mRNA and protein in hippocampus were not reduced by CMS nor did UFP-101 modify these parameters.  DISCUSSION AND CONCLUSION:  This study demonstrated that chronic treatment with UFP-101 produces antidepressant-like effects in rats subjected to CMS supporting the proposal that NOP receptors represent a candidate target for the development of innovative antidepressant drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzV7J6V2CUwe98rul4nhSdfW6udTcc2eY89LmFp9MNyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjisVGmug%253D%253D&md5=5831db52990da8f9a637fc3b28b34882</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1646-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1646-9%26sid%3Dliteratum%253Aachs%26aulast%3DVitale%26aufirst%3DG.%26aulast%3DRuggieri%26aufirst%3DV.%26aulast%3DFilaferro%26aufirst%3DM.%26aulast%3DFrigeri%26aufirst%3DC.%26aulast%3DAlboni%26aufirst%3DS.%26aulast%3DTascedda%26aufirst%3DF.%26aulast%3DBrunello%26aufirst%3DN.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCifani%26aufirst%3DC.%26aulast%3DMassi%26aufirst%3DM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520selective%2520NOP%2520receptor%2520antagonist%2520%255BNphe%25201%252C%2520Arg%252014%252C%2520Lys%252015%255DN%252FOFQ-NH%25202%2520%2528UFP-101%2529%2520reverses%2520the%2520behavioural%2520and%2520biochemical%2520effects%2520of%2520unpredictable%2520chronic%2520mild%2520stress%2520in%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2009%26volume%3D207%26spage%3D173%26epage%3D189%26doi%3D10.1007%2Fs00213-009-1646-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Bigoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Risi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashiba, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span> </span><span class="NLM_article-title">In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist</span> <span class="citation_source-journal">Naunyn-Schmiedeberg's Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span><span class="refDoi"> DOI: 10.1007/s002100000220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1007%2Fs002100000220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10832612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFGjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2000&pages=565-568&author=R.+Bigoniauthor=G.+Caloauthor=A.+Rizziauthor=R.+Guerriniauthor=C.+De+Risiauthor=Y.+Hashimotoauthor=E.+Hashibaauthor=D.+G.+Lambertauthor=D.+Regoli&title=In+vitro+characterization+of+J-113397%2C+a+non-peptide+nociceptin%2Forphanin+FQ+receptor+antagonist&doi=10.1007%2Fs002100000220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist</span></div><div class="casAuthors">Bigoni, R.; Calo, G.; Rizzi, A.; Guerrini, R.; De Risi, C.; Hashimoto, Y.; Hashiba, E.; Lambert, D. G.; Regoli, D.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">565-568</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The lack of availability of a selective, highly potent, competitive antagonist for the nociceptin receptor (OP4) devoid of residual agonistic activity has hampered studies in this area.  The authors report here the in vitro pharmacol. properties of the novel non-peptide OP4 antagonist, J-113397, which was recently discovered by Banyu Pharmaceutical investigators.  The compd. was synthesized as a racemic mixt. in the authors labs.  J-113397 was shown to antagonize (pA2 7.52) the nociceptin-induced inhibition of cAMP formation in cells expressing the recombinant human OP4 receptor (CHOhOP4) and to displace [125I]Tyr14nociceptin from CHOhOP4 membranes with a pKi of 8.56.  It also competitively antagonized the contractile actions of nociceptin in the mouse colon (pA2 8.07) and the inhibitory effect of nociceptin in elec. stimulated prepns. such as the mouse vas deferens (pA2 7.85), the guinea pig ileum (7.75), and the rat vas deferens (7.77).  At high concns. (10 mM), the compd. was devoid of agonist activity in the mouse vas deferens and CHOhOP4, while it contracted the mouse colon and increased the twitch response of the rat vas deferens, and produced a naloxone-sensitive inhibition of the elec. evoked twitches in the guinea pig ileum.  PA2 values for the new antagonist against deltorphin I in the mouse vas deferens (OP1 receptors), or against dermorphin in the guinea pig ileum (OP3 receptors), etorphine in the rat vas deferens (OP receptors), U69593 in the rabbit vas deferens (OP2 receptors) and endomorphin 1 in the mouse colon (OP3 receptors) were lower than 6.  Taken together, these data indicate that J-113397 is a high-affinity, selective and competitive antagonist of the OP4 receptor; this novel pharmacol. tool will be of great value in studies directed at evaluating the physiol. roles of the nociceptin/OP4 system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbXASA1Y0rlbVg90H21EOLACvtfcHk0lh__BgbdRKqVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFGjurc%253D&md5=a88542f84bb42988f9f31b9aa2ea5875</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1007%2Fs002100000220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000220%26sid%3Dliteratum%253Aachs%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DDe%2BRisi%26aufirst%3DC.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520characterization%2520of%2520J-113397%252C%2520a%2520non-peptide%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D361%26spage%3D565%26epage%3D568%26doi%3D10.1007%2Fs002100000220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Koizumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midorikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, N. P.</span><span> </span><span class="NLM_article-title">The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1038/sj.bjp.0705906</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fsj.bjp.0705906" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15289286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVenurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=53-62&author=M.+Koizumiauthor=K.+Sakooriauthor=N.+Midorikawaauthor=N.+P.+Murphy&title=The+NOP+%28ORL1%29+receptor+antagonist+Compound+B+stimulates+mesolimbic+dopamine+release+and+is+rewarding+in+mice+by+a+non-NOP-receptor-mediated+mechanism&doi=10.1038%2Fsj.bjp.0705906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism</span></div><div class="casAuthors">Koizumi, Miwako; Sakoori, Kazuto; Midorikawa, Naoko; Murphy, Niall P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-62</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Compd. B (1-[(3R, 4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one, CompB) is a nociceptin/orphanin FQ (N/OFQ) antagonist showing high selectivity for the NOP (ORL1) receptor over classical opioid receptors.  We studied the effect of s.c. CompB administration on the release of mesolimbic dopamine (DA) and the expression of hedonia in mice.  2 CompB (0.3-30 mg kg-1) dose dependently stimulated mesolimbic DA release as measured by in vivo freely moving microdialysis, without any change in locomotor activity.  However, intracerebroventricular administered N/OFQ (endogenous agonist of the NOP receptor, 6 nmol) did not influence CompB- (10 mg kg-1) induced DA release, despite clearly suppressing release when administered alone.  3 Studies using NOP receptor knockout mice and no-net-flux microdialysis revealed mildly, but not statistically significantly higher endogenous DA levels in mice lacking the NOP receptor compared to wild-type mice.  Administration of CompB (10 mg kg-1) induced identical increases in mesolimbic DA release in wild-type and NOP receptor knockout mice.  4 CompB was rewarding in approx. the same dose range in which CompB induced major increases in mesolimbic DA release when assayed using a conditioned place preference paradigm.  The rewarding effect of CompB (30 mg kg-1) was maintained in NOP receptor knockout mice.  5 These results show that CompB stimulates mesolimbic DA release and is rewarding by an action independent of the NOP receptor, the precise site of which is unclear.  Consequently, caution should be exercised when interpreting the results of studies using this drug, particularly when administered by a peripheral route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkJ-Aw4Re64LVg90H21EOLACvtfcHk0lh__BgbdRKqVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVenurk%253D&md5=b4a0a886721035d0589671e879740abc</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705906%26sid%3Dliteratum%253Aachs%26aulast%3DKoizumi%26aufirst%3DM.%26aulast%3DSakoori%26aufirst%3DK.%26aulast%3DMidorikawa%26aufirst%3DN.%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26atitle%3DThe%2520NOP%2520%2528ORL1%2529%2520receptor%2520antagonist%2520Compound%2520B%2520stimulates%2520mesolimbic%2520dopamine%2520release%2520and%2520is%2520rewarding%2520in%2520mice%2520by%2520a%2520non-NOP-receptor-mediated%2520mechanism%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D53%26epage%3D62%26doi%3D10.1038%2Fsj.bjp.0705906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Benedetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinscheid, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romualdi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candeletti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9591</span><span class="NLM_x">–</span> <span class="NLM_lpage">9601</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2546-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1523%2FJNEUROSCI.2546-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=16237164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=9591-9601&author=M.+Martiauthor=F.+Melaauthor=M.+Fantinauthor=S.+Zucchiniauthor=J.+M.+Brownauthor=J.+Wittaauthor=M.+Di+Benedettoauthor=B.+Buzasauthor=R.+K.+Reinscheidauthor=S.+Salvadoriauthor=R.+Guerriniauthor=P.+Romualdiauthor=S.+Candelettiauthor=M.+Simonatoauthor=B.+M.+Coxauthor=M.+Morari&title=Blockade+of+nociceptin%2Forphanin+FQ+transmission+attenuates+symptoms+and+neurodegeneration+associated+with+Parkinson%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.2546-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease</span></div><div class="casAuthors">Marti, Matteo; Mela, Flora; Fantin, Martina; Zucchini, Silvia; Brown, Jeffrey M.; Witta, Jassir; Di Benedetto, Manuela; Buzas, Beata; Reinscheid, Rainer K.; Salvadori, Severo; Guerrini, Remo; Romualdi, Patrizia; Candeletti, Sanzio; Simonato, Michele; Cox, Brian M.; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">9591-9601</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The opioid-like neuropeptide nociceptin/orphanin FQ (N/OFQ) and its receptor (NOP) are expressed in the substantia nigra (SN), a brain area contg. dopamine neurons that degenerate in Parkinson's disease.  Endogenous N/OFQ facilitates nigral glutamate release and inhibits nigrostriatal dopamine transmission and motor behavior.  Here, we present evidence suggesting that endogenous N/OFQ may contribute to Parkinson's disease.  Pharmacol. blockade of the SN N/OFQ-NOP receptor system attenuated parkinsonian-like akinesia/hypokinesia in 6-hydroxydopamine hemi-lesioned or haloperidol-treated rats, whereas deletion of the NOP receptor gene conferred mice partial protection from haloperidol-induced motor depression.  The antiparkinsonian action of NOP receptor antagonists was assocd. with redn. of glutamate release in the SN.  In 6-hydroxydopamine hemilesioned rats, enhancement of N/OFQ expression and release was detected in the lesioned compared with the unlesioned SN, indicating that parkinsonism may be assocd. with over-activation of the N/OFQ-NOP receptor system in the SN.  Finally, deletion of the N/OFQ gene conferred mice partial protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced loss of SN dopamine neurons.  Based on these data, we propose that NOP receptor antagonists may represent a novel approach for combined (symptomatic and neuroprotective) therapy of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcXWmE9x6-rrVg90H21EOLACvtfcHk0likwydOzCp1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1WqsrjF&md5=893032d6983e5bc603cf446dd290b6b9</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2546-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2546-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMela%26aufirst%3DF.%26aulast%3DFantin%26aufirst%3DM.%26aulast%3DZucchini%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DWitta%26aufirst%3DJ.%26aulast%3DDi%2BBenedetto%26aufirst%3DM.%26aulast%3DBuzas%26aufirst%3DB.%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRomualdi%26aufirst%3DP.%26aulast%3DCandeletti%26aufirst%3DS.%26aulast%3DSimonato%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DB.%2BM.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DBlockade%2520of%2520nociceptin%252Forphanin%2520FQ%2520transmission%2520attenuates%2520symptoms%2520and%2520neurodegeneration%2520associated%2520with%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D9591%26epage%3D9601%26doi%3D10.1523%2FJNEUROSCI.2546-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veronesi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercuri, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">6659</span><span class="NLM_x">–</span> <span class="NLM_lpage">6666</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0987-04.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1523%2FJNEUROSCI.0987-04.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=15282268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=6659-6666&author=M.+Martiauthor=F.+Melaauthor=C.+Veronesiauthor=R.+Guerriniauthor=S.+Salvadoriauthor=M.+Federiciauthor=N.+B.+Mercuriauthor=A.+Rizziauthor=G.+Franchiauthor=L.+Beaniauthor=C.+Bianchiauthor=M.+Morari&title=Blockade+of+nociceptin%2Forphanin+FQ+receptor+signaling+in+rat+substantia+nigra+pars+reticulata+stimulates+nigrostriatal+dopaminergic+transmission+and+motor+behavior&doi=10.1523%2FJNEUROSCI.0987-04.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior</span></div><div class="casAuthors">Marti, Matteo; Mela, Flora; Veronesi, Carlo; Guerrini, Remo; Salvadori, Severo; Federici, Mauro; Mercuri, Nicola B.; Rizzi, Anna; Franchi, Gianfranco; Beani, Lorenzo; Bianchi, Clementina; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">6659-6666</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A multidisciplinary approach was followed to investigate whether the opioid-like peptide nociceptin/orphanin FQ (N/OFQ) regulates the nigrostriatal dopaminergic pathway and motor behavior.  Nigrostriatal dopaminergic cells, which express N/OFQ peptide (NOP) receptors, are located in the substantia nigra pars compacta and extend their dendrites in the substantia nigra pars reticulata, thereby modulating the basal ganglia output neurons.  In vitro electrophysiol. recordings demonstrated that N/OFQ hyperpolarized the dopaminergic cells of the substantia nigra pars compacta and inhibited their firing activity.  In vivo dual-probe microdialysis showed that N/OFQ perfused in the substantia nigra pars reticulata reduced dopamine release in the ipsilateral striatum, whereas UFP-101 ([Nphe1,Arg14,Lys15]N/OFQ(1-13)-NH2) (a selective NOP receptor peptide antagonist) stimulated it.  N/OFQ microinjected in the substantia nigra pars reticulata impaired rat performance on a rotarod app., whereas UFP-101 enhanced it.  Electromyog. revealed that N/OFQ and UFP-101 oppositely affected muscle tone, inducing relaxation and contraction of triceps, resp.  The selective NOP receptor nonpeptide antagonist J-113397 (1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H benzimidazol-2-one), either injected intranigrally or given systemically, also elevated striatal dopamine release and facilitated motor activity, confirming that these effects were caused by blockade of endogenous N/OFQ signaling.  The inhibitory role played by endogenous N/OFQ on motor activity was addnl. strengthened by the finding that mice lacking the NOP receptor gene outperformed wild-type mice on the rotarod.  The authors conclude that NOP receptors in the substantia nigra pars reticulata, activated by endogenous N/OFQ, drive a physiol. inhibitory control on motor behavior, possibly via modulation of the nigrostriatal dopaminergic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKEHVGKjAkn7Vg90H21EOLACvtfcHk0likwydOzCp1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCksLo%253D&md5=84f7e383d4b524170a75b3d581848903</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0987-04.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0987-04.2004%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMela%26aufirst%3DF.%26aulast%3DVeronesi%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DMercuri%26aufirst%3DN.%2BB.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DFranchi%26aufirst%3DG.%26aulast%3DBeani%26aufirst%3DL.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DBlockade%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520signaling%2520in%2520rat%2520substantia%2520nigra%2520pars%2520reticulata%2520stimulates%2520nigrostriatal%2520dopaminergic%2520transmission%2520and%2520motor%2520behavior%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D6659%26epage%3D6666%26doi%3D10.1523%2FJNEUROSCI.0987-04.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Volta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-y l]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4)</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1194</span><span class="NLM_x">–</span> <span class="NLM_lpage">1204</span><span class="refDoi"> DOI: 10.1016/j.peptides.2010.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.peptides.2010.03.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1194-1204&author=M.+Voltaauthor=M.+Martiauthor=J.+McDonaldauthor=S.+Molinariauthor=V.+Camardaauthor=M.+Pelaauthor=C.+Trapellaauthor=M.+Morari&title=Pharmacological+profile+and+antiparkinsonian+properties+of+the+novel+nociceptin%2Forphanin+FQ+receptor+antagonist+1-%5B1-cyclooctylmethyl-5-%281-hydroxy-1-methyl-ethyl%29-1%2C2%2C3%2C6-tetrahydro-pyridin-4-y+l%5D-3-ethyl-1%2C3-dihydro-benzoimidazol-2-one+%28GF-4%29&doi=10.1016%2Fj.peptides.2010.03.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2010.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2010.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DVolta%26aufirst%3DM.%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DPela%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DPharmacological%2520profile%2520and%2520antiparkinsonian%2520properties%2520of%2520the%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%25201-%255B1-cyclooctylmethyl-5-%25281-hydroxy-1-methyl-ethyl%2529-1%252C2%252C3%252C6-tetrahydro-pyridin-4-y%2520l%255D-3-ethyl-1%252C3-dihydro-benzoimidazol-2-one%2520%2528GF-4%2529%26jtitle%3DPeptides%26date%3D2010%26volume%3D31%26spage%3D1194%26epage%3D1204%26doi%3D10.1016%2Fj.peptides.2010.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Marti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morari, M.</span><span> </span><span class="NLM_article-title">The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">1683</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05735.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fj.1471-4159.2008.05735.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19014386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1SrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=1683-1696&author=M.+Martiauthor=C.+Trapellaauthor=M.+Morari&title=The+novel+nociceptin%2Forphanin+FQ+receptor+antagonist+Trap-101+alleviates+experimental+parkinsonism+through+inhibition+of+the+nigro-thalamic+pathway%3A+positive+interaction+with+L-DOPA&doi=10.1111%2Fj.1471-4159.2008.05735.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA</span></div><div class="casAuthors">Marti, Matteo; Trapella, Claudio; Morari, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1683-1696</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In this study we investigated whether the recently discovered antagonist of the nociceptin/orphanin FQ (N/OFQ) opioid peptide (NOP) receptor, 1-[1-(cyclooctylmethyl)-1,2,3,6-tetrahydro-5-(hydroxymethyl)-4-pyridinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (Trap-101) changed motor activity in naive rats and mice, and alleviated parkinsonism in 6-hydroxydopamine hemilesioned rats.  In naive rats, Trap-101 stimulated motor activity at 10 mg/kg and inhibited it at 30 mg/Kg.  Such dual action was also obsd. in wild-type but not NOP receptor knockout mice suggesting specific involvement of NOP receptors.  Trap-101 alleviated akinesia/bradykinesia and improved overall gait ability in hemiparkinsonian rats, being effective starting at 1 mg/Kg and without worsening motor deficit at 30 mg/Kg.  To investigate the circuitry involved in the Trap-101 action, behavioral tests were performed in rats undergoing microdialysis.  The anti-akinetic/anti-bradykinetic effects of Trap-101, given systemically (10 mg/Kg) or perfused in substantia nigra reticulata (10 μM), were assocd. with reduced glutamate and enhanced GABA release in substantia nigra, and reduced GABA release in ipsilateral ventro-medial thalamus.  When combined with ineffective doses of L-DOPA (0.1 mg/Kg), Trap-101 evoked larger neurochem. and behavioral responses.  These data show that Trap-101 is an effective NOP receptor antagonist in vivo and confirm that NOP receptor antagonists alleviate parkinsonism through blockade of nigral NOP receptors and impairment of nigro-thalamic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn1My6a_g6WLVg90H21EOLACvtfcHk0ljwTshdcd6mBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1SrtA%253D%253D&md5=5cc7eea58031e06842f19b8b7750dede</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05735.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05735.x%26sid%3Dliteratum%253Aachs%26aulast%3DMarti%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DMorari%26aufirst%3DM.%26atitle%3DThe%2520novel%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520Trap-101%2520alleviates%2520experimental%2520parkinsonism%2520through%2520inhibition%2520of%2520the%2520nigro-thalamic%2520pathway%253A%2520positive%2520interaction%2520with%2520L-DOPA%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D107%26spage%3D1683%26epage%3D1696%26doi%3D10.1111%2Fj.1471-4159.2008.05735.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Shinkai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, I.</span><span> </span><span class="NLM_article-title">4-Aminoquinolines: novel nociceptin antagonists with analgesic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4667</span><span class="NLM_x">–</span> <span class="NLM_lpage">4677</span><span class="refDoi"> DOI: 10.1021/jm0002073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0002073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4667-4677&author=H.+Shinkaiauthor=T.+Itoauthor=T.+Iidaauthor=Y.+Kitaoauthor=H.+Yamadaauthor=I.+Uchida&title=4-Aminoquinolines%3A+novel+nociceptin+antagonists+with+analgesic+activity&doi=10.1021%2Fjm0002073"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm0002073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002073%26sid%3Dliteratum%253Aachs%26aulast%3DShinkai%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DT.%26aulast%3DKitao%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DH.%26aulast%3DUchida%26aufirst%3DI.%26atitle%3D4-Aminoquinolines%253A%2520novel%2520nociceptin%2520antagonists%2520with%2520analgesic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4667%26epage%3D4677%26doi%3D10.1021%2Fjm0002073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Goto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai-Otsuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagara, T.</span><span> </span><span class="NLM_article-title">Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span><span class="refDoi"> DOI: 10.1021/jm0509851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0509851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=847-849&author=Y.+Gotoauthor=S.+Arai-Otsukiauthor=Y.+Tachibanaauthor=D.+Ichikawaauthor=S.+Ozakiauthor=H.+Takahashiauthor=Y.+Iwasawaauthor=O.+Okamotoauthor=S.+Okudaauthor=H.+Ohtaauthor=T.+Sagara&title=Identification+of+a+novel+spiropiperidine+opioid+receptor-like+1+antagonist+class+by+a+focused+library+approach+featuring+3D-pharmacophore+similarity&doi=10.1021%2Fjm0509851"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm0509851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509851%26sid%3Dliteratum%253Aachs%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DArai-Otsuki%26aufirst%3DS.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DIchikawa%26aufirst%3DD.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DIwasawa%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DOkuda%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DSagara%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520a%2520novel%2520spiropiperidine%2520opioid%2520receptor-like%25201%2520antagonist%2520class%2520by%2520a%2520focused%2520library%2520approach%2520featuring%25203D-pharmacophore%2520similarity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D847%26epage%3D849%26doi%3D10.1021%2Fjm0509851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Fischetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camarda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regoli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">614</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2009.04.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2009.04.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=19445927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVGisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=614&publication_year=2009&pages=50-57&author=C.+Fischettiauthor=V.+Camardaauthor=A.+Rizziauthor=M.+Pelaauthor=C.+Trapellaauthor=R.+Guerriniauthor=J.+McDonaldauthor=D.+G.+Lambertauthor=S.+Salvadoriauthor=D.+Regoliauthor=G.+Calo&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+receptor+non+peptide+antagonist+Compound+24&doi=10.1016%2Fj.ejphar.2009.04.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24</span></div><div class="casAuthors">Fischetti, Carmela; Camarda, Valeria; Rizzi, Anna; Pela, Michela; Trapella, Claudio; Guerrini, Remo; McDonald, John; Lambert, David G.; Salvadori, Severo; Regoli, Domenico; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">614</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">50-57</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compd. 24, 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide was recently identified as a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) ligand.  In this study, the in vitro and in vivo pharmacol. profiles of Compd. 24 were investigated.  In vitro studies were performed measuring receptor and [35S]GTPγS binding and calcium mobilization in cells expressing the recombinant NOP receptor as well as using N/OFQ sensitive tissues.  In vivo studies were conducted using the tail withdrawal assay in mice.  Compd. 24 produced a concn.-dependent displacement of [3H]N/OFQ binding to CHOhNOP cell membranes showing high affinity (pKi 9.62) and selectivity (1000 fold) over classical opioid receptors.  Compd. 24 antagonized with high potency the following in vitro effects of N/OFQ: stimulation of [35S]GTPγS binding in CHOhNOP cell membranes (pA2 9.98), calcium mobilization in CHOhNOP cells expressing the Gαqi5 chimeric protein (pKB 8.73), inhibition of elec. evoked twitches in the mouse (pA2 8.44) and rat (pKB 8.28) vas deferens, and in the guinea pig ileum (pKB 9.12).  In elec. stimulated tissues, Compd. 24 up to 1 μM did not modify the effects of classical opioid receptor agonists.  Finally in vivo, in the mouse tail withdrawal assay, Compd. 24 at 10 mg/kg antagonized the pronociceptive and antinociceptive effects of 1 nmol N/OFQ given supraspinally and spinally, resp.  Under the same exptl. conditions Compd. 24 did not affect the antinociceptive action of 3 nmol endomorphin-1 injected intrathecally.  The present study demonstrated that Compd. 24 is a pure, competitive, and highly potent non-peptide NOP receptor selective antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhw3JL9BZux7Vg90H21EOLACvtfcHk0liZNEe7KAzFjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVGisLY%253D&md5=8888668284839078d49db38556e0065c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.04.054%26sid%3Dliteratum%253Aachs%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DPela%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520non%2520peptide%2520antagonist%2520Compound%252024%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D614%26spage%3D50%26epage%3D57%26doi%3D10.1016%2Fj.ejphar.2009.04.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Thompson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">485</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1038/nature11085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1038%2Fnature11085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=22596163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=395-399&author=A.+A.+Thompsonauthor=W.+Liuauthor=E.+Chunauthor=V.+Katritchauthor=H.+Wuauthor=E.+Vardyauthor=X.+P.+Huangauthor=C.+Trapellaauthor=R.+Guerriniauthor=G.+Caloauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+nociceptin%2Forphanin+FQ+receptor+in+complex+with+a+peptide+mimetic&doi=10.1038%2Fnature11085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span></div><div class="casAuthors">Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia.  Unlike the classical' opioid receptors, δ, κ and μ (δ-OR, κ-OR and μ-OR), which were delineated by pharmacol. criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by mol. cloning and characterization of an orphan GPCR.  Although it shares high sequence similarity with classical opioid GPCR subtypes (∼60%), NOP has a markedly distinct pharmacol., featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands.  Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compd.-24 (C-24), revealing at. details of ligand-receptor recognition and selectivity.  Compd.-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close deriv. of N/OFQ, and provides important clues to the binding of these peptides.  The x-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors κ and μ, and these are probably due to a small no. of residues that vary between these receptors.  The NOP-compd.-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0_U24fZ4r7Vg90H21EOLACvtfcHk0liZNEe7KAzFjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D&md5=56819d10685f8a389710e9005d595d5b</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1038%2Fnature11085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11085%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520in%2520complex%2520with%2520a%2520peptide%2520mimetic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature11085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihyd ro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.1016/S0969-8051(02)00352-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0969-8051%2802%2900352-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=12493543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A280%3ADC%252BD38jjtFentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=51-59&author=M.+Ogawaauthor=K.+Hatanoauthor=Y.+Kawasumiauthor=K.+Ishiwataauthor=K.+Kawamuraauthor=S.+Ozakiauthor=K.+Ito&title=Synthesis+and+evaluation+of+1-%5B%283R%2C4R%29-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%5D-3-%5B11C%5Dethyl-1%2C3-dihyd+ro-2H-benzimidazol-2-one+as+a+brain+ORL1+receptor+imaging+agent+for+positron+emission+tomography&doi=10.1016%2FS0969-8051%2802%2900352-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography</span></div><div class="casAuthors">Ogawa Mikako; Hatano Kentaro; Kawasumi Yasuhiro; Ishiwata Kiichi; Kawamura Kazunori; Ozaki Satoshi; Ito Kengo</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-9</span>
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    </div><div class="casAbstract">1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[(11)C]ethyl-1,3-dihydro-2H-benzimidazol-2-one ([(11)C]CPEB) was synthesized by [(11)C]N-ethylation and evaluated as a potential brain ORL1 receptor imaging agent by positron emission tomography.  The uptake of [(11)C]CPEB in the mouse brain was 1.9% dose/g, 2 min post-injection, and gradually decreased with time.  Receptor-specific binding was observed, however, the contribution of other receptors was observed and the non-specific binding of [(11)C]CPEB was too high for imaging receptors in vivo.  Therefore, [(11)C]CPEB is not a suitable tracer for in vivo ORL1 receptor imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6Aa6vKzKALDDnmmyUf5qOfW6udTcc2eZXAKbMb25vFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jjtFentQ%253D%253D&md5=d8a206c1856b024091f426524047be0f</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2802%2900352-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252802%252900352-9%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DHatano%26aufirst%3DK.%26aulast%3DKawasumi%26aufirst%3DY.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201-%255B%25283R%252C4R%2529-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl%255D-3-%255B11C%255Dethyl-1%252C3-dihyd%2520ro-2H-benzimidazol-2-one%2520as%2520a%2520brain%2520ORL1%2520receptor%2520imaging%2520agent%2520for%2520positron%2520emission%2520tomography%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D51%26epage%3D59%26doi%3D10.1016%2FS0969-8051%2802%2900352-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span> </span><span class="NLM_article-title">Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">947</span><span class="refDoi"> DOI: 10.1016/S0969-8051(01)00260-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2FS0969-8051%2801%2900260-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=11711314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot1Olur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=941-947&author=M.+Ogawaauthor=K.+Hatanoauthor=Y.+Kawasumiauthor=J.+Wichmannauthor=K.+Ito&title=Synthesis+and+in+vivo+evaluation+of+%5B11C%5Dmethyl-Ro+64-6198+as+an+ORL1+receptor+imaging+agent&doi=10.1016%2FS0969-8051%2801%2900260-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent</span></div><div class="casAuthors">Ogawa, Mikako; Hatano, Kentaro; Kawasumi, Yasuhiro; Wichmann, Jurgen; Ito, Kengo</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">941-947</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-3-N-[11C]methyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one ([11C]methyl-Ro 64-6198), a N-methylated analog of Ro 64-6198, was synthesized and evaluated as a potential radiopharmaceutical for investigating brain nociceptin/orphanin FQ receptors (ORL1 receptors) by positron emission tomog.  A racemate of methyl-Ro 64-6198, Ro 66-7931, showed a high affinity and selectivity for the ORL1 receptor in vitro.  An in vivo distribution study in mice demonstrated moderate brain uptake, however, only slight difference was obsd. among brain regions.  Furthermore, pretreating with nociceptin or Ro 66-7931 did not affect the accumulation.  Therefore, despite its high affinity, [11C]methyl-Ro 64-6198 does not appear to be a suitable tracer for in vivo ORL1 receptor imaging studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfqCua3bEUp7Vg90H21EOLACvtfcHk0ljbBnTh7VJpYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot1Olur4%253D&md5=b3e2e97125f1064c370e2fc4b909d38d</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900260-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900260-8%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DHatano%26aufirst%3DK.%26aulast%3DKawasumi%26aufirst%3DY.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255Dmethyl-Ro%252064-6198%2520as%2520an%2520ORL1%2520receptor%2520imaging%2520agent%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D941%26epage%3D947%26doi%3D10.1016%2FS0969-8051%2801%2900260-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedregal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gackenheimer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2687</span><span class="NLM_x">–</span> <span class="NLM_lpage">2700</span><span class="refDoi"> DOI: 10.1021/jm101487v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101487v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2687-2700&author=V.+W.+Pikeauthor=K.+S.+Rashauthor=Z.+Chenauthor=C.+Pedregalauthor=M.+A.+Statnickauthor=Y.+Kimuraauthor=J.+Hongauthor=S.+S.+Zoghbiauthor=M.+Fujitaauthor=M.+A.+Toledoauthor=N.+Diazauthor=S.+L.+Gackenheimerauthor=J.+T.+Tauscherauthor=V.+N.+Barthauthor=R.+B.+Innis&title=Synthesis+and+evaluation+of+radioligands+for+imaging+brain+nociceptin%2Forphanin+FQ+peptide+%28NOP%29+receptors+with+positron+emission+tomography&doi=10.1021%2Fjm101487v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography</span></div><div class="casAuthors">Pike, Victor W.; Rash, Karen S.; Chen, Zhaogen; Pedregal, Concepcion; Statnick, Michael A.; Kimura, Yasuyuki; Hong, Jinsoo; Zoghbi, Sami S.; Fujita, Masahiro; Toledo, Miguel A.; Diaz, Nuria; Gackenheimer, Susan L.; Tauscher, Johannes T.; Barth, Vanessa N.; Innis, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2687-2700</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) coupled to an effective radioligand could provide an important tool for understanding possible links between neuropsychiatric disorders and brain NOP (nociceptin/orphanin FQ peptide) receptors.  We sought to develop such a PET radioligand.  High-affinity NOP ligands were synthesized based on a 3-(2'-fluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)-2(2-halobenzyl)-N-alkylpropanamide scaffold and from exptl. screens in rats, with ex vivo LC-MS/MS measures, three ligands were identified for labeling with carbon-11 and evaluation with PET in monkey.  Each ligand was labeled by 11C-methylation of an N-demethyl precursor and studied in monkey under baseline and NOP receptor-preblock conditions.  The three radioligands, [11C](S)-I (X = F, Cl, R = H; X = F, R = iPr) gave similar results.  Baseline scans showed high entry of radioactivity into the brain to give a distribution reflecting that expected for NOP receptors.  Preblock expts. showed high early peak levels of brain radioactivity, which rapidly declined to a much lower level than seen in baseline scans, thereby indicating a high level of receptor-specific binding in baseline expts.  Overall, [11C](S)-I (X = F, R = iPr) showed the most favorable receptor-specific signal and kinetics and is now selected for evaluation in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLbdZG2H-gRLVg90H21EOLACvtfcHk0lj9_UMqRWIK1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVSisLk%253D&md5=7519fa250770248d3c73c58e20eca3f1</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm101487v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101487v%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DToledo%26aufirst%3DM.%2BA.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DGackenheimer%26aufirst%3DS.%2BL.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520radioligands%2520for%2520imaging%2520brain%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520%2528NOP%2529%2520receptors%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2687%26epage%3D2700%26doi%3D10.1021%2Fjm101487v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Pedregal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafuente, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Grau, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudra, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rash, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Statnick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span> </span><span class="NLM_article-title">Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4955</span><span class="NLM_x">–</span> <span class="NLM_lpage">4967</span><span class="refDoi"> DOI: 10.1021/jm201629q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201629q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4955-4967&author=C.+Pedregalauthor=E.+M.+Joshiauthor=M.+A.+Toledoauthor=C.+Lafuenteauthor=N.+Diazauthor=M.+A.+Martinez-Grauauthor=A.+Jimenezauthor=A.+Benitoauthor=A.+Navarroauthor=Z.+Chenauthor=D.+R.+Mudraauthor=S.+D.+Kahlauthor=K.+S.+Rashauthor=M.+A.+Statnickauthor=V.+N.+Barth&title=Development+of+LC-MS%2FMS-based+receptor+occupancy+tracers+and+positron+emission+tomography+radioligands+for+the+nociceptin%2Forphanin+FQ+%28NOP%29+receptor&doi=10.1021%2Fjm201629q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Development of LC-MS/MS-Based Receptor Occupancy Tracers and Positron Emission Tomography Radioligands for the Nociceptin/Orphanin FQ (NOP) Receptor</span></div><div class="casAuthors">Pedregal, Concepcion; Joshi, Elizabeth M.; Toledo, Miguel A.; Lafuente, Celia; Diaz, Nuria; Martinez-Grau, Maria A.; Jimenez, Alma; Benito, Ana; Navarro, Antonio; Chen, Zhaogen; Mudra, Daniel R.; Kahl, Steven D.; Rash, Karen S.; Statnick, Michael A.; Barth, Vanessa N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4955-4967</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Currently, a lack of sufficient tools has limited the understanding of the relation between neuropsychiatric disorders and the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor.  Herein, we describe the discovery and development of an antagonist NOP receptor occupancy (RO) tracer and a novel positron emission tomog. (PET) radioligand suitable to probe the NOP receptor in human clin. studies.  A thorough structure-activity relation (SAR) around the high-affinity 3-(2'-fluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)-2-(2-halobenzyl)-N-alkylpropanamide scaffold identified a series of subnanomolar, highly selective NOP antagonists.  Subsequently, these unlabeled NOP ligands were evaluated in vivo by liq. chromatog.-tandem mass spectrometry (LC-MS/MS) in rat to det. brain uptake, kinetics and specific binding.  Three compds. were selected for evaluation in nonhuman primates as PET tracers.  Carbon-11 labeling yielded [11C]I, which exhibited minimal generation of central nervous system (CNS) penetrant radiometabolites, improved brain uptake, and was an excellent PET radioligand in both rat and monkey.  Currently [11C]I is being evaluated as a PET radiotracer for the NOP receptor in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9BUDm4qd1VrVg90H21EOLACvtfcHk0lj9_UMqRWIK1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqu7c%253D&md5=37ba5b3497d5300a487c179a668a9055</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm201629q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201629q%26sid%3Dliteratum%253Aachs%26aulast%3DPedregal%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DE.%2BM.%26aulast%3DToledo%26aufirst%3DM.%2BA.%26aulast%3DLafuente%26aufirst%3DC.%26aulast%3DDiaz%26aufirst%3DN.%26aulast%3DMartinez-Grau%26aufirst%3DM.%2BA.%26aulast%3DJimenez%26aufirst%3DA.%26aulast%3DBenito%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DRash%26aufirst%3DK.%2BS.%26aulast%3DStatnick%26aufirst%3DM.%2BA.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26atitle%3DDevelopment%2520of%2520LC-MS%252FMS-based%2520receptor%2520occupancy%2520tracers%2520and%2520positron%2520emission%2520tomography%2520radioligands%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520%2528NOP%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4955%26epage%3D4967%26doi%3D10.1021%2Fjm201629q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araneta, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebl, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span> </span><span class="NLM_article-title">Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2013.10.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.neuroimage.2013.10.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24225488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=89-95&author=T.+G.+Lohithauthor=S.+S.+Zoghbiauthor=C.+L.+Morseauthor=M.+D.+Aranetaauthor=V.+N.+Barthauthor=N.+A.+Goeblauthor=J.+T.+Tauscherauthor=V.+W.+Pikeauthor=R.+B.+Innisauthor=M.+Fujita&title=Retest+imaging+of+%5B11C%5DNOP-1A+binding+to+nociceptin%2Forphanin+FQ+peptide+%28NOP%29+receptors+in+the+brain+of+healthy+humans&doi=10.1016%2Fj.neuroimage.2013.10.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans</span></div><div class="casAuthors">Lohith, Talakad G.; Zoghbi, Sami S.; Morse, Cheryl L.; Araneta, Maria D. Ferraris; Barth, Vanessa N.; Goebl, Nancy A.; Tauscher, Johannes T.; Pike, Victor W.; Innis, Robert B.; Fujita, Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">[11C]NOP-1A is a novel high-affinity PET ligand for imaging nociceptin/orphanin FQ peptide (NOP) receptors.  Here, we report reproducibility and reliability measures of binding parameter ests. for [11C]NOP-1A binding in the brain of healthy humans.  After i.v. injection of [11C]NOP-1A, PET scans were conducted twice on eleven healthy volunteers on the same (10/11 subjects) or different (1/11 subjects) days.  Subjects underwent serial sampling of radial arterial blood to measure parent radioligand concns.  Distribution vol. (VT; a measure of receptor d.) was detd. by compartmental (one- and two-tissue) modeling in large regions and by simpler regression methods (graphical Logan and bilinear MA1) in both large regions and voxel data.  Retest variability and intraclass correlation coeff. (ICC) of VT were detd. as measures of reproducibility and reliability resp.  Regional [11C]NOP-1A uptake in the brain was high, with a peak radioactivity concn. of 4-7 SUV (standardized uptake value) and a rank order of putamen > cingulate cortex > cerebellum.  Brain time-activity curves fitted well in 10 of 11 subjects by unconstrained two-tissue compartmental model.  The retest variability of VT was moderately good across brain regions except cerebellum, and was similar across different modeling methods, averaging 12% for large regions and 14% for voxel-based methods.  The retest reliability of VT was also moderately good in most brain regions, except thalamus and cerebellum, and was similar across different modeling methods averaging 0.46 for large regions and 0.48 for voxels having gray matter probability > 20%.  The lowest retest variability and highest retest reliability of VT were achieved by compartmental modeling for large regions, and by the parametric Logan method for voxel-based methods.  Moderately good reproducibility and reliability measures of VT for [11C]NOP-1A make it a useful PET ligand for comparing NOP receptor binding between different subject groups or under different conditions in the same subject.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3eP0iGbS2IbVg90H21EOLACvtfcHk0liBTTLOQeU5oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyks7s%253D&md5=41e71bf10ab8b68cb8fcae116cd30582</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2013.10.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2013.10.068%26sid%3Dliteratum%253Aachs%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMorse%26aufirst%3DC.%2BL.%26aulast%3DAraneta%26aufirst%3DM.%2BD.%26aulast%3DBarth%26aufirst%3DV.%2BN.%26aulast%3DGoebl%26aufirst%3DN.%2BA.%26aulast%3DTauscher%26aufirst%3DJ.%2BT.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DFujita%26aufirst%3DM.%26atitle%3DRetest%2520imaging%2520of%2520%255B11C%255DNOP-1A%2520binding%2520to%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520%2528NOP%2529%2520receptors%2520in%2520the%2520brain%2520of%2520healthy%2520humans%26jtitle%3DNeuroImage%26date%3D2014%26volume%3D87%26spage%3D89%26epage%3D95%26doi%3D10.1016%2Fj.neuroimage.2013.10.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohórquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depré, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lepeleire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynders, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span> </span><span class="NLM_article-title">Evaluation of [18F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2012.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.neuroimage.2012.11.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=1-10&author=E.+D.+Hostetlerauthor=S.+Sanabria-Boh%C3%B3rquezauthor=W.+Engauthor=A.+D.+Joshiauthor=S.+Patelauthor=R.+E.+Gibsonauthor=S.+O%E2%80%99Malleyauthor=S.+M.+Krauseauthor=C.+Ryanauthor=K.+Riffelauthor=S.+Biauthor=O.+Okamotoauthor=H.+Kawamotoauthor=S.+Ozakiauthor=H.+Ohtaauthor=T.+de+Grootauthor=G.+Bormansauthor=M.+Depr%C3%A9author=J.+de+Hoonauthor=I.+De+Lepeleireauthor=T.+Reyndersauthor=J.+J.+Cookauthor=H.+D.+Burnsauthor=M.+Eganauthor=W.+Choauthor=K.+van+Laereauthor=R.+J.+Hargreaves&title=Evaluation+of+%5B18F%5DMK-0911%2C+a+positron+emission+tomography+%28PET%29+tracer+for+opioid+receptor-like+1+%28ORL1%29%2C+in+rhesus+monkey+and+human&doi=10.1016%2Fj.neuroimage.2012.11.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2012.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2012.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DSanabria-Boh%25C3%25B3rquez%26aufirst%3DS.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DKrause%26aufirst%3DS.%2BM.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DO.%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOzaki%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3Dde%2BGroot%26aufirst%3DT.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DDepr%25C3%25A9%26aufirst%3DM.%26aulast%3Dde%2BHoon%26aufirst%3DJ.%26aulast%3DDe%2BLepeleire%26aufirst%3DI.%26aulast%3DReynders%26aufirst%3DT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DBurns%26aufirst%3DH.%2BD.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DCho%26aufirst%3DW.%26aulast%3Dvan%2BLaere%26aufirst%3DK.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26atitle%3DEvaluation%2520of%2520%255B18F%255DMK-0911%252C%2520a%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520tracer%2520for%2520opioid%2520receptor-like%25201%2520%2528ORL1%2529%252C%2520in%2520rhesus%2520monkey%2520and%2520human%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D68%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.neuroimage.2012.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drozda, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of [3H]PF-7191, a highly specific nociceptin opioid peptide (NOP) receptor radiotracer for in vivo receptor occupancy (RO) studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">5219</span><span class="NLM_x">–</span> <span class="NLM_lpage">5223</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.bmcl.2014.09.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5219-5223&author=L.+Zhangauthor=E.+Drummondauthor=M.+A.+Brodneyauthor=J.+Cianfrognaauthor=S.+E.+Drozdaauthor=S.+Grimwoodauthor=M.+A.+Vanase-Frawleyauthor=A.+Villalobos&title=Design%2C+synthesis+and+evaluation+of+%5B3H%5DPF-7191%2C+a+highly+specific+nociceptin+opioid+peptide+%28NOP%29+receptor+radiotracer+for+in+vivo+receptor+occupancy+%28RO%29+studies&doi=10.1016%2Fj.bmcl.2014.09.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.069%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DDrummond%26aufirst%3DE.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520%255B3H%255DPF-7191%252C%2520a%2520highly%2520specific%2520nociceptin%2520opioid%2520peptide%2520%2528NOP%2529%2520receptor%2520radiotracer%2520for%2520in%2520vivo%2520receptor%2520occupancy%2520%2528RO%2529%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5219%26epage%3D5223%26doi%3D10.1016%2Fj.bmcl.2014.09.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Micheli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare Mannelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanardelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccocioppo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghelardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calò, G.</span><span> </span><span class="NLM_article-title">Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">754</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1016%2Fj.ejphar.2015.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=25704616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsVahs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=754&publication_year=2015&pages=73-81&author=L.+Micheliauthor=L.+Di+Cesare+Mannelliauthor=R.+Guerriniauthor=C.+Trapellaauthor=M.+Zanardelliauthor=R.+Ciccocioppoauthor=A.+Rizziauthor=C.+Ghelardiniauthor=G.+Cal%C3%B2&title=Acute+and+subchronic+antinociceptive+effects+of+nociceptin%2Forphanin+FQ+receptor+agonists+infused+by+intrathecal+route+in+rats&doi=10.1016%2Fj.ejphar.2015.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats</span></div><div class="casAuthors">Micheli, Laura; Di Cesare Mannelli, Lorenzo; Guerrini, Remo; Trapella, Claudio; Zanardelli, Matteo; Ciccocioppo, Roberto; Rizzi, Anna; Ghelardini, Carla; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">754</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-81</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Severe pain occurs in the context of many diseases and conditions and is a leading cause of disability.  Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand of the N/OFQ peptide (NOP) receptor.  This peptidergic system controls pain transmission and in particular spinally administered N/OFQ has robust antinociceptive properties.The aim of this study was to investigate the spinal antinociceptive properties of NOP peptide agonists after acute and subchronic treatment in rats.  Doses unable to alter motor coordination were selected.  UFP-112 (full NOP agonist) and UFP-113 (partial NOP agonist) were administered intrathecally (i.t.) by spinal catheterization.  Acute injection of UFP-112 induced antinociceptive response at lower dosages (0.03-1 nmol i.t.) compared to morphine and similar to N/OFQ.  UFP-113 was effective in a 0.001-1 nmol i.t. dose range.  The antinociceptive effects of NOP ligands were no longer evident in rats knockout for the NOP gene, while those of morphine were maintained.  The continuous spinal infusion (by osmotic pumps) of 0.1 nmol/h UFP-112 and UFP-113 showed antinociceptive action comparable to 1-3 nmol/h morphine or N/OFQ.  The antinociceptive effect of morphine progressively decreased and was no longer significant after 6 days of treatment.  Similar results were obtained with N/OFQ, UFP-112, and UFP-113.  The acute i.t. injection of morphine in animals tolerant to N/OFQ and UFP-112 evoked analgesic effects.  Neither morphine nor N/OFQ induced antinociceptive effects in morphine- and UFP-113-tolerant rats.  In conclusion this study highlights the analgesic efficacy and potency of UFP-112 and UFP-113 underlining the relevance of NOP system in analgesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmvrfiXAFrbVg90H21EOLACvtfcHk0ljMO08i4TWapw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsVahs7w%253D&md5=bf03685287fc82e25a0bbc5be96133c8</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DDi%2BCesare%2BMannelli%26aufirst%3DL.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DZanardelli%26aufirst%3DM.%26aulast%3DCiccocioppo%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DAcute%2520and%2520subchronic%2520antinociceptive%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520agonists%2520infused%2520by%2520intrathecal%2520route%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D754%26spage%3D73%26epage%3D81%26doi%3D10.1016%2Fj.ejphar.2015.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson-Durand, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standifer, K. M.</span><span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1111/bph.12701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=10.1111%2Fbph.12701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=24666365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFaqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=571-582&author=Y.+Zhangauthor=C.+D.+Simpson-Durandauthor=K.+M.+Standifer&title=Nociceptin%2Forphanin+FQ+peptide+receptor+antagonist+JTC-801+reverses+pain+and+anxiety+symptoms+in+a+rat+model+of+post-traumatic+stress+disorder&doi=10.1111%2Fbph.12701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder</span></div><div class="casAuthors">Zhang, Y.; Simpson-Durand, C. D.; Standifer, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-582</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Single-prolonged stress (SPS), a rat model of post-traumatic stress disorder (PTSD), also induces long-lasting hyperalgesia assocd. with hypocortisolism and elevated nociceptin/orphanin FQ (N/OFQ) levels in serum and CSF.  Here, we detd. the effect of JTC-801 (N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride), a nociceptin/orphanin FQ peptide (NOP) receptor antagonist, on symptoms of pain and anxiety in rats after SPS exposure, and examd. N/OFQ-NOP receptor system changes.  Exptl. Approach : Male Sprague Dawley rats received JTC-801 (6 mg kg-1 i.p., once daily) during days 7-21 of SPS.  The ability of JTC-801 to inhibit N/OFQ-stimulated [35S]-GTPγS binding was confirmed in rat brain membranes.  Anxiety-like behavior and pain sensitivity were monitored by changes in elevated plus maze performance and withdrawal responses to thermal and mech. stimuli.  Serum corticosterone and N/OFQ content in CSF, serum and brain tissues were detd. by RIA; NOP receptor protein and gene expression in amygdala, hippocampus and periaqueductal gray (PAG) were examd. by immunoblotting and real-time PCR resp.  Key Results : JTC-801 treatment reversed SPS-induced mech. allodynia, thermal hyperalgesia, anxiety-like behavior and hypocortisolism.  Elevated N/OFQ levels in serum, CSF, PAG and hippocampus at day 21 of SPS were blocked by JTC-801; daily JTC-801 treatment also reversed NOP receptor protein and mRNA up-regulation in amygdala and PAG.  Conclusion and Implications : JTC-801 reversed SPS-induced anxiety- and pain-like behaviors, and NOP receptor system up-regulation.  These findings suggest that N/OFQ plays an important role in hyperalgesia and allodynia maintenance after SPS.  NOP receptor antagonists may provide effective treatment for co-morbid PTSD and pain.  Linked Articles : This article is part of a themed section on Opioids: New Pathways to Functional Selectivity.  To view the other articles in this section visit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRucLJKwtOs7Vg90H21EOLACvtfcHk0lhSwpLYIYTgVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFaqt7vE&md5=4cb9b24c0543a7ab9ac65b049e27ac7d</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fbph.12701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12701%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSimpson-Durand%26aufirst%3DC.%2BD.%26aulast%3DStandifer%26aufirst%3DK.%2BM.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520antagonist%2520JTC-801%2520reverses%2520pain%2520and%2520anxiety%2520symptoms%2520in%2520a%2520rat%2520model%2520of%2520post-traumatic%2520stress%2520disorder%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D571%26epage%3D582%26doi%3D10.1111%2Fbph.12701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01499&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01499%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-15%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01499" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799443499693cb8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
